
<html lang="en"     class="pb-page"  data-request-id="b8c36a86-e5d7-4bb4-8c10-9fca00edc68f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b01136;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target" /></meta><meta name="dc.Creator" content="Sonya  VanPatten" /></meta><meta name="dc.Creator" content="Yousef  Al-Abed" /></meta><meta name="dc.Description" content="High mobility group box-1 (HMGb1) protein, a nuclear non-histone protein that is released or secreted from the cell in response to damage or stress, is a sentinel for the immune system that plays a..." /></meta><meta name="Description" content="High mobility group box-1 (HMGb1) protein, a nuclear non-histone protein that is released or secreted from the cell in response to damage or stress, is a sentinel for the immune system that plays a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 21, 2017" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01136" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01136" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01136" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01136" /></link>
        
    
    

<title>High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01136" /></meta><meta property="og:title" content="High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0002.jpeg" /></meta><meta property="og:description" content="High mobility group box-1 (HMGb1) protein, a nuclear non-histone protein that is released or secreted from the cell in response to damage or stress, is a sentinel for the immune system that plays a critical role in cell survival/death pathways. This review highlights key features of the endogenous danger-associated molecular pattern (DAMP) protein, HMGb1 in the innate inflammatory response along with various cofactors and receptors that regulate its downstream effects. The evidence demonstrating increased levels of HMGb1 in human inflammatory diseases and conditions is presented, along with a summary of current small molecule or peptide-like antagonists proven to specifically target HMGb1. Additionally, we delineate the measures needed toward validating this protein as a clinically relevant biomarker or bioindicator and as a relevant drug target." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01136"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01136">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01136&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01136&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01136&amp;href=/doi/10.1021/acs.jmedchem.7b01136" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5093-5107</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00901" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b01457" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Sonya VanPatten</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sonya VanPatten</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Molecular Innovation, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, New York 11030, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#334045525d43524747565d735d5c41475b44565f5f1d565746"><span class="__cf_email__" data-cfemail="ec9f9a8d829c8d98988982ac82839e98849b898080c2898899">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sonya++VanPatten">Sonya VanPatten</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9304-4579" title="Orcid link">http://orcid.org/0000-0001-9304-4579</a></div></div></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor">Yousef Al-Abed</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yousef Al-Abed</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Molecular Innovation, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, New York 11030, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yousef++Al-Abed">Yousef Al-Abed</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01136&amp;href=/doi/10.1021%2Facs.jmedchem.7b01136" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5093–5107</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 21, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 August 2017</li><li><span class="item_label"><b>Published</b> online</span>21 December 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01136" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01136</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01136"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">7164</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">38</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01136" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sonya&quot;,&quot;last_name&quot;:&quot;VanPatten&quot;},{&quot;first_name&quot;:&quot;Yousef&quot;,&quot;last_name&quot;:&quot;Al-Abed&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5093-5107&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01136&quot;},&quot;abstract&quot;:&quot;High mobility group box-1 (HMGb1) protein, a nuclear non-histone protein that is released or secreted from the cell in response to damage or stress, is a sentinel for the immune system that plays a critical role in cell survival/death pathways. This review highlights key features of the endogenous danger-associated molecular pattern (DAMP) protein, HMGb1 in the innate inflammatory response along with various cofactors and receptors that regulate its downstream effects. The evidence demonstrating increased levels of HMGb1 in human inflammatory diseases and conditions is presented, along with a summary of current small molecule or peptide-like antagonists proven to specifically target HMGb1. Additionally, we delineate the measures needed toward validating this protein as a clinically relevant biomarker or bioindicator and as a relevant drug target.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01136&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01136" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01136&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01136" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01136&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01136" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01136&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01136&amp;href=/doi/10.1021/acs.jmedchem.7b01136" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01136" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01136" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01136%26sid%3Dliteratum%253Aachs%26pmid%3D29268019%26genre%3Darticle%26aulast%3DVanPatten%26date%3D2018%26atitle%3DHigh%2BMobility%2BGroup%2BBox-1%2B%2528HMGb1%2529%253A%2BCurrent%2BWisdom%2Band%2BAdvancement%2Bas%2Ba%2BPotential%2BDrug%2BTarget%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D12%26spage%3D5093%26epage%3D5107%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292224" title="Serum">Serum</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/jmcmar.2018.61.issue-12/20180628/jmcmar.2018.61.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/medium/jm-2017-011362_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01136&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">High mobility group box-1 (HMGb1) protein, a nuclear non-histone protein that is released or secreted from the cell in response to damage or stress, is a sentinel for the immune system that plays a critical role in cell survival/death pathways. This review highlights key features of the endogenous danger-associated molecular pattern (DAMP) protein, HMGb1 in the innate inflammatory response along with various cofactors and receptors that regulate its downstream effects. The evidence demonstrating increased levels of HMGb1 in human inflammatory diseases and conditions is presented, along with a summary of current small molecule or peptide-like antagonists proven to specifically target HMGb1. Additionally, we delineate the measures needed toward validating this protein as a clinically relevant biomarker or bioindicator and as a relevant drug target.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">HMGb1 as an Immune System Signal (DAMP)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inflammation is a natural and necessary response to invading pathogens and trauma/tissue damage and is manifested by an organism’s immune system. Many aspects of the initiation of inflammation and its resolution have been revealed, yet these multifaceted reactions still hold many obscurities. Pathogen-associated molecular patterns (PAMPs), danger-associated molecular patterns (DAMPs),<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and homeostasis-altering molecular processes (HAMPs)<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> are signals the innate immune system uses to recognize these threats to the health of an organism. Upon detection of an inflammatory signal, whether it be DAMP/PAMP or HAMP related, or a proinflammatory mediator (cytokines/chemokines or a modified protein (oxidized or glycated) or lipid), the immune system generally responds with a proportional feed-forward amplification and expansion of the response through pattern recognition receptors (PRRs) and other innate immune receptors, cytokine receptors, and/or inflammasome pathways. To turn off the inflammatory process, the sensing and switching of a proinflammatory response into the resolution phase, as well as activation of anti-inflammatory pathways, have begun to be elucidated, though much remains to be explored.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> The current understanding of the dangers of excessive acute inflammation and unresolved chronic inflammation is well described in the literature in numerous diseases and conditions. HMGb1 was first described as playing an extracellular role in inflammation in 1999 when it was discovered as a late mediator of sepsis,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> although its initial characterization was as an intranuclear non-histone protein that could directly bind DNA. This multifunctional protein is now known for its roles in the nucleus (transcription factor, transcription enhancer, nucleosome sliding, DNA repair, V(D)J recombination, telomere homeostasis),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> cytoplasm (autophagy,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> viral sensing<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>), and extracellular milieu (DAMP secreted or released by cell damage).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> HMGb1’s nuclear function is nearly ubiquitous, and the protein in totality is necessary for life as complete knockout of the gene results in lethality due to hypoglycemia after birth.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Tissue specific conditional knockouts have been successfully generated however.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Various inflammatory signals may initiate export of nuclear HMGb1 to the cytoplasm and culminate in extracellular secretion. Nuclear export has been shown to be regulated by oxidation, ADP-ribosylation, phosphorylation, secondary messengers (reactive oxygen species (ROS), Ca<sup>2+</sup>, nitric oxide (NO)), as well as by both acetylation and methylation.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> The oxidative/reduced state of three critical cysteine residues (yellow highlight, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) has proven a major regulator of specific cellular death related pathways. The all-thiol form where all three cysteines are reduced is associated with autophagy and/or HMGb1’s extracellular chemokine-like chemotactic activity (via CXCL12/CXCR4 and receptor for advanced glycation endproducts (RAGE)), while the disulfide form, in which C23 and C45 form an intrachain bond, relates to its extracellular proinflammatory cytokine-inducting activity via the extracellular RAGE or Toll-like receptor 4 (TLR4). The fully oxidized form has thus far been associated with apoptosis.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The HMGb1 protein contains two similar yet distinct DNA-binding domains, termed A-box and B-box, each containing three α helices that fold into an L or V shaped structure (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, 3D model created using Cn3D version 4.3.1 and PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YRQ">2YRQ</a>). It also contains a negatively charged acidic tail that interacts with specific residues within and between the HMG boxes and thus regulates the 3D structure and DNA binding of the protein. These and additional biochemical and structural aspects of HMGb1 have been reviewed extensively elsewhere.<a onclick="showRef(event, 'ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref14">(12,14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/medium/jm-2017-011362_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Model and schematic view of HMGb1 structure with box regions and cysteine residues highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01136&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Initiation and Early Events in Inflammation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the initial insult of trauma or pathogen exposure, DAMPs, PAMPs, and HAMPs signal PRRs on platelets,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> neutrophils, macrophages/monocytes, and many other cell types.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Platelets have also been shown to actively export HMGb1 to the cell surface after activation,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> which leads to recruitment of other immune cells and amplification of the initial activation signal. Neutrophils are another early responder in inflammation (including sterile), and the generation of neutrophil extracellular traps (NETosis) initiates a series of events that have been reviewed extensively.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Other extracellular factors such as acute phase proteins (fetuin A, C-reactive protein (CRP), serum amyloid A (SAA)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>), pentraxin3 and complement factors,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> endogenous glucocorticoids,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and cytokines/chemokines serve to coordinate and further regulate the initial inflammatory signal. Pattern recognition receptors including TLRs and RAGE bind HMGb1 and other PAMPs and DAMPs including DNA, dsRNA, LPS, flagellin, peptidoglycan, S100 proteins, heat shock proteins (HSPs), uric acid, ROS, advanced glycation endproduct (AGE)-modified proteins, and cell-adhesion molecules and may also signal and influence the overall inflammatory response. HMGb1 alone has been shown to propagate the inflammatory response by inducing the synthesis of CRP, TNFα, IL-6, and MIP1α and -β in human monocytes.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Moreover, HMGb1 is also capable of modulating the adaptive (acquired) immune response.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Anti-Inflammatory Pathways and Inflammation Resolving Factors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24601" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24601" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In order to resolve an inflammatory response, damage and pathogens must be cleared and activated cells need to be removed or reprogrammed to an inert, resting state. The sequential induction of resolvin-type mediators<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> in the normal immune response helps to achieve this endpoint along with activation of anti-inflammatory signals and pathways.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> A few of the main anti-inflammatory pathways that serve to antagonize the proinflammatory response include induction of numerous inhibitory miRNAs, SOCS proteins,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> activation of the hypothalamic–pituitary axis (HPA) (i.e., by cytokines) leading to adrenal corticosteroid production and glucocorticoid receptor activation, resulting in inhibition of proinflammatory gene expression (reviewed in ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>), and stimulation of the cholinergic anti-inflammatory pathway (CAP).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Some of these anti-inflammatory responses are known to regulate HMGb1 levels directly (miRNAs,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> SOCS,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> CAP<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>). Many insights into the molecular pathways of the anti-inflammation/resolution phase have occurred over recent years, including the observation that adaptive immunity is achieved during the post-resolution phase. Nonresolving inflammation or “frustrated resolution” occurs when inflammatory signals are not cleared or switched off and the resolution phase does not progress, hindering the development of adaptive immunity.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Endogenous Modulation of HMGb1 Activity and Signaling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">HMGb1, which normally resides in the nucleus, can be translocated to the cytoplasm in response to various stimuli that regulate its post-translational modifications including acetylation,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> methylation,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> phosphorylation,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and redox modification (reviewed in ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a>). The upstream signals that result in these post-translational modifications (PTMs) may include infection or trauma (sterile injury) resulting in release of PAMPs/DAMPs, oxidative or osmotic stress, ATP excess or depletion (starvation), and/or ischemia/reperfusion (reviewed in ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a>). Additional levels of regulation may include pathways of degradation and cleavage,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> interaction with binding partners,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> or other receptors (CD24/Siglec,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> syndecans,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Mac-1,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> TLR2<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a>). Recently two other proteins have been demonstrated to interact with extracellular HMGb1 and may serve as a form of regulation in specific conditions. Thrombomodulin, a regulator of coagulation, can bind HMGb1 and thereby reduce its inflammatory activity by sequestering it from binding other receptors (reviewed in ref <a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a>). Additionally haptoglobin, an acute-phase protein that binds free hemoglobin to prevent oxidative damage, can also scavenge extracellular HMGb1thereby reducing inflammatory signals.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p last">The concept of intracellular molecular signaling hubs that integrate survival and death signals, leading to generation of the appropriate cellular response, has been proposed.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> These signals, combined with the subsequent amounts of HMGb1 passively released (necrosis) or secreted, have been shown to regulate whether necroptosis, pyroptosis, apoptosis, NETosis, or autophagy pathways are initiated in surrounding areas. One particular signal integration hub involves regulation of intracellular calcium levels.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The cell’s ability to buffer calcium levels, via modulation of ion channel opening and/or synthesis/release of Ca<sup>2+</sup> binding proteins, serves a critical role in signal propagation, cellular functions, and cell fate (survival vs death<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a>). Calcium signaling is crucially involved in a myriad of cellular processes including survival/repair, proliferation, differentiation, death pathways, normal metabolism, gene transcription, signaling pathways (protein phosphorylation), stimulus-induced protein secretion, neurotransmission, and motility. HMGb1 can itself be regulated by calcium signaling<a onclick="showRef(event, 'ref36 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref36 ref50 ref51">(36,50,51)</a> and also induce calcium-related signaling through different receptors and downstream pathways (TLRs,<a onclick="showRef(event, 'ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55">(52−55)</a> RAGE,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> CXCL12/CXCR4,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> transient receptor potential (TRP) channels<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a>). The precise involvement of calcium signaling pathways (interrogated via chelating agents, or specific calcium channel blockers) in different cell types and environments, and in response to different HMGb1 levels, still requires some elucidation but appears to be highly context dependent.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">HMGb1 and Extracellular HMGb1 Receptors as Drug Targets</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The relevance of HMGb1 as a significant drug target and potential biomarker has been demonstrated by measuring its increase extracellularly in plasma/serum and tissue in human diseases and pathological conditions. These include neurodegenerative disease, arthritis, autoimmune diseases, lung injury and disease, cancer, cardiac and vessel disease, diabetes (type 1 and type 2), trauma/ischemia–reperfusion injury, infection, kidney and liver-related disease, pancreatitis, and pregnancy complications (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Human HMGb1 Associated Diseases and Conditions (Not Comprehensive)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">disease/condition</th><th class="colsep0 rowsep0" align="center">receptors/signaling pathways implicated</th><th class="colsep0 rowsep0" align="center">serum/tissue levels (disease vs control, ng/mL)</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Alzheimer’s</td><td class="colsep0 rowsep0" align="left">*sRAGE interference in measurement?</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">*<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">brain, ↑1.5-fold vs control</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tau and amyloid-β colocalization with HMGb1 (separately)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALS</td><td class="colsep0 rowsep0" align="left">TLR2 and -4 and RAGE</td><td class="colsep0 rowsep0" align="left">spinal cord, ↑mRNA and protein staining in slow-progressing ALS samples vs controls</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">↑ protein expression (2- to 3-fold) vs control</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">arthritis</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">osteo (OA)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">synovium-mRNA and protein ↑approximately 2-fold vs control</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">synovial fluid</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">cartilage, 100× ↑mRNA by qPCR vs control</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">juvenile idiopathic (JIA)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (3.4 vs 0.8), <i>p</i> = 0.0014</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rheumatoid (RA)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">synovial fluid (54) in RA vs (12) in OA, <i>p</i> < 0.01</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">asthma</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (6.30 vs 3.71)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cancer</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma and tissue expression (protein) correlated with worse overall and progression-free survival, meta analysis and systemic review</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cardiac disease</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">coronary artery disease (CAD)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">atherosclerosis</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (5.45 vs 2.33), <i>p</i> < 0.01</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">diabetes</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">type 1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma, higher levels in T1D when normalized for confounding factors, plasma levels associated with all cause mortality</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (0.2 vs 0.13 nmol/L), <i>p</i> < 0.01</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">type 2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (8.27 vs 4.57), <i>p</i> < 0.001, obese + type 2 vs type 2 (9.11 vs 7.4), <i>p</i> < 0.001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (15.31 vs 4.82), <i>p</i> < 0.001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung related diseases</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">COPD</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">sputum (15.15 vs 0.41)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pulmonary hypertension</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (severe PAH-CHD 19.12*, mild to mod PAH 8.54*, CHD 5.35**, vs 3.76), <i>p</i> < 0.001*, <i>p</i> < 0.05**</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pneumonia</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">pediatric serum (severe pneumonia 22.5 vs uncomplicated influenza 8.61)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (community acquired 184.0 vs 11.2), <i>p</i> = 0.0001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (peak ALI/ARDS 13.7 vs onset 2.9 vs controls, nondetectable)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ICU patients (various conditions)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (6.3 vs 2.8)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart failure</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (7.57 vs 2.66)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">acute coronary</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (31.39 (NYHA class IV), 28.72 (groups total) vs 25.71)) (ng/mL = μg/L)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ischemia</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (159 vs 1.94), <i>p</i> < 0.001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">infection</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (17.4 (H1N1, groupA) vs 5.5)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inflammatory bowel disease</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">fecal (significantly increased in UC and CD patients vs healthy controls and correlated with endoscopic inflammation index)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ulcerative colitis (UC)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Crohn’s disease (CD)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (CD 26, UC 27 vs 7), <i>p</i> < 0.01</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ischemia/reperfusion injury (transplant or trauma)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">liver transplant (caval effluent 188 vs portal vein 3), <i>p</i> < 0.001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney failure</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum, pediatric dialysis patients, effect of peritonitis (baseline dialysis patients 9.5 vs preperitonitis 32.1 vs T.1 (during) 64 vs T-end of peritonitis 36,), <i>p</i> < 0.0001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (AKI 5.8 vs CKD 3.2 vs hemodialysis 2.5 vs controls 1.7), <i>p</i> < 0.001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">kidney transplant, staining (increased in deceased donor kidneys vs living kidney donors)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (CKD grade 5, 146.7 vs CKD grade 3/4, 85.6 vs control, 10.9), <i>p</i> < 0.001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver failure</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">pediatric serum, HMGb1 found as central inflammatory mediator (node) in all patient subgroups of acute ALF</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum, ALF (3.0 vs 0.3), <i>p</i> < 0.0001</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ALF SIRS score <2 vs >2 (3.8 vs 11), <i>p</i> = 0.0083</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum, acute liver failure vs acute self-limiting viral hepatitis E vs controls (225.3 vs 112.6 vs 12.04), <i>p</i> < 0.0001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mild cognitive impairment (pre-Alzheimer’s)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (approx 5.5 vs 3), <i>p</i> < 0.01</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">multiple sclerosis</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">brain macrophages, ↑4-fold protein staining vs controls (μg/mm<sup>2</sup>), <i>p</i> < 0.0001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CSF mononuclear cell mRNA ↑∼2-fold vs controls, <i>p</i> < 0.0001</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">obesity/metabolic syndrome</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (19.4 vs 3.7), <i>p</i> < 0.0001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HMGb1 correlated with BMI</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pancreatitis</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (5.4 vs 1.7)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(6.02 vs 1.87)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pregnancy complications (preeclampsia)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum? (12.05 vs 9.47)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sepsis</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (nonsurvivors 83.7 vs survivors 25.2 vs controls, nondetectable), <i>p</i> < 0.05</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum levels associated with no. of organ failures (SOFA scores)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (DIC 14.05 vs control, not detectable)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">increased in sepsis nonsurvivors compared with survivors</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">controversy, levels in sepsis vs septic shock, review</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SLE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (30.14 vs 5.09), <i>p</i> < 0.05</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum, renal involvement vs nonrenal SLE (42.6 vs 15.7), <i>p</i> < 0.05</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (27 vs 0), <i>p</i> < 0.001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (5.84 vs 4.45), <i>p</i> = 0.037</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma, active SLEDAI vs inactive SLE vs controls (6.44 vs 4.42 vs 4.45), <i>p</i> = 0.039, 0.049, 0.006, respectively</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (108 vs 13), <i>p</i> < 0.0001</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spinal cord injury</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (0–3 days postinjury, 6 vs 4–7days post, 6.26 vs controls, 1.26), <i>p</i> < 0.01</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stroke</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serum (218 vs 16.8), <i>p</i> < 0.001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">trauma (blunt chest)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma, increased over 1–7 days (day 1, 43.8 to day 7, 74.4) postinjury, no normal controls measured</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma (10.4 vs 1.4), <i>p</i> < 0.0001; 1yr mortality (9.0 (survivors) vs 14.6 (nonsurvivors)), <i>p</i> < 0.001</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">traumatic brain injury</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">pediatric CSF (5.73 vs 1.78) at 0–24 h, <i>p</i> < 0.05</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">ALS, amyotrophic lateral sclerosis; PAH, pulmonary arterial hypertension; CD, Crohn’s disease; UC, ulcerative colitis; CHD, coronary heart disease; AKI, acute kidney injury; CKD, chronic kidney disease; ALF, acute liver failure; ALF-SIRS, ALF-systemic inflammatory response syndrome; SLE, systemic lupus erythematosus; SLEDAI-SLE, disease activity index; CSF, cerebrospinal fluid; SOFA, sequential organ failure assessment; DIC, disseminated intravascular coagulation.</p></div></div></div><div class="NLM_p">HMGb1-directed therapies, focusing on those that directly bind and neutralize extracellular HMGb1 (including antibodies), have been tested in preclinical models of the above-listed, as well as other diseases and conditions. The myriad of potential benefits of HMGb1-specific drugs and therapies is well supported in the scientific literature.<a onclick="showRef(event, 'ref59 ref60 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61 ref62 ref63">(59−63)</a> We provide a summary of directly binding, peptide-based and small-molecule, HMGb1-targeted therapeutics in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Some of these are approved drugs that were found to have off-target effects by directly binding HMGb1, while others have only been tested preclinically. The structures of these directly binding HMGb1 inhibitors are illustrated in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. Going forward, HMGb1-directed therapies with minimal off-targets should be used to reinforce the value of HMGb1 as a specific and effective drug target. An additional point, HMGb1 family member, HMGb2, is highly similar in structure/sequence, and its expression and contribution to inflammation and disease is beginning to be reported.<a onclick="showRef(event, 'ref64 ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66 ref67">(64−67)</a> Equivalent PTMs and receptor binding for HMGb2 can be assumed from sequence similarity (<a href="http://www.uniprot.org/uniprot/p26583" class="extLink">http://www.uniprot.org/uniprot/p26583</a>). The specificity of HMGb1-directed small molecules and peptides for HMGb2 is scant<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and could possibly be exploited for selective targeting as more is learned.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/medium/jm-2017-011362_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of direct HMGb1 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01136&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Directly-Binding HMGb1 and HMGb1-Receptor Small-Molecule and Peptide-Based Antagonists</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">inhibitor</th><th class="colsep0 rowsep0" align="center">target/targeted region (measured affinity)</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glycyrrhizin</td><td class="colsep0 rowsep0" align="left">HMGb1 (A and B box) (<i>K</i><sub>d</sub>, with A box = 103 ± 25 μM, with B box = 87 ± 35 μM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">methotrexate</td><td class="colsep0 rowsep0" align="left">HMGb1, Al and Bj regions (<i>K</i><sub>d</sub>, A1 = 0.5 ± 0.3 μM, Bj = 0.024 ± 0.01 μM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">metformin</td><td class="colsep0 rowsep0" align="left">HMGb1</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inflachromene (<b>1d</b>)</td><td class="colsep0 rowsep0" align="left">HMGb1 and HMGb2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compounds <b>2j</b> and <b>2l</b></td><td class="colsep0 rowsep0" align="left">HMGb1</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(inflachromene derivatives)</td><td class="colsep0 rowsep0" align="left">(order of potency: <b>2j</b> > <b>2l</b> > <b>1d</b>)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGCG (green tea)</td><td class="colsep0 rowsep0" align="left">HMGb1, Cys106 region</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">salicylic acid (SA) and analogues</td><td class="colsep0 rowsep0" align="left">HMGb1, A box and B box, all thiol and disulfide forms (SA <i>K</i><sub>d</sub> ∼ 1–10 μM, 3AESA <i>K</i><sub>d</sub> = 1.48 nM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heparin (glycolipid)</td><td class="colsep0 rowsep0" align="left">HMGb1, amino acid residues 6–12 (<i>K</i><sub>D</sub> = 4.5 nM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref70 ref152'); return false;" href="javascript:void(0);" class="ref ref70 ref152">(70,152)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">eritoran (glycolipid)</td><td class="colsep0 rowsep0" align="left">TLR4 via MD2, *no effect in phase III clinical study of severe sepsis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FP7 (glycolipid)</td><td class="colsep0 rowsep0" align="left">TLR4 via MD-2/CD-14</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TAK-242</td><td class="colsep0 rowsep0" align="left">TLR4/TIR domain, phase III study suspended</td><td class="colsep0 rowsep0" align="left">reviewed in ref <a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TAPs (peptide-based)</td><td class="colsep0 rowsep0" align="left">TLR4/MD-2 (TAP2/MD2-TLR4, <i>K</i><sub>D</sub> = 5.95 μM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MNP</td><td class="colsep0 rowsep0" align="left">TLR4 dimerization</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M2000</td><td class="colsep0 rowsep0" align="left">TLR2/4</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P5779 (peptidomimetic)</td><td class="colsep0 rowsep0" align="left">(TLR4) via MD-2-Tyr102 (with MD2 <i>K</i><sub>d</sub> = 0.65 μM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ZINC library compounds</td><td class="colsep0 rowsep0" align="left">TLR4/MD-2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159,160)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(virtual screen > in vitro confirmation)</td><td class="colsep0 rowsep0" align="left">(zinc compounds T5342126, 25778142, 49563556, 3415865)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">azeliragon (Pf04494700)</td><td class="colsep0 rowsep0" align="left">RAGE-amyloid β interaction, *low dose still in phase III trials, reported (internal report) to block RAGE-HMGb1 interaction<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></td><td class="colsep0 rowsep0" align="left">reviewed in ref <a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FPS-ZM1</td><td class="colsep0 rowsep0" align="left">RAGE/V-domain (blocked RAGE-amyloid β binding akin to HMGB1 antagonist)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A box (peptide)</td><td class="colsep0 rowsep0" align="left">RAGE, TLR?</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref39 ref164 ref165'); return false;" href="javascript:void(0);" class="ref ref39 ref164 ref165">(39,164,165)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R2F8</td><td class="colsep0 rowsep0" align="left">RAGE-HMGb1 interaction (fibronectin type iii scaffold based inhibitor, nonspecific)</td><td class="colsep0 rowsep0" align="left">mentioned in ref <a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S100-based peptides</td><td class="colsep0 rowsep0" align="left">RAGE-HMGb1 interaction</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a></td></tr></tbody></table></div></div><div class="NLM_p">The first directly binding HMGb1 antagonist to be described in the literature was the glycoconjugated triterpene glycyrrhizin, a compound that occurs naturally in the licorice plant. It was found using NMR chemical shift data to bind to both the A and B boxes with <i>K</i><sub>d</sub>’s of 103 ± 25 μM and 87± 35 μM, respectively. This binding was also found to be independent and noncooperative and involved residues F17, Q20, R23, E25, K43, and C44 on the A box and residues R109, I112, D123, and A125 on the B box. Glycyrrhizin inhibited the HMGb1-induced chemotactic and mitogenic activity in the 3T3 fibroblast cell line with an IC<sub>50</sub> of approximately 50 μM. Additional studies showed only a mild effect of the compound on DNA/HMGb1 binding. The binding region on HMGb1 is described as occurring at the crux of the L-fold which has an exposed hydrophobic surface amenable to van der Waals interactions with glycyrrhizin. The structurally related compound carbenoxolone (glucuronic acid substituted with succinyl moiety) was found to bind A box in a manner similar to glycyrrhizin, but data for B box were less clear and showed evidence of aggregation at higher concentrations.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_p">Heparin, an endogenous sulfated glycosoaminoglycan anticoagulant (3–30 kDa) that has been adapted for clinical use (approximate MW of 1.5 kDa), was shown to inhibit HMGb1-induced TNF and IL-6 secretion using an in vitro assay with RAW264.7 macrophages and HUVEC cells in 2011. A direct heparin-HMGb1 interaction was demonstrated with surface plasmon resonance (SPR) experiments, circular dichromism (CD) spectroscopy, and binding studies monitoring tryptophan and tyrosine florescence. SPR gave an estimated <i>K</i><sub>D</sub> of 4.5 nM. HMGb1 amino acid residues 6–12, which contain a consensus sequence similar to other heparin-binding proteins, were responsible for heparin binding, and heparin successfully competed with RAGE binding to HMGb1.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The heparin binding ability of HMGb1 (previously termed p30/amphoterin) was first realized back in 1987<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> before any of its extracellular proinflammatory roles were realized, when it was fractionated out with a heparin-Sepharose column in a screening for neurite outgrowth promoting factors.</div><div class="NLM_p">In 2013, the autoimmune disease and cancer drug methotrexate (Mtx), a biguanidine-folic acid-like derivative known for inhibition of dihydrofolate reductase, deoxycytidine kinase, and nuclear factor κ-light-chain-enhancer of activated B cells (NFκB), was shown to also interact with and inhibit HMGb1. Binding between HMGb1 and Mtx was observed using SPR analysis and electromobility shift assays (EMSA), while docking studies provided further evidence for a direct interaction. Two distinct noncooperative binding sites in the Al(1–87aa) and Bj(88–181aa) box regions were measured with <i>K</i><sub>d</sub>’s of 0.5 ± 0.3 μM and 0.24 ± 0.01 μM, respectively. Functionally, Mtx inhibited HMGb1-induced TNFα secretion and mitogenic activity, and this was likely through interaction with the RAGE receptor as Mtx did not inhibit LPS-induced TNFα release (TLR4 dependent). Furthermore, Mtx was not found to inhibit HMGb1 binding to DNA.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div><div class="NLM_p">The inflachromene series of HMGb1 antagonists was first reported in 2014. These pentacyclic triazolidine-dione-based class of compounds were found in a cell-based phenotypic screening for neuroinflammatory inhibitors in an LPS-induced microglial cell stimulation assay. Inflachromene (ICM-1d) suppressed LPS-induced nitrite release as well as cytokine production in microglial cell lines, primary microglia, and macrophage cell lines. To identify the cellular targets, a photo-cross-linking analogue of ICM was created using structure–activity relationship (SAR) studies and used to pull out HMGb2 (among others). Additional studies using an ICM-linked column proved HMGb2 could be successfully competed out with nonbound ICM, demonstrating its specificity. On the basis of structure-sequence homology, HMGb1 was speculated to also bind ICM. This was shown functionally by using siRNA knockdown of either or both HMGb1 and -2 to prove that ICM lost inhibitory ability on LPS-induced nitrite release after HMGb1/2 knockdown. It was also discovered that ICM directly inhibited post-translational modifications on HMGb1 and -2 responsible for cytosolic and extracellular translocation. Compared to glycyrrhizin, ICM had 600× more potency on microglia and docking studies predicted binding at the DNA binding domain in box A adjacent to a nuclear localization sequence (NLS) where PTMs occur.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> In 2016, this group expanded their SAR studies and identified two additional ICM analogues (<b>2j</b> and <b>2l</b>) with improved solubility and microsomal stability, tighter functional binding and lower energies (modeling). In the cecal ligation and puncture (CLP)-sepsis model the new ICMs (<b>2j</b>, <b>2l</b>) showed 74% and 56% survival rates compared with 45% for the original ICM (<b>1d</b>) compared with control values (vehicle) of 10%.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">Salicylic acid (SA) (the endogenously deacetylated product of aspirin (acetylsalicylic acid)) and both synthetic (3-aminoethyl (AE)-SA) and natural (amorfrutin-B1) analogues of SA were discovered to bind HMGb1 in 2014. This added to the already known anti-inflammatory actions of aspirin through COX1/2 inhibition. The interaction was found using an SA-cross-linked column affinity pulldown/competition analysis and was also measured using NMR and SPR. Although <i>K</i><sub>d</sub>’s for SA were estimated in the low mM range, the SA analogues 3-AESA and amorfrutin B1 had <i>K</i><sub>d</sub>’s in the nM range. These authors found that SA and the select analogues had the same separate binding sites in both the A and B boxes of HMGb1. Additionally, SA and analogues could inhibit the chemoattractant activity of fully reduced HMGb1 (via CXCL12/CXCR4), as well as the cytokine-inducing effect of disulfide HMGb1 (via MD2/TLR4). This biological inhibition was deemed relevant based on estimated plasma SA concentrations after standard dose aspirin administration, while the analogues (3-AESA, amorfrutin B1) were observed to be orders of magnitude more potent.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div><div class="NLM_p">The popular green tea component epigallocatechin 3-gallate (EGCG) had previously been shown to inhibit the LPS-induced release of HMGb1 from macrophage/monocytes, to reduce plasma HMGb1 levels in a model of sepsis,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> and to stimulate autophagy after induction of aggregation of the protein,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> yet the mechanisms remained to be fully elucidated. The reducing agent DTT could disrupt this interaction, providing evidence that cysteine residue sulfide bonds were involved in the binding to EGCG. A computational modeling study in 2016 elaborated on the EGCG interaction using molecular dynamic simulations and potential mean force calculations to project details of the HMGb1-induced aggregation. Modeling with EGCG predicted induction of a large conformational change in the protein which caused burying of certain hydrophobic residues (including Cys106) involved with the catechin ring of EGCG and surface exposure of more charged hydrophilic residues to solution. The molecular polarity of the HMGb1 with EGCG was estimated to be twice that of protein alone; thus favorable electrostatic interactions were implicated in the observed aggregation.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> As EGCG has other known targets and is already broadly commercially available as a dietary supplement, its development and use as a clinically relevant HMGb1 inhibitor is unlikely.</div><div class="NLM_p">Another clinically approved biguanidine-containing drug, metformin, used already in metabolic disease (prediabetes) and type 2 diabetes, was discovered to bind HMGb1 in 2017. The exact cellular mechanisms by which it lowers hepatic blood glucose production and restores insulin sensitivity are not fully elucidated, but effects on the mitochondrial complex 1/gapdh/AMPK pathway and NfκB have been reported. HMGb1 was discovered as an additional metformin target while searching for binding proteins using a biotinylated metformin, avidin-linked column pull-down assay. This interaction was shown to occur through the acidic C-terminal tail region as HMGb1 constructs lacking the tail region (HMGb1-ΔAT) could still stimulate downstream HMGb1-induced readouts including p38 phosphorylation and TNFα production; however administration of metformin with HMGb1-ΔAT no longer had any inhibitory effects on those readouts. These authors also established that metformin did not influence the redox state of HMGb1 and demonstrated that binding was noncovalent in nature using mass spectrometry.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">Two of the most prevalent and well-studied HMGb1 extracellular receptors are TLR-4 and RAGE. These receptors likely work in conjunction and also in accordance with other factors (MD-2,<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> CD-14,<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> LPS<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a>) to propagate downstream inflammatory signals and effects.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> HMGb1 has also been shown to interact with CXCL-12 and mediate chemotactic responses through the CXCR4 receptor. Thus far, numerous studies have confirmed the importance of HMGb1 receptor antagonists in diverse disease models. A more general review of small-molecule TLR4 and RAGE antagonists is described in refs <a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> and <a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a>. Furthermore, antibody-based antagonists against TLRs, and also RAGE, show efficacy in models including neurodegeneration (AD<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a>), liver injury, kidney injury, ischemia/reperfusion injury (trauma), multiple sclerosis (EAE), acute lung injury, xenograft/transplant rejection, systemic inflammation/sepsis,<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> asthma, myocardial infarction, and atherosclerosis to highlight a few. From a small-molecule/peptide perspective, a summary of several more recently described TLR4-specific antagonists is listed in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and structures are presented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. Past reviews describe other TLR4-specific antagonists from previous years.<a onclick="showRef(event, 'ref87 ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref87 ref88 ref89">(87−89)</a> RAGE antagonists are less abundant than those directed at the TLRs, yet also offer potential in the anti-inflammation field and are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> with structures in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. Other isoforms (splice variants) of RAGE, i.e., soluble RAGE (sRAGE) and RAGEΔICD,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> have been shown to function as a competitive inhibitors of RAGE-ligand binding to signaling-competent RAGE by acting as decoys for HMGb1 binding. Thus, regulation of RAGE splicing can provide another level of control by the organism to influence extracellular HMGb1 levels. As both TLR and RAGE receptors bind other ligands, their inhibition may have much broader effects, the advantage or disadvantage of which, in each specific disease, remains to be determined.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/medium/jm-2017-011362_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of indirect HMGb1 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01136&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The ability of HMGb1 to bind CXCL12 and activate CXCR4 chemotactic and migratory responses serves as a potential target for specific antagonist development.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Future research is needed to design antagonists that specifically block HMGb1-CXCL12 binding; however general CXCR4 antagonists (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) are a growing domain in cancer, autoimmune, HIV, and neuroinflammation research.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Achievements and Remaining Challenges to Realizing HMGb1 as a Biomarker/Bioindicator and Drug Target</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The search for biological targets that are upregulated in disease conditions and can be used as biomarkers/indicators of disease activity or exploited for design of small molecule or protein-based antagonists is best exemplified by the development of the tumor necrosis factor (TNF) α antagonists. While generally effective for some patients in many inflammatory diseases, long-term use may lead to an increased risk of infections and/or malignancy.<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93,94)</a> Moreover, in certain inflammatory conditions, antagonism of TNFα (an early phase proinflammatory factor) proves ineffective as it is believed that later stage mediators (including HMGb1) may play a more critical role in the perpetuation of inflammation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">HMGb1 seems primed to become the next viable candidate for an FDA-approved inflammatory biomarker/bioindicator and drug target. Current research in animal models strongly supports its critical role in inflammatory diseases and conditions, and there are several known drugs and preclinical compounds that bind and antagonize HMGb1 directly that can be used to interrogate its relevance (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.).</div><div class="NLM_p">In addition, correlations of disease and disease activity with HMGb1 levels in humans have been advancing (summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), although further clinical studies with larger patient populations are needed. As a first step in this direction, a reliable and standardized assay for both tissue and serum/plasma is necessary. Many studies looking at HMGb1 levels used antibody-based systems (ELISA or immunohistochemistry) employing antibodies with various or unknown specificities. Some antibodies may not give true indications of HMGb1 levels if they target regions of interaction with binding proteins such as sRAGE, etc.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Although several ELISA-based kits are available commercially for preclinical studies, a mass spectrometry based assay would theoretically provide a more consistent measure of biological levels and also be able to distinguish PTMs when desired.<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96,97)</a> The effective development of a standardized, validated clinical assay for HMGb1 is a critical first step on the path toward effective HMGb1 antagonists and therapeutics. We highlight the necessary objectives toward advancement of HMGb1 as a clinical biomarker/indicator and drug target in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Steps toward HMGb1 as a Clinical Biomarker/Bioindicator and Advancement as a Drug Target</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">timeline of end points</th><th class="colsep0 rowsep0" align="center">supporting refs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(1) Standardize assay for serum/plasma and tissue levels with consideration for PTM form, interfering factors<sup>#</sup>, and time of sampling after initial trauma or disease flare (mass spec*, Ab-based?)</td><td class="colsep0 rowsep0" align="left"><sup>#</sup><a onclick="showRef(event, 'ref95 ref167'); return false;" href="javascript:void(0);" class="ref ref95 ref167">(95,167)</a>, *<a onclick="showRef(event, 'ref168 ref169 ref170 ref171'); return false;" href="javascript:void(0);" class="ref ref168 ref169 ref170 ref171">(168−171)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(2) FDA approval of a standardized kit (ELISA) or clinical testing method (MS)</td><td class="colsep0 rowsep0" align="left">Assay with most potential,<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> review of MS methods<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(3) Measurement in different diseases/conditions through clinical trials using validated assay</td><td class="colsep0 rowsep0" align="left">Review of FDA-approved clinical protein assays<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(4) Correlation and conclusions (reporting through publications) from medium to large scale clinical trial analyses</td><td class="colsep0 rowsep0" align="left">Analyses of publication rates after NIH clinical trials<a onclick="showRef(event, 'ref175 ref176'); return false;" href="javascript:void(0);" class="ref ref175 ref176">(175,176)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(5) Pending positive study outcomes, education of appropriate clinical professionals about HMGb1 as a biomarker/indicator, and further development as a drug target in validated diseases/conditions</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_p">At the time of this writing, the NIH Web site, <a href="https://clinicaltrials.gov/" class="extLink">https://clinicaltrials.gov/</a>, listed 37 studies with the query “hmgb1”. Of these, 10 studies are related to measurement of plasma HMGb1 (as either a primary or secondary outcome measure, no intervention), 26 involve some form of intervention (with plasma HMGb1 levels as either a primary or secondary outcome measurement), and 1 study was withdrawn before it was initiated. The interventions include drugs (14 studies), dietary supplements (2 studies), biologic or cell-based therapies (2 studies), exercise (1 study with results posted), rehabilitation (1 study), psychocognitive therapies (1 study), medical devices (4 studies), and 2 studies are related to amphotericin B and mistakenly use the term amphoterin B (an early term for HMGb1) and thus are not relevant, leaving the final tally at 35 HMGb1-related studies. Additional stratification reveals that of these 35 studies, 1 was withdrawn, 1 was terminated, 5 are not yet recruiting, 13 are recruiting, 8 are completed (only 1 posted results), and 7 have an unknown status. It is clear this field is still in its infancy. Furthermore, as the interventions are mainly targeted at other inflammation or cancer-related proteins and pathways, the secondary effects observed on HMGb1 levels do not prove direct correlations with disease activity. Future studies with directly binding HMGb1 inhibitors (with minimal off-targets) will be needed for validation of this specific target in each disease condition.</div><div class="NLM_p last">In conclusion, HMGb1 is poised to become a relevant drug target in inflammatory-related diseases and conditions including, but not limited to, cancer, sepsis, atherosclerosis, diabetes, chronic pain, and autoimmune, neurodegenerative, and heart disease. Refinement of quantitation techniques for HMGb1 from biological samples resulting in a standardized measurement assay, and careful design, execution, and reporting of future clinical trials will ensure the successful advancement of therapeutics that target the extracellular escape and accumulation of this multifunctional protein. Design and testing of antagonists with greater HMGb1 specificity are essential, and additional development of antagonists that target regions of HMGb1’s interaction with binding partners is also an area for development.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01136" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonya VanPatten</span> - <span class="hlFld-Affiliation affiliation">Center for Molecular Innovation, The Feinstein
Institute for Medical Research, 350 Community Drive, Manhasset, New York 11030, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9304-4579" title="Orcid link">http://orcid.org/0000-0001-9304-4579</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9cefeafdf2ecfde8e8f9f2dcf2f3eee8f4ebf9f0f0b2f9f8e9"><span class="__cf_email__" data-cfemail="91e2e7f0ffe1f0e5e5f4ffd1fffee3e5f9e6f4fdfdbff4f5e4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yousef Al-Abed</span> - <span class="hlFld-Affiliation affiliation">Center for Molecular Innovation, The Feinstein
Institute for Medical Research, 350 Community Drive, Manhasset, New York 11030, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Dr. Al-Abed is on patents related to HMGb1 antagonists.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Sonya VanPatten</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01136&amp;id=BIO-d49e1570-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sonya VanPatten</b>, Ph.D., is a research scientist at the Feinstein Institute for Medical Research in Manhasset, NY. She did her thesis work at the Albert Einstein College of Medicine in the Department of Biochemistry and her postdoctoral studies in the laboratory of Dr. Yousef Al-Abed. Her previous research has involved the fields of lipid metabolism, metabolic disease, and type 2 diabetes, as well as drug discovery and development related to inflammation and immunity.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Yousef Al-Abed</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01136&amp;id=BIO-d49e1575-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yousef Al-Abed</b>, Ph.D., obtained his doctorate in Organic Chemistry from Tübingen University in Germany where he focused on the synthesis of sugar-related molecules. He is currently a Professor and Head of the Center for Molecular Innovation at the Feinstein Institute for Medical Research, in Manhasset, New York. The Center leads the discovery and development of novel therapeutics for human diseases, particularly diseases with autoimmune and inflammatory components such as lupus, arthritis, diabetes, cancer, Alzheimer’s, and sepsis.</p></figure></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">HMGb1</td><td class="NLM_def"><p class="first last">high mobility group box 1</p></td></tr><tr><td class="NLM_term">DAMP</td><td class="NLM_def"><p class="first last">danger-associated molecular pattern</p></td></tr><tr><td class="NLM_term">PAMP</td><td class="NLM_def"><p class="first last">pathogen-associated molecular pattern</p></td></tr><tr><td class="NLM_term">HAMP</td><td class="NLM_def"><p class="first last">homeostasis-associated molecular pattern</p></td></tr><tr><td class="NLM_term">PRR</td><td class="NLM_def"><p class="first last">pattern recognition receptor</p></td></tr><tr><td class="NLM_term">V(D)J</td><td class="NLM_def"><p class="first last">variable (diversity) joining</p></td></tr><tr><td class="NLM_term">CXCL-12</td><td class="NLM_def"><p class="first last">C-X-C motif ligand 12</p></td></tr><tr><td class="NLM_term">CXCR4</td><td class="NLM_def"><p class="first last">C-X-C motif receptor 4</p></td></tr><tr><td class="NLM_term">RAGE</td><td class="NLM_def"><p class="first last">receptor for advanced glycation endproducts</p></td></tr><tr><td class="NLM_term">dsRNA</td><td class="NLM_def"><p class="first last">double-stranded RNA</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">neutrophil extracellular trap</p></td></tr><tr><td class="NLM_term">SAA</td><td class="NLM_def"><p class="first last">serum amyloid A</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin 6</p></td></tr><tr><td class="NLM_term">MIP</td><td class="NLM_def"><p class="first last">macrophage inflammatory protein</p></td></tr><tr><td class="NLM_term">miRNA</td><td class="NLM_def"><p class="first last">microRNA</p></td></tr><tr><td class="NLM_term">SOCS</td><td class="NLM_def"><p class="first last">suppressor of cytokine signaling</p></td></tr><tr><td class="NLM_term">HPA</td><td class="NLM_def"><p class="first last">hypothalamic–pituitary axis</p></td></tr><tr><td class="NLM_term">CAP</td><td class="NLM_def"><p class="first last">cholinergic anti-inflammatory pathway</p></td></tr><tr><td class="NLM_term">PTM</td><td class="NLM_def"><p class="first last">post-translational modification</p></td></tr><tr><td class="NLM_term">CD-24</td><td class="NLM_def"><p class="first last">cluster of designation 24</p></td></tr><tr><td class="NLM_term">Mac-1</td><td class="NLM_def"><p class="first last">macrophage-1 antigen</p></td></tr><tr><td class="NLM_term">TRP</td><td class="NLM_def"><p class="first last">transient receptor potential</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">Mtx</td><td class="NLM_def"><p class="first last">methotrexate</p></td></tr><tr><td class="NLM_term">EMSA</td><td class="NLM_def"><p class="first last">electromobility-shift assay</p></td></tr><tr><td class="NLM_term">ICM</td><td class="NLM_def"><p class="first last">inflachromene</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">short-interfering RNA</p></td></tr><tr><td class="NLM_term">NLS</td><td class="NLM_def"><p class="first last">nuclear-localization sequence</p></td></tr><tr><td class="NLM_term">CLP</td><td class="NLM_def"><p class="first last">cecal-ligation and puncture</p></td></tr><tr><td class="NLM_term">SA</td><td class="NLM_def"><p class="first last">salicylic acid</p></td></tr><tr><td class="NLM_term">3-AE-SA</td><td class="NLM_def"><p class="first last">3-aminoethylsalicylic acid</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>d</sub></td><td class="NLM_def"><p class="first last">dissociation constant</p></td></tr><tr><td class="NLM_term">MD-2</td><td class="NLM_def"><p class="first last">myeloid differentiation factor 2</p></td></tr><tr><td class="NLM_term">EGCG</td><td class="NLM_def"><p class="first last">epigallocatechin 3-gallate</p></td></tr><tr><td class="NLM_term">gapdh</td><td class="NLM_def"><p class="first last">glyceraldehyde 3-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">AMPK</td><td class="NLM_def"><p class="first last">AMP-activated protein kinase</p></td></tr><tr><td class="NLM_term">CD-14</td><td class="NLM_def"><p class="first last">cluster of designation 14</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">experimental autoimmune encephalomyelitis</p></td></tr><tr><td class="NLM_term">sRAGE</td><td class="NLM_def"><p class="first last">soluble receptor for advanced glycation endproducts</p></td></tr><tr><td class="NLM_term">OA</td><td class="NLM_def"><p class="first last">osteoarthritis</p></td></tr><tr><td class="NLM_term">JIA</td><td class="NLM_def"><p class="first last">juvenile idiopathic arthritis</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">CAD</td><td class="NLM_def"><p class="first last">coronary artery disease</p></td></tr><tr><td class="NLM_term">PAH</td><td class="NLM_def"><p class="first last">pulmonary arterial hypertension</p></td></tr><tr><td class="NLM_term">CHD</td><td class="NLM_def"><p class="first last">coronary heart disease</p></td></tr><tr><td class="NLM_term">ALI</td><td class="NLM_def"><p class="first last">acute lung injury</p></td></tr><tr><td class="NLM_term">ICU</td><td class="NLM_def"><p class="first last">intensive care unit</p></td></tr><tr><td class="NLM_term">UC</td><td class="NLM_def"><p class="first last">ulcerative colitis</p></td></tr><tr><td class="NLM_term">CD</td><td class="NLM_def"><p class="first last">Crohn’s disease</p></td></tr><tr><td class="NLM_term">AKI</td><td class="NLM_def"><p class="first last">acute kidney injury</p></td></tr><tr><td class="NLM_term">CKD</td><td class="NLM_def"><p class="first last">chronic kidney disease</p></td></tr><tr><td class="NLM_term">ALF</td><td class="NLM_def"><p class="first last">acute liver failure</p></td></tr><tr><td class="NLM_term">SIRS</td><td class="NLM_def"><p class="first last">systemic inflammatory response syndrome</p></td></tr><tr><td class="NLM_term">SLE</td><td class="NLM_def"><p class="first last">systemic lupus erythematosus</p></td></tr><tr><td class="NLM_term">SLEDAI</td><td class="NLM_def"><p class="first last">SLE disease activity index</p></td></tr><tr><td class="NLM_term">SOFA</td><td class="NLM_def"><p class="first last">sequential organ failure assessment</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last">disseminated intravascular coagulation</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 176 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sirisinha, S.</span></span> <span> </span><span class="NLM_article-title">Insight into the mechanisms regulating immune homeostasis in health and disease</span>. <i>Asian Pac J. Allergy Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21560483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtV2jsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1-14&issue=1&author=S.+Sirisinha&title=Insight+into+the+mechanisms+regulating+immune+homeostasis+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into the mechanisms regulating immune homeostasis in health andI disease</span></div><div class="casAuthors">Sirisinha, Stitaya</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific Journal of Allergy and Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">APJIEA</span>;
        ISSN:<span class="NLM_cas:issn">0125-877X</span>.
    
            (<span class="NLM_cas:orgname">Allergy and Immunology Society of Thailand</span>)
        </div><div class="casAbstract">A review.  Innate and adaptive immune systems consist of cells and mols. that work together in concert to fight against microbial infection and maintain homeostasis.  Hosts encounter microbes / exogenous pathogen-assocd. mol. patterns (PAMPs) and endogenous damage-assocd. mol. patterns (DAMPs) all the time and they must have proper mechanisms to counteract the danger such that appropriate responses (e.g., degree of inflammation and types of mediators induced) can be mounted in different scenarios.  Increasing nos. of endogenous danger signals of host origin are being identified including, for example, uric acid and cholesterol crystals, high mobility group box1 (HMGB1) protein, oxidized LDL, vesicans, heat shock proteins (HSPs) and self DNA.  Many of these endogenous ligands have been shown to be assocd. with inflammation-related diseases like atherosclerosis, gout and type 2 diabetes.  Several DAMPs appear to have the ability to interact with more than one receptor.  We are now beginning to understand how the immune system can distinguish infection from endogenous ligands elaborated following cellular insults and tissue damage.  Appropriate responses to maintain the homeostatic state in health and disease depend largely on the recognition and response to these stimuli by germline encoded pattern-recognition receptors (PRRs) present on both immune and non-immune cells.  These receptors are, for example, Toll-like receptors (TLRs), C-type lectin receptors (CLRs) and cytosolic receptors (e.g., RLRs, NLRs and some intracellular DNA sensors).  Atypical PRR "danger" receptors, like the receptor for advanced glycation end products (RAGE) and their ligands have been identified.  A proper response to maintain homeostasis relies on specific neg. regulators and regulatory pathways to dampen its response to tissue injury while maintaining the capacity to eliminate infection and induce proper tissue repair.  Moreover, some PRRs (e.g., TLR2, TLR4 and NLRP3) and atypical PRRs can recognize both PAMPs and DAMPs, either as single entities or after forming complexes (e.g., immune complexes, or DNA- HMGB1 and DNA-LL37 complexes), so there must be a mechanism to selectively depress or alleviate the inflammatory response to DAMPs, while leaving that of PAMPs intact.  Excessive inflammatory responses can induce considerable tissue damage and can be highly detrimental to the host.  For example, CD24 reacting with HMGB1 and HSPs has been implicated to function as neg. regulator for RAGE.  In this review, I will briefly overview the information on various host and microbial components and bring together the information to synthesize a model to explain how homeostasis can be maintained in states of health and disease.  Understanding the mol. mechanisms by which the immune system functions under different scenarios will provide us with ways and means to design appropriate approaches, for example, to prevent or treat autoimmune and inflammatory diseases or the ability to design new drugs or formulate safe chems. for vaccine adjuvants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaXyMzzqHci7Vg90H21EOLACvtfcHk0lhgscXF-EFf0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtV2jsro%253D&md5=311396283644fcfccf58e2c1771b228e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSirisinha%26aufirst%3DS.%26atitle%3DInsight%2520into%2520the%2520mechanisms%2520regulating%2520immune%2520homeostasis%2520in%2520health%2520and%2520disease%26jtitle%3DAsian%2520Pac%2520J.%2520Allergy%2520Immunol.%26date%3D2011%26volume%3D29%26issue%3D1%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liston, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, S. L.</span></span> <span> </span><span class="NLM_article-title">Homeostasis-altering molecular processes as mechanisms of inflammasome activation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1038/nri.2016.151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnri.2016.151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28163301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFemtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=208-214&issue=3&author=A.+Listonauthor=S.+L.+Masters&title=Homeostasis-altering+molecular+processes+as+mechanisms+of+inflammasome+activation&doi=10.1038%2Fnri.2016.151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Homeostasis-altering molecular processes as mechanisms of inflammasome activation</span></div><div class="casAuthors">Liston, Adrian; Masters, Seth L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">208-214</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The innate immune system uses a distinct set of germline-encoded pattern recognition receptors (PRRs) to initiate downstream inflammatory cascades.  This recognition system is in stark contrast to the adaptive immune system, which relies on highly variable, randomly generated antigen receptors.  A key limitation of the innate immune system's reliance on fixed PRRs is its inflexibility in responding to rapidly evolving pathogens.  Recent advances in our understanding of inflammasome activation suggest that the innate immune system also has sophisticated mechanisms for responding to pathogens for which there is no fixed PRR.  This includes the recognition of debris from dying cells, known as danger-assocd. mol. patterns (DAMPs), which can directly activate PRRs in a similar manner to pathogen-assocd. mol. patterns (PAMPs).  Distinct from this, emerging data for the inflammasome components NLRP3 (NOD-, LRR- and pyrin domain-contg. 3) and pyrin suggest that they do not directly detect mol. patterns, but instead act as signal integrators that are capable of detecting perturbations in cytoplasmic homeostasis, for example, as initiated by infection.  Monitoring these perturbations, which we term 'homeostasis-altering mol. processes' (HAMPs), provides potent flexibility in the capacity of the innate immune system to detect evolutionarily novel infections; however, HAMP sensing may also underlie the sterile inflammation that drives chronic inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoclEc3NgrY3bVg90H21EOLACvtfcHk0lhgscXF-EFf0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFemtLk%253D&md5=1b00f5ee553f358597155205c815ea59</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnri.2016.151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri.2016.151%26sid%3Dliteratum%253Aachs%26aulast%3DListon%26aufirst%3DA.%26aulast%3DMasters%26aufirst%3DS.%2BL.%26atitle%3DHomeostasis-altering%2520molecular%2520processes%2520as%2520mechanisms%2520of%2520inflammasome%2520activation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2017%26volume%3D17%26issue%3D3%26spage%3D208%26epage%3D214%26doi%3D10.1038%2Fnri.2016.151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span> <span> </span><span class="NLM_article-title">Treating inflammation and infection in the 21st century: New hints from decoding resolution mediators and mechanisms</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1273</span>– <span class="NLM_lpage">1288</span>, <span class="refDoi"> DOI: 10.1096/fj.201601222R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1096%2Ffj.201601222R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28087575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFGltb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=1273-1288&issue=4&author=C.+N.+Serhan&title=Treating+inflammation+and+infection+in+the+21st+century%3A+New+hints+from+decoding+resolution+mediators+and+mechanisms&doi=10.1096%2Ffj.201601222R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms</span></div><div class="casAuthors">Serhan, Charles N.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1273-1288</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Practitioners of ancient societies from the time of Hippocrates and earlier recognized and treated the signs of inflammation, heat, redness, swelling, and pain with agents that block or inhibit proinflammatory chem. mediators.  More selective drugs are available today, but this therapeutic concept has not changed.  Because the acute inflammatory response is host protective to contain foreign invaders, much of today's pharmacopeia can cause serious unwanted side effects, such as immune suppression.  Uncontrolled inflammation is now considered pathophysiol. and is assocd. with many widely occurring diseases such as cardiovascular disease, neurodegenerative diseases, diabetes, obesity, and asthma, as well as classic inflammatory diseases (e.g., arthritis and periodontal diseases).  The inflammatory response, when self-limited, produces a superfamily of chem. mediators that stimulate resoln. of the response.  Specialized proresolving mediators (SPMs), identified in recent years, are endogenous mediators that include the n-3-derived families resolvins, protectins, and maresins, as well as arachidonic acid-derived (n-6) lipoxins, which promote resoln. of inflammation, clearance of microbes, redn. of pain, and promotion of tissue regeneration via novel mechanisms.  Aspirin and statins have a pos. impact on these resoln. pathways, producing epimeric forms of specific SPMs, whereas other drugs can disrupt timely resoln.  In this article, evidence from recent human and preclin. animal studies is reviewed, indicating that SPMs are physiol. mediators and pharmacol. agonists that stimulate resoln. of inflammation and infection.  The findings suggest that it is time to challenge current treatment practices-namely, using inhibitors and antagonists alone-and to develop immunoresolvents as agonists to test resoln. pharmacol. and their role in catabasis for their therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVtSH45rvck7Vg90H21EOLACvtfcHk0lhO9K06Dhak2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFGltb%252FE&md5=531a652e27d643fe3d5d05debe7bd8cc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1096%2Ffj.201601222R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201601222R%26sid%3Dliteratum%253Aachs%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26atitle%3DTreating%2520inflammation%2520and%2520infection%2520in%2520the%252021st%2520century%253A%2520New%2520hints%2520from%2520decoding%2520resolution%2520mediators%2520and%2520mechanisms%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26issue%3D4%26spage%3D1273%26epage%3D1288%26doi%3D10.1096%2Ffj.201601222R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilroy, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockinger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, P. P.</span></span> <span> </span><span class="NLM_article-title">The resolution of inflammation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1038/nri3362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnri3362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23197111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=59-66&issue=1&author=C.+D.+Buckleyauthor=D.+W.+Gilroyauthor=C.+N.+Serhanauthor=B.+Stockingerauthor=P.+P.+Tak&title=The+resolution+of+inflammation&doi=10.1038%2Fnri3362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The resolution of inflammation</span></div><div class="casAuthors">Buckley, Christopher D.; Gilroy, Derek W.; Serhan, Charles N.; Stockinger, Brigitta; Tak, Paul P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-66</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In 2011, Nature Reviews Immunol. organized a conference that brought together scientists and clinicians from both academia and industry to discuss one of the most pressing questions in medicine - how do we turn off rampant, undesirable inflammation.  There is a growing appreciation that, similarly to the initiation of inflammation, the resoln. of inflammation is an intricate and active process.  Can we therefore harness the mediators involved in resoln. responses to treat patients with chronic inflammatory or autoimmune diseases.  Here, we ask five of the speakers from the conference to share their thoughts on this emerging field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq28c1f6NZat7Vg90H21EOLACvtfcHk0lhO9K06Dhak2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FL&md5=e91a54b735f7cf193c76853398294fb1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnri3362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3362%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DC.%2BD.%26aulast%3DGilroy%26aufirst%3DD.%2BW.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26aulast%3DStockinger%26aufirst%3DB.%26aulast%3DTak%26aufirst%3DP.%2BP.%26atitle%3DThe%2520resolution%2520of%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D13%26issue%3D1%26spage%3D59%26epage%3D66%26doi%3D10.1038%2Fnri3362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishnubhakat, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ombrellino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frazier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borovikova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manogue, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faist, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abumrad, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">Hmg-1 as a late mediator of endotoxin lethality in mice</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">5425</span>),  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">251</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=248-251&issue=5425&author=H.+Wangauthor=O.+Bloomauthor=M.+Zhangauthor=J.+M.+Vishnubhakatauthor=M.+Ombrellinoauthor=J.+Cheauthor=A.+Frazierauthor=H.+Yangauthor=S.+Ivanovaauthor=L.+Borovikovaauthor=K.+R.+Manogueauthor=E.+Faistauthor=E.+Abrahamauthor=J.+Anderssonauthor=U.+Anderssonauthor=P.+E.+Molinaauthor=N.+N.+Abumradauthor=A.+Samaauthor=K.+J.+Tracey&title=Hmg-1+as+a+late+mediator+of+endotoxin+lethality+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBloom%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DVishnubhakat%26aufirst%3DJ.%2BM.%26aulast%3DOmbrellino%26aufirst%3DM.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DFrazier%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DIvanova%26aufirst%3DS.%26aulast%3DBorovikova%26aufirst%3DL.%26aulast%3DManogue%26aufirst%3DK.%2BR.%26aulast%3DFaist%26aufirst%3DE.%26aulast%3DAbraham%26aufirst%3DE.%26aulast%3DAndersson%26aufirst%3DJ.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DMolina%26aufirst%3DP.%2BE.%26aulast%3DAbumrad%26aufirst%3DN.%2BN.%26aulast%3DSama%26aufirst%3DA.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DHmg-1%2520as%2520a%2520late%2520mediator%2520of%2520endotoxin%2520lethality%2520in%2520mice%26jtitle%3DScience%26date%3D1999%26volume%3D285%26issue%3D5425%26spage%3D248%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. O.</span></span> <span> </span><span class="NLM_article-title">HMG1 and 2: Architectural DNA-binding proteins</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1042/bst0290395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1042%2Fbst0290395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=11497996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms1SlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=395-401&issue=4&author=J.+O.+Thomas&title=HMG1+and+2%3A+Architectural+DNA-binding+proteins&doi=10.1042%2Fbst0290395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">HMG1 and 2: architectural DNA-binding proteins</span></div><div class="casAuthors">Thomas, J. O.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-401</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review, with refs.  HMG1 and 2 (high mobility group proteins 1 and 2; renamed HMGB1 and HMGB2) contain two DNA-binding HMG-box domains (A and B) and a long acidic C-terminal domain.  They bind DNA without sequence specificity, but have a high affinity for bent or distorted DNA, and bend linear DNA.  The individual A and B boxes (which, although broadly similar, show both structural and functional differences) exhibit many of the structure-specific properties of the whole protein.  The acidic tail modulates the affinity of the tandem HMG boxes in HMG1 and 2 for a variety of DNA targets, including four-way junctions, but not distorted DNA minicircles, to which the proteins bind with very high affinity.  HMG1 and 2 appear to play important architectural roles in the assembly of nucleoprotein complexes in a variety of biol. processes, for example V(D)J recombination, the initiation of transcription, and DNA repair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrscXD4yJOzQrVg90H21EOLACvtfcHk0lhN3AjO8V35xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms1SlsL4%253D&md5=9daa670566257852530f9299d56e6a45</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2Fbst0290395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0290395%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BO.%26atitle%3DHMG1%2520and%25202%253A%2520Architectural%2520DNA-binding%2520proteins%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2001%26volume%3D29%26issue%3D4%26spage%3D395%26epage%3D401%26doi%3D10.1042%2Fbst0290395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cham, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotze, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boone, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E. B.</span></span> <span> </span><span class="NLM_article-title">Cytosolic hmgb1 controls the cellular autophagy/apoptosis checkpoint during inflammation</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1098</span>– <span class="NLM_lpage">1110</span>, <span class="refDoi"> DOI: 10.1172/JCI76344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1172%2FJCI76344" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=1098-1110&issue=3&author=X.+Zhuauthor=J.+S.+Messerauthor=Y.+Wangauthor=F.+Linauthor=C.+M.+Chamauthor=J.+Changauthor=T.+R.+Billiarauthor=M.+T.+Lotzeauthor=D.+L.+Booneauthor=E.+B.+Chang&title=Cytosolic+hmgb1+controls+the+cellular+autophagy%2Fapoptosis+checkpoint+during+inflammation&doi=10.1172%2FJCI76344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1172%2FJCI76344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI76344%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DMesser%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DCham%26aufirst%3DC.%2BM.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DLotze%26aufirst%3DM.%2BT.%26aulast%3DBoone%26aufirst%3DD.%2BL.%26aulast%3DChang%26aufirst%3DE.%2BB.%26atitle%3DCytosolic%2520hmgb1%2520controls%2520the%2520cellular%2520autophagy%252Fapoptosis%2520checkpoint%2520during%2520inflammation%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26issue%3D3%26spage%3D1098%26epage%3D1110%26doi%3D10.1172%2FJCI76344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negishi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakasato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hangai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koshiba, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savitsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronfani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Hmgb proteins function as universal sentinels for nucleic-acid-mediated innate immune responses</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>462</i></span> (<span class="NLM_issue">7269</span>),  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1038/nature08512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnature08512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=99-103&issue=7269&author=H.+Yanaiauthor=T.+Banauthor=Z.+Wangauthor=M.+K.+Choiauthor=T.+Kawamuraauthor=H.+Negishiauthor=M.+Nakasatoauthor=Y.+Luauthor=S.+Hangaiauthor=R.+Koshibaauthor=D.+Savitskyauthor=L.+Ronfaniauthor=S.+Akiraauthor=M.+E.+Bianchiauthor=K.+Hondaauthor=T.+Tamuraauthor=T.+Kodamaauthor=T.+Taniguchi&title=Hmgb+proteins+function+as+universal+sentinels+for+nucleic-acid-mediated+innate+immune+responses&doi=10.1038%2Fnature08512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature08512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08512%26sid%3Dliteratum%253Aachs%26aulast%3DYanai%26aufirst%3DH.%26aulast%3DBan%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChoi%26aufirst%3DM.%2BK.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DNegishi%26aufirst%3DH.%26aulast%3DNakasato%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DHangai%26aufirst%3DS.%26aulast%3DKoshiba%26aufirst%3DR.%26aulast%3DSavitsky%26aufirst%3DD.%26aulast%3DRonfani%26aufirst%3DL.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DHonda%26aufirst%3DK.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DHmgb%2520proteins%2520function%2520as%2520universal%2520sentinels%2520for%2520nucleic-acid-mediated%2520innate%2520immune%2520responses%26jtitle%3DNature%26date%3D2009%26volume%3D462%26issue%3D7269%26spage%3D99%26epage%3D103%26doi%3D10.1038%2Fnature08512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">Hmg-1 rediscovered as a cytokine</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1097/00024382-200115040-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2F00024382-200115040-00001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=247-253&issue=4&author=H.+Yangauthor=H.+Wangauthor=K.+J.+Tracey&title=Hmg-1+rediscovered+as+a+cytokine&doi=10.1097%2F00024382-200115040-00001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2F00024382-200115040-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00024382-200115040-00001%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DHmg-1%2520rediscovered%2520as%2520a%2520cytokine%26jtitle%3DShock%26date%3D2001%26volume%3D15%26issue%3D4%26spage%3D247%26epage%3D253%26doi%3D10.1097%2F00024382-200115040-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calogero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigtlander, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span> <span> </span><span class="NLM_article-title">The lack of chromosomal protein hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1038/10338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2F10338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10391216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADyaK1MXkt1eqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=276-280&issue=3&author=S.+Calogeroauthor=F.+Grassiauthor=A.+Aguzziauthor=T.+Voigtlanderauthor=P.+Ferrierauthor=S.+Ferrariauthor=M.+E.+Bianchi&title=The+lack+of+chromosomal+protein+hmg1+does+not+disrupt+cell+growth+but+causes+lethal+hypoglycaemia+in+newborn+mice&doi=10.1038%2F10338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycemia in newborn mice</span></div><div class="casAuthors">Calogero, Sabina; Grassi, Fabio; Aguzzi, Adriano; Voigtlander, Till; Ferrier, Pierre; Ferrari, Simona; Bianchi, Marco E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">276-280</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">High mobility group 1 (HMG1) protein is an abundant component of all mammalian nuclei, and related proteins exist in all eukaryotes.  HMG1 binds linear DNA with moderate affinity and no sequence specificity, but bends the double helix significantly on binding through the minor groove.  It binds with high affinity to DNA that is already sharply bent, such as linker DNA at the entry and exit of nucleosomes; thus, it is considered a structural protein of chromatin.  HMG1 is also recruited to DNA by interactions with proteins required for basal and regulated transcription and V(D)J recombination.  Here the authors generate mice harboring deleted Hmg1.  Hmg1-/- pups are born alive, but die within 24 h due to hypoglycemia.  Hmg1-deficient mice survive for several days if given glucose parenterally, then waste away with pleiotropic defects (but no alteration in the immune repertoire).  Cell lines lacking Hmg1 grow normally, but the activation of gene expression by the glucocorticoid receptor (GR, encoded by the gene Grl1) is impaired.  Thus, Hmg1 is not essential for the overall organization of chromatin in the cell nucleus, but is crit. for proper transcriptional control by specific transcription factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogX2wDWqtflbVg90H21EOLACvtfcHk0ljLcXVG6b8IfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkt1eqsbk%253D&md5=09ea7cdb8feb2d7ce3cffdc47717e18b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F10338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F10338%26sid%3Dliteratum%253Aachs%26aulast%3DCalogero%26aufirst%3DS.%26aulast%3DGrassi%26aufirst%3DF.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DVoigtlander%26aufirst%3DT.%26aulast%3DFerrier%26aufirst%3DP.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26atitle%3DThe%2520lack%2520of%2520chromosomal%2520protein%2520hmg1%2520does%2520not%2520disrupt%2520cell%2520growth%2520but%2520causes%2520lethal%2520hypoglycaemia%2520in%2520newborn%2520mice%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D22%26issue%3D3%26spage%3D276%26epage%3D280%26doi%3D10.1038%2F10338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Houten, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeh, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotze, M. T.</span></span> <span> </span><span class="NLM_article-title">High mobility group box 1 (hmgb1) phenotypic role revealed with stress</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.2119/molmed.2014.00063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2014.00063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24937773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CjtLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=359-362&author=D.+Tangauthor=R.+Kangauthor=B.+Van+Houtenauthor=H.+J.+Zehauthor=T.+R.+Billiarauthor=M.+T.+Lotze&title=High+mobility+group+box+1+%28hmgb1%29+phenotypic+role+revealed+with+stress&doi=10.2119%2Fmolmed.2014.00063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box 1 (HMGB1) phenotypic role revealed with stress</span></div><div class="casAuthors">Tang, Daolin; Kang, Rui; Van Houten, Bennett; Zeh, Herbert J.; Billiar, Timothy R.; Lotze, Michael T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">359-362, 4 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">A review.  High mobility group box 1 (HMGB1) is an evolutionarily ancient protein that is present in one form or another in all eukaryotes.  It fundamentally resides in the nucleus but translocates to the cytosol with stress and is subsequently released into the extra cellular space.  HMGB1 global knockout mice exhibit lethal hypoglycemia, whereas tissues and cells from conditional knockout or knock-in mice are born alive without apparent significant functional deficit.  An aberrant response to targeted stress in the liver, pancreas, heart or myeloid cells is consistent with a protective role for HMGB1 in sustaining nuclear homeostasis and enabling other stress responses, including autophagy.  Under some conditions, HMGB1 is not required for liver and heart function.  Many challenges remain with respect to understanding the multiple roles of HMGB1 in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIf0Kp_cd4zLVg90H21EOLACvtfcHk0ljLcXVG6b8IfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CjtLjK&md5=d6835fed1308cc8131199ad5214fa740</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2014.00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2014.00063%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DR.%26aulast%3DVan%2BHouten%26aufirst%3DB.%26aulast%3DZeh%26aufirst%3DH.%2BJ.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DLotze%26aufirst%3DM.%2BT.%26atitle%3DHigh%2520mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520phenotypic%2520role%2520revealed%2520with%2520stress%26jtitle%3DMol.%2520Med.%26date%3D2014%26volume%3D20%26spage%3D359%26epage%3D362%26doi%3D10.2119%2Fmolmed.2014.00063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeh, H. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotze, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 in health and disease</span>. <i>Mol. Aspects Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.mam.2014.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.mam.2014.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25010388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSqt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=1-116&author=R.+Kangauthor=R.+Chenauthor=Q.+Zhangauthor=W.+Houauthor=S.+Wuauthor=L.+Caoauthor=J.+Huangauthor=Y.+Yuauthor=X.+G.+Fanauthor=Z.+Yanauthor=X.+Sunauthor=H.+Wangauthor=Q.+Wangauthor=A.+Tsungauthor=T.+R.+Billiarauthor=H.+J.+Zehauthor=M.+T.+Lotzeauthor=D.+Tang&title=Hmgb1+in+health+and+disease&doi=10.1016%2Fj.mam.2014.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1 in health and disease</span></div><div class="casAuthors">Kang, Rui; Chen, Ruochan; Zhang, Qiuhong; Hou, Wen; Wu, Sha; Cao, Lizhi; Huang, Jin; Yu, Yan; Fan, Xue-gong; Yan, Zhengwen; Sun, Xiaofang; Wang, Haichao; Wang, Qingde; Tsung, Allan; Billiar, Timothy R.; Zeh, Herbert J., III; Lotze, Michael T.; Tang, Daolin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-116</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Complex genetic and physiol. variations as well as environmental factors that drive emergence of chromosomal instability, development of unscheduled cell death, skewed differentiation, and altered metab. are central to the pathogenesis of human diseases and disorders.  Understanding the mol. bases for these processes is important for the development of new diagnostic biomarkers, and for identifying new therapeutic targets.  In 1973, a group of non-histone nuclear proteins with high electrophoretic mobility was discovered and termed high-mobility group (HMG) proteins.  The HMG proteins include three superfamilies termed HMGB, HMGN, and HMGA.  High-mobility group box 1 (HMGB1), the most abundant and well-studied HMG protein, senses and coordinates the cellular stress response and plays a crit. role not only inside of the cell as a DNA chaperone, chromosome guardian, autophagy sustainer, and protector from apoptotic cell death, but also outside the cell as the prototypic damage assocd. mol. pattern mol. (DAMP).  This DAMP, in conjunction with other factors, thus has cytokine, chemokine, and growth factor activity, orchestrating the inflammatory and immune response.  All of these characteristics make HMGB1 a crit. mol. target in multiple human diseases including infectious diseases, ischemia, immune disorders, neurodegenerative diseases, metabolic disorders, and cancer.  Indeed, a no. of emergent strategies have been used to inhibit HMGB1 expression, release, and activity in vitro and in vivo.  These include antibodies, peptide inhibitors, RNAi, anti-coagulants, endogenous hormones, various chem. compds., HMGB1-receptor and signaling pathway inhibition, artificial DNAs, phys. strategies including vagus nerve stimulation and other surgical approaches.  Future work further investigating the details of HMGB1 localization, structure, post-translational modification, and identification of addnl. partners will undoubtedly uncover addnl. secrets regarding HMGB1's multiple functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqwR2-Bj_IQ7Vg90H21EOLACvtfcHk0liPaL5E2mRGhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSqt7vJ&md5=7001bc5114c79a2bc3b92a18c39e24be</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2014.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2014.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DX.%2BG.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DTsung%26aufirst%3DA.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DZeh%26aufirst%3DH.%2BJ.%26aulast%3DLotze%26aufirst%3DM.%2BT.%26aulast%3DTang%26aufirst%3DD.%26atitle%3DHmgb1%2520in%2520health%2520and%2520disease%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2014%26volume%3D40%26spage%3D1%26epage%3D116%26doi%3D10.1016%2Fj.mam.2014.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotze, M. T.</span></span> <span> </span><span class="NLM_article-title">A janus tale of two active high mobility group box 1 (hmgb1) redox states</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1360</span>– <span class="NLM_lpage">1362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2012.00314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23073660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1360-1362&author=D.+Tangauthor=T.+R.+Billiarauthor=M.+T.+Lotze&title=A+janus+tale+of+two+active+high+mobility+group+box+1+%28hmgb1%29+redox+states"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A Janus tale of two active high mobility group box 1 (HMGB1) redox states</span></div><div class="casAuthors">Tang, Daolin; Billiar, Timothy R.; Lotze, Michael T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1360-1362</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">A review.  High mobility group box 1 (HMGB1), the prototypic damage-assocd. mol. pattern mol., is released at sites of inflammation and/or tissue damage.  There, it promotes cytokine prodn. and chemokine prodn./cell migration.  New work shows that the redox status of HMGB1 distinguishes its cytokine-inducing and chemokine activity.  Reduced all-thiol-HMGB1 has sole chemokine activity, whereas disulfide-HMGB1 has only cytokine activity, and oxidized, denatured HMGB1 has neither.  Autophagy (programmed cell survival) and apoptosis (programmed cell death) have been implicated in controlling both innate and adaptive immune functions.  Reduced HMGB1 protein promotes autophagy, whereas oxidized HMGB1 promotes apoptosis.  Thus, the differential activity of HMGB1 in immunity, inflammation and cell death depends on the cellular redox status within tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooOqIITQs9X7Vg90H21EOLACvtfcHk0liPaL5E2mRGhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeks70%253D&md5=2a40dab7c6415ba3c37c2e87b49b19f8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2012.00314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2012.00314%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DD.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DLotze%26aufirst%3DM.%2BT.%26atitle%3DA%2520janus%2520tale%2520of%2520two%2520active%2520high%2520mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520redox%2520states%26jtitle%3DMol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D1360%26epage%3D1362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span> <span> </span><span class="NLM_article-title">High mobility group box protein 1 (hmgb1): The prototypical endogenous danger molecule</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">S6</span>– <span class="NLM_lpage">S12</span>, <span class="refDoi"> DOI: 10.2119/molmed.2015.00087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2015.00087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26605648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFyiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=S6-S12&issue=Suppl.+1&author=H.+Yangauthor=H.+Wangauthor=S.+S.+Chavanauthor=U.+Andersson&title=High+mobility+group+box+protein+1+%28hmgb1%29%3A+The+prototypical+endogenous+danger+molecule&doi=10.2119%2Fmolmed.2015.00087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box protein 1 (HMGB1)- the prototypical endogenous danger molecule</span></div><div class="casAuthors">Yang, Huan; Wang, Haichao; Chavan, Sangeeta S.; Andersson, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">S6-S12</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">High mobility group box protein 1 (HMGB1) is an evolutionary ancient nuclear protein that exerts divergent biol. tasks inside and outside of cells.  The functions of HMGB1 depend on location, binding partners and redox states of the mol.  In the nucleus, HMGB1 organizes DNA and nucleosomes and regulates gene transcription.  Upon cell activation or injury, nuclear HMGB1 can translocate to the cytoplasm, where it is involved in inflammasome activation and pyroptosis, as well as regulation of the autophagy/apoptosis balance.  When actively secreted or passively released into the extracellular milieu, HMGB1 has cytokine, chemokine, neuroimmune and metabolic activities.  Thus, HMGB1 plays multiple roles in the pathogenesis of inflammatory diseases and mediates immune responses that range from inflammation and bacterial killing to tissue repair.  HMGB1 has been assocd. with divergent clin. conditions such as sepsis, rheumatoid arthritis and atherosclerosis.  HMGB1 initiates and perpetuates immune responses during infectious and sterile inflammation, as the archetypical alarmin and damage-assocd. mol. pattern (DAMP) mol.  We here describe advances in the understanding of HMGB1 biol. with focus on recent findings of its mission as a DAMP in danger sensing and as a therapeutic target in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpywgIYpeIwwbVg90H21EOLACvtfcHk0ljkOh7X7MsUBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFyiurs%253D&md5=585ac7e15bf92e03d5daaa019f2db000</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2015.00087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2015.00087%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChavan%26aufirst%3DS.%2BS.%26aulast%3DAndersson%26aufirst%3DU.%26atitle%3DHigh%2520mobility%2520group%2520box%2520protein%25201%2520%2528hmgb1%2529%253A%2520The%2520prototypical%2520endogenous%2520danger%2520molecule%26jtitle%3DMol.%2520Med.%26date%3D2015%26volume%3D21%26issue%3DSuppl.%25201%26spage%3DS6%26epage%3DS12%26doi%3D10.2119%2Fmolmed.2015.00087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiraki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadotani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejiri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, M.</span></span> <span> </span><span class="NLM_article-title">Expression of toll-like receptors on human platelets</span>. <i>Thromb. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1016/j.thromres.2004.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.thromres.2004.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=15226092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1ahu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2004&pages=379-385&issue=6&author=R.+Shirakiauthor=N.+Inoueauthor=S.+Kawasakiauthor=A.+Takeiauthor=M.+Kadotaniauthor=Y.+Ohnishiauthor=J.+Ejiriauthor=S.+Kobayashiauthor=K.+Hirataauthor=S.+Kawashimaauthor=M.+Yokoyama&title=Expression+of+toll-like+receptors+on+human+platelets&doi=10.1016%2Fj.thromres.2004.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Toll-like receptors on human platelets</span></div><div class="casAuthors">Shiraki, Rio; Inoue, Nobutaka; Kawasaki, Satoru; Takei, Asumi; Kadotani, Makoto; Ohnishi, Yoshio; Ejiri, Junya; Kobayashi, Seiichi; Hirata, Ken-ichi; Kawashima, Seinosuke; Yokoyama, Mitsuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">379-385</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Introduction: Platelets play a crucial role in arterial thrombosis, which is the main cause of acute coronary syndrome.  Some mycobacteriums, such as Chlamydia pneumoniae, were assocd. with progression of atherosclerosis and they are interacted with Toll-like receptors (TLRs), which have been defined as pathogen-assocd. mol. pattern recognition mols. in innate immunity.  In the present study, we examd. whether human platelets express TLRs.  Materials and methods: Human platelets were obtained from healthy volunteers and the mRNA and protein level of TLRs on platelets and Meg-01 cells, megakaryoblastic cell line, were investigated.  Results: Reverse transcription-polymerase chain reaction (RT-PCR) demonstrated that TLR1 and TLR6 mRNA were expressed in platelets and Meg-01 cells.  Furthermore, interferon-γ up-regulated their mRNA levels in dose and time dependent manners after stimuli.  Both TLR1 and TLR6 proteins in platelets were detected by Western blotting, and their expression of platelets was more than that of Meg-01 cells.  Flow cytometry anal. revealed the expression of TLR1 and TLR6 on the cell surface of Meg-01 cells.  Furthermore, immunohistochem. anal. using human coronary thrombi obtained from patients with acute coronary syndrome confirmed the expression of TLR1 and TLR6 on platelets.  Conclusion: In summary, we demonstrated that human platelets and Meg-01 cells expressed a family of TLRs for the first time, and our findings indicated that platelets might recognize antigens directly via TLRs.  Our findings suggest a possibility that platelets have the ability to recognize the antigens via TLRs and that there are mechanistic relations between infectious inflammation and atherosclerotic vascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMww6139Fl_rVg90H21EOLACvtfcHk0ljkOh7X7MsUBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1ahu7g%253D&md5=f98c0361e116e5bfc6f298bd9fd02ee1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2004.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2004.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DShiraki%26aufirst%3DR.%26aulast%3DInoue%26aufirst%3DN.%26aulast%3DKawasaki%26aufirst%3DS.%26aulast%3DTakei%26aufirst%3DA.%26aulast%3DKadotani%26aufirst%3DM.%26aulast%3DOhnishi%26aufirst%3DY.%26aulast%3DEjiri%26aufirst%3DJ.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DKawashima%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DM.%26atitle%3DExpression%2520of%2520toll-like%2520receptors%2520on%2520human%2520platelets%26jtitle%3DThromb.%2520Res.%26date%3D2004%26volume%3D113%26issue%3D6%26spage%3D379%26epage%3D385%26doi%3D10.1016%2Fj.thromres.2004.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuentes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, I.</span></span> <span> </span><span class="NLM_article-title">Role of multiligand/rage axis in platelet activation</span>. <i>Thromb. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>133</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1016/j.thromres.2013.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.thromres.2013.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24296115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2gu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2014&pages=308-314&issue=3&author=E.+Fuentesauthor=A.+Rojasauthor=I.+Palomo&title=Role+of+multiligand%2Frage+axis+in+platelet+activation&doi=10.1016%2Fj.thromres.2013.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Role of multiligand/RAGE axis in platelet activation</span></div><div class="casAuthors">Fuentes, Eduardo; Rojas, Armando; Palomo, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-314</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In the context of plaque progression, platelet hyperactivity assocd. with hyperlipidemia contributes to the development of a pro-thrombotic state.  In this context, it has been demonstrated that advanced glycation end products (AGEs) significantly increases platelet activation and receptor for AGEs (RAGE) expression at the platelet surface membrane.  In addn. to AGEs, other ligands (S100, HMGB1 and amyloid β, among others) of RAGE have raised particular attention in platelet activation.  Therefore, in this article we describe platelet hyperactivity by AGEs via RAGE-independent and RAGE-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxvRvM-JbvJrVg90H21EOLACvtfcHk0ljkOh7X7MsUBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2gu7jE&md5=b935e8f53eacb012e27ad6245cc21689</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2013.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2013.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DFuentes%26aufirst%3DE.%26aulast%3DRojas%26aufirst%3DA.%26aulast%3DPalomo%26aufirst%3DI.%26atitle%3DRole%2520of%2520multiligand%252Frage%2520axis%2520in%2520platelet%2520activation%26jtitle%3DThromb.%2520Res.%26date%3D2014%26volume%3D133%26issue%3D3%26spage%3D308%26epage%3D314%26doi%3D10.1016%2Fj.thromres.2013.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Signaling in innate immunity and inflammation</span>. <i>Cold Spring Harbor Perspect. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">a006049</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a006049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1101%2Fcshperspect.a006049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=a006049&issue=3&author=K.+Newtonauthor=V.+M.+Dixit&title=Signaling+in+innate+immunity+and+inflammation&doi=10.1101%2Fcshperspect.a006049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling in innate immunity and inflammation</span></div><div class="casAuthors">Newton, Kim; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">a006049, 19 pp.</span>CODEN:
                <span class="NLM_cas:coden">CSHPEU</span>;
        ISSN:<span class="NLM_cas:issn">1943-0264</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Inflammation is triggered when innate immune cells detect infection or tissue injury.  Surveillance mechanisms involve pattern recognition receptors (PRRs) on the cell surface and in the cytoplasm.  Most PRRs respond to pathogen-assocd. mol. patterns (PAMPs) or host-derived damage-assocd. mol. patterns (DAMPs) by triggering activation of NF-κB, AP1, CREB, c/EBP and IRF transcription factors.  Induction of genes encoding enzymes, chemokines, cytokines, adhesion mols. and regulators of the extracellular matrix promotes the recruitment and activation of leukocytes, which are crit. for eliminating foreign particles and host debris.  A subset of PRRs activates the protease caspase-1, which causes maturation of the cytokines IL1β and IL18.  Cell adhesion mols. and chemokines facilitate leukocyte extravasation from the circulation to the affected site, the chemokines stimulating G-protein-coupled receptors (GPCRs).  Binding initiates signals that regulate leukocyte motility and effector functions.  Other triggers of inflammation include allergens, which form antibody complexes that stimulate Fc receptors on mast cells.  Although the role of inflammation is to resolve infection and injury, increasing evidence indicates that chronic inflammation is a risk factor for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpctYaNBkRO0bVg90H21EOLACvtfcHk0lhFzn8w72Yq4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFyksLc%253D&md5=c9c6ace9e82ae4fd55503633635ebe44</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006049%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DSignaling%2520in%2520innate%2520immunity%2520and%2520inflammation%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2012%26volume%3D4%26issue%3D3%26spage%3Da006049%26doi%3D10.1101%2Fcshperspect.a006049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rouhiainen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauvala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkkinen, J.</span></span> <span> </span><span class="NLM_article-title">Occurrence of amphoterin (hmg1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation</span>. <i>Thromb Haemost.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1094</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=11154118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFarsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2000&pages=1087-1094&issue=6&author=A.+Rouhiainenauthor=S.+Imaiauthor=H.+Rauvalaauthor=J.+Parkkinen&title=Occurrence+of+amphoterin+%28hmg1%29+as+an+endogenous+protein+of+human+platelets+that+is+exported+to+the+cell+surface+upon+platelet+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation</span></div><div class="casAuthors">Rouhiainen, Ari; Imai, Shinji; Rauvala, Heikki; Parkkinen, Jaakko</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1087-1094</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">F. K. Schattauer Verlagsgesellschaft mbH</span>)
        </div><div class="casAbstract">Amphoterin (HMG1) is a 30-kD heparin-binding protein which is functionally assocd. with the outgrowth of cytoplasmic processes in developing neurons.  Amphoterin has been shown to mediate adhesive and proteolytic interactions at the leading edge of motile cells.  Recently it was shown that inhibition of amphoterin interactions with its cell surface receptor (RAGE) suppresses tumor growth and metastasis.  In this work we have identified amphoterin polypeptide and its mRNA in human platelets.  Amphoterin had a cytoplasmic localization in resting platelets according to subcellular fractionation studies and immunogold electron microscopy.  After platelet activation, part of amphoterin was assocd. with the external surface of plasma membrane.  Externalisation of amphoterin during platelet activation was also detected in immunofluorescence studies.  Amphoterin was detectable in human serum (0.2 ng/mL) but not in plasma.  Resting platelets treated with PGI2 and forskolin bound to immobilized recombinant amphoterin independently of divalent cations.  The binding induced a spicular morphol. in platelets, and was effectively inhibited by heparin.  Amphoterin-binding protein components on the platelet surface were not identified, but amphoterin bound to phosphatidylserine and sulfatide in lipid binding assays.  Our results suggest that amphoterin is an endogenous protein in human platelets, which is exported to the cell surface during platelet activation.  Interaction of amphoterin with the platelet surface may be mediated by sulfoglycolipids and phospholipids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGploAzQcJ7d5LVg90H21EOLACvtfcHk0lhFzn8w72Yq4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFarsQ%253D%253D&md5=613a4f442fca97b7e43e9d69d716e86f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRouhiainen%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DRauvala%26aufirst%3DH.%26aulast%3DParkkinen%26aufirst%3DJ.%26atitle%3DOccurrence%2520of%2520amphoterin%2520%2528hmg1%2529%2520as%2520an%2520endogenous%2520protein%2520of%2520human%2520platelets%2520that%2520is%2520exported%2520to%2520the%2520cell%2520surface%2520upon%2520platelet%2520activation%26jtitle%3DThromb%2520Haemost.%26date%3D2000%26volume%3D84%26issue%3D6%26spage%3D1087%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorch, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubes, P.</span></span> <span> </span><span class="NLM_article-title">An emerging role for neutrophil extracellular traps in noninfectious disease</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1038/nm.4294</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnm.4294" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28267716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtlaksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=279-287&issue=3&author=S.+K.+Jorchauthor=P.+Kubes&title=An+emerging+role+for+neutrophil+extracellular+traps+in+noninfectious+disease&doi=10.1038%2Fnm.4294"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">An emerging role for neutrophil extracellular traps in noninfectious disease</span></div><div class="casAuthors">Jorch, Selina K.; Kubes, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-287</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prodn. of neutrophil extracellular traps (NETs) is a process that enables neutrophils to help catch and kill bacteria.  However, increasing evidence suggests that this process might also occur in noninfectious, sterile inflammation.  In this Review, we describe the role of NETosis in autoimmunity, coagulation, acute injuries and cancer, and discuss NETs as potential therapeutic targets.  Furthermore, we consider whether extracellular DNA is always detrimental in sterile inflammation and whether the source is always NETs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLrTI0hCMz4rVg90H21EOLACvtfcHk0lhFzn8w72Yq4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtlaksLY%253D&md5=9d1117c79cf807fd4805a9f57a00155d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnm.4294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4294%26sid%3Dliteratum%253Aachs%26aulast%3DJorch%26aufirst%3DS.%2BK.%26aulast%3DKubes%26aufirst%3DP.%26atitle%3DAn%2520emerging%2520role%2520for%2520neutrophil%2520extracellular%2520traps%2520in%2520noninfectious%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26issue%3D3%26spage%3D279%26epage%3D287%26doi%3D10.1038%2Fnm.4294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span> <span> </span><span class="NLM_article-title">Emerging functions of serum amyloid a in inflammation</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>98</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1189/jlb.3VMR0315-080R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1189%2Fjlb.3VMR0315-080R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26130702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlGqt7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2015&pages=923-929&issue=6&author=R.+D.+Yeauthor=L.+Sun&title=Emerging+functions+of+serum+amyloid+a+in+inflammation&doi=10.1189%2Fjlb.3VMR0315-080R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging functions of serum amyloid A in inflammation</span></div><div class="casAuthors">Ye, Richard D.; Sun, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">923-929</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">SAA is a major acute-phase protein produced in large quantity during APR.  The rise of SAA concn. in blood circulation during APR has been a clin. marker for active inflammation.  In the past decade, research has been conducted to det. whether SAA plays an active role during inflammation and if so, how it influences the course of inflammation.  These efforts have led to the discovery of cytokine-like activities of rhSAA, which is com. available and widely used in most of the published studies.  SAA activates multiple receptors, including the FPR2, the TLRs TLR2 and TLR4, the scavenger receptor SR-BI, and the ATP receptor P2X7.  More recent studies have shown that SAA not only activates transcription factors, such as NF-κB, but also plays a role in epigenetic regulation through a MyD88- IRF4-Jmjd3 pathway.  It is postulated that the activation of these pathways leads to induced expression of proinflammatory factors and a subset of proteins expressed by the M2 macrophages.  These functional properties set SAA apart from well-characterized inflammatory factors, such as LPS and TNF-α, suggesting that it may play a homeostatic role during the course of inflammation.  Ongoing and future studies are directed to addressing unresolved issues, including the difference between rSAA and native SAA isoforms and the exact functions of SAA in physiol. and pathol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqbBv2-znzIbVg90H21EOLACvtfcHk0liHIGMPafcIDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlGqt7%252FO&md5=81c4cedce8f4d186b6c9dc60706b8c5a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1189%2Fjlb.3VMR0315-080R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.3VMR0315-080R%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DR.%2BD.%26aulast%3DSun%26aufirst%3DL.%26atitle%3DEmerging%2520functions%2520of%2520serum%2520amyloid%2520a%2520in%2520inflammation%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2015%26volume%3D98%26issue%3D6%26spage%3D923%26epage%3D929%26doi%3D10.1189%2Fjlb.3VMR0315-080R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottazzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garlanda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Pattern recognition by pentraxins</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>653</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1007/978-1-4419-0901-5_7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2F978-1-4419-0901-5_7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=653&publication_year=2009&pages=98-116&author=A.+Agrawalauthor=P.+P.+Singhauthor=B.+Bottazziauthor=C.+Garlandaauthor=A.+Mantovani&title=Pattern+recognition+by+pentraxins&doi=10.1007%2F978-1-4419-0901-5_7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-0901-5_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4419-0901-5_7%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DP.%2BP.%26aulast%3DBottazzi%26aufirst%3DB.%26aulast%3DGarlanda%26aufirst%3DC.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DPattern%2520recognition%2520by%2520pentraxins%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2009%26volume%3D653%26spage%3D98%26epage%3D116%26doi%3D10.1007%2F978-1-4419-0901-5_7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anunciato, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenstock, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glezer, I.</span></span> <span> </span><span class="NLM_article-title">Gene expression control by glucocorticoid receptors during innate immune responses</span>. <i>Front. Endocrinol. (Lausanne, Switz.)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">31</span>, <span class="refDoi"> DOI: 10.3389/fendo.2016.00031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3389%2Ffendo.2016.00031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27148162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC28bms1CqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=31&author=A.+M.+Xavierauthor=A.+K.+Anunciatoauthor=T.+R.+Rosenstockauthor=I.+Glezer&title=Gene+expression+control+by+glucocorticoid+receptors+during+innate+immune+responses&doi=10.3389%2Ffendo.2016.00031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Gene Expression Control by Glucocorticoid Receptors during Innate Immune Responses</span></div><div class="casAuthors">Xavier Andre Machado; Anunciato Aparecida Kataryna Olimpio; Glezer Isaias; Rosenstock Tatiana Rosado</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31</span>
        ISSN:<span class="NLM_cas:issn">1664-2392</span>.
    </div><div class="casAbstract">Glucocorticoids (GCs) are potent anti-inflammatory compounds that have been extensively used in clinical practice for several decades.  GC's effects on inflammation are generally mediated through GC receptors (GRs).  Signal transduction through these nuclear receptors leads to dramatic changes in gene expression programs in different cell types, typically due to GR binding to DNA or to transcription modulators.  During the last decade, the view of GCs as exclusive anti-inflammatory molecules has been challenged.  GR negative interference in pro-inflammatory gene expression was a landmark in terms of molecular mechanisms that suppress immune activity.  In fact, GR can induce varied inhibitory molecules, including a negative regulator of Toll-like receptors pathway, or subject key transcription factors, such as NF-κB and AP-1, to a repressor mechanism.  In contrast, the expression of some acute-phase proteins and other players of innate immunity generally requires GR signaling.  Consequently, GRs must operate context-dependent inhibitory, permissive, or stimulatory effects on host defense signaling triggered by pathogens or tissue damage.  This review aims to disclose how contradictory or comparable effects on inflammatory gene expression can depend on pharmacological approach (including selective GC receptor modulators; SEGRMs), cell culture, animal treatment, or transgenic strategies used as models.  Although the current view of GR-signaling integrated many advances in the field, some answers to important questions remain elusive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCcXTW0RzAIcNIRw0GKUoEfW6udTcc2eYbcBNfK0Z6Ebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bms1CqsQ%253D%253D&md5=31112fc6512607eafa93000a38a6d630</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2016.00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2016.00031%26sid%3Dliteratum%253Aachs%26aulast%3DXavier%26aufirst%3DA.%2BM.%26aulast%3DAnunciato%26aufirst%3DA.%2BK.%26aulast%3DRosenstock%26aufirst%3DT.%2BR.%26aulast%3DGlezer%26aufirst%3DI.%26atitle%3DGene%2520expression%2520control%2520by%2520glucocorticoid%2520receptors%2520during%2520innate%2520immune%2520responses%26jtitle%3DFront.%2520Endocrinol.%2520%2528Lausanne%252C%2520Switz.%2529%26date%3D2016%26volume%3D7%26spage%3D31%26doi%3D10.3389%2Ffendo.2016.00031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmblad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aveberger, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlandsson-Harris, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">High mobility group 1 protein (hmg-1) stimulates proinflammatory cytokine synthesis in human monocytes</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>192</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1084/jem.192.4.565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1084%2Fjem.192.4.565" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2000&pages=565-570&issue=4&author=U.+Anderssonauthor=H.+Wangauthor=K.+Palmbladauthor=A.+C.+Avebergerauthor=O.+Bloomauthor=H.+Erlandsson-Harrisauthor=A.+Jansonauthor=R.+Kokkolaauthor=M.+Zhangauthor=H.+Yangauthor=K.+J.+Tracey&title=High+mobility+group+1+protein+%28hmg-1%29+stimulates+proinflammatory+cytokine+synthesis+in+human+monocytes&doi=10.1084%2Fjem.192.4.565"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1084%2Fjem.192.4.565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.192.4.565%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DPalmblad%26aufirst%3DK.%26aulast%3DAveberger%26aufirst%3DA.%2BC.%26aulast%3DBloom%26aufirst%3DO.%26aulast%3DErlandsson-Harris%26aufirst%3DH.%26aulast%3DJanson%26aufirst%3DA.%26aulast%3DKokkola%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DHigh%2520mobility%2520group%25201%2520protein%2520%2528hmg-1%2529%2520stimulates%2520proinflammatory%2520cytokine%2520synthesis%2520in%2520human%2520monocytes%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D192%26issue%3D4%26spage%3D565%26epage%3D570%26doi%3D10.1084%2Fjem.192.4.565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manfredi, A. A.</span></span> <span> </span><span class="NLM_article-title">High-mobility group box 1 (hmgb1) protein at the crossroads between innate and adaptive immunity</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>220</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2007.00574.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fj.1600-065X.2007.00574.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=17979838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKgtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2007&pages=35-46&author=M.+E.+Bianchiauthor=A.+A.+Manfredi&title=High-mobility+group+box+1+%28hmgb1%29+protein+at+the+crossroads+between+innate+and+adaptive+immunity&doi=10.1111%2Fj.1600-065X.2007.00574.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity</span></div><div class="casAuthors">Bianchi, Marco E.; Manfredi, Angelo A.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Tissue damage occurs often in the life of mammals and is usually repaired.  Dying cells are swiftly phagocytosed, but before disappearing, they alert surrounding cells to activate homeostatic programs.  They release signals that recruit inflammatory cells to the site of injury, promote cell migration and cell division to replace dead cells, and activate the immune system in anticipation of microbial invasion.  Many of these events involve high-mobility group box 1 protein (HMGB1), a nuclear protein that is released passively when necrotic cells lose the integrity of their membranes.  HMGB1 behaves as a trigger of inflammation, attracting inflammatory cells, and of tissue repair, recruiting stem cells and promoting their proliferation.  Moreover, HMGB1 activates dendritic cells (DCs) and promotes their functional maturation and their response to lymph node chemokines.  Activated leukocytes actively secrete HMGB1 in the microenvironment.  Thus, HMGB1 acts in an autocrine/paracrine fashion and sustains long-term repair and defense programs.  DCs secrete HMGB1 several hours after contact with the first maturation stimulus; HMGB1 secretion is crit. for their ability to reach the lymph nodes, to sustain the proliferation of antigen-specific T cells, to prevent their activation-dependent apoptosis, and to promote their polarization towards a T-helper 1 phenotype.  These immune responses will also be directed against self-antigens that DCs process at the time of injury and can lead to autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCNB0eW0GCmLVg90H21EOLACvtfcHk0lhrg0C_0yunvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKgtr3J&md5=4e65aba0778252da3f3cfc27e49fe50a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2007.00574.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2007.00574.x%26sid%3Dliteratum%253Aachs%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DManfredi%26aufirst%3DA.%2BA.%26atitle%3DHigh-mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520protein%2520at%2520the%2520crossroads%2520between%2520innate%2520and%2520adaptive%2520immunity%26jtitle%3DImmunol.%2520Rev.%26date%3D2007%26volume%3D220%26spage%3D35%26epage%3D46%26doi%3D10.1111%2Fj.1600-065X.2007.00574.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manfredi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovere-Querini, P.</span></span> <span> </span><span class="NLM_article-title">Regulation of dendritic- and t-cell fate by injury-associated endogenous signals</span>. <i>Crit Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1615/CritRevImmunol.v29.i1.30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1615%2FCritRevImmunol.v29.i1.30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=19348611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVSrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=69-86&issue=1&author=A.+A.+Manfrediauthor=A.+Capobiancoauthor=M.+E.+Bianchiauthor=P.+Rovere-Querini&title=Regulation+of+dendritic-+and+t-cell+fate+by+injury-associated+endogenous+signals&doi=10.1615%2FCritRevImmunol.v29.i1.30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of dendritic- and T-cell fate by injury-associated endogenous signals</span></div><div class="casAuthors">Manfredi, Angelo A.; Capobianco, Annalisa; Bianchi, Marco E.; Rovere-Querini, Patrizia</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-86</span>CODEN:
                <span class="NLM_cas:coden">CCRIDE</span>;
        ISSN:<span class="NLM_cas:issn">1040-8401</span>.
    
            (<span class="NLM_cas:orgname">Begell House, Inc.</span>)
        </div><div class="casAbstract">A review.  Two events characterize tissue injury and sterile inflammation: (1) generation/release of autoantigens, and (2) generation of homeostatic inflammatory signals.  Homeostatic signals recruit leukocytes and promote cell migration and division to replace injured cells.  Moreover, they activate antigen-presenting phagocytes, in particular, dendritic cells (DCs), in anticipation of microbial invasion.  Activated DCs undergo a differentiation process, referred to as maturation, and migrate to secondary lymphoid organs.  Maturing DCs upregulate the mol. machinery required for the priming of naive T cells, including T lymphocytes recognizing autoantigens, which represent a substantial fraction of the host T-cell repertoire.  Recent data indicate that cues generated at sites of injury shape T-cell clonal expansion, regulating sensitivity to activation-dependent apoptosis and commitment towards a Th1, Th2, Th17, or regulatory T-cell fate.  Endogenous signals of tissue injury, also called damage-assocd. mol. patterns (DAMPS) or alarmins, therefore provide a code for switching the outcome of the presentation of autoantigens towards results as diverse as T-cell-mediated protective immunity, tissue repair, persistent inflammation and autoimmunity, or tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOiDP26Errh7Vg90H21EOLACvtfcHk0lhrg0C_0yunvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVSrs70%253D&md5=89ffc5ed0a5d668c54c6d4a599249e12</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1615%2FCritRevImmunol.v29.i1.30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1615%252FCritRevImmunol.v29.i1.30%26sid%3Dliteratum%253Aachs%26aulast%3DManfredi%26aufirst%3DA.%2BA.%26aulast%3DCapobianco%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DRovere-Querini%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520dendritic-%2520and%2520t-cell%2520fate%2520by%2520injury-associated%2520endogenous%2520signals%26jtitle%3DCrit%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D29%26issue%3D1%26spage%3D69%26epage%3D86%26doi%3D10.1615%2FCritRevImmunol.v29.i1.30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology</span>. <i>Mol. Aspects Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/j.mam.2017.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.mam.2017.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28263773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC1czjt1egtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=1-11&author=C.+N.+Serhan&title=Discovery+of+specialized+pro-resolving+mediators+marks+the+dawn+of+resolution+physiology+and+pharmacology&doi=10.1016%2Fj.mam.2017.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology</span></div><div class="casAuthors">Serhan Charles N</div><div class="citationInfo"><span class="NLM_cas:title">Molecular aspects of medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">It is with great pleasure that I write this foreword and introduction to this Special Issue dedicated to the protective actions of the pro-resolving mediators and edited by my colleague Dr.  Jesmond Dalli.  Many of my collaborators and colleagues that helped to uncover the actions and clinical potential of the resolvins and other specialized proresolving mediators (SPM), namely, the superfamily of pro-resolving mediators that includes the resolvin (E-series, D-series and DPA-derived), protectin and maresin families, as well as the arachidonic acid-derived lipoxins, join me in this special issue.  They have given contributions that present exciting new results on the remarkable actions and potency of these unique molecules, the SPM moving forward the importance of their mediators and pathways in human biology.  Each contribution to this issue is presented by world authorities in their respective fields covering discoveries that demonstrate the importance and impact of resolution mediators in biology, medicine and surgery.  While some of the authors were students and/or fellows with me and others, they are today the founding "resolutionists" of a new era of appreciation of autacoid biosynthesis and metabolomics in human health and disease with their rigorous attention to experimental detail and discovery.  The chapters of this issue are filled with exciting new discoveries demonstrating the dynamics and potential of resolution mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZbK7HLwqjrkg6wdEZmT2rfW6udTcc2eYt1W6m6l2ohLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czjt1egtA%253D%253D&md5=6b841b9698f49be374c95f408aca3857</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2017.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2017.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26atitle%3DDiscovery%2520of%2520specialized%2520pro-resolving%2520mediators%2520marks%2520the%2520dawn%2520of%2520resolution%2520physiology%2520and%2520pharmacology%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2017%26volume%3D58%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.mam.2017.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strebovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalpke, A. H.</span></span> <span> </span><span class="NLM_article-title">Suppressor of cytokine signaling proteins as regulators of innate immune signaling</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.2741/4008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2741%2F4008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22201825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOhs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1627-1639&author=J.+Strebovskyauthor=P.+Walkerauthor=A.+H.+Dalpke&title=Suppressor+of+cytokine+signaling+proteins+as+regulators+of+innate+immune+signaling&doi=10.2741%2F4008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Suppressor of cytokine signaling proteins as regulators of innate immune signaling</span></div><div class="casAuthors">Strebovsky, Julia; Walker, Patrick; Dalpke, Alexander H.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1627-1639</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The innate immune system builds up the body's first line of defense against invading pathogenic microorganisms.  For effective defense of pathogenic invaders, a structured inflammatory reaction has to be initiated that is strongly dependent on cell-to-cell communication.  Inflammation in turn is a potentially autodestructive reaction that is tightly controlled to balance antimicrobial activity and host damage.  Suppressor of cytokine signaling (SOCS) proteins have been identified as crucial neg. regulators of various hematopoietic cytokines employing Janus kinase (JAK) and signal transducer and activator of transcription (STAT) signaling.  Further results now imply that also signaling by pattern recognition receptors (PRR) of the innate immune system that use a distinct signaling cascade induce and get regulated by SOCS proteins.  Thus, SOCS proteins not only modulate cell communication through JAK/STAT dependent cytokines but also regulate signaling by pattern recognition receptors including the Toll-like receptors (TLRs).  A model is presented that integrates the current, partly conflicting, data on the role of SOCS proteins in innate immunity's NFkappaB signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos9UGNsydb7rVg90H21EOLACvtfcHk0lhrg0C_0yunvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOhs7rI&md5=cb96146c80b028f28f9d7ca4b008f046</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2741%2F4008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F4008%26sid%3Dliteratum%253Aachs%26aulast%3DStrebovsky%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DP.%26aulast%3DDalpke%26aufirst%3DA.%2BH.%26atitle%3DSuppressor%2520of%2520cytokine%2520signaling%2520proteins%2520as%2520regulators%2520of%2520innate%2520immune%2520signaling%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2012%26volume%3D17%26spage%3D1627%26epage%3D1639%26doi%3D10.2741%2F4008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cain, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Specificity and sensitivity of glucocorticoid signaling in health and disease</span>. <i>Best Pract Res. Clin Endocrinol Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1016/j.beem.2015.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.beem.2015.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26303082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=545-556&issue=4&author=D.+W.+Cainauthor=J.+A.+Cidlowski&title=Specificity+and+sensitivity+of+glucocorticoid+signaling+in+health+and+disease&doi=10.1016%2Fj.beem.2015.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity and sensitivity of glucocorticoid signaling in health and disease</span></div><div class="casAuthors">Cain, Derek W.; Cidlowski, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">BPRCE9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Endogenous glucocorticoids regulate a variety of physiol. processes and are crucial to the systemic stress response.  Glucocorticoid receptors are expressed throughout the body, but there is considerable heterogeneity in glucocorticoid sensitivity and induced biol. responses across tissues.  The immunoregulatory properties of glucocorticoids are exploited in the clinic for the treatment of inflammatory and autoimmune disorders as well as certain hematol. malignancies, but adverse side effects hamper prolonged use.  Fully understanding the mol. events that shape the physiol. effects of glucocorticoid treatment will provide insight into optimal glucocorticoid therapies, reliable assessment of glucocorticoid sensitivity in patients, and may advance the development of novel GR agonists that exert immunosuppressive effects while avoiding harmful side effects.  In this review, we provide an overview of mechanisms that affect glucocorticoid specificity and sensitivity in health and disease, focusing on the distinct isoforms of the glucocorticoid receptor and their unique regulatory and functional properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm_PfrGg9m37Vg90H21EOLACvtfcHk0ljlZ26DhaGC_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOhu7g%253D&md5=081d70feddcbfe36fed0369e89deb608</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.beem.2015.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.beem.2015.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DCain%26aufirst%3DD.%2BW.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26atitle%3DSpecificity%2520and%2520sensitivity%2520of%2520glucocorticoid%2520signaling%2520in%2520health%2520and%2520disease%26jtitle%3DBest%2520Pract%2520Res.%2520Clin%2520Endocrinol%2520Metab.%26date%3D2015%26volume%3D29%26issue%3D4%26spage%3D545%26epage%3D556%26doi%3D10.1016%2Fj.beem.2015.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huston, J. M.</span></span> <span> </span><span class="NLM_article-title">The vagus nerve and the inflammatory reflex: Wandering on a new treatment paradigm for systemic inflammation and sepsis</span>. <i>Surg Infect (Larchmt)</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1089/sur.2012.126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1089%2Fsur.2012.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22913335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC38bgtl2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=187-193&issue=4&author=J.+M.+Huston&title=The+vagus+nerve+and+the+inflammatory+reflex%3A+Wandering+on+a+new+treatment+paradigm+for+systemic+inflammation+and+sepsis&doi=10.1089%2Fsur.2012.126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The vagus nerve and the inflammatory reflex: wandering on a new treatment paradigm for systemic inflammation and sepsis</span></div><div class="casAuthors">Huston Jared M</div><div class="citationInfo"><span class="NLM_cas:title">Surgical infections</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">187-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The immune system protects the host against dangerous pathogens and toxins.  The central nervous system is charged with monitoring and coordinating appropriate responses to internal and external stimuli.  The inflammatory reflex sits at the crossroads of these crucial homeostatic systems.  This review highlights how the vagus nerve-mediated inflammatory reflex facilitates rapid and specific exchange of information between the nervous and immune systems to prevent tissue injury and infection.  METHODS:  Review of the pertinent English-language literature.  Nearly two decades of research has elucidated some of the essential anatomic, physiologic, and molecular connections of the inflammatory reflex.  The original descriptions of how these key components contribute to afferent and efferent anti-inflammatory vagus nerve signaling are summarized.  RESULTS:  The central nervous system recognizes peripheral inflammation via afferent vagus nerve signaling.  The brain can attenuate peripheral innate immune responses, including pro-inflammatory cytokine production, leukocyte recruitment, and nuclear factor kappa β activation via α7-nicotinic acetylcholine receptor subunit-dependent, T-lymphocyte-dependent, vagus nerve signaling to spleen.  This efferent arm of the inflammatory reflex is referred to as the "cholinergic anti-inflammatory pathway." Activation of this pathway via vagus nerve stimulation or pharmacologic α7 agonists prevents tissue injury in multiple models of systemic inflammation, shock, and sepsis.  CONCLUSIONS:  The vagus nerve-mediated inflammatory reflex is a powerful ally in the fight against lethal tissue damage after injury and infection.  Further studies will help translate the beneficial effects of this pathway into clinical use for our surgical patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSplUT3seOM7NbHMBt0mMIXfW6udTcc2eZjV-Dd3HCRBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bgtl2gtw%253D%253D&md5=d33bf0a8cae00c270f57428f8e5b986d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1089%2Fsur.2012.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fsur.2012.126%26sid%3Dliteratum%253Aachs%26aulast%3DHuston%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520vagus%2520nerve%2520and%2520the%2520inflammatory%2520reflex%253A%2520Wandering%2520on%2520a%2520new%2520treatment%2520paradigm%2520for%2520systemic%2520inflammation%2520and%2520sepsis%26jtitle%3DSurg%2520Infect%2520%2528Larchmt%2529%26date%3D2012%26volume%3D13%26issue%3D4%26spage%3D187%26epage%3D193%26doi%3D10.1089%2Fsur.2012.126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Mir-212-3p inhibits lps-induced inflammatory response through targeting hmgb1 in murine macrophages</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>350</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2016.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.yexcr.2016.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27940320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGns7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2017&pages=318-326&issue=2&author=W.+Chenauthor=X.+Maauthor=P.+Zhangauthor=Q.+Liauthor=X.+Liangauthor=J.+Liu&title=Mir-212-3p+inhibits+lps-induced+inflammatory+response+through+targeting+hmgb1+in+murine+macrophages&doi=10.1016%2Fj.yexcr.2016.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">MiR-212-3p inhibits LPS-induced inflammatory response through targeting HMGB1 in murine macrophages</span></div><div class="casAuthors">Chen, Weiwei; Ma, Xiaoying; Zhang, Peng; Li, Qifeng; Liang, Xin; Liu, Jianwen</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-326</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sepsis is a major cause of mortality in seriously ill patients characterized by a series of severe systemic inflammatory responses due to an infection.  Thus, there is a critically need to search more accurate biomarkers and targets for diagnosis and treatment of sepsis.  Our study showed that miR-212-3p was up-regulated in LPS-treated macrophage RAW264.7 cells.  Overexpression of miR-212-3p in RAW264.7 cells led to suppression of pro-inflammatory cytokines (TNF-α and IL-6) induced by LPS.  Bioinformatic predictions and exptl. researches both revealed that HMGB1 was a direct target of miR-212-3p.  Meanwhile, the results showed that overexpression of miR-212-3p inhibited the cytoplasmic translocation of HMGB1 in LPS-induced RAW264.7 cells.  Subsequently, transfection of the pcDNA3.1/HMGB1 plasmid, which produced HMGB1 overexpression, exhibited similar effects as the LPS-induced macrophage inflammatory response and markedly activated the MAPKs including p38, ERK and JNK phosphorylation.  Furthermore, we also found that the phosphorylation of p38 MAPK and ERK was downregulated by miR-212-3p mimics upon LPS injection.  In conclusion, these results reveal that miR-212-3p directly targets HMGB1 to suppress inflammatory response in LPS-induced RAW264.7 cells.  All our findings indicate that miR-212-3p may act as a potential pharmacol. target for promising and effective therapeutic intervention in microbial infection in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhypuPjHW8bVg90H21EOLACvtfcHk0lig1wT34dY8oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGns7nE&md5=80fdedee0697415e3c6aee8df478f394</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2016.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2016.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DMir-212-3p%2520inhibits%2520lps-induced%2520inflammatory%2520response%2520through%2520targeting%2520hmgb1%2520in%2520murine%2520macrophages%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2017%26volume%3D350%26issue%3D2%26spage%3D318%26epage%3D326%26doi%3D10.1016%2Fj.yexcr.2016.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Exogenous mscs ameliorate hypoxia/reoxygenation injury in renal tubular epithelial cells through jak/stat signaling pathway-mediated regulation of hmgb1</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2412</span>– <span class="NLM_lpage">2420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28559991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC1cnivVartA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=2412-2420&issue=5&author=L.+Zhangauthor=Y.+Wangauthor=J.+Maauthor=X.+Laiauthor=J.+Fangauthor=G.+Liauthor=L.+Xuauthor=G.+Panauthor=Z.+Chen&title=Exogenous+mscs+ameliorate+hypoxia%2Freoxygenation+injury+in+renal+tubular+epithelial+cells+through+jak%2Fstat+signaling+pathway-mediated+regulation+of+hmgb1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Exogenous MSCs ameliorate hypoxia/reoxygenation injury in renal tubular epithelial cells through JAK/STAT signaling pathway-mediated regulation of HMGB1</span></div><div class="casAuthors">Zhang Lei; Ma Junjie; Lai Xingqiang; Fang Jiali; Li Guanghui; Xu Lu; Pan Guanghui; Chen Zheng; Wang Yan</div><div class="citationInfo"><span class="NLM_cas:title">American journal of translational research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2412-2420</span>
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    </div><div class="casAbstract">This study was conducted to investigate the repair mechanism of hypoxia/reoxygenation injury (HRI) in renal tubular epithelial cells (HK-2) by exogenous mesenchymal stem cells (MSCs).  The activation of the JAK/STAT pathway in HK-2 cells after HRI and treatment of MSCs, JAK inhibitor WP1066 and STAT inhibitor SOCS3 was investigated using Western blot analysis.  HK-2 cells were transfected with siRNA STAT3 and analyzed for expression of STAT3, JAK2 and HMGB1 using fluorescence quantitative PCR and Western blot.  Cell viability and apoptosis were analyzed using the MTT assay and flow cytometry.  After HRI, the JAK/STAT pathway in HK-2 cells was activated, resulting in the upregulation of JAK1, JAK2, JAK3, p-JAK1, p-JAK2, p-JAK3, STAT1, STAT2, STAT3, p-STAT1, p-STAT2 and p-STAT3.  After treatment with MSC conditioned medium (MSCs CM), WP1066, or SOCS, the expression of these proteins was significantly down-regulated.  When the cells were transfected with siRNA STAT3, the expression of STAT3 at protein and mRNA levels and JAK2 and HMGB1 at mRNA level was down-regulated; the cell viability was reduced and apoptosis increased.  It is concluded that exogenous MSCs reduce HRI of HK-2 cells by suppressing the JAK/STAT signaling pathway and down-regulating the expression of HMGB1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpLu9NEims2gvupmecNw_lfW6udTcc2eYc8QyToH857Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnivVartA%253D%253D&md5=24e558cab31d4d891af72bccf8c8df93</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DExogenous%2520mscs%2520ameliorate%2520hypoxia%252Freoxygenation%2520injury%2520in%2520renal%2520tubular%2520epithelial%2520cells%2520through%2520jak%252Fstat%2520signaling%2520pathway-mediated%2520regulation%2520of%2520hmgb1%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2017%26volume%3D9%26issue%3D5%26spage%3D2412%26epage%3D2420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czura, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">Neural inhibition of inflammation: The cholinergic anti-inflammatory pathway</span>. <i>J. Endotoxin Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1177/09680519030090060401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1177%2F09680519030090060401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=14733730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVGquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=409-413&issue=6&author=C.+J.+Czuraauthor=S.+G.+Friedmanauthor=K.+J.+Tracey&title=Neural+inhibition+of+inflammation%3A+The+cholinergic+anti-inflammatory+pathway&doi=10.1177%2F09680519030090060401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neural inhibition of inflammation: the cholinergic anti-inflammatory pathway</span></div><div class="casAuthors">Czura, Christopher J.; Friedman, Steven G.; Tracey, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endotoxin Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">409-413</span>CODEN:
                <span class="NLM_cas:coden">JENREB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0519</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">A review.  The innate immune system is activated by infection and injury to release pro-inflammatory cytokines, which activate macrophages and neutrophils and modulate specific cellular responses.  The magnitude of the cytokine response is crit., because a deficient response may result in secondary infections, while an excessive response may be more injurious than the original insult.  We recently described a neural pathway, termed the "cholinergic anti-inflammatory pathway", that reflexively monitors and adjusts the inflammatory response by inhibiting pro-inflammatory cytokine synthesis.  Efferent signals in the vagus nerve provide a direct mechanism for neural regulation of the immune response that is rapid, localized, and integrated.  Vagus nerve stimulation inhibits the release of TNF, HMGB1, and other cytokines, and protects against endotoxemia and ischemia-reperfusion injury.  This newly identified physiol. mechanism of maintaining immunol. homeostasis suggests that novel therapeutics may effectively modulate inflammatory responses by activating the cholinergic anti-inflammatory pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIozJN65A80bVg90H21EOLACvtfcHk0lh79b1wMktgeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVGquw%253D%253D&md5=26499dd893f38f1cd17007c12765f9b2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F09680519030090060401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F09680519030090060401%26sid%3Dliteratum%253Aachs%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DFriedman%26aufirst%3DS.%2BG.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DNeural%2520inhibition%2520of%2520inflammation%253A%2520The%2520cholinergic%2520anti-inflammatory%2520pathway%26jtitle%3DJ.%2520Endotoxin%2520Res.%26date%3D2003%26volume%3D9%26issue%3D6%26spage%3D409%26epage%3D413%26doi%3D10.1177%2F09680519030090060401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilroy, D. W.</span></span> <span> </span><span class="NLM_article-title">Resolution of inflammation: A new therapeutic frontier</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnrd.2016.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27020098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFGrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=551-567&issue=8&author=J.+N.+Fullertonauthor=D.+W.+Gilroy&title=Resolution+of+inflammation%3A+A+new+therapeutic+frontier&doi=10.1038%2Fnrd.2016.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Resolution of inflammation: a new therapeutic frontier</span></div><div class="casAuthors">Fullerton, James N.; Gilroy, Derek W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">551-567</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dysregulated inflammation is a central pathol. process in diverse disease states.  Traditionally, therapeutic approaches have sought to modulate the pro- or anti-inflammatory limbs of inflammation, with mixed success.  However, insight into the pathways by which inflammation is resolved has highlighted novel opportunities to pharmacol. manipulate these processes - a strategy that might represent a complementary (and perhaps even superior) therapeutic approach.  This Review discusses the state of the art in the biol. of resoln. of inflammation, highlighting the opportunities and challenges for translational research in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvaS77WpHhoLVg90H21EOLACvtfcHk0lh79b1wMktgeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFGrsb4%253D&md5=077da0583b0e280ea1b8640de017affd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.39%26sid%3Dliteratum%253Aachs%26aulast%3DFullerton%26aufirst%3DJ.%2BN.%26aulast%3DGilroy%26aufirst%3DD.%2BW.%26atitle%3DResolution%2520of%2520inflammation%253A%2520A%2520new%2520therapeutic%2520frontier%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26issue%3D8%26spage%3D551%26epage%3D567%26doi%3D10.1038%2Fnrd.2016.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venereau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casalgrandi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiraldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marchis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raeli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shams, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uguccioni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span> <span> </span><span class="NLM_article-title">Mutually exclusive redox forms of hmgb1 promote cell recruitment or proinflammatory cytokine release</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>209</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1519</span>– <span class="NLM_lpage">1528</span>, <span class="refDoi"> DOI: 10.1084/jem.20120189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1084%2Fjem.20120189" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2012&pages=1519-1528&issue=9&author=E.+Venereauauthor=M.+Casalgrandiauthor=M.+Schiraldiauthor=D.+J.+Antoineauthor=A.+Cattaneoauthor=F.+De+Marchisauthor=J.+Liuauthor=A.+Antonelliauthor=A.+Pretiauthor=L.+Raeliauthor=S.+S.+Shamsauthor=H.+Yangauthor=L.+Varaniauthor=U.+Anderssonauthor=K.+J.+Traceyauthor=A.+Bachiauthor=M.+Uguccioniauthor=M.+E.+Bianchi&title=Mutually+exclusive+redox+forms+of+hmgb1+promote+cell+recruitment+or+proinflammatory+cytokine+release&doi=10.1084%2Fjem.20120189"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1084%2Fjem.20120189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20120189%26sid%3Dliteratum%253Aachs%26aulast%3DVenereau%26aufirst%3DE.%26aulast%3DCasalgrandi%26aufirst%3DM.%26aulast%3DSchiraldi%26aufirst%3DM.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DDe%2BMarchis%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DAntonelli%26aufirst%3DA.%26aulast%3DPreti%26aufirst%3DA.%26aulast%3DRaeli%26aufirst%3DL.%26aulast%3DShams%26aufirst%3DS.%2BS.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DVarani%26aufirst%3DL.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DBachi%26aufirst%3DA.%26aulast%3DUguccioni%26aufirst%3DM.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26atitle%3DMutually%2520exclusive%2520redox%2520forms%2520of%2520hmgb1%2520promote%2520cell%2520recruitment%2520or%2520proinflammatory%2520cytokine%2520release%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2012%26volume%3D209%26issue%3D9%26spage%3D1519%26epage%3D1528%26doi%3D10.1084%2Fjem.20120189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukazawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span> <span> </span><span class="NLM_article-title">Post-translational methylation of high mobility group box 1 (hmgb1) causes its cytoplasmic localization in neutrophils</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">16336</span>– <span class="NLM_lpage">16344</span>, <span class="refDoi"> DOI: 10.1074/jbc.M608467200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1074%2Fjbc.M608467200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=16336-16344&issue=22&author=I.+Itoauthor=J.+Fukazawaauthor=M.+Yoshida&title=Post-translational+methylation+of+high+mobility+group+box+1+%28hmgb1%29+causes+its+cytoplasmic+localization+in+neutrophils&doi=10.1074%2Fjbc.M608467200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608467200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608467200%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DI.%26aulast%3DFukazawa%26aufirst%3DJ.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DPost-translational%2520methylation%2520of%2520high%2520mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520causes%2520its%2520cytoplasmic%2520localization%2520in%2520neutrophils%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D22%26spage%3D16336%26epage%3D16344%26doi%3D10.1074%2Fjbc.M608467200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. S.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 is phosphorylated by classical protein kinase c and is secreted by a calcium-dependent mechanism</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">5800</span>– <span class="NLM_lpage">5809</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0801873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.4049%2Fjimmunol.0801873" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=5800-5809&issue=9&author=Y.+J.+Ohauthor=J.+H.+Younauthor=Y.+Jiauthor=S.+E.+Leeauthor=K.+J.+Limauthor=J.+E.+Choiauthor=J.+S.+Shin&title=Hmgb1+is+phosphorylated+by+classical+protein+kinase+c+and+is+secreted+by+a+calcium-dependent+mechanism&doi=10.4049%2Fjimmunol.0801873"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0801873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0801873%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DY.%2BJ.%26aulast%3DYoun%26aufirst%3DJ.%2BH.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%2BE.%26aulast%3DLim%26aufirst%3DK.%2BJ.%26aulast%3DChoi%26aufirst%3DJ.%2BE.%26aulast%3DShin%26aufirst%3DJ.%2BS.%26atitle%3DHmgb1%2520is%2520phosphorylated%2520by%2520classical%2520protein%2520kinase%2520c%2520and%2520is%2520secreted%2520by%2520a%2520calcium-dependent%2520mechanism%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26issue%3D9%26spage%3D5800%26epage%3D5809%26doi%3D10.4049%2Fjimmunol.0801873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">The functions of hmgb1 depend on molecular localization and post-translational modifications</span>. <i>J. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.1111/joim.12309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fjoim.12309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25346011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVantrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2014&pages=420-424&issue=5&author=U.+Anderssonauthor=D.+J.+Antoineauthor=K.+J.+Tracey&title=The+functions+of+hmgb1+depend+on+molecular+localization+and+post-translational+modifications&doi=10.1111%2Fjoim.12309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The functions of HMGB1 depend on molecular localization and post-translational modifications</span></div><div class="casAuthors">Andersson, U.; Antoine, D. J.; Tracey, K. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Internal Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">420-424</span>CODEN:
                <span class="NLM_cas:coden">JINMEO</span>;
        ISSN:<span class="NLM_cas:issn">0954-6820</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">This review highlights on functions of HMGB1 depend on mol. localization and post-translational modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXhICohXEarrVg90H21EOLACvtfcHk0lhHD-YGOo3FmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVantrnE&md5=724484a86892ead7b9adcf34d181ed28</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fjoim.12309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjoim.12309%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520functions%2520of%2520hmgb1%2520depend%2520on%2520molecular%2520localization%2520and%2520post-translational%2520modifications%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2014%26volume%3D276%26issue%3D5%26spage%3D420%26epage%3D424%26doi%3D10.1111%2Fjoim.12309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress-mediated hmgb1 biology</span>. <i>Front. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">93</span>, <span class="refDoi"> DOI: 10.3389/fphys.2015.00093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3389%2Ffphys.2015.00093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25904867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2MjntlChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=93&author=Y.+Yuauthor=D.+Tangauthor=R.+Kang&title=Oxidative+stress-mediated+hmgb1+biology&doi=10.3389%2Ffphys.2015.00093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress-mediated HMGB1 biology</span></div><div class="casAuthors">Yu Yan; Tang Daolin; Kang Rui</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93</span>
        ISSN:<span class="NLM_cas:issn">1664-042X</span>.
    </div><div class="casAbstract">High mobility group box 1 (HMGB1) is a widely-expressed and highly-abundant protein that acts as an extracellular signal upon active secretion by immune cells or passive release by dead, dying, and injured cells.  Both intracellular and extracellular HMGB1 play pivotal roles in regulation of the cellular response to stress.  Targeting the translocation, release, and activity of HMGB1 can limit inflammation and reduce tissue damage during infection and sterile inflammation.  Although the mechanisms contributing to HMGB1 biology are still under investigation, it appears that oxidative stress is a central regulator of HMGB1's translocation, release, and activity in inflammation and cell death (e.g., necrosis, apoptosis, autophagic cell death, pyroptosis, and NETosis).  Thus, targeting HMGB1 with antioxidant compounds may be an attractive therapeutic strategy for inflammation-associated diseases such as sepsis, ischemia and reperfusion injury, arthritis, diabetes, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1z4Mw0xxFlJggzHGM8X5CfW6udTcc2eYf4Eakd6lU0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjntlChsA%253D%253D&md5=714b8400cf5706332a9f08d9cc022806</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2015.00093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2015.00093%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DR.%26atitle%3DOxidative%2520stress-mediated%2520hmgb1%2520biology%26jtitle%3DFront.%2520Physiol.%26date%3D2015%26volume%3D6%26spage%3D93%26doi%3D10.3389%2Ffphys.2015.00093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LeBlanc, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doggett, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durocher, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, M.</span></span> <span> </span><span class="NLM_article-title">An immunogenic peptide in the a-box of hmgb1 protein reverses apoptosis-induced tolerance through rage receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">7777</span>– <span class="NLM_lpage">7786</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.541474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1074%2Fjbc.M113.541474" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=7777-7786&issue=11&author=P.+M.+LeBlancauthor=T.+A.+Doggettauthor=J.+Choiauthor=M.+A.+Hancockauthor=Y.+Durocherauthor=F.+Frankauthor=B.+Nagarauthor=T.+A.+Fergusonauthor=M.+Saleh&title=An+immunogenic+peptide+in+the+a-box+of+hmgb1+protein+reverses+apoptosis-induced+tolerance+through+rage+receptor&doi=10.1074%2Fjbc.M113.541474"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.541474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.541474%26sid%3Dliteratum%253Aachs%26aulast%3DLeBlanc%26aufirst%3DP.%2BM.%26aulast%3DDoggett%26aufirst%3DT.%2BA.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DHancock%26aufirst%3DM.%2BA.%26aulast%3DDurocher%26aufirst%3DY.%26aulast%3DFrank%26aufirst%3DF.%26aulast%3DNagar%26aufirst%3DB.%26aulast%3DFerguson%26aufirst%3DT.%2BA.%26aulast%3DSaleh%26aufirst%3DM.%26atitle%3DAn%2520immunogenic%2520peptide%2520in%2520the%2520a-box%2520of%2520hmgb1%2520protein%2520reverses%2520apoptosis-induced%2520tolerance%2520through%2520rage%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26issue%3D11%26spage%3D7777%26epage%3D7786%26doi%3D10.1074%2Fjbc.M113.541474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirsch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kniemeyer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Settmacher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahmen, U.</span></span> <span> </span><span class="NLM_article-title">Identification of proteins interacting with cytoplasmic high-mobility group box 1 during the hepatocellular response to ischemia reperfusion injury</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">167</span>, <span class="refDoi"> DOI: 10.3390/ijms18010167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3390%2Fijms18010167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1eitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=167&issue=1&author=T.+Zhangauthor=W.+Weiauthor=O.+Dirschauthor=T.+Krugerauthor=C.+Kanauthor=C.+Xieauthor=O.+Kniemeyerauthor=H.+Fangauthor=U.+Settmacherauthor=U.+Dahmen&title=Identification+of+proteins+interacting+with+cytoplasmic+high-mobility+group+box+1+during+the+hepatocellular+response+to+ischemia+reperfusion+injury&doi=10.3390%2Fijms18010167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of proteins interacting with cytoplasmic high-mobility group box 1 during the hepatocellular response to ischemia reperfusion injury</span></div><div class="casAuthors">Zhang, Tianjiao; Wei, Weiwei; Dirsch, Olaf; Krueger, Thomas; Kan, Chunyi; Xie, Chichi; Kniemeyer, Olaf; Fang, Haoshu; Settmacher, Utz; Dahmen, Uta</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">167/1-167/13</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Ischemia/reperfusion injury (IRI) occurs inevitably in liver transplantations and frequently during major resections, and can lead to liver dysfunction as well as systemic disorders.  High-mobility group box 1 (HMGB1) plays a pathogenic role in hepatic IRI.  In the normal liver, HMGB1 is located in the nucleus of hepatocytes; after ischemia reperfusion, it translocates to the cytoplasm and it is further released to the extracellular space.  Unlike the well-explored functions of nuclear and extracellular HMGB1, the role of cytoplasmic HMGB1 in hepatic IRI remains elusive.  We hypothesized that cytoplasmic HMGB1 interacts with binding proteins involved in the hepatocellular response to IRI.  In this study, binding proteins of cytoplasmic HMGB1 during hepatic IRI were identified.  Liver tissues from rats with warm ischemia reperfusion (WI/R) injury and from normal rats were subjected to cytoplasmic protein extn.  Co-immunopptn. using these protein exts. was performed to enrich HMGB1-protein complexes.  To sep. and identify the immunopptd. proteins in eluates, 2-dimensional electrophoresis and subsequent mass spectrometry detection were performed.  Two of the identified proteins were verified using Western blotting: betaine-homocysteine S-methyltransferase 1 (BHMT) and cystathionine γ-lyase (CTH).  Therefore, our results revealed the binding of HMGB1 to BHMT and CTH in cytoplasm during hepatic WI/R.  This finding may help to better understand the cellular response to IRI in the liver and to identify novel mol. targets for reducing ischemic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-1cUZMFlplbVg90H21EOLACvtfcHk0lhyaq3qEtHt3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1eitrY%253D&md5=6bf9d764597043856e0051f23ae1d735</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3390%2Fijms18010167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18010167%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DDirsch%26aufirst%3DO.%26aulast%3DKruger%26aufirst%3DT.%26aulast%3DKan%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DKniemeyer%26aufirst%3DO.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DSettmacher%26aufirst%3DU.%26aulast%3DDahmen%26aufirst%3DU.%26atitle%3DIdentification%2520of%2520proteins%2520interacting%2520with%2520cytoplasmic%2520high-mobility%2520group%2520box%25201%2520during%2520the%2520hepatocellular%2520response%2520to%2520ischemia%2520reperfusion%2520injury%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26issue%3D1%26spage%3D167%26doi%3D10.3390%2Fijms18010167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Cd24 and siglec-10 selectively repress tissue damage-induced immune responses</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>323</i></span> (<span class="NLM_issue">5922</span>),  <span class="NLM_fpage">1722</span>– <span class="NLM_lpage">1725</span>, <span class="refDoi"> DOI: 10.1126/science.1168988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1126%2Fscience.1168988" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=1722-1725&issue=5922&author=G.+Y.+Chenauthor=J.+Tangauthor=P.+Zhengauthor=Y.+Liu&title=Cd24+and+siglec-10+selectively+repress+tissue+damage-induced+immune+responses&doi=10.1126%2Fscience.1168988"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168988%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%2BY.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DCd24%2520and%2520siglec-10%2520selectively%2520repress%2520tissue%2520damage-induced%2520immune%2520responses%26jtitle%3DScience%26date%3D2009%26volume%3D323%26issue%3D5922%26spage%3D1722%26epage%3D1725%26doi%3D10.1126%2Fscience.1168988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salmivirta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauvala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elenius, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalkanen, M.</span></span> <span> </span><span class="NLM_article-title">Neurite growth-promoting protein (amphoterin, p30) binds syndecan</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>200</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1016/0014-4827(92)90194-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2F0014-4827%2892%2990194-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1369684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADyaK38XksVGgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=1992&pages=444-451&issue=2&author=M.+Salmivirtaauthor=H.+Rauvalaauthor=K.+Eleniusauthor=M.+Jalkanen&title=Neurite+growth-promoting+protein+%28amphoterin%2C+p30%29+binds+syndecan&doi=10.1016%2F0014-4827%2892%2990194-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Neurite growth-promoting protein (amphoterin, p30) binds syndecan</span></div><div class="casAuthors">Salmivirta, Markku; Rauvala, Heikki; Elenius, Klaus; Jalkanen, Markku</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">444-51</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    </div><div class="casAbstract">A new ligand for syndecan (a cell surface heparan sulfate-rich proteoglycan) has been discovered.  In the solid-phase binding assay utilizing small nitrocellulose disks to immobilize matrix mols., binding of syndecan to neurite growth-promoting protein, p30/amphoterin, was obsd.  This binding was strongly dependent on the concn. of amphoterin used to coat the disks, but was saturable with an excess amt. of syndecan.  The interaction was inhibitable with heparan sulfate and heparin but less effectively with chondroitin sulfate, indicating that heparan sulfate chains of syndecan were involved in the binding.  Anti-amphoterin antibodies inhibited the binding partially.  Mouse mammary epithelial cells bound amphoterin directly but not after trypsin treatment or in the presence of heparin and to produce amphoterin in the extracellular space.  Both syndecan and amphoterin were localized on lateral surfaces of newly adhered mammary epithelial cells.  Toward confluency amphoterin amts. decreased.  Because amphoterin can be localized to the same sites with syndecan and because of their interaction, amphoterin is a new putative pericellular ligand for syndecan.  These interactions may be involved in the regulation of cell behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt8ZIDHRx0_rVg90H21EOLACvtfcHk0lhyaq3qEtHt3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XksVGgtb4%253D&md5=bbbb0a12dc07f4a2825bb1fea1a58427</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0014-4827%2892%2990194-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-4827%252892%252990194-D%26sid%3Dliteratum%253Aachs%26aulast%3DSalmivirta%26aufirst%3DM.%26aulast%3DRauvala%26aufirst%3DH.%26aulast%3DElenius%26aufirst%3DK.%26aulast%3DJalkanen%26aufirst%3DM.%26atitle%3DNeurite%2520growth-promoting%2520protein%2520%2528amphoterin%252C%2520p30%2529%2520binds%2520syndecan%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1992%26volume%3D200%26issue%3D2%26spage%3D444%26epage%3D451%26doi%3D10.1016%2F0014-4827%2892%2990194-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orlova, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierhaus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihanus, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballantyne, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gahmberg, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nawroth, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavakis, T.</span></span> <span> </span><span class="NLM_article-title">A novel pathway of hmgb1-mediated inflammatory cell recruitment that requires mac-1-integrin</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1129</span>– <span class="NLM_lpage">1139</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fsj.emboj.7601552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1129-1139&issue=4&author=V.+V.+Orlovaauthor=E.+Y.+Choiauthor=C.+Xieauthor=E.+Chavakisauthor=A.+Bierhausauthor=E.+Ihanusauthor=C.+M.+Ballantyneauthor=C.+G.+Gahmbergauthor=M.+E.+Bianchiauthor=P.+P.+Nawrothauthor=T.+Chavakis&title=A+novel+pathway+of+hmgb1-mediated+inflammatory+cell+recruitment+that+requires+mac-1-integrin&doi=10.1038%2Fsj.emboj.7601552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601552%26sid%3Dliteratum%253Aachs%26aulast%3DOrlova%26aufirst%3DV.%2BV.%26aulast%3DChoi%26aufirst%3DE.%2BY.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DChavakis%26aufirst%3DE.%26aulast%3DBierhaus%26aufirst%3DA.%26aulast%3DIhanus%26aufirst%3DE.%26aulast%3DBallantyne%26aufirst%3DC.%2BM.%26aulast%3DGahmberg%26aufirst%3DC.%2BG.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DNawroth%26aufirst%3DP.%2BP.%26aulast%3DChavakis%26aufirst%3DT.%26atitle%3DA%2520novel%2520pathway%2520of%2520hmgb1-mediated%2520inflammatory%2520cell%2520recruitment%2520that%2520requires%2520mac-1-integrin%26jtitle%3DEMBO%2520J.%26date%3D2007%26volume%3D26%26issue%3D4%26spage%3D1129%26epage%3D1139%26doi%3D10.1038%2Fsj.emboj.7601552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czura, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 signals through toll-like receptor (tlr) 4 and tlr2</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1097/01.shk.0000225404.51320.82</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2F01.shk.0000225404.51320.82" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=174-179&issue=2&author=M.+Yuauthor=H.+Wangauthor=A.+Dingauthor=D.+T.+Golenbockauthor=E.+Latzauthor=C.+J.+Czuraauthor=M.+J.+Fentonauthor=K.+J.+Traceyauthor=H.+Yang&title=Hmgb1+signals+through+toll-like+receptor+%28tlr%29+4+and+tlr2&doi=10.1097%2F01.shk.0000225404.51320.82"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1097%2F01.shk.0000225404.51320.82&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.shk.0000225404.51320.82%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DA.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DFenton%26aufirst%3DM.%2BJ.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DYang%26aufirst%3DH.%26atitle%3DHmgb1%2520signals%2520through%2520toll-like%2520receptor%2520%2528tlr%2529%25204%2520and%2520tlr2%26jtitle%3DShock%26date%3D2006%26volume%3D26%26issue%3D2%26spage%3D174%26epage%3D179%26doi%3D10.1097%2F01.shk.0000225404.51320.82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. L.</span></span> <span> </span><span class="NLM_article-title">The role of thrombomodulin lectin-like domain in inflammation</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">34</span>, <span class="refDoi"> DOI: 10.1186/1423-0127-19-34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2F1423-0127-19-34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22449172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFWkur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=34&author=Y.+H.+Liauthor=C.+H.+Kuoauthor=G.+Y.+Shiauthor=H.+L.+Wu&title=The+role+of+thrombomodulin+lectin-like+domain+in+inflammation&doi=10.1186%2F1423-0127-19-34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The role of thrombomodulin lectin-like domain in inflammation</span></div><div class="casAuthors">Li, Yi-Heng; Kuo, Cheng-Hsiang; Shi, Guey-Yueh; Wu, Hua-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Science (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34</span>CODEN:
                <span class="NLM_cas:coden">JBCIEA</span>;
        ISSN:<span class="NLM_cas:issn">1423-0127</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Thrombomodulin (TM) is a cell surface glycoprotein which is widely expressed in a variety of cell types.  It is a cofactor for thrombin binding that mediates protein C activation and inhibits thrombin activity.  In addn. to its anticoagulant activity, recent evidence has revealed that TM, esp. its lectin-like domain, has potent anti-inflammatory function through a variety of mol. mechanisms.  The lectin-like domain of TM plays an important role in suppressing inflammation independent of the TM anticoagulant activity.  This article makes an extensive review of the role of TM in inflammation.  The mol. targets of TM lectin-like domain have also been elucidated.  Recombinant TM protein, esp. the TM lectin-like domain may play a promising role in the management of sepsis, glomerulonephritis and arthritis.  These data demonstrated the potential therapeutic role of TM in the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSi7oVF0lbxbVg90H21EOLACvtfcHk0lhq5hkGMzQhTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFWkur4%253D&md5=14ba9136ba6007e933693b75f47c2857</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2F1423-0127-19-34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1423-0127-19-34%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BH.%26aulast%3DKuo%26aufirst%3DC.%2BH.%26aulast%3DShi%26aufirst%3DG.%2BY.%26aulast%3DWu%26aufirst%3DH.%2BL.%26atitle%3DThe%2520role%2520of%2520thrombomodulin%2520lectin-like%2520domain%2520in%2520inflammation%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2012%26volume%3D19%26spage%3D34%26doi%3D10.1186%2F1423-0127-19-34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addorisio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postiglione, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Abed, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">The haptoglobin beta subunit sequesters hmgb1 toxicity in sterile and infectious inflammation</span>. <i>J. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1111/joim.12619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fjoim.12619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28464519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGgtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2017&pages=76-93&issue=1&author=H.+Yangauthor=H.+Wangauthor=Y.+Wangauthor=M.+Addorisioauthor=J.+Liauthor=M.+J.+Postiglioneauthor=S.+S.+Chavanauthor=Y.+Al-Abedauthor=D.+J.+Antoineauthor=U.+Anderssonauthor=K.+J.+Tracey&title=The+haptoglobin+beta+subunit+sequesters+hmgb1+toxicity+in+sterile+and+infectious+inflammation&doi=10.1111%2Fjoim.12619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation</span></div><div class="casAuthors">Yang, H.; Wang, H.; Wang, Y.; Addorisio, M.; Li, J.; Postiglione, M. J.; Chavan, S. S.; Al-Abed, Y.; Antoine, D. J.; Andersson, U.; Tracey, K. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Internal Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-93</span>CODEN:
                <span class="NLM_cas:coden">JINMEO</span>;
        ISSN:<span class="NLM_cas:issn">0954-6820</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : Extra-corpuscular Hb is an endogenous factor enhancing inflammatory tissue damage, a process counteracted by the Hb-binding plasma protein haptoglobin composed of alpha and beta subunits connected by disulfide bridges.  Recent studies established that haptoglobin also binds and sequesters another pro-inflammatory mediator, HMGB1, via triggering CD163 receptor-mediated anti-inflammatory responses involving heme oxygenase-1 expression and IL-10 release.  The mol. mechanism underlying haptoglobin-HMGB1 interaction remains poorly elucidated.  Methods : Haptoglobin β subunits were tested for HMGB1-binding properties, as well as efficacy in animal models of sterile liver injury (induced by i.p. acetaminophen administration) or infectious peritonitis (induced by cecal ligation and puncture, CLP, surgery) using wild-type (C57BL/6) or haptoglobin gene-deficient mice.  Results : Structural-functional anal. demonstrated that the haptoglobin β subunit recapitulates the HMGB1-binding properties of full-length haptoglobin.  Similar to HMGB1-haptoglobin complexes, the HMGB1-haptoglobin β complexes also elicited anti-inflammatory effects via CD163-mediated IL-10 release and heme oxygenase-1 expression.  Treatment with haptoglobin β protein conferred significant protection in mouse models of polymicrobial sepsis as well as acetaminophen-induced liver injury, two HMGB1-dependent inflammatory conditions.  Conclusions : Haptoglobin β protein offers a novel therapeutic approach to fight against various inflammatory diseases caused by excessive HMGB1 release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTZ2WJ6ac5c7Vg90H21EOLACvtfcHk0lhq5hkGMzQhTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGgtb3L&md5=3cab497fefed3878becdabc42b8009d7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fjoim.12619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjoim.12619%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DAddorisio%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DPostiglione%26aufirst%3DM.%2BJ.%26aulast%3DChavan%26aufirst%3DS.%2BS.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520haptoglobin%2520beta%2520subunit%2520sequesters%2520hmgb1%2520toxicity%2520in%2520sterile%2520and%2520infectious%2520inflammation%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2017%26volume%3D282%26issue%3D1%26spage%3D76%26epage%3D93%26doi%3D10.1111%2Fjoim.12619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du Toit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loos, B.</span></span> <span> </span><span class="NLM_article-title">Autophagy and the invisible line between life and death</span>. <i>Eur. J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">598</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.ejcb.2016.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.ejcb.2016.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28340912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOhtLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2016&pages=598-610&issue=12&author=C.+Swartauthor=A.+Du+Toitauthor=B.+Loos&title=Autophagy+and+the+invisible+line+between+life+and+death&doi=10.1016%2Fj.ejcb.2016.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy and the invisible line between life and death</span></div><div class="casAuthors">Swart, Chrisna; Du Toit, Andre; Loos, Ben</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">598-610</span>CODEN:
                <span class="NLM_cas:coden">EJCBDN</span>;
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  For a considerable time cell death has been considered to represent mutually exclusive states with cell death modalities that are governed by their inherent and unique mode of action involving specific mol. entities and have therefore been studied primarily in isolation.  It is now, however, becoming increasingly clear that these modalities are regulated by similar pathways and share a no. of initiator and effector mols. that control both cell death as well as cell survival mechanisms, demanding a newly aligned and integrative approach of cell death assessment.  Frequently cell death is triggered through a dual action that incorporates signaling events assocd. with more than one death modality.  Apoptosis and necrosis regularly cooperate in a tightly balanced interplay that involves autophagy to serve context dependently either as a pro-survival or a pro-death mechanism.  In this review we will assess current cell death modalities and their mol. overlap with the goal of clarifying the controversial role of autophagy in the cell death response.  By dissecting the key mol. pathways and their positioning within a network of regulatory signalling hubs and checkpoints we discuss a distinct approach that integrates autophagy with a resultant cell death manifestation.  In doing so, former classifications of cell death modalities fade and reveal the intricate mol. proportions and complexities of the cell death response that may contribute towards an enhanced means of cell death control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw_5cXNCu9x7Vg90H21EOLACvtfcHk0lha-wCUxdj40w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOhtLvI&md5=4c054ec57445bffd2d6ae3302092da6a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.ejcb.2016.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejcb.2016.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DSwart%26aufirst%3DC.%26aulast%3DDu%2BToit%26aufirst%3DA.%26aulast%3DLoos%26aufirst%3DB.%26atitle%3DAutophagy%2520and%2520the%2520invisible%2520line%2520between%2520life%2520and%2520death%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D2016%26volume%3D95%26issue%3D12%26spage%3D598%26epage%3D610%26doi%3D10.1016%2Fj.ejcb.2016.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agellon, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalak, M.</span></span> <span> </span><span class="NLM_article-title">Ca(2+) homeostasis and endoplasmic reticulum (er) stress: An integrated view of calcium signaling</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>460</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2015.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.bbrc.2015.02.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2015&pages=114-121&issue=1&author=J.+Krebsauthor=L.+B.+Agellonauthor=M.+Michalak&title=Ca%282%2B%29+homeostasis+and+endoplasmic+reticulum+%28er%29+stress%3A+An+integrated+view+of+calcium+signaling&doi=10.1016%2Fj.bbrc.2015.02.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DKrebs%26aufirst%3DJ.%26aulast%3DAgellon%26aufirst%3DL.%2BB.%26aulast%3DMichalak%26aufirst%3DM.%26atitle%3DCa%25282%252B%2529%2520homeostasis%2520and%2520endoplasmic%2520reticulum%2520%2528er%2529%2520stress%253A%2520An%2520integrated%2520view%2520of%2520calcium%2520signaling%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D460%26issue%3D1%26spage%3D114%26epage%3D121%26doi%3D10.1016%2Fj.bbrc.2015.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orrenius, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogvadze, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span> <span> </span><span class="NLM_article-title">Calcium and mitochondria in the regulation of cell death</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>460</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2015.01.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.bbrc.2015.01.137" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2015&pages=72-81&issue=1&author=S.+Orreniusauthor=V.+Gogvadzeauthor=B.+Zhivotovsky&title=Calcium+and+mitochondria+in+the+regulation+of+cell+death&doi=10.1016%2Fj.bbrc.2015.01.137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.01.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.01.137%26sid%3Dliteratum%253Aachs%26aulast%3DOrrenius%26aufirst%3DS.%26aulast%3DGogvadze%26aufirst%3DV.%26aulast%3DZhivotovsky%26aufirst%3DB.%26atitle%3DCalcium%2520and%2520mitochondria%2520in%2520the%2520regulation%2520of%2520cell%2520death%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D460%26issue%3D1%26spage%3D72%26epage%3D81%26doi%3D10.1016%2Fj.bbrc.2015.01.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, K. I.</span></span> <span> </span><span class="NLM_article-title">Calcium/calmodulin-dependent protein kinase is involved in the release of high mobility group box 1 via the interferon-beta signaling pathway</span>. <i>Immune Netw.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.4110/in.2012.12.4.148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.4110%2Fin.2012.12.4.148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23091438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FnsVGgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=148-154&issue=4&author=L.+Maauthor=S.+J.+Kimauthor=K.+I.+Oh&title=Calcium%2Fcalmodulin-dependent+protein+kinase+is+involved+in+the+release+of+high+mobility+group+box+1+via+the+interferon-beta+signaling+pathway&doi=10.4110%2Fin.2012.12.4.148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium/Calmodulin-Dependent Protein Kinase is Involved in the Release of High Mobility Group Box 1 Via the Interferon-β Signaling Pathway</span></div><div class="casAuthors">Ma Lijuan; Kim Seon-Ju; Oh Kwon Ik</div><div class="citationInfo"><span class="NLM_cas:title">Immune network</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">148-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Previously, we have reported that high mobility group box 1 (HMGB1), a proinflammatory mediator in sepsis, is released via the IFN-β-mediated JAK/STAT pathway.  However, detailed mechanisms are still unclear.  In this study, we dissected upstream signaling pathways of HMGB1 release using various molecular biology methods.  Here, we found that calcium/calmodulin-dependent protein kinase (CaM kinase, CaMK) is involved in HMGB1 release by regulating IFN-β production.  CaMK inhibitor, STO609, treatment inhibits LPS-induced IFN-β production, which is correlated with the phosphorylation of interferon regulatory factor 3 (IRF3).  Additionally, we show that CaMK-I plays a major role in IFN-β production although other CaMK members also seem to contribute to this event.  Furthermore, the CaMK inhibitor treatment reduced IFN-β production in a murine endotoxemia.  Our results suggest CaMKs contribute to HMGB1 release by enhancing IFN-β production in sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQjFK-eqXNi42Zyxfu64m4ffW6udTcc2eYlny4MYwFsQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FnsVGgtw%253D%253D&md5=c7474aa9efcc1a105fa3ce29e7fcfd83</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.4110%2Fin.2012.12.4.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4110%252Fin.2012.12.4.148%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DOh%26aufirst%3DK.%2BI.%26atitle%3DCalcium%252Fcalmodulin-dependent%2520protein%2520kinase%2520is%2520involved%2520in%2520the%2520release%2520of%2520high%2520mobility%2520group%2520box%25201%2520via%2520the%2520interferon-beta%2520signaling%2520pathway%26jtitle%3DImmune%2520Netw.%26date%3D2012%26volume%3D12%26issue%3D4%26spage%3D148%26epage%3D154%26doi%3D10.4110%2Fin.2012.12.4.148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribar, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Means, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angus, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosengart, M. R.</span></span> <span> </span><span class="NLM_article-title">Calcium/calmodulin-dependent protein kinase (camk) iv mediates nucleocytoplasmic shuttling and release of hmgb1 during lipopolysaccharide stimulation of macrophages</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">5015</span>– <span class="NLM_lpage">5023</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.181.7.5015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.4049%2Fjimmunol.181.7.5015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2008&pages=5015-5023&issue=7&author=X.+Zhangauthor=D.+Wheelerauthor=Y.+Tangauthor=L.+Guoauthor=R.+A.+Shapiroauthor=T.+J.+Ribarauthor=A.+R.+Meansauthor=T.+R.+Billiarauthor=D.+C.+Angusauthor=M.+R.+Rosengart&title=Calcium%2Fcalmodulin-dependent+protein+kinase+%28camk%29+iv+mediates+nucleocytoplasmic+shuttling+and+release+of+hmgb1+during+lipopolysaccharide+stimulation+of+macrophages&doi=10.4049%2Fjimmunol.181.7.5015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.181.7.5015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.181.7.5015%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWheeler%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DR.%2BA.%26aulast%3DRibar%26aufirst%3DT.%2BJ.%26aulast%3DMeans%26aufirst%3DA.%2BR.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DAngus%26aufirst%3DD.%2BC.%26aulast%3DRosengart%26aufirst%3DM.%2BR.%26atitle%3DCalcium%252Fcalmodulin-dependent%2520protein%2520kinase%2520%2528camk%2529%2520iv%2520mediates%2520nucleocytoplasmic%2520shuttling%2520and%2520release%2520of%2520hmgb1%2520during%2520lipopolysaccharide%2520stimulation%2520of%2520macrophages%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D181%26issue%3D7%26spage%3D5015%26epage%3D5023%26doi%3D10.4049%2Fjimmunol.181.7.5015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">High-mobility group box 1 (hmgb1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (sr) ca(2+) leak through tlr4-ros signaling in cardiomyocytes</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1016/j.yjmcc.2014.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.yjmcc.2014.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24937603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ens7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=260-273&author=C.+Zhangauthor=M.+Moauthor=W.+Dingauthor=W.+Liuauthor=D.+Yanauthor=J.+Dengauthor=X.+Luoauthor=J.+Liu&title=High-mobility+group+box+1+%28hmgb1%29+impaired+cardiac+excitation-contraction+coupling+by+enhancing+the+sarcoplasmic+reticulum+%28sr%29+ca%282%2B%29+leak+through+tlr4-ros+signaling+in+cardiomyocytes&doi=10.1016%2Fj.yjmcc.2014.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca2 + leak through TLR4-ROS signaling in cardiomyocytes</span></div><div class="casAuthors">Zhang, Cuicui; Mo, Miaohua; Ding, Wenwen; Liu, Wenjuan; Yan, Dewen; Deng, Jianxin; Luo, Xinping; Liu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">260-273</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High-mobility group box 1 (HMGB1) is a proinflammatory mediator playing an important role in the pathogenesis of cardiac dysfunction in many diseases.  In this study, we explored the effects of HMGB1 on Ca2 + handling and cellular contractility in cardiomyocytes to seek for the mechanisms underlying HMGB1-induced cardiac dysfunction.  Our results show that HMGB1 increased the frequency of Ca2 + sparks, reduced the sarcoplasmic reticulum (SR) Ca2 + content, and decreased the amplitude of systolic Ca2 + transient and myocyte contractility in dose-dependent manners in adult rat ventricular myocytes.  Inhibiting high-frequent Ca2 + sparks with tetracaine largely inhibited the alterations of SR load and Ca2 + transient.  Blocking Toll-like receptor 4 (TLR4) with TAK-242 or knockdown of TLR4 by RNA interference remarkably inhibited HMGB1 induced high-frequent Ca2 + sparks and restored the SR Ca2 + content.  Concomitantly, the amplitude of systolic Ca2 + transient and myocyte contractility had significantly increased.  Furthermore, HMGB1 increased the level of intracellular reactive oxygen species (ROS) and consequently enhanced oxidative stress and CaMKII-activated phosphorylation (pSer2814) in ryanodine receptor 2 (RyR2).  TAK-242 pretreatment significantly decreased intracellular ROS levels and oxidative stress and hyperphosphorylation in RyR2, similar to the effects of antioxidant MnTBAP.  Consistently, MnTBAP normalized HMGB1-impaired Ca2 + handling and myocyte contractility.  Taken together, our findings suggest that HMGB1 enhances Ca2 + spark-mediated SR Ca2 + leak through TLR4-ROS signaling pathway, which causes partial depletion of SR Ca2 + content and hence decreases systolic Ca2 + transient and myocyte contractility.  Prevention of SR Ca2 + leak may be an effective therapeutic strategy for the treatment of cardiac dysfunction related to HMGB1 overprodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy5Bl4MmR2M7Vg90H21EOLACvtfcHk0liEfg1OS1ag-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ens7nJ&md5=10df1705d1cf8c9f0a5dacda9194c10c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2014.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2014.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMo%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DHigh-mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520impaired%2520cardiac%2520excitation-contraction%2520coupling%2520by%2520enhancing%2520the%2520sarcoplasmic%2520reticulum%2520%2528sr%2529%2520ca%25282%252B%2529%2520leak%2520through%2520tlr4-ros%2520signaling%2520in%2520cardiomyocytes%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2014%26volume%3D74%26spage%3D260%26epage%3D273%26doi%3D10.1016%2Fj.yjmcc.2014.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Extracellular calcium elicits feedforward regulation of the toll-like receptor-triggered innate immune response</span>. <i>Cell. Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1038/cmi.2015.59</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fcmi.2015.59" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26277896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVyrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=180-191&issue=2&author=S.+Tangauthor=T.+Chenauthor=M.+Yangauthor=L.+Wangauthor=Z.+Yuauthor=B.+Xieauthor=C.+Qianauthor=S.+Xuauthor=N.+Liauthor=X.+Caoauthor=J.+Wang&title=Extracellular+calcium+elicits+feedforward+regulation+of+the+toll-like+receptor-triggered+innate+immune+response&doi=10.1038%2Fcmi.2015.59"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium elicits feedforward regulation of the Toll-like receptor-triggered innate immune response</span></div><div class="casAuthors">Tang, Songqing; Chen, Taoyong; Yang, Mingjin; Wang, Lei; Yu, Zhou; Xie, Bin; Qian, Cheng; Xu, Sheng; Li, Nan; Cao, Xuetao; Wang, Jianli</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-191</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite the expanding knowledge on feedback regulation of Toll-like receptor (TLR) signaling, the feedforward regulation of TLR signaling for the proper innate response to invading microbes is not fully understood.  Here, we report that extracellular calcium can coordinate the activation of the small GTPases Ras and Ras-proximate-1 (Rap1) upon TLR stimulation which favors activation of macrophages through a feedforward mechanism.  We show that different doses of TLR agonists can trigger different levels of cytokine prodn., which can be potentiated by extracellular calcium but are impaired by the chelating reagent ethylene glycol tetraacetic acid (EGTA) or by knockdown of stromal interaction mol. 1 (STIM1).  Upon TLR engagement, GTP-bound Ras levels are increased and GTP-bound Rap1 is decreased, which can be reversed by EGTA-mediated removal of extracellular calcium.  Furthermore, we demonstrate that Rap1 knockdown rescues the inhibitory effects of EGTA on the TLR-triggered innate response.  Examn. of the TLR signaling pathway reveals that extracellular calcium may regulate the TLR response via feedforward activation of the extracellular signal-regulated kinase signaling pathway.  Our data suggest that an influx of extracellular calcium, mediated by STIM1-operated calcium channels, may transmit the information about the intensity of extracellular TLR stimuli to initiate innate responses at an appropriate level.  Our study may provide mechanistic insight into the feedforward regulation of the TLR-triggered innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFhcztefoQPbVg90H21EOLACvtfcHk0lii-qFRsfrYJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVyrurw%253D&md5=d2e52128c3be0f06221f4ff7853f9f5e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fcmi.2015.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcmi.2015.59%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DExtracellular%2520calcium%2520elicits%2520feedforward%2520regulation%2520of%2520the%2520toll-like%2520receptor-triggered%2520innate%2520immune%2520response%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2017%26volume%3D14%26issue%3D2%26spage%3D180%26epage%3D191%26doi%3D10.1038%2Fcmi.2015.59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, M.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor-triggered calcium mobilization protects mice against bacterial infection through extracellular atp release</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5076</span>– <span class="NLM_lpage">5085</span>, <span class="refDoi"> DOI: 10.1128/IAI.02546-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1128%2FIAI.02546-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25245808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyitbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=5076-5085&issue=12&author=H.+Renauthor=Y.+Tengauthor=B.+Tanauthor=X.+Zhangauthor=W.+Jiangauthor=M.+Liuauthor=W.+Jiangauthor=B.+Duauthor=M.+Qian&title=Toll-like+receptor-triggered+calcium+mobilization+protects+mice+against+bacterial+infection+through+extracellular+atp+release&doi=10.1128%2FIAI.02546-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptor-triggered calcium mobilization protects mice against bacterial infection through extracellular ATP release</span></div><div class="casAuthors">Ren, Hua; Teng, Yunfei; Tan, Binghe; Zhang, Xiaoyu; Jiang, Wei; Liu, Mingyao; Jiang, Wenzheng; Du, Bing; Qian, Min</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5076-5085, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Extracellular ATP (eATP), released as a "danger signal" by injured or stressed cells, plays an important role in the regulation of immune responses, but the relationship between ATP release and innate immune responses is still uncertain.  In this study, we demonstrated that ATP was released through Toll-like receptor (TLR)-assocd. signaling in both Escherichia coli-infected mice and lipopolysaccharide (LPS)- or Pam3CSK4-treated macrophages.  This ATP release could be blocked completely only by N-ethylmaleimide (NEM), not by carbenoxolone (CBX), flufenamic acid (FFA), or probenecid, suggesting the key role of exocytosis in this process.  Furthermore, LPS-induced ATP release could also be reduced dramatically through suppressing calcium mobilization by use of U73122, caffeine, and thapsigargin (TG).  In addn., the secretion of interleukin-1β (IL-1β) and CCL-2 was enhanced significantly by ATP, in a time- and dose-dependent manner.  Meanwhile, macrophage-mediated phagocytosis of bacteria was also promoted significantly by ATP stimulation.  Furthermore, extracellular ATP reduced the no. of invading bacteria and protected mice from peritonitis by activating purinergic receptors.  Mechanistically, phosphorylation of AKT and ERK was overtly increased by ATP in antibacterial immune responses.  Accordingly, if we blocked the P2X- and P2Y-assocd. signaling pathway by using suramin and pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid), tetrasodium salt (PPADS), the ATP-enhanced immune response was restrained significantly.  Taken together, our findings reveal an internal relationship between danger signals and TLR signaling in innate immune responses, which suggests a potential therapeutic significance of calcium mobilization-mediated ATP release in infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp05C_inpJ7NbVg90H21EOLACvtfcHk0lii-qFRsfrYJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyitbrI&md5=6fe5e7c497411aa8cdc616d1005fb640</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FIAI.02546-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.02546-14%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DH.%26aulast%3DTeng%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DM.%26atitle%3DToll-like%2520receptor-triggered%2520calcium%2520mobilization%2520protects%2520mice%2520against%2520bacterial%2520infection%2520through%2520extracellular%2520atp%2520release%26jtitle%3DInfect.%2520Immun.%26date%3D2014%26volume%3D82%26issue%3D12%26spage%3D5076%26epage%3D5085%26doi%3D10.1128%2FIAI.02546-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Bernard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzuto, R.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors hit calcium</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1002/embr.201438685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Fembr.201438685" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=468-469&issue=5&author=M.+de%0ABernardauthor=R.+Rizzuto&title=Toll-like+receptors+hit+calcium&doi=10.1002%2Fembr.201438685"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fembr.201438685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fembr.201438685%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBernard%26aufirst%3DM.%26aulast%3DRizzuto%26aufirst%3DR.%26atitle%3DToll-like%2520receptors%2520hit%2520calcium%26jtitle%3DEMBO%2520Rep.%26date%3D2014%26volume%3D15%26issue%3D5%26spage%3D468%26epage%3D469%26doi%3D10.1002%2Fembr.201438685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allette, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Due, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripsch, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, F. A.</span></span> <span> </span><span class="NLM_article-title">Identification of a functional interaction of hmgb1 with receptor for advanced glycation end-products in a model of neuropathic pain</span>. <i>Brain, Behav., Immun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.bbi.2014.06.199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.bbi.2014.06.199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=169-177&author=Y.+M.+Alletteauthor=M.+R.+Dueauthor=S.+M.+Wilsonauthor=P.+Feldmanauthor=M.+S.+Ripschauthor=R.+Khannaauthor=F.+A.+White&title=Identification+of+a+functional+interaction+of+hmgb1+with+receptor+for+advanced+glycation+end-products+in+a+model+of+neuropathic+pain&doi=10.1016%2Fj.bbi.2014.06.199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2014.06.199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2014.06.199%26sid%3Dliteratum%253Aachs%26aulast%3DAllette%26aufirst%3DY.%2BM.%26aulast%3DDue%26aufirst%3DM.%2BR.%26aulast%3DWilson%26aufirst%3DS.%2BM.%26aulast%3DFeldman%26aufirst%3DP.%26aulast%3DRipsch%26aufirst%3DM.%2BS.%26aulast%3DKhanna%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DF.%2BA.%26atitle%3DIdentification%2520of%2520a%2520functional%2520interaction%2520of%2520hmgb1%2520with%2520receptor%2520for%2520advanced%2520glycation%2520end-products%2520in%2520a%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2014%26volume%3D42%26spage%3D169%26epage%3D177%26doi%3D10.1016%2Fj.bbi.2014.06.199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiraldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livoti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celona, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venereau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apuzzo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marchis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proudfoot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uguccioni, M.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with cxcl12 and signaling via cxcr4</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>209</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1084/jem.20111739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1084%2Fjem.20111739" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2012&pages=551-563&issue=3&author=M.+Schiraldiauthor=A.+Raucciauthor=L.+M.+Munozauthor=E.+Livotiauthor=B.+Celonaauthor=E.+Venereauauthor=T.+Apuzzoauthor=F.+De+Marchisauthor=M.+Pedottiauthor=A.+Bachiauthor=M.+Thelenauthor=L.+Varaniauthor=M.+Melladoauthor=A.+Proudfootauthor=M.+E.+Bianchiauthor=M.+Uguccioni&title=Hmgb1+promotes+recruitment+of+inflammatory+cells+to+damaged+tissues+by+forming+a+complex+with+cxcl12+and+signaling+via+cxcr4&doi=10.1084%2Fjem.20111739"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1084%2Fjem.20111739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20111739%26sid%3Dliteratum%253Aachs%26aulast%3DSchiraldi%26aufirst%3DM.%26aulast%3DRaucci%26aufirst%3DA.%26aulast%3DMunoz%26aufirst%3DL.%2BM.%26aulast%3DLivoti%26aufirst%3DE.%26aulast%3DCelona%26aufirst%3DB.%26aulast%3DVenereau%26aufirst%3DE.%26aulast%3DApuzzo%26aufirst%3DT.%26aulast%3DDe%2BMarchis%26aufirst%3DF.%26aulast%3DPedotti%26aufirst%3DM.%26aulast%3DBachi%26aufirst%3DA.%26aulast%3DThelen%26aufirst%3DM.%26aulast%3DVarani%26aufirst%3DL.%26aulast%3DMellado%26aufirst%3DM.%26aulast%3DProudfoot%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DUguccioni%26aufirst%3DM.%26atitle%3DHmgb1%2520promotes%2520recruitment%2520of%2520inflammatory%2520cells%2520to%2520damaged%2520tissues%2520by%2520forming%2520a%2520complex%2520with%2520cxcl12%2520and%2520signaling%2520via%2520cxcr4%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2012%26volume%3D209%26issue%3D3%26spage%3D551%26epage%3D563%26doi%3D10.1084%2Fjem.20111739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, F.</span></span> <span> </span><span class="NLM_article-title">New insights into trp channels: Interaction with pattern recognition receptors</span>. <i>Channels</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.4161/chan.27178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.4161%2Fchan.27178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24299922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12ktbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=13-19&issue=1&author=H.+Hanauthor=F.+Yi&title=New+insights+into+trp+channels%3A+Interaction+with+pattern+recognition+receptors&doi=10.4161%2Fchan.27178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into TRP channels: interaction with pattern recognition receptors</span></div><div class="casAuthors">Han, Huirong; Yi, Fan</div><div class="citationInfo"><span class="NLM_cas:title">Channels</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-19</span>CODEN:
                <span class="NLM_cas:coden">CHANCC</span>;
        ISSN:<span class="NLM_cas:issn">1933-6950</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  An increasing no. of studies have implicated that the activation of innate immune system and inflammatory mechanisms are of importance in the pathogenesis of numerous diseases.  The innate immune system is present in almost all multicellular organisms in response to pathogens or tissue injury, which is performed via germ-line encoded pattern-recognition receptors (PRRs) to recognize pathogen-assocd. mol. patterns (PAMPs) or dangers-assocd. mol. patterns (DAMPs).  Intracellular pathways linking immune and inflammatory response to ion channel expression and function have been recently identified.  Among ion channels, transient receptor potential (TRP) channels are a major family of non-selective cation-permeable channels that function as polymodal cellular sensors involved in many physiol. and pathol. processes.  In this review, we summarize current knowledge about classifications, functions, and interactions of TRP channels and PRRs, which may provide new insights into their roles in the pathogenesis of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB_3-ifzTMSrVg90H21EOLACvtfcHk0lhpkTDoIKGPxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12ktbrJ&md5=00d2b0570d37a7dbd28a877989ce2193</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.4161%2Fchan.27178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fchan.27178%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DH.%26aulast%3DYi%26aufirst%3DF.%26atitle%3DNew%2520insights%2520into%2520trp%2520channels%253A%2520Interaction%2520with%2520pattern%2520recognition%2520receptors%26jtitle%3DChannels%26date%3D2014%26volume%3D8%26issue%3D1%26spage%3D13%26epage%3D19%26doi%3D10.4161%2Fchan.27178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchel, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayball, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, K. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of hmgb1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">5850</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-06205-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fs41598-017-06205-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28724977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC1cjpt1Oisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=5850&issue=1&author=N.+E.+Stevensauthor=M.+J.+Chapmanauthor=C.+K.+Fraserauthor=T.+R.+Kuchelauthor=J.+D.+Hayballauthor=K.+R.+Diener&title=Therapeutic+targeting+of+hmgb1+during+experimental+sepsis+modulates+the+inflammatory+cytokine+profile+to+one+associated+with+improved+clinical+outcomes&doi=10.1038%2Fs41598-017-06205-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes</span></div><div class="casAuthors">Stevens Natalie E; Hayball John D; Diener Kerrilyn R; Chapman Marianne J; Chapman Marianne J; Fraser Cara K; Kuchel Tim R; Hayball John D; Diener Kerrilyn R</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5850</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sepsis remains a significant health burden and a major clinical need exists for therapeutics to dampen the excessive and uncontrolled immune activation.  Nuclear protein high mobility group box protein 1 (HMGB1) is released following cell death and is a late mediator in sepsis pathogenesis.  While approaches targeting HMGB1 have demonstrated reduced mortality in pre-clinical models of sepsis, the impact of HMGB1 blockade on the complex septic inflammatory milieu and the development of subsequent immunosuppression remain enigmatic.  Analysis of plasma samples obtained from septic shock patients established an association between increased HMGB1 and non-survival, higher APACHE II scores, and increased pro-inflammatory cytokine responses.  Pre-clinically, administration of neutralising ovine anti-HMGB1 polyclonal antibodies improved survival in murine endotoxaemia and caecal ligation and puncture-induced sepsis models, and altered early cytokine profiles to one which corresponded to patterns observed in the surviving patient cohort.  Additionally, anti-HMGB1 treated murine sepsis survivors were significantly more resistant to secondary bacterial infection and exhibited altered innate immune cell phenotypes and cytokine responses.  These findings demonstrate that anti-HMGB1 antibodies alter inflammation in murine sepsis models and reduce sepsis mortality without potentiating immunosuppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpqnwfDgZWMZWtyewyzkyLfW6udTcc2eadbFh1lrxAsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjpt1Oisg%253D%253D&md5=f1e3e954601f7cf877a788ae90344711</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-06205-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-06205-z%26sid%3Dliteratum%253Aachs%26aulast%3DStevens%26aufirst%3DN.%2BE.%26aulast%3DChapman%26aufirst%3DM.%2BJ.%26aulast%3DFraser%26aufirst%3DC.%2BK.%26aulast%3DKuchel%26aufirst%3DT.%2BR.%26aulast%3DHayball%26aufirst%3DJ.%2BD.%26aulast%3DDiener%26aufirst%3DK.%2BR.%26atitle%3DTherapeutic%2520targeting%2520of%2520hmgb1%2520during%2520experimental%2520sepsis%2520modulates%2520the%2520inflammatory%2520cytokine%2520profile%2520to%2520one%2520associated%2520with%2520improved%2520clinical%2520outcomes%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D5850%26doi%3D10.1038%2Fs41598-017-06205-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sama, A. E.</span></span> <span> </span><span class="NLM_article-title">Targeting hmgb1 in the treatment of sepsis</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1517/14728222.2014.863876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1517%2F14728222.2014.863876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24392842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1CjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=257-268&issue=3&author=H.+Wangauthor=M.+F.+Wardauthor=A.+E.+Sama&title=Targeting+hmgb1+in+the+treatment+of+sepsis&doi=10.1517%2F14728222.2014.863876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting HMGB1 in the treatment of sepsis</span></div><div class="casAuthors">Wang, Haichao; Ward, Mary F.; Sama, Andrew E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-268</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Sepsis refers to the host's deleterious and non-resolving systemic inflammatory response to microbial infections and represents the leading cause of death in the intensive care unit.  The pathogenesis of sepsis is complex, but partly mediated by a newly identified alarmin mol., the high mobility group box 1 (HMGB1).  Areas covered: Here we review the evidence that support extracellular HMGB1 as a late mediator of exptl. sepsis with a wider therapeutic window and discuss the therapeutic potential of HMGB1-neutralizing antibodies and small mol. inhibitors (herbal components) in exptl. sepsis.  Expert opinion: It will be important to evaluate the efficacy of HMGB1-targeting strategies for the clin. management of human sepsis in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgOhjL4Dw2SrVg90H21EOLACvtfcHk0lhiFU23D1tTpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1CjtLY%253D&md5=a4666b118edce3efd65a8866e586bb22</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.863876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.863876%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWard%26aufirst%3DM.%2BF.%26aulast%3DSama%26aufirst%3DA.%2BE.%26atitle%3DTargeting%2520hmgb1%2520in%2520the%2520treatment%2520of%2520sepsis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26issue%3D3%26spage%3D257%26epage%3D268%26doi%3D10.1517%2F14728222.2014.863876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span> <span> </span><span class="NLM_article-title">The role of hmgb1 in the pathogenesis of rheumatic disease</span>. <i>Biochim. Biophys. Acta, Gene Regul. Mech.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1799</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1016/j.bbagrm.2009.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.bbagrm.2009.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=20123076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslWguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1799&publication_year=2010&pages=141-148&issue=1%E2%80%932&author=U.+Anderssonauthor=H.+E.+Harris&title=The+role+of+hmgb1+in+the+pathogenesis+of+rheumatic+disease&doi=10.1016%2Fj.bbagrm.2009.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The role of HMGB1 in the pathogenesis of rheumatic disease</span></div><div class="casAuthors">Andersson, Ulf; Harris, Helena Erlandsson</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Gene Regulatory Mechanisms</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1799</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">141-148</span>CODEN:
                <span class="NLM_cas:coden">BBAGC6</span>;
        ISSN:<span class="NLM_cas:issn">1874-9399</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  HMGB1 is a ubiquitous nuclear protein that can be released by any damaged cell or by activated macrophages and certain other cell types.  HMGB1 has been successfully therapeutically targeted in multiple preclin. models of infectious and sterile diseases including arthritis.  Extracellular HMGB1 mediates inflammation via induction of cytokine and metalloproteinase prodn. and recruitment and activation of dendritic cells needed for priming of naive T helper type 1 lymphocytes.  HMGB1 can bind endogenous mols. such as IL-1β and nucleosomes and exogenous agents like endotoxin and microbial DNA.  These complexes synergistically increase the capacity for activation of adaptive and innate immunity.  HMGB1-nucleosome complexes induce autoantibody formation against double-stranded DNA and nucleosomes, which does not occur if HMGB1 is absent.  These antibodies are central in the pathogenesis of systemic lupus erythematosus and patients with active disease have both increased HMGB1 and HMGB1-nucleosome levels in circulation.  Furthermore, HMGB1 is strongly bipolar charged, enabling cell membrane passage and intracellular transport of complexed mols. including DNA.  Rheumatoid arthritis patients have excessive extracellular HMGB1 levels in joints and serum.  The HMGB1 release is caused by cytokines, activated complement and hypoxia.  The most prominent HMGB1 protein and mRNA expression arthritis is present in pannus regions, where synovial tissue invades articular cartilage and bone.  HMGB1 promotes the activity of proteolytic enzymes, and osteoclasts need HMGB1 for functional maturation.  Neutralizing HMGB1 therapy in preclin. models of arthritis confers striking protection against structural damage.  This review summarizes selected aspects of HMGB1 biol. relevant for induction and propagation of some autoimmune conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEA5LVMKyz3bVg90H21EOLACvtfcHk0lhiFU23D1tTpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslWguw%253D%253D&md5=bd4c9649ee7cb4143a55c610c1e82794</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagrm.2009.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagrm.2009.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26atitle%3DThe%2520role%2520of%2520hmgb1%2520in%2520the%2520pathogenesis%2520of%2520rheumatic%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gene%2520Regul.%2520Mech.%26date%3D2010%26volume%3D1799%26issue%3D1%25E2%2580%25932%26spage%3D141%26epage%3D148%26doi%3D10.1016%2Fj.bbagrm.2009.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musumeci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roviello, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montesarchio, D.</span></span> <span> </span><span class="NLM_article-title">An overview on hmgb1 inhibitors as potential therapeutic agents in hmgb1-related pathologies</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>141</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2013.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.pharmthera.2013.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24220159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKgtrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2014&pages=347-357&issue=3&author=D.+Musumeciauthor=G.+N.+Rovielloauthor=D.+Montesarchio&title=An+overview+on+hmgb1+inhibitors+as+potential+therapeutic+agents+in+hmgb1-related+pathologies&doi=10.1016%2Fj.pharmthera.2013.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies</span></div><div class="casAuthors">Musumeci, Domenica; Roviello, Giovanni N.; Montesarchio, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-357</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  HMGB1 (High-Mobility Group Box-1) is a nuclear protein that acts as an architectural chromatin-binding factor involved in the maintenance of nucleosome structure and regulation of gene transcription.  It can be released into the extracellular milieu from immune and non-immune cells in response to various stimuli.  Extracellular HMGB1 contributes to the pathogenesis of numerous chronic inflammatory and autoimmune diseases, including sepsis, rheumatoid arthritis, atherosclerosis, chronic kidney disease, systemic lupus erythematosus (SLE), as well as cancer pathogenesis.  Interaction of released HMGB1 with the cell-surface receptor for advanced glycation end products (RAGE) is one of the main signaling pathways triggering these diseases.  It has been also demonstrated that the inhibition of the HMGB1-RAGE interaction represents a promising approach for the modulation of the inflammatory and tumor-facilitating activity of HMGB1.  In this review we describe various approaches recently proposed in the literature to inhibit HMGB1 and the related inflammatory processes, esp. focusing on the block of RAGE-HMGB1 signaling.  Several strategies are based on mols. which mainly interact with RAGE as competitive antagonists of HMGB1.  As an alternative, encouraging results have been obtained with HMGB1-targeting, leading to the identification of compds. that directly bind to HMGB1, ranging from small natural or synthetic mols., such as glycyrrhizin and gabexate mesilate, to HMGB1-specific antibodies, peptides, proteins as well as bent DNA-based duplexes.  Future perspectives are discussed in the light of the overall body of knowledge acquired by a large no. of research groups operating in different but related fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyHiZCTNIRKrVg90H21EOLACvtfcHk0lhiFU23D1tTpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKgtrfN&md5=6401131ce36d0390fb12c8f1bb5fe995</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2013.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2013.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DMusumeci%26aufirst%3DD.%26aulast%3DRoviello%26aufirst%3DG.%2BN.%26aulast%3DMontesarchio%26aufirst%3DD.%26atitle%3DAn%2520overview%2520on%2520hmgb1%2520inhibitors%2520as%2520potential%2520therapeutic%2520agents%2520in%2520hmgb1-related%2520pathologies%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D141%26issue%3D3%26spage%3D347%26epage%3D357%26doi%3D10.1016%2Fj.pharmthera.2013.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musumeci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucci, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roviello, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moccia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedone, C.</span></span> <span> </span><span class="NLM_article-title">DNA-based strategies for blocking hmgb1 cytokine activity: Design, synthesis and preliminary in vitro/in vivo assays of DNA and DNA-like duplexes</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1742</span>– <span class="NLM_lpage">1752</span>, <span class="refDoi"> DOI: 10.1039/c1mb05009e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1039%2Fc1mb05009e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21431162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFSitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=1742-1752&issue=5&author=D.+Musumeciauthor=E.+M.+Bucciauthor=G.+N.+Rovielloauthor=R.+Sapioauthor=M.+Valenteauthor=M.+Mocciaauthor=M.+E.+Bianchiauthor=C.+Pedone&title=DNA-based+strategies+for+blocking+hmgb1+cytokine+activity%3A+Design%2C+synthesis+and+preliminary+in+vitro%2Fin+vivo+assays+of+DNA+and+DNA-like+duplexes&doi=10.1039%2Fc1mb05009e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-based strategies for blocking HMGB1 cytokine activity: design, synthesis and preliminary in vitro/in vivo assays of DNA and DNA-like duplexes</span></div><div class="casAuthors">Musumeci, Domenica; Bucci, Enrico M.; Roviello, Giovanni N.; Sapio, Roberto; Valente, Margherita; Moccia, Maria; Bianchi, Marco E.; Pedone, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1742-1752</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The authors report the design and synthesis of kinked oligonucleotide duplexes as potential inhibitors of HMGB1, a cytokine which triggers a broad range of immunol. effects.  The authors found that the designed ligands can interact with HMGB1, as evidenced by CD spectroscopy, and are able to block some extracellular effects induced by the protein, such as cellular proliferation and migration, as the authors demonstrated by in vitro biol. assays.  After selecting the most stable and active kinked duplex, the authors synthesized the corresponding PNA/DNA chimeric duplex which resulted to be more resistant to enzymic degrdn., and showed a biol. activity comparable to that of the natural duplex.  Preliminary in vivo assays in a mouse inflammatory model, showed a significant decrease of the mortality after administration of the PNA/DNA kinked duplex to LPS-treated mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolrP9Vu8YOs7Vg90H21EOLACvtfcHk0lgcfpB1dM4sIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFSitLY%253D&md5=0cdc262ca15463ee1158a8f48894ea5e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1039%2Fc1mb05009e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1mb05009e%26sid%3Dliteratum%253Aachs%26aulast%3DMusumeci%26aufirst%3DD.%26aulast%3DBucci%26aufirst%3DE.%2BM.%26aulast%3DRoviello%26aufirst%3DG.%2BN.%26aulast%3DSapio%26aufirst%3DR.%26aulast%3DValente%26aufirst%3DM.%26aulast%3DMoccia%26aufirst%3DM.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DPedone%26aufirst%3DC.%26atitle%3DDNA-based%2520strategies%2520for%2520blocking%2520hmgb1%2520cytokine%2520activity%253A%2520Design%252C%2520synthesis%2520and%2520preliminary%2520in%2520vitro%252Fin%2520vivo%2520assays%2520of%2520DNA%2520and%2520DNA-like%2520duplexes%26jtitle%3DMol.%2520BioSyst.%26date%3D2011%26volume%3D7%26issue%3D5%26spage%3D1742%26epage%3D1752%26doi%3D10.1039%2Fc1mb05009e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pusterla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Marchis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span> <span> </span><span class="NLM_article-title">High mobility group b2 is secreted by myeloid cells and has mitogenic and chemoattractant activities similar to high mobility group b1</span>. <i>Autoimmunity</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1080/08916930902831845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1080%2F08916930902831845" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=308-310&issue=4&author=T.+Pusterlaauthor=F.+de+Marchisauthor=R.+Palumboauthor=M.+E.+Bianchi&title=High+mobility+group+b2+is+secreted+by+myeloid+cells+and+has+mitogenic+and+chemoattractant+activities+similar+to+high+mobility+group+b1&doi=10.1080%2F08916930902831845"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1080%2F08916930902831845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08916930902831845%26sid%3Dliteratum%253Aachs%26aulast%3DPusterla%26aufirst%3DT.%26aulast%3Dde%2BMarchis%26aufirst%3DF.%26aulast%3DPalumbo%26aufirst%3DR.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26atitle%3DHigh%2520mobility%2520group%2520b2%2520is%2520secreted%2520by%2520myeloid%2520cells%2520and%2520has%2520mitogenic%2520and%2520chemoattractant%2520activities%2520similar%2520to%2520high%2520mobility%2520group%2520b1%26jtitle%3DAutoimmunity%26date%3D2009%26volume%3D42%26issue%3D4%26spage%3D308%26epage%3D310%26doi%3D10.1080%2F08916930902831845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span> <span> </span><span class="NLM_article-title">Association of serum hmgb2 levels with in-stent restenosis: Hmgb2 promotes neointimal hyperplasia in mice with femoral artery injury and proliferation and migration of vsmcs</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">729</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.116.308210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1161%2FATVBAHA.116.308210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28183701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksF2ktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=717-729&issue=4&author=Y.+H.+Heauthor=X.+Q.+Wangauthor=J.+Zhangauthor=Z.+H.+Liuauthor=W.+Q.+Panauthor=Y.+Shenauthor=Z.+B.+Zhuauthor=L.+J.+Wangauthor=X.+X.+Yanauthor=K.+Yangauthor=R.+Y.+Zhangauthor=W.+F.+Shenauthor=F.+H.+Dingauthor=L.+Lu&title=Association+of+serum+hmgb2+levels+with+in-stent+restenosis%3A+Hmgb2+promotes+neointimal+hyperplasia+in+mice+with+femoral+artery+injury+and+proliferation+and+migration+of+vsmcs&doi=10.1161%2FATVBAHA.116.308210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs</span></div><div class="casAuthors">He, Yu Hu; Wang, Xiao Qun; Zhang, Jian; Liu, Zhu Hui; Pan, Wen Qi; Shen, Ying; Zhu, Zheng Bin; Wang, Ling Jie; Yan, Xiao Xiang; Yang, Ke; Zhang, Rui Yan; Shen, Wei Feng; Ding, Feng Hua; Lu, Lin</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">717-729</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">OBJECTIVE-: In a previous study, we established diabetic and nondiabetic minipig models with coronary artery in-stent restenosis (ISR).  Mass spectrometry showed that high-mobility group box (HMGB) 2 level was higher in ISR than in non-ISR tissue from diabetic minipigs.  We here investigated whether serum HMGB2 levels were related to ISR in coronary artery disease patients.  The effect of HMGB2 was evaluated in mice with femoral artery wire injury and in human aortic smooth muscle cells.  APPROACH AND RESULTS-: From 2513 patients undergoing coronary artery intervention and follow-up angiog. at ≈1 yr, 262 patients were diagnosed with ISR, and 298 patients with no ISR were randomly included as controls.  Serum HMGB2 levels were significantly higher in patients with ISR than in those without ISR and were assocd. with ISR severity.  Multivariable logistic regression anal. showed that HMGB2 level was independently assocd. with ISR.  In expts., HMGB2 expression was increased in vascular tissue after injury.  Perivascular HMGB2 administration promoted injury-induced neointimal hyperplasia in C57Bl/6 mice compared with in the control, whereas such pathophysiol. features were attenuated in Hmgb2 mice.  Mechanistically, HMGB2 enhanced neointimal hyperplasia in mice and proliferation and migration in human aortic smooth muscle cells by inducing reactive oxygen species through increased p47phox phosphorylation.  Knocking down p47phox, however, inhibited HMGB2-induced effects in human aortic smooth muscle cells.  Finally, HMGB2-induced effects were significantly declined in receptor of advanced glycation end products knockdown or deficient cells, but not in Toll-like receptor 4 knockdown or deficient cells.  CONCLUSIONS-: Serum HMGB2 levels were assocd. with ISR in patients.  HMGB2 promoted neointimal hyperplasia in mice with arterial wire injury through reactive oxygen species activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9qb2FlVZT0bVg90H21EOLACvtfcHk0lgcfpB1dM4sIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksF2ktrY%253D&md5=60bd24b11b17fdd6cbf5ddcd94c4594a</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.116.308210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.116.308210%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%2BH.%26aulast%3DPan%26aufirst%3DW.%2BQ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%2BB.%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DYan%26aufirst%3DX.%2BX.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DShen%26aufirst%3DW.%2BF.%26aulast%3DDing%26aufirst%3DF.%2BH.%26aulast%3DLu%26aufirst%3DL.%26atitle%3DAssociation%2520of%2520serum%2520hmgb2%2520levels%2520with%2520in-stent%2520restenosis%253A%2520Hmgb2%2520promotes%2520neointimal%2520hyperplasia%2520in%2520mice%2520with%2520femoral%2520artery%2520injury%2520and%2520proliferation%2520and%2520migration%2520of%2520vsmcs%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2017%26volume%3D37%26issue%3D4%26spage%3D717%26epage%3D729%26doi%3D10.1161%2FATVBAHA.116.308210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span> <span> </span><span class="NLM_article-title">Association of serum hmgb2 level with mace at 1 mo of myocardial infarction: Aggravation of myocardial ischemic injury in rats by hmgb2 via ros</span>. <i>Am. J. Physiol Heart Circ Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>312</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">H422</span>– <span class="NLM_lpage">H436</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00249.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1152%2Fajpheart.00249.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28011583" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2017&pages=H422-H436&issue=3&author=Z.+H.+Liuauthor=D.+P.+Daiauthor=F.+H.+Dingauthor=W.+Q.+Panauthor=Y.+H.+Fangauthor=Q.+Zhangauthor=M.+Liauthor=P.+Yangauthor=X.+Q.+Wangauthor=Y.+Shenauthor=L.+J.+Wangauthor=X.+X.+Yanauthor=Y.+H.+Heauthor=K.+Yangauthor=R.+Y.+Zhangauthor=W.+F.+Shenauthor=Y.+Chenauthor=L.+Lu&title=Association+of+serum+hmgb2+level+with+mace+at+1+mo+of+myocardial+infarction%3A+Aggravation+of+myocardial+ischemic+injury+in+rats+by+hmgb2+via+ros&doi=10.1152%2Fajpheart.00249.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00249.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00249.2016%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BH.%26aulast%3DDai%26aufirst%3DD.%2BP.%26aulast%3DDing%26aufirst%3DF.%2BH.%26aulast%3DPan%26aufirst%3DW.%2BQ.%26aulast%3DFang%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%2BQ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DYan%26aufirst%3DX.%2BX.%26aulast%3DHe%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DShen%26aufirst%3DW.%2BF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DL.%26atitle%3DAssociation%2520of%2520serum%2520hmgb2%2520level%2520with%2520mace%2520at%25201%2520mo%2520of%2520myocardial%2520infarction%253A%2520Aggravation%2520of%2520myocardial%2520ischemic%2520injury%2520in%2520rats%2520by%2520hmgb2%2520via%2520ros%26jtitle%3DAm.%2520J.%2520Physiol%2520Heart%2520Circ%2520Physiol.%26date%3D2017%26volume%3D312%26issue%3D3%26spage%3DH422%26epage%3DH436%26doi%3D10.1152%2Fajpheart.00249.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Expression of hmgb2 indicates worse survival of patients and is required for the maintenance of warburg effect in pancreatic cancer</span>. <i>Acta Biochim. Biophys. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1093/abbs/gmw124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1093%2Fabbs%2Fgmw124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28069585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC1c7jvFGqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=119-127&issue=2&author=X.+Caiauthor=H.+Dingauthor=Y.+Liuauthor=G.+Panauthor=Q.+Liauthor=Z.+Yangauthor=W.+Liu&title=Expression+of+hmgb2+indicates+worse+survival+of+patients+and+is+required+for+the+maintenance+of+warburg+effect+in+pancreatic+cancer&doi=10.1093%2Fabbs%2Fgmw124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer</span></div><div class="casAuthors">Cai Xin; Ding Hongjian; Pan Gaofeng; Yang Zhen; Liu Weiyan; Liu Yanxia; Li Qingguo; Li Qingguo</div><div class="citationInfo"><span class="NLM_cas:title">Acta biochimica et biophysica Sinica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-127</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High mobility group proteins (HMGs) are the second most abundant chromatin proteins and exert global genomic functions in the establishment of active or inactive chromatin domains.  Through interaction with nucleosomes, transcription factors, nucleosome-remodeling machines and histones, the HMGs family proteins contribute to the fine tuning of transcription in response to rapid environmental changes.  Mammalian high mobility group Bs (HMGBs) are characterized by two tandem HMG box domains followed by a long acidic tail.  Recent studies demonstrated that high expression of HMGBs has been found in many cancers, such as prostate, kidney, ovarian, and gastric cancers.  However, their roles in pancreatic cancer have seldom been reported.  In this study, we assessed the diagnostic and prognostic values of HMGBs proteins, including HMGB1, HMGB2, and HMGB3, in pancreatic cancer from the Cancer Genome Atlas (TCGA) dataset.  Our results demonstrated that HMGB2 predicted poor prognosis in pancreatic cancer.  In vitro studies demonstrated that silencing HMGB2 inhibited cell proliferation and viability.  Mechanistically, our results demonstrated that silencing HMGB2 decreased hypoxia inducible factor 1α (HIF1α) protein level and inhibited HIF1α-mediated glycolysis process.  Further analysis indicated that HIF1α-targeted glycolytic genes, including GLUT1, HK2, and LDHA, are all prognostic factors and positively correlated with HMGB2 expression.  Taken together, we discovered new prognostic and predictive markers for pancreatic cancer, and shed light on the novel function of HMGB2 in glycolytic control in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFqt81uaIMMpcXNb62YGmbfW6udTcc2eYQmw7E0kRUTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7jvFGqtg%253D%253D&md5=266643f42481cc8a37c74083078adbbb</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fabbs%2Fgmw124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fabbs%252Fgmw124%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DExpression%2520of%2520hmgb2%2520indicates%2520worse%2520survival%2520of%2520patients%2520and%2520is%2520required%2520for%2520the%2520maintenance%2520of%2520warburg%2520effect%2520in%2520pancreatic%2520cancer%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2017%26volume%3D49%26issue%3D2%26spage%3D119%26epage%3D127%26doi%3D10.1093%2Fabbs%2Fgmw124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span> <span> </span><span class="NLM_article-title">A small molecule binding hmgb1 and hmgb2 inhibits microglia-mediated neuroinflammation</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1060</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnchembio.1669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25306442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOisrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1055-1060&issue=12&author=S.+Leeauthor=Y.+Namauthor=J.+Y.+Kooauthor=D.+Limauthor=J.+Parkauthor=J.+Ockauthor=J.+Kimauthor=K.+Sukauthor=S.+B.+Park&title=A+small+molecule+binding+hmgb1+and+hmgb2+inhibits+microglia-mediated+neuroinflammation&doi=10.1038%2Fnchembio.1669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation</span></div><div class="casAuthors">Lee, Sanghee; Nam, Youngpyo; Koo, Ja Young; Lim, Donghyun; Park, Jongmin; Ock, Jiyeon; Kim, Jaehong; Suk, Kyoungho; Park, Seung Bum</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1055-1060</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Because of the crit. role of neuroinflammation in various neurol. diseases, there are continuous efforts to identify new therapeutic targets as well as new therapeutic agents to treat neuroinflammatory diseases.  Here we report the discovery of inflachromene (ICM), a microglial inhibitor with anti-inflammatory effects.  Using the convergent strategy of phenotypic screening with early stage target identification, we show that the direct binding target of ICM is the high mobility group box (HMGB) proteins.  Mode-of-action studies demonstrate that ICM blocks the sequential processes of cytoplasmic localization and extracellular release of HMGBs by perturbing its post-translational modification.  In addn., ICM effectively downregulates proinflammatory functions of HMGB and reduces neuronal damage in vivo.  Our study reveals that ICM suppresses microglia-mediated inflammation and exerts a neuroprotective effect, demonstrating the therapeutic potential of ICM in neuroinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMF0q7o1ZyqLVg90H21EOLACvtfcHk0lgqVYzEb57Dvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOisrjL&md5=8c06cb9f432a5fc65c0c450e36c97f5a</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1669%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DNam%26aufirst%3DY.%26aulast%3DKoo%26aufirst%3DJ.%2BY.%26aulast%3DLim%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DOck%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSuk%26aufirst%3DK.%26aulast%3DPark%26aufirst%3DS.%2BB.%26atitle%3DA%2520small%2520molecule%2520binding%2520hmgb1%2520and%2520hmgb2%2520inhibits%2520microglia-mediated%2520neuroinflammation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D12%26spage%3D1055%26epage%3D1060%26doi%3D10.1038%2Fnchembio.1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marchis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitaleri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallacosta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennacchini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trisciuoglio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span> <span> </span><span class="NLM_article-title">Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2007.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.chembiol.2007.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=17462578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslaitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=431-441&issue=4&author=L.+Mollicaauthor=F.+De+Marchisauthor=A.+Spitaleriauthor=C.+Dallacostaauthor=D.+Pennacchiniauthor=M.+Zamaiauthor=A.+Agrestiauthor=L.+Trisciuoglioauthor=G.+Muscoauthor=M.+E.+Bianchi&title=Glycyrrhizin+binds+to+high-mobility+group+box+1+protein+and+inhibits+its+cytokine+activities&doi=10.1016%2Fj.chembiol.2007.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities</span></div><div class="casAuthors">Mollica, Luca; De Marchis, Francesco; Spitaleri, Andrea; Dallacosta, Corrado; Pennacchini, Danilo; Zamai, Moreno; Agresti, Alessandra; Trisciuoglio, Lisa; Musco, Giovanna; Bianchi, Marco E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">431-441</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">High-mobility group box 1 protein (HMGB1) is a nuclear component, but extracellularly it serves as a signaling mol. involved in acute and chronic inflammation, for example in sepsis and arthritis.  The identification of HMGB1 inhibitors is therefore of significant exptl. and clin. interest.  We show that glycyrrhizin, a natural anti-inflammatory and antiviral triterpene in clin. use, inhibits HMGB1 chemoattractant and mitogenic activities, and has a weak inhibitory effect on its intranuclear DNA-binding function.  NMR and fluorescence studies indicate that glycyrrhizin binds directly to HMGB1 (Kd ∼150 μM), interacting with two shallow concave surfaces formed by the two arms of both HMG boxes.  Our results explain in part the anti-inflammatory properties of glycyrrhizin, and might direct the design of new derivs. with improved HMGB1-binding properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAehCbVCEOhLVg90H21EOLACvtfcHk0lhUTQilB_P8SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslaitbc%253D&md5=6108501f729f299a82f7789fbdfecb48</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DL.%26aulast%3DDe%2BMarchis%26aufirst%3DF.%26aulast%3DSpitaleri%26aufirst%3DA.%26aulast%3DDallacosta%26aufirst%3DC.%26aulast%3DPennacchini%26aufirst%3DD.%26aulast%3DZamai%26aufirst%3DM.%26aulast%3DAgresti%26aufirst%3DA.%26aulast%3DTrisciuoglio%26aufirst%3DL.%26aulast%3DMusco%26aufirst%3DG.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26atitle%3DGlycyrrhizin%2520binds%2520to%2520high-mobility%2520group%2520box%25201%2520protein%2520and%2520inhibits%2520its%2520cytokine%2520activities%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26issue%3D4%26spage%3D431%26epage%3D441%26doi%3D10.1016%2Fj.chembiol.2007.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span> <span> </span><span class="NLM_article-title">Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.intimp.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21095260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFWnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=187-193&issue=2&author=Y.+Lingauthor=Z.+Y.+Yangauthor=T.+Yinauthor=L.+Liauthor=W.+W.+Yuanauthor=H.+S.+Wuauthor=C.+Y.+Wang&title=Heparin+changes+the+conformation+of+high-mobility+group+protein+1+and+decreases+its+affinity+toward+receptor+for+advanced+glycation+endproducts+in+vitro&doi=10.1016%2Fj.intimp.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro</span></div><div class="casAuthors">Ling, Yan; Yang, Zhi-Yong; Yin, Tao; Li, Li; Yuan, Wei-Wei; Wu, He-Shui; Wang, Chun-You</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-193</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High-mobility group protein 1 (HMGB1) has been identified as a late-acting mediator of inflammation.  The receptor for advanced glycation end products (RAGE) is the main receptor and mediates the cytokine activity of HMGB1.  Since HMGB1 also exhibits heparin-binding activity, we investigated whether heparin interferes with HMGB1/RAGE interaction and prevents the cytokine activity.  We used fluorescence spectrometry, CD spectrometry and SPR biosensor technique to evaluate the effect.  After treatment of HMGB1 with different concns. of heparin (0, 50, 100 and 1000 U/L), the fluorescence peak values of HMGB1 increased and the emission wavelength showed red shifts; further, the secondary structure of HMGB1 showed a marked change in that the content of β-pleated sheet reduced while that of α-helix increased.  The equil. dissocn. consts. (KD) were detd. by SPR technique; KD = 4.5 × 10- 9 mol/L for heparin and HMGB1 and KD = 9.77 × 10- 8 mol/L for HMGB1 and RAGE, resp.  Heparin and RAGE had no interaction.  The amt. of HMGB1 and RAGE bound forms reduced after treatment with heparin.  ELISA revealed that addn. of heparin inhibited the TNF-α and IL-6 released by macrophages RAW264.7 and HUVEC; 10 U/L and 50 U/L of heparin showed the most marked inhibitory effect in RAW264.7 cells and in HUVEC, resp.  In conclusion, heparin can combine with HMGB1 and affect the affinity of HMGB1/RAGE by changing the conformation of HMGB1.  And this effect was independent of heparin concn., so that a low dose of heparin was sufficient to achieve the best anti-inflammatory effect in our test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQZpeRqCzCt7Vg90H21EOLACvtfcHk0lhUTQilB_P8SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFWnug%253D%253D&md5=a8447db928c38cf9e8597d2f3c358cd0</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DYin%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DW.%2BW.%26aulast%3DWu%26aufirst%3DH.%2BS.%26aulast%3DWang%26aufirst%3DC.%2BY.%26atitle%3DHeparin%2520changes%2520the%2520conformation%2520of%2520high-mobility%2520group%2520protein%25201%2520and%2520decreases%2520its%2520affinity%2520toward%2520receptor%2520for%2520advanced%2520glycation%2520endproducts%2520in%2520vitro%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2011%26volume%3D11%26issue%3D2%26spage%3D187%26epage%3D193%26doi%3D10.1016%2Fj.intimp.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rauvala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlaskari, R.</span></span> <span> </span><span class="NLM_article-title">Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>262</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">16625</span>– <span class="NLM_lpage">16635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=16625-16635&issue=34&author=H.+Rauvalaauthor=R.+Pihlaskari&title=Isolation+and+some+characteristics+of+an+adhesive+factor+of+brain+that+enhances+neurite+outgrowth+in+central+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRauvala%26aufirst%3DH.%26aulast%3DPihlaskari%26aufirst%3DR.%26atitle%3DIsolation%2520and%2520some%2520characteristics%2520of%2520an%2520adhesive%2520factor%2520of%2520brain%2520that%2520enhances%2520neurite%2520outgrowth%2520in%2520central%2520neurons%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26issue%3D34%26spage%3D16625%26epage%3D16635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuroiwa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakusagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusayanagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuramochi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, F.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of the direct interaction between methotrexate (mtx) and high-mobility group box 1 (hmgb1) protein</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e63073</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0063073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1371%2Fjournal.pone.0063073" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e63073&issue=5&author=Y.+Kuroiwaauthor=Y.+Takakusagiauthor=T.+Kusayanagiauthor=K.+Kuramochiauthor=T.+Imaiauthor=T.+Hirayamaauthor=I.+Itoauthor=M.+Yoshidaauthor=K.+Sakaguchiauthor=F.+Sugawara&title=Identification+and+characterization+of+the+direct+interaction+between+methotrexate+%28mtx%29+and+high-mobility+group+box+1+%28hmgb1%29+protein&doi=10.1371%2Fjournal.pone.0063073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0063073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0063073%26sid%3Dliteratum%253Aachs%26aulast%3DKuroiwa%26aufirst%3DY.%26aulast%3DTakakusagi%26aufirst%3DY.%26aulast%3DKusayanagi%26aufirst%3DT.%26aulast%3DKuramochi%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DT.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSakaguchi%26aufirst%3DK.%26aulast%3DSugawara%26aufirst%3DF.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520the%2520direct%2520interaction%2520between%2520methotrexate%2520%2528mtx%2529%2520and%2520high-mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520protein%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D5%26spage%3De63073%26doi%3D10.1371%2Fjournal.pone.0063073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span> <span> </span><span class="NLM_article-title">Treatment of sepsis pathogenesis with high mobility group box protein 1-regulating anti-inflammatory agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00954</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00954" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=170-179&issue=1&author=W.+Choauthor=J.+Y.+Kooauthor=Y.+Parkauthor=K.+Ohauthor=S.+Leeauthor=J.+S.+Songauthor=M.+A.+Baeauthor=D.+Limauthor=D.+S.+Leeauthor=S.+B.+Park&title=Treatment+of+sepsis+pathogenesis+with+high+mobility+group+box+protein+1-regulating+anti-inflammatory+agents&doi=10.1021%2Facs.jmedchem.6b00954"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00954%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DW.%26aulast%3DKoo%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DBae%26aufirst%3DM.%2BA.%26aulast%3DLim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BB.%26atitle%3DTreatment%2520of%2520sepsis%2520pathogenesis%2520with%2520high%2520mobility%2520group%2520box%2520protein%25201-regulating%2520anti-inflammatory%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D1%26spage%3D170%26epage%3D179%26doi%3D10.1021%2Facs.jmedchem.6b00954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venereau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swapna, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manohar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorzanelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marchis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonyak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micikas, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montelione, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klessig, D. F.</span></span> <span> </span><span class="NLM_article-title">Aspirin’s active metabolite salicylic acid targets high mobility group box 1 to modulate inflammatory responses</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.2119/molmed.2015.00148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2015.00148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26101955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=526-535&author=H.+W.+Choiauthor=M.+Tianauthor=F.+Songauthor=E.+Venereauauthor=A.+Pretiauthor=S.+W.+Parkauthor=K.+Hamiltonauthor=G.+V.+Swapnaauthor=M.+Manoharauthor=M.+Moreauauthor=A.+Agrestiauthor=A.+Gorzanelliauthor=F.+De+Marchisauthor=H.+Wangauthor=M.+Antonyakauthor=R.+J.+Micikasauthor=D.+R.+Gentileauthor=R.+A.+Cerioneauthor=F.+C.+Schroederauthor=G.+T.+Montelioneauthor=M.+E.+Bianchiauthor=D.+F.+Klessig&title=Aspirin%E2%80%99s+active+metabolite+salicylic+acid+targets+high+mobility+group+box+1+to+modulate+inflammatory+responses&doi=10.2119%2Fmolmed.2015.00148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Aspirin's active metabolite salicylic acid targets high mobility group box 1 to modulate inflammatory responses</span></div><div class="casAuthors">Choi, Hyong Woo; Tian, Miaoying; Song, Fei; Venereau, Emilie; Preti, Alessandro; Park, Sang-Wook; Hamilton, Keith; Swapna, G. V. T.; Manohar, Murli; Moreau, Magali; Agresti, Alessandra; Gorzanelli, Andrea; De Marchis, Francesco; Wang, Huang; Antonyak, Marc; Micikas, Robert J.; Gentile, Daniel R.; Cerione, Richard A.; Schroeder, Frank C.; Montelione, Gaetano T.; Bianchi, Marco E.; Klessig, Daniel F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">526-535</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Salicylic acid (SA) and its derivs. have been used for millennia to reduce pain, fever and inflammation.  In addn., prophylactic use of acetylsalicylic acid, commonly known as aspirin, reduces the risk of heart attack, stroke and certain cancers.  Because aspirin is rapidly de-acetylated by esterases in human plasma, much of aspirin's bioactivity can be attributed to its primary metabolite, SA.  Here we demonstrate that human high mobility group box 1 (HMGB1) is a novel SA-binding protein.  SA-binding sites on HMGB1 were identified in the HMG-box domains by NMR (NMR) spectroscopic studies and confirmed by mutational anal.  Extracellular HMGB1 is a damage-assocd. mol. pattern mol. (DAMP), with multiple redox states.  SA suppresses both the chemoattractant activity of fully reduced HMGB1 and the increased expression of proinflammatory cytokine genes and cyclooxygenase 2 (COX-2) induced by disulfide HMGB1.  Natural and synthetic SA derivs. with greater potency for inhibition of HMGB1 were identified, providing proof-of-concept that new mols. with high efficacy against sterile inflammation are attainable.  An HMGB1 protein mutated in one of the SA-binding sites identified by NMR chem. shift perturbation studies retained chemoattractant activity, but lost binding of and inhibition by SA and its derivs., thereby firmly establishing that SA binding to HMGB1 directly suppresses its proinflammatory activities.  Identification of HMGB1 as a pharmacol. target of SA/aspirin provides new insights into the mechanisms of action of one of the world's longest and most used natural and synthetic drugs.  It may also provide an explanation for the protective effects of low-dose aspirin usage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfZ6wFPYD2ObVg90H21EOLACvtfcHk0liQEnOHszc54A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFajsg%253D%253D&md5=5db7d3f42702f7c63f0b8ef13c45a8a3</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2015.00148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2015.00148%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BW.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DF.%26aulast%3DVenereau%26aufirst%3DE.%26aulast%3DPreti%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DS.%2BW.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DSwapna%26aufirst%3DG.%2BV.%26aulast%3DManohar%26aufirst%3DM.%26aulast%3DMoreau%26aufirst%3DM.%26aulast%3DAgresti%26aufirst%3DA.%26aulast%3DGorzanelli%26aufirst%3DA.%26aulast%3DDe%2BMarchis%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DAntonyak%26aufirst%3DM.%26aulast%3DMicikas%26aufirst%3DR.%2BJ.%26aulast%3DGentile%26aufirst%3DD.%2BR.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26aulast%3DSchroeder%26aufirst%3DF.%2BC.%26aulast%3DMontelione%26aufirst%3DG.%2BT.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DKlessig%26aufirst%3DD.%2BF.%26atitle%3DAspirin%25E2%2580%2599s%2520active%2520metabolite%2520salicylic%2520acid%2520targets%2520high%2520mobility%2520group%2520box%25201%2520to%2520modulate%2520inflammatory%2520responses%26jtitle%3DMol.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D526%26epage%3D535%26doi%3D10.2119%2Fmolmed.2015.00148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashok, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sama, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting hmgb1</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">e1153</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0001153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1371%2Fjournal.pone.0001153" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=e1153&issue=11&author=W.+Liauthor=M.+Ashokauthor=J.+Liauthor=H.+Yangauthor=A.+E.+Samaauthor=H.+Wang&title=A+major+ingredient+of+green+tea+rescues+mice+from+lethal+sepsis+partly+by+inhibiting+hmgb1&doi=10.1371%2Fjournal.pone.0001153"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0001153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0001153%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DAshok%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSama%26aufirst%3DA.%2BE.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DA%2520major%2520ingredient%2520of%2520green%2520tea%2520rescues%2520mice%2520from%2520lethal%2520sepsis%2520partly%2520by%2520inhibiting%2520hmgb1%26jtitle%3DPLoS%2520One%26date%3D2007%26volume%3D2%26issue%3D11%26spage%3De1153%26doi%3D10.1371%2Fjournal.pone.0001153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jundoria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eissa, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sama, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Egcg stimulates autophagy and reduces cytoplasmic hmgb1 levels in endotoxin-stimulated macrophages</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1152</span>– <span class="NLM_lpage">1163</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.bcp.2011.02.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=1152-1163&issue=9&author=W.+Liauthor=S.+Zhuauthor=J.+Liauthor=A.+Assaauthor=A.+Jundoriaauthor=J.+Xuauthor=S.+Fanauthor=N.+T.+Eissaauthor=K.+J.+Traceyauthor=A.+E.+Samaauthor=H.+Wang&title=Egcg+stimulates+autophagy+and+reduces+cytoplasmic+hmgb1+levels+in+endotoxin-stimulated+macrophages&doi=10.1016%2Fj.bcp.2011.02.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DAssa%26aufirst%3DA.%26aulast%3DJundoria%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DEissa%26aufirst%3DN.%2BT.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DSama%26aufirst%3DA.%2BE.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DEgcg%2520stimulates%2520autophagy%2520and%2520reduces%2520cytoplasmic%2520hmgb1%2520levels%2520in%2520endotoxin-stimulated%2520macrophages%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26issue%3D9%26spage%3D1152%26epage%3D1163%26doi%3D10.1016%2Fj.bcp.2011.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span> <span> </span><span class="NLM_article-title">Egcg in green tea induces aggregation of hmgb1 protein through large conformational changes with polarized charge redistribution</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22128</span>, <span class="refDoi"> DOI: 10.1038/srep22128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fsrep22128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26899177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFKgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22128&author=X.+Y.+Mengauthor=B.+Liauthor=S.+Liuauthor=H.+Kangauthor=L.+Zhaoauthor=R.+Zhou&title=Egcg+in+green+tea+induces+aggregation+of+hmgb1+protein+through+large+conformational+changes+with+polarized+charge+redistribution&doi=10.1038%2Fsrep22128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">EGCG in Green Tea Induces Aggregation of HMGB1 Protein through Large Conformational Changes with Polarized Charge Redistribution</span></div><div class="casAuthors">Meng, Xuan-Yu; Li, Baoyu; Liu, Shengtang; Kang, Hongsuk; Zhao, Lin; Zhou, Ruhong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22128</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">As a major effective component in green tea, (-)-epigallocatechin-3-gallate (EGCG)'s potential benefits to human health have been widely investigated.  Recent exptl. evidences indicate that EGCG can induce the aggregation of HMGB1 protein, a late mediator of inflammation, which subsequently stimulates the autophagic degrdn. and thus provides protection from lethal endotoxemia and sepsis.  In this study, we use mol. dynamics (MD) simulations to explore the underlying mol. mechanism of this aggregation of HMGB1 facilitated by EGCG.  Our simulation results reveal that EGCG firmly binds to HMGB1 near Cys106, which supports previous preliminary exptl. evidence.  A large HMGB1 conformational change is obsd., where Box A and Box B, two homogenous domains of HMGB1, are repositioned and packed together by EGCG.  This new HMGB1 conformation has large mol. polarity and distinctive electrostatic potential surface.  We suggest that the highly polarized charge distribution leads to the aggregation of HMGB1, which differs from the previous hypothesis that two HMGB1 monomers are linked by the dimer of EGCG.  Possible aggregating modes have also been investigated with potential of mean force (PMF) calcns.  Finally, we conclude that the conformation induced by EGCG is more aggregation-prone with higher binding free energies as compared to those without EGCG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJDe8SbQPonLVg90H21EOLACvtfcHk0lgN3Wow0ptDbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFKgtr8%253D&md5=196af5bc5370362aa9e299cd3ccd2cd2</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fsrep22128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22128%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%2BY.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DR.%26atitle%3DEgcg%2520in%2520green%2520tea%2520induces%2520aggregation%2520of%2520hmgb1%2520protein%2520through%2520large%2520conformational%2520changes%2520with%2520polarized%2520charge%2520redistribution%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22128%26doi%3D10.1038%2Fsrep22128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horiuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishibori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katagiri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiuchi, H.</span></span> <span> </span><span class="NLM_article-title">Metformin directly binds the alarmin hmgb1 and inhibits its proinflammatory activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8436</span>– <span class="NLM_lpage">8446</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.769380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1074%2Fjbc.M116.769380" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=8436-8446&issue=20&author=T.+Horiuchiauthor=N.+Sakataauthor=Y.+Narumiauthor=T.+Kimuraauthor=T.+Hayashiauthor=K.+Naganoauthor=K.+Liuauthor=M.+Nishiboriauthor=S.+Tsukitaauthor=T.+Yamadaauthor=H.+Katagiriauthor=R.+Shirakawaauthor=H.+Horiuchi&title=Metformin+directly+binds+the+alarmin+hmgb1+and+inhibits+its+proinflammatory+activity&doi=10.1074%2Fjbc.M116.769380"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.769380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.769380%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DT.%26aulast%3DSakata%26aufirst%3DN.%26aulast%3DNarumi%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DNishibori%26aufirst%3DM.%26aulast%3DTsukita%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DKatagiri%26aufirst%3DH.%26aulast%3DShirakawa%26aufirst%3DR.%26aulast%3DHoriuchi%26aufirst%3DH.%26atitle%3DMetformin%2520directly%2520binds%2520the%2520alarmin%2520hmgb1%2520and%2520inhibits%2520its%2520proinflammatory%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D20%26spage%3D8436%26epage%3D8446%26doi%3D10.1074%2Fjbc.M116.769380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragab, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdes-Ferrer, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pribis, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Abed, Y.</span></span> <span> </span><span class="NLM_article-title">Md-2 is required for disulfide hmgb1-dependent tlr4 signaling</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>212</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1084/jem.20141318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1084%2Fjem.20141318" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=5-14&issue=1&author=H.+Yangauthor=H.+Wangauthor=Z.+Juauthor=A.+A.+Ragabauthor=P.+Lundbackauthor=W.+Longauthor=S.+I.+Valdes-Ferrerauthor=M.+Heauthor=J.+P.+Pribisauthor=J.+Liauthor=B.+Luauthor=D.+Geroauthor=C.+Szaboauthor=D.+J.+Antoineauthor=H.+E.+Harrisauthor=D.+T.+Golenbockauthor=J.+Mengauthor=J.+Rothauthor=S.+S.+Chavanauthor=U.+Anderssonauthor=T.+R.+Billiarauthor=K.+J.+Traceyauthor=Y.+Al-Abed&title=Md-2+is+required+for+disulfide+hmgb1-dependent+tlr4+signaling&doi=10.1084%2Fjem.20141318"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1084%2Fjem.20141318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20141318%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DJu%26aufirst%3DZ.%26aulast%3DRagab%26aufirst%3DA.%2BA.%26aulast%3DLundback%26aufirst%3DP.%26aulast%3DLong%26aufirst%3DW.%26aulast%3DValdes-Ferrer%26aufirst%3DS.%2BI.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DPribis%26aufirst%3DJ.%2BP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DGero%26aufirst%3DD.%26aulast%3DSzabo%26aufirst%3DC.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DChavan%26aufirst%3DS.%2BS.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DAl-Abed%26aufirst%3DY.%26atitle%3DMd-2%2520is%2520required%2520for%2520disulfide%2520hmgb1-dependent%2520tlr4%2520signaling%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2015%26volume%3D212%26issue%3D1%26spage%3D5%26epage%3D14%26doi%3D10.1084%2Fjem.20141318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plociennikowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hromada-Judycka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzecka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowska, K.</span></span> <span> </span><span class="NLM_article-title">Co-operation of tlr4 and raft proteins in lps-induced pro-inflammatory signaling</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1007/s00018-014-1762-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs00018-014-1762-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25332099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2gsb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2015&pages=557-581&issue=3&author=A.+Plociennikowskaauthor=A.+Hromada-Judyckaauthor=K.+Borzeckaauthor=K.+Kwiatkowska&title=Co-operation+of+tlr4+and+raft+proteins+in+lps-induced+pro-inflammatory+signaling&doi=10.1007%2Fs00018-014-1762-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling</span></div><div class="casAuthors">Plociennikowska, Agnieszka; Hromada-Judycka, Aneta; Borzecka, Kinga; Kwiatkowska, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">557-581</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Toll-like receptor 4 (TLR4) is activated by lipopolysaccharide (LPS), a component of Gram-neg. bacteria to induce prodn. of pro-inflammatory mediators aiming at eradication of the bacteria.  Dysregulation of the host responses to LPS can lead to a systemic inflammatory condition named sepsis.  In a typical scenario, activation of TLR4 is preceded by binding of LPS to CD14 protein anchored in cholesterol- and sphingolipid-rich microdomains of the plasma membrane called rafts.  CD14 then transfers the LPS to the TLR4/MD-2 complex which dimerizes and triggers MyD88- and TRIF-dependent prodn. of pro-inflammatory cytokines and type I interferons.  The TRIF-dependent signaling is linked with endocytosis of the activated TLR4, which is controlled by CD14.  In addn. to CD14, other raft proteins like Lyn tyrosine kinase of the Src family, acid sphingomyelinase, CD44, Hsp70, and CD36 participate in the TLR4 signaling triggered by LPS and non-microbial endogenous ligands.  In this review, we summarize the current state of the knowledge on the involvement of rafts in TLR4 signaling, with an emphasis on how the raft proteins regulate the TLR4 signaling pathways.  CD14-bearing rafts, and possibly CD36-rich rafts, are believed to be preferred sites of the assembly of a multimol. complex which mediates the endocytosis of activated TLR4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Py2Q9X5ha7Vg90H21EOLACvtfcHk0ljbfaeteoTORg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2gsb3I&md5=403e8073b6ba005e7a8cca66b32fe5d3</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2Fs00018-014-1762-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-014-1762-5%26sid%3Dliteratum%253Aachs%26aulast%3DPlociennikowska%26aufirst%3DA.%26aulast%3DHromada-Judycka%26aufirst%3DA.%26aulast%3DBorzecka%26aufirst%3DK.%26aulast%3DKwiatkowska%26aufirst%3DK.%26atitle%3DCo-operation%2520of%2520tlr4%2520and%2520raft%2520proteins%2520in%2520lps-induced%2520pro-inflammatory%2520signaling%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2015%26volume%3D72%26issue%3D3%26spage%3D557%26epage%3D581%26doi%3D10.1007%2Fs00018-014-1762-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hreggvidsdottir, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundberg, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aveberger, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevenvall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span> <span> </span><span class="NLM_article-title">High mobility group box protein 1 (hmgb1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.2119/molmed.2011.00327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2011.00327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22076468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFeksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=224-230&author=H.+S.+Hreggvidsdottirauthor=A.+M.+Lundbergauthor=A.+C.+Avebergerauthor=L.+Klevenvallauthor=U.+Anderssonauthor=H.+E.+Harris&title=High+mobility+group+box+protein+1+%28hmgb1%29-partner+molecule+complexes+enhance+cytokine+production+by+signaling+through+the+partner+molecule+receptor&doi=10.2119%2Fmolmed.2011.00327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor</span></div><div class="casAuthors">Hreggvidsdottir, Hulda Sigridur; Lundberg, Anna M.; Aveberger, Ann-Charlotte; Klevenvall, Lena; Andersson, Ulf; Harris, Helena Erlandsson</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">224-230</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">The nuclear protein high mobility group box protein 1 (HMGB1) promotes inflammation upon extracellular release.  HMGB1 induces proinflammatory cytokine prodn. in macrophages via Toll-like receptor (TLR)-4 signaling in a redox-dependent fashion.  Independent of its redox state and endogenous cytokine-inducing ability, HMGB1 can form highly immunostimulatory complexes by interaction with certain proinflammatory mediators.  Such complexes have the ability to enhance the induced immune response up to 100-fold, compared with induction by the ligand alone.  To clarify the mechanisms for these strong synergistic effects, we studied receptor requirements.  Interleukin (IL)-6 prodn. was assessed in supernatants from cultured peritoneal macrophages from mice each deficient in one of the HMGB1 receptors (receptor for advanced glycation end products (RAGE), TLR2 or TLR4) or from wild-type controls.  The cultures were stimulated with the TLR4 ligand lipopolysaccaride (LPS), the TLR2 ligand Pam3CysSerLys4 (Pam3CSK4), noninflammatory HMGB1 or each TLR ligand in complex with noninflammatory HMGB1.  The activity of the HMGB1-TLR ligand complexes relied on engagement of the same receptor as for the noncomplexed TLR ligand, since HMGB1-LPS complexes used TLR4 and HMGB1-Pam3CSK4 complexes used TLR2.  Deletion of any of the intracellular adaptor mols. used by TLR2 (myeloid differentiation factor-88 (MyD88), TIR domain-contg. adaptor protein (TIRAP)) or TLR4 (MyD88, TIRAP, TIR domain-contg. adaptor-inducing interferon-β (TRIF), TRIF-related adaptor mol. (TRAM)) had similar effects on HMGB1 complex activation compared with noncomplexed LPS or Pam3CSK4.  This result implies that the enhancing effects of HMGB1-partner mol. complexes are not regulated by the induction of addnl. signaling cascades.  Elucidating HMGB1 receptor usage in processes where HMGB1 acts alone or in complex with other mols. is essential for the understanding of basic HMGB1 biol. and for designing HMGB1-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomnpdkyxgLKbVg90H21EOLACvtfcHk0ljbfaeteoTORg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFeksbY%253D&md5=9f89c3a5cea4a0abf3bd0ec25a52326f</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2011.00327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2011.00327%26sid%3Dliteratum%253Aachs%26aulast%3DHreggvidsdottir%26aufirst%3DH.%2BS.%26aulast%3DLundberg%26aufirst%3DA.%2BM.%26aulast%3DAveberger%26aufirst%3DA.%2BC.%26aulast%3DKlevenvall%26aufirst%3DL.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26atitle%3DHigh%2520mobility%2520group%2520box%2520protein%25201%2520%2528hmgb1%2529-partner%2520molecule%2520complexes%2520enhance%2520cytokine%2520production%2520by%2520signaling%2520through%2520the%2520partner%2520molecule%2520receptor%26jtitle%3DMol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D224%26epage%3D230%26doi%3D10.2119%2Fmolmed.2011.00327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armour, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukkar, M. B.</span></span> <span> </span><span class="NLM_article-title">Rage and tlrs: Relatives, friends or neighbours?</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">744</span>, <span class="refDoi"> DOI: 10.1016/j.molimm.2013.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.molimm.2013.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23954397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOmsr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=739-744&issue=4&author=Z.+A.+Ibrahimauthor=C.+L.+Armourauthor=S.+Phippsauthor=M.+B.+Sukkar&title=Rage+and+tlrs%3A+Relatives%2C+friends+or+neighbours%3F&doi=10.1016%2Fj.molimm.2013.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE and TLRs: Relatives, friends or neighbours?</span></div><div class="casAuthors">Ibrahim, Zaridatul Aini; Armour, Carol L.; Phipps, Simon; Sukkar, Maria B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The innate immune system forms the first line of protection against infectious and non-infectious tissue injury.  Cells of the innate immune system detect pathogen-assocd. mol. patterns or endogenous mols. released as a result of tissue injury or inflammation through various innate immune receptors, collectively termed pattern-recognition receptors.  Members of the Toll-like receptor (TLR) family of pattern-recognition receptors have well established roles in the host immune response to infection, while the receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor predominantly involved in the recognition of endogenous mols. released in the context of infection, physiol. stress or chronic inflammation.  RAGE and TLRs share common ligands and signaling pathways, and accumulating evidence points towards their co-operative interaction in the host immune response.  At present however, little is known about the mechanisms that result in TLR vs. RAGE signaling or RAGE-TLR cross-talk in response to their shared ligands.  Here we review what is known in relation to the physicochem. basis of ligand interactions between TLRs and RAGE, focusing on three shared ligands of these receptors: HMGB1, S100A8/A9 and LPS.  Our aim is to discuss what is known about differential ligand interactions with RAGE and TLRs and to highlight important areas for further investigation so that we may better understand the role of these receptors and their relationship in host defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Ala_9ZeVorVg90H21EOLACvtfcHk0lh6L9pGC82jwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOmsr7P&md5=04c3c549b89e95827b30fe58c2a635d2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2013.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2013.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DIbrahim%26aufirst%3DZ.%2BA.%26aulast%3DArmour%26aufirst%3DC.%2BL.%26aulast%3DPhipps%26aufirst%3DS.%26aulast%3DSukkar%26aufirst%3DM.%2BB.%26atitle%3DRage%2520and%2520tlrs%253A%2520Relatives%252C%2520friends%2520or%2520neighbours%253F%26jtitle%3DMol.%2520Immunol.%26date%3D2013%26volume%3D56%26issue%3D4%26spage%3D739%26epage%3D744%26doi%3D10.1016%2Fj.molimm.2013.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, V.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor 4 (tlr4) modulation by synthetic and natural compounds: An update</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3612</span>– <span class="NLM_lpage">3622</span>, <span class="refDoi"> DOI: 10.1021/jm401006s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401006s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslaksLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3612-3622&issue=9&author=F.+Periauthor=V.+Calabrese&title=Toll-like+receptor+4+%28tlr4%29+modulation+by+synthetic+and+natural+compounds%3A+An+update&doi=10.1021%2Fjm401006s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update</span></div><div class="casAuthors">Peri, Francesco; Calabrese, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3612-3622</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Toll-like receptor 4 (TLR4), together with MD-2, binds bacterial endotoxins (E) with high affinity, triggering formation of the activated homodimer (E.MD-2.TLR4)2.  Activated TLR4 induces intracellular signaling leading to activation of transcription factors that result in cytokine and chemokine prodn. and initiation of inflammatory and immune responses.  TLR4 also responds to endogenous ligands called danger assocd. mol. patterns (DAMPs).  Increased sensitivity to infection and a variety of immune pathologies have been assocd. with either too little or too much TLR4 activation.  We review here the mol. mechanisms of TLR4 activation (agonism) or inhibition (antagonism) by small org. mols. of both natural and synthetic origin.  The role of co-receptors MD-2 and CD14 in the TLR4 modulation process is also discussed.  Recent achievements in the field of chem. TLR4 modulation are reviewed, with special focus on nonclassical TLR4 ligands with a chem. structure different from that of lipid A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmVf0w_guHebVg90H21EOLACvtfcHk0lh6L9pGC82jwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslaksLnN&md5=dce69e6a3b1a44e148c14212ef82327b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm401006s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401006s%26sid%3Dliteratum%253Aachs%26aulast%3DPeri%26aufirst%3DF.%26aulast%3DCalabrese%26aufirst%3DV.%26atitle%3DToll-like%2520receptor%25204%2520%2528tlr4%2529%2520modulation%2520by%2520synthetic%2520and%2520natural%2520compounds%253A%2520An%2520update%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D9%26spage%3D3612%26epage%3D3622%26doi%3D10.1021%2Fjm401006s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bongarzone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savickas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, A. D.</span></span> <span> </span><span class="NLM_article-title">Targeting the receptor for advanced glycation endproducts (rage): A medicinal chemistry perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7213</span>– <span class="NLM_lpage">7232</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00058</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7213-7232&issue=17&author=S.+Bongarzoneauthor=V.+Savickasauthor=F.+Luziauthor=A.+D.+Gee&title=Targeting+the+receptor+for+advanced+glycation+endproducts+%28rage%29%3A+A+medicinal+chemistry+perspective&doi=10.1021%2Facs.jmedchem.7b00058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00058%26sid%3Dliteratum%253Aachs%26aulast%3DBongarzone%26aufirst%3DS.%26aulast%3DSavickas%26aufirst%3DV.%26aulast%3DLuzi%26aufirst%3DF.%26aulast%3DGee%26aufirst%3DA.%2BD.%26atitle%3DTargeting%2520the%2520receptor%2520for%2520advanced%2520glycation%2520endproducts%2520%2528rage%2529%253A%2520A%2520medicinal%2520chemistry%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D17%26spage%3D7213%26epage%3D7232%26doi%3D10.1021%2Facs.jmedchem.7b00058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sturchler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galichet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weibel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heizmann, C. W.</span></span> <span> </span><span class="NLM_article-title">Site-specific blockade of rage-vd prevents amyloid-beta oligomer neurotoxicity</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">5149</span>– <span class="NLM_lpage">5158</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4878-07.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1523%2FJNEUROSCI.4878-07.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=18480271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1SltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=5149-5158&issue=20&author=E.+Sturchlerauthor=A.+Galichetauthor=M.+Weibelauthor=E.+Leclercauthor=C.+W.+Heizmann&title=Site-specific+blockade+of+rage-vd+prevents+amyloid-beta+oligomer+neurotoxicity&doi=10.1523%2FJNEUROSCI.4878-07.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific blockade of RAGE-Vd prevents amyloid-β oligomer neurotoxicity</span></div><div class="casAuthors">Sturchler, Emmanuel; Galichet, Arnaud; Weibel, Mirjam; Leclerc, Estelle; Heizmann, Claus W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5149-5158</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In the genesis of Alzheimer's disease (AD), converging lines of evidence suggest that amyloid-β peptide (Aβ) triggers a pathogenic cascade leading to neuronal loss.  It was long assumed that Aβ had to be assembled into extracellular amyloid fibrils or aggregates to exert its cytotoxic effects.  Over the past decade, characterization of sol. oligomeric Aβ species in the brains of AD patients and in transgenic models has raised the possibility that different conformations of Aβ may contribute to AD pathol. via different mechanisms.  The receptor for advanced glycation end products (RAGE), a member of the Ig superfamily, is a cellular binding site for Aβ.  Here, we investigate the role of RAGE in apoptosis induced by distinct well characterized Aβ conformations: Aβ oligomers (AβOs), Aβ fibrils (AβFs), and Aβ aggregates (AβAs).  In our in vitro system, treatment with polyclonal anti-RAGE antibodies significantly improves SHSY-5Y cell and neuronal survival exposed to either AβOs or AβAs but does not affect AβF toxicity.  Interestingly, using site-specific antibodies, we demonstrate that targeting of the Vd domain of RAGE attenuates AβO-induced toxicity in both SHSY-5Y cells and rat cortical neurons, whereas inhibition of AβA-induced apoptosis requires the neutralization of the C1d domain of the receptor.  Thus, our data indicate that distinct regions of RAGE are involved in Aβ-induced cellular and neuronal toxicity with respect to the Aβ aggregation state, and they suggest the blockage of particular sites of the receptor as a potential therapeutic strategy to attenuate neuronal death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo358TfBYty9LVg90H21EOLACvtfcHk0lh6L9pGC82jwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1SltrY%253D&md5=2c53047bf295e60a12d51b42dc39ef5b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4878-07.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4878-07.2008%26sid%3Dliteratum%253Aachs%26aulast%3DSturchler%26aufirst%3DE.%26aulast%3DGalichet%26aufirst%3DA.%26aulast%3DWeibel%26aufirst%3DM.%26aulast%3DLeclerc%26aufirst%3DE.%26aulast%3DHeizmann%26aufirst%3DC.%2BW.%26atitle%3DSite-specific%2520blockade%2520of%2520rage-vd%2520prevents%2520amyloid-beta%2520oligomer%2520neurotoxicity%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26issue%3D20%26spage%3D5149%26epage%3D5158%26doi%3D10.1523%2FJNEUROSCI.4878-07.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darmanin-Sheehan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahon, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piche, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittman, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tchistiakova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodangattil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hufton, S. E.</span></span> <span> </span><span class="NLM_article-title">Affinity maturation of a humanized rat antibody for anti-rage therapy: Comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>388</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2009.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.jmb.2009.03.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=541-558&issue=3&author=W.+J.+Finlayauthor=O.+Cunninghamauthor=M.+A.+Lambertauthor=A.+Darmanin-Sheehanauthor=X.+Liuauthor=B.+J.+Fennellauthor=C.+M.+Mahonauthor=E.+Cumminsauthor=J.+M.+Wadeauthor=C.+M.+O%E2%80%99Sullivanauthor=X.+Y.+Tanauthor=N.+Picheauthor=D.+D.+Pittmanauthor=J.+Paulsenauthor=L.+Tchistiakovaauthor=S.+Kodangattilauthor=D.+Gillauthor=S.+E.+Hufton&title=Affinity+maturation+of+a+humanized+rat+antibody+for+anti-rage+therapy%3A+Comprehensive+mutagenesis+reveals+a+high+level+of+mutational+plasticity+both+inside+and+outside+the+complementarity-determining+regions&doi=10.1016%2Fj.jmb.2009.03.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DW.%2BJ.%26aulast%3DCunningham%26aufirst%3DO.%26aulast%3DLambert%26aufirst%3DM.%2BA.%26aulast%3DDarmanin-Sheehan%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DFennell%26aufirst%3DB.%2BJ.%26aulast%3DMahon%26aufirst%3DC.%2BM.%26aulast%3DCummins%26aufirst%3DE.%26aulast%3DWade%26aufirst%3DJ.%2BM.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DC.%2BM.%26aulast%3DTan%26aufirst%3DX.%2BY.%26aulast%3DPiche%26aufirst%3DN.%26aulast%3DPittman%26aufirst%3DD.%2BD.%26aulast%3DPaulsen%26aufirst%3DJ.%26aulast%3DTchistiakova%26aufirst%3DL.%26aulast%3DKodangattil%26aufirst%3DS.%26aulast%3DGill%26aufirst%3DD.%26aulast%3DHufton%26aufirst%3DS.%2BE.%26atitle%3DAffinity%2520maturation%2520of%2520a%2520humanized%2520rat%2520antibody%2520for%2520anti-rage%2520therapy%253A%2520Comprehensive%2520mutagenesis%2520reveals%2520a%2520high%2520level%2520of%2520mutational%2520plasticity%2520both%2520inside%2520and%2520outside%2520the%2520complementarity-determining%2520regions%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26issue%3D3%26spage%3D541%26epage%3D558%26doi%3D10.1016%2Fj.jmb.2009.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">Targeting toll-like receptors with small molecule agents</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4859</span>– <span class="NLM_lpage">4866</span>, <span class="refDoi"> DOI: 10.1039/c3cs60039d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1039%2Fc3cs60039d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23503527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1ers7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=4859-4866&issue=12&author=X.+Wangauthor=C.+Smithauthor=H.+Yin&title=Targeting+toll-like+receptors+with+small+molecule+agents&doi=10.1039%2Fc3cs60039d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Toll-like receptors with small molecule agents</span></div><div class="casAuthors">Wang, Xiaohui; Smith, Christina; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4859-4866</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) are type I transmembrane proteins that are key regulators of both innate and adaptive immune responses.  To protect the host from viral and bacterial threats, TLRs trigger a pro-inflammatory immune response by detecting pathogen and danger assocd. mol. patterns.  Considerable evidence has accumulated to show that the dysregulation of TLR signaling contributes to the development and progression of numerous diseases.  Therefore, TLRs are emerging as important drug discovery targets.  Currently, there is great interest in the development of TLR small mol. modulators for interrogating TLR signaling and treating diseases caused by TLR signaling malfunctions.  In this tutorial review, we will outline methods for the discovery of TLR small mol. modulators and the up-to-date progress in this field.  Small mols. targeting TLRs not only provide an opportunity to identify promising drug candidates, but also unveil knowledge regarding TLR signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppuJ6XFSOMzrVg90H21EOLACvtfcHk0lgIrSNRD-FdMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1ers7Y%253D&md5=dd4e739bb0a67354ab45f4aa5511701d</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1039%2Fc3cs60039d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cs60039d%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DTargeting%2520toll-like%2520receptors%2520with%2520small%2520molecule%2520agents%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2013%26volume%3D42%26issue%3D12%26spage%3D4859%26epage%3D4866%26doi%3D10.1039%2Fc3cs60039d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Recent progress in the development of toll-like receptor (tlr) antagonists</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1080/13543776.2016.1185415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1080%2F13543776.2016.1185415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27136061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFOrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=719-730&issue=6&author=M.+C.+Patraauthor=S.+Choi&title=Recent+progress+in+the+development+of+toll-like+receptor+%28tlr%29+antagonists&doi=10.1080%2F13543776.2016.1185415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of Toll-like receptor (TLR) antagonists</span></div><div class="casAuthors">Patra, Mahesh Chandra; Choi, Sangdun</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-730</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  : Pattern recognition receptors (PRRs) of the innate immune system mediate and control the activation and progression of adaptive immunity.  Toll-like receptors (TLRs) are the most notable of the PRRs: they play crucial roles in protecting the host body against invading pathogens or endogenously released hazardous mols.  Sustained TLR signaling even after the clearance of pathogens or failure to distinguish between 'self' and 'non-self' mols. can cause inflammatory disorders, autoimmune diseases, and cancer.  This review focuses on recently developed therapeutic agents with TLR-antagonistic activities.  In recent years, several research institutes and pharmaceutical companies have achieved fundamental successes in inhibiting or reducing TLR signaling and assocd. effector mechanisms by using novel inhibitors.  These inhibitory mols. include antibodies against TLRs, TLR-derived transmembrane (TM) peptides, bacterial-secreted proteins, and natural or synthetic small mols., peptides, and proteins.  Antagonist developers generally target the TLR ectodomain to block receptor activation.  The TM and cytosolic Toll/IL-1 receptor domains also have regions that should be explored for the design of peptide-based and small mol. blocking agents.  A no. of preclin. and clin. breakthroughs may result in the availability of improved TLR immunomodulatory drugs to address important unmet medical needs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqbKGU6yn83rVg90H21EOLACvtfcHk0lgIrSNRD-FdMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFOrurc%253D&md5=11a223116a4186220fecbd19a4377cd6</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1080%2F13543776.2016.1185415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2016.1185415%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%2BC.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520toll-like%2520receptor%2520%2528tlr%2529%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26issue%3D6%26spage%3D719%26epage%3D730%26doi%3D10.1080%2F13543776.2016.1185415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yesudhas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors: Promising therapeutic targets for inflammatory diseases</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1007/s12272-016-0806-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs12272-016-0806-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27515048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlChsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=1032-1049&issue=8&author=A.+Achekauthor=D.+Yesudhasauthor=S.+Choi&title=Toll-like+receptors%3A+Promising+therapeutic+targets+for+inflammatory+diseases&doi=10.1007%2Fs12272-016-0806-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors: promising therapeutic targets for inflammatory diseases</span></div><div class="casAuthors">Achek, Asma; Yesudhas, Dhanusha; Choi, Sangdun</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1032-1049</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  The health of living organisms is constantly challenged by bacterial and viral threats.  The recognition of pathogenic microorganisms by diverse receptors triggers a variety of host defense mechanisms, leading to their eradication.  Toll-like receptors (TLRs), which are type I transmembrane proteins, recognize specific signatures of the invading microbes and activate a cascade of downstream signals inducing the secretion of inflammatory cytokines, chemokines, and type I interferons.  The TLR response not only counteracts the pathogens but also initiates and shapes the adaptive immune response.  Under normal conditions, inflammation is downregulated after the removal of the pathogen and cellular debris.  However, a dysfunctional TLR-mediated response maintains a chronic inflammatory state and leads to local and systemic deleterious effects in host cells and tissues.  Such inappropriate TLR response has been attributed to the development and progression of multiple diseases such as cancer, autoimmune, and inflammatory diseases.  In this review, we discuss the emerging role of TLRs in the pathogenesis of inflammatory diseases and how targeting of TLRs offers a promising therapeutic strategy for the prevention and treatment of various inflammatory diseases.  Addnl., we highlight a no. of TLR-targeting agents that are in the developmental stage or in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKA3cWXQ7UqrVg90H21EOLACvtfcHk0lg9gY3JLDFPmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlChsL7L&md5=2a2c871c48ae870982f4e7e0c1ee6260</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1007%2Fs12272-016-0806-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-016-0806-9%26sid%3Dliteratum%253Aachs%26aulast%3DAchek%26aufirst%3DA.%26aulast%3DYesudhas%26aufirst%3DD.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DToll-like%2520receptors%253A%2520Promising%2520therapeutic%2520targets%2520for%2520inflammatory%2520diseases%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2016%26volume%3D39%26issue%3D8%26spage%3D1032%26epage%3D1049%26doi%3D10.1007%2Fs12272-016-0806-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jules, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiguel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. I.</span></span> <span> </span><span class="NLM_article-title">Alternative splicing of the rage cytoplasmic domain regulates cell signaling and function</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">e78267</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0078267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1371%2Fjournal.pone.0078267" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e78267&issue=11&author=J.+Julesauthor=D.+Maiguelauthor=B.+I.+Hudson&title=Alternative+splicing+of+the+rage+cytoplasmic+domain+regulates+cell+signaling+and+function&doi=10.1371%2Fjournal.pone.0078267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0078267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0078267%26sid%3Dliteratum%253Aachs%26aulast%3DJules%26aufirst%3DJ.%26aulast%3DMaiguel%26aufirst%3DD.%26aulast%3DHudson%26aufirst%3DB.%2BI.%26atitle%3DAlternative%2520splicing%2520of%2520the%2520rage%2520cytoplasmic%2520domain%2520regulates%2520cell%2520signaling%2520and%2520function%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D11%26spage%3De78267%26doi%3D10.1371%2Fjournal.pone.0078267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kew, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habiel, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcu, K. B.</span></span> <span> </span><span class="NLM_article-title">The ikkalpha-dependent nf-kappab p52/relb noncanonical pathway is essential to sustain a cxcl12 autocrine loop in cells migrating in response to hmgb1</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>188</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2380</span>– <span class="NLM_lpage">2386</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1102454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.4049%2Fjimmunol.1102454" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2012&pages=2380-2386&issue=5&author=R.+R.+Kewauthor=M.+Penzoauthor=D.+M.+Habielauthor=K.+B.+Marcu&title=The+ikkalpha-dependent+nf-kappab+p52%2Frelb+noncanonical+pathway+is+essential+to+sustain+a+cxcl12+autocrine+loop+in+cells+migrating+in+response+to+hmgb1&doi=10.4049%2Fjimmunol.1102454"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1102454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1102454%26sid%3Dliteratum%253Aachs%26aulast%3DKew%26aufirst%3DR.%2BR.%26aulast%3DPenzo%26aufirst%3DM.%26aulast%3DHabiel%26aufirst%3DD.%2BM.%26aulast%3DMarcu%26aufirst%3DK.%2BB.%26atitle%3DThe%2520ikkalpha-dependent%2520nf-kappab%2520p52%252Frelb%2520noncanonical%2520pathway%2520is%2520essential%2520to%2520sustain%2520a%2520cxcl12%2520autocrine%2520loop%2520in%2520cells%2520migrating%2520in%2520response%2520to%2520hmgb1%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D188%26issue%3D5%26spage%3D2380%26epage%3D2386%26doi%3D10.4049%2Fjimmunol.1102454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Hout, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’huys, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schols, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Loy, T.</span></span> <span> </span><span class="NLM_article-title">Comparison of cell-based assays for the identification and evaluation of competitive cxcr4 inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">e0176057</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0176057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1371%2Fjournal.pone.0176057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0176057&issue=4&author=A.+van%0AHoutauthor=T.+D%E2%80%99huysauthor=M.+Oeyenauthor=D.+Scholsauthor=T.+Van+Loy&title=Comparison+of+cell-based+assays+for+the+identification+and+evaluation+of+competitive+cxcr4+inhibitors&doi=10.1371%2Fjournal.pone.0176057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0176057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0176057%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHout%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599huys%26aufirst%3DT.%26aulast%3DOeyen%26aufirst%3DM.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DVan%2BLoy%26aufirst%3DT.%26atitle%3DComparison%2520of%2520cell-based%2520assays%2520for%2520the%2520identification%2520and%2520evaluation%2520of%2520competitive%2520cxcr4%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D4%26spage%3De0176057%26doi%3D10.1371%2Fjournal.pone.0176057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bongartz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeting, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montori, V.</span></span> <span> </span><span class="NLM_article-title">Anti-tnf antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>295</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2285</span>, <span class="refDoi"> DOI: 10.1001/jama.295.19.2275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1001%2Fjama.295.19.2275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2006&pages=2275-2285&issue=19&author=T.+Bongartzauthor=A.+J.+Suttonauthor=M.+J.+Sweetingauthor=I.+Buchanauthor=E.+L.+Mattesonauthor=V.+Montori&title=Anti-tnf+antibody+therapy+in+rheumatoid+arthritis+and+the+risk+of+serious+infections+and+malignancies%3A+Systematic+review+and+meta-analysis+of+rare+harmful+effects+in+randomized+controlled+trials&doi=10.1001%2Fjama.295.19.2275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1001%2Fjama.295.19.2275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.295.19.2275%26sid%3Dliteratum%253Aachs%26aulast%3DBongartz%26aufirst%3DT.%26aulast%3DSutton%26aufirst%3DA.%2BJ.%26aulast%3DSweeting%26aufirst%3DM.%2BJ.%26aulast%3DBuchan%26aufirst%3DI.%26aulast%3DMatteson%26aufirst%3DE.%2BL.%26aulast%3DMontori%26aufirst%3DV.%26atitle%3DAnti-tnf%2520antibody%2520therapy%2520in%2520rheumatoid%2520arthritis%2520and%2520the%2520risk%2520of%2520serious%2520infections%2520and%2520malignancies%253A%2520Systematic%2520review%2520and%2520meta-analysis%2520of%2520rare%2520harmful%2520effects%2520in%2520randomized%2520controlled%2520trials%26jtitle%3DJAMA%26date%3D2006%26volume%3D295%26issue%3D19%26spage%3D2275%26epage%3D2285%26doi%3D10.1001%2Fjama.295.19.2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minozzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonovas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lytras, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecoraro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Lorenzo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastiampillai, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielli, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonati, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinquini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tocci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goletti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantini, F.</span></span> <span> </span><span class="NLM_article-title">Risk of infections using anti-tnf agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: A systematic review and meta-analysis</span>. <i>Expert Opin. Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">sup1</span>),  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1080/14740338.2016.1240783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1080%2F14740338.2016.1240783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27924643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=11-34&issue=sup1&author=S.+Minozziauthor=S.+Bonovasauthor=T.+Lytrasauthor=V.+Pecoraroauthor=M.+Gonzalez-Lorenzoauthor=A.+J.+Bastiampillaiauthor=E.+M.+Gabrielliauthor=A.+C.+Lonatiauthor=L.+Mojaauthor=M.+Cinquiniauthor=V.+Marinoauthor=A.+Matucciauthor=G.+M.+Milanoauthor=G.+Tocciauthor=R.+Scarpaauthor=D.+Golettiauthor=F.+Cantini&title=Risk+of+infections+using+anti-tnf+agents+in+rheumatoid+arthritis%2C+psoriatic+arthritis%2C+and+ankylosing+spondylitis%3A+A+systematic+review+and+meta-analysis&doi=10.1080%2F14740338.2016.1240783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis</span></div><div class="casAuthors">Minozzi, Silvia; Bonovas, Stefanos; Lytras, Theodore; Pecoraro, Valentina; Gonzalez-Lorenzo, Marien; Bastiampillai, Anan Judina; Gabrielli, Eugenia Maria; Lonati, Andrea Carlo; Moja, Lorenzo; Cinquini, Michela; Marino, Valentina; Matucci, Andrea; Milano, Giuseppe Maria; Tocci, Giuliano; Scarpa, Raffaele; Goletti, Delia; Cantini, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">sup1</span>),
    <span class="NLM_cas:pages">11-34</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory approval for use in rheumatol.: adalimumab, golimumab, infliximab, certolizumab, and etanercept.  Apart from their well-documented therapeutic value, it is still uncertain to what extent they are assocd. with an increased risk of infectious adverse events.  We conducted a systematic review and meta-anal. of published randomized studies to det. the effect of anti-TNF drugs on the occurrence of infectious adverse events (serious infections; tuberculosis; opportunistic infections; any infection).  We searched Medline, Embase, and the Cochrane Library up to May 2014 to identify eligible studies in adult patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis that evaluated anti-TNF drugs compared with placebo or no treatment.  Our study encompassed data from 71 randomized controlled trials involving 22,760 participants (range of follow-up: 1-36 mo) and seven open label extension studies with 2,236 participants (range of follow-up: 6-48 mo).  Quant. synthesis of the available data found statistically significant increases in the occurrence of any infections (20%), serious infections (40%), and tuberculosis (250%) assocd. with anti-TNF drug use, while the data for opportunistic infections were scarce.  The quality of synthesized evidence was judged as moderate.  Further evidence from registries and long-term epidemiol. studies are needed to better define the relationship between anti-TNF agents and infection complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjPpoFUt50VbVg90H21EOLACvtfcHk0lgh-73P2I_5DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2rtbc%253D&md5=39be1b54462fcd5ff22c30a8ea852aab</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1080%2F14740338.2016.1240783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14740338.2016.1240783%26sid%3Dliteratum%253Aachs%26aulast%3DMinozzi%26aufirst%3DS.%26aulast%3DBonovas%26aufirst%3DS.%26aulast%3DLytras%26aufirst%3DT.%26aulast%3DPecoraro%26aufirst%3DV.%26aulast%3DGonzalez-Lorenzo%26aufirst%3DM.%26aulast%3DBastiampillai%26aufirst%3DA.%2BJ.%26aulast%3DGabrielli%26aufirst%3DE.%2BM.%26aulast%3DLonati%26aufirst%3DA.%2BC.%26aulast%3DMoja%26aufirst%3DL.%26aulast%3DCinquini%26aufirst%3DM.%26aulast%3DMarino%26aufirst%3DV.%26aulast%3DMatucci%26aufirst%3DA.%26aulast%3DMilano%26aufirst%3DG.%2BM.%26aulast%3DTocci%26aufirst%3DG.%26aulast%3DScarpa%26aufirst%3DR.%26aulast%3DGoletti%26aufirst%3DD.%26aulast%3DCantini%26aufirst%3DF.%26atitle%3DRisk%2520of%2520infections%2520using%2520anti-tnf%2520agents%2520in%2520rheumatoid%2520arthritis%252C%2520psoriatic%2520arthritis%252C%2520and%2520ankylosing%2520spondylitis%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2016%26volume%3D15%26issue%3Dsup1%26spage%3D11%26epage%3D34%26doi%3D10.1080%2F14740338.2016.1240783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urbonaviciute, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furnrohr, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haslbeck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. E.</span></span> <span> </span><span class="NLM_article-title">Factors masking hmgb1 in human serum and plasma</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1189/jlb.0306196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1189%2Fjlb.0306196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=17060363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BD28jkslWntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=67-74&issue=1&author=V.+Urbonaviciuteauthor=B.+G.+Furnrohrauthor=C.+Weberauthor=M.+Haslbeckauthor=S.+Wilhelmauthor=M.+Herrmannauthor=R.+E.+Voll&title=Factors+masking+hmgb1+in+human+serum+and+plasma&doi=10.1189%2Fjlb.0306196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Factors masking HMGB1 in human serum and plasma</span></div><div class="casAuthors">Urbonaviciute Vilma; Furnrohr Barbara G; Weber Christian; Haslbeck Martin; Wilhelm Sabine; Herrmann Martin; Voll Reinhard E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of leukocyte biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-74</span>
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    </div><div class="casAbstract">High mobility group box 1 protein (HMGB1) is a ubiquitously expressed architectural chromosomal protein.  Recently, it has become obvious that HMGB1 can also act as a proinflammatory mediator when actively secreted during cell activation or passively released from necrotic cells.  HMGB1 appears to play an important role in the pathogenesis of diseases, including sepsis and rheumatoid arthritis.  However, easy, sensitive, and reliable detection systems are required to investigate the clinical significance of HMGB1 in clinical samples for diagnosis and prognosis of diseases.  Here, we describe sensitive ELISAs for the detection of HMGB1 in cell culture medium and cell lysates.  However, these assays failed to reliably quantitate HMGB1 in serum and plasma when compared with immunoblot analysis.  We found that serum/plasma components bind to HMGB1 and interfere with its detection by ELISA systems.  In most serum/plasma samples investigated, including those from healthy individuals, we detected IgG antibodies binding to HMGB1.  The titers of these antibodies correlated with the capacity of sera to interfere with the detection of recombinant HMGB1 by ELISA.  Furthermore, HMGB1 coimmunoprecipitated with several proteins including IgG1, as identified by mass spectrometry.  These HMGB1 interacting proteins are currently characterized and may contribute to complex formation, masking, and possibly, modulation of cytokine activity of HMGB1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0CGBldOxMXq-9TkgmBqTqfW6udTcc2eauKVC8pUmd2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jkslWntA%253D%253D&md5=8cd5b6051d6611756a70040619bbddcc</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1189%2Fjlb.0306196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.0306196%26sid%3Dliteratum%253Aachs%26aulast%3DUrbonaviciute%26aufirst%3DV.%26aulast%3DFurnrohr%26aufirst%3DB.%2BG.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DHaslbeck%26aufirst%3DM.%26aulast%3DWilhelm%26aufirst%3DS.%26aulast%3DHerrmann%26aufirst%3DM.%26aulast%3DVoll%26aufirst%3DR.%2BE.%26atitle%3DFactors%2520masking%2520hmgb1%2520in%2520human%2520serum%2520and%2520plasma%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2007%26volume%3D81%26issue%3D1%26spage%3D67%26epage%3D74%26doi%3D10.1189%2Fjlb.0306196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bults, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Merbel, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, R.</span></span> <span> </span><span class="NLM_article-title">Quantification of biopharmaceuticals and biomarkers in complex biological matrices: A comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays</span>. <i>Expert Rev. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1586/14789450.2015.1050384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1586%2F14789450.2015.1050384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26005069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOltr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=355-374&issue=4&author=P.+Bultsauthor=N.+C.+van+de+Merbelauthor=R.+Bischoff&title=Quantification+of+biopharmaceuticals+and+biomarkers+in+complex+biological+matrices%3A+A+comparison+of+liquid+chromatography+coupled+to+tandem+mass+spectrometry+and+ligand+binding+assays&doi=10.1586%2F14789450.2015.1050384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays</span></div><div class="casAuthors">Bults, Peter; van de Merbel, Nico C.; Bischoff, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Proteomics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-374</span>CODEN:
                <span class="NLM_cas:coden">ERPXA3</span>;
        ISSN:<span class="NLM_cas:issn">1478-9450</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The quantification of proteins (biopharmaceuticals or biomarkers) in complex biol. samples such as blood plasma requires exquisite sensitivity and selectivity, as all biol. matrixes contain myriads of proteins that are all made of the same 20 proteinogenic amino acids, notwithstanding post-translational modifications.  This review describes and compares the two main approaches, namely, ligand binding assays (LBAs) and liq. chromatog. coupled to tandem mass spectrometry in the selected reaction monitoring (SRM) mode.  While LBAs remain the most widely used approach, SRM assays are gaining interest due to their generally better anal. performance (precision and accuracy) and their capacity for multiplex analyses.  This article focuses on the possible reasons for the discrepancies between results obtained by LBAs and SRM assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_nDecSE7eKrVg90H21EOLACvtfcHk0lhYDBvtWsiDbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOltr%252FK&md5=3db1e8564bf37d613a373a1ce615a26b</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1586%2F14789450.2015.1050384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14789450.2015.1050384%26sid%3Dliteratum%253Aachs%26aulast%3DBults%26aufirst%3DP.%26aulast%3Dvan%2Bde%2BMerbel%26aufirst%3DN.%2BC.%26aulast%3DBischoff%26aufirst%3DR.%26atitle%3DQuantification%2520of%2520biopharmaceuticals%2520and%2520biomarkers%2520in%2520complex%2520biological%2520matrices%253A%2520A%2520comparison%2520of%2520liquid%2520chromatography%2520coupled%2520to%2520tandem%2520mass%2520spectrometry%2520and%2520ligand%2520binding%2520assays%26jtitle%3DExpert%2520Rev.%2520Proteomics%26date%3D2015%26volume%3D12%26issue%3D4%26spage%3D355%26epage%3D374%26doi%3D10.1586%2F14789450.2015.1050384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Izrael-Tomasevic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnott, D.</span></span> <span> </span><span class="NLM_article-title">Targeting interferon alpha subtypes in serum: A comparison of analytical approaches to the detection and quantitation of proteins in complex biological matrices</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3132</span>– <span class="NLM_lpage">3140</span>, <span class="refDoi"> DOI: 10.1021/pr900076q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr900076q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFWjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3132-3140&issue=6&author=A.+Izrael-Tomasevicauthor=L.+Phuauthor=Q.+T.+Phungauthor=J.+R.+Lillauthor=D.+Arnott&title=Targeting+interferon+alpha+subtypes+in+serum%3A+A+comparison+of+analytical+approaches+to+the+detection+and+quantitation+of+proteins+in+complex+biological+matrices&doi=10.1021%2Fpr900076q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Interferon Alpha Subtypes in Serum: A Comparison of Analytical Approaches to the Detection and Quantitation of Proteins in Complex Biological Matrices</span></div><div class="casAuthors">Izrael-Tomasevic, Anita; Phu, Lilian; Phung, Qui T.; Lill, Jennie R.; Arnott, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3132-3140</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The targeted detection and quantitation of proteins in complex biol. fluids such as blood is as anal. challenging as it is crucial for biomedical research.  Antibody-based techniques such as the ELISA are the current stds. for such measurements, having in favorable cases high specificity and pg/mL detection limits.  Long development timelines and susceptibility to cross reactivity have led researchers to investigate mass spectrometric alternatives.  The literature contains diverse schemes for sample prepn. and multiple platforms for mass spectrometric detection.  Crit. evaluations of competing technologies are, however, badly needed.  Taking closely related subtypes of the pro-inflammatory cytokine interferon alpha as a test case, the authors compared a sample prepn. workflow based on affinity enrichment to 1 based on generic multidimensional chromatog., and evaluated mass spectrometric techniques using tandem mass spectrometry on low resoln. ion traps, high resoln. "accurate mass tags," and triple quadrupole selective reaction monitoring.  Each workflow and detection method proved capable of detecting and discriminating between these proteins at or below the ng/mL level in human serum.  Quantitation by isotope diln. was evaluated using full length protein as the internal std.  Both triple quadrupole selected reaction monitoring and orbitrap selected ion monitoring produced linear calibration curves from 1 ng/mL to 1 μg/mL, with lower limits of quantitation below 5 and 50 ng/mL, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJoMttwq8vcrVg90H21EOLACvtfcHk0lg2df2R5hDuCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFWjur8%253D&md5=f6a2e77507c0c4e53a19df79ae3ecd90</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fpr900076q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr900076q%26sid%3Dliteratum%253Aachs%26aulast%3DIzrael-Tomasevic%26aufirst%3DA.%26aulast%3DPhu%26aufirst%3DL.%26aulast%3DPhung%26aufirst%3DQ.%2BT.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DArnott%26aufirst%3DD.%26atitle%3DTargeting%2520interferon%2520alpha%2520subtypes%2520in%2520serum%253A%2520A%2520comparison%2520of%2520analytical%2520approaches%2520to%2520the%2520detection%2520and%2520quantitation%2520of%2520proteins%2520in%2520complex%2520biological%2520matrices%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2009%26volume%3D8%26issue%3D6%26spage%3D3132%26epage%3D3140%26doi%3D10.1021%2Fpr900076q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Festoff, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajja, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dreden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucullo, L.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">194</span>, <span class="refDoi"> DOI: 10.1186/s12974-016-0670-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2Fs12974-016-0670-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27553758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVGktrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=194&issue=1&author=B.+W.+Festoffauthor=R.+K.+Sajjaauthor=P.+van+Dredenauthor=L.+Cucullo&title=Hmgb1+and+thrombin+mediate+the+blood-brain+barrier+dysfunction+acting+as+biomarkers+of+neuroinflammation+and+progression+to+neurodegeneration+in+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs12974-016-0670-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease</span></div><div class="casAuthors">Festoff, Barry W.; Sajja, Ravi K.; van Dreden, Patrick; Cucullo, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">194/1-194/12</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The blood-brain barrier (BBB) dysfunction represents an early feature of Alzheimer's disease (AD) that precedes the hallmarks of amyloid beta (amyloid β) plaque deposition and neuronal neurofibrillary tangle (NFT) formation.  A damaged BBB correlates directly with neuroinflammation involving microglial activation and reactive astrogliosis, which is assocd. with increased expression and/or release of high-mobility group box protein 1 (HMGB1) and thrombin.  However, the link between the presence of these mols., BBB damage, and progression to neurodegeneration in AD is still elusive.  Therefore, we aimed to profile and validate non-invasive clin. biomarkers of BBB dysfunction and neuroinflammation to assess the progression to neurodegeneration in mild cognitive impairment (MCI) and AD patients.  Methods: We detd. the serum levels of various proinflammatory damage-assocd. mols. in aged control subjects and patients with MCI or AD using validated ELISA kits.  We then assessed the specific and direct effects of such mols. on BBB integrity in vitro using human primary brain microvascular endothelial cells or a cell line.  Results: We obsd. a significant increase in serum HMGB1 and sol. receptor for advanced glycation end products (sRAGE) that correlated well with amyloid beta levels in AD patients (vs. control subjects).  Interestingly, serum HMGB1 levels were significantly elevated in MCI patients compared to controls or AD patients.  In addn., as a marker of BBB damage, sol. thrombomodulin (sTM) antigen, and activity were significantly (and distinctly) increased in MCI and AD patients.  Direct in vitro BBB integrity assessment further revealed a significant and concn.-dependent increase in paracellular permeability to dextrans by HMGB1 or a-thrombin, possibly through disruption of zona occludins-1 bands.  Pre-treatment with anti-HMGB1 monoclonal antibody blocked HMGB1 effects and leaving BBB integrity intact.  Conclusions: Our current studies indicate that thrombin and HMGB1 are causal proximate proinflammatory mediators of BBB dysfunction, while sTM levels may indicate BBB endothelial damage; HMGB1 and sRAGE might serve as clin. biomarkers for progression and/or therapeutic efficacy along the AD spectrum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6tmxZhEnauLVg90H21EOLACvtfcHk0lg2df2R5hDuCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVGktrjE&md5=d6f6c8722da83b2c3488eb6cfb719794</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1186%2Fs12974-016-0670-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-016-0670-z%26sid%3Dliteratum%253Aachs%26aulast%3DFestoff%26aufirst%3DB.%2BW.%26aulast%3DSajja%26aufirst%3DR.%2BK.%26aulast%3Dvan%2BDreden%26aufirst%3DP.%26aulast%3DCucullo%26aufirst%3DL.%26atitle%3DHmgb1%2520and%2520thrombin%2520mediate%2520the%2520blood-brain%2520barrier%2520dysfunction%2520acting%2520as%2520biomarkers%2520of%2520neuroinflammation%2520and%2520progression%2520to%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2016%26volume%3D13%26issue%3D1%26spage%3D194%26doi%3D10.1186%2Fs12974-016-0670-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilson, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton Whittle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas Crain, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo-Carranza, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayed, R.</span></span> <span> </span><span class="NLM_article-title">Tau oligomers associate with inflammation in the brain and retina of tauopathy mice and in neurodegenerative diseases</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1083</span>– <span class="NLM_lpage">1099</span>, <span class="refDoi"> DOI: 10.3233/JAD-160912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3233%2FJAD-160912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27716675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyrtrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2017&pages=1083-1099&issue=3&author=A.+N.+Nilsonauthor=K.+C.+Englishauthor=J.+E.+Gersonauthor=T.+Barton+Whittleauthor=C.+Nicolas+Crainauthor=J.+Xueauthor=U.+Senguptaauthor=D.+L.+Castillo-Carranzaauthor=W.+Zhangauthor=P.+Guptaauthor=R.+Kayed&title=Tau+oligomers+associate+with+inflammation+in+the+brain+and+retina+of+tauopathy+mice+and+in+neurodegenerative+diseases&doi=10.3233%2FJAD-160912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases</span></div><div class="casAuthors">Nilson, Ashley N.; English, Kelsey C.; Gerson, Julia E.; Barton Whittle, T.; Nicolas Crain, C.; Xue, Judy; Sengupta, Urmi; Castillo-Carranza, Diana L.; Zhang, Wenbo; Gupta, Praveena; Kayed, Rakez</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1083-1099</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">It is well-established that inflammation plays an important role in Alzheimer's disease (AD) and frontotemporal lobar dementia (FTLD).  Inflammation and synapse loss occur in disease prior to the formation of larger aggregates, but the contribution of tau to inflammation has not yet been thoroughly investigated.  Tau pathol. aggregates to form large fibrillar structures known as tangles.  However, evidence suggests that smaller sol. aggregates, called oligomers, are the most toxic species and form prior to tangles.  Furthermore, tau oligomers can spread to neighboring cells and between anatomically connected brain regions.  In addn., recent evidence suggests that inspecting the retina may be a window to brain pathol.  We hypothesized that there is a relationship between tau oligomers and inflammation, which are hallmarks of early disease.  We conducted immunofluorescence and biochem. analyses on tauopathy mice, FTLD, and AD subjects.  We showed that oligomers co-localize with astrocytes, microglia, and HMGB1, a pro-inflammatory cytokine.  Addnl., we show that tau oligomers are present in the retina and are assocd. with inflammatory cells suggesting that the retina may be a valid non-invasive biomarker for brain pathol.  These results suggest that there may be a toxic relationship between tau oligomers and inflammation.  Therefore, the ability of tau oligomers to spread may initiate a feed-forward cycle in which tau oligomers induce inflammation, leading to neuronal damage, and thus more inflammation.  Further mechanistic studies are warranted in order to understand this relationship, which may have crit. implications for improving the treatment of tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNdqYZalNN6rVg90H21EOLACvtfcHk0lhr4oQJpqBJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyrtrfO&md5=b52190000eb3fc0dcb18457261cff53d</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.3233%2FJAD-160912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-160912%26sid%3Dliteratum%253Aachs%26aulast%3DNilson%26aufirst%3DA.%2BN.%26aulast%3DEnglish%26aufirst%3DK.%2BC.%26aulast%3DGerson%26aufirst%3DJ.%2BE.%26aulast%3DBarton%2BWhittle%26aufirst%3DT.%26aulast%3DNicolas%2BCrain%26aufirst%3DC.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DSengupta%26aufirst%3DU.%26aulast%3DCastillo-Carranza%26aufirst%3DD.%2BL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DKayed%26aufirst%3DR.%26atitle%3DTau%2520oligomers%2520associate%2520with%2520inflammation%2520in%2520the%2520brain%2520and%2520retina%2520of%2520tauopathy%2520mice%2520and%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2017%26volume%3D55%26issue%3D3%26spage%3D1083%26epage%3D1099%26doi%3D10.3233%2FJAD-160912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakimura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibagaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchiya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimohama, S.</span></span> <span> </span><span class="NLM_article-title">Role of high mobility group protein-1 (hmg1) in amyloid-beta homeostasis</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>301</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(03)00024-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2FS0006-291X%2803%2900024-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2003&pages=699-703&issue=3&author=K.+Takataauthor=Y.+Kitamuraauthor=J.+Kakimuraauthor=K.+Shibagakiauthor=D.+Tsuchiyaauthor=T.+Taniguchiauthor=M.+A.+Smithauthor=G.+Perryauthor=S.+Shimohama&title=Role+of+high+mobility+group+protein-1+%28hmg1%29+in+amyloid-beta+homeostasis&doi=10.1016%2FS0006-291X%2803%2900024-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2900024-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252900024-X%26sid%3Dliteratum%253Aachs%26aulast%3DTakata%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DKakimura%26aufirst%3DJ.%26aulast%3DShibagaki%26aufirst%3DK.%26aulast%3DTsuchiya%26aufirst%3DD.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DShimohama%26aufirst%3DS.%26atitle%3DRole%2520of%2520high%2520mobility%2520group%2520protein-1%2520%2528hmg1%2529%2520in%2520amyloid-beta%2520homeostasis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D301%26issue%3D3%26spage%3D699%26epage%3D703%26doi%3D10.1016%2FS0006-291X%2803%2900024-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spliet, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steentjes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronica, E.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2011.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.neuroscience.2011.02.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=233-243&author=M.+Casulaauthor=A.+M.+Iyerauthor=W.+G.+Splietauthor=J.+J.+Aninkauthor=K.+Steentjesauthor=M.+Staauthor=D.+Troostauthor=E.+Aronica&title=Toll-like+receptor+signaling+in+amyotrophic+lateral+sclerosis+spinal+cord+tissue&doi=10.1016%2Fj.neuroscience.2011.02.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2011.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2011.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DCasula%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DA.%2BM.%26aulast%3DSpliet%26aufirst%3DW.%2BG.%26aulast%3DAnink%26aufirst%3DJ.%2BJ.%26aulast%3DSteentjes%26aufirst%3DK.%26aulast%3DSta%26aufirst%3DM.%26aulast%3DTroost%26aufirst%3DD.%26aulast%3DAronica%26aufirst%3DE.%26atitle%3DToll-like%2520receptor%2520signaling%2520in%2520amyotrophic%2520lateral%2520sclerosis%2520spinal%2520cord%2520tissue%26jtitle%3DNeuroscience%26date%3D2011%26volume%3D179%26spage%3D233%26epage%3D243%26doi%3D10.1016%2Fj.neuroscience.2011.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juranek, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daffu, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtkiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacomis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kofler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. M.</span></span> <span> </span><span class="NLM_article-title">Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">485</span>, <span class="refDoi"> DOI: 10.3389/fncel.2015.00485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3389%2Ffncel.2015.00485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26733811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvV2lt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=485&author=J.+K.+Juranekauthor=G.+K.+Daffuauthor=J.+Wojtkiewiczauthor=D.+Lacomisauthor=J.+Koflerauthor=A.+M.+Schmidt&title=Receptor+for+advanced+glycation+end+products+and+its+inflammatory+ligands+are+upregulated+in+amyotrophic+lateral+sclerosis&doi=10.3389%2Ffncel.2015.00485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Juranek, Judyta K.; Daffu, Gurdip K.; Wojtkiewicz, Joanna; Lacomis, David; Kofler, Julia; Schmidt, Ann Marie</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">485/1-485/12</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder of largely unknown pathogenesis.  Recent studies suggest that enhanced oxidative stress and neuroinflammation contribute to the progression of the disease.  Mounting evidence implicates the receptor for advanced glycation end-products (RAGE) as a significant contributor to the pathogenesis of certain neurodegenerative diseases and chronic conditions.  It is hypothesized that detrimental actions of RAGE are triggered upon binding to its ligands, such as AGEs (advanced glycation end products), S100/calgranulin family members, and High Mobility Group Box-1 (HMGB1) proteins.  Here, we examd. the expression of RAGE and its ligands in human ALS spinal cord.  Tissue samples from age-matched human control and ALS spinal cords were tested for the expression of RAGE, carboxymethyllysine (CML) AGE, S100B, and HMGB1, and intensity of the immunofluorescent and immunoblotting signals was assessed.  We found that the expression of both RAGE and its ligands was significantly increased in the spinal cords of ALS patients vs. age-matched control subjects.  Our study is the first report describing co-expression of both RAGE and its ligands in human ALS spinal cords.  These findings suggest that further probing of RAGE as a mechanism of neurodegeneration in human ALS is rational.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5xB-iUAe407Vg90H21EOLACvtfcHk0lhr4oQJpqBJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvV2lt7g%253D&md5=33ccd40a4e9cc593fcdef05811d214af</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2015.00485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2015.00485%26sid%3Dliteratum%253Aachs%26aulast%3DJuranek%26aufirst%3DJ.%2BK.%26aulast%3DDaffu%26aufirst%3DG.%2BK.%26aulast%3DWojtkiewicz%26aufirst%3DJ.%26aulast%3DLacomis%26aufirst%3DD.%26aulast%3DKofler%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26atitle%3DReceptor%2520for%2520advanced%2520glycation%2520end%2520products%2520and%2520its%2520inflammatory%2520ligands%2520are%2520upregulated%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D485%26doi%3D10.3389%2Ffncel.2015.00485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Expression and significance of high-mobility group protein b1 (hmgb1) and the receptor for advanced glycation end-product (rage) in knee osteoarthritis</span>. <i>Med. Sci. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2105</span>– <span class="NLM_lpage">2112</span>, <span class="refDoi"> DOI: 10.12659/MSM.895689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.12659%2FMSM.895689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27320800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnvVWgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=2105-2112&author=X.+H.+Sunauthor=Y.+Liuauthor=Y.+Hanauthor=J.+Wang&title=Expression+and+significance+of+high-mobility+group+protein+b1+%28hmgb1%29+and+the+receptor+for+advanced+glycation+end-product+%28rage%29+in+knee+osteoarthritis&doi=10.12659%2FMSM.895689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and significance of high-mobility group protein B1 (HMGB1) and the receptor for advanced glycation end-product (RAGE) in knee osteoarthritis</span></div><div class="casAuthors">Sun, Xue-Hui; Liu, Ying; Han, Yun; Wang, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Medical Science Monitor</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2105-2112</span>CODEN:
                <span class="NLM_cas:coden">MSMOFR</span>;
        ISSN:<span class="NLM_cas:issn">1643-3750</span>.
    
            (<span class="NLM_cas:orgname">International Scientific Information, Inc.</span>)
        </div><div class="casAbstract">Background: This study was performed with the aim to explore the expression of high-mobility group protein B1 (HMGB1) and the receptor for advanced glycation end-product (RAGE) in knee osteoarthritis (KOA) and its clin. significance.  Material/Methods: A total of 108 synovial tissues selected from KOA patients were included in the exptl. group.  Seventy-five synovial tissues of knee joints, selected from patients who were clin. and pathol. confirmed without joint lesion, were included in the control group.  The mRNA and protein expressions of HMGB1 and RAGE were detd. by using RT-PCR and immunohistochem., resp.  Western blotting was used for measuring relative protein expression.  An ROC curve was drawn to evaluate the diagnostic value of HMGB1 and RAGE for KOA.  Results: The pos. cell no. and pos. expression intensity of HMGB1 and RAGE in synovial tissue was higher in the exptl. group than in the control group.  PI for HMGB1 and RAGE expression in KOA patients was pos. correlated with clin. classification of X-ray films (P<0.05).  HMGB1 and RAGE mRNA expressions, as well as relative protein expression of HMGB1 and RAGE in synovial tissue, were higher in the exptl. group than in the control group (all P<0.05).  The sensitivity of HMGB1 protein, RAGE protein, HMGB1 mRNA, and RAGE mRNA were 76.9%, 64.8%, 86.1%, and 64.8%, resp.; and the specificity was 100%, 96%, 74.7%, and 80%, resp.  Conclusions: The protein and mRNA expressions of HMGB1 and RAGE are both increased in KOA patients, suggesting that they are involved in KOA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreS_OwJrQBWrVg90H21EOLACvtfcHk0liOtA9ATxQc8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnvVWgt74%253D&md5=fe4e501e2c345b77d9f63d8f47dbe145</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.12659%2FMSM.895689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12659%252FMSM.895689%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%2BH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DExpression%2520and%2520significance%2520of%2520high-mobility%2520group%2520protein%2520b1%2520%2528hmgb1%2529%2520and%2520the%2520receptor%2520for%2520advanced%2520glycation%2520end-product%2520%2528rage%2529%2520in%2520knee%2520osteoarthritis%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2016%26volume%3D22%26spage%3D2105%26epage%3D2112%26doi%3D10.12659%2FMSM.895689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ke, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, B.</span></span> <span> </span><span class="NLM_article-title">Synovial fluid hmgb-1 levels are associated with osteoarthritis severity</span>. <i>Clin. Lab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">818</span>, <span class="refDoi"> DOI: 10.7754/Clin.Lab.2015.141205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.7754%2FClin.Lab.2015.141205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26299081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGhsLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=809-818&issue=7&author=X.+Keauthor=G.+Jinauthor=Y.+Yangauthor=X.+Caoauthor=R.+Fangauthor=X.+Fengauthor=B.+Lei&title=Synovial+fluid+hmgb-1+levels+are+associated+with+osteoarthritis+severity&doi=10.7754%2FClin.Lab.2015.141205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Synovial fluid HMGB-1 levels are associated with osteoarthritis severity</span></div><div class="casAuthors">Ke, Xueru; Jin, Gele; Yang, Yi; Cao, Xinghua; Fang, Rui; Feng, Xiaoyun; Lei, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Laboratory (Mainz, Germany)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">809-818</span>CODEN:
                <span class="NLM_cas:coden">CLLAFP</span>;
        ISSN:<span class="NLM_cas:issn">1433-6510</span>.
    
            (<span class="NLM_cas:orgname">Clinical Laboratory Publications GmbH</span>)
        </div><div class="casAbstract">Background: Recent data have shown that enhanced cytokine prodn. in knee osteoarthritis (OA) synovium arc believed to promote pathol. OA.  High-mobility group box 1 (HMGB-1) as a well-known pro-inflammatory cytokine may influence the development of knee OA.  The purpose of this study is to analyze the amt. of and location of HMGB-1 in OA synovium and to compare it with controls who are afflicted with acute meniscal or cruciate ligament tears.  We also evaluated the relationship between the level of HMGB-I in synovial fluid with the severity of synovitis, clin. symptoms (pain, stiffness, daily activity), and radiol. changes in patients with knee OA.  Methods: Synovium and synovial fluid were harvested from seventy-four knee OA patients and thirty-four controls afflicted with acute meniscal or cruciate ligament tears.  Kellgren-Lawrence (KL) grading system and Western Ontario McMaster University Osteoarthritis Index (WOMAC) assessment scale were applied to evaluate the radiol. and clinic severity of OA patients.  Addnl., for all patients, the microscopic synovitis was graded to evaluate the severity of synovium pathol.  The location of HMGB-1 was detd. in the synovium by immunohistochem.  Synovium and synovial fluid HNIGB-1 levels were measured by western blotting and ELISA (ELISA), resp.  Results: Synovium immunohistochem. anal. revealed that HMGB-1 displayed a strictly nuclear localization in controls; however, both nuclear and cytoplasmic distributions were present in OA patients.  The percentage of HMGB-1 pos. cells as well as cytoplasmic HMGB-1 cell population in OA patients were higher than those of controls (42.5% vs. 39.7% and 24.0% vs. 5.7%).  Both synovium and synovial fluid HMGB-1 levels in OA patients were significantly higher than controls.  In OA patients, IIMGB-1 in the KU2/3 group was higher than in the KL4 group.  Addnl., synovial fluid IIMGB-I levels in OA patients were pos. assocd. with the severity of synovitis, pain, and daily activities.  Conclusions: Our results demonstrated that HMGB-1 is overexpressed and relocated in synovial membranes of patients with knee OA.  The increased synovial fluid HMGB-1 levels were assocd. with the severity of synovitis, pain, and daily activities in knee OA patients.  These results suggested that HMGB-1, as a pro-inflammatory cytokine, may play a crucial role in the progression of knee OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry4V-4EFRosrVg90H21EOLACvtfcHk0liOtA9ATxQc8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGhsLjN&md5=6314aa9a593dde70c1909f802da1182e</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.7754%2FClin.Lab.2015.141205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7754%252FClin.Lab.2015.141205%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DR.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DB.%26atitle%3DSynovial%2520fluid%2520hmgb-1%2520levels%2520are%2520associated%2520with%2520osteoarthritis%2520severity%26jtitle%3DClin.%2520Lab.%26date%3D2015%26volume%3D61%26issue%3D7%26spage%3D809%26epage%3D818%26doi%3D10.7754%2FClin.Lab.2015.141205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amin, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, A. B.</span></span> <span> </span><span class="NLM_article-title">Genomic analysis and differential expression of hmg and s100a family in human arthritis: Upregulated expression of chemokines, il-8 and nitric oxide by hmgb1</span>. <i>DNA Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">550</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1089/dna.2013.2198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1089%2Fdna.2013.2198" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=550-565&issue=8&author=A.+R.+Aminauthor=A.+B.+Islam&title=Genomic+analysis+and+differential+expression+of+hmg+and+s100a+family+in+human+arthritis%3A+Upregulated+expression+of+chemokines%2C+il-8+and+nitric+oxide+by+hmgb1&doi=10.1089%2Fdna.2013.2198"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1089%2Fdna.2013.2198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fdna.2013.2198%26sid%3Dliteratum%253Aachs%26aulast%3DAmin%26aufirst%3DA.%2BR.%26aulast%3DIslam%26aufirst%3DA.%2BB.%26atitle%3DGenomic%2520analysis%2520and%2520differential%2520expression%2520of%2520hmg%2520and%2520s100a%2520family%2520in%2520human%2520arthritis%253A%2520Upregulated%2520expression%2520of%2520chemokines%252C%2520il-8%2520and%2520nitric%2520oxide%2520by%2520hmgb1%26jtitle%3DDNA%2520Cell%2520Biol.%26date%3D2014%26volume%3D33%26issue%3D8%26spage%3D550%26epage%3D565%26doi%3D10.1089%2Fdna.2013.2198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pullerits, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schierbeck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uibo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liivamagi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarraste, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talvik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruunsild, C.</span></span> <span> </span><span class="NLM_article-title">High mobility group box protein 1-a prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis</span>. <i>Semin. Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1016/j.semarthrit.2016.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.semarthrit.2016.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27756498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslSnsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=444-450&issue=4&author=R.+Pulleritsauthor=H.+Schierbeckauthor=K.+Uiboauthor=H.+Liivamagiauthor=S.+Tarrasteauthor=T.+Talvikauthor=E.+Sundbergauthor=C.+Pruunsild&title=High+mobility+group+box+protein+1-a+prognostic+marker+for+structural+joint+damage+in+10-year+follow-up+of+patients+with+juvenile+idiopathic+arthritis&doi=10.1016%2Fj.semarthrit.2016.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box protein 1-A prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis</span></div><div class="casAuthors">Pullerits, Rille; Schierbeck, Hanna; Uibo, Karin; Liivamaegi, Hille; Tarraste, Sirje; Talvik, Tiina; Sundberg, Erik; Pruunsild, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Arthritis and Rheumatism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">444-450</span>CODEN:
                <span class="NLM_cas:coden">SAHRBF</span>;
        ISSN:<span class="NLM_cas:issn">0049-0172</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">High mobility group box protein 1 (HMGB1) is an important pro-inflammatory mediator in adult rheumatoid arthritis.  The diagnostic utility of HMGB1 in Juvenile Idiopathic Arthritis (JIA) is still unclear.  The aim was to examine whether serum HMGB1 levels are assocd. with inflammation, radiol. disease progression, and long-term prognosis in JIA.  We included 131 children with JIA from a population-based prevalence study; 38 of them were prospectively followed up for 10 years.  Clin. and lab. disease characteristics at study entry and after 10 years as well as radiol. progression over 10 years were recorded.  HMGB1 levels were analyzed by an ELISA.  The HMGB1 levels were similar in children with different JIA subgroups and in children with established (53%) or newly diagnosed (47%) disease.  HMGB1 levels did not differ between groups at entry into the study or at 10 years, by sex, or by the presence or absence of RF or ANA antibodies.  HMGB1 levels at the study entry correlated with HMGB1 levels at 10 years and with blood neutrophil count.  Most importantly, children with destructive arthritis at 10 years had a tendency toward higher HMGB1 levels at study entry (median 1.2 vs 0.6 ng/mL, ns) and displayed 4-fold higher circulating HMGB1 levels (median 3.4 vs 0.8 ng/mL, p = 0.0014) than children without radiol. destructions.  Our results suggest that HMGB1 is a marker of inflammatory activity in children with JIA.  Higher serum HMGB1 levels are related to more destructive JIA and could be used as a neg. prognostic marker at the disease start.  Trial registration: Clinicaltrials.gov NCT01905319.  Registered July 16, 2013.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpbmX5Izlws7Vg90H21EOLACvtfcHk0liOtA9ATxQc8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslSnsLbM&md5=b3c0d1031312d9983c5cbe99c1ee0df5</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.semarthrit.2016.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semarthrit.2016.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DPullerits%26aufirst%3DR.%26aulast%3DSchierbeck%26aufirst%3DH.%26aulast%3DUibo%26aufirst%3DK.%26aulast%3DLiivamagi%26aufirst%3DH.%26aulast%3DTarraste%26aufirst%3DS.%26aulast%3DTalvik%26aufirst%3DT.%26aulast%3DSundberg%26aufirst%3DE.%26aulast%3DPruunsild%26aufirst%3DC.%26atitle%3DHigh%2520mobility%2520group%2520box%2520protein%25201-a%2520prognostic%2520marker%2520for%2520structural%2520joint%2520damage%2520in%252010-year%2520follow-up%2520of%2520patients%2520with%2520juvenile%2520idiopathic%2520arthritis%26jtitle%3DSemin.%2520Arthritis%2520Rheum.%26date%3D2017%26volume%3D46%26issue%3D4%26spage%3D444%26epage%3D450%26doi%3D10.1016%2Fj.semarthrit.2016.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yone, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashiguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijiri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, I.</span></span> <span> </span><span class="NLM_article-title">High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1002/art.10859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Fart.10859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=12687539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlKnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=971-981&issue=4&author=N.+Taniguchiauthor=K.+Kawaharaauthor=K.+Yoneauthor=T.+Hashiguchiauthor=M.+Yamakuchiauthor=M.+Gotoauthor=K.+Inoueauthor=S.+Yamadaauthor=K.+Ijiriauthor=S.+Matsunagaauthor=T.+Nakajimaauthor=S.+Komiyaauthor=I.+Maruyama&title=High+mobility+group+box+chromosomal+protein+1+plays+a+role+in+the+pathogenesis+of+rheumatoid+arthritis+as+a+novel+cytokine&doi=10.1002%2Fart.10859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine</span></div><div class="casAuthors">Taniguchi, Noboru; Kawahara, Ko-Ichi; Yone, Kazunori; Hashiguchi, Teruto; Yamakuchi, Munekazu; Goto, Masamichi; Inoue, Keiichi; Yamada, Shingo; Ijiri, Kosei; Matsunaga, Shunji; Nakajima, Toshihiro; Komiya, Setsuro; Maruyama, Ikuro</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">971-981</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">High mobility group box chromosomal protein 1 (HMGB-1), a nuclear DNA binding protein, was recently rediscovered as a new proinflammatory cytokine.  The purpose of this study was to demonstrate HMGB-1 expression in vivo and to identify the role of HMGB-1 in the pathogenesis of rheumatoid arthritis (RA).  HMGB-1 concns. in synovial fluid (SF) and serum from RA and osteoarthritis (OA) patients were measured by immunoblot anal.  The protein's specific receptor, receptor for advanced glycation end products (RAGE), was examd. in SF macrophages (SFMs).  We measured levels of proinflammatory cytokines released by SFMs treated with HMGB-1 via ELISA and used sol. RAGE (sRAGE) to block the release of tumor necrosis factor α (TNFα).  Immunohistochem. anal. and immunofluorescence assay were employed to examine localization of HMGB-1 in RA synovium and its translocation in SFMs after TNFα stimulation.  HMGB-1 concns. were significantly higher in SF of RA patients than in that of OA patients.  SFMs expressed RAGE and released TNFα, interleukin-1β (IL-1β), and IL-6 upon stimulation with HMGB-1.  HMGB-1 was found in CD68-pos. cells of RA synovium, and TNFα stimulation translocated HMGB-1 from the nucleus to the cytosol in SFMs.  Blockade by sRAGE inhibited the release of TNFα from SFMs.  HMGB-1 was more strongly expressed in SF of RA patients than in that of OA patients, inducing the release of proinflammatory cytokines from SFMs.  HMGB-1 plays a pivotal role in the pathogenesis of RA and may be an original target of therapy as a novel cytokine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS2txNCtkijrVg90H21EOLACvtfcHk0liLHba5N61Jig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlKnsrk%253D&md5=83823045c2a4cbe78cc66792f088544f</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1002%2Fart.10859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.10859%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DN.%26aulast%3DKawahara%26aufirst%3DK.%26aulast%3DYone%26aufirst%3DK.%26aulast%3DHashiguchi%26aufirst%3DT.%26aulast%3DYamakuchi%26aufirst%3DM.%26aulast%3DGoto%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DIjiri%26aufirst%3DK.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DKomiya%26aufirst%3DS.%26aulast%3DMaruyama%26aufirst%3DI.%26atitle%3DHigh%2520mobility%2520group%2520box%2520chromosomal%2520protein%25201%2520plays%2520a%2520role%2520in%2520the%2520pathogenesis%2520of%2520rheumatoid%2520arthritis%2520as%2520a%2520novel%2520cytokine%26jtitle%3DArthritis%2520Rheum.%26date%3D2003%26volume%3D48%26issue%3D4%26spage%3D971%26epage%3D981%26doi%3D10.1002%2Fart.10859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, F.</span></span> <span> </span><span class="NLM_article-title">High mobility group protein b1 (hmgb1) in asthma: Comparison of patients with chronic obstructive pulmonary disease and healthy controls</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">7–8</span>),  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.2119/molmed.2010.00173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2010.00173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21380479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVemurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=807-815&issue=7%E2%80%938&author=C.+Houauthor=H.+Zhaoauthor=L.+Liuauthor=W.+Liauthor=X.+Zhouauthor=Y.+Lvauthor=X.+Shenauthor=Z.+Liangauthor=S.+Caiauthor=F.+Zou&title=High+mobility+group+protein+b1+%28hmgb1%29+in+asthma%3A+Comparison+of+patients+with+chronic+obstructive+pulmonary+disease+and+healthy+controls&doi=10.2119%2Fmolmed.2010.00173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls</span></div><div class="casAuthors">Hou, Changchun; Zhao, Haijin; Liu, Laiyu; Li, Wenjun; Zhou, Xiaoting; Lv, Yanhua; Shen, Xiangbo; Liang, Zhenyu; Cai, Shaoxi; Zou, Fei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">807-815</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">High mobility group protein B1 (HMGB1) has been implicated as an important mediator in the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD).  However, the expression of HMGB1 in plasma and sputum of patients with asthma and COPD across disease severity needs to be defined.  The objective of the study was to examine the induced sputum and plasma concns. of HMGB1 in COPD and asthmatic patients to det. differences in HMGB1 levels between these diseases and their relationship with airway obstruction and inflammatory patterns.  A total of 147 participants were enrolled in this study.  The participants included 34 control subjects, 61 patients with persistent asthma (according to the Global Initiative for Asthma (GINA) guidelines) and 47 patients with stable COPD (stratified by Global Initiative for Chronic Obstructive Lung Disease [GOLD] status).  Spirometry was performed before sputum induction.  HMGB1 levels in induced sputum and plasma were detd. by ELISA.  Sputum and plasma concns. of HMGB1 in patients with asthma and COPD were significantly higher than concns. in control subjects and were significantly neg. correlated with forced expiratory vol. in 1 s (FEV1), FEV1 (% predicted) in all 147 participants.  The levels of HMGB1 in induced sputum of COPD patients were significantly higher than those of asthma patients and healthy controls (P < 0.001).  This difference was present even after adjusting for sex, age, smoking status, daily dose of inhaled corticosteroids and disease severity.  There were no significant differences in HMGB1 levels between patients with eosinophilic and noneosinophilic asthma.  HMGB1 levels in asthmatic and COPD patients were pos. correlated with neutrophil counts and percentage of neutrophils.  In multivariate anal., the two diseases (asthma and COPD) and disease severity were independent predictors of sputum HMGB1, but not smoking, age or use of inhaled corticosteroids.  In conclusion, these data support a potential role for HMGB1 as a biomarker and diagnostic tool for the differential diagnosis of asthma and COPD.  The importance of this observation on asthma and COPD mechanisms and outcomes should be further investigated in large prospective studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolxUaxVuByW7Vg90H21EOLACvtfcHk0liLHba5N61Jig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVemurrN&md5=83ff0e5f5fcc1fe97fcec1037d9fbb9a</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2010.00173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2010.00173%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DS.%26aulast%3DZou%26aufirst%3DF.%26atitle%3DHigh%2520mobility%2520group%2520protein%2520b1%2520%2528hmgb1%2529%2520in%2520asthma%253A%2520Comparison%2520of%2520patients%2520with%2520chronic%2520obstructive%2520pulmonary%2520disease%2520and%2520healthy%2520controls%26jtitle%3DMol.%2520Med.%26date%3D2011%26volume%3D17%26issue%3D7%25E2%2580%25938%26spage%3D807%26epage%3D815%26doi%3D10.2119%2Fmolmed.2010.00173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 overexpression as a prognostic factor for survival in cancer: A meta-analysis and systematic review</span>. <i>Oncotarget.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">50417</span>– <span class="NLM_lpage">50427</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.18632%2Foncotarget.10413" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=50417-50427&issue=31&author=T.+Wuauthor=W.+Zhangauthor=G.+Yangauthor=H.+Liauthor=Q.+Chenauthor=R.+Songauthor=L.+Zhao&title=Hmgb1+overexpression+as+a+prognostic+factor+for+survival+in+cancer%3A+A+meta-analysis+and+systematic+review&doi=10.18632%2Foncotarget.10413"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10413%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DSong%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DL.%26atitle%3DHmgb1%2520overexpression%2520as%2520a%2520prognostic%2520factor%2520for%2520survival%2520in%2520cancer%253A%2520A%2520meta-analysis%2520and%2520systematic%2520review%26jtitle%3DOncotarget.%26date%3D2016%26volume%3D7%26issue%3D31%26spage%3D50417%26epage%3D50427%26doi%3D10.18632%2Foncotarget.10413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W. F.</span></span> <span> </span><span class="NLM_article-title">Increased serum hmgb1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>205</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">548</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2008.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.atherosclerosis.2008.12.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2009&pages=544-548&issue=2&author=X.+X.+Yanauthor=L.+Luauthor=W.+H.+Pengauthor=L.+J.+Wangauthor=Q.+Zhangauthor=R.+Y.+Zhangauthor=Q.+J.+Chenauthor=W.+F.+Shen&title=Increased+serum+hmgb1+level+is+associated+with+coronary+artery+disease+in+nondiabetic+and+type+2+diabetic+patients&doi=10.1016%2Fj.atherosclerosis.2008.12.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2008.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2008.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.%2BX.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DW.%2BH.%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DChen%26aufirst%3DQ.%2BJ.%26aulast%3DShen%26aufirst%3DW.%2BF.%26atitle%3DIncreased%2520serum%2520hmgb1%2520level%2520is%2520associated%2520with%2520coronary%2520artery%2520disease%2520in%2520nondiabetic%2520and%2520type%25202%2520diabetic%2520patients%26jtitle%3DAtherosclerosis%26date%3D2009%26volume%3D205%26issue%3D2%26spage%3D544%26epage%3D548%26doi%3D10.1016%2Fj.atherosclerosis.2008.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. A.</span></span> <span> </span><span class="NLM_article-title">Hmgb1modulates the treg/th17 ratio in atherosclerotic patients</span>. <i>J. Atheroscler. Thromb.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.5551/jat.31088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.5551%2Fjat.31088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26830200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVehsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=737-745&issue=6&author=J.+W.+Dingauthor=X.+X.+Zhengauthor=T.+Zhouauthor=X.+H.+Tongauthor=C.+Y.+Luoauthor=X.+A.+Wang&title=Hmgb1modulates+the+treg%2Fth17+ratio+in+atherosclerotic+patients&doi=10.5551%2Fjat.31088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1modulates the Treg/Th17 ratio in atherosclerotic patients</span></div><div class="casAuthors">Ding, Jia-wang; Zheng, Xia-xia; Zhou, Tian; Tong, Xiao-hong; Luo, Cai-yun; Wang, Xin-an</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Atherosclerosis and Thrombosis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-745</span>CODEN:
                <span class="NLM_cas:coden">JATHEH</span>;
        ISSN:<span class="NLM_cas:issn">1340-3478</span>.
    
            (<span class="NLM_cas:orgname">Japan Atherosclerosis Society</span>)
        </div><div class="casAbstract">Aim: Atherosclerosis (AS) characterized as a chronic inflammatory disease.  Multiple immune cells and inflammatory cytokines, such as high mobility group protein (HMGB1), regulatory T (Treg) cells, T helper (Th17) cells, and inflammation-related cytokines, play a key role in its pathophysiol.  A large no. of studies report that HMGB1 and Th17 cells may promote atherosclerosis progression, whereas Treg cells may play a protective role in atherosclerosis; thus, alterations in the Treg/Th17 ratio may exist in atherosclerosis diseases.  Up till now, the relationships between HMGB1 levels and the Treg/Th17 ratio remain incompletely understood.  The major purpose of this study was to investigate the relationship between HMGB1 levels and the Treg/Th17 ratio in patients with coronary artery atherosclerotic plaques.  Methods: We enrolled patients with coronary atherosclerosis and normal coronary artery as the research subjects.  Flow cytometry was used to analyze the Treg cells, the Th17 cells frequency, and the Treg/Th17 ratio.  Otherwise, real-time polymerase chain reaction was used for assays the mRNA expressions of HMGB1, retinoic acid-related orphan nuclear receptor C (RORC), and forkhead-winged helix transcription factor (Foxp3).  Moreover, enzyme-linked immunosorbent assays were used to detect the level of protein and cytokines, such as HMGB1, IL-10, TGF-β1, IL-17A, and IL-23.  Results: Using flow cytometry, we obsd. a significantly increased of Th17 cell frequency, whereas Treg cell frequency significantly decreased in atherosclerotic patients.  Consistently, the levels of RORC mRNA were significantly increased in coronary atherosclerosis (AS) group compared to normal coronary artery (NCA) group (P<0.01).  In contrast, the expression of Foxp3 mRNA was markedly lower in the AS group than in the NCA group (P<0.01).  Furthermore, we obsd. the serum concns. of HMGB1, IL-17A, and IL-23 were significantly higher in the AS group than in the NCA group (P<0.01, resp.), whereas the concns. of serum IL-10 and TGF-β1 were significantly lower in the AS group than in the NCA group (P<0.01, resp.).  In addn., we also found that HMGB1 levels showed neg. correlation with the Treg/Th17 ratio in the two groups (r = -0.6984, P<0.01).  Conclusions: The data in our study indicated that HMGB1 may promote atherosclerosis progression via modulating the imbalance in the Treg/Th17 ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW-gXUntaFmLVg90H21EOLACvtfcHk0ljc9npBY3WbuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVehsLfJ&md5=f4e6ee21fd10035d9ec599ffbe5f351f</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.5551%2Fjat.31088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5551%252Fjat.31088%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DJ.%2BW.%26aulast%3DZheng%26aufirst%3DX.%2BX.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DTong%26aufirst%3DX.%2BH.%26aulast%3DLuo%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DX.%2BA.%26atitle%3DHmgb1modulates%2520the%2520treg%252Fth17%2520ratio%2520in%2520atherosclerotic%2520patients%26jtitle%3DJ.%2520Atheroscler.%2520Thromb.%26date%3D2016%26volume%3D23%26issue%3D6%26spage%3D737%26epage%3D745%26doi%3D10.5551%2Fjat.31088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nin, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalkwijk, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorsal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prins, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parving, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarnow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossing, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stehouwer, C. D.</span></span> <span> </span><span class="NLM_article-title">Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12 year follow-up study</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2489</span>– <span class="NLM_lpage">2493</span>, <span class="refDoi"> DOI: 10.1007/s00125-012-2622-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs00125-012-2622-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2489-2493&issue=9&author=J.+W.+Ninauthor=I.+Ferreiraauthor=C.+G.+Schalkwijkauthor=A.+Jorsalauthor=M.+H.+Prinsauthor=H.+H.+Parvingauthor=L.+Tarnowauthor=P.+Rossingauthor=C.+D.+Stehouwer&title=Higher+plasma+high-mobility+group+box+1+levels+are+associated+with+incident+cardiovascular+disease+and+all-cause+mortality+in+type+1+diabetes%3A+A+12+year+follow-up+study&doi=10.1007%2Fs00125-012-2622-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1007%2Fs00125-012-2622-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-012-2622-1%26sid%3Dliteratum%253Aachs%26aulast%3DNin%26aufirst%3DJ.%2BW.%26aulast%3DFerreira%26aufirst%3DI.%26aulast%3DSchalkwijk%26aufirst%3DC.%2BG.%26aulast%3DJorsal%26aufirst%3DA.%26aulast%3DPrins%26aufirst%3DM.%2BH.%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DTarnow%26aufirst%3DL.%26aulast%3DRossing%26aufirst%3DP.%26aulast%3DStehouwer%26aufirst%3DC.%2BD.%26atitle%3DHigher%2520plasma%2520high-mobility%2520group%2520box%25201%2520levels%2520are%2520associated%2520with%2520incident%2520cardiovascular%2520disease%2520and%2520all-cause%2520mortality%2520in%2520type%25201%2520diabetes%253A%2520A%252012%2520year%2520follow-up%2520study%26jtitle%3DDiabetologia%26date%3D2012%26volume%3D55%26issue%3D9%26spage%3D2489%26epage%3D2493%26doi%3D10.1007%2Fs00125-012-2622-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devaraj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasu, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jialal, I.</span></span> <span> </span><span class="NLM_article-title">Increased levels of ligands of toll-like receptors 2 and 4 in type 1 diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1668</span>, <span class="refDoi"> DOI: 10.1007/s00125-009-1394-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs00125-009-1394-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1665-1668&issue=8&author=S.+Devarajauthor=M.+R.+Dasuauthor=S.+H.+Parkauthor=I.+Jialal&title=Increased+levels+of+ligands+of+toll-like+receptors+2+and+4+in+type+1+diabetes&doi=10.1007%2Fs00125-009-1394-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1007%2Fs00125-009-1394-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-009-1394-8%26sid%3Dliteratum%253Aachs%26aulast%3DDevaraj%26aufirst%3DS.%26aulast%3DDasu%26aufirst%3DM.%2BR.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DJialal%26aufirst%3DI.%26atitle%3DIncreased%2520levels%2520of%2520ligands%2520of%2520toll-like%2520receptors%25202%2520and%25204%2520in%2520type%25201%2520diabetes%26jtitle%3DDiabetologia%26date%3D2009%26volume%3D52%26issue%3D8%26spage%3D1665%26epage%3D1668%26doi%3D10.1007%2Fs00125-009-1394-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span> <span> </span><span class="NLM_article-title">Plasma hmgb-1 levels in subjects with obesity and type 2 diabetes: A cross-sectional study in china</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">e0136564</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0136564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1371%2Fjournal.pone.0136564" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0136564&issue=8&author=H.+Wangauthor=H.+Quauthor=H.+Deng&title=Plasma+hmgb-1+levels+in+subjects+with+obesity+and+type+2+diabetes%3A+A+cross-sectional+study+in+china&doi=10.1371%2Fjournal.pone.0136564"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0136564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0136564%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DH.%26atitle%3DPlasma%2520hmgb-1%2520levels%2520in%2520subjects%2520with%2520obesity%2520and%2520type%25202%2520diabetes%253A%2520A%2520cross-sectional%2520study%2520in%2520china%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26issue%3D8%26spage%3De0136564%26doi%3D10.1371%2Fjournal.pone.0136564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 is activated in type 2 diabetes mellitus patients and in mesangial cells in response to high glucose</span>. <i>Int. J. Clin. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">6683</span>– <span class="NLM_lpage">6691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26261550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFChu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=6683-6691&issue=6&author=Y.+Chenauthor=F.+Qiaoauthor=Y.+Zhaoauthor=Y.+Wangauthor=G.+Liu&title=Hmgb1+is+activated+in+type+2+diabetes+mellitus+patients+and+in+mesangial+cells+in+response+to+high+glucose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1 is activated in type 2 diabetes mellitus patients and in mesangial cells in response to high glucose</span></div><div class="casAuthors">Chen, Yan; Qiao, Fengli; Zhao, Ying; Wang, Yanjun; Liu, Guifeng</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">6683-6691</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Diabetic nephropathy (DN) is one of the most devastating complications of diabetes, leading the cause of end-stage renal disease (ESRD).  And investigations into mechanisms underlying renal inflammation may provide new insight into novel therapeutic targets for patients with DN.  However, little is known about the promotion of inflammation in DN.  In the present study, we examd. the promotion by high glucose to High-mobility group box-1 (HMGB1) in patients with type 2 diabetes mellitus or in renal mesangial SV40 MES 13 cells.  Results demonstrated that high glucose promoted the pre-inflammatory cytokines, such as TNF-α, IL-1β and IL-6 in patients with T2DM or in SV40 MES 13 cells.  And the serum HMGB1 was also upregulated in T2DM patients, correlating with serum IL-6 and TNFα.  The in vitro results indicated that HMGB1 mediated the D-glucose-induced pro-inflammatory cytokines in mesangial cells.  And the NF-κB signaling pathway involved in the promotion of pro-inflammatory cytokines by D-glucose.  In summary, the present study indicated that HMGB1 was significantly promoted by the glucose in vivo or in vitro, in an assocn. with an upregulation of pro-inflammatory cytokines, via activating NF-κB signaling pathway.  And the strategy of HMGB1 inhibition reduced the upregulation of pro-inflammatory cytokines in response to high glucose, via inhibiting the NF-κB signaling pathway.  It implies the regulatory role of HMGB1 in the inflammatory responses in DN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosOhxSzFLKX7Vg90H21EOLACvtfcHk0lgrxD0NXEbjnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFChu7c%253D&md5=62e2f90e977eb013f7e476bfc732d2d8</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQiao%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DHmgb1%2520is%2520activated%2520in%2520type%25202%2520diabetes%2520mellitus%2520patients%2520and%2520in%2520mesangial%2520cells%2520in%2520response%2520to%2520high%2520glucose%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2015%26volume%3D8%26issue%3D6%26spage%3D6683%26epage%3D6691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Elevated serum hmgb1 in pulmonary arterial hypertension secondary to congenital heart disease</span>. <i>Vasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.vph.2016.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.vph.2016.08.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2016&pages=66-72&author=Y.+Y.+Huangauthor=W.+Suauthor=Z.+W.+Zhuauthor=L.+Tangauthor=X.+Q.+Huauthor=S.+H.+Zhouauthor=Z.+F.+Fangauthor=J.+Li&title=Elevated+serum+hmgb1+in+pulmonary+arterial+hypertension+secondary+to+congenital+heart+disease&doi=10.1016%2Fj.vph.2016.08.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.vph.2016.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vph.2016.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%2BY.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DZ.%2BW.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DX.%2BQ.%26aulast%3DZhou%26aufirst%3DS.%2BH.%26aulast%3DFang%26aufirst%3DZ.%2BF.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DElevated%2520serum%2520hmgb1%2520in%2520pulmonary%2520arterial%2520hypertension%2520secondary%2520to%2520congenital%2520heart%2520disease%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2016%26volume%3D85%26spage%3D66%26epage%3D72%26doi%3D10.1016%2Fj.vph.2016.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span> <span> </span><span class="NLM_article-title">Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 h1n1 influenza-infected children</span>. <i>Cytokine</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2011.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.cyto.2011.07.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2011&pages=180-187&issue=2&author=Y.+Itoauthor=Y.+Toriiauthor=R.+Ohtaauthor=M.+Imaiauthor=S.+Haraauthor=Y.+Kawanoauthor=T.+Matsubayashiauthor=A.+Inuiauthor=T.+Yoshikawaauthor=N.+Nishimuraauthor=T.+Ozakiauthor=T.+Morishimaauthor=H.+Kimura&title=Increased+levels+of+cytokines+and+high-mobility+group+box+1+are+associated+with+the+development+of+severe+pneumonia%2C+but+not+acute+encephalopathy%2C+in+2009+h1n1+influenza-infected+children&doi=10.1016%2Fj.cyto.2011.07.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2011.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2011.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DY.%26aulast%3DTorii%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DR.%26aulast%3DImai%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DY.%26aulast%3DMatsubayashi%26aufirst%3DT.%26aulast%3DInui%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DN.%26aulast%3DOzaki%26aufirst%3DT.%26aulast%3DMorishima%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DH.%26atitle%3DIncreased%2520levels%2520of%2520cytokines%2520and%2520high-mobility%2520group%2520box%25201%2520are%2520associated%2520with%2520the%2520development%2520of%2520severe%2520pneumonia%252C%2520but%2520not%2520acute%2520encephalopathy%252C%2520in%25202009%2520h1n1%2520influenza-infected%2520children%26jtitle%3DCytokine%26date%3D2011%26volume%3D56%26issue%3D2%26spage%3D180%26epage%3D187%26doi%3D10.1016%2Fj.cyto.2011.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angus, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellum, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delude, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissfeld, L.</span></span> <span> </span><span class="NLM_article-title">Circulating high-mobility group box 1 (hmgb1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis</span>. <i>Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1061</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1097/01.CCM.0000259534.68873.2A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2F01.CCM.0000259534.68873.2A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=17334246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BD2s3gslOgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1061-1067&issue=4&author=D.+C.+Angusauthor=L.+Yangauthor=L.+Kongauthor=J.+A.+Kellumauthor=R.+L.+Deludeauthor=K.+J.+Traceyauthor=L.+Weissfeld&title=Circulating+high-mobility+group+box+1+%28hmgb1%29+concentrations+are+elevated+in+both+uncomplicated+pneumonia+and+pneumonia+with+severe+sepsis&doi=10.1097%2F01.CCM.0000259534.68873.2A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis</span></div><div class="casAuthors">Angus Derek C; Yang Lihong; Kong Lan; Kellum John A; Delude Russell L; Tracey Kevin J; Weissfeld Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Critical care medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1061-7</span>
        ISSN:<span class="NLM_cas:issn">0090-3493</span>.
    </div><div class="casAbstract">OBJECTIVE:  High-mobility group box 1 (HMGB1) has been proposed as a late mediator of sepsis, but human data are sparse and conflicting.  We describe plasma HMGB1 concentrations in humans with community-acquired pneumonia (CAP), the most common cause of severe sepsis, and test the hypotheses that HMGB1 levels are higher in CAP than healthy controls, higher in CAP with severe sepsis than CAP without severe sepsis, and higher in severe sepsis nonsurvivors than survivors.  DESIGN:  Random, outcome-stratified sample from a prospective study of 1,895 subjects hospitalized with CAP.  SETTING:  Twenty-eight U.S. teaching and community hospitals.  PATIENTS:  There were 122 CAP subjects (43 never developed severe sepsis, 49 developed severe sepsis and survived hospitalization, and 30 developed severe sepsis and died) and 38 healthy controls.  INTERVENTIONS:  None.  MEASUREMENTS AND MAIN RESULTS:  Median day of onset of severe sepsis was day of admission.  HMGB1 was measured daily for the first week and analyzed using repeated-measures models with and without multivariable adjustment for baseline characteristics.  HMGB1 concentrations were higher in CAP subjects compared with controls (median concentration on day of admission vs. controls, 190 vs. 0 ng/mL, p = .0001; 93.7% of all CAP measurements were elevated).  HMGB1 remained elevated throughout the hospital course with no significant trend (p = .64) and did not differ between those with and without severe sepsis (p = .30).  HMGB1 concentrations were higher in severe sepsis nonsurvivors than survivors (p = .001).  HMGB1 concentrations remained elevated at discharge (median final HMGB1 measure, 176 ng/mL).  Findings persisted in multivariable models and were robust to sensitivity analyses using alternative definitions of severe sepsis.  CONCLUSIONS:  HMGB1 is elevated in almost all CAP subjects, and higher circulating HMGB1 is associated with mortality.  But immunodetectable HMGB1 levels were also persistently elevated in those patients who fared well.  Thus, additional work is needed to understand the biological activities of serum HMGB1 in sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgcpCsKHqCba__Jf7-eMvJfW6udTcc2eam30lds4XanLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3gslOgsg%253D%253D&md5=5cc08abaa081f245ed8db0ee9bff71bf</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1097%2F01.CCM.0000259534.68873.2A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.CCM.0000259534.68873.2A%26sid%3Dliteratum%253Aachs%26aulast%3DAngus%26aufirst%3DD.%2BC.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DKellum%26aufirst%3DJ.%2BA.%26aulast%3DDelude%26aufirst%3DR.%2BL.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DWeissfeld%26aufirst%3DL.%26atitle%3DCirculating%2520high-mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520concentrations%2520are%2520elevated%2520in%2520both%2520uncomplicated%2520pneumonia%2520and%2520pneumonia%2520with%2520severe%2520sepsis%26jtitle%3DCrit.%2520Care%2520Med.%26date%3D2007%26volume%3D35%26issue%3D4%26spage%3D1061%26epage%3D1067%26doi%3D10.1097%2F01.CCM.0000259534.68873.2A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaya, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejima, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaka, A.</span></span> <span> </span><span class="NLM_article-title">Contributions of high mobility group box protein in experimental and clinical acute lung injury</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>170</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1310</span>– <span class="NLM_lpage">1316</span>, <span class="refDoi"> DOI: 10.1164/rccm.200402-188OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1164%2Frccm.200402-188OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=15374839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BD2cnhsFOquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2004&pages=1310-1316&issue=12&author=H.+Uenoauthor=T.+Matsudaauthor=S.+Hashimotoauthor=F.+Amayaauthor=Y.+Kitamuraauthor=M.+Tanakaauthor=A.+Kobayashiauthor=I.+Maruyamaauthor=S.+Yamadaauthor=N.+Hasegawaauthor=J.+Soejimaauthor=H.+Kohauthor=A.+Ishizaka&title=Contributions+of+high+mobility+group+box+protein+in+experimental+and+clinical+acute+lung+injury&doi=10.1164%2Frccm.200402-188OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Contributions of high mobility group box protein in experimental and clinical acute lung injury</span></div><div class="casAuthors">Ueno Hiroshi; Matsuda Tomoyuki; Hashimoto Satoru; Amaya Fumimasa; Kitamura Yoshihiro; Tanaka Masaki; Kobayashi Atsuko; Maruyama Ikuro; Yamada Shingo; Hasegawa Naoki; Soejima Junko; Koh Hidefumi; Ishizaka Akitoshi</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1310-6</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">This study was performed to examine the putative role of high mobility group box (HMGB) protein in the pathogenesis of acute lung injury (ALI).  Observations were made (1) in 21 patients who were septic with ALI and 15 patients with normal lung function and (2) in a mouse model 24 hours after intratracheal instillation of lipopolysaccharide (LPS).  The concentrations of HMGB1 were increased in plasma and lung epithelial lining fluid of patients with ALI and mice instilled with LPS.  LPS-induced ALI was mitigated by anti-HMGB1 antibody.  Although this protein was not detected in the plasma of control humans or mice, the concentrations of HMGB1 in lung epithelial lining fluid or in bronchoalveolar lavage fluid were unexpectedly high.  The nuclear expression of HMGB1 was apparent in epithelial cells surrounding terminal bronchioles in normal mice, whereas its nuclear and cytoplasmic expression was observed in alveolar macrophages in LPS-instilled mice.  Lung instillation of HMGB2 did not cause as much inflammation as HMGB1.  Extracellular HMGB1 may play a key role in the pathogenesis of clinical and experimental ALI.  However, its expression in normal airways is noteworthy and suggests that it also plays a physiologic role in the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0fiC8rEUIxIMcDoIzZtNkfW6udTcc2eam30lds4XanLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnhsFOquw%253D%253D&md5=b166b9020cbf15ab906fce765b9fba2e</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1164%2Frccm.200402-188OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200402-188OC%26sid%3Dliteratum%253Aachs%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DS.%26aulast%3DAmaya%26aufirst%3DF.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DMaruyama%26aufirst%3DI.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DN.%26aulast%3DSoejima%26aufirst%3DJ.%26aulast%3DKoh%26aufirst%3DH.%26aulast%3DIshizaka%26aufirst%3DA.%26atitle%3DContributions%2520of%2520high%2520mobility%2520group%2520box%2520protein%2520in%2520experimental%2520and%2520clinical%2520acute%2520lung%2520injury%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2004%26volume%3D170%26issue%3D12%26spage%3D1310%26epage%3D1316%26doi%3D10.1164%2Frccm.200402-188OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ingels, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derese, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den
Berghe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhorebeek, I.</span></span> <span> </span><span class="NLM_article-title">Soluble rage and the rage ligands hmgb1 and s100a12 in critical illness: Impact of glycemic control with insulin and relation with clinical outcome</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1097/SHK.0000000000000278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2FSHK.0000000000000278" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=109-116&issue=2&author=C.+Ingelsauthor=I.+Dereseauthor=P.+J.+Woutersauthor=G.+Van+den%0ABergheauthor=I.+Vanhorebeek&title=Soluble+rage+and+the+rage+ligands+hmgb1+and+s100a12+in+critical+illness%3A+Impact+of+glycemic+control+with+insulin+and+relation+with+clinical+outcome&doi=10.1097%2FSHK.0000000000000278"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1097%2FSHK.0000000000000278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FSHK.0000000000000278%26sid%3Dliteratum%253Aachs%26aulast%3DIngels%26aufirst%3DC.%26aulast%3DDerese%26aufirst%3DI.%26aulast%3DWouters%26aufirst%3DP.%2BJ.%26aulast%3DVan%2Bden%2BBerghe%26aufirst%3DG.%26aulast%3DVanhorebeek%26aufirst%3DI.%26atitle%3DSoluble%2520rage%2520and%2520the%2520rage%2520ligands%2520hmgb1%2520and%2520s100a12%2520in%2520critical%2520illness%253A%2520Impact%2520of%2520glycemic%2520control%2520with%2520insulin%2520and%2520relation%2520with%2520clinical%2520outcome%26jtitle%3DShock%26date%3D2015%26volume%3D43%26issue%3D2%26spage%3D109%26epage%3D116%26doi%3D10.1097%2FSHK.0000000000000278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Caterina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W. F.</span></span> <span> </span><span class="NLM_article-title">Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure</span>. <i>Eur. J. Heart Failure</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1093/eurjhf/hfq231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1093%2Feurjhf%2Fhfq231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21266376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFegur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=440-449&issue=4&author=L.+J.+Wangauthor=L.+Luauthor=F.+R.+Zhangauthor=Q.+J.+Chenauthor=R.+De+Caterinaauthor=W.+F.+Shen&title=Increased+serum+high-mobility+group+box-1+and+cleaved+receptor+for+advanced+glycation+endproducts+levels+and+decreased+endogenous+secretory+receptor+for+advanced+glycation+endproducts+levels+in+diabetic+and+non-diabetic+patients+with+heart+failure&doi=10.1093%2Feurjhf%2Fhfq231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure</span></div><div class="casAuthors">Wang, Ling Jie; Lu, Lin; Zhang, Feng Ru; Chen, Qiu Jing; De Caterina, Raffaele; Shen, Wei Feng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Heart Failure</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">440-449</span>CODEN:
                <span class="NLM_cas:coden">EJHFFS</span>;
        ISSN:<span class="NLM_cas:issn">1388-9842</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims High-mobility group box-1 (HMGB1) is a ligand for the receptor for advanced glycation endproducts (RAGE).  An HMGB1-RAGE interaction has been implicated in cardiac dysfunction.  We assessed the assocn. of HMGB1 and RAGE isoforms with heart failure (HF) in diabetic and non-diabetic patients.  Methods and results We assayed serum levels of HMGB1, cleaved RAGE (cRAGE), endogenous secretory RAGE (esRAGE), high-sensitivity C-reactive protein (hsCRP), and N-terminal pro-brain natriuretic peptide (NT-proBNP) in parallel with assessment of left ventricular vols. and function in 125 diabetic and 222 non-diabetic Chinese patients with chronic HF.  Of the total, 79 diabetic patients without HF and 220 normal subjects served as diabetic and normal controls, resp.  Serum HMGB1, cRAGE, hsCRP, and NT-proBNP levels were higher and, in contrast, esRAGE levels lower in HF patients than in subjects without HF (for all; P < 0.01), with higher levels of cRAGE and hsCRP in diabetic HF vs. non-diabetic HF patients (P < 0.01).  For HF patients-with or without diabetes-HMGB1 levels correlated pos. with left ventricular end-diastolic and end-systolic vols. (r = 0.267 and r = 0.321, resp.) and NT-proBNP values (r = 0.497), and were inversely related to ejection fraction (r = -0.461; all P < 0.001).  Serum cRAGE levels correlated with NT-proBNP values (r = 0.451) and New York Heart Assocn. functional class (r = 0.402; both P < 0.001).  Multivariable regression anal. revealed that HMGB1, cRAGE, and esRAGE were consistently assocd. with HF in diabetic and non-diabetic patients.  Conclusion Heart failure patients have increased serum HMGB1 and cRAGE and decreased esRAGE levels, and these are related to the severity of HF in both diabetic and non-diabetic patients.  Such assocns. are worth further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXt4CUgpMgArVg90H21EOLACvtfcHk0ljBCPKdzNVXNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFegur4%253D&md5=df1478cdd36c5ec00925bc09d4e9b30a</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1093%2Feurjhf%2Fhfq231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurjhf%252Fhfq231%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DF.%2BR.%26aulast%3DChen%26aufirst%3DQ.%2BJ.%26aulast%3DDe%2BCaterina%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DW.%2BF.%26atitle%3DIncreased%2520serum%2520high-mobility%2520group%2520box-1%2520and%2520cleaved%2520receptor%2520for%2520advanced%2520glycation%2520endproducts%2520levels%2520and%2520decreased%2520endogenous%2520secretory%2520receptor%2520for%2520advanced%2520glycation%2520endproducts%2520levels%2520in%2520diabetic%2520and%2520non-diabetic%2520patients%2520with%2520heart%2520failure%26jtitle%3DEur.%2520J.%2520Heart%2520Failure%26date%3D2011%26volume%3D13%26issue%3D4%26spage%3D440%26epage%3D449%26doi%3D10.1093%2Feurjhf%2Fhfq231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H. C.</span></span> <span> </span><span class="NLM_article-title">Increased serum hmgb1 level may predict the fatal outcomes in patients with chronic heart failure</span>. <i>Int. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1016/j.ijcard.2015.02.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.ijcard.2015.02.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25746492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhvFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2015&pages=318-320&author=T.+Liuauthor=D.+Y.+Zhangauthor=Y.+H.+Zhouauthor=Q.+F.+Hanauthor=L.+H.+Wangauthor=L.+Wuauthor=H.+C.+Yao&title=Increased+serum+hmgb1+level+may+predict+the+fatal+outcomes+in+patients+with+chronic+heart+failure&doi=10.1016%2Fj.ijcard.2015.02.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure</span></div><div class="casAuthors">Liu Tao; Zhang De-Yong; Zhou Yan-Hong; Han Qian-Feng; Wang Lan-Hua; Wu Lei; Yao Heng-Chen</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cardiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">318-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1KL40A2V-aGhHGZei4OW9fW6udTcc2eZ4EtJEC5sEFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhvFOiug%253D%253D&md5=5678d306d9a36019f16856892817714e</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2015.02.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2015.02.088%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DD.%2BY.%26aulast%3DZhou%26aufirst%3DY.%2BH.%26aulast%3DHan%26aufirst%3DQ.%2BF.%26aulast%3DWang%26aufirst%3DL.%2BH.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DH.%2BC.%26atitle%3DIncreased%2520serum%2520hmgb1%2520level%2520may%2520predict%2520the%2520fatal%2520outcomes%2520in%2520patients%2520with%2520chronic%2520heart%2520failure%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2015%26volume%3D184%26spage%3D318%26epage%3D320%26doi%3D10.1016%2Fj.ijcard.2015.02.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallowitsch-Puerta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosas-Ballina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huston, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czura, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchfeld, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesser, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Church, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litroff, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sama, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1097/01.shk.0000209540.99176.72</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2F01.shk.0000209540.99176.72" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=571-574&issue=6&author=R.+S.+Goldsteinauthor=M.+Gallowitsch-Puertaauthor=L.+Yangauthor=M.+Rosas-Ballinaauthor=J.+M.+Hustonauthor=C.+J.+Czuraauthor=D.+C.+Leeauthor=M.+F.+Wardauthor=A.+N.+Bruchfeldauthor=H.+Wangauthor=M.+L.+Lesserauthor=A.+L.+Churchauthor=A.+H.+Litroffauthor=A.+E.+Samaauthor=K.+J.+Tracey&title=Elevated+high-mobility+group+box+1+levels+in+patients+with+cerebral+and+myocardial+ischemia&doi=10.1097%2F01.shk.0000209540.99176.72"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1097%2F01.shk.0000209540.99176.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.shk.0000209540.99176.72%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DR.%2BS.%26aulast%3DGallowitsch-Puerta%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DRosas-Ballina%26aufirst%3DM.%26aulast%3DHuston%26aufirst%3DJ.%2BM.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DLee%26aufirst%3DD.%2BC.%26aulast%3DWard%26aufirst%3DM.%2BF.%26aulast%3DBruchfeld%26aufirst%3DA.%2BN.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLesser%26aufirst%3DM.%2BL.%26aulast%3DChurch%26aufirst%3DA.%2BL.%26aulast%3DLitroff%26aufirst%3DA.%2BH.%26aulast%3DSama%26aufirst%3DA.%2BE.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DElevated%2520high-mobility%2520group%2520box%25201%2520levels%2520in%2520patients%2520with%2520cerebral%2520and%2520myocardial%2520ischemia%26jtitle%3DShock%26date%3D2006%26volume%3D25%26issue%3D6%26spage%3D571%26epage%3D574%26doi%3D10.1097%2F01.shk.0000209540.99176.72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Momonaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushige, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichiyama, T.</span></span> <span> </span><span class="NLM_article-title">High mobility group box 1 in patients with 2009 pandemic h1n1 influenza-associated encephalopathy</span>. <i>Brain Dev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1016/j.braindev.2013.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.braindev.2013.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23907181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC3sflvFCnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2014&pages=484-488&issue=6&author=H.+Momonakaauthor=S.+Hasegawaauthor=T.+Matsushigeauthor=H.+Inoueauthor=M.+Kajimotoauthor=S.+Okadaauthor=K.+Nakatsukaauthor=T.+Morishimaauthor=T.+Ichiyama&title=High+mobility+group+box+1+in+patients+with+2009+pandemic+h1n1+influenza-associated+encephalopathy&doi=10.1016%2Fj.braindev.2013.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box 1 in patients with 2009 pandemic H1N1 influenza-associated encephalopathy</span></div><div class="casAuthors">Momonaka Hiroshi; Matsushige Takeshi; Inoue Hirofumi; Kajimoto Madoka; Okada Seigo; Ichiyama Takashi; Hasegawa Shunji; Nakatsuka Kenji; Morishima Tsuneo</div><div class="citationInfo"><span class="NLM_cas:title">Brain & development</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">484-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Patients with 2009 pandemic H1N1 influenza-associated encephalopathy (pIE) have been reported in Japan.  The most common clinical symptoms of this condition are seizures and progressive coma with high-grade fever.  We previously highlighted the cytokine profile of pIE; our results suggest that proinflammatory cytokines play an important role in the pathogenesis.  High mobility group box 1 (HMGB1) protein is a late mediator of inflammation or sepsis.  However, there are few reports regarding the serum and cerebrospinal fluid (CSF) levels of HMGB1 in pIE patients.  METHODS:  We measured serum and CSF levels of HMGB1 in the following: pIE patients with poor outcomes, pIE patients without neurological sequelae, influenza patients without pIE, and control subjects.  RESULTS:  Serum HMGB1 levels were significantly higher in pIE patients with poor outcomes compared to those without neurological sequelae.  In contrast, there was no difference in CSF HMGB1 levels among all groups.  Regarding pIE patients, we found a significant positive correlation between HMGB1 levels and IL-6 in the serum but not in the CSF.  CONCLUSIONS:  Our results suggest that HMGB1 protein may be involved in the pathogenesis of pIE and that a high serum, but not CSF, level of inflammatory cytokines plays an important role in the severity of pIE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRFLtycHlYaRUcLvDNbOD4DfW6udTcc2eafxuJyLvohz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sflvFCnug%253D%253D&md5=09a81e0a43cdce7b017f4ab01b07b422</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.braindev.2013.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.braindev.2013.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMomonaka%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DS.%26aulast%3DMatsushige%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DKajimoto%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DNakatsuka%26aufirst%3DK.%26aulast%3DMorishima%26aufirst%3DT.%26aulast%3DIchiyama%26aufirst%3DT.%26atitle%3DHigh%2520mobility%2520group%2520box%25201%2520in%2520patients%2520with%25202009%2520pandemic%2520h1n1%2520influenza-associated%2520encephalopathy%26jtitle%3DBrain%2520Dev.%26date%3D2014%26volume%3D36%26issue%3D6%26spage%3D484%26epage%3D488%26doi%3D10.1016%2Fj.braindev.2013.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchiara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierdomenico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negroni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aloi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felice, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stronati, L.</span></span> <span> </span><span class="NLM_article-title">Role of hmgb1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease</span>. <i>Inflamm Bowel Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1457</span>, <span class="refDoi"> DOI: 10.1097/MIB.0000000000000113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2FMIB.0000000000000113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24983978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2cfot1SrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1448-1457&issue=8&author=F.+Paloneauthor=R.+Vitaliauthor=S.+Cucchiaraauthor=M.+Pierdomenicoauthor=A.+Negroniauthor=M.+Aloiauthor=F.+Nutiauthor=C.+Feliceauthor=A.+Armuzziauthor=L.+Stronati&title=Role+of+hmgb1+as+a+suitable+biomarker+of+subclinical+intestinal+inflammation+and+mucosal+healing+in+patients+with+inflammatory+bowel+disease&doi=10.1097%2FMIB.0000000000000113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease</span></div><div class="casAuthors">Palone Francesca; Vitali Roberta; Cucchiara Salvatore; Pierdomenico Maria; Negroni Anna; Aloi Marina; Nuti Federica; Felice Carla; Armuzzi Alessandro; Stronati Laura</div><div class="citationInfo"><span class="NLM_cas:title">Inflammatory bowel diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1448-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Noninvasive biomarkers of high- and low-grade intestinal inflammation and of mucosal healing (MH) in patients with inflammatory bowel disease are currently lacking.  We have recently shown that fecal high mobility group box 1 (HMGB1) protein is a novel biomarker of gut inflammation.  We aimed at investigating in a mouse model if HMGB1 was able to foresee both a clinically evident and a subclinical gut inflammation and if its normalization indicated MH.  We also aimed at confirming the results in patients with Crohn's disease (CD) and ulcerative colitis.  METHODS:  C57BL6/J mice were treated with increasing doses of dextran sodium sulphate to induce colitis of different severity degrees; 28 with CD, 23 with ulcerative colitis, and 17 controls were also enrolled.  Fecal HMGB1 was analyzed by enzyme-linked immunosorbent assay and immunoblotting.  RESULTS:  Fecal HMGB1 increased by 5-, 11-, 18-, and 24-folds with dextran sodium sulphate doses of 0.25%, 0.50%, 1%, and 4%, respectively, showing that the protein detected a high-grade and a subclinical inflammation.  After a recovery time of 4-week posttreatment, HMGB1 returned to control levels, paralleling MH.  In patients, fecal HMGB1 significantly correlated with endoscopic indexes (Simple Endoscopic Score for Crohn's Disease [SES-CD], endoscopic Mayo subscore), but not with the disease activity indexes (Crohn's disease Activity Index, partial Mayo score).  CONCLUSIONS:  Fecal HMGB1 is a robust noninvasive biomarker of clinically overt and subclinical gut inflammation; it can also be a surrogate marker of MH.  We suggest the use of fecal HMGB1 to monitor the disease course and assess therapy outcomes in inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSa2XfG_ZAxDIxhnOQkIHOxfW6udTcc2eZSavgPda3-urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfot1SrtQ%253D%253D&md5=0ce2e1ea71ff13c44c640b3b55ef2fb1</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1097%2FMIB.0000000000000113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMIB.0000000000000113%26sid%3Dliteratum%253Aachs%26aulast%3DPalone%26aufirst%3DF.%26aulast%3DVitali%26aufirst%3DR.%26aulast%3DCucchiara%26aufirst%3DS.%26aulast%3DPierdomenico%26aufirst%3DM.%26aulast%3DNegroni%26aufirst%3DA.%26aulast%3DAloi%26aufirst%3DM.%26aulast%3DNuti%26aufirst%3DF.%26aulast%3DFelice%26aufirst%3DC.%26aulast%3DArmuzzi%26aufirst%3DA.%26aulast%3DStronati%26aufirst%3DL.%26atitle%3DRole%2520of%2520hmgb1%2520as%2520a%2520suitable%2520biomarker%2520of%2520subclinical%2520intestinal%2520inflammation%2520and%2520mucosal%2520healing%2520in%2520patients%2520with%2520inflammatory%2520bowel%2520disease%26jtitle%3DInflamm%2520Bowel%2520Dis.%26date%3D2014%26volume%3D20%26issue%3D8%26spage%3D1448%26epage%3D1457%26doi%3D10.1097%2FMIB.0000000000000113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noronha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coukos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farraye, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganley-Leal, L. M.</span></span> <span> </span><span class="NLM_article-title">Systemic toll-like receptor ligands modify b-cell responses in human inflammatory bowel disease</span>. <i>Inflamm Bowel Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1002/ibd.21424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Fibd.21424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=20806343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FivFCjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=298-307&issue=1&author=M.+McDonnellauthor=Y.+Liangauthor=A.+Noronhaauthor=J.+Coukosauthor=D.+L.+Kasperauthor=F.+A.+Farrayeauthor=L.+M.+Ganley-Leal&title=Systemic+toll-like+receptor+ligands+modify+b-cell+responses+in+human+inflammatory+bowel+disease&doi=10.1002%2Fibd.21424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease</span></div><div class="casAuthors">McDonnell Marie; Liang Yanmei; Noronha Ansu; Coukos Jennifer; Kasper Dennis L; Farraye Francis A; Ganley-Leal Lisa M</div><div class="citationInfo"><span class="NLM_cas:title">Inflammatory bowel diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">298-307</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Bacteria have a central, although poorly understood, role in inflammatory bowel disease (IBD).  Host-bacteria interactions primarily take place in the gastrointestinal tract, but cells may also encounter translocated bacteria in the bloodstream.  IBD is associated with activated, circulating Toll-like receptor (TLR)2 and TLR4-expressing B cells suggesting that blood-borne microbial TLR ligands modulate B cell responses.  METHODS:  Serum levels of lipopolysaccharide (LPS)/endotoxin and high mobility group box 1 (HMGB1), an endogenous TLR ligand, were quantified in Crohn's disease (CD) and ulcerative colitis (UC).  Responses of purified B cells to LPS and HMGB1 were correlated with levels of systemic TLR ligands and clinical parameters of disease.  RESULTS:  While IBD patients have increased levels of blood LPS, the net effect of endotoxemia has unexpected characteristics illustrating that LPS has both pro- and antiinflammatory roles through TLR4+ B cells.  Experimental treatment of B cells demonstrates that the antiinflammatory effect of LPS is due to its hypo-acylation of lipid A suggesting an increased prevalence of systemic, hypo-acylated LPS in CD.  In contrast, high levels of LPS are associated with disease activity in UC.  HMGB1 activates B cells through TLR2 and CD36.  Serum levels of HMGB1 correlate with spontaneous IL-8 production by B cells suggesting that blood-borne TLR2 ligands increase B-cell activation in vivo.  CONCLUSIONS:  Systemic TLR ligands modulate B cells towards either proinflammatory or antiinflammatory activity depending on the predominant ligand(s).  Further, the circulating B cell may represent an important proxy for quantifying the LPS lipid A acylation burden in patients with IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYWESsH91pUMERNNga7KD-fW6udTcc2eYed_4IMPKpa7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FivFCjuw%253D%253D&md5=560fef3319ddcb44f5c732c44841b0f8</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2Fibd.21424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fibd.21424%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DNoronha%26aufirst%3DA.%26aulast%3DCoukos%26aufirst%3DJ.%26aulast%3DKasper%26aufirst%3DD.%2BL.%26aulast%3DFarraye%26aufirst%3DF.%2BA.%26aulast%3DGanley-Leal%26aufirst%3DL.%2BM.%26atitle%3DSystemic%2520toll-like%2520receptor%2520ligands%2520modify%2520b-cell%2520responses%2520in%2520human%2520inflammatory%2520bowel%2520disease%26jtitle%3DInflamm%2520Bowel%2520Dis.%26date%3D2011%26volume%3D17%26issue%3D1%26spage%3D298%26epage%3D307%26doi%3D10.1002%2Fibd.21424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ilmakunnas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tukiainen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouhiainen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauvala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makisalo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hockerstedt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isoniemi, H.</span></span> <span> </span><span class="NLM_article-title">High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation</span>. <i>Liver Transpl.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1517</span>– <span class="NLM_lpage">1525</span>, <span class="refDoi"> DOI: 10.1002/lt.21573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Flt.21573" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1517-1525&issue=10&author=M.+Ilmakunnasauthor=E.+M.+Tukiainenauthor=A.+Rouhiainenauthor=H.+Rauvalaauthor=J.+Arolaauthor=A.+Nordinauthor=H.+Makisaloauthor=K.+Hockerstedtauthor=H.+Isoniemi&title=High+mobility+group+box+1+protein+as+a+marker+of+hepatocellular+injury+in+human+liver+transplantation&doi=10.1002%2Flt.21573"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1002%2Flt.21573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Flt.21573%26sid%3Dliteratum%253Aachs%26aulast%3DIlmakunnas%26aufirst%3DM.%26aulast%3DTukiainen%26aufirst%3DE.%2BM.%26aulast%3DRouhiainen%26aufirst%3DA.%26aulast%3DRauvala%26aufirst%3DH.%26aulast%3DArola%26aufirst%3DJ.%26aulast%3DNordin%26aufirst%3DA.%26aulast%3DMakisalo%26aufirst%3DH.%26aulast%3DHockerstedt%26aufirst%3DK.%26aulast%3DIsoniemi%26aufirst%3DH.%26atitle%3DHigh%2520mobility%2520group%2520box%25201%2520protein%2520as%2520a%2520marker%2520of%2520hepatocellular%2520injury%2520in%2520human%2520liver%2520transplantation%26jtitle%3DLiver%2520Transpl.%26date%3D2008%26volume%3D14%26issue%3D10%26spage%3D1517%26epage%3D1525%26doi%3D10.1002%2Flt.21573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacquaniti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colavita, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirico, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fede, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fede, C.</span></span> <span> </span><span class="NLM_article-title">High mobility group box 1 and tumor growth factor beta: Useful biomarkers in pediatric patients receiving peritoneal dialysis</span>. <i>Renal Failure</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1370</span>– <span class="NLM_lpage">1376</span>, <span class="refDoi"> DOI: 10.1080/0886022X.2016.1216711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1080%2F0886022X.2016.1216711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCisLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2016&pages=1370-1376&issue=9&author=R.+Chimenzauthor=A.+Lacquanitiauthor=L.+Colavitaauthor=V.+Chiricoauthor=C.+Fedeauthor=M.+Buemiauthor=C.+Fede&title=High+mobility+group+box+1+and+tumor+growth+factor+beta%3A+Useful+biomarkers+in+pediatric+patients+receiving+peritoneal+dialysis&doi=10.1080%2F0886022X.2016.1216711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box 1 and tumor growth factor β: useful biomarkers in pediatric patients receiving peritoneal dialysis</span></div><div class="casAuthors">Chimenz, Roberto; Lacquaniti, Antonio; Colavita, Laura; Chirico, Valeria; Fede, Claudia; Buemi, Michele; Fede, Carmelo</div><div class="citationInfo"><span class="NLM_cas:title">Renal Failure</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1370-1376</span>CODEN:
                <span class="NLM_cas:coden">REFAE8</span>;
        ISSN:<span class="NLM_cas:issn">0886-022X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Peritonitis, the most important limitation of peritoneal dialysis (PD), could be detected by biomarkers in dialyzate effluent, representing a noninvasive method to indirectly assess the peritoneum status.  The aim of our study was to test high mobility group box 1 (HMGB1) in PD patients, evaluating its role as precocious marker of peritoneum damage during peritonitis.  Transforming growth factor (TGF)-β was correlated with peritoneal transport characteristics.  Six patients, treated by ambulatory PD, were enrolled.  Samples were collected at the onset of peritonitis (T1) and every day until its resoln. (T-end).  Serum (s) and peritoneal (p) white blood cell (WBC) count was also evaluated.  Peritoneal Equilibration Test evaluated the filter activity of peritoneum.  In patients with acute peritonitis, the highest serum and peritoneal HMGB1 values (64 ± 3.6 and 70 ± 5.3 ng/mL, resp.) were assessed, with a progressive decrease of their levels at the resoln. time (T-end: sHMGB1:36 ± 2.5; pHMGB1:30.5 ± 7.0 ng/mL).  While no differences of sWBC and pWBC were obsd. between baseline and T-end values, pHMGB1 levels remained higher at T-end than those obsd. at T0 (pHMGB1:30.5 ± 7.0 vs. 6.9 ± 3.6; p < 0.0001).  TGF-β levels were higher in patients with low peritoneal permeability than in medium or high transporter patients (81 ± 15.5 vs. 24.3 ± 7.5 pg/mL; p = 0.01).  An inverse correlation was found between TGF-β levels and dialyzate/plasmatic creatinine values (r = -0.83; p = 0.03).  HMGB1 represents a useful biomarker for peritoneum evaluation in PD patients.  A prognostic role of this alarmin, as a marker of response to therapy, could be hypothesized.  TGF-β could predict the peritoneal transport status and dialysis technique adequacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO6KhqULEjC7Vg90H21EOLACvtfcHk0ljloaxYEslzww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCisLzF&md5=d142de5983253396ca7f4b838755c23b</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1080%2F0886022X.2016.1216711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F0886022X.2016.1216711%26sid%3Dliteratum%253Aachs%26aulast%3DChimenz%26aufirst%3DR.%26aulast%3DLacquaniti%26aufirst%3DA.%26aulast%3DColavita%26aufirst%3DL.%26aulast%3DChirico%26aufirst%3DV.%26aulast%3DFede%26aufirst%3DC.%26aulast%3DBuemi%26aufirst%3DM.%26aulast%3DFede%26aufirst%3DC.%26atitle%3DHigh%2520mobility%2520group%2520box%25201%2520and%2520tumor%2520growth%2520factor%2520beta%253A%2520Useful%2520biomarkers%2520in%2520pediatric%2520patients%2520receiving%2520peritoneal%2520dialysis%26jtitle%3DRenal%2520Failure%26date%3D2016%26volume%3D38%26issue%3D9%26spage%3D1370%26epage%3D1376%26doi%3D10.1080%2F0886022X.2016.1216711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakiyanov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalousova, M.</span></span> <span> </span><span class="NLM_article-title">Placental growth factor, pregnancy-associated plasma protein-a, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: A cross sectional study</span>. <i>BMC Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">245</span>, <span class="refDoi"> DOI: 10.1186/1471-2369-14-245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2F1471-2369-14-245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24188108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVOhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=245&author=O.+Zakiyanovauthor=V.+Krihaauthor=J.+Vachekauthor=T.+Zimaauthor=V.+Tesarauthor=M.+Kalousova&title=Placental+growth+factor%2C+pregnancy-associated+plasma+protein-a%2C+soluble+receptor+for+advanced+glycation+end+products%2C+extracellular+newly+identified+receptor+for+receptor+for+advanced+glycation+end+products+binding+protein+and+high+mobility+group+box+1+levels+in+patients+with+acute+kidney+injury%3A+A+cross+sectional+study&doi=10.1186%2F1471-2369-14-245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study</span></div><div class="casAuthors">Zakiyanov, Oskar; Kriha, Vitezslav; Vachek, Jan; Zima, Tomas; Tesar, Vladimir; Kalousova, Marta</div><div class="citationInfo"><span class="NLM_cas:title">BMC Nephrology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245/1-245/11</span>CODEN:
                <span class="NLM_cas:coden">BNMEB7</span>;
        ISSN:<span class="NLM_cas:issn">1471-2369</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Placental growth factor (PlGF), pregnancy-assocd. plasma protein-A (PAPP-A), sol. receptor for advanced glycation end products (sRAGE), extracellular newly identified receptor for RAGE binding protein (EN-RAGE) and high mobility group box 1 (HMGB-1) are novel biomarkers in chronic kidney disease (CKD).  However, their clin. significance in acute kidney injury (AKI) is unknown.  The aim of this cross-sectional study was to det. whether selected biomarkers are changed in AKI patients.  Methods: Serum PlGF, PAPP-A, sRAGE, EN-RAGE and HMGB-1 levels were assessed in 40 patients with AKI, 42 CKD 5 patients, 31 haemodialysis patients (HD) and 39 age-matched healthy controls.  Results: PAPP-A was elevated in AKI (20.6 ± 16.9 mIU/L) compared with controls (9.1 ± 2.3 mIU/L, p < 0.001).  PlGF was not increased in AKI (11.7 ± 7.4 pg/mL) vs. controls (8.5 ± 2.4 pg/mL, n.s.), as well as sRAGE was not elevated in AKI (2400 ± 1400 pg/mL) compared with controls (1760 ± 730 pg/mL, n.s), but was lower compared with CKD 5 (3200 ± 1500 pg/mL, p < 0.05); EN-RAGE was elevated in AKI 480 ± 450 ng/mL in comparison with controls (60 ± 62 ng/mL), CKD 5 (190 ± 120 ng/mL), and HD (120 ± 100 ng/mL), all p < 0.001.  Similarly, HMGB-1 was increased in AKI (5.8 ± 7.5 ng/mL) vs. controls (1.7 ± 1.4 ng/mL), CKD 5 (3.2 ± 3.1 ng/mL) and HD (2.5 ±2.1 ng/mL), all p < 0.001.  In AKI group, in multivariate regression anal.: PAPP-A levels were assocd. with transferrin (p < 0.001), neg. with albumin (p < 0.01) and prealbumin (p < 0.05); PlGF levels were assocd. with C - reactive protein (p < 0.001).  EN-RAGE levels were assocd. with ferritin (p < 0.01) and orosomucoid (p = 0.02), and HMGB-1 levels with leukocyte count (p < 0.01) and neg. with proteinuria (p = 0.02).  Conclusions: In AKI patients, PAPP-A, EN-RAGE and HMGB1 are elevated, but sRAGE and PlGF are not increased.  Whereas PAPP-A correlates with markers of nutrition; PlGF, EN-RAGE and HMGB-1 are related to inflammatory parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzVr4FxfvZbVg90H21EOLACvtfcHk0ljloaxYEslzww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVOhtrY%253D&md5=3f44fcda1f93379cfc44a909e3b14ff6</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1186%2F1471-2369-14-245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2369-14-245%26sid%3Dliteratum%253Aachs%26aulast%3DZakiyanov%26aufirst%3DO.%26aulast%3DKriha%26aufirst%3DV.%26aulast%3DVachek%26aufirst%3DJ.%26aulast%3DZima%26aufirst%3DT.%26aulast%3DTesar%26aufirst%3DV.%26aulast%3DKalousova%26aufirst%3DM.%26atitle%3DPlacental%2520growth%2520factor%252C%2520pregnancy-associated%2520plasma%2520protein-a%252C%2520soluble%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%252C%2520extracellular%2520newly%2520identified%2520receptor%2520for%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520binding%2520protein%2520and%2520high%2520mobility%2520group%2520box%25201%2520levels%2520in%2520patients%2520with%2520acute%2520kidney%2520injury%253A%2520A%2520cross%2520sectional%2520study%26jtitle%3DBMC%2520Nephrol.%26date%3D2013%26volume%3D14%26spage%3D245%26doi%3D10.1186%2F1471-2369-14-245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhillon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromberg, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischereder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heeger, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroppel, B.</span></span> <span> </span><span class="NLM_article-title">Donor toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3390</span>– <span class="NLM_lpage">3395</span>, <span class="refDoi"> DOI: 10.1073/pnas.0810169106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1073%2Fpnas.0810169106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=3390-3395&issue=9&author=B.+Krugerauthor=S.+Krickauthor=N.+Dhillonauthor=S.+M.+Lernerauthor=S.+Amesauthor=J.+S.+Brombergauthor=M.+Linauthor=L.+Walshauthor=J.+Vellaauthor=M.+Fischerederauthor=B.+K.+Kramerauthor=R.+B.+Colvinauthor=P.+S.+Heegerauthor=B.+T.+Murphyauthor=B.+Schroppel&title=Donor+toll-like+receptor+4+contributes+to+ischemia+and+reperfusion+injury+following+human+kidney+transplantation&doi=10.1073%2Fpnas.0810169106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0810169106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0810169106%26sid%3Dliteratum%253Aachs%26aulast%3DKruger%26aufirst%3DB.%26aulast%3DKrick%26aufirst%3DS.%26aulast%3DDhillon%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DS.%2BM.%26aulast%3DAmes%26aufirst%3DS.%26aulast%3DBromberg%26aufirst%3DJ.%2BS.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DWalsh%26aufirst%3DL.%26aulast%3DVella%26aufirst%3DJ.%26aulast%3DFischereder%26aufirst%3DM.%26aulast%3DKramer%26aufirst%3DB.%2BK.%26aulast%3DColvin%26aufirst%3DR.%2BB.%26aulast%3DHeeger%26aufirst%3DP.%2BS.%26aulast%3DMurphy%26aufirst%3DB.%2BT.%26aulast%3DSchroppel%26aufirst%3DB.%26atitle%3DDonor%2520toll-like%2520receptor%25204%2520contributes%2520to%2520ischemia%2520and%2520reperfusion%2520injury%2520following%2520human%2520kidney%2520transplantation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D9%26spage%3D3390%26epage%3D3395%26doi%3D10.1073%2Fpnas.0810169106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruchfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qureshi, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindholm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barany, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvinkel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">High mobility group box protein-1 correlates with renal function in chronic kidney disease (ckd)</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.2119/2007-00107.Bruchfeld</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2F2007-00107.Bruchfeld" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=18317568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksVegu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=109-115&issue=3%E2%80%934&author=A.+Bruchfeldauthor=A.+R.+Qureshiauthor=B.+Lindholmauthor=P.+Baranyauthor=L.+Yangauthor=P.+Stenvinkelauthor=K.+J.+Tracey&title=High+mobility+group+box+protein-1+correlates+with+renal+function+in+chronic+kidney+disease+%28ckd%29&doi=10.2119%2F2007-00107.Bruchfeld"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)</span></div><div class="casAuthors">Bruchfeld, Annette; Qureshi, Abdul Rashid; Lindholm, Bengt; Barany, Peter; Yang, LiHong; Stenvinkel, Peter; Tracey, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">109-115</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Chronic kidney disease (CKD) is assocd. with inflammation and malnutrition and carries a markedly increased risk of cardiovascular disease (CVD).  High Mobility Group Box Protein-1 (HMGB-1) is a 30-kDa nuclear and cytosolic protein known as a transcription and growth factor, recently identified as a pro-inflammatory mediator of tissue injury.  Recent data implicates HMGB-1 in endotoxin lethality, rheumatoid arthritis, and atherosclerosis.  The aim of this post-hoc, cross-sectional study was to det. whether HMGB-1 serum levels are elevated in CKD patients.  The study groups were categorized as follows: 110 patients starting dialysis defined as CKD 5; 67 patients with moderately to severely reduced renal function or CKD 3-4; and 48 healthy controls.  High-sensitivity C-reactive-protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor (TNF), serum-albumin (S-albumin), Hb A1c (HbA1c), Hb, subjective global nutritional assessment (SGA), and glomerular filtration rate (GFR) were analyzed.  Kruskal-Wallis test was used to compare groups and Spearman's rank correlation test was used for continuous variables.  HMGB-1, measured by Western blot, was significantly (P < 0.001) elevated in CKD 5 (146.7 ± 58.6 ng/mL) and CKD 3-4 (85.6 ± 31.8) compared with controls (10.9 ± 10.5).  HMGB-1 levels were correlated pos. with TNF (Rho = 0.52; P < 0.001), hs-CRP (Rho = 0.38; P < 0.001), IL-6 (Rho = 0.30; P < 0.001), HbA1c (Rho = 0.14; P = 0.02) and SGA (Rho = 0.21; P = 0.002) and neg. correlated with GFR (Rho = -0.69; P = 0.0001), Hb (Rho = -0.60; P < 0.001), S-albumin (Rho = -0.31; P < 0.001).  The current study has revealed that HMGB-1 is elevated significantly in CKD patients and correlates with GFR as well as markers of inflammation and malnutrition.  Future studies may delineate whether HMGB-1 is also a marker of disease activity and severity as well as a predictor of outcome in CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxMoclencv4bVg90H21EOLACvtfcHk0li7Xij4KTJ6sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksVegu7s%253D&md5=bd93c49c166a3e3ee5e83f517d5d38d5</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.2119%2F2007-00107.Bruchfeld&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252F2007-00107.Bruchfeld%26sid%3Dliteratum%253Aachs%26aulast%3DBruchfeld%26aufirst%3DA.%26aulast%3DQureshi%26aufirst%3DA.%2BR.%26aulast%3DLindholm%26aufirst%3DB.%26aulast%3DBarany%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DStenvinkel%26aufirst%3DP.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DHigh%2520mobility%2520group%2520box%2520protein-1%2520correlates%2520with%2520renal%2520function%2520in%2520chronic%2520kidney%2520disease%2520%2528ckd%2529%26jtitle%3DMol.%2520Med.%26date%3D2008%26volume%3D14%26issue%3D3%25E2%2580%25934%26spage%3D109%26epage%3D115%26doi%3D10.2119%2F2007-00107.Bruchfeld" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zamora, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vodovotz, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barclay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horslen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudnick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loomes, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squires, R. H.</span></span> <span> </span><span class="NLM_article-title">Data-driven modeling for precision medicine in pediatric acute liver failure</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">829</span>, <span class="refDoi"> DOI: 10.2119/molmed.2016.00183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2016.00183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosFagsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=821-829&author=R.+Zamoraauthor=Y.+Vodovotzauthor=Q.+Miauthor=D.+Barclayauthor=J.+Yinauthor=S.+Horslenauthor=D.+Rudnickauthor=K.+M.+Loomesauthor=R.+H.+Squires&title=Data-driven+modeling+for+precision+medicine+in+pediatric+acute+liver+failure&doi=10.2119%2Fmolmed.2016.00183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Data-driven modeling for precision medicine in pediatric acute liver failure</span></div><div class="casAuthors">Zamora, Ruben; Vodovotz, Yoram; Mi, Qi; Barclay, Derek; Yin, Jinling; Horslen, Simon; Rudnick, David; Loomes, Kathleen M.; Squires, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">821-829</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">The absence of early outcome biomarkers for pediatric acute liver failure (PALF) hinders medical and liver transplant decisions.  We sought to define dynamic interactions among circulating inflammatory mediators to gain insights into PALF outcome subgroups.  Serum samples from 101 participants in the PALF study, collected over the first 7 d following enrollment, were assayed for 27 inflammatory mediators.  Outcomes (spontaneous survivors (S, n = 61), nonsurvivors (NS, n = 12) and liver transplant patients [LTx, n = 28]) were assessed at 21 d post-enrollment.  Dynamic interrelations among mediators were defined using data-driven algorithms.  Dynamic Bayesian network inference identified a common network motif, with HMGB1 as a central node in all patient subgroups.  The networks in S and LTx were similar, and differed from NS.  Dynamic network anal. suggested similar dynamic connectivity in S and LTx, but a more highly interconnected network in NS that increased with time.  A dynamic robustness index calcd. to quantify how inflammatory network connectivity changes as a function of correlation stringency differentiated all three patient subgroups.  Our results suggest that increasing inflammatory network connectivity is assocd. with nonsurvival in PALF and could ultimately lead to better patient outcome stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooqi8lMx_ZpLVg90H21EOLACvtfcHk0li7Xij4KTJ6sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosFagsb4%253D&md5=4d9eafadfd507acd97135b2070ad3221</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2016.00183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2016.00183%26sid%3Dliteratum%253Aachs%26aulast%3DZamora%26aufirst%3DR.%26aulast%3DVodovotz%26aufirst%3DY.%26aulast%3DMi%26aufirst%3DQ.%26aulast%3DBarclay%26aufirst%3DD.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DHorslen%26aufirst%3DS.%26aulast%3DRudnick%26aufirst%3DD.%26aulast%3DLoomes%26aufirst%3DK.%2BM.%26aulast%3DSquires%26aufirst%3DR.%2BH.%26atitle%3DData-driven%2520modeling%2520for%2520precision%2520medicine%2520in%2520pediatric%2520acute%2520liver%2520failure%26jtitle%3DMol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D821%26epage%3D829%26doi%3D10.2119%2Fmolmed.2016.00183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Turco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarra, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. M.</span></span> <span> </span><span class="NLM_article-title">Acute Liver Failure Study, G. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure</span>. <i>Liver Transpl.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">847</span>– <span class="NLM_lpage">854</span>, <span class="refDoi"> DOI: 10.1002/lt.24129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Flt.24129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=847-854&issue=6&author=G.+Bastaauthor=S.+Del+Turcoauthor=T.+Navarraauthor=W.+M.+Lee&title=Acute+Liver+Failure+Study%2C+G.+Circulating+levels+of+soluble+receptor+for+advanced+glycation+end+products+and+ligands+of+the+receptor+for+advanced+glycation+end+products+in+patients+with+acute+liver+failure&doi=10.1002%2Flt.24129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1002%2Flt.24129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Flt.24129%26sid%3Dliteratum%253Aachs%26aulast%3DBasta%26aufirst%3DG.%26aulast%3DDel%2BTurco%26aufirst%3DS.%26aulast%3DNavarra%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DW.%2BM.%26atitle%3DAcute%2520Liver%2520Failure%2520Study%252C%2520G.%2520Circulating%2520levels%2520of%2520soluble%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520and%2520ligands%2520of%2520the%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520in%2520patients%2520with%2520acute%2520liver%2520failure%26jtitle%3DLiver%2520Transpl.%26date%3D2015%26volume%3D21%26issue%3D6%26spage%3D847%26epage%3D854%26doi%3D10.1002%2Flt.24129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chawla, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M. P.</span></span> <span> </span><span class="NLM_article-title">High levels of circulating hmgb1 as a biomarker of acute liver failure in patients with viral hepatitis e</span>. <i>Liver Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1341</span>– <span class="NLM_lpage">1348</span>, <span class="refDoi"> DOI: 10.1111/liv.12197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fliv.12197" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1341-1348&issue=9&author=M.+Majumdarauthor=R.+Rathoauthor=Y.+Chawlaauthor=M.+P.+Singh&title=High+levels+of+circulating+hmgb1+as+a+biomarker+of+acute+liver+failure+in+patients+with+viral+hepatitis+e&doi=10.1111%2Fliv.12197"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1111%2Fliv.12197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fliv.12197%26sid%3Dliteratum%253Aachs%26aulast%3DMajumdar%26aufirst%3DM.%26aulast%3DRatho%26aufirst%3DR.%26aulast%3DChawla%26aufirst%3DY.%26aulast%3DSingh%26aufirst%3DM.%2BP.%26atitle%3DHigh%2520levels%2520of%2520circulating%2520hmgb1%2520as%2520a%2520biomarker%2520of%2520acute%2520liver%2520failure%2520in%2520patients%2520with%2520viral%2520hepatitis%2520e%26jtitle%3DLiver%2520Int.%26date%3D2013%26volume%3D33%26issue%3D9%26spage%3D1341%26epage%3D1348%26doi%3D10.1111%2Fliv.12197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covacu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunnemark, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danilov, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Bianco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khademi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallstrom, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brundin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. A.</span></span> <span> </span><span class="NLM_article-title">Pivotal advance: Hmgb1 expression in active lesions of human and experimental multiple sclerosis</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1248</span>– <span class="NLM_lpage">1255</span>, <span class="refDoi"> DOI: 10.1189/jlb.1207844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1189%2Fjlb.1207844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=18644848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWgu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2008&pages=1248-1255&issue=5&author=A.+Anderssonauthor=R.+Covacuauthor=D.+Sunnemarkauthor=A.+I.+Danilovauthor=A.+Dal+Biancoauthor=M.+Khademiauthor=E.+Wallstromauthor=A.+Lobellauthor=L.+Brundinauthor=H.+Lassmannauthor=R.+A.+Harris&title=Pivotal+advance%3A+Hmgb1+expression+in+active+lesions+of+human+and+experimental+multiple+sclerosis&doi=10.1189%2Fjlb.1207844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis</span></div><div class="casAuthors">Andersson, Aasa; Covacu, Ruxandra; Sunnemark, Dan; Danilov, Alexandre I.; Dal Bianco, Assunta; Khademi, Mohsen; Wallstroem, Erik; Lobell, Anna; Brundin, Lou; Lassmann, Hans; Harris, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1248-1255</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the CNS, most frequently starting with a series of bouts, each followed by complete remission and then a secondary, progressive phase during which the neurol. deficit increases steadily.  The underlying mol. mechanisms responsible for disease progression are still unclear.  Herein, we demonstrate that high mobility group box chromosomal protein 1 (HMGB1), a DNA-binding protein with proinflammatory properties, is evident in active lesions of MS and exptl. autoimmune encephalomyelitis (EAE) and that HMGB1 levels correlate with active inflammation.  Furthermore, the expression of the innate HMGB1 receptors-receptor for advanced glycation end products, TLR2, and TLR4-was also highly increased in MS and rodent EAE.  Addnl., in vitro activation of rodent CNS-derived microglia and bone marrow-derived macrophages demonstrated that microglia were equally as capable as macrophages of translocating HMGB1 following LPS/IFN-γ stimulation.  Significant expression of HMGB1 and its receptors on accumulating activated macrophages and resident microglia may thus provide a pos. feedback loop that amplifies the inflammatory response during MS and EAE pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoskdyS3KpNG7Vg90H21EOLACvtfcHk0ljKvLRwQCnhhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWgu7jI&md5=2db0ee24795ce9a882b0f3b871d80fcf</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1189%2Fjlb.1207844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.1207844%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DA.%26aulast%3DCovacu%26aufirst%3DR.%26aulast%3DSunnemark%26aufirst%3DD.%26aulast%3DDanilov%26aufirst%3DA.%2BI.%26aulast%3DDal%2BBianco%26aufirst%3DA.%26aulast%3DKhademi%26aufirst%3DM.%26aulast%3DWallstrom%26aufirst%3DE.%26aulast%3DLobell%26aufirst%3DA.%26aulast%3DBrundin%26aufirst%3DL.%26aulast%3DLassmann%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26atitle%3DPivotal%2520advance%253A%2520Hmgb1%2520expression%2520in%2520active%2520lesions%2520of%2520human%2520and%2520experimental%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2008%26volume%3D84%26issue%3D5%26spage%3D1248%26epage%3D1255%26doi%3D10.1189%2Fjlb.1207844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrigo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirico, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salpietro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munafo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gitto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacquaniti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salpietro, C.</span></span> <span> </span><span class="NLM_article-title">High-mobility group protein b1: A new biomarker of metabolic syndrome in obese children</span>. <i>Eur. J. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>168</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1530/EJE-13-0037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1530%2FEJE-13-0037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23384711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVanurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=631-638&issue=4&author=T.+Arrigoauthor=V.+Chiricoauthor=V.+Salpietroauthor=C.+Munafoauthor=V.+Ferrauauthor=E.+Gittoauthor=A.+Lacquanitiauthor=C.+Salpietro&title=High-mobility+group+protein+b1%3A+A+new+biomarker+of+metabolic+syndrome+in+obese+children&doi=10.1530%2FEJE-13-0037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children</span></div><div class="casAuthors">Arrigo, Teresa; Chirico, Valeria; Salpietro, Vincenzo; Munafo, Caterina; Ferrau, Valeria; Gitto, Eloisa; Lacquaniti, Antonio; Salpietro, Carmelo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">631-638</span>CODEN:
                <span class="NLM_cas:coden">EJOEEP</span>;
        ISSN:<span class="NLM_cas:issn">0804-4643</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">Introduction: Obesity is assocd. with a chronic low-grade inflammation.  High-mobility group box 1 protein (HMGB1) plays a key role in inflammation and immunostimulatory and chemotactic processes.  The aim of the study was to assess the role of HMGB1 in obese children and to evaluate its diagnostic profile in identifying childhood obesity-related complications, such as the metabolic syndrome (MS).  Patients and methods: Sixty obese children were enrolled and compared with 40 healthy children (control).  Homeostasis model assessment of insulin resistance (HOMA-IR), lipid profile, thyroid hormones, and pro- and anti-inflammatory peptides such as C-reactive protein (CRP), adiponectin, interleukin 6 (IL6), IL18, IL23, TNFα, resistin, and HMGB1 were evaluated.  Receiver operating characteristics (ROC) anal. was employed to calc. the area under the curve (AUC) for HMGB1, IL6, and adiponectin to find the best cutoff values capable of identifying MS in obese children.  Results: HMGB1 levels were statistically higher in obese patients than in the control group (19.4 ± 6.8 vs 3.7 ± 1.2 ng/mL; P<0.0001).  In obese patients, IL18, IL6, and resistin levels were significantly high, while adiponectin levels were low.  At multivariate anal., HMGB1 was found to be independently correlated with BMI, IL23, IL6, free triiodothyronine, HDL, and HOMA-IR.  At ROC anal., HMGB1 showed higher sensitivity and specificity (AUC, 0.992; sensitivity, 94.7%; specificity, 97.5%) than IL6 and adiponectin in identifying MS in obese children.  Conclusion: HMGB1 plays an important role in the inflammatory process assocd. with childhood obesity.  This peptide may be an important diagnostic marker for obesity-related complications, such as MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEy-ZgqfN7ULVg90H21EOLACvtfcHk0ljKvLRwQCnhhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVanurc%253D&md5=fda7f7aa22ec6d5a3e3e9f7cfc27d5d9</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1530%2FEJE-13-0037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FEJE-13-0037%26sid%3Dliteratum%253Aachs%26aulast%3DArrigo%26aufirst%3DT.%26aulast%3DChirico%26aufirst%3DV.%26aulast%3DSalpietro%26aufirst%3DV.%26aulast%3DMunafo%26aufirst%3DC.%26aulast%3DFerrau%26aufirst%3DV.%26aulast%3DGitto%26aufirst%3DE.%26aulast%3DLacquaniti%26aufirst%3DA.%26aulast%3DSalpietro%26aufirst%3DC.%26atitle%3DHigh-mobility%2520group%2520protein%2520b1%253A%2520A%2520new%2520biomarker%2520of%2520metabolic%2520syndrome%2520in%2520obese%2520children%26jtitle%3DEur.%2520J.%2520Endocrinol.%26date%3D2013%26volume%3D168%26issue%3D4%26spage%3D631%26epage%3D638%26doi%3D10.1530%2FEJE-13-0037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinzeki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujino, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, Y.</span></span> <span> </span><span class="NLM_article-title">Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis</span>. <i>Pancreas</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1097/01.mpa.0000236741.15477.8b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2F01.mpa.0000236741.15477.8b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=359-363&issue=4&author=T.+Yasudaauthor=T.+Uedaauthor=Y.+Takeyamaauthor=M.+Shinzekiauthor=H.+Sawaauthor=T.+Nakajimaauthor=T.+Ajikiauthor=Y.+Fujinoauthor=Y.+Suzukiauthor=Y.+Kuroda&title=Significant+increase+of+serum+high-mobility+group+box+chromosomal+protein+1+levels+in+patients+with+severe+acute+pancreatitis&doi=10.1097%2F01.mpa.0000236741.15477.8b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1097%2F01.mpa.0000236741.15477.8b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.mpa.0000236741.15477.8b%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DTakeyama%26aufirst%3DY.%26aulast%3DShinzeki%26aufirst%3DM.%26aulast%3DSawa%26aufirst%3DH.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DAjiki%26aufirst%3DT.%26aulast%3DFujino%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DKuroda%26aufirst%3DY.%26atitle%3DSignificant%2520increase%2520of%2520serum%2520high-mobility%2520group%2520box%2520chromosomal%2520protein%25201%2520levels%2520in%2520patients%2520with%2520severe%2520acute%2520pancreatitis%26jtitle%3DPancreas%26date%3D2006%26volume%3D33%26issue%3D4%26spage%3D359%26epage%3D363%26doi%3D10.1097%2F01.mpa.0000236741.15477.8b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. J.</span></span> <span> </span><span class="NLM_article-title">Increased of serum high-mobility group box chromosomal protein 1 correlated with intestinal mucosal barrier injury in patients with severe acute pancreatitis</span>. <i>World J. Emerg Surg.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1186/1749-7922-9-61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2F1749-7922-9-61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25926862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjptl2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=61&author=G.+F.+Xuauthor=M.+Guoauthor=Z.+Q.+Tianauthor=G.+Z.+Wuauthor=X.+P.+Zouauthor=W.+J.+Zhang&title=Increased+of+serum+high-mobility+group+box+chromosomal+protein+1+correlated+with+intestinal+mucosal+barrier+injury+in+patients+with+severe+acute+pancreatitis&doi=10.1186%2F1749-7922-9-61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Increased of serum high-mobility group box chromosomal protein 1 correlated with intestinal mucosal barrier injury in patients with severe acute pancreatitis</span></div><div class="casAuthors">Xu Gui-Fang; Zou Xiao-Ping; Guo Ming; Tian Zhi-Qiang; Wu Guo-Zhong; Zhang Wei-Jie</div><div class="citationInfo"><span class="NLM_cas:title">World journal of emergency surgery : WJES</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61</span>
        ISSN:<span class="NLM_cas:issn">1749-7922</span>.
    </div><div class="casAbstract">BACKGROUND:  Secondary infections are the leading cause of death in patients with severe acute pancreatitis (SAP).  The gut represents the main source of pancreatic contamination and related septic complications.  High-mobility group box chromosomal protein 1 (HMGB1) was recently identified to play an important role in the SAP intestinal mucosal barrier dysfunction.  OBJECTIVE:  To investigate the correlation of high-mobility group box 1 (HMGB1) with intestinal barrier injury and infections in patients with severe acute pancreatitis (SAP).  METHODS:  The serum levels of HMGB1, amylase, lipase, and biochemical indicators were measured in 80 patients with SAP at the time of admission.  Furthermore, relationship between their serum HMGB1 levels and intestinal barrier injury, infection and other clinical factors were analyzed.  RESULTS:  The mean value of serum HMGB1 levels was significantly higher in patients with SAP (6.02 ± 2.42 ng/mL) than that in healthy volunteers (1.87 ± 0.63 ng/mL).  Serum HMGB1 levels were significantly positively correlated with the Ranson score.  The HMGB1 levels were higher in patients with infection during the clinical course, the HMGB1 levels in non-survivors were higher than those in survivors, and positively correlated with DAO activity, L/M ratio, the concentration of endotoxin (R = 0.484, P <0.01).  CONCLUSIONS:  HMGBl level of patients with severe acute pancreatitis was significantly increased, and can be used as an important indicator to determine the intestinal barrier dysfunction and infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNxJHoYhBCXDUE-swuRqsHfW6udTcc2eZRBDv6rRiNCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjptl2htg%253D%253D&md5=a570af3119c12e575ec3c5f63da8539a</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1186%2F1749-7922-9-61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1749-7922-9-61%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DG.%2BF.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DZ.%2BQ.%26aulast%3DWu%26aufirst%3DG.%2BZ.%26aulast%3DZou%26aufirst%3DX.%2BP.%26aulast%3DZhang%26aufirst%3DW.%2BJ.%26atitle%3DIncreased%2520of%2520serum%2520high-mobility%2520group%2520box%2520chromosomal%2520protein%25201%2520correlated%2520with%2520intestinal%2520mucosal%2520barrier%2520injury%2520in%2520patients%2520with%2520severe%2520acute%2520pancreatitis%26jtitle%3DWorld%2520J.%2520Emerg%2520Surg.%26date%3D2014%26volume%3D9%26spage%3D61%26doi%3D10.1186%2F1749-7922-9-61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span> <span> </span><span class="NLM_article-title">Hmgb1-rage signaling pathway in severe preeclampsia</span>. <i>Placenta</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1148</span>– <span class="NLM_lpage">1152</span>, <span class="refDoi"> DOI: 10.1016/j.placenta.2015.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.placenta.2015.08.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=1148-1152&issue=10&author=L.+Zhuauthor=Z.+Zhangauthor=L.+Zhangauthor=Y.+Shiauthor=J.+Qiauthor=A.+Changauthor=J.+Gaoauthor=Y.+Fengauthor=X.+Yang&title=Hmgb1-rage+signaling+pathway+in+severe+preeclampsia&doi=10.1016%2Fj.placenta.2015.08.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.placenta.2015.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.placenta.2015.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26atitle%3DHmgb1-rage%2520signaling%2520pathway%2520in%2520severe%2520preeclampsia%26jtitle%3DPlacenta%26date%3D2015%26volume%3D36%26issue%3D10%26spage%3D1148%26epage%3D1152%26doi%3D10.1016%2Fj.placenta.2015.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuno, N.</span></span> <span> </span><span class="NLM_article-title">Hmgb-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing pmx-dhp</span>. <i>J. Surg. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/j.jss.2009.11.708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.jss.2009.11.708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=20338589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlarsbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2011&pages=183-190&issue=1&author=T.+Uenoauthor=T.+Ikedaauthor=K.+Ikedaauthor=H.+Taniuchiauthor=S.+Sudaauthor=M.+Y.+Yeungauthor=N.+Matsuno&title=Hmgb-1+as+a+useful+prognostic+biomarker+in+sepsis-induced+organ+failure+in+patients+undergoing+pmx-dhp&doi=10.1016%2Fj.jss.2009.11.708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB-1 as a Useful Prognostic Biomarker in Sepsis-Induced Organ Failure in Patients Undergoing PMX-DHP</span></div><div class="casAuthors">Ueno, Takuya; Ikeda, Toshiaki; Ikeda, Kazumi; Taniuchi, Hitoshi; Suda, Shingo; Yeung, Melissa Y.; Matsuno, Naoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Surgical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">183-190</span>CODEN:
                <span class="NLM_cas:coden">JSGRA2</span>;
        ISSN:<span class="NLM_cas:issn">0022-4804</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: High mobility group box 1 (HMGB-1) has recently received attention as a late mediator of lipopolysaccharide-induced shock, and is thought to function as a mediator in such a disorder as multi-organ failure (MOF).  In Japan, we have access to an immobilized polymyxin B fiber column using a direct hemoperfusion (PMX-DHP) for patients with septic shock to improve hemodynamics and organ dysfunction.  In this study, we looked at HMGB-1 levels in each category based on the sequential organ failure assessment (SOFA) scores to further dissect its importance in specific aspects of organ failure in patients undergoing PMX-DHP.  Patients and Methods: Sixty patients with septic shock (40 survivors and 20 non-survivors).  We analyzed HMGB-1 and IL-6 levels before and after PMX-DHP and defined organ failure as two or more SOFA points.  Results: There was a significant pos. correlation between SOFA score and HMGB-1 level (P < 0.05).  The HMGB-1 level before PMX-DHP significantly increased as the no. of organ failures increased (P < 0.01: comparing 2 vs. 5 organ failures).  IL-6 levels decreased after PMX-DHP (P < 0.05 compared with before PMX-DHP), but HMGB-1 levels remained unchanged.  HMGB-1 levels of survivors with organ failure in liver decreased after PMX-DHP, but those of non-survivors significantly increased 24h after PMX-DHP compared with before PMX-DHP (P < 0.01).  In non-survivors with organ failure in liver, HMGB-1 levels were significantly higher than among survivors 24h after PMX-DHP (P < 0.01).  Conclusions: Our results indicate that HMGB-1 is a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0isKW5WOdm7Vg90H21EOLACvtfcHk0ljH2F2XqVV1IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlarsbrF&md5=dcbc4196cea2f6e0b08f613badc6c91f</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.jss.2009.11.708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jss.2009.11.708%26sid%3Dliteratum%253Aachs%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DTaniuchi%26aufirst%3DH.%26aulast%3DSuda%26aufirst%3DS.%26aulast%3DYeung%26aufirst%3DM.%2BY.%26aulast%3DMatsuno%26aufirst%3DN.%26atitle%3DHmgb-1%2520as%2520a%2520useful%2520prognostic%2520biomarker%2520in%2520sepsis-induced%2520organ%2520failure%2520in%2520patients%2520undergoing%2520pmx-dhp%26jtitle%3DJ.%2520Surg.%2520Res.%26date%3D2011%26volume%3D171%26issue%3D1%26spage%3D183%26epage%3D190%26doi%3D10.1016%2Fj.jss.2009.11.708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hatada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uemoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, I.</span></span> <span> </span><span class="NLM_article-title">Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation</span>. <i>Thromb. Haemostasis</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1160/TH05-05-0316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1160%2FTH05-05-0316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=16363239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Kgt7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=975-979&issue=5&author=T.+Hatadaauthor=H.+Wadaauthor=T.+Noboriauthor=K.+Okabayashiauthor=K.+Maruyamaauthor=Y.+Abeauthor=S.+Uemotoauthor=S.+Yamadaauthor=I.+Maruyama&title=Plasma+concentrations+and+importance+of+high+mobility+group+box+protein+in+the+prognosis+of+organ+failure+in+patients+with+disseminated+intravascular+coagulation&doi=10.1160%2FTH05-05-0316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation</span></div><div class="casAuthors">Hatada, Tsuyoshi; Wada, Hideo; Nobori, Tsutomu; Okabayashi, Kazuhiro; Maruyama, Kazuo; Abe, Yasunori; Uemoto, Shinji; Yamada, Shingo; Maruyama, Ikuro</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">975-979</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">High Mobility Group Box chromosomal protein 1 (HMGB1) is a nuclear DNA-binding protein acting as a proinflammatory cytokine when released in the extracellular space from necrotic cells, activated macrophages and dendritic cells.  HMGB1 acts on a specific receptor, RAGE (receptor for advanced glycation end-products), and induces prolonged inflammation, organ failure, septicemia and death.  The aim of the study was to det. the diagnostic value of plasma HMGB1 concn. and its role in the development of organ failure in patients with disseminated intravascular coagulation (DIC).  Plasma HMGB-1 levels were measured in patients with suspected DIC and their relationships with DIC, organ failure and clin. outcome were detd.  The study took place at the intensive care facility, Mie University School of Medicine and comprised 201 patients with suspected DIC.  Plasma HMGB1 was below the detection limit in normal subjects, but moderately elevated in patients with infectious diseases (4.54±8.18 ng/mL, mean±SD), malignancies (2.15±5.34 ng/mL), and traumas (6.47±13.13 ng/mL).  DIC was assocd. with significantly high plasma HMGB1 (14.05±12.56 ng/mL) in these patients.  The highest HMGB1 levels were in patients with organ failure (8.29±10.99 ng/mL) and non-survivors (16.58±11.01 ng/mL).  HMGB1 plasma levels correlated with the DIC score and sepsis-related organ failure assessment (SOFA) score.  In conclusion, our data suggest that HMGB-1 is a potentially suitable prognostic marker of OF or DIC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBj0AbJkMbZbVg90H21EOLACvtfcHk0ljGv_HhvWM4jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Kgt7zF&md5=be9434ba7a1be72d699c41cbfc631bcb</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1160%2FTH05-05-0316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH05-05-0316%26sid%3Dliteratum%253Aachs%26aulast%3DHatada%26aufirst%3DT.%26aulast%3DWada%26aufirst%3DH.%26aulast%3DNobori%26aufirst%3DT.%26aulast%3DOkabayashi%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DK.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DUemoto%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DMaruyama%26aufirst%3DI.%26atitle%3DPlasma%2520concentrations%2520and%2520importance%2520of%2520high%2520mobility%2520group%2520box%2520protein%2520in%2520the%2520prognosis%2520of%2520organ%2520failure%2520in%2520patients%2520with%2520disseminated%2520intravascular%2520coagulation%26jtitle%3DThromb.%2520Haemostasis%26date%3D2005%26volume%3D94%26issue%3D5%26spage%3D975%26epage%3D979%26doi%3D10.1160%2FTH05-05-0316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span> <span> </span><span class="NLM_article-title">Prognostic value of dynamic monitoring of cellular immunity and hmgb1 in severe sepsis: Delayed chronic inflammation may be the leading cause of death in late severe sepsis</span>. <i>Clin. Lab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2379</span>– <span class="NLM_lpage">2385</span>, <span class="refDoi"> DOI: 10.7754/Clin.Lab.2016.160530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.7754%2FClin.Lab.2016.160530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28164547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVWnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2016&pages=2379-2385&issue=12&author=H.+Yuauthor=Z.+Qiauthor=L.+Zhaoauthor=R.+Shaoauthor=Y.+Fangauthor=C.+Li&title=Prognostic+value+of+dynamic+monitoring+of+cellular+immunity+and+hmgb1+in+severe+sepsis%3A+Delayed+chronic+inflammation+may+be+the+leading+cause+of+death+in+late+severe+sepsis&doi=10.7754%2FClin.Lab.2016.160530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic value of dynamic monitoring of cellular immunity and HMGB1 in severe sepsis: delayed chronic inflammation may be the leading cause of death in late severe sepsis</span></div><div class="casAuthors">Yu, Han; Qi, Zhijiang; Zhao, Lianxiang; Shao, Rui; Fang, Yingying; Li, Chunsheng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Laboratory (Mainz, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2379-2385</span>CODEN:
                <span class="NLM_cas:coden">CLLAFP</span>;
        ISSN:<span class="NLM_cas:issn">1433-6510</span>.
    
            (<span class="NLM_cas:orgname">Clinical Laboratory Publications GmbH</span>)
        </div><div class="casAbstract">Background: Sepsis is a life-threatening response to infection with a high mortality rate.  In order to explore the prognostic value of dynamic monitoring of cellular immunity during late severe sepsis, we assessed levels of T-lymphocyte subsets, the human leukocyte antigen D-related (HLA-DR), and the high mobility group box-1 (HMGB1) protein.  Methods: Study participants included 247 consecutive severe sepsis patients who were admitted to Beijing Chao-Yang Hospital's Emergency Intensive Care Unit.  Patients were divided into survivors and non-survivors based on 90-day survival rates, and clin. data were collected.  T-lymphocyte subsets on days 1 and 7, HLA-DR on days 1 and 12, and HMGB1 on days 1, 3, 5, 7, and 12 were analyzed.  Results: Counts of CD3+, CD3+CD4+, and CD3+CD8+T cells on day 1 in non-survivors were lower than those in survivors.  By day 7 counts of all three types of T cells had increased in both survivors and non-survivors, but CD3+ and CD+CD8+ T cells remained lower in non-survivors than in survivors. there was no significant difference in HLA-DR levels between survivors and non-survivors on day 1, but HLA-DR levels increased in survivors and decreased in non-survivors by day 12.  In contrast, over days 1 - 12, HMGB1 levels increased in non-survivors and decreased in survivors.  Conclusions: Patients with severe sepsis present with cellular immune dysfunction and persistent chronic inflammation, both of which may lead to death in the late phase of severe sepsis.  Dynamic monitoring of indicators of cellular immunity and HMGB1 is useful for evaluating the immune status, chronic inflammation processes, and prognosis of patients with severe sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdCOklbVFjubVg90H21EOLACvtfcHk0ljGv_HhvWM4jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVWnu78%253D&md5=691cdaa1d80286a7d4b898f2d778fba2</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.7754%2FClin.Lab.2016.160530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7754%252FClin.Lab.2016.160530%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DQi%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DShao%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DPrognostic%2520value%2520of%2520dynamic%2520monitoring%2520of%2520cellular%2520immunity%2520and%2520hmgb1%2520in%2520severe%2520sepsis%253A%2520Delayed%2520chronic%2520inflammation%2520may%2520be%2520the%2520leading%2520cause%2520of%2520death%2520in%2520late%2520severe%2520sepsis%26jtitle%3DClin.%2520Lab.%26date%3D2016%26volume%3D62%26issue%3D12%26spage%3D2379%26epage%3D2385%26doi%3D10.7754%2FClin.Lab.2016.160530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bae, J. S.</span></span> <span> </span><span class="NLM_article-title">Role of high mobility group box 1 in inflammatory disease: Focus on sepsis</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1511</span>– <span class="NLM_lpage">1523</span>, <span class="refDoi"> DOI: 10.1007/s12272-012-0901-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs12272-012-0901-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23054707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKrur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=1511-1523&issue=9&author=J.+S.+Bae&title=Role+of+high+mobility+group+box+1+in+inflammatory+disease%3A+Focus+on+sepsis&doi=10.1007%2Fs12272-012-0901-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Role of high mobility group box 1 in inflammatory disease: Focus on sepsis</span></div><div class="casAuthors">Bae, Jong-Sup</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1511-1523</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  High mobility group box 1 (HMGB1) is a highly conserved, ubiquitous protein present in the nuclei and cytoplasm of nearly all cell types.  In response to infection or injury, HMGB1 is actively secreted by innate immune cells and/or released passively by injured or damaged cells.  Thus, serum and tissue levels of HMGB1 are elevated during infection, and esp. during sepsis.  Sepsis is a systemic inflammatory response to disease and the most severe complication of infections, and HMGB1 acts as a potent proinflammatory cytokine and is involved in delayed endotoxin lethality and sepsis.  Furthermore, the targeting of HMGB1 with antibodies or specific antagonists has been found to have protective effects in established preclin. inflammatory disease models, including models of lethal endotoxemia and sepsis.  In the present study, emerging evidence supporting the notion that extracellular HMGB1 acts as a proinflammatory danger signal is reviewed, and the potential therapeutic effects of a wide array of HMGB1 inhibitors agents in sepsis and ischemic injury are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm-dygrUAjh7Vg90H21EOLACvtfcHk0ljbZVeXqB_LGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKrur%252FM&md5=762ad1ccae4e251a3c28d5ad508cb6dd</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1007%2Fs12272-012-0901-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-012-0901-5%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DJ.%2BS.%26atitle%3DRole%2520of%2520high%2520mobility%2520group%2520box%25201%2520in%2520inflammatory%2520disease%253A%2520Focus%2520on%2520sepsis%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2012%26volume%3D35%26issue%3D9%26spage%3D1511%26epage%3D1523%26doi%3D10.1007%2Fs12272-012-0901-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, S.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 promotes systemic lupus erythematosus by enhancing macrophage inflammatory response</span>. <i>J. Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2015</i></span>,  <span class="NLM_fpage">946748</span>, <span class="refDoi"> DOI: 10.1155/2015/946748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1155%2F2015%2F946748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26078984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2MbktVOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2015&publication_year=2015&pages=946748&author=M.+Luauthor=S.+Yuauthor=W.+Xuauthor=B.+Gaoauthor=S.+Xiong&title=Hmgb1+promotes+systemic+lupus+erythematosus+by+enhancing+macrophage+inflammatory+response&doi=10.1155%2F2015%2F946748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response</span></div><div class="casAuthors">Lu Mudan; Yu Shanshan; Gao Bo; Xu Wei; Xiong Sidong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2015</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">946748</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Background/Purpose.  HMGB1, which may act as a proinflammatory mediator, has been proposed to contribute to the pathogenesis of multiple chronic inflammatory and autoimmune diseases including systemic lupus erythematosus (SLE); however, the precise mechanism of HMGB1 in the pathogenic process of SLE remains obscure.  Method.  The expression of HMGB1 was measured by ELISA and western blot.  The ELISA was also applied to detect proinflammatory cytokines levels.  Furthermore, nephritic pathology was evaluated by H&E staining of renal tissues.  Results.  In this study, we found that HMGB1 levels were significantly increased and correlated with SLE disease activity in both clinical patients and murine model.  Furthermore, gain- and loss-of-function analysis showed that HMGB1 exacerbated the severity of SLE.  Of note, the HMGB1 levels were found to be associated with the levels of proinflammatory cytokines such as TNF-α and IL-6 in SLE patients.  Further study demonstrated that increased HMGB1 expression deteriorated the severity of SLE via enhancing macrophage inflammatory response.  Moreover, we found that receptor of advanced glycation end products played a critical role in HMGB1-mediated macrophage inflammatory response.  Conclusion.  These findings suggested that HMGB1 might be a risk factor for SLE, and manipulation of HMGB1 signaling might provide a therapeutic strategy for SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpnJMlUSMmosRAV4D_Ins_fW6udTcc2eZ_LhEIl0fw-Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbktVOgsA%253D%253D&md5=128cfe82f4e3b740b2b117512c8c1866</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1155%2F2015%2F946748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2015%252F946748%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DXiong%26aufirst%3DS.%26atitle%3DHmgb1%2520promotes%2520systemic%2520lupus%2520erythematosus%2520by%2520enhancing%2520macrophage%2520inflammatory%2520response%26jtitle%3DJ.%2520Immunol.%2520Res.%26date%3D2015%26volume%3D2015%26spage%3D946748%26doi%3D10.1155%2F2015%2F946748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus</span>. <i>J. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">766</span>– <span class="NLM_lpage">775</span>, <span class="refDoi"> DOI: 10.3899/jrheum.090663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3899%2Fjrheum.090663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=20110525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFCru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=766-775&issue=4&author=J.+Liauthor=H.+Xieauthor=T.+Wenauthor=H.+Liuauthor=W.+Zhuauthor=X.+Chen&title=Expression+of+high+mobility+group+box+chromosomal+protein+1+and+its+modulating+effects+on+downstream+cytokines+in+systemic+lupus+erythematosus&doi=10.3899%2Fjrheum.090663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus</span></div><div class="casAuthors">Li, Jie; Xie, Hongfu; Wen, Ting; Liu, Hongbo; Zhu, Wu; Chen, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">766-775</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">Objective. To compare the expression of high mobility group box chromosomal protein 1 (HMGB1) and the modulating effects on its downstream cytokines in patients with systemic lupus erythematosus (SLE) and healthy controls.  Methods. HMGB1 concns. in serum from SLE patients and controls were measured by immunoblot anal.  HMGB1 mRNA expression in peripheral blood mononuclear cells (PBMC) was detected by real-time reverse transcription-polymerase chain reaction.  Immunofluorescence assay was employed to examine the translocation of HMGB1 in monocytes after endotoxin stimulation.  Release of tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) by PBMC after rHMGB1 stimulation was also measured.  Results. Serum HMGB1 levels and HMGB1 mRNA expressions in PBMC were elevated in SLE patients compared with controls.  A pos. correlation was demonstrated between HMGB1 concns. and SLE Disease Activity Index.  There was an inverse correlation between HMGB1 levels and C4 and C3 concns. in SLE patients.  HMGB1 concns. were higher in patients with vasculitis and myositis.  Lipopolysaccharide stimulated a temporarily elevated release of HMGB1 in SLE patients compared with controls.  The pattern and localization of HMGB1 staining in monocytes were similar in both groups.  After stimulation with rHMGB1, TNF-α level decreased but IL-6 level increased in SLE patients compared with controls.  Conclusion. Our findings suggest that increased serum levels of HMGB1 in SLE may be assocd. with lupus disease activity.  The altered prodn. of TNF-α and IL-6 in response to rHMGB1 stimulation may participate in the disruption of cytokine homeostasis in SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMBThbWYnocrVg90H21EOLACvtfcHk0ljbZVeXqB_LGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFCru7o%253D&md5=cdea6c9bd43d332b635f4e05ae34084d</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.090663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.090663%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DWen%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DExpression%2520of%2520high%2520mobility%2520group%2520box%2520chromosomal%2520protein%25201%2520and%2520its%2520modulating%2520effects%2520on%2520downstream%2520cytokines%2520in%2520systemic%2520lupus%2520erythematosus%26jtitle%3DJ.%2520Rheumatol.%26date%3D2010%26volume%3D37%26issue%3D4%26spage%3D766%26epage%3D775%26doi%3D10.3899%2Fjrheum.090663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. R.</span></span> <span> </span><span class="NLM_article-title">Elevated plasma level of hmgb1 is associated with disease activity and combined alterations with ifn-alpha and tnf-alpha in systemic lupus erythematosus</span>. <i>Rheumatol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1007/s00296-010-1636-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs00296-010-1636-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21120500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=395-402&issue=2&author=C.+Y.+Maauthor=Y.+L.+Jiaoauthor=J.+Zhangauthor=Q.+R.+Yangauthor=Z.+F.+Zhangauthor=Y.+J.+Shenauthor=Z.+J.+Chenauthor=Y.+R.+Zhao&title=Elevated+plasma+level+of+hmgb1+is+associated+with+disease+activity+and+combined+alterations+with+ifn-alpha+and+tnf-alpha+in+systemic+lupus+erythematosus&doi=10.1007%2Fs00296-010-1636-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus</span></div><div class="casAuthors">Ma, Chun-yan; Jiao, Yu-lian; Zhang, Jie; Yang, Qing-rui; Zhang, Zhi-fen; Shen, Ya-juan; Chen, Zi-jiang; Zhao, Yue-ran</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">395-402</span>CODEN:
                <span class="NLM_cas:coden">RHINDE</span>;
        ISSN:<span class="NLM_cas:issn">0172-8172</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Recent studies indicate that high-mobility group box protein 1 (HMGB1) contributes to the pathogenesis of diverse autoimmune disorders.  It induces the prodn. of interferon-alpha (IFN-alpha) and tumor necrosis factor alpha (TNF-alpha) in vitro.  In the present study, plasma HMGB1, TNF-alpha, and IFN-alpha were detd. with ELISA in 37 patients with systemic lupus erythematosus (SLE) and 39 age- and sex-matched healthy controls (HC).  The possible assocns. of these cytokines with disease activities, autoantibodies, and certain lab. parameters were also explored.  The plasma levels of HMGB1, TNF-alpha, and IFN-alpha were increased in SLE patients compared with those of HC (P < 0.05).  Moreover, the levels of HMGB1 and TNF-alpha in the active SLE patients were elevated compared with those in inactive patients and HC.  Addnl., plasma HMGB1 was pos. correlated with peripheral neutrophils, and plasma TNF-alpha was pos. correlated with anti-Sm, ESR and CRP, while plasma IFN-alpha was inversely correlated with the age and platelet level in SLE patients.  Our data indicated that increased plasma HMGB1 was assocd. with disease activity in SLE, which was similar to TNF-alpha.  High level of plasma IFN-alpha may be related to nephritis and thrombocytopenia in SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3FeXc_9kb9LVg90H21EOLACvtfcHk0ljbbt_ETD694A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWhurk%253D&md5=29c00081677571473f51859e97767514</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs00296-010-1636-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00296-010-1636-6%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%2BY.%26aulast%3DJiao%26aufirst%3DY.%2BL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%2BR.%26aulast%3DZhang%26aufirst%3DZ.%2BF.%26aulast%3DShen%26aufirst%3DY.%2BJ.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%26aulast%3DZhao%26aufirst%3DY.%2BR.%26atitle%3DElevated%2520plasma%2520level%2520of%2520hmgb1%2520is%2520associated%2520with%2520disease%2520activity%2520and%2520combined%2520alterations%2520with%2520ifn-alpha%2520and%2520tnf-alpha%2520in%2520systemic%2520lupus%2520erythematosus%26jtitle%3DRheumatol.%2520Int.%26date%3D2012%26volume%3D32%26issue%3D2%26spage%3D395%26epage%3D402%26doi%3D10.1007%2Fs00296-010-1636-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zickert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmblad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundelin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunnarsson, I.</span></span> <span> </span><span class="NLM_article-title">Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">R36</span>, <span class="refDoi"> DOI: 10.1186/ar3747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2Far3747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22348591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVynsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=R36&issue=1&author=A.+Zickertauthor=K.+Palmbladauthor=B.+Sundelinauthor=S.+Chavanauthor=K.+J.+Traceyauthor=A.+Bruchfeldauthor=I.+Gunnarsson&title=Renal+expression+and+serum+levels+of+high+mobility+group+box+1+protein+in+lupus+nephritis&doi=10.1186%2Far3747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis</span></div><div class="casAuthors">Zickert, Agneta; Palmblad, Karin; Sundelin, Birgitta; Chavan, Sangeeta; Tracey, Kevin J.; Bruchfeld, Annette; Gunnarsson, Iva</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">R36</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">High mobility group box 1 protein (HMGB1) is a nuclear DNA binding protein acting as a pro-inflammatory mediator following extracellular release.  HMGB1 has been increasingly recognized as a pathogenic mediator in several inflammatory diseases.  Elevated serum levels of HMGB1 have been detected in autoimmune diseases including Systemic lupus erythematosus (SLE).  However, the local expression of HMGB1 in active lupus nephritis (LN) is not known.  Here we aimed to study both tissue expression and serum levels of HMGB1 in LN patients with active disease and after induction therapy.  Thirty-five patients with active LN were included.  Renal biopsies were performed at baseline and after std. induction therapy; corticosteroids combined with immunosuppressive drugs.  The biopsies were evaluated according to the World Health Organization (WHO) classification and renal disease activity was estd. using the British Isles lupus assessment group (BILAG) index.  Serum levels of HMGB1 were analyzed by western blot.  HMGB1 expression in renal tissue was assessed by immunohistochem. at baseline and follow-up biopsies in 25 patients.  Baseline biopsies showed WHO class III, IV or V and all patients had high renal disease activity (BILAG A/B).  Follow-up biopsies showed WHO I to II (n = 14), III (n = 6), IV (n = 3) or V (n = 12), and 15/35 patients were regarded as renal responders (BILAG C/D).  At baseline HMGB1 was significantly elevated in serum compared to healthy controls (P < 0.0001).  In all patients, serum levels decreased only slightly; however, in patients with baseline WHO class IV a significant decrease was obsd. (P = 0.03).  Immunostaining revealed a pronounced extranuclear HMGB1 expression predominantly outlining the glomerular endothelium and in the mesangium.  There was no clear difference in HMGB1 expression comparing baseline and follow-up biopsies or any apparent assocn. to histopathol. classification or clin. outcome.  Renal tissue expression and serum levels of HMGB1 were increased in LN.  The lack of decrease of HMGB1 in serum and tissue after immunosuppressive therapy in the current study may reflect persistent inflammatory activity.  This study clearly indicates a role for HMGB1 in LN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOQFcTyw1vsrVg90H21EOLACvtfcHk0limpiMFxd9Scw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVynsLw%253D&md5=1d4e68bd8e0e2e661e0974733f28285e</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1186%2Far3747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far3747%26sid%3Dliteratum%253Aachs%26aulast%3DZickert%26aufirst%3DA.%26aulast%3DPalmblad%26aufirst%3DK.%26aulast%3DSundelin%26aufirst%3DB.%26aulast%3DChavan%26aufirst%3DS.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DBruchfeld%26aufirst%3DA.%26aulast%3DGunnarsson%26aufirst%3DI.%26atitle%3DRenal%2520expression%2520and%2520serum%2520levels%2520of%2520high%2520mobility%2520group%2520box%25201%2520protein%2520in%2520lupus%2520nephritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2012%26volume%3D14%26issue%3D1%26spage%3DR36%26doi%3D10.1186%2Far3747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papatheodorou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bank, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sison, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, O.</span></span> <span> </span><span class="NLM_article-title">High-mobility group box 1 (hmgb1) is elevated systemically in persons with acute or chronic traumatic spinal cord injury</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">746</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1089/neu.2016.4596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1089%2Fneu.2016.4596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27673428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2svktVyrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=746-754&issue=3&author=A.+Papatheodorouauthor=A.+Steinauthor=M.+Bankauthor=C.+P.+Sisonauthor=K.+Gibbsauthor=P.+Daviesauthor=O.+Bloom&title=High-mobility+group+box+1+%28hmgb1%29+is+elevated+systemically+in+persons+with+acute+or+chronic+traumatic+spinal+cord+injury&doi=10.1089%2Fneu.2016.4596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury</span></div><div class="casAuthors">Papatheodorou Angelos; Bloom Ona; Stein Adam; Gibbs Katie; Bloom Ona; Bank Matthew; Sison Cristina P; Bloom Ona; Davies Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">746-754</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation in traumatic spinal cord injury (SCI) has been proposed to promote damage acutely and oppose functional recovery chronically.  However, we do not yet understand the signals that initiate or prolong inflammation in persons with SCI.  High-Mobility Group Box 1 (HMGB1) is a potent systemic inflammatory cytokine-or damage-associated molecular pattern molecule (DAMP)-studied in a variety of clinical settings.  It is elevated in pre-clinical models of traumatic spinal cord injury (SCI), where it promotes secondary injury, and strategies that block HMGB1 improve functional recovery.  To investigate the potential translational relevance of these observations, we measured HMGB1 in plasma from adults with acute (≤ 1 week post-SCI, n = 16) or chronic (≥ 1 year post-SCI, n = 47) SCI.  Plasma from uninjured persons (n = 51) served as controls for comparison.  In persons with acute SCI, average HMGB1 levels were significantly elevated within 0-3 days post-injury (6.00 ± 1.8 ng/mL, mean ± standard error of the mean [SEM]) or 4-7 (6.26 ± 1.3 ng/mL, mean ± SEM), compared with controls (1.26 ± 0.24 ng/mL, mean ± SEM; p ≤ 0.001 and p ≤ 0.01, respectively).  In persons with chronic SCI who were injured for 15 ± 1.5 years (mean ± SEM), HMGB1 also was significantly elevated, compared with uninjured persons (3.7 ± 0.69 vs. 1.26 ± 0.24 ng/mL, mean ± SEM; p ≤ 0.0001).  Together, these data suggest that HMGB1 may be a common, early, and persistent danger signal promoting inflammation in individuals with SCI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSPV-njIIuiOdfST00W0BcfW6udTcc2ebZP2YryW1mQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svktVyrsA%253D%253D&md5=195502f5801ac454cb068e72613c5e80</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1089%2Fneu.2016.4596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2016.4596%26sid%3Dliteratum%253Aachs%26aulast%3DPapatheodorou%26aufirst%3DA.%26aulast%3DStein%26aufirst%3DA.%26aulast%3DBank%26aufirst%3DM.%26aulast%3DSison%26aufirst%3DC.%2BP.%26aulast%3DGibbs%26aufirst%3DK.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DBloom%26aufirst%3DO.%26atitle%3DHigh-mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520is%2520elevated%2520systemically%2520in%2520persons%2520with%2520acute%2520or%2520chronic%2520traumatic%2520spinal%2520cord%2520injury%26jtitle%3DJ.%2520Neurotrauma%26date%3D2017%26volume%3D34%26issue%3D3%26spage%3D746%26epage%3D754%26doi%3D10.1089%2Fneu.2016.4596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z. Q.</span></span> <span> </span><span class="NLM_article-title">High plasma levels of high mobility group box 1 is associated with the risk of sepsis in severe blunt chest trauma patients: A prospective cohort study</span>. <i>J. Cardiothorac Surg.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">133</span>, <span class="refDoi"> DOI: 10.1186/s13019-014-0133-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2Fs13019-014-0133-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25085006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2cbotFSgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=133&author=X.+W.+Wangauthor=A.+Karkiauthor=X.+J.+Zhaoauthor=X.+Y.+Xiangauthor=Z.+Q.+Lu&title=High+plasma+levels+of+high+mobility+group+box+1+is+associated+with+the+risk+of+sepsis+in+severe+blunt+chest+trauma+patients%3A+A+prospective+cohort+study&doi=10.1186%2Fs13019-014-0133-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">High plasma levels of high mobility group box 1 is associated with the risk of sepsis in severe blunt chest trauma patients: a prospective cohort study</span></div><div class="casAuthors">Wang Xiao-Wen; Karki Avash; Zhao Xing-Ji; Xiang Xiao-Yong; Lu Zhi-Qian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiothoracic surgery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  High mobility group box 1 (HMGB1) is a late mediator of systemic inflammation.  Extracellular HMGB1 play a central pathogenic role in critical illness.  The purpose of the study was to investigate the association between plasma HMGB1 concentrations and the risk of poor outcomes in patients with severe blunt chest trauma.  METHODS:  The plasma concentrations of HMGB1 in patients with severe blunt chest trauma (AIS ≥ 3) were measured by a quantitative enzyme-linked immunosorbent assay at four time points during seven days after admission, and the dynamic release patterns were monitored.  The biomarker levels were compared between patients with sepsis and non-sepsis, and between patients with multiple organ dysfunction syndrome (MODS) and non-MODS.  The related factors of prognosis were analyzed by using multivariate logistic regression analysis.  The short-form 36 was used to evaluate the quality of life of patients at 12 months after injury.  RESULTS:  Plasma HMGB1 levels were significantly higher both in sepsis and MODS group on post-trauma day 3, 5, and 7 compared with the non-sepsis and non-MODS groups, respectively.  Multivariate analysis showed that HMGB1 levels and ISS were independent risk factors for sepsis and MODS in patients with severe blunt chest trauma.  CONCLUSIONS:  Plasma HMGB1 levels were significantly elevated in patients with severe blunt chest trauma.  HMGB1 levels were associated with the risk of poor outcome in patients with severe blunt chest trauma.  Daily HMGB1 levels measurements is a potential useful tool in the early identification of post-trauma complications.  Further studies are needed to determine whether HMGB1 intervention could prevent the development of sepsis and MODS in patients with severe blunt chest trauma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVpWr6ZFcPPbqxQ2mb9Pu8fW6udTcc2eb7NKFESlr2Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbotFSgsw%253D%253D&md5=48c99235dbdf665ab69fa1eb802f80f2</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1186%2Fs13019-014-0133-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13019-014-0133-5%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BW.%26aulast%3DKarki%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DX.%2BJ.%26aulast%3DXiang%26aufirst%3DX.%2BY.%26aulast%3DLu%26aufirst%3DZ.%2BQ.%26atitle%3DHigh%2520plasma%2520levels%2520of%2520high%2520mobility%2520group%2520box%25201%2520is%2520associated%2520with%2520the%2520risk%2520of%2520sepsis%2520in%2520severe%2520blunt%2520chest%2520trauma%2520patients%253A%2520A%2520prospective%2520cohort%2520study%26jtitle%3DJ.%2520Cardiothorac%2520Surg.%26date%3D2014%26volume%3D9%26spage%3D133%26doi%3D10.1186%2Fs13019-014-0133-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X. Q.</span></span> <span> </span><span class="NLM_article-title">Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury</span>. <i>Clin. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>413</i></span> (<span class="NLM_issue">21–22</span>),  <span class="NLM_fpage">1737</span>– <span class="NLM_lpage">1741</span>, <span class="refDoi"> DOI: 10.1016/j.cca.2012.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.cca.2012.07.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2012&pages=1737-1741&issue=21%E2%80%9322&author=K.+Y.+Wangauthor=G.+F.+Yuauthor=Z.+Y.+Zhangauthor=Q.+Huangauthor=X.+Q.+Dong&title=Plasma+high-mobility+group+box+1+levels+and+prediction+of+outcome+in+patients+with+traumatic+brain+injury&doi=10.1016%2Fj.cca.2012.07.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2012.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2012.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%2BY.%26aulast%3DYu%26aufirst%3DG.%2BF.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DDong%26aufirst%3DX.%2BQ.%26atitle%3DPlasma%2520high-mobility%2520group%2520box%25201%2520levels%2520and%2520prediction%2520of%2520outcome%2520in%2520patients%2520with%2520traumatic%2520brain%2520injury%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2012%26volume%3D413%26issue%3D21%25E2%2580%259322%26spage%3D1737%26epage%3D1741%26doi%3D10.1016%2Fj.cca.2012.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Au, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adelson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochanek, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. S.</span></span> <span> </span><span class="NLM_article-title">Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome c predict outcome after pediatric traumatic brain injury</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2021</span>, <span class="refDoi"> DOI: 10.1089/neu.2011.2171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1089%2Fneu.2011.2171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22540160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC38ros1KnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=2013-2021&issue=11&author=A.+K.+Auauthor=R.+K.+Anejaauthor=M.+J.+Bellauthor=H.+Bayirauthor=K.+Feldmanauthor=P.+D.+Adelsonauthor=E.+L.+Finkauthor=P.+M.+Kochanekauthor=R.+S.+Clark&title=Cerebrospinal+fluid+levels+of+high-mobility+group+box+1+and+cytochrome+c+predict+outcome+after+pediatric+traumatic+brain+injury&doi=10.1089%2Fneu.2011.2171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury</span></div><div class="casAuthors">Au Alicia K; Aneja Rajesh K; Bell Michael J; Bayir Hulya; Feldman Keri; Adelson P David; Fink Ericka L; Kochanek Patrick M; Clark Robert S B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2013-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High-mobility group box 1 (HMGB1) is a ubiquitous nuclear protein that is passively released from damaged and necrotic cells, and actively released from immune cells.  In contrast, cytochrome c is released from mitochondria in apoptotic cells, and is considered a reliable biomarker of apoptosis.  Thus, HMGB1 and cytochrome c may in part reflect the degree of necrosis and apoptosis present after traumatic brain injury (TBI), where both are felt to contribute to cell death and neurological morbidity.  Ventricular cerebrospinal fluid (CSF) was obtained from children admitted to the intensive care unit (ICU) after TBI (n=37).  CSF levels of HMGB1 and cytochrome c were determined at four time intervals (0-24 h, 25-48 h, 49-72 h, and>72 h after injury) using enzyme-linked immunosorbent assay (ELISA).  Lumbar CSF from children without TBI served as controls (n=12).  CSF HMGB1 levels were: control=1.78±0.29, 0-24 h=5.73±1.45, 25-48 h=5.16±1.73, 49-72 h=4.13±0.75,>72 h=3.80±0.90 ng/mL (mean±SEM).  Peak HMGB1 levels were inversely and independently associated with favorable Glasgow Outcome Scale (GOS) scores at 6 mo (0.49 [0.24-0.97]; OR [5-95% CI]).  CSF cytochrome c levels were: control=0.37±0.10, 0-24 h=0.69±0.15, 25-48 h=0.82±0.48, 49-72 h=1.52±1.08,>72 h=1.38±1.02 ng/mL (mean±SEM).  Peak cytochrome c levels were independently associated with abusive head trauma (AHT; 24.29 [1.77-334.03]) and inversely and independently associated with favorable GOS scores (0.42 [0.18-0.99]).  In conclusion, increased CSF levels of HMGB1 and cytochrome c were associated with poor outcome after TBI in infants and children.  These data are also consistent with the designation of HMGB1 as a "danger signal." Distinctly increased CSF cytochrome c levels in infants and children with AHT and poor outcome suggests that apoptosis may play an important role in this unique patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVK9662BJ2E7rIbt-tGZmxfW6udTcc2eb7NKFESlr2Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38ros1KnsA%253D%253D&md5=ac3f4f7ddeeaef02f059952fb14ea97d</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1089%2Fneu.2011.2171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2011.2171%26sid%3Dliteratum%253Aachs%26aulast%3DAu%26aufirst%3DA.%2BK.%26aulast%3DAneja%26aufirst%3DR.%2BK.%26aulast%3DBell%26aufirst%3DM.%2BJ.%26aulast%3DBayir%26aufirst%3DH.%26aulast%3DFeldman%26aufirst%3DK.%26aulast%3DAdelson%26aufirst%3DP.%2BD.%26aulast%3DFink%26aufirst%3DE.%2BL.%26aulast%3DKochanek%26aufirst%3DP.%2BM.%26aulast%3DClark%26aufirst%3DR.%2BS.%26atitle%3DCerebrospinal%2520fluid%2520levels%2520of%2520high-mobility%2520group%2520box%25201%2520and%2520cytochrome%2520c%2520predict%2520outcome%2520after%2520pediatric%2520traumatic%2520brain%2520injury%26jtitle%3DJ.%2520Neurotrauma%26date%3D2012%26volume%3D29%26issue%3D11%26spage%3D2013%26epage%3D2021%26doi%3D10.1089%2Fneu.2011.2171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span> <span> </span><span class="NLM_article-title">Heparin inhibits the inflammatory response induced by lps and hmgb1 by blocking the binding of hmgb1 to the surface of macrophages</span>. <i>Cytokine</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2014.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.cyto.2014.12.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2015&pages=36-42&issue=1&author=L.+Liauthor=Y.+Lingauthor=M.+Huangauthor=T.+Yinauthor=S.+M.+Gouauthor=N.+Y.+Zhanauthor=J.+X.+Xiongauthor=H.+S.+Wuauthor=Z.+Y.+Yangauthor=C.+Y.+Wang&title=Heparin+inhibits+the+inflammatory+response+induced+by+lps+and+hmgb1+by+blocking+the+binding+of+hmgb1+to+the+surface+of+macrophages&doi=10.1016%2Fj.cyto.2014.12.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2014.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2014.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DT.%26aulast%3DGou%26aufirst%3DS.%2BM.%26aulast%3DZhan%26aufirst%3DN.%2BY.%26aulast%3DXiong%26aufirst%3DJ.%2BX.%26aulast%3DWu%26aufirst%3DH.%2BS.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DWang%26aufirst%3DC.%2BY.%26atitle%3DHeparin%2520inhibits%2520the%2520inflammatory%2520response%2520induced%2520by%2520lps%2520and%2520hmgb1%2520by%2520blocking%2520the%2520binding%2520of%2520hmgb1%2520to%2520the%2520surface%2520of%2520macrophages%26jtitle%3DCytokine%26date%3D2015%26volume%3D72%26issue%3D1%26spage%3D36%26epage%3D42%26doi%3D10.1016%2Fj.cyto.2014.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Opal, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laterre, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francois, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRosa, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angus, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mira, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittebole, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugernier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrotin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidswell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jauregui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peckelsen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordasco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalil, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nuffelen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossignol, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogate, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. L.</span></span> <span> </span><span class="NLM_article-title">Effect of eritoran, an antagonist of md2-tlr4, on mortality in patients with severe sepsis: The access randomized trial</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>309</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1154</span>– <span class="NLM_lpage">1162</span>, <span class="refDoi"> DOI: 10.1001/jama.2013.2194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1001%2Fjama.2013.2194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23512062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltlyqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2013&pages=1154-1162&issue=11&author=S.+M.+Opalauthor=P.+F.+Laterreauthor=B.+Francoisauthor=S.+P.+LaRosaauthor=D.+C.+Angusauthor=J.+P.+Miraauthor=X.+Witteboleauthor=T.+Dugernierauthor=D.+Perrotinauthor=M.+Tidswellauthor=L.+Jaureguiauthor=K.+Krellauthor=J.+Pachlauthor=T.+Takahashiauthor=C.+Peckelsenauthor=E.+Cordascoauthor=C.+S.+Changauthor=S.+Oeyenauthor=N.+Aikawaauthor=T.+Maruyamaauthor=R.+Scheinauthor=A.+C.+Kalilauthor=M.+Van+Nuffelenauthor=M.+Lynnauthor=D.+P.+Rossignolauthor=J.+Gogateauthor=M.+B.+Robertsauthor=J.+L.+Wheelerauthor=J.+L.+Vincent&title=Effect+of+eritoran%2C+an+antagonist+of+md2-tlr4%2C+on+mortality+in+patients+with+severe+sepsis%3A+The+access+randomized+trial&doi=10.1001%2Fjama.2013.2194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis. The ACCESS randomized trial</span></div><div class="casAuthors">Opal, Steven M.; Laterre, Pierre-Francois; Francois, Bruno; LaRosa, Steven P.; Angus, Derek C.; Mira, Jean-Paul; Wittebole, Xavier; Dugernier, Thierry; Perrotin, Dominique; Tidswell, Mark; Jauregui, Luis; Krell, Kenneth; Pachl, Jan; Takahashi, Takeshi; Peckelsen, Claus; Cordasco, Edward; Chang, Chia-Sheng; Oeyen, Sandra; Aikawa, Naoki; Maruyama, Tatsuya; Schein, Roland; Kalil, Andre C.; Van Nuffelen, Marc; Lynn, Melvyn; Rossignol, Daniel P.; Gogate, Jogadish; Roberts, Mary B.; Wheeler, Janice L.; Vincent, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1154-1162</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Importance: Eritoran is a synthetic lipid A antagonist that blocks Iipopolysaccharide (LPS) from binding at the cell surface MD2-TLR4 receptor.  LPS is a major component of the outer membrane of gram-neg. bacteria and is a potent activator of the acute inflammatory response.  Objective: To det. if eritoran, a TLR4 antagonist, would significantly reduce sepsis-induced mortality.  Design, Setting, and Participants: We performed a randomized, double-blind, placebo-controlled, multinational phase 3 trial in 197 intensive care units.  Patients were enrolled from June 2006 to Sept. 2010 and final follow-up was completed in Sept. 2011.  Interventions: Patients with severe sepsis (n = 1961) were randomized and treated within 12 h of onset of first organ dysfunction in a 2:1 ratio with a 6-day course of either eritoran tetrasodium (105 mg total) or placebo, with n = 1304 and n = 657 patients, resp.  Main Outcome Measures: The primary end point was 28-day all-cause mortality.  The secondary end points were all-cause mortality at 3, 6, and 12 mo after beginning treatment.  Results: Baseline characteristics of the 2 study groups were similar.  In the modified intent-to-treat anal. (randomized patients who received at least 1 dose) there was no significant difference in the primary end point of 28-day all-cause mortality with 28.1% (366/1304) in the eritoran group vs 26.9% (177/657) in the placebo group (P = .59; hazard ratio, 1.05; 95% CI, 0.88-1.26; difference in mortality rate, -1.1; 95% CI, -5.3 to 3.1) or in the key secondary end point of 1-yr all-cause mortality with 44.1% (290/657) in the eritoran group vs 43.3% (565/1304) in the placebo group, Kaplan-Meier anal. of time to death by 1 yr, P = .79 (hazard ratio, 0.98; 0.85-1.13).  No significant differences were obsd. in any of the prespecified subgroups.  Adverse events, including secondary infection rates, did not differ between study groups.  Conclusions and Relevance: Among patients with severe sepsis, the use of eritoran, compared with placebo, did not result in reduced 28-day mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrbHqr8OtY8bVg90H21EOLACvtfcHk0liz69W2WAebFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltlyqt7o%253D&md5=adf1d02bc28953d8e6b30e9d627fcfa9</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1001%2Fjama.2013.2194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2013.2194%26sid%3Dliteratum%253Aachs%26aulast%3DOpal%26aufirst%3DS.%2BM.%26aulast%3DLaterre%26aufirst%3DP.%2BF.%26aulast%3DFrancois%26aufirst%3DB.%26aulast%3DLaRosa%26aufirst%3DS.%2BP.%26aulast%3DAngus%26aufirst%3DD.%2BC.%26aulast%3DMira%26aufirst%3DJ.%2BP.%26aulast%3DWittebole%26aufirst%3DX.%26aulast%3DDugernier%26aufirst%3DT.%26aulast%3DPerrotin%26aufirst%3DD.%26aulast%3DTidswell%26aufirst%3DM.%26aulast%3DJauregui%26aufirst%3DL.%26aulast%3DKrell%26aufirst%3DK.%26aulast%3DPachl%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DPeckelsen%26aufirst%3DC.%26aulast%3DCordasco%26aufirst%3DE.%26aulast%3DChang%26aufirst%3DC.%2BS.%26aulast%3DOeyen%26aufirst%3DS.%26aulast%3DAikawa%26aufirst%3DN.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DSchein%26aufirst%3DR.%26aulast%3DKalil%26aufirst%3DA.%2BC.%26aulast%3DVan%2BNuffelen%26aufirst%3DM.%26aulast%3DLynn%26aufirst%3DM.%26aulast%3DRossignol%26aufirst%3DD.%2BP.%26aulast%3DGogate%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DM.%2BB.%26aulast%3DWheeler%26aufirst%3DJ.%2BL.%26aulast%3DVincent%26aufirst%3DJ.%2BL.%26atitle%3DEffect%2520of%2520eritoran%252C%2520an%2520antagonist%2520of%2520md2-tlr4%252C%2520on%2520mortality%2520in%2520patients%2520with%2520severe%2520sepsis%253A%2520The%2520access%2520randomized%2520trial%26jtitle%3DJAMA%26date%3D2013%26volume%3D309%26issue%3D11%26spage%3D1154%26epage%3D1162%26doi%3D10.1001%2Fjama.2013.2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perrin-Cocon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aublin-Gex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sestito, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirey, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotteau, V.</span></span> <span> </span><span class="NLM_article-title">Tlr4 antagonist fp7 inhibits lps-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">40791</span>, <span class="refDoi"> DOI: 10.1038/srep40791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fsrep40791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28106157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFalsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=40791&author=L.+Perrin-Coconauthor=A.+Aublin-Gexauthor=S.+E.+Sestitoauthor=K.+A.+Shireyauthor=M.+C.+Patelauthor=P.+Andreauthor=J.+C.+Blancoauthor=S.+N.+Vogelauthor=F.+Periauthor=V.+Lotteau&title=Tlr4+antagonist+fp7+inhibits+lps-induced+cytokine+production+and+glycolytic+reprogramming+in+dendritic+cells%2C+and+protects+mice+from+lethal+influenza+infection&doi=10.1038%2Fsrep40791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection</span></div><div class="casAuthors">Perrin-Cocon, Laure; Aublin-Gex, Anne; Sestito, Stefania E.; Shirey, Kari Ann; Patel, Mira C.; Andre, Patrice; Blanco, Jorge C.; Vogel, Stefanie N.; Peri, Francesco; Lotteau, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">40791</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dysregulated Toll-like receptor (TLR)-4 activation is involved in acute systemic sepsis, chronic inflammatory diseases, such as atherosclerosis and diabetes, and in viral infections, such as influenza infection.  Thus, therapeutic control of the TLR4 signalling pathway is of major interest.  Here we tested the activity of the small-mol. synthetic TLR4 antagonist, FP7, in vitro on human monocytes and monocyte-derived dendritic cells (DCs) and in vivo during influenza virus infection of mice.  Our results indicate that FP7 antagonized the secretion of proinflammatory cytokines (IL-6, IL-8, and MIP-1β) by monocytes and DCs (IC50 < 1 μM) and prevented DC maturation upon TLR4 activation by ultrapure lipopolysaccharide (LPS).  FP7 selectively blocked TLR4 stimulation, but not TLR1/2, TLR2/6, or TLR3 activation.  TLR4 stimulation of human DCs resulted in increased glycolytic activity that was also antagonized by FP7.  FP7 protected mice from influenza virus-induced lethality and reduced both proinflammatory cytokine gene expression in the lungs and acute lung injury (ALI).  Therefore, FP7 can antagonize TLR4 activation in vitro and protect mice from severe influenza infection, most likely by reducing TLR4-dependent cytokine storm mediated by damage-assocd. mol. patterns (DAMPs) like HMGB1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8FTFfz6-_h7Vg90H21EOLACvtfcHk0lhNQgjdFZVHFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFalsbg%253D&md5=827f7dc6b699b416341bb3a627b817a7</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1038%2Fsrep40791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep40791%26sid%3Dliteratum%253Aachs%26aulast%3DPerrin-Cocon%26aufirst%3DL.%26aulast%3DAublin-Gex%26aufirst%3DA.%26aulast%3DSestito%26aufirst%3DS.%2BE.%26aulast%3DShirey%26aufirst%3DK.%2BA.%26aulast%3DPatel%26aufirst%3DM.%2BC.%26aulast%3DAndre%26aufirst%3DP.%26aulast%3DBlanco%26aufirst%3DJ.%2BC.%26aulast%3DVogel%26aufirst%3DS.%2BN.%26aulast%3DPeri%26aufirst%3DF.%26aulast%3DLotteau%26aufirst%3DV.%26atitle%3DTlr4%2520antagonist%2520fp7%2520inhibits%2520lps-induced%2520cytokine%2520production%2520and%2520glycolytic%2520reprogramming%2520in%2520dendritic%2520cells%252C%2520and%2520protects%2520mice%2520from%2520lethal%2520influenza%2520infection%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D40791%26doi%3D10.1038%2Fsrep40791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, L. A.</span></span> <span> </span><span class="NLM_article-title">Targeting toll-like receptors: Emerging therapeutics?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1038/nrd3203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnrd3203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=20380038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksF2itb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=293-307&issue=4&author=E.+J.+Hennessyauthor=A.+E.+Parkerauthor=L.+A.+O%E2%80%99Neill&title=Targeting+toll-like+receptors%3A+Emerging+therapeutics%3F&doi=10.1038%2Fnrd3203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Toll-like receptors: emerging therapeutics?</span></div><div class="casAuthors">Hennessy, Elizabeth J.; Parker, Andrew E.; O'Neill, Luke A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-307</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a growing interest in the targeting of Toll-like receptors (TLRs) for the prevention and treatment of cancer, rheumatoid arthritis, inflammatory bowel disease and systemic lupus erythematosus (SLE).  Several new compds. are now undergoing preclin. and clin. evaluation, with a particular focus on TLR7 and TLR9 activators as adjuvants in infection and cancer, and inhibitors of TLR2, TLR4, TLR7 and TLR9 for the treatment of sepsis and inflammatory diseases.  Here, we focus on TLRs that hold the most promise for drug discovery research, highlighting agents that are in the discovery phase and in clin. trials, and on the emerging new aspects of TLR-mediated signaling - such as control by ubiquitination and regulation by microRNAs - that might offer further possibilities of therapeutic manipulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHrGGa9XDou7Vg90H21EOLACvtfcHk0lhjHR2pmdhPjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksF2itb4%253D&md5=ed2da43668217c9d470f5a53dd214708</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fnrd3203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3203%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DParker%26aufirst%3DA.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520toll-like%2520receptors%253A%2520Emerging%2520therapeutics%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26issue%3D4%26spage%3D293%26epage%3D307%26doi%3D10.1038%2Fnrd3203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anwar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Tlr4/md2 specific peptides stalled in vivo lps-induced immune exacerbation</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2017.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.biomaterials.2017.02.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28254693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Sjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=49-60&author=S.+Parkauthor=H.+J.+Shinauthor=M.+Shahauthor=H.+Y.+Choauthor=M.+A.+Anwarauthor=A.+Achekauthor=H.+K.+Kwonauthor=B.+Leeauthor=T.+H.+Yooauthor=S.+Choi&title=Tlr4%2Fmd2+specific+peptides+stalled+in+vivo+lps-induced+immune+exacerbation&doi=10.1016%2Fj.biomaterials.2017.02.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation</span></div><div class="casAuthors">Park, Seolhee; Shin, Hyeon-Jun; Shah, Masaud; Cho, Hey-Young; Anwar, Muhammad Ayaz; Achek, Asma; Kwon, Hyuk-Kwon; Lee, Byugsung; Yoo, Tae Hyeon; Choi, Sangdun</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Neg. regulation of Toll-like receptor-4 (TLR4) is anticipated to control the pathogen-induced exaggerated immune response.  However, effective TLR4 antagonists with scarce off-target effects are yet to be developed.  To fill this void, we sought to design small peptide-inhibitors of the TLR4/MD2-LPS interaction.  Here we report novel TLR4-antagonistic peptides (TAP), identified through phage display, endowed with the LPS-induced proinflammation inhibition, and confirmed in mice.  TAPs-attributed TLR4-antagonism were initially evaluated through NF-κB inhibition in HEK-blue hTLR4 and RAW264.7 cells, and further reinforced by the downregulation of MAPKs (mitogen-activated protein kinases), NF-κB, interleukin 6, and suppression of the oxidative-stress products and iNOS in macrophages and human peripheral blood mononuclear cells (hPBMCs).  Among these, TAP2 specifically halted the TLR4, but not other TLRs signaling, which was further confirmed by the biophys. kinetic assay.  Finally, TAP2 diminished LPS-elicited systemic cytokine response in vivo, suggesting that TAPs, specifically TAP2, have the potential to treat TLR4-mediated immune ailments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL_NlzP0ZTSbVg90H21EOLACvtfcHk0lhjHR2pmdhPjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Sjsr0%253D&md5=8a141d68f7dd155954e6007addc0a6f9</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2017.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2017.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%26aulast%3DShin%26aufirst%3DH.%2BJ.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DH.%2BY.%26aulast%3DAnwar%26aufirst%3DM.%2BA.%26aulast%3DAchek%26aufirst%3DA.%26aulast%3DKwon%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DYoo%26aufirst%3DT.%2BH.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DTlr4%252Fmd2%2520specific%2520peptides%2520stalled%2520in%2520vivo%2520lps-induced%2520immune%2520exacerbation%26jtitle%3DBiomaterials%26date%3D2017%26volume%3D126%26spage%3D49%26epage%3D60%26doi%3D10.1016%2Fj.biomaterials.2017.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youn, H. S.</span></span> <span> </span><span class="NLM_article-title">Suppression of toll-like receptor 4 dimerization by 1-[5-methoxy-2-(2-nitrovinyl)phenyl]pyrrolidine</span>. <i>Arch. Pharm. (Weinheim, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>349</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">785</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1002/ardp.201600159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Fardp.201600159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27515124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlagtbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2016&pages=785-790&issue=10&author=S.+I.+Ahnauthor=J.+S.+Kimauthor=G.+J.+Guauthor=H.+M.+Shinauthor=A.+Y.+Kimauthor=H.+J.+Shimauthor=Y.+J.+Kimauthor=K.+O.+Kohauthor=J.+Y.+Mangauthor=D.+Y.+Kimauthor=H.+S.+Youn&title=Suppression+of+toll-like+receptor+4+dimerization+by+1-%5B5-methoxy-2-%282-nitrovinyl%29phenyl%5Dpyrrolidine&doi=10.1002%2Fardp.201600159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of toll-like receptor 4 dimerization by 1-[5-methoxy-2-(2-nitrovinyl)phenyl]pyrrolidine</span></div><div class="casAuthors">Ahn, Sang-Il; Kim, Ji-Soo; Gu, Gyo-Jeong; Shin, Hyeon-Myeong; Kim, Ah-Yeon; Shim, Hyun-Jin; Kim, Yeon Joo; Koh, Kwang Oh; Mang, Joo Yang; Kim, Dae Young; Youn, Hyung-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">785-790</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Toll-like receptor 4 (TLR4) recognizes lipopolysaccharide (LPS) and triggers the activation of myeloid differentiation factor 88 (MyD88) and the Toll/interleukin-1 receptor domain-contg. adapter, inducing interferon-β (TRIF)-dependent major downstream signaling pathways.  To evaluate the therapeutic potential of 1-[5-methoxy-2-(2-nitrovinyl)phenyl]pyrrolidine (MNP), previously synthesized in our lab., its effect on signal transduction via the TLR signaling pathways was examd.  Here, we investigated whether MNP modulates the TLR4 signaling pathways and which anti-inflammatory target in TLR4 signaling is regulated by MNP.  MNP inhibited the activation of nuclear factor-κB (NF-κB) induced by LPS (TLR4 agonist), and it also inhibited the expression of cyclooxygenase-2 and inducible nitric oxide synthase.  MNP inhibited LPS-induced NF-κB activation by targeting TLR4 dimerization in addn. to IKKβ.  These results suggest that MNP can modulate the TLR4 signaling pathway at the receptor level to decrease inflammatory gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohrUKFSNZjpbVg90H21EOLACvtfcHk0lhjHR2pmdhPjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlagtbjF&md5=6a5444b461ed0cb3aac30aa415efabcc</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1002%2Fardp.201600159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201600159%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DS.%2BI.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DGu%26aufirst%3DG.%2BJ.%26aulast%3DShin%26aufirst%3DH.%2BM.%26aulast%3DKim%26aufirst%3DA.%2BY.%26aulast%3DShim%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DKoh%26aufirst%3DK.%2BO.%26aulast%3DMang%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DD.%2BY.%26aulast%3DYoun%26aufirst%3DH.%2BS.%26atitle%3DSuppression%2520of%2520toll-like%2520receptor%25204%2520dimerization%2520by%25201-%255B5-methoxy-2-%25282-nitrovinyl%2529phenyl%255Dpyrrolidine%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2016%26volume%3D349%26issue%3D10%26spage%3D785%26epage%3D790%26doi%3D10.1002%2Fardp.201600159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aletaha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roozbehkia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigdeli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asgary, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmoudi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirshafiey, A.</span></span> <span> </span><span class="NLM_article-title">M2000 (beta-d-mannuronic acid) as a novel antagonist for blocking the tlr2 and tlr4 downstream signalling pathway</span>. <i>Scand J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1111/sji.12519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fsji.12519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27943385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1SktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2017&pages=122-129&issue=2&author=S.+Aletahaauthor=L.+Haddadauthor=M.+Roozbehkiaauthor=R.+Bigdeliauthor=V.+Asgaryauthor=M.+Mahmoudiauthor=A.+Mirshafiey&title=M2000+%28beta-d-mannuronic+acid%29+as+a+novel+antagonist+for+blocking+the+tlr2+and+tlr4+downstream+signalling+pathway&doi=10.1111%2Fsji.12519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway</span></div><div class="casAuthors">Aletaha, S.; Haddad, L.; Roozbehkia, M.; Bigdeli, R.; Asgary, V.; Mahmoudi, M.; Mirshafiey, A.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">122-129</span>CODEN:
                <span class="NLM_cas:coden">SJIMAX</span>;
        ISSN:<span class="NLM_cas:issn">1365-3083</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">To date, selective blockade of Toll-like receptor (TLR) signalling has been developed as a new approach for treatment for many inflammatory diseases.  As β-D-mannuronic acid (M2000) has been known as an anti-inflammatory mol. in several exptl. models, we investigated the antagonistic effects of M2000 on TLR2 and TLR4 downstream signalling transduction pathway in human embryonic kidney (HEK) 293 cell lines overexpressing TLR2/CD14 and the TLR4/MD2/CD14 complex, resp.  M2000 effectively inhibited mRNA expression of MyD88 and p65, major subunit of nuclear factor-κB, in HEK293 cells stimulated by lipoteichoic acid (LTA, a TLR2 agonist) and lipopolysaccharide (LPS, a TLR4 agonist) with no evidence of cytotoxicity.  In addn., M2000 also suppressed LTA and LPS-induced prodn. of TNF-α and IL-6 inflammatory cytokines in these cells.  Furthermore, the results revealed that M2000 had no significant effect on Tollip mRNA expression as a neg. regulator of TLR signalling in aforesaid cells.  Overall, these data point to M2000 inhibitory effect on Toll-like receptor (TLR) 2, 4 signalling in HEK293 cells.  This information might provide new insights into the possible roles of this small drug in order to introduce it as a TLR signalling pathway inhibitor.  However, more studies are needed to confirm β-D-mannuronic acid antagonistic effects including the effects of M2000 on peritoneal isolated macrophages and also on blood cells in patients with inflammatory diseases such as ankylosing spondylitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnOdZm4x-q7Vg90H21EOLACvtfcHk0ljlgNNrYs5aag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1SktLk%253D&md5=5955ebeb7da9f04072f8146d6d836559</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1111%2Fsji.12519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fsji.12519%26sid%3Dliteratum%253Aachs%26aulast%3DAletaha%26aufirst%3DS.%26aulast%3DHaddad%26aufirst%3DL.%26aulast%3DRoozbehkia%26aufirst%3DM.%26aulast%3DBigdeli%26aufirst%3DR.%26aulast%3DAsgary%26aufirst%3DV.%26aulast%3DMahmoudi%26aufirst%3DM.%26aulast%3DMirshafiey%26aufirst%3DA.%26atitle%3DM2000%2520%2528beta-d-mannuronic%2520acid%2529%2520as%2520a%2520novel%2520antagonist%2520for%2520blocking%2520the%2520tlr2%2520and%2520tlr4%2520downstream%2520signalling%2520pathway%26jtitle%3DScand%2520J.%2520Immunol.%26date%3D2017%26volume%3D85%26issue%3D2%26spage%3D122%26epage%3D129%26doi%3D10.1111%2Fsji.12519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Regidor, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarioh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Santamaria, S.</span></span> <span> </span><span class="NLM_article-title">Virtual screening approaches towards the discovery of toll-like receptor modulators</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1508</span>, <span class="refDoi"> DOI: 10.3390/ijms17091508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3390%2Fijms17091508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1508&issue=9&author=L.+Perez-Regidorauthor=M.+Zariohauthor=L.+Ortegaauthor=S.+Martin-Santamaria&title=Virtual+screening+approaches+towards+the+discovery+of+toll-like+receptor+modulators&doi=10.3390%2Fijms17091508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.3390%2Fijms17091508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17091508%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Regidor%26aufirst%3DL.%26aulast%3DZarioh%26aufirst%3DM.%26aulast%3DOrtega%26aufirst%3DL.%26aulast%3DMartin-Santamaria%26aufirst%3DS.%26atitle%3DVirtual%2520screening%2520approaches%2520towards%2520the%2520discovery%2520of%2520toll-like%2520receptor%2520modulators%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26issue%3D9%26spage%3D1508%26doi%3D10.3390%2Fijms17091508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Billod, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacetera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Caldentey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Santamaria, S.</span></span> <span> </span><span class="NLM_article-title">Computational approaches to toll-like receptor 4 modulation</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">994</span>, <span class="refDoi"> DOI: 10.3390/molecules21080994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3390%2Fmolecules21080994" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=994&issue=8&author=J.+M.+Billodauthor=A.+Laceteraauthor=J.+Guzman-Caldenteyauthor=S.+Martin-Santamaria&title=Computational+approaches+to+toll-like+receptor+4+modulation&doi=10.3390%2Fmolecules21080994"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21080994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21080994%26sid%3Dliteratum%253Aachs%26aulast%3DBillod%26aufirst%3DJ.%2BM.%26aulast%3DLacetera%26aufirst%3DA.%26aulast%3DGuzman-Caldentey%26aufirst%3DJ.%26aulast%3DMartin-Santamaria%26aufirst%3DS.%26atitle%3DComputational%2520approaches%2520to%2520toll-like%2520receptor%25204%2520modulation%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26issue%3D8%26spage%3D994%26doi%3D10.3390%2Fmolecules21080994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galasko, D.</span></span> <span> </span><span class="NLM_article-title">Pf-04494700, an oral inhibitor of receptor for advanced glycation end products (rage), in alzheimer disease</span>. <i>Alzheimer Dis. Assoc. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1097/WAD.0b013e318204b550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2FWAD.0b013e318204b550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21192237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2hurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=206-212&issue=3&author=M.+N.+Sabbaghauthor=A.+Agroauthor=J.+Bellauthor=P.+S.+Aisenauthor=E.+Schweizerauthor=D.+Galasko&title=Pf-04494700%2C+an+oral+inhibitor+of+receptor+for+advanced+glycation+end+products+%28rage%29%2C+in+alzheimer+disease&doi=10.1097%2FWAD.0b013e318204b550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease</span></div><div class="casAuthors">Sabbagh, Marwan N.; Agro, Albert; Bell, Joanne; Aisen, Paul S.; Schweizer, Edward; Galasko, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-212</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To evaluate the safety and tolerability of PF-04494700, an oral inhibitor of receptor for advanced glycation end products, in patients with mild-to-moderate dementia of the Alzheimer type.  Patients aged 50 years and older who met the National Institute of Neurol. and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Assocn. criteria for Alzheimer disease with an Mini-Mental State Examn. (MMSE) score between 12 and 26 (inclusive) were randomized to 10 wk of double-blind treatment with either a 10 mg "low dose" of PF-04494700 (after a 6-d loading dose of 30 mg/d), a 20 mg "high dose" of PF-04494700 (after a loading dose of 60 mg/d), or placebo.  Safety measures included adverse events, lab. tests, vital signs, and 12-lead ECG.  27 Patients received PF-04494700 30/co mg (female: 63%; mean age: 74.6 y; mean MMSE: 21.1), 28 patients received PF-04494700 60/20 mg (female: 57%; mean age: 76.6 y; mean MMSE: 21.6), and 12 patients received placebo (female: 67%; mean age: 74.1 y; mean MMSE: 19.2).  A higher proportion of patients completed 10 wk of double-blind treatment on both the "low-dose" regimen of PF-04494700 (88.9%) and the "high-dose" regimen (85.7%) than patients who were on placebo (66.7%).  Discontinuation owing to adverse events and incidence of severe adverse events, resp., were lower in the "low-dose" regimen (7.4%, 11.1%) and the "high-dose" regimen (3.6%, 10.7%) compared with placebo (25.0%, 16.7%).  There were no clin. meaningful differences in vital signs, lab. test results, or mean ECG parameters in patients treated with PF-04494700.  PF-04494700 had no consistent effect on plasma levels of β-amyloid, inflammatory biomarkers, or secondary cognitive outcomes.  Ten weeks of treatment with PF-04494700 was safe and well tolerated in patients with mild-to-moderate Alzheimer disease, indicating the feasibility of a larger long-term efficacy trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYOId4vbstBLVg90H21EOLACvtfcHk0liP-DNpHFvWXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2hurfL&md5=99a792014511f247fe283378d8503ceb</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1097%2FWAD.0b013e318204b550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWAD.0b013e318204b550%26sid%3Dliteratum%253Aachs%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26aulast%3DAgro%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DJ.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DGalasko%26aufirst%3DD.%26atitle%3DPf-04494700%252C%2520an%2520oral%2520inhibitor%2520of%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520%2528rage%2529%252C%2520in%2520alzheimer%2520disease%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2011%26volume%3D25%26issue%3D3%26spage%3D206%26epage%3D212%26doi%3D10.1097%2FWAD.0b013e318204b550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seripa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solfrizzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbimbo, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozupone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagliardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lofano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creanza, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisceglia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellomo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logroscino, G.</span></span> <span> </span><span class="NLM_article-title">Emerging drugs to reduce abnormal beta-amyloid protein in Alzheimer’s disease patients</span>. <i>Expert Opin. Emerging Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">391</span>, <span class="refDoi"> DOI: 10.1080/14728214.2016.1241232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1080%2F14728214.2016.1241232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27678025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GqsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=377-391&issue=4&author=F.+Panzaauthor=D.+Seripaauthor=V.+Solfrizziauthor=B.+P.+Imbimboauthor=M.+Lozuponeauthor=A.+Leoauthor=R.+Sardoneauthor=G.+Gagliardiauthor=L.+Lofanoauthor=B.+C.+Creanzaauthor=P.+Biscegliaauthor=A.+Danieleauthor=A.+Bellomoauthor=A.+Grecoauthor=G.+Logroscino&title=Emerging+drugs+to+reduce+abnormal+beta-amyloid+protein+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1080%2F14728214.2016.1241232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients</span></div><div class="casAuthors">Panza, Francesco; Seripa, Davide; Solfrizzi, Vincenzo; Imbimbo, Bruno P.; Lozupone, Madia; Leo, Antonio; Sardone, Rodolfo; Gagliardi, Gaetano; Lofano, Lucia; Creanza, Bianca C.; Bisceglia, Paola; Daniele, Antonio; Bellomo, Antonello; Greco, Antonio; Logroscino, Giancarlo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-391</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Currently available drugs against Alzheimer's disease (AD) target cholinergic and glutamatergic neurotransmissions without affecting the underlying disease process.  Putative disease-modifying drugs are in development and target β-amyloid (Aβ) peptide and tau protein, the principal neurophatol. hallmarks of the disease.  Phase III clin. studies of emerging anti-Aβ drugs for the treatment of AD were searched in US and EU clin. trial registries and in the medical literature until May 2016.  Drugs in Phase III clin. development for AD include one inhibitor of the β-secretase cleaving enzyme (BACE) (verubecestat), three anti-Aβ monoclonal antibodies (solanezumab, gantenerumab, and aducanumab), an inhibitor of receptor for advanced glycation end products (RAGE) (azeliragon) and the combination of cromolyn sodium and ibuprofen (ALZT-OP1).  These drugs are mainly being tested in subjects during early phases of AD or in subjects at preclin. stage of familial AD or even in asymptomatic subjects at high risk of developing AD.  The hope is to intervene in the disease process when it is not too late.  However, previous clin. failures with anti-Aβ drugs and the lack of fully understanding of the pathophysiol. role of Aβ in the development of AD, put the new drugs at substantial risk of failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosj9ZA53CLV7Vg90H21EOLACvtfcHk0liP-DNpHFvWXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GqsLzE&md5=21f712334120698ea46f008b4f9e62c0</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1080%2F14728214.2016.1241232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728214.2016.1241232%26sid%3Dliteratum%253Aachs%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DSeripa%26aufirst%3DD.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DLozupone%26aufirst%3DM.%26aulast%3DLeo%26aufirst%3DA.%26aulast%3DSardone%26aufirst%3DR.%26aulast%3DGagliardi%26aufirst%3DG.%26aulast%3DLofano%26aufirst%3DL.%26aulast%3DCreanza%26aufirst%3DB.%2BC.%26aulast%3DBisceglia%26aufirst%3DP.%26aulast%3DDaniele%26aufirst%3DA.%26aulast%3DBellomo%26aufirst%3DA.%26aulast%3DGreco%26aufirst%3DA.%26aulast%3DLogroscino%26aufirst%3DG.%26atitle%3DEmerging%2520drugs%2520to%2520reduce%2520abnormal%2520beta-amyloid%2520protein%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D377%26epage%3D391%26doi%3D10.1080%2F14728214.2016.1241232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deane, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagare, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deane, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiyagarajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarcone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">A multimodal rage-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of alzheimer disease</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1377</span>– <span class="NLM_lpage">1392</span>, <span class="refDoi"> DOI: 10.1172/JCI58642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1172%2FJCI58642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=1377-1392&issue=4&author=R.+Deaneauthor=I.+Singhauthor=A.+P.+Sagareauthor=R.+D.+Bellauthor=N.+T.+Rossauthor=B.+LaRueauthor=R.+Loveauthor=S.+Perryauthor=N.+Paquetteauthor=R.+J.+Deaneauthor=M.+Thiyagarajanauthor=T.+Zarconeauthor=G.+Fritzauthor=A.+E.+Friedmanauthor=B.+L.+Millerauthor=B.+V.+Zlokovic&title=A+multimodal+rage-specific+inhibitor+reduces+amyloid+beta-mediated+brain+disorder+in+a+mouse+model+of+alzheimer+disease&doi=10.1172%2FJCI58642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1172%2FJCI58642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI58642%26sid%3Dliteratum%253Aachs%26aulast%3DDeane%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DI.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DBell%26aufirst%3DR.%2BD.%26aulast%3DRoss%26aufirst%3DN.%2BT.%26aulast%3DLaRue%26aufirst%3DB.%26aulast%3DLove%26aufirst%3DR.%26aulast%3DPerry%26aufirst%3DS.%26aulast%3DPaquette%26aufirst%3DN.%26aulast%3DDeane%26aufirst%3DR.%2BJ.%26aulast%3DThiyagarajan%26aufirst%3DM.%26aulast%3DZarcone%26aufirst%3DT.%26aulast%3DFritz%26aufirst%3DG.%26aulast%3DFriedman%26aufirst%3DA.%2BE.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DA%2520multimodal%2520rage-specific%2520inhibitor%2520reduces%2520amyloid%2520beta-mediated%2520brain%2520disorder%2520in%2520a%2520mouse%2520model%2520of%2520alzheimer%2520disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26issue%3D4%26spage%3D1377%26epage%3D1392%26doi%3D10.1172%2FJCI58642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokkola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aveberger, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmblad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span> <span> </span><span class="NLM_article-title">Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2052</span>– <span class="NLM_lpage">2058</span>, <span class="refDoi"> DOI: 10.1002/art.11161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Fart.11161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=12847700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFartbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=2052-2058&issue=7&author=R.+Kokkolaauthor=J.+Liauthor=E.+Sundbergauthor=A.+C.+Avebergerauthor=K.+Palmbladauthor=H.+Yangauthor=K.+J.+Traceyauthor=U.+Anderssonauthor=H.+E.+Harris&title=Successful+treatment+of+collagen-induced+arthritis+in+mice+and+rats+by+targeting+extracellular+high+mobility+group+box+chromosomal+protein+1+activity&doi=10.1002%2Fart.11161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity</span></div><div class="casAuthors">Kokkola, R.; Li, J.; Sundberg, E.; Aveberger, A.-C.; Palmblad, K.; Yang, H.; Tracey, K. J.; Andersson, U.; Harris, H. Erlandsson</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2052-2058</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective.  Extracellular high mobility group box chromosomal protein 1 (HMGB-1) is a recently identified, endogenous, potent tumor necrosis factor- and interleukin-1 (IL-1)-inducing protein detectable in inflamed synovia in both human and exptl. disease.  In the present study, the authors examd. clin. effects in collagen-induced arthritis (CIA) using therapeutic administration of neutralizing HMGB-1 antibodies or truncated HMGB-1-derived A-box protein, a specific, competitive antagonist of HMGB-1.  Methods.  CIA was induced in DBA/1j mice or dark agouti rats, and animals were examd. daily for signs of arthritis.  Treatment with polyclonal anti-HMGB-1 antibodies or the A-box protein was initiated at the onset of disease and was administered i.p. twice daily for 7 days.  Animals were killed 8 days after initiation of therapy, and immunohistochem. anal. of synovial tissue specimens was performed.  Results.  Systemic administration of anti-HMGB-1 antibodies or A-box protein significantly reduced the mean arthritis score, the disease-induced wt., loss, and the histol. severity of arthritis.  Beneficial effects were obsd. in both mice and rats.  Immunohistochem. anal. revealed pronounced synovial IL-1β expression and articular cartilage destruction in vehicle-treated mice.  Both these features were significantly less manifested in animals treated with anti-HMGB-1 antibodies or A-box protein.  Conclusion.  Counteracting extracellular HMGB-1 with either neutralizing antibodies or a specific HMGB-1 antagonist may offer a new method for the successful treatment of arthritis.  Inflammation and tissue destruction were suppressed in CIA after HMGB-1 blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfIAT8v8joerVg90H21EOLACvtfcHk0lii-VuwFBuCuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFartbc%253D&md5=4fd1bb6ee45519a8687c6e7b19ef748a</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1002%2Fart.11161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.11161%26sid%3Dliteratum%253Aachs%26aulast%3DKokkola%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSundberg%26aufirst%3DE.%26aulast%3DAveberger%26aufirst%3DA.%2BC.%26aulast%3DPalmblad%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26atitle%3DSuccessful%2520treatment%2520of%2520collagen-induced%2520arthritis%2520in%2520mice%2520and%2520rats%2520by%2520targeting%2520extracellular%2520high%2520mobility%2520group%2520box%2520chromosomal%2520protein%25201%2520activity%26jtitle%3DArthritis%2520Rheum.%26date%3D2003%26volume%3D48%26issue%3D7%26spage%3D2052%26epage%3D2058%26doi%3D10.1002%2Fart.11161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susarla, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulloa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiRaimo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czura, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">Reversing established sepsis with antagonists of endogenous high-mobility group box 1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1073/pnas.2434651100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1073%2Fpnas.2434651100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=296-301&issue=1&author=H.+Yangauthor=M.+Ochaniauthor=J.+Liauthor=X.+Qiangauthor=M.+Tanovicauthor=H.+E.+Harrisauthor=S.+M.+Susarlaauthor=L.+Ulloaauthor=H.+Wangauthor=R.+DiRaimoauthor=C.+J.+Czuraauthor=H.+Wangauthor=J.+Rothauthor=H.+S.+Warrenauthor=M.+P.+Finkauthor=M.+J.+Fentonauthor=U.+Anderssonauthor=K.+J.+Tracey&title=Reversing+established+sepsis+with+antagonists+of+endogenous+high-mobility+group+box+1&doi=10.1073%2Fpnas.2434651100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2434651100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2434651100%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DOchani%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DQiang%26aufirst%3DX.%26aulast%3DTanovic%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26aulast%3DSusarla%26aufirst%3DS.%2BM.%26aulast%3DUlloa%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDiRaimo%26aufirst%3DR.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DWarren%26aufirst%3DH.%2BS.%26aulast%3DFink%26aufirst%3DM.%2BP.%26aulast%3DFenton%26aufirst%3DM.%2BJ.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DReversing%2520established%2520sepsis%2520with%2520antagonists%2520of%2520endogenous%2520high-mobility%2520group%2520box%25201%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D1%26spage%3D296%26epage%3D301%26doi%3D10.1073%2Fpnas.2434651100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logsdon, C. D.</span></span> <span> </span><span class="NLM_article-title">S100p-derived rage antagonistic peptide reduces tumor growth and metastasis</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">4356</span>– <span class="NLM_lpage">4364</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-0221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1158%2F1078-0432.CCR-12-0221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22718861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ajs7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=4356-4364&issue=16&author=T.+Arumugamauthor=V.+Ramachandranauthor=S.+B.+Gomezauthor=A.+M.+Schmidtauthor=C.+D.+Logsdon&title=S100p-derived+rage+antagonistic+peptide+reduces+tumor+growth+and+metastasis&doi=10.1158%2F1078-0432.CCR-12-0221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis</span></div><div class="casAuthors">Arumugam, Thiruvengadam; Ramachandran, Vijaya; Gomez, Sobeyda B.; Schmidt, Ann M.; Logsdon, Craig D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4356-4364</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The receptor for advanced glycation end products (RAGE) contributes to multiple pathologies, including diabetes, arthritis, neurodegenerative diseases, and cancer.  Despite the obvious need, no RAGE inhibitors are in common clin. use.  Therefore, we developed a novel small RAGE antagonist peptide (RAP) that blocks activation by multiple ligands.  Exptl. Design: RAGE and its ligands were visualized by immunohistochem. anal. of human pancreatic tissues, and siRNA was used to analyze their functions.  Interactions between RAGE and S100P, S100A4, and HMGB-1 were measured by ELISA.  Three S100P-derived small antagonistic peptides were designed, synthesized, and tested for inhibition of RAGE binding.  The effects of the peptide blockers on NFκB-luciferase reporter activity was used to assess effects on RAGE-mediated signaling.  The most effective peptide was tested on glioma and pancreatic ductal adenocarcinoma (PDAC) models.  Results: Immunohistochem. anal. confirmed the expression of RAGE and its ligands S100P, S100A4, and HMGB-1 in human PDAC. siRNA silencing of RAGE or its ligands reduced the growth and migration of PDAC cells in vitro.  The most effective RAP inhibited the interaction of S100P, S100A4, and HMGB-1 with RAGE at micromolar concns.  RAP also reduced the ability of the ligands to stimulate RAGE activation of NFκB in cancer cells in vitro and in vivo.  Importantly, systemic in vivo administration of RAP reduced the growth and metastasis of pancreatic tumors and also inhibited glioma tumor growth.  Conclusion: RAP shows promise as a tool for the investigation of RAGE function and as an in vivo treatment for RAGE-related disorders.  Clin Cancer Res; 18(16); 4356-64. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjzKO-K6XacrVg90H21EOLACvtfcHk0ljO1MnJkut_OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ajs7fJ&md5=2b4c38aa9ed0163c4c280035649662ee</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-0221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-0221%26sid%3Dliteratum%253Aachs%26aulast%3DArumugam%26aufirst%3DT.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DGomez%26aufirst%3DS.%2BB.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26aulast%3DLogsdon%26aufirst%3DC.%2BD.%26atitle%3DS100p-derived%2520rage%2520antagonistic%2520peptide%2520reduces%2520tumor%2520growth%2520and%2520metastasis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26issue%3D16%26spage%3D4356%26epage%3D4364%26doi%3D10.1158%2F1078-0432.CCR-12-0221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnay-Verdier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borde, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marechal, V.</span></span> <span> </span><span class="NLM_article-title">Pca-elisa: A sensitive method to quantify free and masked forms of hmgb1</span>. <i>Cytokine</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2011.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.cyto.2011.03.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=4-7&issue=1&author=S.+Barnay-Verdierauthor=C.+Gaillardauthor=M.+Messmerauthor=C.+Bordeauthor=S.+Gibotauthor=V.+Marechal&title=Pca-elisa%3A+A+sensitive+method+to+quantify+free+and+masked+forms+of+hmgb1&doi=10.1016%2Fj.cyto.2011.03.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2011.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2011.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DBarnay-Verdier%26aufirst%3DS.%26aulast%3DGaillard%26aufirst%3DC.%26aulast%3DMessmer%26aufirst%3DM.%26aulast%3DBorde%26aufirst%3DC.%26aulast%3DGibot%26aufirst%3DS.%26aulast%3DMarechal%26aufirst%3DV.%26atitle%3DPca-elisa%253A%2520A%2520sensitive%2520method%2520to%2520quantify%2520free%2520and%2520masked%2520forms%2520of%2520hmgb1%26jtitle%3DCytokine%26date%3D2011%26volume%3D55%26issue%3D1%26spage%3D4%26epage%3D7%26doi%3D10.1016%2Fj.cyto.2011.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathish, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfp235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1093%2Ftoxsci%2Fkfp235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=19783637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVajurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2009&pages=521-531&issue=2&author=D.+J.+Antoineauthor=D.+P.+Williamsauthor=A.+Kiparauthor=R.+E.+Jenkinsauthor=S.+L.+Reganauthor=J.+G.+Sathishauthor=N.+R.+Kitteringhamauthor=B.+K.+Park&title=High-mobility+group+box-1+protein+and+keratin-18%2C+circulating+serum+proteins+informative+of+acetaminophen-induced+necrosis+and+apoptosis+in+vivo&doi=10.1093%2Ftoxsci%2Fkfp235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">High-Mobility Group Box-1 Protein and Keratin-18, Circulating Serum Proteins Informative of Acetaminophen-Induced Necrosis and Apoptosis In Vivo</span></div><div class="casAuthors">Antoine, Daniel J.; Williams, Dominic P.; Kipar, Anja; Jenkins, Rosalind E.; Regan, Sophie L.; Sathish, Jean G.; Kitteringham, Neil R.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">521-531</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Drug-induced hepatotoxicity represents a major clin. problem and an impediment to new medicine development.  Serum biomarkers hold the potential to provide information about pathways leading to cellular responses within inaccessible tissues, which can inform the medicinal chemist and the clinician with respect to safe drug design and use.  Hepatocyte apoptosis, necrosis, and innate immune activation have been defined as features of the toxicol. response assocd. with the hepatotoxin acetaminophen (APAP).  Within this investigation, we have unambiguously identified and characterized by liq. chromatog.-tandem mass spectrometry differing circulating mol. forms of high-mobility group box-1 protein (HMGB1) and keratin-18 (K18), which are linked to the mechanisms and pathol. changes induced by APAP in the mouse.  Hypoacetylated HMGB1 (necrosis indicator), caspase-cleaved K18 (apoptosis indicator), and full-length K18 (necrosis indicator) present in serum showed strong correlations with the histol. time course of cell death and was more sensitive than alanine aminotransferase activity.  We have further identified a hyperacetylated form of HMGB1 (inflammatory indicator) in serum, which indicated that hepatotoxicity was assocd. with an inflammatory response.  The inhibition of APAP-induced apoptosis and K18 cleavage by the caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp(OMe) fluoromethyl ketone are assocd. with increased hepatic damage, by a shift to necrotic cell death only.  These findings illustrate the initial verification of K18 and HMGB1 mol. forms as serum-based sensitive tools that provide insights into the cellular dynamics involved in APAP hepatotoxicity within an inaccessible tissue.  Based on these findings, potential exists for the qualification and measurement of these proteins to further assist in vitro, in vivo, and clin. bridging in toxicol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSh9ZHuQzS8rVg90H21EOLACvtfcHk0lhEsW-93pqhCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVajurzF&md5=c11e67157cd922ba4e46270cf20a57b4</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfp235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfp235%26sid%3Dliteratum%253Aachs%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DKipar%26aufirst%3DA.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DRegan%26aufirst%3DS.%2BL.%26aulast%3DSathish%26aufirst%3DJ.%2BG.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DHigh-mobility%2520group%2520box-1%2520protein%2520and%2520keratin-18%252C%2520circulating%2520serum%2520proteins%2520informative%2520of%2520acetaminophen-induced%2520necrosis%2520and%2520apoptosis%2520in%2520vivo%26jtitle%3DToxicol.%2520Sci.%26date%3D2009%26volume%3D112%26issue%3D2%26spage%3D521%26epage%3D531%26doi%3D10.1093%2Ftoxsci%2Fkfp235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. H.</span></span> <span> </span><span class="NLM_article-title">In vivo relative quantitative proteomics reveals hmgb1 as a downstream mediator of oestrogen-stimulated keratinocyte migration</span>. <i>Exp Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1111/exd.12713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fexd.12713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25828589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVKhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=478-480&issue=6&author=J.+U.+Shinauthor=J.+Y.+Nohauthor=J.+H.+Leeauthor=W.+J.+Leeauthor=J.+S.+Yooauthor=J.+Y.+Kimauthor=H.+Kimauthor=I.+Jungauthor=S.+Jinauthor=K.+H.+Lee&title=In+vivo+relative+quantitative+proteomics+reveals+hmgb1+as+a+downstream+mediator+of+oestrogen-stimulated+keratinocyte+migration&doi=10.1111%2Fexd.12713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo relative quantitative proteomics reveals HMGB1 as a downstream mediator of oestrogen-stimulated keratinocyte migration</span></div><div class="casAuthors">Shin, Jung U.; Noh, Ji Yeon; Lee, Ju Hee; Lee, Won Jai; Yoo, Jong Shin; Kim, Jin Young; Kim, Hyeran; Jung, Inhee; Jin, Shan; Lee, Kwang Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Dermatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">478-480</span>CODEN:
                <span class="NLM_cas:coden">EXDEEY</span>;
        ISSN:<span class="NLM_cas:issn">1600-0625</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">It is known that estrogen influences skin wound healing by modulating the inflammatory response, cytokine expression and extracellular matrix deposition; accelerating re-epithelialization; and stimulating angiogenesis.  To identify novel proteins assocd. with effects of estrogen on keratinocyte, stable isotope labeling by amino acids in cell culture (SILAC)-based mass spectrometry was performed.  Using SILAC, quantification of 1085 proteins was achieved.  Among these proteins, 60 proteins were upregulated and 32 proteins were downregulated.  Among significantly upregulated proteins, high-mobility group protein B1 (HMGB1) has been further evaluated for its role in the effect of estrogen on keratinocytes.  HMGB1 expression was strongly induced in estrogen-treated keratinocytes in dose- and time-dependent manner.  Further, HMGB1 was able to significantly accelerate the rate of HaCaT cell migration.  To det. whether HMGB1 is involved in E2-induced HaCaT cell migration, cells were transfected with HMGB1 siRNA.  Knockdown of HMGB1 blocked estrogen-induced keratinocyte migration.  Collectively, these expts. demonstrate that HMGB1 is a novel downstream mediator of estrogen-stimulated keratinocyte migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK_mVNtbfqgLVg90H21EOLACvtfcHk0lip72ZZycNkaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVKhsrs%253D&md5=b80f2086b7c2d0b2d968c2fad66bb952</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1111%2Fexd.12713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fexd.12713%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%2BU.%26aulast%3DNoh%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DW.%2BJ.%26aulast%3DYoo%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DI.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DIn%2520vivo%2520relative%2520quantitative%2520proteomics%2520reveals%2520hmgb1%2520as%2520a%2520downstream%2520mediator%2520of%2520oestrogen-stimulated%2520keratinocyte%2520migration%26jtitle%3DExp%2520Dermatol.%26date%3D2015%26volume%3D24%26issue%3D6%26spage%3D478%26epage%3D480%26doi%3D10.1111%2Fexd.12713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stridh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevenvall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span> <span> </span><span class="NLM_article-title">Characterization of the inflammatory properties of actively released hmgb1 in juvenile idiopathic arthritis</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1089/ars.2014.6039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1089%2Fars.2014.6039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25532033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2MzovVOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=605-619&issue=12&author=P.+Lundbackauthor=P.+Stridhauthor=L.+Klevenvallauthor=R.+E.+Jenkinsauthor=M.+Fischerauthor=E.+Sundbergauthor=U.+Anderssonauthor=D.+J.+Antoineauthor=H.+E.+Harris&title=Characterization+of+the+inflammatory+properties+of+actively+released+hmgb1+in+juvenile+idiopathic+arthritis&doi=10.1089%2Fars.2014.6039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis</span></div><div class="casAuthors">Lundback Peter; Fischer Marie; Harris Helena Erlandsson; Stridh Pernilla; Klevenvall Lena; Sundberg Erik; Andersson Ulf; Jenkins Rosalind E; Antoine Daniel J</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & redox signaling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">605-19</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  Pathogenic effects of the endogenous inflammatory mediator high mobility group box protein 1 (HMGB1) have been described in several inflammatory diseases.  Recent reports have underlined the importance of post-translational modifications (PTMs) in determination of HMGB1 function and release mechanisms.  We investigated the occurrence of PTMs of HMGB1 obtained from synovial fluid (SF) of juvenile idiopathic arthritis (JIA) patients.  RESULTS:  Analyses of 17 JIA patients confirmed high HMGB1 levels in SF.  Liquid chromatography tandem mass-spectrometry (LC-MS/MS) analyses of PTMs revealed that total HMGB1 levels were not associated with increased lactate dehydrogenase activity but strongly correlated with nuclear location sequence 2 (NLS2) hyperacetylation, indicating active release of HMGB1.  The correlation between total HMGB1 levels and NLS2 hypoacetylation suggests additional, acetylation-independent release mechanisms.  Monomethylation of lysine 43 (K43), a proposed neutrophil-specific PTM, was strongly associated with high HMGB1 levels, implying that neutrophils are a source of released HMGB1.  Analysis of cysteine redox isoforms, fully reduced HMGB1, disulfide HMGB1, and oxidized HMGB1, revealed that HMGB1 acts as both a chemotactic and a cytokine-inducing mediator.  These properties were associated with actively released HMGB1.  INNOVATION:  This is the first report that characterizes HMGB1-specific PTMs during a chronic inflammatory condition.  CONCLUSION:  HMGB1 in SF from JIA patients is actively released through both acetylation-dependent and -nondependent manners.  The presence of various functional HMGB1 redox isoforms confirms the complexity of their pathogenic role during chronic inflammation.  Defining HMGB1 release pathways and redox isoforms is critical for the understanding of the contribution of HMGB1 during inflammatory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLpa4wiLjfD3T4ugvCDgnZfW6udTcc2ea1cqAbEOGbD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzovVOgtw%253D%253D&md5=88504385bb3b6972452bd022069a63de</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1089%2Fars.2014.6039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2014.6039%26sid%3Dliteratum%253Aachs%26aulast%3DLundback%26aufirst%3DP.%26aulast%3DStridh%26aufirst%3DP.%26aulast%3DKlevenvall%26aufirst%3DL.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DSundberg%26aufirst%3DE.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26atitle%3DCharacterization%2520of%2520the%2520inflammatory%2520properties%2520of%2520actively%2520released%2520hmgb1%2520in%2520juvenile%2520idiopathic%2520arthritis%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2016%26volume%3D24%26issue%3D12%26spage%3D605%26epage%3D619%26doi%3D10.1089%2Fars.2014.6039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span> <span> </span><span class="NLM_article-title">Itraq-based quantitative proteomic analysis for identification of oligodendroglioma biomarkers related with loss of heterozygosity on chromosomal arm 1p</span>. <i>J. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1016/j.jprot.2012.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.jprot.2012.09.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23041135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1aqsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=480-491&author=L.+S.+Yangauthor=X.+E.+Xuauthor=X.+P.+Liuauthor=H.+Jinauthor=Z.+Q.+Chenauthor=X.+H.+Liuauthor=Y.+Wangauthor=F.+P.+Huangauthor=Q.+Shi&title=Itraq-based+quantitative+proteomic+analysis+for+identification+of+oligodendroglioma+biomarkers+related+with+loss+of+heterozygosity+on+chromosomal+arm+1p&doi=10.1016%2Fj.jprot.2012.09.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">iTRAQ-based quantitative proteomic analysis for identification of oligodendroglioma biomarkers related with loss of heterozygosity on chromosomal arm 1p</span></div><div class="casAuthors">Yang, Liu-song; Xu, Xiao-en; Liu, Xiu-ping; Jin, Hong; Chen, Zhong-qing; Liu, Xiao-hui; Wang, Yin; Huang, Feng-ping; Shi, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteomics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">480-491</span>CODEN:
                <span class="NLM_cas:coden">JPORFQ</span>;
        ISSN:<span class="NLM_cas:issn">1874-3919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The oligodendroglioma (OG) type of glial cell tumors accounts for 2-5% of primary brain neoplasms and 4-15% of gliomas diagnosed worldwide.  Allelic losses on 1p, or on 1p and 19q, correlate with chemotherapy response and good prognosis in OG patients; however, the underlying mechanisms are not yet clearly defined.  Therefore, we utilized a quant. proteomics strategy that combined 8-plex isobaric tags for relative and abs. quantitation (iTRAQ) labeling and two-dimensional liq. chromatog.-tandem mass spectrometry (2D-LC/MS/MS) to identify mol. signatures, reveal mechanisms, and develop predictive markers of OG patients with 1p loss of heterozygosity (LOH).  An initial screening of four OG patients with 1p LOH and four without were identified, and 449 differentially expressed proteins were quantified, 13 of which were significantly different between the two groups.  Anal. of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway suggested that 1p LOH may affect the actin network in OG.  The differential expression of four of the 13 candidates (UBA1, ubiquitin-like modifier activating enzyme 1; ATP6V1E1, ATPase, H + transporting, lysosomal 31 kDa, V1 subunit E1; MAP2, microtubule-assocd. protein 2; and HMGB1, high-mobility group protein B1) was validated in 39 addnl. OG samples using immunohistochem.  Decision tree modeling indicated that MAP2 expression is a powerful predictor of 1p LOH.  Our results not only demonstrate the utility of iTRAQ-based high-throughput quant. proteomic anal. in glioma research, but also provide novel markers that may help to reveal the mechanisms of 1p LOH-assocd. chemosensitivity, and to design diagnostic and prognostic assays and therapeutics for OG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroklGFOCXFhbVg90H21EOLACvtfcHk0li-YEPjn0pm0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1aqsrjF&md5=383306601ff7a677b9681426f256d554</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.jprot.2012.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jprot.2012.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%2BS.%26aulast%3DXu%26aufirst%3DX.%2BE.%26aulast%3DLiu%26aufirst%3DX.%2BP.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%2BQ.%26aulast%3DLiu%26aufirst%3DX.%2BH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DF.%2BP.%26aulast%3DShi%26aufirst%3DQ.%26atitle%3DItraq-based%2520quantitative%2520proteomic%2520analysis%2520for%2520identification%2520of%2520oligodendroglioma%2520biomarkers%2520related%2520with%2520loss%2520of%2520heterozygosity%2520on%2520chromosomal%2520arm%25201p%26jtitle%3DJ.%2520Proteomics%26date%3D2012%26volume%3D77%26spage%3D480%26epage%3D491%26doi%3D10.1016%2Fj.jprot.2012.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spacil, Z.</span></span> <span> </span><span class="NLM_article-title">A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition</span>. <i>Anal. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>964</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.aca.2017.01.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.aca.2017.01.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28351641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisVejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=964&publication_year=2017&pages=7-23&author=V.+Vidovaauthor=Z.+Spacil&title=A+review+on+mass+spectrometry-based+quantitative+proteomics%3A+Targeted+and+data+independent+acquisition&doi=10.1016%2Fj.aca.2017.01.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition</span></div><div class="casAuthors">Vidova, Veronika; Spacil, Zdenek</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">964</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-23</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the mass spectrometry-based targeted quant. proteomics based on the selected reaction monitoring (SRM) technol., and applications of SRM in basic biol. research and clin. biomarker studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq0mZ1OtmMdLVg90H21EOLACvtfcHk0li-YEPjn0pm0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisVejsrY%253D&md5=6bf1234e5a4756bc4e466b458c70cfce</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.aca.2017.01.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.aca.2017.01.059%26sid%3Dliteratum%253Aachs%26aulast%3DVidova%26aufirst%3DV.%26aulast%3DSpacil%26aufirst%3DZ.%26atitle%3DA%2520review%2520on%2520mass%2520spectrometry-based%2520quantitative%2520proteomics%253A%2520Targeted%2520and%2520data%2520independent%2520acquisition%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2017%26volume%3D964%26spage%3D7%26epage%3D23%26doi%3D10.1016%2Fj.aca.2017.01.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trenchevska, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedelkov, D.</span></span> <span> </span><span class="NLM_article-title">Mass spectrometric immunoassays in characterization of clinically significant proteoforms</span>. <i>Proteomes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">13</span>, <span class="refDoi"> DOI: 10.3390/proteomes4010013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3390%2Fproteomes4010013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=13&issue=1&author=O.+Trenchevskaauthor=R.+W.+Nelsonauthor=D.+Nedelkov&title=Mass+spectrometric+immunoassays+in+characterization+of+clinically+significant+proteoforms&doi=10.3390%2Fproteomes4010013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.3390%2Fproteomes4010013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fproteomes4010013%26sid%3Dliteratum%253Aachs%26aulast%3DTrenchevska%26aufirst%3DO.%26aulast%3DNelson%26aufirst%3DR.%2BW.%26aulast%3DNedelkov%26aufirst%3DD.%26atitle%3DMass%2520spectrometric%2520immunoassays%2520in%2520characterization%2520of%2520clinically%2520significant%2520proteoforms%26jtitle%3DProteomes%26date%3D2016%26volume%3D4%26issue%3D1%26spage%3D13%26doi%3D10.3390%2Fproteomes4010013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, N. L.</span></span> <span> </span><span class="NLM_article-title">The clinical plasma proteome: A survey of clinical assays for proteins in plasma and serum</span>. <i>Clin. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1373/clinchem.2009.126706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1373%2Fclinchem.2009.126706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=19884488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslaksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2010&pages=177-185&issue=2&author=N.+L.+Anderson&title=The+clinical+plasma+proteome%3A+A+survey+of+clinical+assays+for+proteins+in+plasma+and+serum&doi=10.1373%2Fclinchem.2009.126706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum</span></div><div class="casAuthors">Anderson, N. Leigh</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-185</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">A review presents the available data regarding the clin. assays for proteins in plasma and serum.  The diagnostic protein portfolio is growing much too slowly to meet important medical needs, which include tests for Alzheimer's disease, chronic obstructive pulmonary disease, any imminent cardiovascular event, occlusive vs hemorrhagic stroke, and most forms of cancer.  In reality, early detection of almost any serious disease constitutes a significant unmet need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjyfjJrtUDfbVg90H21EOLACvtfcHk0lgp_Px1r1lz2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslaksL4%253D&md5=83ec455863e9bf5bb58db9dd57961a1b</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2009.126706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2009.126706%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DN.%2BL.%26atitle%3DThe%2520clinical%2520plasma%2520proteome%253A%2520A%2520survey%2520of%2520clinical%2520assays%2520for%2520proteins%2520in%2520plasma%2520and%2520serum%26jtitle%3DClin.%2520Chem.%26date%3D2010%26volume%3D56%26issue%3D2%26spage%3D177%26epage%3D185%26doi%3D10.1373%2Fclinchem.2009.126706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowell, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keil, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platts-Mills, T. F.</span></span> <span> </span><span class="NLM_article-title">Non-publication of large randomized clinical trials: Cross sectional analysis</span>. <i>BMJ.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">f6104</span>, <span class="refDoi"> DOI: 10.1136/bmj.f6104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1136%2Fbmj.f6104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=f6104&author=C.+W.+Jonesauthor=L.+Handlerauthor=K.+E.+Crowellauthor=L.+G.+Keilauthor=M.+A.+Weaverauthor=T.+F.+Platts-Mills&title=Non-publication+of+large+randomized+clinical+trials%3A+Cross+sectional+analysis&doi=10.1136%2Fbmj.f6104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1136%2Fbmj.f6104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.f6104%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BW.%26aulast%3DHandler%26aufirst%3DL.%26aulast%3DCrowell%26aufirst%3DK.%2BE.%26aulast%3DKeil%26aufirst%3DL.%2BG.%26aulast%3DWeaver%26aufirst%3DM.%2BA.%26aulast%3DPlatts-Mills%26aufirst%3DT.%2BF.%26atitle%3DNon-publication%2520of%2520large%2520randomized%2520clinical%2520trials%253A%2520Cross%2520sectional%2520analysis%26jtitle%3DBMJ.%26date%3D2013%26volume%3D347%26spage%3Df6104%26doi%3D10.1136%2Fbmj.f6104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumholz, H. M.</span></span> <span> </span><span class="NLM_article-title">Publication of nih funded trials registered in clinicaltrials.Gov: Cross sectional analysis</span>. <i>BMJ.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">d7292</span>, <span class="refDoi"> DOI: 10.1136/bmj.d7292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1136%2Fbmj.d7292" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2011&pages=d7292&author=J.+S.+Rossauthor=T.+Tseauthor=D.+A.+Zarinauthor=H.+Xuauthor=L.+Zhouauthor=H.+M.+Krumholz&title=Publication+of+nih+funded+trials+registered+in+clinicaltrials.Gov%3A+Cross+sectional+analysis&doi=10.1136%2Fbmj.d7292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1136%2Fbmj.d7292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.d7292%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DJ.%2BS.%26aulast%3DTse%26aufirst%3DT.%26aulast%3DZarin%26aufirst%3DD.%2BA.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DKrumholz%26aufirst%3DH.%2BM.%26atitle%3DPublication%2520of%2520nih%2520funded%2520trials%2520registered%2520in%2520clinicaltrials.Gov%253A%2520Cross%2520sectional%2520analysis%26jtitle%3DBMJ.%26date%3D2011%26volume%3D344%26spage%3Dd7292%26doi%3D10.1136%2Fbmj.d7292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 38 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaojun  Peng</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Yongjie  Xin</span>, <span class="hlFld-ContribAuthor ">Wei  Zhao</span>, <span class="hlFld-ContribAuthor ">Meixiao  Zhan</span>, <span class="hlFld-ContribAuthor ">Jingchao  Li</span>, <span class="hlFld-ContribAuthor ">Rong  Cai</span>, <span class="hlFld-ContribAuthor ">Ligong  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Second near-infrared photoactivatable hydrogen selenide nanogenerators for metastasis-inhibited cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Nano Today</span><span> <strong>2021,</strong> <em>40 </em>, 101240. <a href="https://doi.org/10.1016/j.nantod.2021.101240" title="DOI URL">https://doi.org/10.1016/j.nantod.2021.101240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nantod.2021.101240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nantod.2021.101240%26sid%3Dliteratum%253Aachs%26jtitle%3DNano%2520Today%26atitle%3DSecond%252Bnear-infrared%252Bphotoactivatable%252Bhydrogen%252Bselenide%252Bnanogenerators%252Bfor%252Bmetastasis-inhibited%252Bcancer%252Btherapy%26aulast%3DPeng%26aufirst%3DShaojun%26date%3D2021%26volume%3D40%26spage%3D101240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annachiara  Mollace</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Coluccio</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Donato</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Mollace</span>, <span class="hlFld-ContribAuthor ">Natalia  Malara</span>. </span><span class="cited-content_cbyCitation_article-title">Cross-talks in colon cancer between RAGE/AGEs axis and inflammation/immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2021,</strong> <em>12 </em>
                                    (13)
                                     , 1281-1295. <a href="https://doi.org/10.18632/oncotarget.27990" title="DOI URL">https://doi.org/10.18632/oncotarget.27990</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.27990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.27990%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DCross-talks%252Bin%252Bcolon%252Bcancer%252Bbetween%252BRAGE%25252FAGEs%252Baxis%252Band%252Binflammation%25252Fimmunotherapy%26aulast%3DMollace%26aufirst%3DAnnachiara%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D13%26spage%3D1281%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sha  Sha</span>, <span class="hlFld-ContribAuthor ">Jin  Tan</span>, <span class="hlFld-ContribAuthor ">Yuyang  Miao</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Autophagy in Hypoxia-Induced Neuroinflammation. </span><span class="cited-content_cbyCitation_journal-name">DNA and Cell Biology</span><span> <strong>2021,</strong> <em>40 </em>
                                    (6)
                                     , 733-739. <a href="https://doi.org/10.1089/dna.2020.6186" title="DOI URL">https://doi.org/10.1089/dna.2020.6186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/dna.2020.6186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fdna.2020.6186%26sid%3Dliteratum%253Aachs%26jtitle%3DDNA%2520and%2520Cell%2520Biology%26atitle%3DThe%252BRole%252Bof%252BAutophagy%252Bin%252BHypoxia-Induced%252BNeuroinflammation%26aulast%3DSha%26aufirst%3DSha%26date%3D2021%26volume%3D40%26issue%3D6%26spage%3D733%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun  Ge</span>, <span class="hlFld-ContribAuthor ">Man  Huang</span>, <span class="hlFld-ContribAuthor ">Yong-ming  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 1044. <a href="https://doi.org/10.3390/cells10051044" title="DOI URL">https://doi.org/10.3390/cells10051044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10051044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10051044%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DThe%252BEffect%252Band%252BRegulatory%252BMechanism%252Bof%252BHigh%252BMobility%252BGroup%252BBox-1%252BProtein%252Bon%252BImmune%252BCells%252Bin%252BInflammatory%252BDiseases%26aulast%3DGe%26aufirst%3DYun%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D5%26spage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Tommy</span>, <span class="hlFld-ContribAuthor ">Andi A.  Islam</span>, <span class="hlFld-ContribAuthor ">Mochammad  Hatta</span>, <span class="hlFld-ContribAuthor ">Agussalim  Bukhari</span>, <span class="hlFld-ContribAuthor ">Nasrullah</span>, <span class="hlFld-ContribAuthor ">Willy  Adhimarta</span>, <span class="hlFld-ContribAuthor ">Aminuddin</span>, <span class="hlFld-ContribAuthor ">Andi Alfian  Zainuddin</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of folinic acid on serum homocysteine, TNFα, IL-10, and HMGB1 gene expression in head injury model. </span><span class="cited-content_cbyCitation_journal-name">Annals of Medicine and Surgery</span><span> <strong>2021,</strong> <em>65 </em>, 102273. <a href="https://doi.org/10.1016/j.amsu.2021.102273" title="DOI URL">https://doi.org/10.1016/j.amsu.2021.102273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.amsu.2021.102273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.amsu.2021.102273%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Medicine%2520and%2520Surgery%26atitle%3DEffect%252Bof%252Bfolinic%252Bacid%252Bon%252Bserum%252Bhomocysteine%25252C%252BTNF%2525CE%2525B1%25252C%252BIL-10%25252C%252Band%252BHMGB1%252Bgene%252Bexpression%252Bin%252Bhead%252Binjury%252Bmodel%26aulast%3DTommy%26aufirst%3DThomas%26date%3D2021%26volume%3D65%26spage%3D102273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sushant  Khanal</span>, <span class="hlFld-ContribAuthor ">Madison  Schank</span>, <span class="hlFld-ContribAuthor ">Mohamed  El Gazzar</span>, <span class="hlFld-ContribAuthor ">Jonathan P.  Moorman</span>, <span class="hlFld-ContribAuthor ">Zhi Q.  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (2)
                                     , 475. <a href="https://doi.org/10.3390/cells10020475" title="DOI URL">https://doi.org/10.3390/cells10020475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10020475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10020475%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DHIV-1%252BLatency%252Band%252BViral%252BReservoirs%25253A%252BExisting%252BReversal%252BApproaches%252Band%252BPotential%252BTechnologies%25252C%252BTargets%25252C%252Band%252BPathways%252BInvolved%252Bin%252BHIV%252BLatency%252BStudies%26aulast%3DKhanal%26aufirst%3DSushant%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D2%26spage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Zongmin  Yu</span>, <span class="hlFld-ContribAuthor ">Hu  Yuan</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Ning  Xie</span>, <span class="hlFld-ContribAuthor ">Zhibin  Wang</span>, <span class="hlFld-ContribAuthor ">Qingyan  Sun</span>, <span class="hlFld-ContribAuthor ">Weidong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of glycyrrhetinic acid derivatives as potent anti-sepsis agents targeting high-mobility group box-1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>106 </em>, 104461. <a href="https://doi.org/10.1016/j.bioorg.2020.104461" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104461%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructure-based%252Bdesign%252Bof%252Bglycyrrhetinic%252Bacid%252Bderivatives%252Bas%252Bpotent%252Banti-sepsis%252Bagents%252Btargeting%252Bhigh-mobility%252Bgroup%252Bbox-1%26aulast%3DWang%26aufirst%3DYuanyuan%26date%3D2021%26volume%3D106%26spage%3D104461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fumiko  Sekiguchi</span>, <span class="hlFld-ContribAuthor ">Atsufumi  Kawabata</span>. </span><span class="cited-content_cbyCitation_article-title">Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (1)
                                     , 367. <a href="https://doi.org/10.3390/ijms22010367" title="DOI URL">https://doi.org/10.3390/ijms22010367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22010367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22010367%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DRole%252Bof%252BHMGB1%252Bin%252BChemotherapy-Induced%252BPeripheral%252BNeuropathy%26aulast%3DSekiguchi%26aufirst%3DFumiko%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D1%26spage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianying  Zhang</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Daibang  Nie</span>, <span class="hlFld-ContribAuthor ">Kentaro  Onishi</span>, <span class="hlFld-ContribAuthor ">MaCalus V.  Hogan</span>, <span class="hlFld-ContribAuthor ">James H-C.  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of Metformin on Development of Tendinopathy Due to Mechanical Overloading in an Animal Model. </span><span class="cited-content_cbyCitation_journal-name">Foot & Ankle International</span><span> <strong>2020,</strong> <em>41 </em>
                                    (12)
                                     , 1455-1465. <a href="https://doi.org/10.1177/1071100720966318" title="DOI URL">https://doi.org/10.1177/1071100720966318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1071100720966318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1071100720966318%26sid%3Dliteratum%253Aachs%26jtitle%3DFoot%2520%2526%2520Ankle%2520International%26atitle%3DEffect%252Bof%252BMetformin%252Bon%252BDevelopment%252Bof%252BTendinopathy%252BDue%252Bto%252BMechanical%252BOverloading%252Bin%252Ban%252BAnimal%252BModel%26aulast%3DZhang%26aufirst%3DJianying%26date%3D2020%26date%3D2020%26volume%3D41%26issue%3D12%26spage%3D1455%26epage%3D1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Tu</span>, <span class="hlFld-ContribAuthor ">Rong  Tian</span>, <span class="hlFld-ContribAuthor ">Yan  Lu</span>, <span class="hlFld-ContribAuthor ">Yunyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhu</span>, <span class="hlFld-ContribAuthor ">Lijun  Ling</span>, <span class="hlFld-ContribAuthor ">Hong  Li</span>, <span class="hlFld-ContribAuthor ">Daofeng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Beneficial effect of Indigo Naturalis on acute lung injury induced by influenza A virus. </span><span class="cited-content_cbyCitation_journal-name">Chinese Medicine</span><span> <strong>2020,</strong> <em>15 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13020-020-00415-w" title="DOI URL">https://doi.org/10.1186/s13020-020-00415-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13020-020-00415-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13020-020-00415-w%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Medicine%26atitle%3DBeneficial%252Beffect%252Bof%252BIndigo%252BNaturalis%252Bon%252Bacute%252Blung%252Binjury%252Binduced%252Bby%252Binfluenza%252BA%252Bvirus%26aulast%3DTu%26aufirst%3DPeng%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  De Leo</span>, <span class="hlFld-ContribAuthor ">Giacomo  Quilici</span>, <span class="hlFld-ContribAuthor ">Francesco  De Marchis</span>, <span class="hlFld-ContribAuthor ">Malisa Vittoria  Mantonico</span>, <span class="hlFld-ContribAuthor ">Marco Emilio  Bianchi</span>, <span class="hlFld-ContribAuthor ">Giovanna  Musco</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5,5′-Methylenedi-2,3-Cresotic Acid as a Potent Inhibitor of the Chemotactic Activity of the HMGB1·CXCL12 Heterocomplex Using Virtual Screening and NMR Validation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.598710" title="DOI URL">https://doi.org/10.3389/fchem.2020.598710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.598710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.598710%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DDiscovery%252Bof%252B5%25252C5%2525E2%252580%2525B2-Methylenedi-2%25252C3-Cresotic%252BAcid%252Bas%252Ba%252BPotent%252BInhibitor%252Bof%252Bthe%252BChemotactic%252BActivity%252Bof%252Bthe%252BHMGB1%2525C2%2525B7CXCL12%252BHeterocomplex%252BUsing%252BVirtual%252BScreening%252Band%252BNMR%252BValidation%26aulast%3DDe%2BLeo%26aufirst%3DFederica%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farzaneh  Kianian</span>, <span class="hlFld-ContribAuthor ">Mehri  Kadkhodaee</span>, <span class="hlFld-ContribAuthor ">Hamid Reza  Sadeghipour</span>, <span class="hlFld-ContribAuthor ">Seyed Morteza  Karimian</span>, <span class="hlFld-ContribAuthor ">Behjat  Seifi</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of high-mobility group box 1, a potent pro-inflammatory cytokine in asthma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Basic and Clinical Physiology and Pharmacology</span><span> <strong>2020,</strong> <em>31 </em>
                                    (6)
                                     <a href="https://doi.org/10.1515/jbcpp-2019-0363" title="DOI URL">https://doi.org/10.1515/jbcpp-2019-0363</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/jbcpp-2019-0363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fjbcpp-2019-0363%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Basic%2520and%2520Clinical%2520Physiology%2520and%2520Pharmacology%26atitle%3DAn%252Boverview%252Bof%252Bhigh-mobility%252Bgroup%252Bbox%252B1%25252C%252Ba%252Bpotent%252Bpro-inflammatory%252Bcytokine%252Bin%252Basthma%26aulast%3DKianian%26aufirst%3DFarzaneh%26date%3D2020%26date%3D2020%26volume%3D31%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Tommy</span>, <span class="hlFld-ContribAuthor ">Andi A.  Islam</span>, <span class="hlFld-ContribAuthor ">Mochammad  Hatta</span>, <span class="hlFld-ContribAuthor ">Agussalim  Bukhari</span>. </span><span class="cited-content_cbyCitation_article-title">Immunomodulatory properties of high mobility group box 1 and its potential role in brain injury: Review article. </span><span class="cited-content_cbyCitation_journal-name">Annals of Medicine and Surgery</span><span> <strong>2020,</strong> <em>59 </em>, 106-109. <a href="https://doi.org/10.1016/j.amsu.2020.09.025" title="DOI URL">https://doi.org/10.1016/j.amsu.2020.09.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.amsu.2020.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.amsu.2020.09.025%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Medicine%2520and%2520Surgery%26atitle%3DImmunomodulatory%252Bproperties%252Bof%252Bhigh%252Bmobility%252Bgroup%252Bbox%252B1%252Band%252Bits%252Bpotential%252Brole%252Bin%252Bbrain%252Binjury%25253A%252BReview%252Barticle%26aulast%3DTommy%26aufirst%3DThomas%26date%3D2020%26volume%3D59%26spage%3D106%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nitish  Jangde</span>, <span class="hlFld-ContribAuthor ">Rashmi  Ray</span>, <span class="hlFld-ContribAuthor ">Vivek  Rai</span>. </span><span class="cited-content_cbyCitation_article-title">RAGE and its ligands: from pathogenesis to therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Biochemistry and Molecular Biology</span><span> <strong>2020,</strong> <em>55 </em>
                                    (6)
                                     , 555-575. <a href="https://doi.org/10.1080/10409238.2020.1819194" title="DOI URL">https://doi.org/10.1080/10409238.2020.1819194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10409238.2020.1819194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10409238.2020.1819194%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DRAGE%252Band%252Bits%252Bligands%25253A%252Bfrom%252Bpathogenesis%252Bto%252Btherapeutics%26aulast%3DJangde%26aufirst%3DNitish%26date%3D2020%26date%3D2020%26volume%3D55%26issue%3D6%26spage%3D555%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emel  Ulusoy</span>, <span class="hlFld-ContribAuthor ">Murat  Duman</span>, <span class="hlFld-ContribAuthor ">Aykut  Çağlar</span>, <span class="hlFld-ContribAuthor ">Tuncay  Küme</span>, <span class="hlFld-ContribAuthor ">Anil  Er</span>, <span class="hlFld-ContribAuthor ">Fatma  Akgül</span>, <span class="hlFld-ContribAuthor ">Hale  Çitlenbik</span>, <span class="hlFld-ContribAuthor ">Durgül  Yilmaz</span>, <span class="hlFld-ContribAuthor ">Hale  Ören</span>. </span><span class="cited-content_cbyCitation_article-title">High-mobility Group Box 1 Protein in Pediatric Trauma Patients With Acute Traumatic Coagulopathy or Disseminated Intravascular Coagulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pediatric Hematology/Oncology</span><span> <strong>2020,</strong> <em>42 </em>
                                    (8)
                                     , e712-e717. <a href="https://doi.org/10.1097/MPH.0000000000001788" title="DOI URL">https://doi.org/10.1097/MPH.0000000000001788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MPH.0000000000001788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMPH.0000000000001788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pediatric%2520Hematology%252FOncology%26atitle%3DHigh-mobility%252BGroup%252BBox%252B1%252BProtein%252Bin%252BPediatric%252BTrauma%252BPatients%252BWith%252BAcute%252BTraumatic%252BCoagulopathy%252Bor%252BDisseminated%252BIntravascular%252BCoagulation%26aulast%3DUlusoy%26aufirst%3DEmel%26date%3D2020%26date%3D2020%26volume%3D42%26issue%3D8%26spage%3De712%26epage%3De717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liping  Chen</span>, <span class="hlFld-ContribAuthor ">Junhua  Li</span>, <span class="hlFld-ContribAuthor ">Zhenghao  Ye</span>, <span class="hlFld-ContribAuthor ">Binghua  Sun</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Han</span>, <span class="hlFld-ContribAuthor ">Meiping  Yu</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Qi  Zhou</span>, <span class="hlFld-ContribAuthor ">Ursula  Seidler</span>, <span class="hlFld-ContribAuthor ">De’an  Tian</span>, <span class="hlFld-ContribAuthor ">Fang  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fimmu.2020.585094" title="DOI URL">https://doi.org/10.3389/fimmu.2020.585094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2020.585094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2020.585094%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DAnti-High%252BMobility%252BGroup%252BBox%252B1%252BNeutralizing-Antibody%252BAmeliorates%252BDextran%252BSodium%252BSulfate%252BColitis%252Bin%252BMice%26aulast%3DChen%26aufirst%3DLiping%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gérard  Vergoten</span>, <span class="hlFld-ContribAuthor ">Christian  Bailly</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of glycyrrhizin binding to protein HMGB1. </span><span class="cited-content_cbyCitation_journal-name">Medicine in Drug Discovery</span><span> <strong>2020,</strong> <em>7 </em>, 100058. <a href="https://doi.org/10.1016/j.medidd.2020.100058" title="DOI URL">https://doi.org/10.1016/j.medidd.2020.100058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.medidd.2020.100058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.medidd.2020.100058%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicine%2520in%2520Drug%2520Discovery%26atitle%3DAnalysis%252Bof%252Bglycyrrhizin%252Bbinding%252Bto%252Bprotein%252BHMGB1%26aulast%3DVergoten%26aufirst%3DG%25C3%25A9rard%26date%3D2020%26volume%3D7%26spage%3D100058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jihong  Jiang</span>, <span class="hlFld-ContribAuthor ">Qi  Chen</span>, <span class="hlFld-ContribAuthor ">Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Jinbao  Li</span>, <span class="hlFld-ContribAuthor ">Shitong  Li</span>, <span class="hlFld-ContribAuthor ">Bin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Magnesium sulfate ameliorates sepsis-induced diaphragm dysfunction in rats via inhibiting HMGB1/TLR4/NF-κB pathway. </span><span class="cited-content_cbyCitation_journal-name">NeuroReport</span><span> <strong>2020,</strong> <em>31 </em>
                                    (12)
                                     , 902-908. <a href="https://doi.org/10.1097/WNR.0000000000001478" title="DOI URL">https://doi.org/10.1097/WNR.0000000000001478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/WNR.0000000000001478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FWNR.0000000000001478%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroReport%26atitle%3DMagnesium%252Bsulfate%252Bameliorates%252Bsepsis-induced%252Bdiaphragm%252Bdysfunction%252Bin%252Brats%252Bvia%252Binhibiting%252BHMGB1%25252FTLR4%25252FNF-%2525CE%2525BAB%252Bpathway%26aulast%3DJiang%26aufirst%3DJihong%26date%3D2020%26date%3D2020%26volume%3D31%26issue%3D12%26spage%3D902%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Man Sup  Kwak</span>, <span class="hlFld-ContribAuthor ">Hee Sue  Kim</span>, <span class="hlFld-ContribAuthor ">Bin  Lee</span>, <span class="hlFld-ContribAuthor ">Young Hun  Kim</span>, <span class="hlFld-ContribAuthor ">Myoungsun  Son</span>, <span class="hlFld-ContribAuthor ">Jeon-Soo  Shin</span>. </span><span class="cited-content_cbyCitation_article-title">Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fimmu.2020.01189" title="DOI URL">https://doi.org/10.3389/fimmu.2020.01189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2020.01189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2020.01189%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DImmunological%252BSignificance%252Bof%252BHMGB1%252BPost-Translational%252BModification%252Band%252BRedox%252BBiology%26aulast%3DKwak%26aufirst%3DMan%2BSup%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yam Nath  Paudel</span>, <span class="hlFld-ContribAuthor ">Efthalia  Angelopoulou</span>, <span class="hlFld-ContribAuthor ">Christina  Piperi</span>, <span class="hlFld-ContribAuthor ">Iekhsan  Othman</span>, <span class="hlFld-ContribAuthor ">Mohd. Farooq  Shaikh</span>. </span><span class="cited-content_cbyCitation_article-title">Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>156 </em>, 104792. <a href="https://doi.org/10.1016/j.phrs.2020.104792" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.104792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.104792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.104792%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DImplication%252Bof%252BHMGB1%252Bsignaling%252Bpathways%252Bin%252BAmyotrophic%252Blateral%252Bsclerosis%252B%252528ALS%252529%25253A%252BFrom%252Bmolecular%252Bmechanisms%252Bto%252Bpre-clinical%252Bresults%26aulast%3DPaudel%26aufirst%3DYam%2BNath%26date%3D2020%26volume%3D156%26spage%3D104792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Walter Gottlieb  Land</span>. </span><span class="cited-content_cbyCitation_article-title">Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diagnosis & Therapy</span><span> <strong>2020,</strong> <em>24 </em>
                                    (3)
                                     , 251-262. <a href="https://doi.org/10.1007/s40291-020-00460-z" title="DOI URL">https://doi.org/10.1007/s40291-020-00460-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40291-020-00460-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40291-020-00460-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diagnosis%2520%2526%2520Therapy%26atitle%3DUse%252Bof%252BDAMPs%252Band%252BSAMPs%252Bas%252BTherapeutic%252BTargets%252Bor%252BTherapeutics%25253A%252BA%252BNote%252Bof%252BCaution%26aulast%3DLand%26aufirst%3DWalter%2BGottlieb%26date%3D2020%26date%3D2020%26volume%3D24%26issue%3D3%26spage%3D251%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reverien  Habimana</span>, <span class="hlFld-ContribAuthor ">Insu  Choi</span>, <span class="hlFld-ContribAuthor ">Hwa Jin  Cho</span>, <span class="hlFld-ContribAuthor ">Dowan  Kim</span>, <span class="hlFld-ContribAuthor ">Kyoseon  Lee</span>, <span class="hlFld-ContribAuthor ">Inseok  Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Sepsis-induced cardiac dysfunction: a review of pathophysiology. </span><span class="cited-content_cbyCitation_journal-name">Acute and Critical Care</span><span> <strong>2020,</strong> <em>35 </em>
                                    (2)
                                     , 57-66. <a href="https://doi.org/10.4266/acc.2020.00248" title="DOI URL">https://doi.org/10.4266/acc.2020.00248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4266/acc.2020.00248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4266%2Facc.2020.00248%26sid%3Dliteratum%253Aachs%26jtitle%3DAcute%2520and%2520Critical%2520Care%26atitle%3DSepsis-induced%252Bcardiac%252Bdysfunction%25253A%252Ba%252Breview%252Bof%252Bpathophysiology%26aulast%3DHabimana%26aufirst%3DReverien%26date%3D2020%26volume%3D35%26issue%3D2%26spage%3D57%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Walter Gottlieb  Land</span>. </span><span class="cited-content_cbyCitation_article-title">DAMPs and SAMPs as Molecular Biomarkers, Therapeutic Targets, and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 261-278. <a href="https://doi.org/10.1007/978-3-030-53868-2_7" title="DOI URL">https://doi.org/10.1007/978-3-030-53868-2_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53868-2_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53868-2_7%26sid%3Dliteratum%253Aachs%26atitle%3DDAMPs%252Band%252BSAMPs%252Bas%252BMolecular%252BBiomarkers%25252C%252BTherapeutic%252BTargets%25252C%252Band%252BTherapeutics%26aulast%3DLand%26aufirst%3DWalter%2BGottlieb%26date%3D2020%26date%3D2020%26spage%3D261%26epage%3D278%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDamage-Associated%252BMolecular%252BPatterns%252Bin%252BHuman%252BDiseases%26aulast%3DLand%26aufirst%3DWalter%2BGottlieb%26date%3D2020%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Walter Gottlieb  Land</span>. </span><span class="cited-content_cbyCitation_article-title">DAMP-Controlled and Uncontrolled Responses to Trauma: Wound Healing and Polytrauma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 279-335. <a href="https://doi.org/10.1007/978-3-030-53868-2_8" title="DOI URL">https://doi.org/10.1007/978-3-030-53868-2_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53868-2_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53868-2_8%26sid%3Dliteratum%253Aachs%26atitle%3DDAMP-Controlled%252Band%252BUncontrolled%252BResponses%252Bto%252BTrauma%25253A%252BWound%252BHealing%252Band%252BPolytrauma%26aulast%3DLand%26aufirst%3DWalter%2BGottlieb%26date%3D2020%26date%3D2020%26spage%3D279%26epage%3D335%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDamage-Associated%252BMolecular%252BPatterns%252Bin%252BHuman%252BDiseases%26aulast%3DLand%26aufirst%3DWalter%2BGottlieb%26date%3D2020%26volume%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaogui  Qi</span>, <span class="hlFld-ContribAuthor ">Guowei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingying  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiali  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Saxagliptin protects against hypoxia-induced damage in H9c2 cells. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2020,</strong> <em>315 </em>, 108864. <a href="https://doi.org/10.1016/j.cbi.2019.108864" title="DOI URL">https://doi.org/10.1016/j.cbi.2019.108864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2019.108864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2019.108864%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DSaxagliptin%252Bprotects%252Bagainst%252Bhypoxia-induced%252Bdamage%252Bin%252BH9c2%252Bcells%26aulast%3DZhang%26aufirst%3DLili%26date%3D2020%26volume%3D315%26spage%3D108864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanan  Hassan</span>, <span class="hlFld-ContribAuthor ">Lamya  Al-Wahaibi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Elmorsy</span>, <span class="hlFld-ContribAuthor ">Yasmen  Mahran</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Suppression of Cisplatin-Induced Hepatic Injury in Rats Through Alarmin High-Mobility Group Box-1 Pathway by <em>Ganoderma lucidum</em>: Theoretical and Experimental Study</p>. </span><span class="cited-content_cbyCitation_journal-name">Drug Design, Development and Therapy</span><span> <strong>2020,</strong> <em>Volume 14 </em>, 2335-2353. <a href="https://doi.org/10.2147/DDDT.S249093" title="DOI URL">https://doi.org/10.2147/DDDT.S249093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/DDDT.S249093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FDDDT.S249093%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Design%252C%2520Development%2520and%2520Therapy%26atitle%3D%25253Cp%25253ESuppression%252Bof%252BCisplatin-Induced%252BHepatic%252BInjury%252Bin%252BRats%252BThrough%252BAlarmin%252BHigh-Mobility%252BGroup%252BBox-1%252BPathway%252Bby%252B%25253Cem%25253EGanoderma%252Blucidum%25253C%25252Fem%25253E%25253A%252BTheoretical%252Band%252BExperimental%252BStudy%25253C%25252Fp%25253E%26aulast%3DHassan%26aufirst%3DHanan%26date%3D2020%26date%3D2020%26volume%3DVolume%252014%26spage%3D2335%26epage%3D2353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Xinyue  Wang</span>, <span class="hlFld-ContribAuthor ">Pengtao  Wang</span>, <span class="hlFld-ContribAuthor ">Haojun  Fan</span>, <span class="hlFld-ContribAuthor ">Shike  Hou</span>, <span class="hlFld-ContribAuthor ">Yanhua  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging medical therapies in crush syndrome – progress report from basic sciences and potential future avenues. </span><span class="cited-content_cbyCitation_journal-name">Renal Failure</span><span> <strong>2020,</strong> <em>42 </em>
                                    (1)
                                     , 656-666. <a href="https://doi.org/10.1080/0886022X.2020.1792928" title="DOI URL">https://doi.org/10.1080/0886022X.2020.1792928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/0886022X.2020.1792928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F0886022X.2020.1792928%26sid%3Dliteratum%253Aachs%26jtitle%3DRenal%2520Failure%26atitle%3DEmerging%252Bmedical%252Btherapies%252Bin%252Bcrush%252Bsyndrome%252B%2525E2%252580%252593%252Bprogress%252Breport%252Bfrom%252Bbasic%252Bsciences%252Band%252Bpotential%252Bfuture%252Bavenues%26aulast%3DLi%26aufirst%3DNing%26date%3D2020%26date%3D2020%26volume%3D42%26issue%3D1%26spage%3D656%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanjana Mahadev  Bhat</span>, <span class="hlFld-ContribAuthor ">Nyzil  Massey</span>, <span class="hlFld-ContribAuthor ">Locke A.  Karriker</span>, <span class="hlFld-ContribAuthor ">Baljit  Singh</span>, <span class="hlFld-ContribAuthor ">Chandrashekhar  Charavaryamath</span>. </span><span class="cited-content_cbyCitation_article-title">Ethyl pyruvate reduces organic dust-induced airway inflammation by targeting HMGB1-RAGE signaling. </span><span class="cited-content_cbyCitation_journal-name">Respiratory Research</span><span> <strong>2019,</strong> <em>20 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12931-019-0992-3" title="DOI URL">https://doi.org/10.1186/s12931-019-0992-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12931-019-0992-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12931-019-0992-3%26sid%3Dliteratum%253Aachs%26jtitle%3DRespiratory%2520Research%26atitle%3DEthyl%252Bpyruvate%252Breduces%252Borganic%252Bdust-induced%252Bairway%252Binflammation%252Bby%252Btargeting%252BHMGB1-RAGE%252Bsignaling%26aulast%3DBhat%26aufirst%3DSanjana%2BMahadev%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunyao  Li</span>, <span class="hlFld-ContribAuthor ">Jianwei  Xie</span>, <span class="hlFld-ContribAuthor ">Xinyu  Li</span>, <span class="hlFld-ContribAuthor ">Jianpei  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Poly (ADP‑ribosylation) of HMGB1 facilitates its acetylation and promotes HMGB1 translocation‑associated chemotherapy‑induced autophagy in leukaemia cells. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2019,</strong> <em> </em><a href="https://doi.org/10.3892/ol.2019.11116" title="DOI URL">https://doi.org/10.3892/ol.2019.11116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2019.11116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2019.11116%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DPoly%252B%252528ADP%2525E2%252580%252591ribosylation%252529%252Bof%252BHMGB1%252Bfacilitates%252Bits%252Bacetylation%252Band%252Bpromotes%252BHMGB1%252Btranslocation%2525E2%252580%252591associated%252Bchemotherapy%2525E2%252580%252591induced%252Bautophagy%252Bin%252Bleukaemia%252Bcells%26aulast%3DLi%26aufirst%3DYunyao%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bilon  Khambu</span>, <span class="hlFld-ContribAuthor ">Shengmin  Yan</span>, <span class="hlFld-ContribAuthor ">Nazmul  Huda</span>, <span class="hlFld-ContribAuthor ">Xiao-Ming  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Role of High-Mobility Group Box-1 in Liver Pathogenesis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (21)
                                     , 5314. <a href="https://doi.org/10.3390/ijms20215314" title="DOI URL">https://doi.org/10.3390/ijms20215314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20215314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20215314%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DRole%252Bof%252BHigh-Mobility%252BGroup%252BBox-1%252Bin%252BLiver%252BPathogenesis%26aulast%3DKhambu%26aufirst%3DBilon%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D21%26spage%3D5314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  De Leo</span>, <span class="hlFld-ContribAuthor ">Giacomo  Quilici</span>, <span class="hlFld-ContribAuthor ">Mario  Tirone</span>, <span class="hlFld-ContribAuthor ">Francesco  De Marchis</span>, <span class="hlFld-ContribAuthor ">Valeria  Mannella</span>, <span class="hlFld-ContribAuthor ">Chiara  Zucchelli</span>, <span class="hlFld-ContribAuthor ">Alessandro  Preti</span>, <span class="hlFld-ContribAuthor ">Alessandro  Gori</span>, <span class="hlFld-ContribAuthor ">Maura  Casalgrandi</span>, <span class="hlFld-ContribAuthor ">Rosanna  Mezzapelle</span>, <span class="hlFld-ContribAuthor ">Marco E  Bianchi</span>, <span class="hlFld-ContribAuthor ">Giovanna  Musco</span>. </span><span class="cited-content_cbyCitation_article-title">Diflunisal targets the
              HMGB
              1/
              CXCL
              12 heterocomplex and blocks immune cell recruitment. </span><span class="cited-content_cbyCitation_journal-name">EMBO reports</span><span> <strong>2019,</strong> <em>20 </em>
                                    (10)
                                     <a href="https://doi.org/10.15252/embr.201947788" title="DOI URL">https://doi.org/10.15252/embr.201947788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/embr.201947788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Fembr.201947788%26sid%3Dliteratum%253Aachs%26jtitle%3DEMBO%2520reports%26atitle%3DDiflunisal%252Btargets%252Bthe%252BHMGB%252B1%25252F%252BCXCL%252B12%252Bheterocomplex%252Band%252Bblocks%252Bimmune%252Bcell%252Brecruitment%26aulast%3DDe%2BLeo%26aufirst%3DFederica%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shan  Sun</span>, <span class="hlFld-ContribAuthor ">Mingzhu  He</span>, <span class="hlFld-ContribAuthor ">Sonya  VanPatten</span>, <span class="hlFld-ContribAuthor ">Yousef  Al-Abed</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic insights into high mobility group box-1 (HMGb1)-induced Toll-like receptor 4 (TLR4) dimer formation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (14)
                                     , 3721-3730. <a href="https://doi.org/10.1080/07391102.2018.1526712" title="DOI URL">https://doi.org/10.1080/07391102.2018.1526712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1526712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1526712%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMechanistic%252Binsights%252Binto%252Bhigh%252Bmobility%252Bgroup%252Bbox-1%252B%252528HMGb1%252529-induced%252BToll-like%252Breceptor%252B4%252B%252528TLR4%252529%252Bdimer%252Bformation%26aulast%3DSun%26aufirst%3DShan%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D14%26spage%3D3721%26epage%3D3730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soo Jeong  Kim</span>, <span class="hlFld-ContribAuthor ">Min Jeong  Ryu</span>, <span class="hlFld-ContribAuthor ">Jeongsu  Han</span>, <span class="hlFld-ContribAuthor ">Yunseon  Jang</span>, <span class="hlFld-ContribAuthor ">Min Joung  Lee</span>, <span class="hlFld-ContribAuthor ">Xianshu  Ju</span>, <span class="hlFld-ContribAuthor ">Ilhwan  Ryu</span>, <span class="hlFld-ContribAuthor ">Yu Lim  Lee</span>, <span class="hlFld-ContribAuthor ">Eungseok  Oh</span>, <span class="hlFld-ContribAuthor ">Woosuk  Chung</span>, <span class="hlFld-ContribAuthor ">Jun Young  Heo</span>, <span class="hlFld-ContribAuthor ">Gi Ryang  Kweon</span>. </span><span class="cited-content_cbyCitation_article-title">Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse model. </span><span class="cited-content_cbyCitation_journal-name">Laboratory Investigation</span><span> <strong>2019,</strong> <em>99 </em>
                                    (9)
                                     , 1389-1399. <a href="https://doi.org/10.1038/s41374-019-0254-5" title="DOI URL">https://doi.org/10.1038/s41374-019-0254-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41374-019-0254-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41374-019-0254-5%26sid%3Dliteratum%253Aachs%26jtitle%3DLaboratory%2520Investigation%26atitle%3DNon-cell%2525C2%2525A0autonomous%252Bmodulation%252Bof%252Btyrosine%252Bhydroxylase%252Bby%252BHMGB1%252Breleased%252Bfrom%252Bastrocytes%252Bin%252Ban%252Bacute%252BMPTP-induced%252BParkinsonian%252Bmouse%252Bmodel%26aulast%3DKim%26aufirst%3DSoo%2BJeong%26date%3D2019%26date%3D2019%26volume%3D99%26issue%3D9%26spage%3D1389%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yam Nath  Paudel</span>, <span class="hlFld-ContribAuthor ">Efthalia  Angelopoulou</span>, <span class="hlFld-ContribAuthor ">Christina  Piperi</span>, <span class="hlFld-ContribAuthor ">Vinod R.M.T.  Balasubramaniam</span>, <span class="hlFld-ContribAuthor ">Iekhsan  Othman</span>, <span class="hlFld-ContribAuthor ">Mohd Farooq  Shaikh</span>. </span><span class="cited-content_cbyCitation_article-title">Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2019,</strong> <em>858 </em>, 172487. <a href="https://doi.org/10.1016/j.ejphar.2019.172487" title="DOI URL">https://doi.org/10.1016/j.ejphar.2019.172487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2019.172487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2019.172487%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DEnlightening%252Bthe%252Brole%252Bof%252Bhigh%252Bmobility%252Bgroup%252Bbox%252B1%252B%252528HMGB1%252529%252Bin%252Binflammation%25253A%252BUpdates%252Bon%252Breceptor%252Bsignalling%26aulast%3DPaudel%26aufirst%3DYam%2BNath%26date%3D2019%26volume%3D858%26spage%3D172487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arunya  Jiraviriyakul</span>, <span class="hlFld-ContribAuthor ">Worawat  Songjang</span>, <span class="hlFld-ContribAuthor ">Pongsathorn  Kaewthet</span>, <span class="hlFld-ContribAuthor ">Phachsita  Tanawatkitichai</span>, <span class="hlFld-ContribAuthor ">Punyapat  Bayan</span>, <span class="hlFld-ContribAuthor ">Sutatip  Pongcharoen</span>. </span><span class="cited-content_cbyCitation_article-title">Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Gastroenterology</span><span> <strong>2019,</strong> <em>25 </em>
                                    (29)
                                     , 3941-3955. <a href="https://doi.org/10.3748/wjg.v25.i29.3941" title="DOI URL">https://doi.org/10.3748/wjg.v25.i29.3941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3748/wjg.v25.i29.3941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3748%2Fwjg.v25.i29.3941%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Gastroenterology%26atitle%3DHonokiol-enhanced%252Bcytotoxic%252BT%252Blymphocyte%252Bactivity%252Bagainst%252Bcholangiocarcinoma%252Bcells%252Bmediated%252Bby%252Bdendritic%252Bcells%252Bpulsed%252Bwith%252Bdamage-associated%252Bmolecular%252Bpatterns%26aulast%3DJiraviriyakul%26aufirst%3DArunya%26date%3D2019%26volume%3D25%26issue%3D29%26spage%3D3941%26epage%3D3955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gina  Manda</span>, <span class="hlFld-ContribAuthor ">Mihail E.  Hinescu</span>, <span class="hlFld-ContribAuthor ">Ionela V.  Neagoe</span>, <span class="hlFld-ContribAuthor ">Luis F.V.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Rica  Boscencu</span>, <span class="hlFld-ContribAuthor ">Paul  Vasos</span>, <span class="hlFld-ContribAuthor ">Selma H.  Basaga</span>, <span class="hlFld-ContribAuthor ">Antonio  Cuadrado</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Therapeutic Targets in Oncologic Photodynamic Therapy. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2019,</strong> <em>24 </em>
                                    (44)
                                     , 5268-5295. <a href="https://doi.org/10.2174/1381612825666190122163832" title="DOI URL">https://doi.org/10.2174/1381612825666190122163832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612825666190122163832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612825666190122163832%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DEmerging%252BTherapeutic%252BTargets%252Bin%252BOncologic%252BPhotodynamic%252BTherapy%26aulast%3DManda%26aufirst%3DGina%26date%3D2019%26volume%3D24%26issue%3D44%26spage%3D5268%26epage%3D5295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enrico M.A.  Fassi</span>, <span class="hlFld-ContribAuthor ">Jacopo  Sgrignani</span>, <span class="hlFld-ContribAuthor ">Gianluca  D'Agostino</span>, <span class="hlFld-ContribAuthor ">Valentina  Cecchinato</span>, <span class="hlFld-ContribAuthor ">Maura  Garofalo</span>, <span class="hlFld-ContribAuthor ">Giovanni  Grazioso</span>, <span class="hlFld-ContribAuthor ">Mariagrazia  Uguccioni</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidation State Dependent Conformational Changes of HMGB1 Regulate the Formation of the CXCL12/HMGB1 Heterocomplex. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2019,</strong> <em>17 </em>, 886-894. <a href="https://doi.org/10.1016/j.csbj.2019.06.020" title="DOI URL">https://doi.org/10.1016/j.csbj.2019.06.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2019.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2019.06.020%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DOxidation%252BState%252BDependent%252BConformational%252BChanges%252Bof%252BHMGB1%252BRegulate%252Bthe%252BFormation%252Bof%252Bthe%252BCXCL12%25252FHMGB1%252BHeterocomplex%26aulast%3DFassi%26aufirst%3DEnrico%2BM.A.%26date%3D2019%26volume%3D17%26spage%3D886%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kailing  Wang</span>, <span class="hlFld-ContribAuthor ">Shan  Shan</span>, <span class="hlFld-ContribAuthor ">Shenqi  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Gu</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Zhou</span>, <span class="hlFld-ContribAuthor ">Tao  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">HMGB1-containing nucleosome mediates chemotherapy-induced metastasis of human lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2018,</strong> <em>500 </em>
                                    (3)
                                     , 758-764. <a href="https://doi.org/10.1016/j.bbrc.2018.04.150" title="DOI URL">https://doi.org/10.1016/j.bbrc.2018.04.150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2018.04.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2018.04.150%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DHMGB1-containing%252Bnucleosome%252Bmediates%252Bchemotherapy-induced%252Bmetastasis%252Bof%252Bhuman%252Blung%252Bcancer%26aulast%3DWang%26aufirst%3DKailing%26date%3D2018%26volume%3D500%26issue%3D3%26spage%3D758%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/medium/jm-2017-011362_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01136&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/medium/jm-2017-011362_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Model and schematic view of HMGb1 structure with box regions and cysteine residues highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01136&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/medium/jm-2017-011362_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of direct HMGb1 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01136&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/medium/jm-2017-011362_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of indirect HMGb1 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.7b01136/20180622/images/large/jm-2017-011362_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01136&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i14">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 176 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sirisinha, S.</span></span> <span> </span><span class="NLM_article-title">Insight into the mechanisms regulating immune homeostasis in health and disease</span>. <i>Asian Pac J. Allergy Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21560483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtV2jsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1-14&issue=1&author=S.+Sirisinha&title=Insight+into+the+mechanisms+regulating+immune+homeostasis+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into the mechanisms regulating immune homeostasis in health andI disease</span></div><div class="casAuthors">Sirisinha, Stitaya</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific Journal of Allergy and Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">APJIEA</span>;
        ISSN:<span class="NLM_cas:issn">0125-877X</span>.
    
            (<span class="NLM_cas:orgname">Allergy and Immunology Society of Thailand</span>)
        </div><div class="casAbstract">A review.  Innate and adaptive immune systems consist of cells and mols. that work together in concert to fight against microbial infection and maintain homeostasis.  Hosts encounter microbes / exogenous pathogen-assocd. mol. patterns (PAMPs) and endogenous damage-assocd. mol. patterns (DAMPs) all the time and they must have proper mechanisms to counteract the danger such that appropriate responses (e.g., degree of inflammation and types of mediators induced) can be mounted in different scenarios.  Increasing nos. of endogenous danger signals of host origin are being identified including, for example, uric acid and cholesterol crystals, high mobility group box1 (HMGB1) protein, oxidized LDL, vesicans, heat shock proteins (HSPs) and self DNA.  Many of these endogenous ligands have been shown to be assocd. with inflammation-related diseases like atherosclerosis, gout and type 2 diabetes.  Several DAMPs appear to have the ability to interact with more than one receptor.  We are now beginning to understand how the immune system can distinguish infection from endogenous ligands elaborated following cellular insults and tissue damage.  Appropriate responses to maintain the homeostatic state in health and disease depend largely on the recognition and response to these stimuli by germline encoded pattern-recognition receptors (PRRs) present on both immune and non-immune cells.  These receptors are, for example, Toll-like receptors (TLRs), C-type lectin receptors (CLRs) and cytosolic receptors (e.g., RLRs, NLRs and some intracellular DNA sensors).  Atypical PRR "danger" receptors, like the receptor for advanced glycation end products (RAGE) and their ligands have been identified.  A proper response to maintain homeostasis relies on specific neg. regulators and regulatory pathways to dampen its response to tissue injury while maintaining the capacity to eliminate infection and induce proper tissue repair.  Moreover, some PRRs (e.g., TLR2, TLR4 and NLRP3) and atypical PRRs can recognize both PAMPs and DAMPs, either as single entities or after forming complexes (e.g., immune complexes, or DNA- HMGB1 and DNA-LL37 complexes), so there must be a mechanism to selectively depress or alleviate the inflammatory response to DAMPs, while leaving that of PAMPs intact.  Excessive inflammatory responses can induce considerable tissue damage and can be highly detrimental to the host.  For example, CD24 reacting with HMGB1 and HSPs has been implicated to function as neg. regulator for RAGE.  In this review, I will briefly overview the information on various host and microbial components and bring together the information to synthesize a model to explain how homeostasis can be maintained in states of health and disease.  Understanding the mol. mechanisms by which the immune system functions under different scenarios will provide us with ways and means to design appropriate approaches, for example, to prevent or treat autoimmune and inflammatory diseases or the ability to design new drugs or formulate safe chems. for vaccine adjuvants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaXyMzzqHci7Vg90H21EOLACvtfcHk0liGqCKw6931VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtV2jsro%253D&md5=311396283644fcfccf58e2c1771b228e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSirisinha%26aufirst%3DS.%26atitle%3DInsight%2520into%2520the%2520mechanisms%2520regulating%2520immune%2520homeostasis%2520in%2520health%2520and%2520disease%26jtitle%3DAsian%2520Pac%2520J.%2520Allergy%2520Immunol.%26date%3D2011%26volume%3D29%26issue%3D1%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liston, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, S. L.</span></span> <span> </span><span class="NLM_article-title">Homeostasis-altering molecular processes as mechanisms of inflammasome activation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1038/nri.2016.151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnri.2016.151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28163301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFemtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=208-214&issue=3&author=A.+Listonauthor=S.+L.+Masters&title=Homeostasis-altering+molecular+processes+as+mechanisms+of+inflammasome+activation&doi=10.1038%2Fnri.2016.151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Homeostasis-altering molecular processes as mechanisms of inflammasome activation</span></div><div class="casAuthors">Liston, Adrian; Masters, Seth L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">208-214</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The innate immune system uses a distinct set of germline-encoded pattern recognition receptors (PRRs) to initiate downstream inflammatory cascades.  This recognition system is in stark contrast to the adaptive immune system, which relies on highly variable, randomly generated antigen receptors.  A key limitation of the innate immune system's reliance on fixed PRRs is its inflexibility in responding to rapidly evolving pathogens.  Recent advances in our understanding of inflammasome activation suggest that the innate immune system also has sophisticated mechanisms for responding to pathogens for which there is no fixed PRR.  This includes the recognition of debris from dying cells, known as danger-assocd. mol. patterns (DAMPs), which can directly activate PRRs in a similar manner to pathogen-assocd. mol. patterns (PAMPs).  Distinct from this, emerging data for the inflammasome components NLRP3 (NOD-, LRR- and pyrin domain-contg. 3) and pyrin suggest that they do not directly detect mol. patterns, but instead act as signal integrators that are capable of detecting perturbations in cytoplasmic homeostasis, for example, as initiated by infection.  Monitoring these perturbations, which we term 'homeostasis-altering mol. processes' (HAMPs), provides potent flexibility in the capacity of the innate immune system to detect evolutionarily novel infections; however, HAMP sensing may also underlie the sterile inflammation that drives chronic inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoclEc3NgrY3bVg90H21EOLACvtfcHk0lgVw5THVsS6Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFemtLk%253D&md5=1b00f5ee553f358597155205c815ea59</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnri.2016.151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri.2016.151%26sid%3Dliteratum%253Aachs%26aulast%3DListon%26aufirst%3DA.%26aulast%3DMasters%26aufirst%3DS.%2BL.%26atitle%3DHomeostasis-altering%2520molecular%2520processes%2520as%2520mechanisms%2520of%2520inflammasome%2520activation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2017%26volume%3D17%26issue%3D3%26spage%3D208%26epage%3D214%26doi%3D10.1038%2Fnri.2016.151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span> <span> </span><span class="NLM_article-title">Treating inflammation and infection in the 21st century: New hints from decoding resolution mediators and mechanisms</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1273</span>– <span class="NLM_lpage">1288</span>, <span class="refDoi"> DOI: 10.1096/fj.201601222R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1096%2Ffj.201601222R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28087575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFGltb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=1273-1288&issue=4&author=C.+N.+Serhan&title=Treating+inflammation+and+infection+in+the+21st+century%3A+New+hints+from+decoding+resolution+mediators+and+mechanisms&doi=10.1096%2Ffj.201601222R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms</span></div><div class="casAuthors">Serhan, Charles N.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1273-1288</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Practitioners of ancient societies from the time of Hippocrates and earlier recognized and treated the signs of inflammation, heat, redness, swelling, and pain with agents that block or inhibit proinflammatory chem. mediators.  More selective drugs are available today, but this therapeutic concept has not changed.  Because the acute inflammatory response is host protective to contain foreign invaders, much of today's pharmacopeia can cause serious unwanted side effects, such as immune suppression.  Uncontrolled inflammation is now considered pathophysiol. and is assocd. with many widely occurring diseases such as cardiovascular disease, neurodegenerative diseases, diabetes, obesity, and asthma, as well as classic inflammatory diseases (e.g., arthritis and periodontal diseases).  The inflammatory response, when self-limited, produces a superfamily of chem. mediators that stimulate resoln. of the response.  Specialized proresolving mediators (SPMs), identified in recent years, are endogenous mediators that include the n-3-derived families resolvins, protectins, and maresins, as well as arachidonic acid-derived (n-6) lipoxins, which promote resoln. of inflammation, clearance of microbes, redn. of pain, and promotion of tissue regeneration via novel mechanisms.  Aspirin and statins have a pos. impact on these resoln. pathways, producing epimeric forms of specific SPMs, whereas other drugs can disrupt timely resoln.  In this article, evidence from recent human and preclin. animal studies is reviewed, indicating that SPMs are physiol. mediators and pharmacol. agonists that stimulate resoln. of inflammation and infection.  The findings suggest that it is time to challenge current treatment practices-namely, using inhibitors and antagonists alone-and to develop immunoresolvents as agonists to test resoln. pharmacol. and their role in catabasis for their therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVtSH45rvck7Vg90H21EOLACvtfcHk0ljC7eqvaoEsBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFGltb%252FE&md5=531a652e27d643fe3d5d05debe7bd8cc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1096%2Ffj.201601222R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201601222R%26sid%3Dliteratum%253Aachs%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26atitle%3DTreating%2520inflammation%2520and%2520infection%2520in%2520the%252021st%2520century%253A%2520New%2520hints%2520from%2520decoding%2520resolution%2520mediators%2520and%2520mechanisms%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26issue%3D4%26spage%3D1273%26epage%3D1288%26doi%3D10.1096%2Ffj.201601222R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilroy, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockinger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, P. P.</span></span> <span> </span><span class="NLM_article-title">The resolution of inflammation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1038/nri3362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnri3362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23197111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=59-66&issue=1&author=C.+D.+Buckleyauthor=D.+W.+Gilroyauthor=C.+N.+Serhanauthor=B.+Stockingerauthor=P.+P.+Tak&title=The+resolution+of+inflammation&doi=10.1038%2Fnri3362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The resolution of inflammation</span></div><div class="casAuthors">Buckley, Christopher D.; Gilroy, Derek W.; Serhan, Charles N.; Stockinger, Brigitta; Tak, Paul P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-66</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In 2011, Nature Reviews Immunol. organized a conference that brought together scientists and clinicians from both academia and industry to discuss one of the most pressing questions in medicine - how do we turn off rampant, undesirable inflammation.  There is a growing appreciation that, similarly to the initiation of inflammation, the resoln. of inflammation is an intricate and active process.  Can we therefore harness the mediators involved in resoln. responses to treat patients with chronic inflammatory or autoimmune diseases.  Here, we ask five of the speakers from the conference to share their thoughts on this emerging field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq28c1f6NZat7Vg90H21EOLACvtfcHk0ljC7eqvaoEsBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FL&md5=e91a54b735f7cf193c76853398294fb1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnri3362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3362%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DC.%2BD.%26aulast%3DGilroy%26aufirst%3DD.%2BW.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26aulast%3DStockinger%26aufirst%3DB.%26aulast%3DTak%26aufirst%3DP.%2BP.%26atitle%3DThe%2520resolution%2520of%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D13%26issue%3D1%26spage%3D59%26epage%3D66%26doi%3D10.1038%2Fnri3362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishnubhakat, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ombrellino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frazier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borovikova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manogue, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faist, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abumrad, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">Hmg-1 as a late mediator of endotoxin lethality in mice</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">5425</span>),  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">251</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=248-251&issue=5425&author=H.+Wangauthor=O.+Bloomauthor=M.+Zhangauthor=J.+M.+Vishnubhakatauthor=M.+Ombrellinoauthor=J.+Cheauthor=A.+Frazierauthor=H.+Yangauthor=S.+Ivanovaauthor=L.+Borovikovaauthor=K.+R.+Manogueauthor=E.+Faistauthor=E.+Abrahamauthor=J.+Anderssonauthor=U.+Anderssonauthor=P.+E.+Molinaauthor=N.+N.+Abumradauthor=A.+Samaauthor=K.+J.+Tracey&title=Hmg-1+as+a+late+mediator+of+endotoxin+lethality+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBloom%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DVishnubhakat%26aufirst%3DJ.%2BM.%26aulast%3DOmbrellino%26aufirst%3DM.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DFrazier%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DIvanova%26aufirst%3DS.%26aulast%3DBorovikova%26aufirst%3DL.%26aulast%3DManogue%26aufirst%3DK.%2BR.%26aulast%3DFaist%26aufirst%3DE.%26aulast%3DAbraham%26aufirst%3DE.%26aulast%3DAndersson%26aufirst%3DJ.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DMolina%26aufirst%3DP.%2BE.%26aulast%3DAbumrad%26aufirst%3DN.%2BN.%26aulast%3DSama%26aufirst%3DA.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DHmg-1%2520as%2520a%2520late%2520mediator%2520of%2520endotoxin%2520lethality%2520in%2520mice%26jtitle%3DScience%26date%3D1999%26volume%3D285%26issue%3D5425%26spage%3D248%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. O.</span></span> <span> </span><span class="NLM_article-title">HMG1 and 2: Architectural DNA-binding proteins</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1042/bst0290395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1042%2Fbst0290395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=11497996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms1SlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=395-401&issue=4&author=J.+O.+Thomas&title=HMG1+and+2%3A+Architectural+DNA-binding+proteins&doi=10.1042%2Fbst0290395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">HMG1 and 2: architectural DNA-binding proteins</span></div><div class="casAuthors">Thomas, J. O.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-401</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review, with refs.  HMG1 and 2 (high mobility group proteins 1 and 2; renamed HMGB1 and HMGB2) contain two DNA-binding HMG-box domains (A and B) and a long acidic C-terminal domain.  They bind DNA without sequence specificity, but have a high affinity for bent or distorted DNA, and bend linear DNA.  The individual A and B boxes (which, although broadly similar, show both structural and functional differences) exhibit many of the structure-specific properties of the whole protein.  The acidic tail modulates the affinity of the tandem HMG boxes in HMG1 and 2 for a variety of DNA targets, including four-way junctions, but not distorted DNA minicircles, to which the proteins bind with very high affinity.  HMG1 and 2 appear to play important architectural roles in the assembly of nucleoprotein complexes in a variety of biol. processes, for example V(D)J recombination, the initiation of transcription, and DNA repair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrscXD4yJOzQrVg90H21EOLACvtfcHk0lg6QnuaaUDiQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms1SlsL4%253D&md5=9daa670566257852530f9299d56e6a45</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2Fbst0290395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0290395%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BO.%26atitle%3DHMG1%2520and%25202%253A%2520Architectural%2520DNA-binding%2520proteins%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2001%26volume%3D29%26issue%3D4%26spage%3D395%26epage%3D401%26doi%3D10.1042%2Fbst0290395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cham, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotze, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boone, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E. B.</span></span> <span> </span><span class="NLM_article-title">Cytosolic hmgb1 controls the cellular autophagy/apoptosis checkpoint during inflammation</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1098</span>– <span class="NLM_lpage">1110</span>, <span class="refDoi"> DOI: 10.1172/JCI76344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1172%2FJCI76344" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=1098-1110&issue=3&author=X.+Zhuauthor=J.+S.+Messerauthor=Y.+Wangauthor=F.+Linauthor=C.+M.+Chamauthor=J.+Changauthor=T.+R.+Billiarauthor=M.+T.+Lotzeauthor=D.+L.+Booneauthor=E.+B.+Chang&title=Cytosolic+hmgb1+controls+the+cellular+autophagy%2Fapoptosis+checkpoint+during+inflammation&doi=10.1172%2FJCI76344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1172%2FJCI76344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI76344%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DMesser%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DCham%26aufirst%3DC.%2BM.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DLotze%26aufirst%3DM.%2BT.%26aulast%3DBoone%26aufirst%3DD.%2BL.%26aulast%3DChang%26aufirst%3DE.%2BB.%26atitle%3DCytosolic%2520hmgb1%2520controls%2520the%2520cellular%2520autophagy%252Fapoptosis%2520checkpoint%2520during%2520inflammation%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26issue%3D3%26spage%3D1098%26epage%3D1110%26doi%3D10.1172%2FJCI76344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negishi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakasato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hangai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koshiba, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savitsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronfani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Hmgb proteins function as universal sentinels for nucleic-acid-mediated innate immune responses</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>462</i></span> (<span class="NLM_issue">7269</span>),  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1038/nature08512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnature08512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=99-103&issue=7269&author=H.+Yanaiauthor=T.+Banauthor=Z.+Wangauthor=M.+K.+Choiauthor=T.+Kawamuraauthor=H.+Negishiauthor=M.+Nakasatoauthor=Y.+Luauthor=S.+Hangaiauthor=R.+Koshibaauthor=D.+Savitskyauthor=L.+Ronfaniauthor=S.+Akiraauthor=M.+E.+Bianchiauthor=K.+Hondaauthor=T.+Tamuraauthor=T.+Kodamaauthor=T.+Taniguchi&title=Hmgb+proteins+function+as+universal+sentinels+for+nucleic-acid-mediated+innate+immune+responses&doi=10.1038%2Fnature08512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature08512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08512%26sid%3Dliteratum%253Aachs%26aulast%3DYanai%26aufirst%3DH.%26aulast%3DBan%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChoi%26aufirst%3DM.%2BK.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DNegishi%26aufirst%3DH.%26aulast%3DNakasato%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DHangai%26aufirst%3DS.%26aulast%3DKoshiba%26aufirst%3DR.%26aulast%3DSavitsky%26aufirst%3DD.%26aulast%3DRonfani%26aufirst%3DL.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DHonda%26aufirst%3DK.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DHmgb%2520proteins%2520function%2520as%2520universal%2520sentinels%2520for%2520nucleic-acid-mediated%2520innate%2520immune%2520responses%26jtitle%3DNature%26date%3D2009%26volume%3D462%26issue%3D7269%26spage%3D99%26epage%3D103%26doi%3D10.1038%2Fnature08512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">Hmg-1 rediscovered as a cytokine</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1097/00024382-200115040-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2F00024382-200115040-00001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=247-253&issue=4&author=H.+Yangauthor=H.+Wangauthor=K.+J.+Tracey&title=Hmg-1+rediscovered+as+a+cytokine&doi=10.1097%2F00024382-200115040-00001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2F00024382-200115040-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00024382-200115040-00001%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DHmg-1%2520rediscovered%2520as%2520a%2520cytokine%26jtitle%3DShock%26date%3D2001%26volume%3D15%26issue%3D4%26spage%3D247%26epage%3D253%26doi%3D10.1097%2F00024382-200115040-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calogero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigtlander, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span> <span> </span><span class="NLM_article-title">The lack of chromosomal protein hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1038/10338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2F10338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10391216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADyaK1MXkt1eqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=276-280&issue=3&author=S.+Calogeroauthor=F.+Grassiauthor=A.+Aguzziauthor=T.+Voigtlanderauthor=P.+Ferrierauthor=S.+Ferrariauthor=M.+E.+Bianchi&title=The+lack+of+chromosomal+protein+hmg1+does+not+disrupt+cell+growth+but+causes+lethal+hypoglycaemia+in+newborn+mice&doi=10.1038%2F10338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycemia in newborn mice</span></div><div class="casAuthors">Calogero, Sabina; Grassi, Fabio; Aguzzi, Adriano; Voigtlander, Till; Ferrier, Pierre; Ferrari, Simona; Bianchi, Marco E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">276-280</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">High mobility group 1 (HMG1) protein is an abundant component of all mammalian nuclei, and related proteins exist in all eukaryotes.  HMG1 binds linear DNA with moderate affinity and no sequence specificity, but bends the double helix significantly on binding through the minor groove.  It binds with high affinity to DNA that is already sharply bent, such as linker DNA at the entry and exit of nucleosomes; thus, it is considered a structural protein of chromatin.  HMG1 is also recruited to DNA by interactions with proteins required for basal and regulated transcription and V(D)J recombination.  Here the authors generate mice harboring deleted Hmg1.  Hmg1-/- pups are born alive, but die within 24 h due to hypoglycemia.  Hmg1-deficient mice survive for several days if given glucose parenterally, then waste away with pleiotropic defects (but no alteration in the immune repertoire).  Cell lines lacking Hmg1 grow normally, but the activation of gene expression by the glucocorticoid receptor (GR, encoded by the gene Grl1) is impaired.  Thus, Hmg1 is not essential for the overall organization of chromatin in the cell nucleus, but is crit. for proper transcriptional control by specific transcription factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogX2wDWqtflbVg90H21EOLACvtfcHk0lgHaW5qEF-CQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkt1eqsbk%253D&md5=09ea7cdb8feb2d7ce3cffdc47717e18b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F10338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F10338%26sid%3Dliteratum%253Aachs%26aulast%3DCalogero%26aufirst%3DS.%26aulast%3DGrassi%26aufirst%3DF.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DVoigtlander%26aufirst%3DT.%26aulast%3DFerrier%26aufirst%3DP.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26atitle%3DThe%2520lack%2520of%2520chromosomal%2520protein%2520hmg1%2520does%2520not%2520disrupt%2520cell%2520growth%2520but%2520causes%2520lethal%2520hypoglycaemia%2520in%2520newborn%2520mice%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D22%26issue%3D3%26spage%3D276%26epage%3D280%26doi%3D10.1038%2F10338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Houten, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeh, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotze, M. T.</span></span> <span> </span><span class="NLM_article-title">High mobility group box 1 (hmgb1) phenotypic role revealed with stress</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.2119/molmed.2014.00063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2014.00063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24937773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CjtLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=359-362&author=D.+Tangauthor=R.+Kangauthor=B.+Van+Houtenauthor=H.+J.+Zehauthor=T.+R.+Billiarauthor=M.+T.+Lotze&title=High+mobility+group+box+1+%28hmgb1%29+phenotypic+role+revealed+with+stress&doi=10.2119%2Fmolmed.2014.00063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box 1 (HMGB1) phenotypic role revealed with stress</span></div><div class="casAuthors">Tang, Daolin; Kang, Rui; Van Houten, Bennett; Zeh, Herbert J.; Billiar, Timothy R.; Lotze, Michael T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">359-362, 4 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">A review.  High mobility group box 1 (HMGB1) is an evolutionarily ancient protein that is present in one form or another in all eukaryotes.  It fundamentally resides in the nucleus but translocates to the cytosol with stress and is subsequently released into the extra cellular space.  HMGB1 global knockout mice exhibit lethal hypoglycemia, whereas tissues and cells from conditional knockout or knock-in mice are born alive without apparent significant functional deficit.  An aberrant response to targeted stress in the liver, pancreas, heart or myeloid cells is consistent with a protective role for HMGB1 in sustaining nuclear homeostasis and enabling other stress responses, including autophagy.  Under some conditions, HMGB1 is not required for liver and heart function.  Many challenges remain with respect to understanding the multiple roles of HMGB1 in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIf0Kp_cd4zLVg90H21EOLACvtfcHk0lgHaW5qEF-CQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CjtLjK&md5=d6835fed1308cc8131199ad5214fa740</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2014.00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2014.00063%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DR.%26aulast%3DVan%2BHouten%26aufirst%3DB.%26aulast%3DZeh%26aufirst%3DH.%2BJ.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DLotze%26aufirst%3DM.%2BT.%26atitle%3DHigh%2520mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520phenotypic%2520role%2520revealed%2520with%2520stress%26jtitle%3DMol.%2520Med.%26date%3D2014%26volume%3D20%26spage%3D359%26epage%3D362%26doi%3D10.2119%2Fmolmed.2014.00063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeh, H. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotze, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 in health and disease</span>. <i>Mol. Aspects Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.mam.2014.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.mam.2014.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25010388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSqt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=1-116&author=R.+Kangauthor=R.+Chenauthor=Q.+Zhangauthor=W.+Houauthor=S.+Wuauthor=L.+Caoauthor=J.+Huangauthor=Y.+Yuauthor=X.+G.+Fanauthor=Z.+Yanauthor=X.+Sunauthor=H.+Wangauthor=Q.+Wangauthor=A.+Tsungauthor=T.+R.+Billiarauthor=H.+J.+Zehauthor=M.+T.+Lotzeauthor=D.+Tang&title=Hmgb1+in+health+and+disease&doi=10.1016%2Fj.mam.2014.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1 in health and disease</span></div><div class="casAuthors">Kang, Rui; Chen, Ruochan; Zhang, Qiuhong; Hou, Wen; Wu, Sha; Cao, Lizhi; Huang, Jin; Yu, Yan; Fan, Xue-gong; Yan, Zhengwen; Sun, Xiaofang; Wang, Haichao; Wang, Qingde; Tsung, Allan; Billiar, Timothy R.; Zeh, Herbert J., III; Lotze, Michael T.; Tang, Daolin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-116</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Complex genetic and physiol. variations as well as environmental factors that drive emergence of chromosomal instability, development of unscheduled cell death, skewed differentiation, and altered metab. are central to the pathogenesis of human diseases and disorders.  Understanding the mol. bases for these processes is important for the development of new diagnostic biomarkers, and for identifying new therapeutic targets.  In 1973, a group of non-histone nuclear proteins with high electrophoretic mobility was discovered and termed high-mobility group (HMG) proteins.  The HMG proteins include three superfamilies termed HMGB, HMGN, and HMGA.  High-mobility group box 1 (HMGB1), the most abundant and well-studied HMG protein, senses and coordinates the cellular stress response and plays a crit. role not only inside of the cell as a DNA chaperone, chromosome guardian, autophagy sustainer, and protector from apoptotic cell death, but also outside the cell as the prototypic damage assocd. mol. pattern mol. (DAMP).  This DAMP, in conjunction with other factors, thus has cytokine, chemokine, and growth factor activity, orchestrating the inflammatory and immune response.  All of these characteristics make HMGB1 a crit. mol. target in multiple human diseases including infectious diseases, ischemia, immune disorders, neurodegenerative diseases, metabolic disorders, and cancer.  Indeed, a no. of emergent strategies have been used to inhibit HMGB1 expression, release, and activity in vitro and in vivo.  These include antibodies, peptide inhibitors, RNAi, anti-coagulants, endogenous hormones, various chem. compds., HMGB1-receptor and signaling pathway inhibition, artificial DNAs, phys. strategies including vagus nerve stimulation and other surgical approaches.  Future work further investigating the details of HMGB1 localization, structure, post-translational modification, and identification of addnl. partners will undoubtedly uncover addnl. secrets regarding HMGB1's multiple functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqwR2-Bj_IQ7Vg90H21EOLACvtfcHk0lgHaW5qEF-CQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSqt7vJ&md5=7001bc5114c79a2bc3b92a18c39e24be</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2014.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2014.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DX.%2BG.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DTsung%26aufirst%3DA.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DZeh%26aufirst%3DH.%2BJ.%26aulast%3DLotze%26aufirst%3DM.%2BT.%26aulast%3DTang%26aufirst%3DD.%26atitle%3DHmgb1%2520in%2520health%2520and%2520disease%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2014%26volume%3D40%26spage%3D1%26epage%3D116%26doi%3D10.1016%2Fj.mam.2014.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotze, M. T.</span></span> <span> </span><span class="NLM_article-title">A janus tale of two active high mobility group box 1 (hmgb1) redox states</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1360</span>– <span class="NLM_lpage">1362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2012.00314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23073660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1360-1362&author=D.+Tangauthor=T.+R.+Billiarauthor=M.+T.+Lotze&title=A+janus+tale+of+two+active+high+mobility+group+box+1+%28hmgb1%29+redox+states"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A Janus tale of two active high mobility group box 1 (HMGB1) redox states</span></div><div class="casAuthors">Tang, Daolin; Billiar, Timothy R.; Lotze, Michael T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1360-1362</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">A review.  High mobility group box 1 (HMGB1), the prototypic damage-assocd. mol. pattern mol., is released at sites of inflammation and/or tissue damage.  There, it promotes cytokine prodn. and chemokine prodn./cell migration.  New work shows that the redox status of HMGB1 distinguishes its cytokine-inducing and chemokine activity.  Reduced all-thiol-HMGB1 has sole chemokine activity, whereas disulfide-HMGB1 has only cytokine activity, and oxidized, denatured HMGB1 has neither.  Autophagy (programmed cell survival) and apoptosis (programmed cell death) have been implicated in controlling both innate and adaptive immune functions.  Reduced HMGB1 protein promotes autophagy, whereas oxidized HMGB1 promotes apoptosis.  Thus, the differential activity of HMGB1 in immunity, inflammation and cell death depends on the cellular redox status within tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooOqIITQs9X7Vg90H21EOLACvtfcHk0lhHBoDeoppHIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeks70%253D&md5=2a40dab7c6415ba3c37c2e87b49b19f8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2012.00314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2012.00314%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DD.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DLotze%26aufirst%3DM.%2BT.%26atitle%3DA%2520janus%2520tale%2520of%2520two%2520active%2520high%2520mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520redox%2520states%26jtitle%3DMol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D1360%26epage%3D1362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span> <span> </span><span class="NLM_article-title">High mobility group box protein 1 (hmgb1): The prototypical endogenous danger molecule</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">S6</span>– <span class="NLM_lpage">S12</span>, <span class="refDoi"> DOI: 10.2119/molmed.2015.00087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2015.00087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26605648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFyiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=S6-S12&issue=Suppl.+1&author=H.+Yangauthor=H.+Wangauthor=S.+S.+Chavanauthor=U.+Andersson&title=High+mobility+group+box+protein+1+%28hmgb1%29%3A+The+prototypical+endogenous+danger+molecule&doi=10.2119%2Fmolmed.2015.00087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box protein 1 (HMGB1)- the prototypical endogenous danger molecule</span></div><div class="casAuthors">Yang, Huan; Wang, Haichao; Chavan, Sangeeta S.; Andersson, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">S6-S12</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">High mobility group box protein 1 (HMGB1) is an evolutionary ancient nuclear protein that exerts divergent biol. tasks inside and outside of cells.  The functions of HMGB1 depend on location, binding partners and redox states of the mol.  In the nucleus, HMGB1 organizes DNA and nucleosomes and regulates gene transcription.  Upon cell activation or injury, nuclear HMGB1 can translocate to the cytoplasm, where it is involved in inflammasome activation and pyroptosis, as well as regulation of the autophagy/apoptosis balance.  When actively secreted or passively released into the extracellular milieu, HMGB1 has cytokine, chemokine, neuroimmune and metabolic activities.  Thus, HMGB1 plays multiple roles in the pathogenesis of inflammatory diseases and mediates immune responses that range from inflammation and bacterial killing to tissue repair.  HMGB1 has been assocd. with divergent clin. conditions such as sepsis, rheumatoid arthritis and atherosclerosis.  HMGB1 initiates and perpetuates immune responses during infectious and sterile inflammation, as the archetypical alarmin and damage-assocd. mol. pattern (DAMP) mol.  We here describe advances in the understanding of HMGB1 biol. with focus on recent findings of its mission as a DAMP in danger sensing and as a therapeutic target in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpywgIYpeIwwbVg90H21EOLACvtfcHk0lirHfMNohTALA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFyiurs%253D&md5=585ac7e15bf92e03d5daaa019f2db000</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2015.00087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2015.00087%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChavan%26aufirst%3DS.%2BS.%26aulast%3DAndersson%26aufirst%3DU.%26atitle%3DHigh%2520mobility%2520group%2520box%2520protein%25201%2520%2528hmgb1%2529%253A%2520The%2520prototypical%2520endogenous%2520danger%2520molecule%26jtitle%3DMol.%2520Med.%26date%3D2015%26volume%3D21%26issue%3DSuppl.%25201%26spage%3DS6%26epage%3DS12%26doi%3D10.2119%2Fmolmed.2015.00087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiraki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadotani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejiri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, M.</span></span> <span> </span><span class="NLM_article-title">Expression of toll-like receptors on human platelets</span>. <i>Thromb. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1016/j.thromres.2004.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.thromres.2004.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=15226092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1ahu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2004&pages=379-385&issue=6&author=R.+Shirakiauthor=N.+Inoueauthor=S.+Kawasakiauthor=A.+Takeiauthor=M.+Kadotaniauthor=Y.+Ohnishiauthor=J.+Ejiriauthor=S.+Kobayashiauthor=K.+Hirataauthor=S.+Kawashimaauthor=M.+Yokoyama&title=Expression+of+toll-like+receptors+on+human+platelets&doi=10.1016%2Fj.thromres.2004.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Toll-like receptors on human platelets</span></div><div class="casAuthors">Shiraki, Rio; Inoue, Nobutaka; Kawasaki, Satoru; Takei, Asumi; Kadotani, Makoto; Ohnishi, Yoshio; Ejiri, Junya; Kobayashi, Seiichi; Hirata, Ken-ichi; Kawashima, Seinosuke; Yokoyama, Mitsuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">379-385</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Introduction: Platelets play a crucial role in arterial thrombosis, which is the main cause of acute coronary syndrome.  Some mycobacteriums, such as Chlamydia pneumoniae, were assocd. with progression of atherosclerosis and they are interacted with Toll-like receptors (TLRs), which have been defined as pathogen-assocd. mol. pattern recognition mols. in innate immunity.  In the present study, we examd. whether human platelets express TLRs.  Materials and methods: Human platelets were obtained from healthy volunteers and the mRNA and protein level of TLRs on platelets and Meg-01 cells, megakaryoblastic cell line, were investigated.  Results: Reverse transcription-polymerase chain reaction (RT-PCR) demonstrated that TLR1 and TLR6 mRNA were expressed in platelets and Meg-01 cells.  Furthermore, interferon-γ up-regulated their mRNA levels in dose and time dependent manners after stimuli.  Both TLR1 and TLR6 proteins in platelets were detected by Western blotting, and their expression of platelets was more than that of Meg-01 cells.  Flow cytometry anal. revealed the expression of TLR1 and TLR6 on the cell surface of Meg-01 cells.  Furthermore, immunohistochem. anal. using human coronary thrombi obtained from patients with acute coronary syndrome confirmed the expression of TLR1 and TLR6 on platelets.  Conclusion: In summary, we demonstrated that human platelets and Meg-01 cells expressed a family of TLRs for the first time, and our findings indicated that platelets might recognize antigens directly via TLRs.  Our findings suggest a possibility that platelets have the ability to recognize the antigens via TLRs and that there are mechanistic relations between infectious inflammation and atherosclerotic vascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMww6139Fl_rVg90H21EOLACvtfcHk0lirHfMNohTALA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1ahu7g%253D&md5=f98c0361e116e5bfc6f298bd9fd02ee1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2004.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2004.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DShiraki%26aufirst%3DR.%26aulast%3DInoue%26aufirst%3DN.%26aulast%3DKawasaki%26aufirst%3DS.%26aulast%3DTakei%26aufirst%3DA.%26aulast%3DKadotani%26aufirst%3DM.%26aulast%3DOhnishi%26aufirst%3DY.%26aulast%3DEjiri%26aufirst%3DJ.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DKawashima%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DM.%26atitle%3DExpression%2520of%2520toll-like%2520receptors%2520on%2520human%2520platelets%26jtitle%3DThromb.%2520Res.%26date%3D2004%26volume%3D113%26issue%3D6%26spage%3D379%26epage%3D385%26doi%3D10.1016%2Fj.thromres.2004.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuentes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, I.</span></span> <span> </span><span class="NLM_article-title">Role of multiligand/rage axis in platelet activation</span>. <i>Thromb. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>133</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1016/j.thromres.2013.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.thromres.2013.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24296115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2gu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2014&pages=308-314&issue=3&author=E.+Fuentesauthor=A.+Rojasauthor=I.+Palomo&title=Role+of+multiligand%2Frage+axis+in+platelet+activation&doi=10.1016%2Fj.thromres.2013.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Role of multiligand/RAGE axis in platelet activation</span></div><div class="casAuthors">Fuentes, Eduardo; Rojas, Armando; Palomo, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-314</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In the context of plaque progression, platelet hyperactivity assocd. with hyperlipidemia contributes to the development of a pro-thrombotic state.  In this context, it has been demonstrated that advanced glycation end products (AGEs) significantly increases platelet activation and receptor for AGEs (RAGE) expression at the platelet surface membrane.  In addn. to AGEs, other ligands (S100, HMGB1 and amyloid β, among others) of RAGE have raised particular attention in platelet activation.  Therefore, in this article we describe platelet hyperactivity by AGEs via RAGE-independent and RAGE-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxvRvM-JbvJrVg90H21EOLACvtfcHk0ljQmorySzoczg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2gu7jE&md5=b935e8f53eacb012e27ad6245cc21689</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2013.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2013.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DFuentes%26aufirst%3DE.%26aulast%3DRojas%26aufirst%3DA.%26aulast%3DPalomo%26aufirst%3DI.%26atitle%3DRole%2520of%2520multiligand%252Frage%2520axis%2520in%2520platelet%2520activation%26jtitle%3DThromb.%2520Res.%26date%3D2014%26volume%3D133%26issue%3D3%26spage%3D308%26epage%3D314%26doi%3D10.1016%2Fj.thromres.2013.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Signaling in innate immunity and inflammation</span>. <i>Cold Spring Harbor Perspect. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">a006049</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a006049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1101%2Fcshperspect.a006049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=a006049&issue=3&author=K.+Newtonauthor=V.+M.+Dixit&title=Signaling+in+innate+immunity+and+inflammation&doi=10.1101%2Fcshperspect.a006049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling in innate immunity and inflammation</span></div><div class="casAuthors">Newton, Kim; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">a006049, 19 pp.</span>CODEN:
                <span class="NLM_cas:coden">CSHPEU</span>;
        ISSN:<span class="NLM_cas:issn">1943-0264</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Inflammation is triggered when innate immune cells detect infection or tissue injury.  Surveillance mechanisms involve pattern recognition receptors (PRRs) on the cell surface and in the cytoplasm.  Most PRRs respond to pathogen-assocd. mol. patterns (PAMPs) or host-derived damage-assocd. mol. patterns (DAMPs) by triggering activation of NF-κB, AP1, CREB, c/EBP and IRF transcription factors.  Induction of genes encoding enzymes, chemokines, cytokines, adhesion mols. and regulators of the extracellular matrix promotes the recruitment and activation of leukocytes, which are crit. for eliminating foreign particles and host debris.  A subset of PRRs activates the protease caspase-1, which causes maturation of the cytokines IL1β and IL18.  Cell adhesion mols. and chemokines facilitate leukocyte extravasation from the circulation to the affected site, the chemokines stimulating G-protein-coupled receptors (GPCRs).  Binding initiates signals that regulate leukocyte motility and effector functions.  Other triggers of inflammation include allergens, which form antibody complexes that stimulate Fc receptors on mast cells.  Although the role of inflammation is to resolve infection and injury, increasing evidence indicates that chronic inflammation is a risk factor for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpctYaNBkRO0bVg90H21EOLACvtfcHk0ljQmorySzoczg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFyksLc%253D&md5=c9c6ace9e82ae4fd55503633635ebe44</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006049%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DSignaling%2520in%2520innate%2520immunity%2520and%2520inflammation%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2012%26volume%3D4%26issue%3D3%26spage%3Da006049%26doi%3D10.1101%2Fcshperspect.a006049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rouhiainen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauvala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkkinen, J.</span></span> <span> </span><span class="NLM_article-title">Occurrence of amphoterin (hmg1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation</span>. <i>Thromb Haemost.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1094</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=11154118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFarsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2000&pages=1087-1094&issue=6&author=A.+Rouhiainenauthor=S.+Imaiauthor=H.+Rauvalaauthor=J.+Parkkinen&title=Occurrence+of+amphoterin+%28hmg1%29+as+an+endogenous+protein+of+human+platelets+that+is+exported+to+the+cell+surface+upon+platelet+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation</span></div><div class="casAuthors">Rouhiainen, Ari; Imai, Shinji; Rauvala, Heikki; Parkkinen, Jaakko</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1087-1094</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">F. K. Schattauer Verlagsgesellschaft mbH</span>)
        </div><div class="casAbstract">Amphoterin (HMG1) is a 30-kD heparin-binding protein which is functionally assocd. with the outgrowth of cytoplasmic processes in developing neurons.  Amphoterin has been shown to mediate adhesive and proteolytic interactions at the leading edge of motile cells.  Recently it was shown that inhibition of amphoterin interactions with its cell surface receptor (RAGE) suppresses tumor growth and metastasis.  In this work we have identified amphoterin polypeptide and its mRNA in human platelets.  Amphoterin had a cytoplasmic localization in resting platelets according to subcellular fractionation studies and immunogold electron microscopy.  After platelet activation, part of amphoterin was assocd. with the external surface of plasma membrane.  Externalisation of amphoterin during platelet activation was also detected in immunofluorescence studies.  Amphoterin was detectable in human serum (0.2 ng/mL) but not in plasma.  Resting platelets treated with PGI2 and forskolin bound to immobilized recombinant amphoterin independently of divalent cations.  The binding induced a spicular morphol. in platelets, and was effectively inhibited by heparin.  Amphoterin-binding protein components on the platelet surface were not identified, but amphoterin bound to phosphatidylserine and sulfatide in lipid binding assays.  Our results suggest that amphoterin is an endogenous protein in human platelets, which is exported to the cell surface during platelet activation.  Interaction of amphoterin with the platelet surface may be mediated by sulfoglycolipids and phospholipids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGploAzQcJ7d5LVg90H21EOLACvtfcHk0ljG8Pi56oBfKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFarsQ%253D%253D&md5=613a4f442fca97b7e43e9d69d716e86f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRouhiainen%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DRauvala%26aufirst%3DH.%26aulast%3DParkkinen%26aufirst%3DJ.%26atitle%3DOccurrence%2520of%2520amphoterin%2520%2528hmg1%2529%2520as%2520an%2520endogenous%2520protein%2520of%2520human%2520platelets%2520that%2520is%2520exported%2520to%2520the%2520cell%2520surface%2520upon%2520platelet%2520activation%26jtitle%3DThromb%2520Haemost.%26date%3D2000%26volume%3D84%26issue%3D6%26spage%3D1087%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorch, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubes, P.</span></span> <span> </span><span class="NLM_article-title">An emerging role for neutrophil extracellular traps in noninfectious disease</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1038/nm.4294</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnm.4294" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28267716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtlaksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=279-287&issue=3&author=S.+K.+Jorchauthor=P.+Kubes&title=An+emerging+role+for+neutrophil+extracellular+traps+in+noninfectious+disease&doi=10.1038%2Fnm.4294"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">An emerging role for neutrophil extracellular traps in noninfectious disease</span></div><div class="casAuthors">Jorch, Selina K.; Kubes, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-287</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prodn. of neutrophil extracellular traps (NETs) is a process that enables neutrophils to help catch and kill bacteria.  However, increasing evidence suggests that this process might also occur in noninfectious, sterile inflammation.  In this Review, we describe the role of NETosis in autoimmunity, coagulation, acute injuries and cancer, and discuss NETs as potential therapeutic targets.  Furthermore, we consider whether extracellular DNA is always detrimental in sterile inflammation and whether the source is always NETs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLrTI0hCMz4rVg90H21EOLACvtfcHk0ljG8Pi56oBfKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtlaksLY%253D&md5=9d1117c79cf807fd4805a9f57a00155d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnm.4294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4294%26sid%3Dliteratum%253Aachs%26aulast%3DJorch%26aufirst%3DS.%2BK.%26aulast%3DKubes%26aufirst%3DP.%26atitle%3DAn%2520emerging%2520role%2520for%2520neutrophil%2520extracellular%2520traps%2520in%2520noninfectious%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26issue%3D3%26spage%3D279%26epage%3D287%26doi%3D10.1038%2Fnm.4294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span> <span> </span><span class="NLM_article-title">Emerging functions of serum amyloid a in inflammation</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>98</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1189/jlb.3VMR0315-080R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1189%2Fjlb.3VMR0315-080R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26130702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlGqt7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2015&pages=923-929&issue=6&author=R.+D.+Yeauthor=L.+Sun&title=Emerging+functions+of+serum+amyloid+a+in+inflammation&doi=10.1189%2Fjlb.3VMR0315-080R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging functions of serum amyloid A in inflammation</span></div><div class="casAuthors">Ye, Richard D.; Sun, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">923-929</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">SAA is a major acute-phase protein produced in large quantity during APR.  The rise of SAA concn. in blood circulation during APR has been a clin. marker for active inflammation.  In the past decade, research has been conducted to det. whether SAA plays an active role during inflammation and if so, how it influences the course of inflammation.  These efforts have led to the discovery of cytokine-like activities of rhSAA, which is com. available and widely used in most of the published studies.  SAA activates multiple receptors, including the FPR2, the TLRs TLR2 and TLR4, the scavenger receptor SR-BI, and the ATP receptor P2X7.  More recent studies have shown that SAA not only activates transcription factors, such as NF-κB, but also plays a role in epigenetic regulation through a MyD88- IRF4-Jmjd3 pathway.  It is postulated that the activation of these pathways leads to induced expression of proinflammatory factors and a subset of proteins expressed by the M2 macrophages.  These functional properties set SAA apart from well-characterized inflammatory factors, such as LPS and TNF-α, suggesting that it may play a homeostatic role during the course of inflammation.  Ongoing and future studies are directed to addressing unresolved issues, including the difference between rSAA and native SAA isoforms and the exact functions of SAA in physiol. and pathol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqbBv2-znzIbVg90H21EOLACvtfcHk0lgXi19vT440jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlGqt7%252FO&md5=81c4cedce8f4d186b6c9dc60706b8c5a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1189%2Fjlb.3VMR0315-080R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.3VMR0315-080R%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DR.%2BD.%26aulast%3DSun%26aufirst%3DL.%26atitle%3DEmerging%2520functions%2520of%2520serum%2520amyloid%2520a%2520in%2520inflammation%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2015%26volume%3D98%26issue%3D6%26spage%3D923%26epage%3D929%26doi%3D10.1189%2Fjlb.3VMR0315-080R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottazzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garlanda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Pattern recognition by pentraxins</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>653</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1007/978-1-4419-0901-5_7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2F978-1-4419-0901-5_7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=653&publication_year=2009&pages=98-116&author=A.+Agrawalauthor=P.+P.+Singhauthor=B.+Bottazziauthor=C.+Garlandaauthor=A.+Mantovani&title=Pattern+recognition+by+pentraxins&doi=10.1007%2F978-1-4419-0901-5_7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-0901-5_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4419-0901-5_7%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DP.%2BP.%26aulast%3DBottazzi%26aufirst%3DB.%26aulast%3DGarlanda%26aufirst%3DC.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DPattern%2520recognition%2520by%2520pentraxins%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2009%26volume%3D653%26spage%3D98%26epage%3D116%26doi%3D10.1007%2F978-1-4419-0901-5_7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anunciato, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenstock, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glezer, I.</span></span> <span> </span><span class="NLM_article-title">Gene expression control by glucocorticoid receptors during innate immune responses</span>. <i>Front. Endocrinol. (Lausanne, Switz.)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">31</span>, <span class="refDoi"> DOI: 10.3389/fendo.2016.00031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3389%2Ffendo.2016.00031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27148162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC28bms1CqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=31&author=A.+M.+Xavierauthor=A.+K.+Anunciatoauthor=T.+R.+Rosenstockauthor=I.+Glezer&title=Gene+expression+control+by+glucocorticoid+receptors+during+innate+immune+responses&doi=10.3389%2Ffendo.2016.00031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Gene Expression Control by Glucocorticoid Receptors during Innate Immune Responses</span></div><div class="casAuthors">Xavier Andre Machado; Anunciato Aparecida Kataryna Olimpio; Glezer Isaias; Rosenstock Tatiana Rosado</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31</span>
        ISSN:<span class="NLM_cas:issn">1664-2392</span>.
    </div><div class="casAbstract">Glucocorticoids (GCs) are potent anti-inflammatory compounds that have been extensively used in clinical practice for several decades.  GC's effects on inflammation are generally mediated through GC receptors (GRs).  Signal transduction through these nuclear receptors leads to dramatic changes in gene expression programs in different cell types, typically due to GR binding to DNA or to transcription modulators.  During the last decade, the view of GCs as exclusive anti-inflammatory molecules has been challenged.  GR negative interference in pro-inflammatory gene expression was a landmark in terms of molecular mechanisms that suppress immune activity.  In fact, GR can induce varied inhibitory molecules, including a negative regulator of Toll-like receptors pathway, or subject key transcription factors, such as NF-κB and AP-1, to a repressor mechanism.  In contrast, the expression of some acute-phase proteins and other players of innate immunity generally requires GR signaling.  Consequently, GRs must operate context-dependent inhibitory, permissive, or stimulatory effects on host defense signaling triggered by pathogens or tissue damage.  This review aims to disclose how contradictory or comparable effects on inflammatory gene expression can depend on pharmacological approach (including selective GC receptor modulators; SEGRMs), cell culture, animal treatment, or transgenic strategies used as models.  Although the current view of GR-signaling integrated many advances in the field, some answers to important questions remain elusive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCcXTW0RzAIcNIRw0GKUoEfW6udTcc2eas4z_D4rApT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bms1CqsQ%253D%253D&md5=31112fc6512607eafa93000a38a6d630</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2016.00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2016.00031%26sid%3Dliteratum%253Aachs%26aulast%3DXavier%26aufirst%3DA.%2BM.%26aulast%3DAnunciato%26aufirst%3DA.%2BK.%26aulast%3DRosenstock%26aufirst%3DT.%2BR.%26aulast%3DGlezer%26aufirst%3DI.%26atitle%3DGene%2520expression%2520control%2520by%2520glucocorticoid%2520receptors%2520during%2520innate%2520immune%2520responses%26jtitle%3DFront.%2520Endocrinol.%2520%2528Lausanne%252C%2520Switz.%2529%26date%3D2016%26volume%3D7%26spage%3D31%26doi%3D10.3389%2Ffendo.2016.00031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmblad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aveberger, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlandsson-Harris, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">High mobility group 1 protein (hmg-1) stimulates proinflammatory cytokine synthesis in human monocytes</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>192</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1084/jem.192.4.565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1084%2Fjem.192.4.565" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2000&pages=565-570&issue=4&author=U.+Anderssonauthor=H.+Wangauthor=K.+Palmbladauthor=A.+C.+Avebergerauthor=O.+Bloomauthor=H.+Erlandsson-Harrisauthor=A.+Jansonauthor=R.+Kokkolaauthor=M.+Zhangauthor=H.+Yangauthor=K.+J.+Tracey&title=High+mobility+group+1+protein+%28hmg-1%29+stimulates+proinflammatory+cytokine+synthesis+in+human+monocytes&doi=10.1084%2Fjem.192.4.565"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1084%2Fjem.192.4.565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.192.4.565%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DPalmblad%26aufirst%3DK.%26aulast%3DAveberger%26aufirst%3DA.%2BC.%26aulast%3DBloom%26aufirst%3DO.%26aulast%3DErlandsson-Harris%26aufirst%3DH.%26aulast%3DJanson%26aufirst%3DA.%26aulast%3DKokkola%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DHigh%2520mobility%2520group%25201%2520protein%2520%2528hmg-1%2529%2520stimulates%2520proinflammatory%2520cytokine%2520synthesis%2520in%2520human%2520monocytes%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D192%26issue%3D4%26spage%3D565%26epage%3D570%26doi%3D10.1084%2Fjem.192.4.565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manfredi, A. A.</span></span> <span> </span><span class="NLM_article-title">High-mobility group box 1 (hmgb1) protein at the crossroads between innate and adaptive immunity</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>220</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2007.00574.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fj.1600-065X.2007.00574.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=17979838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKgtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2007&pages=35-46&author=M.+E.+Bianchiauthor=A.+A.+Manfredi&title=High-mobility+group+box+1+%28hmgb1%29+protein+at+the+crossroads+between+innate+and+adaptive+immunity&doi=10.1111%2Fj.1600-065X.2007.00574.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity</span></div><div class="casAuthors">Bianchi, Marco E.; Manfredi, Angelo A.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Tissue damage occurs often in the life of mammals and is usually repaired.  Dying cells are swiftly phagocytosed, but before disappearing, they alert surrounding cells to activate homeostatic programs.  They release signals that recruit inflammatory cells to the site of injury, promote cell migration and cell division to replace dead cells, and activate the immune system in anticipation of microbial invasion.  Many of these events involve high-mobility group box 1 protein (HMGB1), a nuclear protein that is released passively when necrotic cells lose the integrity of their membranes.  HMGB1 behaves as a trigger of inflammation, attracting inflammatory cells, and of tissue repair, recruiting stem cells and promoting their proliferation.  Moreover, HMGB1 activates dendritic cells (DCs) and promotes their functional maturation and their response to lymph node chemokines.  Activated leukocytes actively secrete HMGB1 in the microenvironment.  Thus, HMGB1 acts in an autocrine/paracrine fashion and sustains long-term repair and defense programs.  DCs secrete HMGB1 several hours after contact with the first maturation stimulus; HMGB1 secretion is crit. for their ability to reach the lymph nodes, to sustain the proliferation of antigen-specific T cells, to prevent their activation-dependent apoptosis, and to promote their polarization towards a T-helper 1 phenotype.  These immune responses will also be directed against self-antigens that DCs process at the time of injury and can lead to autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCNB0eW0GCmLVg90H21EOLACvtfcHk0lgWfPd1x57yzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKgtr3J&md5=4e65aba0778252da3f3cfc27e49fe50a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2007.00574.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2007.00574.x%26sid%3Dliteratum%253Aachs%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DManfredi%26aufirst%3DA.%2BA.%26atitle%3DHigh-mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520protein%2520at%2520the%2520crossroads%2520between%2520innate%2520and%2520adaptive%2520immunity%26jtitle%3DImmunol.%2520Rev.%26date%3D2007%26volume%3D220%26spage%3D35%26epage%3D46%26doi%3D10.1111%2Fj.1600-065X.2007.00574.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manfredi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovere-Querini, P.</span></span> <span> </span><span class="NLM_article-title">Regulation of dendritic- and t-cell fate by injury-associated endogenous signals</span>. <i>Crit Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1615/CritRevImmunol.v29.i1.30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1615%2FCritRevImmunol.v29.i1.30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=19348611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVSrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=69-86&issue=1&author=A.+A.+Manfrediauthor=A.+Capobiancoauthor=M.+E.+Bianchiauthor=P.+Rovere-Querini&title=Regulation+of+dendritic-+and+t-cell+fate+by+injury-associated+endogenous+signals&doi=10.1615%2FCritRevImmunol.v29.i1.30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of dendritic- and T-cell fate by injury-associated endogenous signals</span></div><div class="casAuthors">Manfredi, Angelo A.; Capobianco, Annalisa; Bianchi, Marco E.; Rovere-Querini, Patrizia</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-86</span>CODEN:
                <span class="NLM_cas:coden">CCRIDE</span>;
        ISSN:<span class="NLM_cas:issn">1040-8401</span>.
    
            (<span class="NLM_cas:orgname">Begell House, Inc.</span>)
        </div><div class="casAbstract">A review.  Two events characterize tissue injury and sterile inflammation: (1) generation/release of autoantigens, and (2) generation of homeostatic inflammatory signals.  Homeostatic signals recruit leukocytes and promote cell migration and division to replace injured cells.  Moreover, they activate antigen-presenting phagocytes, in particular, dendritic cells (DCs), in anticipation of microbial invasion.  Activated DCs undergo a differentiation process, referred to as maturation, and migrate to secondary lymphoid organs.  Maturing DCs upregulate the mol. machinery required for the priming of naive T cells, including T lymphocytes recognizing autoantigens, which represent a substantial fraction of the host T-cell repertoire.  Recent data indicate that cues generated at sites of injury shape T-cell clonal expansion, regulating sensitivity to activation-dependent apoptosis and commitment towards a Th1, Th2, Th17, or regulatory T-cell fate.  Endogenous signals of tissue injury, also called damage-assocd. mol. patterns (DAMPS) or alarmins, therefore provide a code for switching the outcome of the presentation of autoantigens towards results as diverse as T-cell-mediated protective immunity, tissue repair, persistent inflammation and autoimmunity, or tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOiDP26Errh7Vg90H21EOLACvtfcHk0ljWIVi0mie2VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVSrs70%253D&md5=89ffc5ed0a5d668c54c6d4a599249e12</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1615%2FCritRevImmunol.v29.i1.30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1615%252FCritRevImmunol.v29.i1.30%26sid%3Dliteratum%253Aachs%26aulast%3DManfredi%26aufirst%3DA.%2BA.%26aulast%3DCapobianco%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DRovere-Querini%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520dendritic-%2520and%2520t-cell%2520fate%2520by%2520injury-associated%2520endogenous%2520signals%26jtitle%3DCrit%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D29%26issue%3D1%26spage%3D69%26epage%3D86%26doi%3D10.1615%2FCritRevImmunol.v29.i1.30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology</span>. <i>Mol. Aspects Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/j.mam.2017.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.mam.2017.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28263773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC1czjt1egtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=1-11&author=C.+N.+Serhan&title=Discovery+of+specialized+pro-resolving+mediators+marks+the+dawn+of+resolution+physiology+and+pharmacology&doi=10.1016%2Fj.mam.2017.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology</span></div><div class="casAuthors">Serhan Charles N</div><div class="citationInfo"><span class="NLM_cas:title">Molecular aspects of medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">It is with great pleasure that I write this foreword and introduction to this Special Issue dedicated to the protective actions of the pro-resolving mediators and edited by my colleague Dr.  Jesmond Dalli.  Many of my collaborators and colleagues that helped to uncover the actions and clinical potential of the resolvins and other specialized proresolving mediators (SPM), namely, the superfamily of pro-resolving mediators that includes the resolvin (E-series, D-series and DPA-derived), protectin and maresin families, as well as the arachidonic acid-derived lipoxins, join me in this special issue.  They have given contributions that present exciting new results on the remarkable actions and potency of these unique molecules, the SPM moving forward the importance of their mediators and pathways in human biology.  Each contribution to this issue is presented by world authorities in their respective fields covering discoveries that demonstrate the importance and impact of resolution mediators in biology, medicine and surgery.  While some of the authors were students and/or fellows with me and others, they are today the founding "resolutionists" of a new era of appreciation of autacoid biosynthesis and metabolomics in human health and disease with their rigorous attention to experimental detail and discovery.  The chapters of this issue are filled with exciting new discoveries demonstrating the dynamics and potential of resolution mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZbK7HLwqjrkg6wdEZmT2rfW6udTcc2eZOmDZ4-Bj82bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czjt1egtA%253D%253D&md5=6b841b9698f49be374c95f408aca3857</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2017.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2017.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26atitle%3DDiscovery%2520of%2520specialized%2520pro-resolving%2520mediators%2520marks%2520the%2520dawn%2520of%2520resolution%2520physiology%2520and%2520pharmacology%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2017%26volume%3D58%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.mam.2017.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strebovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalpke, A. H.</span></span> <span> </span><span class="NLM_article-title">Suppressor of cytokine signaling proteins as regulators of innate immune signaling</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.2741/4008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2741%2F4008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22201825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOhs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1627-1639&author=J.+Strebovskyauthor=P.+Walkerauthor=A.+H.+Dalpke&title=Suppressor+of+cytokine+signaling+proteins+as+regulators+of+innate+immune+signaling&doi=10.2741%2F4008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Suppressor of cytokine signaling proteins as regulators of innate immune signaling</span></div><div class="casAuthors">Strebovsky, Julia; Walker, Patrick; Dalpke, Alexander H.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1627-1639</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The innate immune system builds up the body's first line of defense against invading pathogenic microorganisms.  For effective defense of pathogenic invaders, a structured inflammatory reaction has to be initiated that is strongly dependent on cell-to-cell communication.  Inflammation in turn is a potentially autodestructive reaction that is tightly controlled to balance antimicrobial activity and host damage.  Suppressor of cytokine signaling (SOCS) proteins have been identified as crucial neg. regulators of various hematopoietic cytokines employing Janus kinase (JAK) and signal transducer and activator of transcription (STAT) signaling.  Further results now imply that also signaling by pattern recognition receptors (PRR) of the innate immune system that use a distinct signaling cascade induce and get regulated by SOCS proteins.  Thus, SOCS proteins not only modulate cell communication through JAK/STAT dependent cytokines but also regulate signaling by pattern recognition receptors including the Toll-like receptors (TLRs).  A model is presented that integrates the current, partly conflicting, data on the role of SOCS proteins in innate immunity's NFkappaB signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos9UGNsydb7rVg90H21EOLACvtfcHk0li7wWTkY2iX_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOhs7rI&md5=cb96146c80b028f28f9d7ca4b008f046</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2741%2F4008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F4008%26sid%3Dliteratum%253Aachs%26aulast%3DStrebovsky%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DP.%26aulast%3DDalpke%26aufirst%3DA.%2BH.%26atitle%3DSuppressor%2520of%2520cytokine%2520signaling%2520proteins%2520as%2520regulators%2520of%2520innate%2520immune%2520signaling%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2012%26volume%3D17%26spage%3D1627%26epage%3D1639%26doi%3D10.2741%2F4008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cain, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Specificity and sensitivity of glucocorticoid signaling in health and disease</span>. <i>Best Pract Res. Clin Endocrinol Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1016/j.beem.2015.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.beem.2015.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26303082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=545-556&issue=4&author=D.+W.+Cainauthor=J.+A.+Cidlowski&title=Specificity+and+sensitivity+of+glucocorticoid+signaling+in+health+and+disease&doi=10.1016%2Fj.beem.2015.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity and sensitivity of glucocorticoid signaling in health and disease</span></div><div class="casAuthors">Cain, Derek W.; Cidlowski, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">BPRCE9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Endogenous glucocorticoids regulate a variety of physiol. processes and are crucial to the systemic stress response.  Glucocorticoid receptors are expressed throughout the body, but there is considerable heterogeneity in glucocorticoid sensitivity and induced biol. responses across tissues.  The immunoregulatory properties of glucocorticoids are exploited in the clinic for the treatment of inflammatory and autoimmune disorders as well as certain hematol. malignancies, but adverse side effects hamper prolonged use.  Fully understanding the mol. events that shape the physiol. effects of glucocorticoid treatment will provide insight into optimal glucocorticoid therapies, reliable assessment of glucocorticoid sensitivity in patients, and may advance the development of novel GR agonists that exert immunosuppressive effects while avoiding harmful side effects.  In this review, we provide an overview of mechanisms that affect glucocorticoid specificity and sensitivity in health and disease, focusing on the distinct isoforms of the glucocorticoid receptor and their unique regulatory and functional properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm_PfrGg9m37Vg90H21EOLACvtfcHk0li7wWTkY2iX_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOhu7g%253D&md5=081d70feddcbfe36fed0369e89deb608</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.beem.2015.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.beem.2015.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DCain%26aufirst%3DD.%2BW.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26atitle%3DSpecificity%2520and%2520sensitivity%2520of%2520glucocorticoid%2520signaling%2520in%2520health%2520and%2520disease%26jtitle%3DBest%2520Pract%2520Res.%2520Clin%2520Endocrinol%2520Metab.%26date%3D2015%26volume%3D29%26issue%3D4%26spage%3D545%26epage%3D556%26doi%3D10.1016%2Fj.beem.2015.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huston, J. M.</span></span> <span> </span><span class="NLM_article-title">The vagus nerve and the inflammatory reflex: Wandering on a new treatment paradigm for systemic inflammation and sepsis</span>. <i>Surg Infect (Larchmt)</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1089/sur.2012.126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1089%2Fsur.2012.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22913335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC38bgtl2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=187-193&issue=4&author=J.+M.+Huston&title=The+vagus+nerve+and+the+inflammatory+reflex%3A+Wandering+on+a+new+treatment+paradigm+for+systemic+inflammation+and+sepsis&doi=10.1089%2Fsur.2012.126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The vagus nerve and the inflammatory reflex: wandering on a new treatment paradigm for systemic inflammation and sepsis</span></div><div class="casAuthors">Huston Jared M</div><div class="citationInfo"><span class="NLM_cas:title">Surgical infections</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">187-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The immune system protects the host against dangerous pathogens and toxins.  The central nervous system is charged with monitoring and coordinating appropriate responses to internal and external stimuli.  The inflammatory reflex sits at the crossroads of these crucial homeostatic systems.  This review highlights how the vagus nerve-mediated inflammatory reflex facilitates rapid and specific exchange of information between the nervous and immune systems to prevent tissue injury and infection.  METHODS:  Review of the pertinent English-language literature.  Nearly two decades of research has elucidated some of the essential anatomic, physiologic, and molecular connections of the inflammatory reflex.  The original descriptions of how these key components contribute to afferent and efferent anti-inflammatory vagus nerve signaling are summarized.  RESULTS:  The central nervous system recognizes peripheral inflammation via afferent vagus nerve signaling.  The brain can attenuate peripheral innate immune responses, including pro-inflammatory cytokine production, leukocyte recruitment, and nuclear factor kappa β activation via α7-nicotinic acetylcholine receptor subunit-dependent, T-lymphocyte-dependent, vagus nerve signaling to spleen.  This efferent arm of the inflammatory reflex is referred to as the "cholinergic anti-inflammatory pathway." Activation of this pathway via vagus nerve stimulation or pharmacologic α7 agonists prevents tissue injury in multiple models of systemic inflammation, shock, and sepsis.  CONCLUSIONS:  The vagus nerve-mediated inflammatory reflex is a powerful ally in the fight against lethal tissue damage after injury and infection.  Further studies will help translate the beneficial effects of this pathway into clinical use for our surgical patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSplUT3seOM7NbHMBt0mMIXfW6udTcc2eb59jZQQ30Gurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bgtl2gtw%253D%253D&md5=d33bf0a8cae00c270f57428f8e5b986d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1089%2Fsur.2012.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fsur.2012.126%26sid%3Dliteratum%253Aachs%26aulast%3DHuston%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520vagus%2520nerve%2520and%2520the%2520inflammatory%2520reflex%253A%2520Wandering%2520on%2520a%2520new%2520treatment%2520paradigm%2520for%2520systemic%2520inflammation%2520and%2520sepsis%26jtitle%3DSurg%2520Infect%2520%2528Larchmt%2529%26date%3D2012%26volume%3D13%26issue%3D4%26spage%3D187%26epage%3D193%26doi%3D10.1089%2Fsur.2012.126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Mir-212-3p inhibits lps-induced inflammatory response through targeting hmgb1 in murine macrophages</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>350</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2016.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.yexcr.2016.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27940320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGns7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2017&pages=318-326&issue=2&author=W.+Chenauthor=X.+Maauthor=P.+Zhangauthor=Q.+Liauthor=X.+Liangauthor=J.+Liu&title=Mir-212-3p+inhibits+lps-induced+inflammatory+response+through+targeting+hmgb1+in+murine+macrophages&doi=10.1016%2Fj.yexcr.2016.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">MiR-212-3p inhibits LPS-induced inflammatory response through targeting HMGB1 in murine macrophages</span></div><div class="casAuthors">Chen, Weiwei; Ma, Xiaoying; Zhang, Peng; Li, Qifeng; Liang, Xin; Liu, Jianwen</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-326</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sepsis is a major cause of mortality in seriously ill patients characterized by a series of severe systemic inflammatory responses due to an infection.  Thus, there is a critically need to search more accurate biomarkers and targets for diagnosis and treatment of sepsis.  Our study showed that miR-212-3p was up-regulated in LPS-treated macrophage RAW264.7 cells.  Overexpression of miR-212-3p in RAW264.7 cells led to suppression of pro-inflammatory cytokines (TNF-α and IL-6) induced by LPS.  Bioinformatic predictions and exptl. researches both revealed that HMGB1 was a direct target of miR-212-3p.  Meanwhile, the results showed that overexpression of miR-212-3p inhibited the cytoplasmic translocation of HMGB1 in LPS-induced RAW264.7 cells.  Subsequently, transfection of the pcDNA3.1/HMGB1 plasmid, which produced HMGB1 overexpression, exhibited similar effects as the LPS-induced macrophage inflammatory response and markedly activated the MAPKs including p38, ERK and JNK phosphorylation.  Furthermore, we also found that the phosphorylation of p38 MAPK and ERK was downregulated by miR-212-3p mimics upon LPS injection.  In conclusion, these results reveal that miR-212-3p directly targets HMGB1 to suppress inflammatory response in LPS-induced RAW264.7 cells.  All our findings indicate that miR-212-3p may act as a potential pharmacol. target for promising and effective therapeutic intervention in microbial infection in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhypuPjHW8bVg90H21EOLACvtfcHk0lie-BY589Gj1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGns7nE&md5=80fdedee0697415e3c6aee8df478f394</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2016.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2016.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DMir-212-3p%2520inhibits%2520lps-induced%2520inflammatory%2520response%2520through%2520targeting%2520hmgb1%2520in%2520murine%2520macrophages%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2017%26volume%3D350%26issue%3D2%26spage%3D318%26epage%3D326%26doi%3D10.1016%2Fj.yexcr.2016.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Exogenous mscs ameliorate hypoxia/reoxygenation injury in renal tubular epithelial cells through jak/stat signaling pathway-mediated regulation of hmgb1</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2412</span>– <span class="NLM_lpage">2420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28559991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC1cnivVartA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=2412-2420&issue=5&author=L.+Zhangauthor=Y.+Wangauthor=J.+Maauthor=X.+Laiauthor=J.+Fangauthor=G.+Liauthor=L.+Xuauthor=G.+Panauthor=Z.+Chen&title=Exogenous+mscs+ameliorate+hypoxia%2Freoxygenation+injury+in+renal+tubular+epithelial+cells+through+jak%2Fstat+signaling+pathway-mediated+regulation+of+hmgb1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Exogenous MSCs ameliorate hypoxia/reoxygenation injury in renal tubular epithelial cells through JAK/STAT signaling pathway-mediated regulation of HMGB1</span></div><div class="casAuthors">Zhang Lei; Ma Junjie; Lai Xingqiang; Fang Jiali; Li Guanghui; Xu Lu; Pan Guanghui; Chen Zheng; Wang Yan</div><div class="citationInfo"><span class="NLM_cas:title">American journal of translational research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2412-2420</span>
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    </div><div class="casAbstract">This study was conducted to investigate the repair mechanism of hypoxia/reoxygenation injury (HRI) in renal tubular epithelial cells (HK-2) by exogenous mesenchymal stem cells (MSCs).  The activation of the JAK/STAT pathway in HK-2 cells after HRI and treatment of MSCs, JAK inhibitor WP1066 and STAT inhibitor SOCS3 was investigated using Western blot analysis.  HK-2 cells were transfected with siRNA STAT3 and analyzed for expression of STAT3, JAK2 and HMGB1 using fluorescence quantitative PCR and Western blot.  Cell viability and apoptosis were analyzed using the MTT assay and flow cytometry.  After HRI, the JAK/STAT pathway in HK-2 cells was activated, resulting in the upregulation of JAK1, JAK2, JAK3, p-JAK1, p-JAK2, p-JAK3, STAT1, STAT2, STAT3, p-STAT1, p-STAT2 and p-STAT3.  After treatment with MSC conditioned medium (MSCs CM), WP1066, or SOCS, the expression of these proteins was significantly down-regulated.  When the cells were transfected with siRNA STAT3, the expression of STAT3 at protein and mRNA levels and JAK2 and HMGB1 at mRNA level was down-regulated; the cell viability was reduced and apoptosis increased.  It is concluded that exogenous MSCs reduce HRI of HK-2 cells by suppressing the JAK/STAT signaling pathway and down-regulating the expression of HMGB1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpLu9NEims2gvupmecNw_lfW6udTcc2eaSXPWDB1U90Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnivVartA%253D%253D&md5=24e558cab31d4d891af72bccf8c8df93</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DExogenous%2520mscs%2520ameliorate%2520hypoxia%252Freoxygenation%2520injury%2520in%2520renal%2520tubular%2520epithelial%2520cells%2520through%2520jak%252Fstat%2520signaling%2520pathway-mediated%2520regulation%2520of%2520hmgb1%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2017%26volume%3D9%26issue%3D5%26spage%3D2412%26epage%3D2420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czura, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">Neural inhibition of inflammation: The cholinergic anti-inflammatory pathway</span>. <i>J. Endotoxin Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1177/09680519030090060401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1177%2F09680519030090060401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=14733730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVGquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=409-413&issue=6&author=C.+J.+Czuraauthor=S.+G.+Friedmanauthor=K.+J.+Tracey&title=Neural+inhibition+of+inflammation%3A+The+cholinergic+anti-inflammatory+pathway&doi=10.1177%2F09680519030090060401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neural inhibition of inflammation: the cholinergic anti-inflammatory pathway</span></div><div class="casAuthors">Czura, Christopher J.; Friedman, Steven G.; Tracey, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endotoxin Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">409-413</span>CODEN:
                <span class="NLM_cas:coden">JENREB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0519</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">A review.  The innate immune system is activated by infection and injury to release pro-inflammatory cytokines, which activate macrophages and neutrophils and modulate specific cellular responses.  The magnitude of the cytokine response is crit., because a deficient response may result in secondary infections, while an excessive response may be more injurious than the original insult.  We recently described a neural pathway, termed the "cholinergic anti-inflammatory pathway", that reflexively monitors and adjusts the inflammatory response by inhibiting pro-inflammatory cytokine synthesis.  Efferent signals in the vagus nerve provide a direct mechanism for neural regulation of the immune response that is rapid, localized, and integrated.  Vagus nerve stimulation inhibits the release of TNF, HMGB1, and other cytokines, and protects against endotoxemia and ischemia-reperfusion injury.  This newly identified physiol. mechanism of maintaining immunol. homeostasis suggests that novel therapeutics may effectively modulate inflammatory responses by activating the cholinergic anti-inflammatory pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIozJN65A80bVg90H21EOLACvtfcHk0lie-BY589Gj1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVGquw%253D%253D&md5=26499dd893f38f1cd17007c12765f9b2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F09680519030090060401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F09680519030090060401%26sid%3Dliteratum%253Aachs%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DFriedman%26aufirst%3DS.%2BG.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DNeural%2520inhibition%2520of%2520inflammation%253A%2520The%2520cholinergic%2520anti-inflammatory%2520pathway%26jtitle%3DJ.%2520Endotoxin%2520Res.%26date%3D2003%26volume%3D9%26issue%3D6%26spage%3D409%26epage%3D413%26doi%3D10.1177%2F09680519030090060401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilroy, D. W.</span></span> <span> </span><span class="NLM_article-title">Resolution of inflammation: A new therapeutic frontier</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnrd.2016.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27020098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFGrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=551-567&issue=8&author=J.+N.+Fullertonauthor=D.+W.+Gilroy&title=Resolution+of+inflammation%3A+A+new+therapeutic+frontier&doi=10.1038%2Fnrd.2016.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Resolution of inflammation: a new therapeutic frontier</span></div><div class="casAuthors">Fullerton, James N.; Gilroy, Derek W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">551-567</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dysregulated inflammation is a central pathol. process in diverse disease states.  Traditionally, therapeutic approaches have sought to modulate the pro- or anti-inflammatory limbs of inflammation, with mixed success.  However, insight into the pathways by which inflammation is resolved has highlighted novel opportunities to pharmacol. manipulate these processes - a strategy that might represent a complementary (and perhaps even superior) therapeutic approach.  This Review discusses the state of the art in the biol. of resoln. of inflammation, highlighting the opportunities and challenges for translational research in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvaS77WpHhoLVg90H21EOLACvtfcHk0ljedS_-w5Yy3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFGrsb4%253D&md5=077da0583b0e280ea1b8640de017affd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.39%26sid%3Dliteratum%253Aachs%26aulast%3DFullerton%26aufirst%3DJ.%2BN.%26aulast%3DGilroy%26aufirst%3DD.%2BW.%26atitle%3DResolution%2520of%2520inflammation%253A%2520A%2520new%2520therapeutic%2520frontier%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26issue%3D8%26spage%3D551%26epage%3D567%26doi%3D10.1038%2Fnrd.2016.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venereau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casalgrandi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiraldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marchis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raeli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shams, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uguccioni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span> <span> </span><span class="NLM_article-title">Mutually exclusive redox forms of hmgb1 promote cell recruitment or proinflammatory cytokine release</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>209</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1519</span>– <span class="NLM_lpage">1528</span>, <span class="refDoi"> DOI: 10.1084/jem.20120189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1084%2Fjem.20120189" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2012&pages=1519-1528&issue=9&author=E.+Venereauauthor=M.+Casalgrandiauthor=M.+Schiraldiauthor=D.+J.+Antoineauthor=A.+Cattaneoauthor=F.+De+Marchisauthor=J.+Liuauthor=A.+Antonelliauthor=A.+Pretiauthor=L.+Raeliauthor=S.+S.+Shamsauthor=H.+Yangauthor=L.+Varaniauthor=U.+Anderssonauthor=K.+J.+Traceyauthor=A.+Bachiauthor=M.+Uguccioniauthor=M.+E.+Bianchi&title=Mutually+exclusive+redox+forms+of+hmgb1+promote+cell+recruitment+or+proinflammatory+cytokine+release&doi=10.1084%2Fjem.20120189"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1084%2Fjem.20120189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20120189%26sid%3Dliteratum%253Aachs%26aulast%3DVenereau%26aufirst%3DE.%26aulast%3DCasalgrandi%26aufirst%3DM.%26aulast%3DSchiraldi%26aufirst%3DM.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DDe%2BMarchis%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DAntonelli%26aufirst%3DA.%26aulast%3DPreti%26aufirst%3DA.%26aulast%3DRaeli%26aufirst%3DL.%26aulast%3DShams%26aufirst%3DS.%2BS.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DVarani%26aufirst%3DL.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DBachi%26aufirst%3DA.%26aulast%3DUguccioni%26aufirst%3DM.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26atitle%3DMutually%2520exclusive%2520redox%2520forms%2520of%2520hmgb1%2520promote%2520cell%2520recruitment%2520or%2520proinflammatory%2520cytokine%2520release%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2012%26volume%3D209%26issue%3D9%26spage%3D1519%26epage%3D1528%26doi%3D10.1084%2Fjem.20120189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukazawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span> <span> </span><span class="NLM_article-title">Post-translational methylation of high mobility group box 1 (hmgb1) causes its cytoplasmic localization in neutrophils</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">16336</span>– <span class="NLM_lpage">16344</span>, <span class="refDoi"> DOI: 10.1074/jbc.M608467200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1074%2Fjbc.M608467200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=16336-16344&issue=22&author=I.+Itoauthor=J.+Fukazawaauthor=M.+Yoshida&title=Post-translational+methylation+of+high+mobility+group+box+1+%28hmgb1%29+causes+its+cytoplasmic+localization+in+neutrophils&doi=10.1074%2Fjbc.M608467200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608467200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608467200%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DI.%26aulast%3DFukazawa%26aufirst%3DJ.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DPost-translational%2520methylation%2520of%2520high%2520mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520causes%2520its%2520cytoplasmic%2520localization%2520in%2520neutrophils%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D22%26spage%3D16336%26epage%3D16344%26doi%3D10.1074%2Fjbc.M608467200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. S.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 is phosphorylated by classical protein kinase c and is secreted by a calcium-dependent mechanism</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">5800</span>– <span class="NLM_lpage">5809</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0801873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.4049%2Fjimmunol.0801873" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=5800-5809&issue=9&author=Y.+J.+Ohauthor=J.+H.+Younauthor=Y.+Jiauthor=S.+E.+Leeauthor=K.+J.+Limauthor=J.+E.+Choiauthor=J.+S.+Shin&title=Hmgb1+is+phosphorylated+by+classical+protein+kinase+c+and+is+secreted+by+a+calcium-dependent+mechanism&doi=10.4049%2Fjimmunol.0801873"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0801873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0801873%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DY.%2BJ.%26aulast%3DYoun%26aufirst%3DJ.%2BH.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%2BE.%26aulast%3DLim%26aufirst%3DK.%2BJ.%26aulast%3DChoi%26aufirst%3DJ.%2BE.%26aulast%3DShin%26aufirst%3DJ.%2BS.%26atitle%3DHmgb1%2520is%2520phosphorylated%2520by%2520classical%2520protein%2520kinase%2520c%2520and%2520is%2520secreted%2520by%2520a%2520calcium-dependent%2520mechanism%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26issue%3D9%26spage%3D5800%26epage%3D5809%26doi%3D10.4049%2Fjimmunol.0801873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">The functions of hmgb1 depend on molecular localization and post-translational modifications</span>. <i>J. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.1111/joim.12309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fjoim.12309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25346011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVantrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2014&pages=420-424&issue=5&author=U.+Anderssonauthor=D.+J.+Antoineauthor=K.+J.+Tracey&title=The+functions+of+hmgb1+depend+on+molecular+localization+and+post-translational+modifications&doi=10.1111%2Fjoim.12309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The functions of HMGB1 depend on molecular localization and post-translational modifications</span></div><div class="casAuthors">Andersson, U.; Antoine, D. J.; Tracey, K. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Internal Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">420-424</span>CODEN:
                <span class="NLM_cas:coden">JINMEO</span>;
        ISSN:<span class="NLM_cas:issn">0954-6820</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">This review highlights on functions of HMGB1 depend on mol. localization and post-translational modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXhICohXEarrVg90H21EOLACvtfcHk0ljwG2YUIeo4Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVantrnE&md5=724484a86892ead7b9adcf34d181ed28</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fjoim.12309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjoim.12309%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520functions%2520of%2520hmgb1%2520depend%2520on%2520molecular%2520localization%2520and%2520post-translational%2520modifications%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2014%26volume%3D276%26issue%3D5%26spage%3D420%26epage%3D424%26doi%3D10.1111%2Fjoim.12309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress-mediated hmgb1 biology</span>. <i>Front. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">93</span>, <span class="refDoi"> DOI: 10.3389/fphys.2015.00093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3389%2Ffphys.2015.00093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25904867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2MjntlChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=93&author=Y.+Yuauthor=D.+Tangauthor=R.+Kang&title=Oxidative+stress-mediated+hmgb1+biology&doi=10.3389%2Ffphys.2015.00093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress-mediated HMGB1 biology</span></div><div class="casAuthors">Yu Yan; Tang Daolin; Kang Rui</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93</span>
        ISSN:<span class="NLM_cas:issn">1664-042X</span>.
    </div><div class="casAbstract">High mobility group box 1 (HMGB1) is a widely-expressed and highly-abundant protein that acts as an extracellular signal upon active secretion by immune cells or passive release by dead, dying, and injured cells.  Both intracellular and extracellular HMGB1 play pivotal roles in regulation of the cellular response to stress.  Targeting the translocation, release, and activity of HMGB1 can limit inflammation and reduce tissue damage during infection and sterile inflammation.  Although the mechanisms contributing to HMGB1 biology are still under investigation, it appears that oxidative stress is a central regulator of HMGB1's translocation, release, and activity in inflammation and cell death (e.g., necrosis, apoptosis, autophagic cell death, pyroptosis, and NETosis).  Thus, targeting HMGB1 with antioxidant compounds may be an attractive therapeutic strategy for inflammation-associated diseases such as sepsis, ischemia and reperfusion injury, arthritis, diabetes, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1z4Mw0xxFlJggzHGM8X5CfW6udTcc2eZcfVeomLd047ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjntlChsA%253D%253D&md5=714b8400cf5706332a9f08d9cc022806</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2015.00093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2015.00093%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DR.%26atitle%3DOxidative%2520stress-mediated%2520hmgb1%2520biology%26jtitle%3DFront.%2520Physiol.%26date%3D2015%26volume%3D6%26spage%3D93%26doi%3D10.3389%2Ffphys.2015.00093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LeBlanc, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doggett, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durocher, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, M.</span></span> <span> </span><span class="NLM_article-title">An immunogenic peptide in the a-box of hmgb1 protein reverses apoptosis-induced tolerance through rage receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">7777</span>– <span class="NLM_lpage">7786</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.541474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1074%2Fjbc.M113.541474" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=7777-7786&issue=11&author=P.+M.+LeBlancauthor=T.+A.+Doggettauthor=J.+Choiauthor=M.+A.+Hancockauthor=Y.+Durocherauthor=F.+Frankauthor=B.+Nagarauthor=T.+A.+Fergusonauthor=M.+Saleh&title=An+immunogenic+peptide+in+the+a-box+of+hmgb1+protein+reverses+apoptosis-induced+tolerance+through+rage+receptor&doi=10.1074%2Fjbc.M113.541474"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.541474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.541474%26sid%3Dliteratum%253Aachs%26aulast%3DLeBlanc%26aufirst%3DP.%2BM.%26aulast%3DDoggett%26aufirst%3DT.%2BA.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DHancock%26aufirst%3DM.%2BA.%26aulast%3DDurocher%26aufirst%3DY.%26aulast%3DFrank%26aufirst%3DF.%26aulast%3DNagar%26aufirst%3DB.%26aulast%3DFerguson%26aufirst%3DT.%2BA.%26aulast%3DSaleh%26aufirst%3DM.%26atitle%3DAn%2520immunogenic%2520peptide%2520in%2520the%2520a-box%2520of%2520hmgb1%2520protein%2520reverses%2520apoptosis-induced%2520tolerance%2520through%2520rage%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26issue%3D11%26spage%3D7777%26epage%3D7786%26doi%3D10.1074%2Fjbc.M113.541474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirsch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kniemeyer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Settmacher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahmen, U.</span></span> <span> </span><span class="NLM_article-title">Identification of proteins interacting with cytoplasmic high-mobility group box 1 during the hepatocellular response to ischemia reperfusion injury</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">167</span>, <span class="refDoi"> DOI: 10.3390/ijms18010167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3390%2Fijms18010167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1eitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=167&issue=1&author=T.+Zhangauthor=W.+Weiauthor=O.+Dirschauthor=T.+Krugerauthor=C.+Kanauthor=C.+Xieauthor=O.+Kniemeyerauthor=H.+Fangauthor=U.+Settmacherauthor=U.+Dahmen&title=Identification+of+proteins+interacting+with+cytoplasmic+high-mobility+group+box+1+during+the+hepatocellular+response+to+ischemia+reperfusion+injury&doi=10.3390%2Fijms18010167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of proteins interacting with cytoplasmic high-mobility group box 1 during the hepatocellular response to ischemia reperfusion injury</span></div><div class="casAuthors">Zhang, Tianjiao; Wei, Weiwei; Dirsch, Olaf; Krueger, Thomas; Kan, Chunyi; Xie, Chichi; Kniemeyer, Olaf; Fang, Haoshu; Settmacher, Utz; Dahmen, Uta</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">167/1-167/13</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Ischemia/reperfusion injury (IRI) occurs inevitably in liver transplantations and frequently during major resections, and can lead to liver dysfunction as well as systemic disorders.  High-mobility group box 1 (HMGB1) plays a pathogenic role in hepatic IRI.  In the normal liver, HMGB1 is located in the nucleus of hepatocytes; after ischemia reperfusion, it translocates to the cytoplasm and it is further released to the extracellular space.  Unlike the well-explored functions of nuclear and extracellular HMGB1, the role of cytoplasmic HMGB1 in hepatic IRI remains elusive.  We hypothesized that cytoplasmic HMGB1 interacts with binding proteins involved in the hepatocellular response to IRI.  In this study, binding proteins of cytoplasmic HMGB1 during hepatic IRI were identified.  Liver tissues from rats with warm ischemia reperfusion (WI/R) injury and from normal rats were subjected to cytoplasmic protein extn.  Co-immunopptn. using these protein exts. was performed to enrich HMGB1-protein complexes.  To sep. and identify the immunopptd. proteins in eluates, 2-dimensional electrophoresis and subsequent mass spectrometry detection were performed.  Two of the identified proteins were verified using Western blotting: betaine-homocysteine S-methyltransferase 1 (BHMT) and cystathionine γ-lyase (CTH).  Therefore, our results revealed the binding of HMGB1 to BHMT and CTH in cytoplasm during hepatic WI/R.  This finding may help to better understand the cellular response to IRI in the liver and to identify novel mol. targets for reducing ischemic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-1cUZMFlplbVg90H21EOLACvtfcHk0ljwG2YUIeo4Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1eitrY%253D&md5=6bf9d764597043856e0051f23ae1d735</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3390%2Fijms18010167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18010167%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DDirsch%26aufirst%3DO.%26aulast%3DKruger%26aufirst%3DT.%26aulast%3DKan%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DKniemeyer%26aufirst%3DO.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DSettmacher%26aufirst%3DU.%26aulast%3DDahmen%26aufirst%3DU.%26atitle%3DIdentification%2520of%2520proteins%2520interacting%2520with%2520cytoplasmic%2520high-mobility%2520group%2520box%25201%2520during%2520the%2520hepatocellular%2520response%2520to%2520ischemia%2520reperfusion%2520injury%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26issue%3D1%26spage%3D167%26doi%3D10.3390%2Fijms18010167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Cd24 and siglec-10 selectively repress tissue damage-induced immune responses</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>323</i></span> (<span class="NLM_issue">5922</span>),  <span class="NLM_fpage">1722</span>– <span class="NLM_lpage">1725</span>, <span class="refDoi"> DOI: 10.1126/science.1168988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1126%2Fscience.1168988" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=1722-1725&issue=5922&author=G.+Y.+Chenauthor=J.+Tangauthor=P.+Zhengauthor=Y.+Liu&title=Cd24+and+siglec-10+selectively+repress+tissue+damage-induced+immune+responses&doi=10.1126%2Fscience.1168988"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168988%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%2BY.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DCd24%2520and%2520siglec-10%2520selectively%2520repress%2520tissue%2520damage-induced%2520immune%2520responses%26jtitle%3DScience%26date%3D2009%26volume%3D323%26issue%3D5922%26spage%3D1722%26epage%3D1725%26doi%3D10.1126%2Fscience.1168988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salmivirta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauvala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elenius, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalkanen, M.</span></span> <span> </span><span class="NLM_article-title">Neurite growth-promoting protein (amphoterin, p30) binds syndecan</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>200</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1016/0014-4827(92)90194-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2F0014-4827%2892%2990194-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1369684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADyaK38XksVGgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=1992&pages=444-451&issue=2&author=M.+Salmivirtaauthor=H.+Rauvalaauthor=K.+Eleniusauthor=M.+Jalkanen&title=Neurite+growth-promoting+protein+%28amphoterin%2C+p30%29+binds+syndecan&doi=10.1016%2F0014-4827%2892%2990194-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Neurite growth-promoting protein (amphoterin, p30) binds syndecan</span></div><div class="casAuthors">Salmivirta, Markku; Rauvala, Heikki; Elenius, Klaus; Jalkanen, Markku</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">444-51</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    </div><div class="casAbstract">A new ligand for syndecan (a cell surface heparan sulfate-rich proteoglycan) has been discovered.  In the solid-phase binding assay utilizing small nitrocellulose disks to immobilize matrix mols., binding of syndecan to neurite growth-promoting protein, p30/amphoterin, was obsd.  This binding was strongly dependent on the concn. of amphoterin used to coat the disks, but was saturable with an excess amt. of syndecan.  The interaction was inhibitable with heparan sulfate and heparin but less effectively with chondroitin sulfate, indicating that heparan sulfate chains of syndecan were involved in the binding.  Anti-amphoterin antibodies inhibited the binding partially.  Mouse mammary epithelial cells bound amphoterin directly but not after trypsin treatment or in the presence of heparin and to produce amphoterin in the extracellular space.  Both syndecan and amphoterin were localized on lateral surfaces of newly adhered mammary epithelial cells.  Toward confluency amphoterin amts. decreased.  Because amphoterin can be localized to the same sites with syndecan and because of their interaction, amphoterin is a new putative pericellular ligand for syndecan.  These interactions may be involved in the regulation of cell behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt8ZIDHRx0_rVg90H21EOLACvtfcHk0ljSymK_OHSBew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XksVGgtb4%253D&md5=bbbb0a12dc07f4a2825bb1fea1a58427</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0014-4827%2892%2990194-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-4827%252892%252990194-D%26sid%3Dliteratum%253Aachs%26aulast%3DSalmivirta%26aufirst%3DM.%26aulast%3DRauvala%26aufirst%3DH.%26aulast%3DElenius%26aufirst%3DK.%26aulast%3DJalkanen%26aufirst%3DM.%26atitle%3DNeurite%2520growth-promoting%2520protein%2520%2528amphoterin%252C%2520p30%2529%2520binds%2520syndecan%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1992%26volume%3D200%26issue%3D2%26spage%3D444%26epage%3D451%26doi%3D10.1016%2F0014-4827%2892%2990194-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orlova, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierhaus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihanus, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballantyne, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gahmberg, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nawroth, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavakis, T.</span></span> <span> </span><span class="NLM_article-title">A novel pathway of hmgb1-mediated inflammatory cell recruitment that requires mac-1-integrin</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1129</span>– <span class="NLM_lpage">1139</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fsj.emboj.7601552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1129-1139&issue=4&author=V.+V.+Orlovaauthor=E.+Y.+Choiauthor=C.+Xieauthor=E.+Chavakisauthor=A.+Bierhausauthor=E.+Ihanusauthor=C.+M.+Ballantyneauthor=C.+G.+Gahmbergauthor=M.+E.+Bianchiauthor=P.+P.+Nawrothauthor=T.+Chavakis&title=A+novel+pathway+of+hmgb1-mediated+inflammatory+cell+recruitment+that+requires+mac-1-integrin&doi=10.1038%2Fsj.emboj.7601552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601552%26sid%3Dliteratum%253Aachs%26aulast%3DOrlova%26aufirst%3DV.%2BV.%26aulast%3DChoi%26aufirst%3DE.%2BY.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DChavakis%26aufirst%3DE.%26aulast%3DBierhaus%26aufirst%3DA.%26aulast%3DIhanus%26aufirst%3DE.%26aulast%3DBallantyne%26aufirst%3DC.%2BM.%26aulast%3DGahmberg%26aufirst%3DC.%2BG.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DNawroth%26aufirst%3DP.%2BP.%26aulast%3DChavakis%26aufirst%3DT.%26atitle%3DA%2520novel%2520pathway%2520of%2520hmgb1-mediated%2520inflammatory%2520cell%2520recruitment%2520that%2520requires%2520mac-1-integrin%26jtitle%3DEMBO%2520J.%26date%3D2007%26volume%3D26%26issue%3D4%26spage%3D1129%26epage%3D1139%26doi%3D10.1038%2Fsj.emboj.7601552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czura, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 signals through toll-like receptor (tlr) 4 and tlr2</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1097/01.shk.0000225404.51320.82</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2F01.shk.0000225404.51320.82" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=174-179&issue=2&author=M.+Yuauthor=H.+Wangauthor=A.+Dingauthor=D.+T.+Golenbockauthor=E.+Latzauthor=C.+J.+Czuraauthor=M.+J.+Fentonauthor=K.+J.+Traceyauthor=H.+Yang&title=Hmgb1+signals+through+toll-like+receptor+%28tlr%29+4+and+tlr2&doi=10.1097%2F01.shk.0000225404.51320.82"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1097%2F01.shk.0000225404.51320.82&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.shk.0000225404.51320.82%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DA.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DFenton%26aufirst%3DM.%2BJ.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DYang%26aufirst%3DH.%26atitle%3DHmgb1%2520signals%2520through%2520toll-like%2520receptor%2520%2528tlr%2529%25204%2520and%2520tlr2%26jtitle%3DShock%26date%3D2006%26volume%3D26%26issue%3D2%26spage%3D174%26epage%3D179%26doi%3D10.1097%2F01.shk.0000225404.51320.82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. L.</span></span> <span> </span><span class="NLM_article-title">The role of thrombomodulin lectin-like domain in inflammation</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">34</span>, <span class="refDoi"> DOI: 10.1186/1423-0127-19-34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2F1423-0127-19-34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22449172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFWkur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=34&author=Y.+H.+Liauthor=C.+H.+Kuoauthor=G.+Y.+Shiauthor=H.+L.+Wu&title=The+role+of+thrombomodulin+lectin-like+domain+in+inflammation&doi=10.1186%2F1423-0127-19-34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The role of thrombomodulin lectin-like domain in inflammation</span></div><div class="casAuthors">Li, Yi-Heng; Kuo, Cheng-Hsiang; Shi, Guey-Yueh; Wu, Hua-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Science (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34</span>CODEN:
                <span class="NLM_cas:coden">JBCIEA</span>;
        ISSN:<span class="NLM_cas:issn">1423-0127</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Thrombomodulin (TM) is a cell surface glycoprotein which is widely expressed in a variety of cell types.  It is a cofactor for thrombin binding that mediates protein C activation and inhibits thrombin activity.  In addn. to its anticoagulant activity, recent evidence has revealed that TM, esp. its lectin-like domain, has potent anti-inflammatory function through a variety of mol. mechanisms.  The lectin-like domain of TM plays an important role in suppressing inflammation independent of the TM anticoagulant activity.  This article makes an extensive review of the role of TM in inflammation.  The mol. targets of TM lectin-like domain have also been elucidated.  Recombinant TM protein, esp. the TM lectin-like domain may play a promising role in the management of sepsis, glomerulonephritis and arthritis.  These data demonstrated the potential therapeutic role of TM in the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSi7oVF0lbxbVg90H21EOLACvtfcHk0lgF-hAKL7pTlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFWkur4%253D&md5=14ba9136ba6007e933693b75f47c2857</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2F1423-0127-19-34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1423-0127-19-34%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BH.%26aulast%3DKuo%26aufirst%3DC.%2BH.%26aulast%3DShi%26aufirst%3DG.%2BY.%26aulast%3DWu%26aufirst%3DH.%2BL.%26atitle%3DThe%2520role%2520of%2520thrombomodulin%2520lectin-like%2520domain%2520in%2520inflammation%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2012%26volume%3D19%26spage%3D34%26doi%3D10.1186%2F1423-0127-19-34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addorisio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postiglione, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Abed, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">The haptoglobin beta subunit sequesters hmgb1 toxicity in sterile and infectious inflammation</span>. <i>J. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1111/joim.12619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fjoim.12619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28464519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGgtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2017&pages=76-93&issue=1&author=H.+Yangauthor=H.+Wangauthor=Y.+Wangauthor=M.+Addorisioauthor=J.+Liauthor=M.+J.+Postiglioneauthor=S.+S.+Chavanauthor=Y.+Al-Abedauthor=D.+J.+Antoineauthor=U.+Anderssonauthor=K.+J.+Tracey&title=The+haptoglobin+beta+subunit+sequesters+hmgb1+toxicity+in+sterile+and+infectious+inflammation&doi=10.1111%2Fjoim.12619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation</span></div><div class="casAuthors">Yang, H.; Wang, H.; Wang, Y.; Addorisio, M.; Li, J.; Postiglione, M. J.; Chavan, S. S.; Al-Abed, Y.; Antoine, D. J.; Andersson, U.; Tracey, K. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Internal Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-93</span>CODEN:
                <span class="NLM_cas:coden">JINMEO</span>;
        ISSN:<span class="NLM_cas:issn">0954-6820</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : Extra-corpuscular Hb is an endogenous factor enhancing inflammatory tissue damage, a process counteracted by the Hb-binding plasma protein haptoglobin composed of alpha and beta subunits connected by disulfide bridges.  Recent studies established that haptoglobin also binds and sequesters another pro-inflammatory mediator, HMGB1, via triggering CD163 receptor-mediated anti-inflammatory responses involving heme oxygenase-1 expression and IL-10 release.  The mol. mechanism underlying haptoglobin-HMGB1 interaction remains poorly elucidated.  Methods : Haptoglobin β subunits were tested for HMGB1-binding properties, as well as efficacy in animal models of sterile liver injury (induced by i.p. acetaminophen administration) or infectious peritonitis (induced by cecal ligation and puncture, CLP, surgery) using wild-type (C57BL/6) or haptoglobin gene-deficient mice.  Results : Structural-functional anal. demonstrated that the haptoglobin β subunit recapitulates the HMGB1-binding properties of full-length haptoglobin.  Similar to HMGB1-haptoglobin complexes, the HMGB1-haptoglobin β complexes also elicited anti-inflammatory effects via CD163-mediated IL-10 release and heme oxygenase-1 expression.  Treatment with haptoglobin β protein conferred significant protection in mouse models of polymicrobial sepsis as well as acetaminophen-induced liver injury, two HMGB1-dependent inflammatory conditions.  Conclusions : Haptoglobin β protein offers a novel therapeutic approach to fight against various inflammatory diseases caused by excessive HMGB1 release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTZ2WJ6ac5c7Vg90H21EOLACvtfcHk0lgF-hAKL7pTlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGgtb3L&md5=3cab497fefed3878becdabc42b8009d7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fjoim.12619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjoim.12619%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DAddorisio%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DPostiglione%26aufirst%3DM.%2BJ.%26aulast%3DChavan%26aufirst%3DS.%2BS.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520haptoglobin%2520beta%2520subunit%2520sequesters%2520hmgb1%2520toxicity%2520in%2520sterile%2520and%2520infectious%2520inflammation%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2017%26volume%3D282%26issue%3D1%26spage%3D76%26epage%3D93%26doi%3D10.1111%2Fjoim.12619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du Toit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loos, B.</span></span> <span> </span><span class="NLM_article-title">Autophagy and the invisible line between life and death</span>. <i>Eur. J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">598</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.ejcb.2016.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.ejcb.2016.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28340912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOhtLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2016&pages=598-610&issue=12&author=C.+Swartauthor=A.+Du+Toitauthor=B.+Loos&title=Autophagy+and+the+invisible+line+between+life+and+death&doi=10.1016%2Fj.ejcb.2016.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy and the invisible line between life and death</span></div><div class="casAuthors">Swart, Chrisna; Du Toit, Andre; Loos, Ben</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">598-610</span>CODEN:
                <span class="NLM_cas:coden">EJCBDN</span>;
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  For a considerable time cell death has been considered to represent mutually exclusive states with cell death modalities that are governed by their inherent and unique mode of action involving specific mol. entities and have therefore been studied primarily in isolation.  It is now, however, becoming increasingly clear that these modalities are regulated by similar pathways and share a no. of initiator and effector mols. that control both cell death as well as cell survival mechanisms, demanding a newly aligned and integrative approach of cell death assessment.  Frequently cell death is triggered through a dual action that incorporates signaling events assocd. with more than one death modality.  Apoptosis and necrosis regularly cooperate in a tightly balanced interplay that involves autophagy to serve context dependently either as a pro-survival or a pro-death mechanism.  In this review we will assess current cell death modalities and their mol. overlap with the goal of clarifying the controversial role of autophagy in the cell death response.  By dissecting the key mol. pathways and their positioning within a network of regulatory signalling hubs and checkpoints we discuss a distinct approach that integrates autophagy with a resultant cell death manifestation.  In doing so, former classifications of cell death modalities fade and reveal the intricate mol. proportions and complexities of the cell death response that may contribute towards an enhanced means of cell death control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw_5cXNCu9x7Vg90H21EOLACvtfcHk0lgF-hAKL7pTlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOhtLvI&md5=4c054ec57445bffd2d6ae3302092da6a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.ejcb.2016.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejcb.2016.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DSwart%26aufirst%3DC.%26aulast%3DDu%2BToit%26aufirst%3DA.%26aulast%3DLoos%26aufirst%3DB.%26atitle%3DAutophagy%2520and%2520the%2520invisible%2520line%2520between%2520life%2520and%2520death%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D2016%26volume%3D95%26issue%3D12%26spage%3D598%26epage%3D610%26doi%3D10.1016%2Fj.ejcb.2016.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agellon, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalak, M.</span></span> <span> </span><span class="NLM_article-title">Ca(2+) homeostasis and endoplasmic reticulum (er) stress: An integrated view of calcium signaling</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>460</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2015.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.bbrc.2015.02.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2015&pages=114-121&issue=1&author=J.+Krebsauthor=L.+B.+Agellonauthor=M.+Michalak&title=Ca%282%2B%29+homeostasis+and+endoplasmic+reticulum+%28er%29+stress%3A+An+integrated+view+of+calcium+signaling&doi=10.1016%2Fj.bbrc.2015.02.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DKrebs%26aufirst%3DJ.%26aulast%3DAgellon%26aufirst%3DL.%2BB.%26aulast%3DMichalak%26aufirst%3DM.%26atitle%3DCa%25282%252B%2529%2520homeostasis%2520and%2520endoplasmic%2520reticulum%2520%2528er%2529%2520stress%253A%2520An%2520integrated%2520view%2520of%2520calcium%2520signaling%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D460%26issue%3D1%26spage%3D114%26epage%3D121%26doi%3D10.1016%2Fj.bbrc.2015.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orrenius, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogvadze, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span> <span> </span><span class="NLM_article-title">Calcium and mitochondria in the regulation of cell death</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>460</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2015.01.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.bbrc.2015.01.137" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2015&pages=72-81&issue=1&author=S.+Orreniusauthor=V.+Gogvadzeauthor=B.+Zhivotovsky&title=Calcium+and+mitochondria+in+the+regulation+of+cell+death&doi=10.1016%2Fj.bbrc.2015.01.137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.01.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.01.137%26sid%3Dliteratum%253Aachs%26aulast%3DOrrenius%26aufirst%3DS.%26aulast%3DGogvadze%26aufirst%3DV.%26aulast%3DZhivotovsky%26aufirst%3DB.%26atitle%3DCalcium%2520and%2520mitochondria%2520in%2520the%2520regulation%2520of%2520cell%2520death%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D460%26issue%3D1%26spage%3D72%26epage%3D81%26doi%3D10.1016%2Fj.bbrc.2015.01.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, K. I.</span></span> <span> </span><span class="NLM_article-title">Calcium/calmodulin-dependent protein kinase is involved in the release of high mobility group box 1 via the interferon-beta signaling pathway</span>. <i>Immune Netw.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.4110/in.2012.12.4.148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.4110%2Fin.2012.12.4.148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23091438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FnsVGgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=148-154&issue=4&author=L.+Maauthor=S.+J.+Kimauthor=K.+I.+Oh&title=Calcium%2Fcalmodulin-dependent+protein+kinase+is+involved+in+the+release+of+high+mobility+group+box+1+via+the+interferon-beta+signaling+pathway&doi=10.4110%2Fin.2012.12.4.148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium/Calmodulin-Dependent Protein Kinase is Involved in the Release of High Mobility Group Box 1 Via the Interferon-β Signaling Pathway</span></div><div class="casAuthors">Ma Lijuan; Kim Seon-Ju; Oh Kwon Ik</div><div class="citationInfo"><span class="NLM_cas:title">Immune network</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">148-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Previously, we have reported that high mobility group box 1 (HMGB1), a proinflammatory mediator in sepsis, is released via the IFN-β-mediated JAK/STAT pathway.  However, detailed mechanisms are still unclear.  In this study, we dissected upstream signaling pathways of HMGB1 release using various molecular biology methods.  Here, we found that calcium/calmodulin-dependent protein kinase (CaM kinase, CaMK) is involved in HMGB1 release by regulating IFN-β production.  CaMK inhibitor, STO609, treatment inhibits LPS-induced IFN-β production, which is correlated with the phosphorylation of interferon regulatory factor 3 (IRF3).  Additionally, we show that CaMK-I plays a major role in IFN-β production although other CaMK members also seem to contribute to this event.  Furthermore, the CaMK inhibitor treatment reduced IFN-β production in a murine endotoxemia.  Our results suggest CaMKs contribute to HMGB1 release by enhancing IFN-β production in sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQjFK-eqXNi42Zyxfu64m4ffW6udTcc2eYYSk3UnDgLIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FnsVGgtw%253D%253D&md5=c7474aa9efcc1a105fa3ce29e7fcfd83</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.4110%2Fin.2012.12.4.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4110%252Fin.2012.12.4.148%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DOh%26aufirst%3DK.%2BI.%26atitle%3DCalcium%252Fcalmodulin-dependent%2520protein%2520kinase%2520is%2520involved%2520in%2520the%2520release%2520of%2520high%2520mobility%2520group%2520box%25201%2520via%2520the%2520interferon-beta%2520signaling%2520pathway%26jtitle%3DImmune%2520Netw.%26date%3D2012%26volume%3D12%26issue%3D4%26spage%3D148%26epage%3D154%26doi%3D10.4110%2Fin.2012.12.4.148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribar, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Means, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angus, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosengart, M. R.</span></span> <span> </span><span class="NLM_article-title">Calcium/calmodulin-dependent protein kinase (camk) iv mediates nucleocytoplasmic shuttling and release of hmgb1 during lipopolysaccharide stimulation of macrophages</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">5015</span>– <span class="NLM_lpage">5023</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.181.7.5015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.4049%2Fjimmunol.181.7.5015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2008&pages=5015-5023&issue=7&author=X.+Zhangauthor=D.+Wheelerauthor=Y.+Tangauthor=L.+Guoauthor=R.+A.+Shapiroauthor=T.+J.+Ribarauthor=A.+R.+Meansauthor=T.+R.+Billiarauthor=D.+C.+Angusauthor=M.+R.+Rosengart&title=Calcium%2Fcalmodulin-dependent+protein+kinase+%28camk%29+iv+mediates+nucleocytoplasmic+shuttling+and+release+of+hmgb1+during+lipopolysaccharide+stimulation+of+macrophages&doi=10.4049%2Fjimmunol.181.7.5015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.181.7.5015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.181.7.5015%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWheeler%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DR.%2BA.%26aulast%3DRibar%26aufirst%3DT.%2BJ.%26aulast%3DMeans%26aufirst%3DA.%2BR.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DAngus%26aufirst%3DD.%2BC.%26aulast%3DRosengart%26aufirst%3DM.%2BR.%26atitle%3DCalcium%252Fcalmodulin-dependent%2520protein%2520kinase%2520%2528camk%2529%2520iv%2520mediates%2520nucleocytoplasmic%2520shuttling%2520and%2520release%2520of%2520hmgb1%2520during%2520lipopolysaccharide%2520stimulation%2520of%2520macrophages%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D181%26issue%3D7%26spage%3D5015%26epage%3D5023%26doi%3D10.4049%2Fjimmunol.181.7.5015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">High-mobility group box 1 (hmgb1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (sr) ca(2+) leak through tlr4-ros signaling in cardiomyocytes</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1016/j.yjmcc.2014.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.yjmcc.2014.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24937603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ens7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=260-273&author=C.+Zhangauthor=M.+Moauthor=W.+Dingauthor=W.+Liuauthor=D.+Yanauthor=J.+Dengauthor=X.+Luoauthor=J.+Liu&title=High-mobility+group+box+1+%28hmgb1%29+impaired+cardiac+excitation-contraction+coupling+by+enhancing+the+sarcoplasmic+reticulum+%28sr%29+ca%282%2B%29+leak+through+tlr4-ros+signaling+in+cardiomyocytes&doi=10.1016%2Fj.yjmcc.2014.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca2 + leak through TLR4-ROS signaling in cardiomyocytes</span></div><div class="casAuthors">Zhang, Cuicui; Mo, Miaohua; Ding, Wenwen; Liu, Wenjuan; Yan, Dewen; Deng, Jianxin; Luo, Xinping; Liu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">260-273</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High-mobility group box 1 (HMGB1) is a proinflammatory mediator playing an important role in the pathogenesis of cardiac dysfunction in many diseases.  In this study, we explored the effects of HMGB1 on Ca2 + handling and cellular contractility in cardiomyocytes to seek for the mechanisms underlying HMGB1-induced cardiac dysfunction.  Our results show that HMGB1 increased the frequency of Ca2 + sparks, reduced the sarcoplasmic reticulum (SR) Ca2 + content, and decreased the amplitude of systolic Ca2 + transient and myocyte contractility in dose-dependent manners in adult rat ventricular myocytes.  Inhibiting high-frequent Ca2 + sparks with tetracaine largely inhibited the alterations of SR load and Ca2 + transient.  Blocking Toll-like receptor 4 (TLR4) with TAK-242 or knockdown of TLR4 by RNA interference remarkably inhibited HMGB1 induced high-frequent Ca2 + sparks and restored the SR Ca2 + content.  Concomitantly, the amplitude of systolic Ca2 + transient and myocyte contractility had significantly increased.  Furthermore, HMGB1 increased the level of intracellular reactive oxygen species (ROS) and consequently enhanced oxidative stress and CaMKII-activated phosphorylation (pSer2814) in ryanodine receptor 2 (RyR2).  TAK-242 pretreatment significantly decreased intracellular ROS levels and oxidative stress and hyperphosphorylation in RyR2, similar to the effects of antioxidant MnTBAP.  Consistently, MnTBAP normalized HMGB1-impaired Ca2 + handling and myocyte contractility.  Taken together, our findings suggest that HMGB1 enhances Ca2 + spark-mediated SR Ca2 + leak through TLR4-ROS signaling pathway, which causes partial depletion of SR Ca2 + content and hence decreases systolic Ca2 + transient and myocyte contractility.  Prevention of SR Ca2 + leak may be an effective therapeutic strategy for the treatment of cardiac dysfunction related to HMGB1 overprodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy5Bl4MmR2M7Vg90H21EOLACvtfcHk0lgWOS55exzThQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ens7nJ&md5=10df1705d1cf8c9f0a5dacda9194c10c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2014.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2014.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMo%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DHigh-mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520impaired%2520cardiac%2520excitation-contraction%2520coupling%2520by%2520enhancing%2520the%2520sarcoplasmic%2520reticulum%2520%2528sr%2529%2520ca%25282%252B%2529%2520leak%2520through%2520tlr4-ros%2520signaling%2520in%2520cardiomyocytes%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2014%26volume%3D74%26spage%3D260%26epage%3D273%26doi%3D10.1016%2Fj.yjmcc.2014.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Extracellular calcium elicits feedforward regulation of the toll-like receptor-triggered innate immune response</span>. <i>Cell. Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1038/cmi.2015.59</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fcmi.2015.59" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26277896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVyrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=180-191&issue=2&author=S.+Tangauthor=T.+Chenauthor=M.+Yangauthor=L.+Wangauthor=Z.+Yuauthor=B.+Xieauthor=C.+Qianauthor=S.+Xuauthor=N.+Liauthor=X.+Caoauthor=J.+Wang&title=Extracellular+calcium+elicits+feedforward+regulation+of+the+toll-like+receptor-triggered+innate+immune+response&doi=10.1038%2Fcmi.2015.59"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium elicits feedforward regulation of the Toll-like receptor-triggered innate immune response</span></div><div class="casAuthors">Tang, Songqing; Chen, Taoyong; Yang, Mingjin; Wang, Lei; Yu, Zhou; Xie, Bin; Qian, Cheng; Xu, Sheng; Li, Nan; Cao, Xuetao; Wang, Jianli</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-191</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite the expanding knowledge on feedback regulation of Toll-like receptor (TLR) signaling, the feedforward regulation of TLR signaling for the proper innate response to invading microbes is not fully understood.  Here, we report that extracellular calcium can coordinate the activation of the small GTPases Ras and Ras-proximate-1 (Rap1) upon TLR stimulation which favors activation of macrophages through a feedforward mechanism.  We show that different doses of TLR agonists can trigger different levels of cytokine prodn., which can be potentiated by extracellular calcium but are impaired by the chelating reagent ethylene glycol tetraacetic acid (EGTA) or by knockdown of stromal interaction mol. 1 (STIM1).  Upon TLR engagement, GTP-bound Ras levels are increased and GTP-bound Rap1 is decreased, which can be reversed by EGTA-mediated removal of extracellular calcium.  Furthermore, we demonstrate that Rap1 knockdown rescues the inhibitory effects of EGTA on the TLR-triggered innate response.  Examn. of the TLR signaling pathway reveals that extracellular calcium may regulate the TLR response via feedforward activation of the extracellular signal-regulated kinase signaling pathway.  Our data suggest that an influx of extracellular calcium, mediated by STIM1-operated calcium channels, may transmit the information about the intensity of extracellular TLR stimuli to initiate innate responses at an appropriate level.  Our study may provide mechanistic insight into the feedforward regulation of the TLR-triggered innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFhcztefoQPbVg90H21EOLACvtfcHk0lgWOS55exzThQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVyrurw%253D&md5=d2e52128c3be0f06221f4ff7853f9f5e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fcmi.2015.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcmi.2015.59%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DExtracellular%2520calcium%2520elicits%2520feedforward%2520regulation%2520of%2520the%2520toll-like%2520receptor-triggered%2520innate%2520immune%2520response%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2017%26volume%3D14%26issue%3D2%26spage%3D180%26epage%3D191%26doi%3D10.1038%2Fcmi.2015.59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, M.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor-triggered calcium mobilization protects mice against bacterial infection through extracellular atp release</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5076</span>– <span class="NLM_lpage">5085</span>, <span class="refDoi"> DOI: 10.1128/IAI.02546-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1128%2FIAI.02546-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25245808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyitbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=5076-5085&issue=12&author=H.+Renauthor=Y.+Tengauthor=B.+Tanauthor=X.+Zhangauthor=W.+Jiangauthor=M.+Liuauthor=W.+Jiangauthor=B.+Duauthor=M.+Qian&title=Toll-like+receptor-triggered+calcium+mobilization+protects+mice+against+bacterial+infection+through+extracellular+atp+release&doi=10.1128%2FIAI.02546-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptor-triggered calcium mobilization protects mice against bacterial infection through extracellular ATP release</span></div><div class="casAuthors">Ren, Hua; Teng, Yunfei; Tan, Binghe; Zhang, Xiaoyu; Jiang, Wei; Liu, Mingyao; Jiang, Wenzheng; Du, Bing; Qian, Min</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5076-5085, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Extracellular ATP (eATP), released as a "danger signal" by injured or stressed cells, plays an important role in the regulation of immune responses, but the relationship between ATP release and innate immune responses is still uncertain.  In this study, we demonstrated that ATP was released through Toll-like receptor (TLR)-assocd. signaling in both Escherichia coli-infected mice and lipopolysaccharide (LPS)- or Pam3CSK4-treated macrophages.  This ATP release could be blocked completely only by N-ethylmaleimide (NEM), not by carbenoxolone (CBX), flufenamic acid (FFA), or probenecid, suggesting the key role of exocytosis in this process.  Furthermore, LPS-induced ATP release could also be reduced dramatically through suppressing calcium mobilization by use of U73122, caffeine, and thapsigargin (TG).  In addn., the secretion of interleukin-1β (IL-1β) and CCL-2 was enhanced significantly by ATP, in a time- and dose-dependent manner.  Meanwhile, macrophage-mediated phagocytosis of bacteria was also promoted significantly by ATP stimulation.  Furthermore, extracellular ATP reduced the no. of invading bacteria and protected mice from peritonitis by activating purinergic receptors.  Mechanistically, phosphorylation of AKT and ERK was overtly increased by ATP in antibacterial immune responses.  Accordingly, if we blocked the P2X- and P2Y-assocd. signaling pathway by using suramin and pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid), tetrasodium salt (PPADS), the ATP-enhanced immune response was restrained significantly.  Taken together, our findings reveal an internal relationship between danger signals and TLR signaling in innate immune responses, which suggests a potential therapeutic significance of calcium mobilization-mediated ATP release in infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp05C_inpJ7NbVg90H21EOLACvtfcHk0lgWOS55exzThQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyitbrI&md5=6fe5e7c497411aa8cdc616d1005fb640</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FIAI.02546-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.02546-14%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DH.%26aulast%3DTeng%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DM.%26atitle%3DToll-like%2520receptor-triggered%2520calcium%2520mobilization%2520protects%2520mice%2520against%2520bacterial%2520infection%2520through%2520extracellular%2520atp%2520release%26jtitle%3DInfect.%2520Immun.%26date%3D2014%26volume%3D82%26issue%3D12%26spage%3D5076%26epage%3D5085%26doi%3D10.1128%2FIAI.02546-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Bernard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzuto, R.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors hit calcium</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1002/embr.201438685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Fembr.201438685" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=468-469&issue=5&author=M.+de%0ABernardauthor=R.+Rizzuto&title=Toll-like+receptors+hit+calcium&doi=10.1002%2Fembr.201438685"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fembr.201438685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fembr.201438685%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBernard%26aufirst%3DM.%26aulast%3DRizzuto%26aufirst%3DR.%26atitle%3DToll-like%2520receptors%2520hit%2520calcium%26jtitle%3DEMBO%2520Rep.%26date%3D2014%26volume%3D15%26issue%3D5%26spage%3D468%26epage%3D469%26doi%3D10.1002%2Fembr.201438685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allette, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Due, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripsch, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, F. A.</span></span> <span> </span><span class="NLM_article-title">Identification of a functional interaction of hmgb1 with receptor for advanced glycation end-products in a model of neuropathic pain</span>. <i>Brain, Behav., Immun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.bbi.2014.06.199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.bbi.2014.06.199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=169-177&author=Y.+M.+Alletteauthor=M.+R.+Dueauthor=S.+M.+Wilsonauthor=P.+Feldmanauthor=M.+S.+Ripschauthor=R.+Khannaauthor=F.+A.+White&title=Identification+of+a+functional+interaction+of+hmgb1+with+receptor+for+advanced+glycation+end-products+in+a+model+of+neuropathic+pain&doi=10.1016%2Fj.bbi.2014.06.199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2014.06.199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2014.06.199%26sid%3Dliteratum%253Aachs%26aulast%3DAllette%26aufirst%3DY.%2BM.%26aulast%3DDue%26aufirst%3DM.%2BR.%26aulast%3DWilson%26aufirst%3DS.%2BM.%26aulast%3DFeldman%26aufirst%3DP.%26aulast%3DRipsch%26aufirst%3DM.%2BS.%26aulast%3DKhanna%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DF.%2BA.%26atitle%3DIdentification%2520of%2520a%2520functional%2520interaction%2520of%2520hmgb1%2520with%2520receptor%2520for%2520advanced%2520glycation%2520end-products%2520in%2520a%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2014%26volume%3D42%26spage%3D169%26epage%3D177%26doi%3D10.1016%2Fj.bbi.2014.06.199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiraldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livoti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celona, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venereau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apuzzo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marchis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proudfoot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uguccioni, M.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with cxcl12 and signaling via cxcr4</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>209</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1084/jem.20111739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1084%2Fjem.20111739" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2012&pages=551-563&issue=3&author=M.+Schiraldiauthor=A.+Raucciauthor=L.+M.+Munozauthor=E.+Livotiauthor=B.+Celonaauthor=E.+Venereauauthor=T.+Apuzzoauthor=F.+De+Marchisauthor=M.+Pedottiauthor=A.+Bachiauthor=M.+Thelenauthor=L.+Varaniauthor=M.+Melladoauthor=A.+Proudfootauthor=M.+E.+Bianchiauthor=M.+Uguccioni&title=Hmgb1+promotes+recruitment+of+inflammatory+cells+to+damaged+tissues+by+forming+a+complex+with+cxcl12+and+signaling+via+cxcr4&doi=10.1084%2Fjem.20111739"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1084%2Fjem.20111739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20111739%26sid%3Dliteratum%253Aachs%26aulast%3DSchiraldi%26aufirst%3DM.%26aulast%3DRaucci%26aufirst%3DA.%26aulast%3DMunoz%26aufirst%3DL.%2BM.%26aulast%3DLivoti%26aufirst%3DE.%26aulast%3DCelona%26aufirst%3DB.%26aulast%3DVenereau%26aufirst%3DE.%26aulast%3DApuzzo%26aufirst%3DT.%26aulast%3DDe%2BMarchis%26aufirst%3DF.%26aulast%3DPedotti%26aufirst%3DM.%26aulast%3DBachi%26aufirst%3DA.%26aulast%3DThelen%26aufirst%3DM.%26aulast%3DVarani%26aufirst%3DL.%26aulast%3DMellado%26aufirst%3DM.%26aulast%3DProudfoot%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DUguccioni%26aufirst%3DM.%26atitle%3DHmgb1%2520promotes%2520recruitment%2520of%2520inflammatory%2520cells%2520to%2520damaged%2520tissues%2520by%2520forming%2520a%2520complex%2520with%2520cxcl12%2520and%2520signaling%2520via%2520cxcr4%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2012%26volume%3D209%26issue%3D3%26spage%3D551%26epage%3D563%26doi%3D10.1084%2Fjem.20111739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, F.</span></span> <span> </span><span class="NLM_article-title">New insights into trp channels: Interaction with pattern recognition receptors</span>. <i>Channels</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.4161/chan.27178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.4161%2Fchan.27178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24299922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12ktbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=13-19&issue=1&author=H.+Hanauthor=F.+Yi&title=New+insights+into+trp+channels%3A+Interaction+with+pattern+recognition+receptors&doi=10.4161%2Fchan.27178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into TRP channels: interaction with pattern recognition receptors</span></div><div class="casAuthors">Han, Huirong; Yi, Fan</div><div class="citationInfo"><span class="NLM_cas:title">Channels</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-19</span>CODEN:
                <span class="NLM_cas:coden">CHANCC</span>;
        ISSN:<span class="NLM_cas:issn">1933-6950</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  An increasing no. of studies have implicated that the activation of innate immune system and inflammatory mechanisms are of importance in the pathogenesis of numerous diseases.  The innate immune system is present in almost all multicellular organisms in response to pathogens or tissue injury, which is performed via germ-line encoded pattern-recognition receptors (PRRs) to recognize pathogen-assocd. mol. patterns (PAMPs) or dangers-assocd. mol. patterns (DAMPs).  Intracellular pathways linking immune and inflammatory response to ion channel expression and function have been recently identified.  Among ion channels, transient receptor potential (TRP) channels are a major family of non-selective cation-permeable channels that function as polymodal cellular sensors involved in many physiol. and pathol. processes.  In this review, we summarize current knowledge about classifications, functions, and interactions of TRP channels and PRRs, which may provide new insights into their roles in the pathogenesis of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB_3-ifzTMSrVg90H21EOLACvtfcHk0lj0_ZxWGH9M0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12ktbrJ&md5=00d2b0570d37a7dbd28a877989ce2193</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.4161%2Fchan.27178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fchan.27178%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DH.%26aulast%3DYi%26aufirst%3DF.%26atitle%3DNew%2520insights%2520into%2520trp%2520channels%253A%2520Interaction%2520with%2520pattern%2520recognition%2520receptors%26jtitle%3DChannels%26date%3D2014%26volume%3D8%26issue%3D1%26spage%3D13%26epage%3D19%26doi%3D10.4161%2Fchan.27178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchel, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayball, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, K. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of hmgb1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">5850</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-06205-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fs41598-017-06205-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28724977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC1cjpt1Oisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=5850&issue=1&author=N.+E.+Stevensauthor=M.+J.+Chapmanauthor=C.+K.+Fraserauthor=T.+R.+Kuchelauthor=J.+D.+Hayballauthor=K.+R.+Diener&title=Therapeutic+targeting+of+hmgb1+during+experimental+sepsis+modulates+the+inflammatory+cytokine+profile+to+one+associated+with+improved+clinical+outcomes&doi=10.1038%2Fs41598-017-06205-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes</span></div><div class="casAuthors">Stevens Natalie E; Hayball John D; Diener Kerrilyn R; Chapman Marianne J; Chapman Marianne J; Fraser Cara K; Kuchel Tim R; Hayball John D; Diener Kerrilyn R</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5850</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sepsis remains a significant health burden and a major clinical need exists for therapeutics to dampen the excessive and uncontrolled immune activation.  Nuclear protein high mobility group box protein 1 (HMGB1) is released following cell death and is a late mediator in sepsis pathogenesis.  While approaches targeting HMGB1 have demonstrated reduced mortality in pre-clinical models of sepsis, the impact of HMGB1 blockade on the complex septic inflammatory milieu and the development of subsequent immunosuppression remain enigmatic.  Analysis of plasma samples obtained from septic shock patients established an association between increased HMGB1 and non-survival, higher APACHE II scores, and increased pro-inflammatory cytokine responses.  Pre-clinically, administration of neutralising ovine anti-HMGB1 polyclonal antibodies improved survival in murine endotoxaemia and caecal ligation and puncture-induced sepsis models, and altered early cytokine profiles to one which corresponded to patterns observed in the surviving patient cohort.  Additionally, anti-HMGB1 treated murine sepsis survivors were significantly more resistant to secondary bacterial infection and exhibited altered innate immune cell phenotypes and cytokine responses.  These findings demonstrate that anti-HMGB1 antibodies alter inflammation in murine sepsis models and reduce sepsis mortality without potentiating immunosuppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpqnwfDgZWMZWtyewyzkyLfW6udTcc2eZ8wJ58DZ_ASrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjpt1Oisg%253D%253D&md5=f1e3e954601f7cf877a788ae90344711</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-06205-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-06205-z%26sid%3Dliteratum%253Aachs%26aulast%3DStevens%26aufirst%3DN.%2BE.%26aulast%3DChapman%26aufirst%3DM.%2BJ.%26aulast%3DFraser%26aufirst%3DC.%2BK.%26aulast%3DKuchel%26aufirst%3DT.%2BR.%26aulast%3DHayball%26aufirst%3DJ.%2BD.%26aulast%3DDiener%26aufirst%3DK.%2BR.%26atitle%3DTherapeutic%2520targeting%2520of%2520hmgb1%2520during%2520experimental%2520sepsis%2520modulates%2520the%2520inflammatory%2520cytokine%2520profile%2520to%2520one%2520associated%2520with%2520improved%2520clinical%2520outcomes%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D5850%26doi%3D10.1038%2Fs41598-017-06205-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sama, A. E.</span></span> <span> </span><span class="NLM_article-title">Targeting hmgb1 in the treatment of sepsis</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1517/14728222.2014.863876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1517%2F14728222.2014.863876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24392842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1CjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=257-268&issue=3&author=H.+Wangauthor=M.+F.+Wardauthor=A.+E.+Sama&title=Targeting+hmgb1+in+the+treatment+of+sepsis&doi=10.1517%2F14728222.2014.863876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting HMGB1 in the treatment of sepsis</span></div><div class="casAuthors">Wang, Haichao; Ward, Mary F.; Sama, Andrew E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-268</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Sepsis refers to the host's deleterious and non-resolving systemic inflammatory response to microbial infections and represents the leading cause of death in the intensive care unit.  The pathogenesis of sepsis is complex, but partly mediated by a newly identified alarmin mol., the high mobility group box 1 (HMGB1).  Areas covered: Here we review the evidence that support extracellular HMGB1 as a late mediator of exptl. sepsis with a wider therapeutic window and discuss the therapeutic potential of HMGB1-neutralizing antibodies and small mol. inhibitors (herbal components) in exptl. sepsis.  Expert opinion: It will be important to evaluate the efficacy of HMGB1-targeting strategies for the clin. management of human sepsis in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgOhjL4Dw2SrVg90H21EOLACvtfcHk0livwVpqgc_5fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1CjtLY%253D&md5=a4666b118edce3efd65a8866e586bb22</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.863876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.863876%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWard%26aufirst%3DM.%2BF.%26aulast%3DSama%26aufirst%3DA.%2BE.%26atitle%3DTargeting%2520hmgb1%2520in%2520the%2520treatment%2520of%2520sepsis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26issue%3D3%26spage%3D257%26epage%3D268%26doi%3D10.1517%2F14728222.2014.863876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span> <span> </span><span class="NLM_article-title">The role of hmgb1 in the pathogenesis of rheumatic disease</span>. <i>Biochim. Biophys. Acta, Gene Regul. Mech.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1799</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1016/j.bbagrm.2009.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.bbagrm.2009.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=20123076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslWguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1799&publication_year=2010&pages=141-148&issue=1%E2%80%932&author=U.+Anderssonauthor=H.+E.+Harris&title=The+role+of+hmgb1+in+the+pathogenesis+of+rheumatic+disease&doi=10.1016%2Fj.bbagrm.2009.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The role of HMGB1 in the pathogenesis of rheumatic disease</span></div><div class="casAuthors">Andersson, Ulf; Harris, Helena Erlandsson</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Gene Regulatory Mechanisms</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1799</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">141-148</span>CODEN:
                <span class="NLM_cas:coden">BBAGC6</span>;
        ISSN:<span class="NLM_cas:issn">1874-9399</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  HMGB1 is a ubiquitous nuclear protein that can be released by any damaged cell or by activated macrophages and certain other cell types.  HMGB1 has been successfully therapeutically targeted in multiple preclin. models of infectious and sterile diseases including arthritis.  Extracellular HMGB1 mediates inflammation via induction of cytokine and metalloproteinase prodn. and recruitment and activation of dendritic cells needed for priming of naive T helper type 1 lymphocytes.  HMGB1 can bind endogenous mols. such as IL-1β and nucleosomes and exogenous agents like endotoxin and microbial DNA.  These complexes synergistically increase the capacity for activation of adaptive and innate immunity.  HMGB1-nucleosome complexes induce autoantibody formation against double-stranded DNA and nucleosomes, which does not occur if HMGB1 is absent.  These antibodies are central in the pathogenesis of systemic lupus erythematosus and patients with active disease have both increased HMGB1 and HMGB1-nucleosome levels in circulation.  Furthermore, HMGB1 is strongly bipolar charged, enabling cell membrane passage and intracellular transport of complexed mols. including DNA.  Rheumatoid arthritis patients have excessive extracellular HMGB1 levels in joints and serum.  The HMGB1 release is caused by cytokines, activated complement and hypoxia.  The most prominent HMGB1 protein and mRNA expression arthritis is present in pannus regions, where synovial tissue invades articular cartilage and bone.  HMGB1 promotes the activity of proteolytic enzymes, and osteoclasts need HMGB1 for functional maturation.  Neutralizing HMGB1 therapy in preclin. models of arthritis confers striking protection against structural damage.  This review summarizes selected aspects of HMGB1 biol. relevant for induction and propagation of some autoimmune conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEA5LVMKyz3bVg90H21EOLACvtfcHk0livwVpqgc_5fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslWguw%253D%253D&md5=bd4c9649ee7cb4143a55c610c1e82794</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagrm.2009.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagrm.2009.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26atitle%3DThe%2520role%2520of%2520hmgb1%2520in%2520the%2520pathogenesis%2520of%2520rheumatic%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gene%2520Regul.%2520Mech.%26date%3D2010%26volume%3D1799%26issue%3D1%25E2%2580%25932%26spage%3D141%26epage%3D148%26doi%3D10.1016%2Fj.bbagrm.2009.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musumeci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roviello, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montesarchio, D.</span></span> <span> </span><span class="NLM_article-title">An overview on hmgb1 inhibitors as potential therapeutic agents in hmgb1-related pathologies</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>141</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2013.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.pharmthera.2013.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24220159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKgtrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2014&pages=347-357&issue=3&author=D.+Musumeciauthor=G.+N.+Rovielloauthor=D.+Montesarchio&title=An+overview+on+hmgb1+inhibitors+as+potential+therapeutic+agents+in+hmgb1-related+pathologies&doi=10.1016%2Fj.pharmthera.2013.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies</span></div><div class="casAuthors">Musumeci, Domenica; Roviello, Giovanni N.; Montesarchio, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-357</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  HMGB1 (High-Mobility Group Box-1) is a nuclear protein that acts as an architectural chromatin-binding factor involved in the maintenance of nucleosome structure and regulation of gene transcription.  It can be released into the extracellular milieu from immune and non-immune cells in response to various stimuli.  Extracellular HMGB1 contributes to the pathogenesis of numerous chronic inflammatory and autoimmune diseases, including sepsis, rheumatoid arthritis, atherosclerosis, chronic kidney disease, systemic lupus erythematosus (SLE), as well as cancer pathogenesis.  Interaction of released HMGB1 with the cell-surface receptor for advanced glycation end products (RAGE) is one of the main signaling pathways triggering these diseases.  It has been also demonstrated that the inhibition of the HMGB1-RAGE interaction represents a promising approach for the modulation of the inflammatory and tumor-facilitating activity of HMGB1.  In this review we describe various approaches recently proposed in the literature to inhibit HMGB1 and the related inflammatory processes, esp. focusing on the block of RAGE-HMGB1 signaling.  Several strategies are based on mols. which mainly interact with RAGE as competitive antagonists of HMGB1.  As an alternative, encouraging results have been obtained with HMGB1-targeting, leading to the identification of compds. that directly bind to HMGB1, ranging from small natural or synthetic mols., such as glycyrrhizin and gabexate mesilate, to HMGB1-specific antibodies, peptides, proteins as well as bent DNA-based duplexes.  Future perspectives are discussed in the light of the overall body of knowledge acquired by a large no. of research groups operating in different but related fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyHiZCTNIRKrVg90H21EOLACvtfcHk0livwVpqgc_5fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKgtrfN&md5=6401131ce36d0390fb12c8f1bb5fe995</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2013.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2013.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DMusumeci%26aufirst%3DD.%26aulast%3DRoviello%26aufirst%3DG.%2BN.%26aulast%3DMontesarchio%26aufirst%3DD.%26atitle%3DAn%2520overview%2520on%2520hmgb1%2520inhibitors%2520as%2520potential%2520therapeutic%2520agents%2520in%2520hmgb1-related%2520pathologies%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D141%26issue%3D3%26spage%3D347%26epage%3D357%26doi%3D10.1016%2Fj.pharmthera.2013.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musumeci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucci, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roviello, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moccia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedone, C.</span></span> <span> </span><span class="NLM_article-title">DNA-based strategies for blocking hmgb1 cytokine activity: Design, synthesis and preliminary in vitro/in vivo assays of DNA and DNA-like duplexes</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1742</span>– <span class="NLM_lpage">1752</span>, <span class="refDoi"> DOI: 10.1039/c1mb05009e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1039%2Fc1mb05009e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21431162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFSitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=1742-1752&issue=5&author=D.+Musumeciauthor=E.+M.+Bucciauthor=G.+N.+Rovielloauthor=R.+Sapioauthor=M.+Valenteauthor=M.+Mocciaauthor=M.+E.+Bianchiauthor=C.+Pedone&title=DNA-based+strategies+for+blocking+hmgb1+cytokine+activity%3A+Design%2C+synthesis+and+preliminary+in+vitro%2Fin+vivo+assays+of+DNA+and+DNA-like+duplexes&doi=10.1039%2Fc1mb05009e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-based strategies for blocking HMGB1 cytokine activity: design, synthesis and preliminary in vitro/in vivo assays of DNA and DNA-like duplexes</span></div><div class="casAuthors">Musumeci, Domenica; Bucci, Enrico M.; Roviello, Giovanni N.; Sapio, Roberto; Valente, Margherita; Moccia, Maria; Bianchi, Marco E.; Pedone, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1742-1752</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The authors report the design and synthesis of kinked oligonucleotide duplexes as potential inhibitors of HMGB1, a cytokine which triggers a broad range of immunol. effects.  The authors found that the designed ligands can interact with HMGB1, as evidenced by CD spectroscopy, and are able to block some extracellular effects induced by the protein, such as cellular proliferation and migration, as the authors demonstrated by in vitro biol. assays.  After selecting the most stable and active kinked duplex, the authors synthesized the corresponding PNA/DNA chimeric duplex which resulted to be more resistant to enzymic degrdn., and showed a biol. activity comparable to that of the natural duplex.  Preliminary in vivo assays in a mouse inflammatory model, showed a significant decrease of the mortality after administration of the PNA/DNA kinked duplex to LPS-treated mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolrP9Vu8YOs7Vg90H21EOLACvtfcHk0lg91wMsLc0jyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFSitLY%253D&md5=0cdc262ca15463ee1158a8f48894ea5e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1039%2Fc1mb05009e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1mb05009e%26sid%3Dliteratum%253Aachs%26aulast%3DMusumeci%26aufirst%3DD.%26aulast%3DBucci%26aufirst%3DE.%2BM.%26aulast%3DRoviello%26aufirst%3DG.%2BN.%26aulast%3DSapio%26aufirst%3DR.%26aulast%3DValente%26aufirst%3DM.%26aulast%3DMoccia%26aufirst%3DM.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DPedone%26aufirst%3DC.%26atitle%3DDNA-based%2520strategies%2520for%2520blocking%2520hmgb1%2520cytokine%2520activity%253A%2520Design%252C%2520synthesis%2520and%2520preliminary%2520in%2520vitro%252Fin%2520vivo%2520assays%2520of%2520DNA%2520and%2520DNA-like%2520duplexes%26jtitle%3DMol.%2520BioSyst.%26date%3D2011%26volume%3D7%26issue%3D5%26spage%3D1742%26epage%3D1752%26doi%3D10.1039%2Fc1mb05009e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pusterla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Marchis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span> <span> </span><span class="NLM_article-title">High mobility group b2 is secreted by myeloid cells and has mitogenic and chemoattractant activities similar to high mobility group b1</span>. <i>Autoimmunity</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1080/08916930902831845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1080%2F08916930902831845" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=308-310&issue=4&author=T.+Pusterlaauthor=F.+de+Marchisauthor=R.+Palumboauthor=M.+E.+Bianchi&title=High+mobility+group+b2+is+secreted+by+myeloid+cells+and+has+mitogenic+and+chemoattractant+activities+similar+to+high+mobility+group+b1&doi=10.1080%2F08916930902831845"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1080%2F08916930902831845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08916930902831845%26sid%3Dliteratum%253Aachs%26aulast%3DPusterla%26aufirst%3DT.%26aulast%3Dde%2BMarchis%26aufirst%3DF.%26aulast%3DPalumbo%26aufirst%3DR.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26atitle%3DHigh%2520mobility%2520group%2520b2%2520is%2520secreted%2520by%2520myeloid%2520cells%2520and%2520has%2520mitogenic%2520and%2520chemoattractant%2520activities%2520similar%2520to%2520high%2520mobility%2520group%2520b1%26jtitle%3DAutoimmunity%26date%3D2009%26volume%3D42%26issue%3D4%26spage%3D308%26epage%3D310%26doi%3D10.1080%2F08916930902831845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span> <span> </span><span class="NLM_article-title">Association of serum hmgb2 levels with in-stent restenosis: Hmgb2 promotes neointimal hyperplasia in mice with femoral artery injury and proliferation and migration of vsmcs</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">729</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.116.308210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1161%2FATVBAHA.116.308210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28183701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksF2ktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=717-729&issue=4&author=Y.+H.+Heauthor=X.+Q.+Wangauthor=J.+Zhangauthor=Z.+H.+Liuauthor=W.+Q.+Panauthor=Y.+Shenauthor=Z.+B.+Zhuauthor=L.+J.+Wangauthor=X.+X.+Yanauthor=K.+Yangauthor=R.+Y.+Zhangauthor=W.+F.+Shenauthor=F.+H.+Dingauthor=L.+Lu&title=Association+of+serum+hmgb2+levels+with+in-stent+restenosis%3A+Hmgb2+promotes+neointimal+hyperplasia+in+mice+with+femoral+artery+injury+and+proliferation+and+migration+of+vsmcs&doi=10.1161%2FATVBAHA.116.308210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs</span></div><div class="casAuthors">He, Yu Hu; Wang, Xiao Qun; Zhang, Jian; Liu, Zhu Hui; Pan, Wen Qi; Shen, Ying; Zhu, Zheng Bin; Wang, Ling Jie; Yan, Xiao Xiang; Yang, Ke; Zhang, Rui Yan; Shen, Wei Feng; Ding, Feng Hua; Lu, Lin</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">717-729</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">OBJECTIVE-: In a previous study, we established diabetic and nondiabetic minipig models with coronary artery in-stent restenosis (ISR).  Mass spectrometry showed that high-mobility group box (HMGB) 2 level was higher in ISR than in non-ISR tissue from diabetic minipigs.  We here investigated whether serum HMGB2 levels were related to ISR in coronary artery disease patients.  The effect of HMGB2 was evaluated in mice with femoral artery wire injury and in human aortic smooth muscle cells.  APPROACH AND RESULTS-: From 2513 patients undergoing coronary artery intervention and follow-up angiog. at ≈1 yr, 262 patients were diagnosed with ISR, and 298 patients with no ISR were randomly included as controls.  Serum HMGB2 levels were significantly higher in patients with ISR than in those without ISR and were assocd. with ISR severity.  Multivariable logistic regression anal. showed that HMGB2 level was independently assocd. with ISR.  In expts., HMGB2 expression was increased in vascular tissue after injury.  Perivascular HMGB2 administration promoted injury-induced neointimal hyperplasia in C57Bl/6 mice compared with in the control, whereas such pathophysiol. features were attenuated in Hmgb2 mice.  Mechanistically, HMGB2 enhanced neointimal hyperplasia in mice and proliferation and migration in human aortic smooth muscle cells by inducing reactive oxygen species through increased p47phox phosphorylation.  Knocking down p47phox, however, inhibited HMGB2-induced effects in human aortic smooth muscle cells.  Finally, HMGB2-induced effects were significantly declined in receptor of advanced glycation end products knockdown or deficient cells, but not in Toll-like receptor 4 knockdown or deficient cells.  CONCLUSIONS-: Serum HMGB2 levels were assocd. with ISR in patients.  HMGB2 promoted neointimal hyperplasia in mice with arterial wire injury through reactive oxygen species activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9qb2FlVZT0bVg90H21EOLACvtfcHk0lg91wMsLc0jyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksF2ktrY%253D&md5=60bd24b11b17fdd6cbf5ddcd94c4594a</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.116.308210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.116.308210%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%2BH.%26aulast%3DPan%26aufirst%3DW.%2BQ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%2BB.%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DYan%26aufirst%3DX.%2BX.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DShen%26aufirst%3DW.%2BF.%26aulast%3DDing%26aufirst%3DF.%2BH.%26aulast%3DLu%26aufirst%3DL.%26atitle%3DAssociation%2520of%2520serum%2520hmgb2%2520levels%2520with%2520in-stent%2520restenosis%253A%2520Hmgb2%2520promotes%2520neointimal%2520hyperplasia%2520in%2520mice%2520with%2520femoral%2520artery%2520injury%2520and%2520proliferation%2520and%2520migration%2520of%2520vsmcs%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2017%26volume%3D37%26issue%3D4%26spage%3D717%26epage%3D729%26doi%3D10.1161%2FATVBAHA.116.308210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span> <span> </span><span class="NLM_article-title">Association of serum hmgb2 level with mace at 1 mo of myocardial infarction: Aggravation of myocardial ischemic injury in rats by hmgb2 via ros</span>. <i>Am. J. Physiol Heart Circ Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>312</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">H422</span>– <span class="NLM_lpage">H436</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00249.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1152%2Fajpheart.00249.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28011583" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2017&pages=H422-H436&issue=3&author=Z.+H.+Liuauthor=D.+P.+Daiauthor=F.+H.+Dingauthor=W.+Q.+Panauthor=Y.+H.+Fangauthor=Q.+Zhangauthor=M.+Liauthor=P.+Yangauthor=X.+Q.+Wangauthor=Y.+Shenauthor=L.+J.+Wangauthor=X.+X.+Yanauthor=Y.+H.+Heauthor=K.+Yangauthor=R.+Y.+Zhangauthor=W.+F.+Shenauthor=Y.+Chenauthor=L.+Lu&title=Association+of+serum+hmgb2+level+with+mace+at+1+mo+of+myocardial+infarction%3A+Aggravation+of+myocardial+ischemic+injury+in+rats+by+hmgb2+via+ros&doi=10.1152%2Fajpheart.00249.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00249.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00249.2016%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BH.%26aulast%3DDai%26aufirst%3DD.%2BP.%26aulast%3DDing%26aufirst%3DF.%2BH.%26aulast%3DPan%26aufirst%3DW.%2BQ.%26aulast%3DFang%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%2BQ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DYan%26aufirst%3DX.%2BX.%26aulast%3DHe%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DShen%26aufirst%3DW.%2BF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DL.%26atitle%3DAssociation%2520of%2520serum%2520hmgb2%2520level%2520with%2520mace%2520at%25201%2520mo%2520of%2520myocardial%2520infarction%253A%2520Aggravation%2520of%2520myocardial%2520ischemic%2520injury%2520in%2520rats%2520by%2520hmgb2%2520via%2520ros%26jtitle%3DAm.%2520J.%2520Physiol%2520Heart%2520Circ%2520Physiol.%26date%3D2017%26volume%3D312%26issue%3D3%26spage%3DH422%26epage%3DH436%26doi%3D10.1152%2Fajpheart.00249.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Expression of hmgb2 indicates worse survival of patients and is required for the maintenance of warburg effect in pancreatic cancer</span>. <i>Acta Biochim. Biophys. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1093/abbs/gmw124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1093%2Fabbs%2Fgmw124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28069585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC1c7jvFGqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=119-127&issue=2&author=X.+Caiauthor=H.+Dingauthor=Y.+Liuauthor=G.+Panauthor=Q.+Liauthor=Z.+Yangauthor=W.+Liu&title=Expression+of+hmgb2+indicates+worse+survival+of+patients+and+is+required+for+the+maintenance+of+warburg+effect+in+pancreatic+cancer&doi=10.1093%2Fabbs%2Fgmw124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer</span></div><div class="casAuthors">Cai Xin; Ding Hongjian; Pan Gaofeng; Yang Zhen; Liu Weiyan; Liu Yanxia; Li Qingguo; Li Qingguo</div><div class="citationInfo"><span class="NLM_cas:title">Acta biochimica et biophysica Sinica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-127</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High mobility group proteins (HMGs) are the second most abundant chromatin proteins and exert global genomic functions in the establishment of active or inactive chromatin domains.  Through interaction with nucleosomes, transcription factors, nucleosome-remodeling machines and histones, the HMGs family proteins contribute to the fine tuning of transcription in response to rapid environmental changes.  Mammalian high mobility group Bs (HMGBs) are characterized by two tandem HMG box domains followed by a long acidic tail.  Recent studies demonstrated that high expression of HMGBs has been found in many cancers, such as prostate, kidney, ovarian, and gastric cancers.  However, their roles in pancreatic cancer have seldom been reported.  In this study, we assessed the diagnostic and prognostic values of HMGBs proteins, including HMGB1, HMGB2, and HMGB3, in pancreatic cancer from the Cancer Genome Atlas (TCGA) dataset.  Our results demonstrated that HMGB2 predicted poor prognosis in pancreatic cancer.  In vitro studies demonstrated that silencing HMGB2 inhibited cell proliferation and viability.  Mechanistically, our results demonstrated that silencing HMGB2 decreased hypoxia inducible factor 1α (HIF1α) protein level and inhibited HIF1α-mediated glycolysis process.  Further analysis indicated that HIF1α-targeted glycolytic genes, including GLUT1, HK2, and LDHA, are all prognostic factors and positively correlated with HMGB2 expression.  Taken together, we discovered new prognostic and predictive markers for pancreatic cancer, and shed light on the novel function of HMGB2 in glycolytic control in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFqt81uaIMMpcXNb62YGmbfW6udTcc2ebFA30Ba5swk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7jvFGqtg%253D%253D&md5=266643f42481cc8a37c74083078adbbb</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fabbs%2Fgmw124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fabbs%252Fgmw124%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DExpression%2520of%2520hmgb2%2520indicates%2520worse%2520survival%2520of%2520patients%2520and%2520is%2520required%2520for%2520the%2520maintenance%2520of%2520warburg%2520effect%2520in%2520pancreatic%2520cancer%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2017%26volume%3D49%26issue%3D2%26spage%3D119%26epage%3D127%26doi%3D10.1093%2Fabbs%2Fgmw124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span> <span> </span><span class="NLM_article-title">A small molecule binding hmgb1 and hmgb2 inhibits microglia-mediated neuroinflammation</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1060</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnchembio.1669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25306442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOisrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1055-1060&issue=12&author=S.+Leeauthor=Y.+Namauthor=J.+Y.+Kooauthor=D.+Limauthor=J.+Parkauthor=J.+Ockauthor=J.+Kimauthor=K.+Sukauthor=S.+B.+Park&title=A+small+molecule+binding+hmgb1+and+hmgb2+inhibits+microglia-mediated+neuroinflammation&doi=10.1038%2Fnchembio.1669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation</span></div><div class="casAuthors">Lee, Sanghee; Nam, Youngpyo; Koo, Ja Young; Lim, Donghyun; Park, Jongmin; Ock, Jiyeon; Kim, Jaehong; Suk, Kyoungho; Park, Seung Bum</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1055-1060</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Because of the crit. role of neuroinflammation in various neurol. diseases, there are continuous efforts to identify new therapeutic targets as well as new therapeutic agents to treat neuroinflammatory diseases.  Here we report the discovery of inflachromene (ICM), a microglial inhibitor with anti-inflammatory effects.  Using the convergent strategy of phenotypic screening with early stage target identification, we show that the direct binding target of ICM is the high mobility group box (HMGB) proteins.  Mode-of-action studies demonstrate that ICM blocks the sequential processes of cytoplasmic localization and extracellular release of HMGBs by perturbing its post-translational modification.  In addn., ICM effectively downregulates proinflammatory functions of HMGB and reduces neuronal damage in vivo.  Our study reveals that ICM suppresses microglia-mediated inflammation and exerts a neuroprotective effect, demonstrating the therapeutic potential of ICM in neuroinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMF0q7o1ZyqLVg90H21EOLACvtfcHk0li7v8Uoyq3Hcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOisrjL&md5=8c06cb9f432a5fc65c0c450e36c97f5a</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1669%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DNam%26aufirst%3DY.%26aulast%3DKoo%26aufirst%3DJ.%2BY.%26aulast%3DLim%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DOck%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSuk%26aufirst%3DK.%26aulast%3DPark%26aufirst%3DS.%2BB.%26atitle%3DA%2520small%2520molecule%2520binding%2520hmgb1%2520and%2520hmgb2%2520inhibits%2520microglia-mediated%2520neuroinflammation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D12%26spage%3D1055%26epage%3D1060%26doi%3D10.1038%2Fnchembio.1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marchis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitaleri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallacosta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennacchini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trisciuoglio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span> <span> </span><span class="NLM_article-title">Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2007.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.chembiol.2007.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=17462578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslaitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=431-441&issue=4&author=L.+Mollicaauthor=F.+De+Marchisauthor=A.+Spitaleriauthor=C.+Dallacostaauthor=D.+Pennacchiniauthor=M.+Zamaiauthor=A.+Agrestiauthor=L.+Trisciuoglioauthor=G.+Muscoauthor=M.+E.+Bianchi&title=Glycyrrhizin+binds+to+high-mobility+group+box+1+protein+and+inhibits+its+cytokine+activities&doi=10.1016%2Fj.chembiol.2007.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities</span></div><div class="casAuthors">Mollica, Luca; De Marchis, Francesco; Spitaleri, Andrea; Dallacosta, Corrado; Pennacchini, Danilo; Zamai, Moreno; Agresti, Alessandra; Trisciuoglio, Lisa; Musco, Giovanna; Bianchi, Marco E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">431-441</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">High-mobility group box 1 protein (HMGB1) is a nuclear component, but extracellularly it serves as a signaling mol. involved in acute and chronic inflammation, for example in sepsis and arthritis.  The identification of HMGB1 inhibitors is therefore of significant exptl. and clin. interest.  We show that glycyrrhizin, a natural anti-inflammatory and antiviral triterpene in clin. use, inhibits HMGB1 chemoattractant and mitogenic activities, and has a weak inhibitory effect on its intranuclear DNA-binding function.  NMR and fluorescence studies indicate that glycyrrhizin binds directly to HMGB1 (Kd ∼150 μM), interacting with two shallow concave surfaces formed by the two arms of both HMG boxes.  Our results explain in part the anti-inflammatory properties of glycyrrhizin, and might direct the design of new derivs. with improved HMGB1-binding properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAehCbVCEOhLVg90H21EOLACvtfcHk0li7v8Uoyq3Hcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslaitbc%253D&md5=6108501f729f299a82f7789fbdfecb48</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DL.%26aulast%3DDe%2BMarchis%26aufirst%3DF.%26aulast%3DSpitaleri%26aufirst%3DA.%26aulast%3DDallacosta%26aufirst%3DC.%26aulast%3DPennacchini%26aufirst%3DD.%26aulast%3DZamai%26aufirst%3DM.%26aulast%3DAgresti%26aufirst%3DA.%26aulast%3DTrisciuoglio%26aufirst%3DL.%26aulast%3DMusco%26aufirst%3DG.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26atitle%3DGlycyrrhizin%2520binds%2520to%2520high-mobility%2520group%2520box%25201%2520protein%2520and%2520inhibits%2520its%2520cytokine%2520activities%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26issue%3D4%26spage%3D431%26epage%3D441%26doi%3D10.1016%2Fj.chembiol.2007.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span> <span> </span><span class="NLM_article-title">Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.intimp.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21095260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFWnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=187-193&issue=2&author=Y.+Lingauthor=Z.+Y.+Yangauthor=T.+Yinauthor=L.+Liauthor=W.+W.+Yuanauthor=H.+S.+Wuauthor=C.+Y.+Wang&title=Heparin+changes+the+conformation+of+high-mobility+group+protein+1+and+decreases+its+affinity+toward+receptor+for+advanced+glycation+endproducts+in+vitro&doi=10.1016%2Fj.intimp.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro</span></div><div class="casAuthors">Ling, Yan; Yang, Zhi-Yong; Yin, Tao; Li, Li; Yuan, Wei-Wei; Wu, He-Shui; Wang, Chun-You</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-193</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High-mobility group protein 1 (HMGB1) has been identified as a late-acting mediator of inflammation.  The receptor for advanced glycation end products (RAGE) is the main receptor and mediates the cytokine activity of HMGB1.  Since HMGB1 also exhibits heparin-binding activity, we investigated whether heparin interferes with HMGB1/RAGE interaction and prevents the cytokine activity.  We used fluorescence spectrometry, CD spectrometry and SPR biosensor technique to evaluate the effect.  After treatment of HMGB1 with different concns. of heparin (0, 50, 100 and 1000 U/L), the fluorescence peak values of HMGB1 increased and the emission wavelength showed red shifts; further, the secondary structure of HMGB1 showed a marked change in that the content of β-pleated sheet reduced while that of α-helix increased.  The equil. dissocn. consts. (KD) were detd. by SPR technique; KD = 4.5 × 10- 9 mol/L for heparin and HMGB1 and KD = 9.77 × 10- 8 mol/L for HMGB1 and RAGE, resp.  Heparin and RAGE had no interaction.  The amt. of HMGB1 and RAGE bound forms reduced after treatment with heparin.  ELISA revealed that addn. of heparin inhibited the TNF-α and IL-6 released by macrophages RAW264.7 and HUVEC; 10 U/L and 50 U/L of heparin showed the most marked inhibitory effect in RAW264.7 cells and in HUVEC, resp.  In conclusion, heparin can combine with HMGB1 and affect the affinity of HMGB1/RAGE by changing the conformation of HMGB1.  And this effect was independent of heparin concn., so that a low dose of heparin was sufficient to achieve the best anti-inflammatory effect in our test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQZpeRqCzCt7Vg90H21EOLACvtfcHk0li7v8Uoyq3Hcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFWnug%253D%253D&md5=a8447db928c38cf9e8597d2f3c358cd0</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DYin%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DW.%2BW.%26aulast%3DWu%26aufirst%3DH.%2BS.%26aulast%3DWang%26aufirst%3DC.%2BY.%26atitle%3DHeparin%2520changes%2520the%2520conformation%2520of%2520high-mobility%2520group%2520protein%25201%2520and%2520decreases%2520its%2520affinity%2520toward%2520receptor%2520for%2520advanced%2520glycation%2520endproducts%2520in%2520vitro%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2011%26volume%3D11%26issue%3D2%26spage%3D187%26epage%3D193%26doi%3D10.1016%2Fj.intimp.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rauvala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlaskari, R.</span></span> <span> </span><span class="NLM_article-title">Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>262</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">16625</span>– <span class="NLM_lpage">16635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=16625-16635&issue=34&author=H.+Rauvalaauthor=R.+Pihlaskari&title=Isolation+and+some+characteristics+of+an+adhesive+factor+of+brain+that+enhances+neurite+outgrowth+in+central+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRauvala%26aufirst%3DH.%26aulast%3DPihlaskari%26aufirst%3DR.%26atitle%3DIsolation%2520and%2520some%2520characteristics%2520of%2520an%2520adhesive%2520factor%2520of%2520brain%2520that%2520enhances%2520neurite%2520outgrowth%2520in%2520central%2520neurons%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26issue%3D34%26spage%3D16625%26epage%3D16635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuroiwa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakusagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusayanagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuramochi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, F.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of the direct interaction between methotrexate (mtx) and high-mobility group box 1 (hmgb1) protein</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e63073</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0063073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1371%2Fjournal.pone.0063073" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e63073&issue=5&author=Y.+Kuroiwaauthor=Y.+Takakusagiauthor=T.+Kusayanagiauthor=K.+Kuramochiauthor=T.+Imaiauthor=T.+Hirayamaauthor=I.+Itoauthor=M.+Yoshidaauthor=K.+Sakaguchiauthor=F.+Sugawara&title=Identification+and+characterization+of+the+direct+interaction+between+methotrexate+%28mtx%29+and+high-mobility+group+box+1+%28hmgb1%29+protein&doi=10.1371%2Fjournal.pone.0063073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0063073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0063073%26sid%3Dliteratum%253Aachs%26aulast%3DKuroiwa%26aufirst%3DY.%26aulast%3DTakakusagi%26aufirst%3DY.%26aulast%3DKusayanagi%26aufirst%3DT.%26aulast%3DKuramochi%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DT.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSakaguchi%26aufirst%3DK.%26aulast%3DSugawara%26aufirst%3DF.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520the%2520direct%2520interaction%2520between%2520methotrexate%2520%2528mtx%2529%2520and%2520high-mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520protein%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D5%26spage%3De63073%26doi%3D10.1371%2Fjournal.pone.0063073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span> <span> </span><span class="NLM_article-title">Treatment of sepsis pathogenesis with high mobility group box protein 1-regulating anti-inflammatory agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00954</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00954" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=170-179&issue=1&author=W.+Choauthor=J.+Y.+Kooauthor=Y.+Parkauthor=K.+Ohauthor=S.+Leeauthor=J.+S.+Songauthor=M.+A.+Baeauthor=D.+Limauthor=D.+S.+Leeauthor=S.+B.+Park&title=Treatment+of+sepsis+pathogenesis+with+high+mobility+group+box+protein+1-regulating+anti-inflammatory+agents&doi=10.1021%2Facs.jmedchem.6b00954"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00954%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DW.%26aulast%3DKoo%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DBae%26aufirst%3DM.%2BA.%26aulast%3DLim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BB.%26atitle%3DTreatment%2520of%2520sepsis%2520pathogenesis%2520with%2520high%2520mobility%2520group%2520box%2520protein%25201-regulating%2520anti-inflammatory%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D1%26spage%3D170%26epage%3D179%26doi%3D10.1021%2Facs.jmedchem.6b00954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venereau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swapna, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manohar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorzanelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marchis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonyak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micikas, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerione, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montelione, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klessig, D. F.</span></span> <span> </span><span class="NLM_article-title">Aspirin’s active metabolite salicylic acid targets high mobility group box 1 to modulate inflammatory responses</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.2119/molmed.2015.00148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2015.00148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26101955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=526-535&author=H.+W.+Choiauthor=M.+Tianauthor=F.+Songauthor=E.+Venereauauthor=A.+Pretiauthor=S.+W.+Parkauthor=K.+Hamiltonauthor=G.+V.+Swapnaauthor=M.+Manoharauthor=M.+Moreauauthor=A.+Agrestiauthor=A.+Gorzanelliauthor=F.+De+Marchisauthor=H.+Wangauthor=M.+Antonyakauthor=R.+J.+Micikasauthor=D.+R.+Gentileauthor=R.+A.+Cerioneauthor=F.+C.+Schroederauthor=G.+T.+Montelioneauthor=M.+E.+Bianchiauthor=D.+F.+Klessig&title=Aspirin%E2%80%99s+active+metabolite+salicylic+acid+targets+high+mobility+group+box+1+to+modulate+inflammatory+responses&doi=10.2119%2Fmolmed.2015.00148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Aspirin's active metabolite salicylic acid targets high mobility group box 1 to modulate inflammatory responses</span></div><div class="casAuthors">Choi, Hyong Woo; Tian, Miaoying; Song, Fei; Venereau, Emilie; Preti, Alessandro; Park, Sang-Wook; Hamilton, Keith; Swapna, G. V. T.; Manohar, Murli; Moreau, Magali; Agresti, Alessandra; Gorzanelli, Andrea; De Marchis, Francesco; Wang, Huang; Antonyak, Marc; Micikas, Robert J.; Gentile, Daniel R.; Cerione, Richard A.; Schroeder, Frank C.; Montelione, Gaetano T.; Bianchi, Marco E.; Klessig, Daniel F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">526-535</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Salicylic acid (SA) and its derivs. have been used for millennia to reduce pain, fever and inflammation.  In addn., prophylactic use of acetylsalicylic acid, commonly known as aspirin, reduces the risk of heart attack, stroke and certain cancers.  Because aspirin is rapidly de-acetylated by esterases in human plasma, much of aspirin's bioactivity can be attributed to its primary metabolite, SA.  Here we demonstrate that human high mobility group box 1 (HMGB1) is a novel SA-binding protein.  SA-binding sites on HMGB1 were identified in the HMG-box domains by NMR (NMR) spectroscopic studies and confirmed by mutational anal.  Extracellular HMGB1 is a damage-assocd. mol. pattern mol. (DAMP), with multiple redox states.  SA suppresses both the chemoattractant activity of fully reduced HMGB1 and the increased expression of proinflammatory cytokine genes and cyclooxygenase 2 (COX-2) induced by disulfide HMGB1.  Natural and synthetic SA derivs. with greater potency for inhibition of HMGB1 were identified, providing proof-of-concept that new mols. with high efficacy against sterile inflammation are attainable.  An HMGB1 protein mutated in one of the SA-binding sites identified by NMR chem. shift perturbation studies retained chemoattractant activity, but lost binding of and inhibition by SA and its derivs., thereby firmly establishing that SA binding to HMGB1 directly suppresses its proinflammatory activities.  Identification of HMGB1 as a pharmacol. target of SA/aspirin provides new insights into the mechanisms of action of one of the world's longest and most used natural and synthetic drugs.  It may also provide an explanation for the protective effects of low-dose aspirin usage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfZ6wFPYD2ObVg90H21EOLACvtfcHk0lj0AxlZ7zdavA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFajsg%253D%253D&md5=5db7d3f42702f7c63f0b8ef13c45a8a3</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2015.00148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2015.00148%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BW.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DF.%26aulast%3DVenereau%26aufirst%3DE.%26aulast%3DPreti%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DS.%2BW.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DSwapna%26aufirst%3DG.%2BV.%26aulast%3DManohar%26aufirst%3DM.%26aulast%3DMoreau%26aufirst%3DM.%26aulast%3DAgresti%26aufirst%3DA.%26aulast%3DGorzanelli%26aufirst%3DA.%26aulast%3DDe%2BMarchis%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DAntonyak%26aufirst%3DM.%26aulast%3DMicikas%26aufirst%3DR.%2BJ.%26aulast%3DGentile%26aufirst%3DD.%2BR.%26aulast%3DCerione%26aufirst%3DR.%2BA.%26aulast%3DSchroeder%26aufirst%3DF.%2BC.%26aulast%3DMontelione%26aufirst%3DG.%2BT.%26aulast%3DBianchi%26aufirst%3DM.%2BE.%26aulast%3DKlessig%26aufirst%3DD.%2BF.%26atitle%3DAspirin%25E2%2580%2599s%2520active%2520metabolite%2520salicylic%2520acid%2520targets%2520high%2520mobility%2520group%2520box%25201%2520to%2520modulate%2520inflammatory%2520responses%26jtitle%3DMol.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D526%26epage%3D535%26doi%3D10.2119%2Fmolmed.2015.00148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashok, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sama, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting hmgb1</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">e1153</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0001153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1371%2Fjournal.pone.0001153" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=e1153&issue=11&author=W.+Liauthor=M.+Ashokauthor=J.+Liauthor=H.+Yangauthor=A.+E.+Samaauthor=H.+Wang&title=A+major+ingredient+of+green+tea+rescues+mice+from+lethal+sepsis+partly+by+inhibiting+hmgb1&doi=10.1371%2Fjournal.pone.0001153"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0001153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0001153%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DAshok%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSama%26aufirst%3DA.%2BE.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DA%2520major%2520ingredient%2520of%2520green%2520tea%2520rescues%2520mice%2520from%2520lethal%2520sepsis%2520partly%2520by%2520inhibiting%2520hmgb1%26jtitle%3DPLoS%2520One%26date%3D2007%26volume%3D2%26issue%3D11%26spage%3De1153%26doi%3D10.1371%2Fjournal.pone.0001153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jundoria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eissa, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sama, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Egcg stimulates autophagy and reduces cytoplasmic hmgb1 levels in endotoxin-stimulated macrophages</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1152</span>– <span class="NLM_lpage">1163</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.bcp.2011.02.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=1152-1163&issue=9&author=W.+Liauthor=S.+Zhuauthor=J.+Liauthor=A.+Assaauthor=A.+Jundoriaauthor=J.+Xuauthor=S.+Fanauthor=N.+T.+Eissaauthor=K.+J.+Traceyauthor=A.+E.+Samaauthor=H.+Wang&title=Egcg+stimulates+autophagy+and+reduces+cytoplasmic+hmgb1+levels+in+endotoxin-stimulated+macrophages&doi=10.1016%2Fj.bcp.2011.02.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DAssa%26aufirst%3DA.%26aulast%3DJundoria%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DEissa%26aufirst%3DN.%2BT.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DSama%26aufirst%3DA.%2BE.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DEgcg%2520stimulates%2520autophagy%2520and%2520reduces%2520cytoplasmic%2520hmgb1%2520levels%2520in%2520endotoxin-stimulated%2520macrophages%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26issue%3D9%26spage%3D1152%26epage%3D1163%26doi%3D10.1016%2Fj.bcp.2011.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span> <span> </span><span class="NLM_article-title">Egcg in green tea induces aggregation of hmgb1 protein through large conformational changes with polarized charge redistribution</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22128</span>, <span class="refDoi"> DOI: 10.1038/srep22128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fsrep22128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26899177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFKgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22128&author=X.+Y.+Mengauthor=B.+Liauthor=S.+Liuauthor=H.+Kangauthor=L.+Zhaoauthor=R.+Zhou&title=Egcg+in+green+tea+induces+aggregation+of+hmgb1+protein+through+large+conformational+changes+with+polarized+charge+redistribution&doi=10.1038%2Fsrep22128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">EGCG in Green Tea Induces Aggregation of HMGB1 Protein through Large Conformational Changes with Polarized Charge Redistribution</span></div><div class="casAuthors">Meng, Xuan-Yu; Li, Baoyu; Liu, Shengtang; Kang, Hongsuk; Zhao, Lin; Zhou, Ruhong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22128</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">As a major effective component in green tea, (-)-epigallocatechin-3-gallate (EGCG)'s potential benefits to human health have been widely investigated.  Recent exptl. evidences indicate that EGCG can induce the aggregation of HMGB1 protein, a late mediator of inflammation, which subsequently stimulates the autophagic degrdn. and thus provides protection from lethal endotoxemia and sepsis.  In this study, we use mol. dynamics (MD) simulations to explore the underlying mol. mechanism of this aggregation of HMGB1 facilitated by EGCG.  Our simulation results reveal that EGCG firmly binds to HMGB1 near Cys106, which supports previous preliminary exptl. evidence.  A large HMGB1 conformational change is obsd., where Box A and Box B, two homogenous domains of HMGB1, are repositioned and packed together by EGCG.  This new HMGB1 conformation has large mol. polarity and distinctive electrostatic potential surface.  We suggest that the highly polarized charge distribution leads to the aggregation of HMGB1, which differs from the previous hypothesis that two HMGB1 monomers are linked by the dimer of EGCG.  Possible aggregating modes have also been investigated with potential of mean force (PMF) calcns.  Finally, we conclude that the conformation induced by EGCG is more aggregation-prone with higher binding free energies as compared to those without EGCG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJDe8SbQPonLVg90H21EOLACvtfcHk0liYHOBWnJNOlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFKgtr8%253D&md5=196af5bc5370362aa9e299cd3ccd2cd2</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fsrep22128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22128%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%2BY.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DR.%26atitle%3DEgcg%2520in%2520green%2520tea%2520induces%2520aggregation%2520of%2520hmgb1%2520protein%2520through%2520large%2520conformational%2520changes%2520with%2520polarized%2520charge%2520redistribution%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22128%26doi%3D10.1038%2Fsrep22128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horiuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishibori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katagiri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiuchi, H.</span></span> <span> </span><span class="NLM_article-title">Metformin directly binds the alarmin hmgb1 and inhibits its proinflammatory activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8436</span>– <span class="NLM_lpage">8446</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.769380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1074%2Fjbc.M116.769380" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=8436-8446&issue=20&author=T.+Horiuchiauthor=N.+Sakataauthor=Y.+Narumiauthor=T.+Kimuraauthor=T.+Hayashiauthor=K.+Naganoauthor=K.+Liuauthor=M.+Nishiboriauthor=S.+Tsukitaauthor=T.+Yamadaauthor=H.+Katagiriauthor=R.+Shirakawaauthor=H.+Horiuchi&title=Metformin+directly+binds+the+alarmin+hmgb1+and+inhibits+its+proinflammatory+activity&doi=10.1074%2Fjbc.M116.769380"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.769380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.769380%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DT.%26aulast%3DSakata%26aufirst%3DN.%26aulast%3DNarumi%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DNishibori%26aufirst%3DM.%26aulast%3DTsukita%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DKatagiri%26aufirst%3DH.%26aulast%3DShirakawa%26aufirst%3DR.%26aulast%3DHoriuchi%26aufirst%3DH.%26atitle%3DMetformin%2520directly%2520binds%2520the%2520alarmin%2520hmgb1%2520and%2520inhibits%2520its%2520proinflammatory%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D20%26spage%3D8436%26epage%3D8446%26doi%3D10.1074%2Fjbc.M116.769380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragab, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdes-Ferrer, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pribis, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Abed, Y.</span></span> <span> </span><span class="NLM_article-title">Md-2 is required for disulfide hmgb1-dependent tlr4 signaling</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>212</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1084/jem.20141318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1084%2Fjem.20141318" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=5-14&issue=1&author=H.+Yangauthor=H.+Wangauthor=Z.+Juauthor=A.+A.+Ragabauthor=P.+Lundbackauthor=W.+Longauthor=S.+I.+Valdes-Ferrerauthor=M.+Heauthor=J.+P.+Pribisauthor=J.+Liauthor=B.+Luauthor=D.+Geroauthor=C.+Szaboauthor=D.+J.+Antoineauthor=H.+E.+Harrisauthor=D.+T.+Golenbockauthor=J.+Mengauthor=J.+Rothauthor=S.+S.+Chavanauthor=U.+Anderssonauthor=T.+R.+Billiarauthor=K.+J.+Traceyauthor=Y.+Al-Abed&title=Md-2+is+required+for+disulfide+hmgb1-dependent+tlr4+signaling&doi=10.1084%2Fjem.20141318"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1084%2Fjem.20141318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20141318%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DJu%26aufirst%3DZ.%26aulast%3DRagab%26aufirst%3DA.%2BA.%26aulast%3DLundback%26aufirst%3DP.%26aulast%3DLong%26aufirst%3DW.%26aulast%3DValdes-Ferrer%26aufirst%3DS.%2BI.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DPribis%26aufirst%3DJ.%2BP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DGero%26aufirst%3DD.%26aulast%3DSzabo%26aufirst%3DC.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DChavan%26aufirst%3DS.%2BS.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DAl-Abed%26aufirst%3DY.%26atitle%3DMd-2%2520is%2520required%2520for%2520disulfide%2520hmgb1-dependent%2520tlr4%2520signaling%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2015%26volume%3D212%26issue%3D1%26spage%3D5%26epage%3D14%26doi%3D10.1084%2Fjem.20141318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plociennikowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hromada-Judycka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzecka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowska, K.</span></span> <span> </span><span class="NLM_article-title">Co-operation of tlr4 and raft proteins in lps-induced pro-inflammatory signaling</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1007/s00018-014-1762-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs00018-014-1762-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25332099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2gsb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2015&pages=557-581&issue=3&author=A.+Plociennikowskaauthor=A.+Hromada-Judyckaauthor=K.+Borzeckaauthor=K.+Kwiatkowska&title=Co-operation+of+tlr4+and+raft+proteins+in+lps-induced+pro-inflammatory+signaling&doi=10.1007%2Fs00018-014-1762-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling</span></div><div class="casAuthors">Plociennikowska, Agnieszka; Hromada-Judycka, Aneta; Borzecka, Kinga; Kwiatkowska, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">557-581</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Toll-like receptor 4 (TLR4) is activated by lipopolysaccharide (LPS), a component of Gram-neg. bacteria to induce prodn. of pro-inflammatory mediators aiming at eradication of the bacteria.  Dysregulation of the host responses to LPS can lead to a systemic inflammatory condition named sepsis.  In a typical scenario, activation of TLR4 is preceded by binding of LPS to CD14 protein anchored in cholesterol- and sphingolipid-rich microdomains of the plasma membrane called rafts.  CD14 then transfers the LPS to the TLR4/MD-2 complex which dimerizes and triggers MyD88- and TRIF-dependent prodn. of pro-inflammatory cytokines and type I interferons.  The TRIF-dependent signaling is linked with endocytosis of the activated TLR4, which is controlled by CD14.  In addn. to CD14, other raft proteins like Lyn tyrosine kinase of the Src family, acid sphingomyelinase, CD44, Hsp70, and CD36 participate in the TLR4 signaling triggered by LPS and non-microbial endogenous ligands.  In this review, we summarize the current state of the knowledge on the involvement of rafts in TLR4 signaling, with an emphasis on how the raft proteins regulate the TLR4 signaling pathways.  CD14-bearing rafts, and possibly CD36-rich rafts, are believed to be preferred sites of the assembly of a multimol. complex which mediates the endocytosis of activated TLR4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Py2Q9X5ha7Vg90H21EOLACvtfcHk0ljvwzGsmDVwoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2gsb3I&md5=403e8073b6ba005e7a8cca66b32fe5d3</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2Fs00018-014-1762-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-014-1762-5%26sid%3Dliteratum%253Aachs%26aulast%3DPlociennikowska%26aufirst%3DA.%26aulast%3DHromada-Judycka%26aufirst%3DA.%26aulast%3DBorzecka%26aufirst%3DK.%26aulast%3DKwiatkowska%26aufirst%3DK.%26atitle%3DCo-operation%2520of%2520tlr4%2520and%2520raft%2520proteins%2520in%2520lps-induced%2520pro-inflammatory%2520signaling%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2015%26volume%3D72%26issue%3D3%26spage%3D557%26epage%3D581%26doi%3D10.1007%2Fs00018-014-1762-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hreggvidsdottir, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundberg, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aveberger, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevenvall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span> <span> </span><span class="NLM_article-title">High mobility group box protein 1 (hmgb1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.2119/molmed.2011.00327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2011.00327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22076468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFeksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=224-230&author=H.+S.+Hreggvidsdottirauthor=A.+M.+Lundbergauthor=A.+C.+Avebergerauthor=L.+Klevenvallauthor=U.+Anderssonauthor=H.+E.+Harris&title=High+mobility+group+box+protein+1+%28hmgb1%29-partner+molecule+complexes+enhance+cytokine+production+by+signaling+through+the+partner+molecule+receptor&doi=10.2119%2Fmolmed.2011.00327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor</span></div><div class="casAuthors">Hreggvidsdottir, Hulda Sigridur; Lundberg, Anna M.; Aveberger, Ann-Charlotte; Klevenvall, Lena; Andersson, Ulf; Harris, Helena Erlandsson</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">224-230</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">The nuclear protein high mobility group box protein 1 (HMGB1) promotes inflammation upon extracellular release.  HMGB1 induces proinflammatory cytokine prodn. in macrophages via Toll-like receptor (TLR)-4 signaling in a redox-dependent fashion.  Independent of its redox state and endogenous cytokine-inducing ability, HMGB1 can form highly immunostimulatory complexes by interaction with certain proinflammatory mediators.  Such complexes have the ability to enhance the induced immune response up to 100-fold, compared with induction by the ligand alone.  To clarify the mechanisms for these strong synergistic effects, we studied receptor requirements.  Interleukin (IL)-6 prodn. was assessed in supernatants from cultured peritoneal macrophages from mice each deficient in one of the HMGB1 receptors (receptor for advanced glycation end products (RAGE), TLR2 or TLR4) or from wild-type controls.  The cultures were stimulated with the TLR4 ligand lipopolysaccaride (LPS), the TLR2 ligand Pam3CysSerLys4 (Pam3CSK4), noninflammatory HMGB1 or each TLR ligand in complex with noninflammatory HMGB1.  The activity of the HMGB1-TLR ligand complexes relied on engagement of the same receptor as for the noncomplexed TLR ligand, since HMGB1-LPS complexes used TLR4 and HMGB1-Pam3CSK4 complexes used TLR2.  Deletion of any of the intracellular adaptor mols. used by TLR2 (myeloid differentiation factor-88 (MyD88), TIR domain-contg. adaptor protein (TIRAP)) or TLR4 (MyD88, TIRAP, TIR domain-contg. adaptor-inducing interferon-β (TRIF), TRIF-related adaptor mol. (TRAM)) had similar effects on HMGB1 complex activation compared with noncomplexed LPS or Pam3CSK4.  This result implies that the enhancing effects of HMGB1-partner mol. complexes are not regulated by the induction of addnl. signaling cascades.  Elucidating HMGB1 receptor usage in processes where HMGB1 acts alone or in complex with other mols. is essential for the understanding of basic HMGB1 biol. and for designing HMGB1-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomnpdkyxgLKbVg90H21EOLACvtfcHk0ljvwzGsmDVwoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFeksbY%253D&md5=9f89c3a5cea4a0abf3bd0ec25a52326f</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2011.00327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2011.00327%26sid%3Dliteratum%253Aachs%26aulast%3DHreggvidsdottir%26aufirst%3DH.%2BS.%26aulast%3DLundberg%26aufirst%3DA.%2BM.%26aulast%3DAveberger%26aufirst%3DA.%2BC.%26aulast%3DKlevenvall%26aufirst%3DL.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26atitle%3DHigh%2520mobility%2520group%2520box%2520protein%25201%2520%2528hmgb1%2529-partner%2520molecule%2520complexes%2520enhance%2520cytokine%2520production%2520by%2520signaling%2520through%2520the%2520partner%2520molecule%2520receptor%26jtitle%3DMol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D224%26epage%3D230%26doi%3D10.2119%2Fmolmed.2011.00327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armour, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukkar, M. B.</span></span> <span> </span><span class="NLM_article-title">Rage and tlrs: Relatives, friends or neighbours?</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">744</span>, <span class="refDoi"> DOI: 10.1016/j.molimm.2013.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.molimm.2013.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23954397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOmsr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=739-744&issue=4&author=Z.+A.+Ibrahimauthor=C.+L.+Armourauthor=S.+Phippsauthor=M.+B.+Sukkar&title=Rage+and+tlrs%3A+Relatives%2C+friends+or+neighbours%3F&doi=10.1016%2Fj.molimm.2013.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE and TLRs: Relatives, friends or neighbours?</span></div><div class="casAuthors">Ibrahim, Zaridatul Aini; Armour, Carol L.; Phipps, Simon; Sukkar, Maria B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The innate immune system forms the first line of protection against infectious and non-infectious tissue injury.  Cells of the innate immune system detect pathogen-assocd. mol. patterns or endogenous mols. released as a result of tissue injury or inflammation through various innate immune receptors, collectively termed pattern-recognition receptors.  Members of the Toll-like receptor (TLR) family of pattern-recognition receptors have well established roles in the host immune response to infection, while the receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor predominantly involved in the recognition of endogenous mols. released in the context of infection, physiol. stress or chronic inflammation.  RAGE and TLRs share common ligands and signaling pathways, and accumulating evidence points towards their co-operative interaction in the host immune response.  At present however, little is known about the mechanisms that result in TLR vs. RAGE signaling or RAGE-TLR cross-talk in response to their shared ligands.  Here we review what is known in relation to the physicochem. basis of ligand interactions between TLRs and RAGE, focusing on three shared ligands of these receptors: HMGB1, S100A8/A9 and LPS.  Our aim is to discuss what is known about differential ligand interactions with RAGE and TLRs and to highlight important areas for further investigation so that we may better understand the role of these receptors and their relationship in host defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Ala_9ZeVorVg90H21EOLACvtfcHk0lhGGjmEQNjvbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOmsr7P&md5=04c3c549b89e95827b30fe58c2a635d2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2013.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2013.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DIbrahim%26aufirst%3DZ.%2BA.%26aulast%3DArmour%26aufirst%3DC.%2BL.%26aulast%3DPhipps%26aufirst%3DS.%26aulast%3DSukkar%26aufirst%3DM.%2BB.%26atitle%3DRage%2520and%2520tlrs%253A%2520Relatives%252C%2520friends%2520or%2520neighbours%253F%26jtitle%3DMol.%2520Immunol.%26date%3D2013%26volume%3D56%26issue%3D4%26spage%3D739%26epage%3D744%26doi%3D10.1016%2Fj.molimm.2013.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, V.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor 4 (tlr4) modulation by synthetic and natural compounds: An update</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3612</span>– <span class="NLM_lpage">3622</span>, <span class="refDoi"> DOI: 10.1021/jm401006s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401006s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslaksLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3612-3622&issue=9&author=F.+Periauthor=V.+Calabrese&title=Toll-like+receptor+4+%28tlr4%29+modulation+by+synthetic+and+natural+compounds%3A+An+update&doi=10.1021%2Fjm401006s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update</span></div><div class="casAuthors">Peri, Francesco; Calabrese, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3612-3622</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Toll-like receptor 4 (TLR4), together with MD-2, binds bacterial endotoxins (E) with high affinity, triggering formation of the activated homodimer (E.MD-2.TLR4)2.  Activated TLR4 induces intracellular signaling leading to activation of transcription factors that result in cytokine and chemokine prodn. and initiation of inflammatory and immune responses.  TLR4 also responds to endogenous ligands called danger assocd. mol. patterns (DAMPs).  Increased sensitivity to infection and a variety of immune pathologies have been assocd. with either too little or too much TLR4 activation.  We review here the mol. mechanisms of TLR4 activation (agonism) or inhibition (antagonism) by small org. mols. of both natural and synthetic origin.  The role of co-receptors MD-2 and CD14 in the TLR4 modulation process is also discussed.  Recent achievements in the field of chem. TLR4 modulation are reviewed, with special focus on nonclassical TLR4 ligands with a chem. structure different from that of lipid A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmVf0w_guHebVg90H21EOLACvtfcHk0lhGGjmEQNjvbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslaksLnN&md5=dce69e6a3b1a44e148c14212ef82327b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm401006s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401006s%26sid%3Dliteratum%253Aachs%26aulast%3DPeri%26aufirst%3DF.%26aulast%3DCalabrese%26aufirst%3DV.%26atitle%3DToll-like%2520receptor%25204%2520%2528tlr4%2529%2520modulation%2520by%2520synthetic%2520and%2520natural%2520compounds%253A%2520An%2520update%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D9%26spage%3D3612%26epage%3D3622%26doi%3D10.1021%2Fjm401006s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bongarzone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savickas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, A. D.</span></span> <span> </span><span class="NLM_article-title">Targeting the receptor for advanced glycation endproducts (rage): A medicinal chemistry perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7213</span>– <span class="NLM_lpage">7232</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00058</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7213-7232&issue=17&author=S.+Bongarzoneauthor=V.+Savickasauthor=F.+Luziauthor=A.+D.+Gee&title=Targeting+the+receptor+for+advanced+glycation+endproducts+%28rage%29%3A+A+medicinal+chemistry+perspective&doi=10.1021%2Facs.jmedchem.7b00058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00058%26sid%3Dliteratum%253Aachs%26aulast%3DBongarzone%26aufirst%3DS.%26aulast%3DSavickas%26aufirst%3DV.%26aulast%3DLuzi%26aufirst%3DF.%26aulast%3DGee%26aufirst%3DA.%2BD.%26atitle%3DTargeting%2520the%2520receptor%2520for%2520advanced%2520glycation%2520endproducts%2520%2528rage%2529%253A%2520A%2520medicinal%2520chemistry%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D17%26spage%3D7213%26epage%3D7232%26doi%3D10.1021%2Facs.jmedchem.7b00058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sturchler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galichet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weibel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heizmann, C. W.</span></span> <span> </span><span class="NLM_article-title">Site-specific blockade of rage-vd prevents amyloid-beta oligomer neurotoxicity</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">5149</span>– <span class="NLM_lpage">5158</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4878-07.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1523%2FJNEUROSCI.4878-07.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=18480271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1SltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=5149-5158&issue=20&author=E.+Sturchlerauthor=A.+Galichetauthor=M.+Weibelauthor=E.+Leclercauthor=C.+W.+Heizmann&title=Site-specific+blockade+of+rage-vd+prevents+amyloid-beta+oligomer+neurotoxicity&doi=10.1523%2FJNEUROSCI.4878-07.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific blockade of RAGE-Vd prevents amyloid-β oligomer neurotoxicity</span></div><div class="casAuthors">Sturchler, Emmanuel; Galichet, Arnaud; Weibel, Mirjam; Leclerc, Estelle; Heizmann, Claus W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5149-5158</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In the genesis of Alzheimer's disease (AD), converging lines of evidence suggest that amyloid-β peptide (Aβ) triggers a pathogenic cascade leading to neuronal loss.  It was long assumed that Aβ had to be assembled into extracellular amyloid fibrils or aggregates to exert its cytotoxic effects.  Over the past decade, characterization of sol. oligomeric Aβ species in the brains of AD patients and in transgenic models has raised the possibility that different conformations of Aβ may contribute to AD pathol. via different mechanisms.  The receptor for advanced glycation end products (RAGE), a member of the Ig superfamily, is a cellular binding site for Aβ.  Here, we investigate the role of RAGE in apoptosis induced by distinct well characterized Aβ conformations: Aβ oligomers (AβOs), Aβ fibrils (AβFs), and Aβ aggregates (AβAs).  In our in vitro system, treatment with polyclonal anti-RAGE antibodies significantly improves SHSY-5Y cell and neuronal survival exposed to either AβOs or AβAs but does not affect AβF toxicity.  Interestingly, using site-specific antibodies, we demonstrate that targeting of the Vd domain of RAGE attenuates AβO-induced toxicity in both SHSY-5Y cells and rat cortical neurons, whereas inhibition of AβA-induced apoptosis requires the neutralization of the C1d domain of the receptor.  Thus, our data indicate that distinct regions of RAGE are involved in Aβ-induced cellular and neuronal toxicity with respect to the Aβ aggregation state, and they suggest the blockage of particular sites of the receptor as a potential therapeutic strategy to attenuate neuronal death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo358TfBYty9LVg90H21EOLACvtfcHk0lj7fg_yLiS92g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1SltrY%253D&md5=2c53047bf295e60a12d51b42dc39ef5b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4878-07.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4878-07.2008%26sid%3Dliteratum%253Aachs%26aulast%3DSturchler%26aufirst%3DE.%26aulast%3DGalichet%26aufirst%3DA.%26aulast%3DWeibel%26aufirst%3DM.%26aulast%3DLeclerc%26aufirst%3DE.%26aulast%3DHeizmann%26aufirst%3DC.%2BW.%26atitle%3DSite-specific%2520blockade%2520of%2520rage-vd%2520prevents%2520amyloid-beta%2520oligomer%2520neurotoxicity%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26issue%3D20%26spage%3D5149%26epage%3D5158%26doi%3D10.1523%2FJNEUROSCI.4878-07.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darmanin-Sheehan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahon, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piche, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittman, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tchistiakova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodangattil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hufton, S. E.</span></span> <span> </span><span class="NLM_article-title">Affinity maturation of a humanized rat antibody for anti-rage therapy: Comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>388</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2009.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.jmb.2009.03.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=541-558&issue=3&author=W.+J.+Finlayauthor=O.+Cunninghamauthor=M.+A.+Lambertauthor=A.+Darmanin-Sheehanauthor=X.+Liuauthor=B.+J.+Fennellauthor=C.+M.+Mahonauthor=E.+Cumminsauthor=J.+M.+Wadeauthor=C.+M.+O%E2%80%99Sullivanauthor=X.+Y.+Tanauthor=N.+Picheauthor=D.+D.+Pittmanauthor=J.+Paulsenauthor=L.+Tchistiakovaauthor=S.+Kodangattilauthor=D.+Gillauthor=S.+E.+Hufton&title=Affinity+maturation+of+a+humanized+rat+antibody+for+anti-rage+therapy%3A+Comprehensive+mutagenesis+reveals+a+high+level+of+mutational+plasticity+both+inside+and+outside+the+complementarity-determining+regions&doi=10.1016%2Fj.jmb.2009.03.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DW.%2BJ.%26aulast%3DCunningham%26aufirst%3DO.%26aulast%3DLambert%26aufirst%3DM.%2BA.%26aulast%3DDarmanin-Sheehan%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DFennell%26aufirst%3DB.%2BJ.%26aulast%3DMahon%26aufirst%3DC.%2BM.%26aulast%3DCummins%26aufirst%3DE.%26aulast%3DWade%26aufirst%3DJ.%2BM.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DC.%2BM.%26aulast%3DTan%26aufirst%3DX.%2BY.%26aulast%3DPiche%26aufirst%3DN.%26aulast%3DPittman%26aufirst%3DD.%2BD.%26aulast%3DPaulsen%26aufirst%3DJ.%26aulast%3DTchistiakova%26aufirst%3DL.%26aulast%3DKodangattil%26aufirst%3DS.%26aulast%3DGill%26aufirst%3DD.%26aulast%3DHufton%26aufirst%3DS.%2BE.%26atitle%3DAffinity%2520maturation%2520of%2520a%2520humanized%2520rat%2520antibody%2520for%2520anti-rage%2520therapy%253A%2520Comprehensive%2520mutagenesis%2520reveals%2520a%2520high%2520level%2520of%2520mutational%2520plasticity%2520both%2520inside%2520and%2520outside%2520the%2520complementarity-determining%2520regions%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26issue%3D3%26spage%3D541%26epage%3D558%26doi%3D10.1016%2Fj.jmb.2009.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">Targeting toll-like receptors with small molecule agents</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4859</span>– <span class="NLM_lpage">4866</span>, <span class="refDoi"> DOI: 10.1039/c3cs60039d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1039%2Fc3cs60039d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23503527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1ers7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=4859-4866&issue=12&author=X.+Wangauthor=C.+Smithauthor=H.+Yin&title=Targeting+toll-like+receptors+with+small+molecule+agents&doi=10.1039%2Fc3cs60039d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Toll-like receptors with small molecule agents</span></div><div class="casAuthors">Wang, Xiaohui; Smith, Christina; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4859-4866</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) are type I transmembrane proteins that are key regulators of both innate and adaptive immune responses.  To protect the host from viral and bacterial threats, TLRs trigger a pro-inflammatory immune response by detecting pathogen and danger assocd. mol. patterns.  Considerable evidence has accumulated to show that the dysregulation of TLR signaling contributes to the development and progression of numerous diseases.  Therefore, TLRs are emerging as important drug discovery targets.  Currently, there is great interest in the development of TLR small mol. modulators for interrogating TLR signaling and treating diseases caused by TLR signaling malfunctions.  In this tutorial review, we will outline methods for the discovery of TLR small mol. modulators and the up-to-date progress in this field.  Small mols. targeting TLRs not only provide an opportunity to identify promising drug candidates, but also unveil knowledge regarding TLR signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppuJ6XFSOMzrVg90H21EOLACvtfcHk0lj7fg_yLiS92g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1ers7Y%253D&md5=dd4e739bb0a67354ab45f4aa5511701d</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1039%2Fc3cs60039d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cs60039d%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DTargeting%2520toll-like%2520receptors%2520with%2520small%2520molecule%2520agents%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2013%26volume%3D42%26issue%3D12%26spage%3D4859%26epage%3D4866%26doi%3D10.1039%2Fc3cs60039d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Recent progress in the development of toll-like receptor (tlr) antagonists</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1080/13543776.2016.1185415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1080%2F13543776.2016.1185415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27136061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFOrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=719-730&issue=6&author=M.+C.+Patraauthor=S.+Choi&title=Recent+progress+in+the+development+of+toll-like+receptor+%28tlr%29+antagonists&doi=10.1080%2F13543776.2016.1185415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of Toll-like receptor (TLR) antagonists</span></div><div class="casAuthors">Patra, Mahesh Chandra; Choi, Sangdun</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-730</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  : Pattern recognition receptors (PRRs) of the innate immune system mediate and control the activation and progression of adaptive immunity.  Toll-like receptors (TLRs) are the most notable of the PRRs: they play crucial roles in protecting the host body against invading pathogens or endogenously released hazardous mols.  Sustained TLR signaling even after the clearance of pathogens or failure to distinguish between 'self' and 'non-self' mols. can cause inflammatory disorders, autoimmune diseases, and cancer.  This review focuses on recently developed therapeutic agents with TLR-antagonistic activities.  In recent years, several research institutes and pharmaceutical companies have achieved fundamental successes in inhibiting or reducing TLR signaling and assocd. effector mechanisms by using novel inhibitors.  These inhibitory mols. include antibodies against TLRs, TLR-derived transmembrane (TM) peptides, bacterial-secreted proteins, and natural or synthetic small mols., peptides, and proteins.  Antagonist developers generally target the TLR ectodomain to block receptor activation.  The TM and cytosolic Toll/IL-1 receptor domains also have regions that should be explored for the design of peptide-based and small mol. blocking agents.  A no. of preclin. and clin. breakthroughs may result in the availability of improved TLR immunomodulatory drugs to address important unmet medical needs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqbKGU6yn83rVg90H21EOLACvtfcHk0lj7fg_yLiS92g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFOrurc%253D&md5=11a223116a4186220fecbd19a4377cd6</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1080%2F13543776.2016.1185415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2016.1185415%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%2BC.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520toll-like%2520receptor%2520%2528tlr%2529%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26issue%3D6%26spage%3D719%26epage%3D730%26doi%3D10.1080%2F13543776.2016.1185415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yesudhas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors: Promising therapeutic targets for inflammatory diseases</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1007/s12272-016-0806-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs12272-016-0806-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27515048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlChsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=1032-1049&issue=8&author=A.+Achekauthor=D.+Yesudhasauthor=S.+Choi&title=Toll-like+receptors%3A+Promising+therapeutic+targets+for+inflammatory+diseases&doi=10.1007%2Fs12272-016-0806-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors: promising therapeutic targets for inflammatory diseases</span></div><div class="casAuthors">Achek, Asma; Yesudhas, Dhanusha; Choi, Sangdun</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1032-1049</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  The health of living organisms is constantly challenged by bacterial and viral threats.  The recognition of pathogenic microorganisms by diverse receptors triggers a variety of host defense mechanisms, leading to their eradication.  Toll-like receptors (TLRs), which are type I transmembrane proteins, recognize specific signatures of the invading microbes and activate a cascade of downstream signals inducing the secretion of inflammatory cytokines, chemokines, and type I interferons.  The TLR response not only counteracts the pathogens but also initiates and shapes the adaptive immune response.  Under normal conditions, inflammation is downregulated after the removal of the pathogen and cellular debris.  However, a dysfunctional TLR-mediated response maintains a chronic inflammatory state and leads to local and systemic deleterious effects in host cells and tissues.  Such inappropriate TLR response has been attributed to the development and progression of multiple diseases such as cancer, autoimmune, and inflammatory diseases.  In this review, we discuss the emerging role of TLRs in the pathogenesis of inflammatory diseases and how targeting of TLRs offers a promising therapeutic strategy for the prevention and treatment of various inflammatory diseases.  Addnl., we highlight a no. of TLR-targeting agents that are in the developmental stage or in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKA3cWXQ7UqrVg90H21EOLACvtfcHk0ljkK4tBKNq_ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlChsL7L&md5=2a2c871c48ae870982f4e7e0c1ee6260</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1007%2Fs12272-016-0806-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-016-0806-9%26sid%3Dliteratum%253Aachs%26aulast%3DAchek%26aufirst%3DA.%26aulast%3DYesudhas%26aufirst%3DD.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DToll-like%2520receptors%253A%2520Promising%2520therapeutic%2520targets%2520for%2520inflammatory%2520diseases%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2016%26volume%3D39%26issue%3D8%26spage%3D1032%26epage%3D1049%26doi%3D10.1007%2Fs12272-016-0806-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jules, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiguel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. I.</span></span> <span> </span><span class="NLM_article-title">Alternative splicing of the rage cytoplasmic domain regulates cell signaling and function</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">e78267</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0078267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1371%2Fjournal.pone.0078267" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e78267&issue=11&author=J.+Julesauthor=D.+Maiguelauthor=B.+I.+Hudson&title=Alternative+splicing+of+the+rage+cytoplasmic+domain+regulates+cell+signaling+and+function&doi=10.1371%2Fjournal.pone.0078267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0078267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0078267%26sid%3Dliteratum%253Aachs%26aulast%3DJules%26aufirst%3DJ.%26aulast%3DMaiguel%26aufirst%3DD.%26aulast%3DHudson%26aufirst%3DB.%2BI.%26atitle%3DAlternative%2520splicing%2520of%2520the%2520rage%2520cytoplasmic%2520domain%2520regulates%2520cell%2520signaling%2520and%2520function%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D11%26spage%3De78267%26doi%3D10.1371%2Fjournal.pone.0078267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kew, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habiel, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcu, K. B.</span></span> <span> </span><span class="NLM_article-title">The ikkalpha-dependent nf-kappab p52/relb noncanonical pathway is essential to sustain a cxcl12 autocrine loop in cells migrating in response to hmgb1</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>188</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2380</span>– <span class="NLM_lpage">2386</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1102454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.4049%2Fjimmunol.1102454" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2012&pages=2380-2386&issue=5&author=R.+R.+Kewauthor=M.+Penzoauthor=D.+M.+Habielauthor=K.+B.+Marcu&title=The+ikkalpha-dependent+nf-kappab+p52%2Frelb+noncanonical+pathway+is+essential+to+sustain+a+cxcl12+autocrine+loop+in+cells+migrating+in+response+to+hmgb1&doi=10.4049%2Fjimmunol.1102454"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1102454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1102454%26sid%3Dliteratum%253Aachs%26aulast%3DKew%26aufirst%3DR.%2BR.%26aulast%3DPenzo%26aufirst%3DM.%26aulast%3DHabiel%26aufirst%3DD.%2BM.%26aulast%3DMarcu%26aufirst%3DK.%2BB.%26atitle%3DThe%2520ikkalpha-dependent%2520nf-kappab%2520p52%252Frelb%2520noncanonical%2520pathway%2520is%2520essential%2520to%2520sustain%2520a%2520cxcl12%2520autocrine%2520loop%2520in%2520cells%2520migrating%2520in%2520response%2520to%2520hmgb1%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D188%26issue%3D5%26spage%3D2380%26epage%3D2386%26doi%3D10.4049%2Fjimmunol.1102454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Hout, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’huys, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schols, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Loy, T.</span></span> <span> </span><span class="NLM_article-title">Comparison of cell-based assays for the identification and evaluation of competitive cxcr4 inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">e0176057</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0176057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1371%2Fjournal.pone.0176057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0176057&issue=4&author=A.+van%0AHoutauthor=T.+D%E2%80%99huysauthor=M.+Oeyenauthor=D.+Scholsauthor=T.+Van+Loy&title=Comparison+of+cell-based+assays+for+the+identification+and+evaluation+of+competitive+cxcr4+inhibitors&doi=10.1371%2Fjournal.pone.0176057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0176057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0176057%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHout%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599huys%26aufirst%3DT.%26aulast%3DOeyen%26aufirst%3DM.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DVan%2BLoy%26aufirst%3DT.%26atitle%3DComparison%2520of%2520cell-based%2520assays%2520for%2520the%2520identification%2520and%2520evaluation%2520of%2520competitive%2520cxcr4%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D4%26spage%3De0176057%26doi%3D10.1371%2Fjournal.pone.0176057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bongartz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeting, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montori, V.</span></span> <span> </span><span class="NLM_article-title">Anti-tnf antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>295</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2285</span>, <span class="refDoi"> DOI: 10.1001/jama.295.19.2275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1001%2Fjama.295.19.2275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2006&pages=2275-2285&issue=19&author=T.+Bongartzauthor=A.+J.+Suttonauthor=M.+J.+Sweetingauthor=I.+Buchanauthor=E.+L.+Mattesonauthor=V.+Montori&title=Anti-tnf+antibody+therapy+in+rheumatoid+arthritis+and+the+risk+of+serious+infections+and+malignancies%3A+Systematic+review+and+meta-analysis+of+rare+harmful+effects+in+randomized+controlled+trials&doi=10.1001%2Fjama.295.19.2275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1001%2Fjama.295.19.2275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.295.19.2275%26sid%3Dliteratum%253Aachs%26aulast%3DBongartz%26aufirst%3DT.%26aulast%3DSutton%26aufirst%3DA.%2BJ.%26aulast%3DSweeting%26aufirst%3DM.%2BJ.%26aulast%3DBuchan%26aufirst%3DI.%26aulast%3DMatteson%26aufirst%3DE.%2BL.%26aulast%3DMontori%26aufirst%3DV.%26atitle%3DAnti-tnf%2520antibody%2520therapy%2520in%2520rheumatoid%2520arthritis%2520and%2520the%2520risk%2520of%2520serious%2520infections%2520and%2520malignancies%253A%2520Systematic%2520review%2520and%2520meta-analysis%2520of%2520rare%2520harmful%2520effects%2520in%2520randomized%2520controlled%2520trials%26jtitle%3DJAMA%26date%3D2006%26volume%3D295%26issue%3D19%26spage%3D2275%26epage%3D2285%26doi%3D10.1001%2Fjama.295.19.2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minozzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonovas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lytras, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecoraro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Lorenzo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastiampillai, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielli, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonati, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinquini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tocci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goletti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantini, F.</span></span> <span> </span><span class="NLM_article-title">Risk of infections using anti-tnf agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: A systematic review and meta-analysis</span>. <i>Expert Opin. Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">sup1</span>),  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1080/14740338.2016.1240783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1080%2F14740338.2016.1240783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27924643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=11-34&issue=sup1&author=S.+Minozziauthor=S.+Bonovasauthor=T.+Lytrasauthor=V.+Pecoraroauthor=M.+Gonzalez-Lorenzoauthor=A.+J.+Bastiampillaiauthor=E.+M.+Gabrielliauthor=A.+C.+Lonatiauthor=L.+Mojaauthor=M.+Cinquiniauthor=V.+Marinoauthor=A.+Matucciauthor=G.+M.+Milanoauthor=G.+Tocciauthor=R.+Scarpaauthor=D.+Golettiauthor=F.+Cantini&title=Risk+of+infections+using+anti-tnf+agents+in+rheumatoid+arthritis%2C+psoriatic+arthritis%2C+and+ankylosing+spondylitis%3A+A+systematic+review+and+meta-analysis&doi=10.1080%2F14740338.2016.1240783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis</span></div><div class="casAuthors">Minozzi, Silvia; Bonovas, Stefanos; Lytras, Theodore; Pecoraro, Valentina; Gonzalez-Lorenzo, Marien; Bastiampillai, Anan Judina; Gabrielli, Eugenia Maria; Lonati, Andrea Carlo; Moja, Lorenzo; Cinquini, Michela; Marino, Valentina; Matucci, Andrea; Milano, Giuseppe Maria; Tocci, Giuliano; Scarpa, Raffaele; Goletti, Delia; Cantini, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">sup1</span>),
    <span class="NLM_cas:pages">11-34</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory approval for use in rheumatol.: adalimumab, golimumab, infliximab, certolizumab, and etanercept.  Apart from their well-documented therapeutic value, it is still uncertain to what extent they are assocd. with an increased risk of infectious adverse events.  We conducted a systematic review and meta-anal. of published randomized studies to det. the effect of anti-TNF drugs on the occurrence of infectious adverse events (serious infections; tuberculosis; opportunistic infections; any infection).  We searched Medline, Embase, and the Cochrane Library up to May 2014 to identify eligible studies in adult patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis that evaluated anti-TNF drugs compared with placebo or no treatment.  Our study encompassed data from 71 randomized controlled trials involving 22,760 participants (range of follow-up: 1-36 mo) and seven open label extension studies with 2,236 participants (range of follow-up: 6-48 mo).  Quant. synthesis of the available data found statistically significant increases in the occurrence of any infections (20%), serious infections (40%), and tuberculosis (250%) assocd. with anti-TNF drug use, while the data for opportunistic infections were scarce.  The quality of synthesized evidence was judged as moderate.  Further evidence from registries and long-term epidemiol. studies are needed to better define the relationship between anti-TNF agents and infection complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjPpoFUt50VbVg90H21EOLACvtfcHk0ljZswSn5_IcWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2rtbc%253D&md5=39be1b54462fcd5ff22c30a8ea852aab</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1080%2F14740338.2016.1240783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14740338.2016.1240783%26sid%3Dliteratum%253Aachs%26aulast%3DMinozzi%26aufirst%3DS.%26aulast%3DBonovas%26aufirst%3DS.%26aulast%3DLytras%26aufirst%3DT.%26aulast%3DPecoraro%26aufirst%3DV.%26aulast%3DGonzalez-Lorenzo%26aufirst%3DM.%26aulast%3DBastiampillai%26aufirst%3DA.%2BJ.%26aulast%3DGabrielli%26aufirst%3DE.%2BM.%26aulast%3DLonati%26aufirst%3DA.%2BC.%26aulast%3DMoja%26aufirst%3DL.%26aulast%3DCinquini%26aufirst%3DM.%26aulast%3DMarino%26aufirst%3DV.%26aulast%3DMatucci%26aufirst%3DA.%26aulast%3DMilano%26aufirst%3DG.%2BM.%26aulast%3DTocci%26aufirst%3DG.%26aulast%3DScarpa%26aufirst%3DR.%26aulast%3DGoletti%26aufirst%3DD.%26aulast%3DCantini%26aufirst%3DF.%26atitle%3DRisk%2520of%2520infections%2520using%2520anti-tnf%2520agents%2520in%2520rheumatoid%2520arthritis%252C%2520psoriatic%2520arthritis%252C%2520and%2520ankylosing%2520spondylitis%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2016%26volume%3D15%26issue%3Dsup1%26spage%3D11%26epage%3D34%26doi%3D10.1080%2F14740338.2016.1240783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urbonaviciute, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furnrohr, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haslbeck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. E.</span></span> <span> </span><span class="NLM_article-title">Factors masking hmgb1 in human serum and plasma</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1189/jlb.0306196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1189%2Fjlb.0306196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=17060363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BD28jkslWntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=67-74&issue=1&author=V.+Urbonaviciuteauthor=B.+G.+Furnrohrauthor=C.+Weberauthor=M.+Haslbeckauthor=S.+Wilhelmauthor=M.+Herrmannauthor=R.+E.+Voll&title=Factors+masking+hmgb1+in+human+serum+and+plasma&doi=10.1189%2Fjlb.0306196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Factors masking HMGB1 in human serum and plasma</span></div><div class="casAuthors">Urbonaviciute Vilma; Furnrohr Barbara G; Weber Christian; Haslbeck Martin; Wilhelm Sabine; Herrmann Martin; Voll Reinhard E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of leukocyte biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-74</span>
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    </div><div class="casAbstract">High mobility group box 1 protein (HMGB1) is a ubiquitously expressed architectural chromosomal protein.  Recently, it has become obvious that HMGB1 can also act as a proinflammatory mediator when actively secreted during cell activation or passively released from necrotic cells.  HMGB1 appears to play an important role in the pathogenesis of diseases, including sepsis and rheumatoid arthritis.  However, easy, sensitive, and reliable detection systems are required to investigate the clinical significance of HMGB1 in clinical samples for diagnosis and prognosis of diseases.  Here, we describe sensitive ELISAs for the detection of HMGB1 in cell culture medium and cell lysates.  However, these assays failed to reliably quantitate HMGB1 in serum and plasma when compared with immunoblot analysis.  We found that serum/plasma components bind to HMGB1 and interfere with its detection by ELISA systems.  In most serum/plasma samples investigated, including those from healthy individuals, we detected IgG antibodies binding to HMGB1.  The titers of these antibodies correlated with the capacity of sera to interfere with the detection of recombinant HMGB1 by ELISA.  Furthermore, HMGB1 coimmunoprecipitated with several proteins including IgG1, as identified by mass spectrometry.  These HMGB1 interacting proteins are currently characterized and may contribute to complex formation, masking, and possibly, modulation of cytokine activity of HMGB1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0CGBldOxMXq-9TkgmBqTqfW6udTcc2ebWgX5yr2xUgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jkslWntA%253D%253D&md5=8cd5b6051d6611756a70040619bbddcc</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1189%2Fjlb.0306196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.0306196%26sid%3Dliteratum%253Aachs%26aulast%3DUrbonaviciute%26aufirst%3DV.%26aulast%3DFurnrohr%26aufirst%3DB.%2BG.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DHaslbeck%26aufirst%3DM.%26aulast%3DWilhelm%26aufirst%3DS.%26aulast%3DHerrmann%26aufirst%3DM.%26aulast%3DVoll%26aufirst%3DR.%2BE.%26atitle%3DFactors%2520masking%2520hmgb1%2520in%2520human%2520serum%2520and%2520plasma%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2007%26volume%3D81%26issue%3D1%26spage%3D67%26epage%3D74%26doi%3D10.1189%2Fjlb.0306196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bults, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Merbel, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, R.</span></span> <span> </span><span class="NLM_article-title">Quantification of biopharmaceuticals and biomarkers in complex biological matrices: A comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays</span>. <i>Expert Rev. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1586/14789450.2015.1050384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1586%2F14789450.2015.1050384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26005069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOltr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=355-374&issue=4&author=P.+Bultsauthor=N.+C.+van+de+Merbelauthor=R.+Bischoff&title=Quantification+of+biopharmaceuticals+and+biomarkers+in+complex+biological+matrices%3A+A+comparison+of+liquid+chromatography+coupled+to+tandem+mass+spectrometry+and+ligand+binding+assays&doi=10.1586%2F14789450.2015.1050384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays</span></div><div class="casAuthors">Bults, Peter; van de Merbel, Nico C.; Bischoff, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Proteomics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-374</span>CODEN:
                <span class="NLM_cas:coden">ERPXA3</span>;
        ISSN:<span class="NLM_cas:issn">1478-9450</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The quantification of proteins (biopharmaceuticals or biomarkers) in complex biol. samples such as blood plasma requires exquisite sensitivity and selectivity, as all biol. matrixes contain myriads of proteins that are all made of the same 20 proteinogenic amino acids, notwithstanding post-translational modifications.  This review describes and compares the two main approaches, namely, ligand binding assays (LBAs) and liq. chromatog. coupled to tandem mass spectrometry in the selected reaction monitoring (SRM) mode.  While LBAs remain the most widely used approach, SRM assays are gaining interest due to their generally better anal. performance (precision and accuracy) and their capacity for multiplex analyses.  This article focuses on the possible reasons for the discrepancies between results obtained by LBAs and SRM assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_nDecSE7eKrVg90H21EOLACvtfcHk0liEGGjmKFfbEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOltr%252FK&md5=3db1e8564bf37d613a373a1ce615a26b</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1586%2F14789450.2015.1050384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14789450.2015.1050384%26sid%3Dliteratum%253Aachs%26aulast%3DBults%26aufirst%3DP.%26aulast%3Dvan%2Bde%2BMerbel%26aufirst%3DN.%2BC.%26aulast%3DBischoff%26aufirst%3DR.%26atitle%3DQuantification%2520of%2520biopharmaceuticals%2520and%2520biomarkers%2520in%2520complex%2520biological%2520matrices%253A%2520A%2520comparison%2520of%2520liquid%2520chromatography%2520coupled%2520to%2520tandem%2520mass%2520spectrometry%2520and%2520ligand%2520binding%2520assays%26jtitle%3DExpert%2520Rev.%2520Proteomics%26date%3D2015%26volume%3D12%26issue%3D4%26spage%3D355%26epage%3D374%26doi%3D10.1586%2F14789450.2015.1050384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Izrael-Tomasevic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnott, D.</span></span> <span> </span><span class="NLM_article-title">Targeting interferon alpha subtypes in serum: A comparison of analytical approaches to the detection and quantitation of proteins in complex biological matrices</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3132</span>– <span class="NLM_lpage">3140</span>, <span class="refDoi"> DOI: 10.1021/pr900076q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr900076q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFWjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3132-3140&issue=6&author=A.+Izrael-Tomasevicauthor=L.+Phuauthor=Q.+T.+Phungauthor=J.+R.+Lillauthor=D.+Arnott&title=Targeting+interferon+alpha+subtypes+in+serum%3A+A+comparison+of+analytical+approaches+to+the+detection+and+quantitation+of+proteins+in+complex+biological+matrices&doi=10.1021%2Fpr900076q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Interferon Alpha Subtypes in Serum: A Comparison of Analytical Approaches to the Detection and Quantitation of Proteins in Complex Biological Matrices</span></div><div class="casAuthors">Izrael-Tomasevic, Anita; Phu, Lilian; Phung, Qui T.; Lill, Jennie R.; Arnott, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3132-3140</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The targeted detection and quantitation of proteins in complex biol. fluids such as blood is as anal. challenging as it is crucial for biomedical research.  Antibody-based techniques such as the ELISA are the current stds. for such measurements, having in favorable cases high specificity and pg/mL detection limits.  Long development timelines and susceptibility to cross reactivity have led researchers to investigate mass spectrometric alternatives.  The literature contains diverse schemes for sample prepn. and multiple platforms for mass spectrometric detection.  Crit. evaluations of competing technologies are, however, badly needed.  Taking closely related subtypes of the pro-inflammatory cytokine interferon alpha as a test case, the authors compared a sample prepn. workflow based on affinity enrichment to 1 based on generic multidimensional chromatog., and evaluated mass spectrometric techniques using tandem mass spectrometry on low resoln. ion traps, high resoln. "accurate mass tags," and triple quadrupole selective reaction monitoring.  Each workflow and detection method proved capable of detecting and discriminating between these proteins at or below the ng/mL level in human serum.  Quantitation by isotope diln. was evaluated using full length protein as the internal std.  Both triple quadrupole selected reaction monitoring and orbitrap selected ion monitoring produced linear calibration curves from 1 ng/mL to 1 μg/mL, with lower limits of quantitation below 5 and 50 ng/mL, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJoMttwq8vcrVg90H21EOLACvtfcHk0liEGGjmKFfbEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFWjur8%253D&md5=f6a2e77507c0c4e53a19df79ae3ecd90</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fpr900076q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr900076q%26sid%3Dliteratum%253Aachs%26aulast%3DIzrael-Tomasevic%26aufirst%3DA.%26aulast%3DPhu%26aufirst%3DL.%26aulast%3DPhung%26aufirst%3DQ.%2BT.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DArnott%26aufirst%3DD.%26atitle%3DTargeting%2520interferon%2520alpha%2520subtypes%2520in%2520serum%253A%2520A%2520comparison%2520of%2520analytical%2520approaches%2520to%2520the%2520detection%2520and%2520quantitation%2520of%2520proteins%2520in%2520complex%2520biological%2520matrices%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2009%26volume%3D8%26issue%3D6%26spage%3D3132%26epage%3D3140%26doi%3D10.1021%2Fpr900076q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Festoff, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajja, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dreden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucullo, L.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">194</span>, <span class="refDoi"> DOI: 10.1186/s12974-016-0670-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2Fs12974-016-0670-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27553758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVGktrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=194&issue=1&author=B.+W.+Festoffauthor=R.+K.+Sajjaauthor=P.+van+Dredenauthor=L.+Cucullo&title=Hmgb1+and+thrombin+mediate+the+blood-brain+barrier+dysfunction+acting+as+biomarkers+of+neuroinflammation+and+progression+to+neurodegeneration+in+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs12974-016-0670-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease</span></div><div class="casAuthors">Festoff, Barry W.; Sajja, Ravi K.; van Dreden, Patrick; Cucullo, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">194/1-194/12</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The blood-brain barrier (BBB) dysfunction represents an early feature of Alzheimer's disease (AD) that precedes the hallmarks of amyloid beta (amyloid β) plaque deposition and neuronal neurofibrillary tangle (NFT) formation.  A damaged BBB correlates directly with neuroinflammation involving microglial activation and reactive astrogliosis, which is assocd. with increased expression and/or release of high-mobility group box protein 1 (HMGB1) and thrombin.  However, the link between the presence of these mols., BBB damage, and progression to neurodegeneration in AD is still elusive.  Therefore, we aimed to profile and validate non-invasive clin. biomarkers of BBB dysfunction and neuroinflammation to assess the progression to neurodegeneration in mild cognitive impairment (MCI) and AD patients.  Methods: We detd. the serum levels of various proinflammatory damage-assocd. mols. in aged control subjects and patients with MCI or AD using validated ELISA kits.  We then assessed the specific and direct effects of such mols. on BBB integrity in vitro using human primary brain microvascular endothelial cells or a cell line.  Results: We obsd. a significant increase in serum HMGB1 and sol. receptor for advanced glycation end products (sRAGE) that correlated well with amyloid beta levels in AD patients (vs. control subjects).  Interestingly, serum HMGB1 levels were significantly elevated in MCI patients compared to controls or AD patients.  In addn., as a marker of BBB damage, sol. thrombomodulin (sTM) antigen, and activity were significantly (and distinctly) increased in MCI and AD patients.  Direct in vitro BBB integrity assessment further revealed a significant and concn.-dependent increase in paracellular permeability to dextrans by HMGB1 or a-thrombin, possibly through disruption of zona occludins-1 bands.  Pre-treatment with anti-HMGB1 monoclonal antibody blocked HMGB1 effects and leaving BBB integrity intact.  Conclusions: Our current studies indicate that thrombin and HMGB1 are causal proximate proinflammatory mediators of BBB dysfunction, while sTM levels may indicate BBB endothelial damage; HMGB1 and sRAGE might serve as clin. biomarkers for progression and/or therapeutic efficacy along the AD spectrum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6tmxZhEnauLVg90H21EOLACvtfcHk0liEGGjmKFfbEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVGktrjE&md5=d6f6c8722da83b2c3488eb6cfb719794</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1186%2Fs12974-016-0670-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-016-0670-z%26sid%3Dliteratum%253Aachs%26aulast%3DFestoff%26aufirst%3DB.%2BW.%26aulast%3DSajja%26aufirst%3DR.%2BK.%26aulast%3Dvan%2BDreden%26aufirst%3DP.%26aulast%3DCucullo%26aufirst%3DL.%26atitle%3DHmgb1%2520and%2520thrombin%2520mediate%2520the%2520blood-brain%2520barrier%2520dysfunction%2520acting%2520as%2520biomarkers%2520of%2520neuroinflammation%2520and%2520progression%2520to%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2016%26volume%3D13%26issue%3D1%26spage%3D194%26doi%3D10.1186%2Fs12974-016-0670-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilson, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton Whittle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas Crain, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo-Carranza, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayed, R.</span></span> <span> </span><span class="NLM_article-title">Tau oligomers associate with inflammation in the brain and retina of tauopathy mice and in neurodegenerative diseases</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1083</span>– <span class="NLM_lpage">1099</span>, <span class="refDoi"> DOI: 10.3233/JAD-160912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3233%2FJAD-160912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27716675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyrtrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2017&pages=1083-1099&issue=3&author=A.+N.+Nilsonauthor=K.+C.+Englishauthor=J.+E.+Gersonauthor=T.+Barton+Whittleauthor=C.+Nicolas+Crainauthor=J.+Xueauthor=U.+Senguptaauthor=D.+L.+Castillo-Carranzaauthor=W.+Zhangauthor=P.+Guptaauthor=R.+Kayed&title=Tau+oligomers+associate+with+inflammation+in+the+brain+and+retina+of+tauopathy+mice+and+in+neurodegenerative+diseases&doi=10.3233%2FJAD-160912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases</span></div><div class="casAuthors">Nilson, Ashley N.; English, Kelsey C.; Gerson, Julia E.; Barton Whittle, T.; Nicolas Crain, C.; Xue, Judy; Sengupta, Urmi; Castillo-Carranza, Diana L.; Zhang, Wenbo; Gupta, Praveena; Kayed, Rakez</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1083-1099</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">It is well-established that inflammation plays an important role in Alzheimer's disease (AD) and frontotemporal lobar dementia (FTLD).  Inflammation and synapse loss occur in disease prior to the formation of larger aggregates, but the contribution of tau to inflammation has not yet been thoroughly investigated.  Tau pathol. aggregates to form large fibrillar structures known as tangles.  However, evidence suggests that smaller sol. aggregates, called oligomers, are the most toxic species and form prior to tangles.  Furthermore, tau oligomers can spread to neighboring cells and between anatomically connected brain regions.  In addn., recent evidence suggests that inspecting the retina may be a window to brain pathol.  We hypothesized that there is a relationship between tau oligomers and inflammation, which are hallmarks of early disease.  We conducted immunofluorescence and biochem. analyses on tauopathy mice, FTLD, and AD subjects.  We showed that oligomers co-localize with astrocytes, microglia, and HMGB1, a pro-inflammatory cytokine.  Addnl., we show that tau oligomers are present in the retina and are assocd. with inflammatory cells suggesting that the retina may be a valid non-invasive biomarker for brain pathol.  These results suggest that there may be a toxic relationship between tau oligomers and inflammation.  Therefore, the ability of tau oligomers to spread may initiate a feed-forward cycle in which tau oligomers induce inflammation, leading to neuronal damage, and thus more inflammation.  Further mechanistic studies are warranted in order to understand this relationship, which may have crit. implications for improving the treatment of tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNdqYZalNN6rVg90H21EOLACvtfcHk0lit69eaEM-70A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyrtrfO&md5=b52190000eb3fc0dcb18457261cff53d</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.3233%2FJAD-160912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-160912%26sid%3Dliteratum%253Aachs%26aulast%3DNilson%26aufirst%3DA.%2BN.%26aulast%3DEnglish%26aufirst%3DK.%2BC.%26aulast%3DGerson%26aufirst%3DJ.%2BE.%26aulast%3DBarton%2BWhittle%26aufirst%3DT.%26aulast%3DNicolas%2BCrain%26aufirst%3DC.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DSengupta%26aufirst%3DU.%26aulast%3DCastillo-Carranza%26aufirst%3DD.%2BL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DKayed%26aufirst%3DR.%26atitle%3DTau%2520oligomers%2520associate%2520with%2520inflammation%2520in%2520the%2520brain%2520and%2520retina%2520of%2520tauopathy%2520mice%2520and%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2017%26volume%3D55%26issue%3D3%26spage%3D1083%26epage%3D1099%26doi%3D10.3233%2FJAD-160912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakimura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibagaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchiya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimohama, S.</span></span> <span> </span><span class="NLM_article-title">Role of high mobility group protein-1 (hmg1) in amyloid-beta homeostasis</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>301</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(03)00024-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2FS0006-291X%2803%2900024-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2003&pages=699-703&issue=3&author=K.+Takataauthor=Y.+Kitamuraauthor=J.+Kakimuraauthor=K.+Shibagakiauthor=D.+Tsuchiyaauthor=T.+Taniguchiauthor=M.+A.+Smithauthor=G.+Perryauthor=S.+Shimohama&title=Role+of+high+mobility+group+protein-1+%28hmg1%29+in+amyloid-beta+homeostasis&doi=10.1016%2FS0006-291X%2803%2900024-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2900024-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252900024-X%26sid%3Dliteratum%253Aachs%26aulast%3DTakata%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DKakimura%26aufirst%3DJ.%26aulast%3DShibagaki%26aufirst%3DK.%26aulast%3DTsuchiya%26aufirst%3DD.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DShimohama%26aufirst%3DS.%26atitle%3DRole%2520of%2520high%2520mobility%2520group%2520protein-1%2520%2528hmg1%2529%2520in%2520amyloid-beta%2520homeostasis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D301%26issue%3D3%26spage%3D699%26epage%3D703%26doi%3D10.1016%2FS0006-291X%2803%2900024-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spliet, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steentjes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronica, E.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2011.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.neuroscience.2011.02.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=233-243&author=M.+Casulaauthor=A.+M.+Iyerauthor=W.+G.+Splietauthor=J.+J.+Aninkauthor=K.+Steentjesauthor=M.+Staauthor=D.+Troostauthor=E.+Aronica&title=Toll-like+receptor+signaling+in+amyotrophic+lateral+sclerosis+spinal+cord+tissue&doi=10.1016%2Fj.neuroscience.2011.02.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2011.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2011.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DCasula%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DA.%2BM.%26aulast%3DSpliet%26aufirst%3DW.%2BG.%26aulast%3DAnink%26aufirst%3DJ.%2BJ.%26aulast%3DSteentjes%26aufirst%3DK.%26aulast%3DSta%26aufirst%3DM.%26aulast%3DTroost%26aufirst%3DD.%26aulast%3DAronica%26aufirst%3DE.%26atitle%3DToll-like%2520receptor%2520signaling%2520in%2520amyotrophic%2520lateral%2520sclerosis%2520spinal%2520cord%2520tissue%26jtitle%3DNeuroscience%26date%3D2011%26volume%3D179%26spage%3D233%26epage%3D243%26doi%3D10.1016%2Fj.neuroscience.2011.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juranek, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daffu, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtkiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacomis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kofler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. M.</span></span> <span> </span><span class="NLM_article-title">Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">485</span>, <span class="refDoi"> DOI: 10.3389/fncel.2015.00485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3389%2Ffncel.2015.00485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26733811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvV2lt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=485&author=J.+K.+Juranekauthor=G.+K.+Daffuauthor=J.+Wojtkiewiczauthor=D.+Lacomisauthor=J.+Koflerauthor=A.+M.+Schmidt&title=Receptor+for+advanced+glycation+end+products+and+its+inflammatory+ligands+are+upregulated+in+amyotrophic+lateral+sclerosis&doi=10.3389%2Ffncel.2015.00485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Juranek, Judyta K.; Daffu, Gurdip K.; Wojtkiewicz, Joanna; Lacomis, David; Kofler, Julia; Schmidt, Ann Marie</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">485/1-485/12</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder of largely unknown pathogenesis.  Recent studies suggest that enhanced oxidative stress and neuroinflammation contribute to the progression of the disease.  Mounting evidence implicates the receptor for advanced glycation end-products (RAGE) as a significant contributor to the pathogenesis of certain neurodegenerative diseases and chronic conditions.  It is hypothesized that detrimental actions of RAGE are triggered upon binding to its ligands, such as AGEs (advanced glycation end products), S100/calgranulin family members, and High Mobility Group Box-1 (HMGB1) proteins.  Here, we examd. the expression of RAGE and its ligands in human ALS spinal cord.  Tissue samples from age-matched human control and ALS spinal cords were tested for the expression of RAGE, carboxymethyllysine (CML) AGE, S100B, and HMGB1, and intensity of the immunofluorescent and immunoblotting signals was assessed.  We found that the expression of both RAGE and its ligands was significantly increased in the spinal cords of ALS patients vs. age-matched control subjects.  Our study is the first report describing co-expression of both RAGE and its ligands in human ALS spinal cords.  These findings suggest that further probing of RAGE as a mechanism of neurodegeneration in human ALS is rational.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5xB-iUAe407Vg90H21EOLACvtfcHk0lit69eaEM-70A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvV2lt7g%253D&md5=33ccd40a4e9cc593fcdef05811d214af</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2015.00485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2015.00485%26sid%3Dliteratum%253Aachs%26aulast%3DJuranek%26aufirst%3DJ.%2BK.%26aulast%3DDaffu%26aufirst%3DG.%2BK.%26aulast%3DWojtkiewicz%26aufirst%3DJ.%26aulast%3DLacomis%26aufirst%3DD.%26aulast%3DKofler%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26atitle%3DReceptor%2520for%2520advanced%2520glycation%2520end%2520products%2520and%2520its%2520inflammatory%2520ligands%2520are%2520upregulated%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D485%26doi%3D10.3389%2Ffncel.2015.00485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Expression and significance of high-mobility group protein b1 (hmgb1) and the receptor for advanced glycation end-product (rage) in knee osteoarthritis</span>. <i>Med. Sci. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2105</span>– <span class="NLM_lpage">2112</span>, <span class="refDoi"> DOI: 10.12659/MSM.895689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.12659%2FMSM.895689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27320800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnvVWgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=2105-2112&author=X.+H.+Sunauthor=Y.+Liuauthor=Y.+Hanauthor=J.+Wang&title=Expression+and+significance+of+high-mobility+group+protein+b1+%28hmgb1%29+and+the+receptor+for+advanced+glycation+end-product+%28rage%29+in+knee+osteoarthritis&doi=10.12659%2FMSM.895689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and significance of high-mobility group protein B1 (HMGB1) and the receptor for advanced glycation end-product (RAGE) in knee osteoarthritis</span></div><div class="casAuthors">Sun, Xue-Hui; Liu, Ying; Han, Yun; Wang, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Medical Science Monitor</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2105-2112</span>CODEN:
                <span class="NLM_cas:coden">MSMOFR</span>;
        ISSN:<span class="NLM_cas:issn">1643-3750</span>.
    
            (<span class="NLM_cas:orgname">International Scientific Information, Inc.</span>)
        </div><div class="casAbstract">Background: This study was performed with the aim to explore the expression of high-mobility group protein B1 (HMGB1) and the receptor for advanced glycation end-product (RAGE) in knee osteoarthritis (KOA) and its clin. significance.  Material/Methods: A total of 108 synovial tissues selected from KOA patients were included in the exptl. group.  Seventy-five synovial tissues of knee joints, selected from patients who were clin. and pathol. confirmed without joint lesion, were included in the control group.  The mRNA and protein expressions of HMGB1 and RAGE were detd. by using RT-PCR and immunohistochem., resp.  Western blotting was used for measuring relative protein expression.  An ROC curve was drawn to evaluate the diagnostic value of HMGB1 and RAGE for KOA.  Results: The pos. cell no. and pos. expression intensity of HMGB1 and RAGE in synovial tissue was higher in the exptl. group than in the control group.  PI for HMGB1 and RAGE expression in KOA patients was pos. correlated with clin. classification of X-ray films (P<0.05).  HMGB1 and RAGE mRNA expressions, as well as relative protein expression of HMGB1 and RAGE in synovial tissue, were higher in the exptl. group than in the control group (all P<0.05).  The sensitivity of HMGB1 protein, RAGE protein, HMGB1 mRNA, and RAGE mRNA were 76.9%, 64.8%, 86.1%, and 64.8%, resp.; and the specificity was 100%, 96%, 74.7%, and 80%, resp.  Conclusions: The protein and mRNA expressions of HMGB1 and RAGE are both increased in KOA patients, suggesting that they are involved in KOA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreS_OwJrQBWrVg90H21EOLACvtfcHk0lhqN_bCNYE35w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnvVWgt74%253D&md5=fe4e501e2c345b77d9f63d8f47dbe145</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.12659%2FMSM.895689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12659%252FMSM.895689%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%2BH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DExpression%2520and%2520significance%2520of%2520high-mobility%2520group%2520protein%2520b1%2520%2528hmgb1%2529%2520and%2520the%2520receptor%2520for%2520advanced%2520glycation%2520end-product%2520%2528rage%2529%2520in%2520knee%2520osteoarthritis%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2016%26volume%3D22%26spage%3D2105%26epage%3D2112%26doi%3D10.12659%2FMSM.895689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ke, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, B.</span></span> <span> </span><span class="NLM_article-title">Synovial fluid hmgb-1 levels are associated with osteoarthritis severity</span>. <i>Clin. Lab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">818</span>, <span class="refDoi"> DOI: 10.7754/Clin.Lab.2015.141205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.7754%2FClin.Lab.2015.141205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26299081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGhsLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=809-818&issue=7&author=X.+Keauthor=G.+Jinauthor=Y.+Yangauthor=X.+Caoauthor=R.+Fangauthor=X.+Fengauthor=B.+Lei&title=Synovial+fluid+hmgb-1+levels+are+associated+with+osteoarthritis+severity&doi=10.7754%2FClin.Lab.2015.141205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Synovial fluid HMGB-1 levels are associated with osteoarthritis severity</span></div><div class="casAuthors">Ke, Xueru; Jin, Gele; Yang, Yi; Cao, Xinghua; Fang, Rui; Feng, Xiaoyun; Lei, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Laboratory (Mainz, Germany)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">809-818</span>CODEN:
                <span class="NLM_cas:coden">CLLAFP</span>;
        ISSN:<span class="NLM_cas:issn">1433-6510</span>.
    
            (<span class="NLM_cas:orgname">Clinical Laboratory Publications GmbH</span>)
        </div><div class="casAbstract">Background: Recent data have shown that enhanced cytokine prodn. in knee osteoarthritis (OA) synovium arc believed to promote pathol. OA.  High-mobility group box 1 (HMGB-1) as a well-known pro-inflammatory cytokine may influence the development of knee OA.  The purpose of this study is to analyze the amt. of and location of HMGB-1 in OA synovium and to compare it with controls who are afflicted with acute meniscal or cruciate ligament tears.  We also evaluated the relationship between the level of HMGB-I in synovial fluid with the severity of synovitis, clin. symptoms (pain, stiffness, daily activity), and radiol. changes in patients with knee OA.  Methods: Synovium and synovial fluid were harvested from seventy-four knee OA patients and thirty-four controls afflicted with acute meniscal or cruciate ligament tears.  Kellgren-Lawrence (KL) grading system and Western Ontario McMaster University Osteoarthritis Index (WOMAC) assessment scale were applied to evaluate the radiol. and clinic severity of OA patients.  Addnl., for all patients, the microscopic synovitis was graded to evaluate the severity of synovium pathol.  The location of HMGB-1 was detd. in the synovium by immunohistochem.  Synovium and synovial fluid HNIGB-1 levels were measured by western blotting and ELISA (ELISA), resp.  Results: Synovium immunohistochem. anal. revealed that HMGB-1 displayed a strictly nuclear localization in controls; however, both nuclear and cytoplasmic distributions were present in OA patients.  The percentage of HMGB-1 pos. cells as well as cytoplasmic HMGB-1 cell population in OA patients were higher than those of controls (42.5% vs. 39.7% and 24.0% vs. 5.7%).  Both synovium and synovial fluid HMGB-1 levels in OA patients were significantly higher than controls.  In OA patients, IIMGB-1 in the KU2/3 group was higher than in the KL4 group.  Addnl., synovial fluid IIMGB-I levels in OA patients were pos. assocd. with the severity of synovitis, pain, and daily activities.  Conclusions: Our results demonstrated that HMGB-1 is overexpressed and relocated in synovial membranes of patients with knee OA.  The increased synovial fluid HMGB-1 levels were assocd. with the severity of synovitis, pain, and daily activities in knee OA patients.  These results suggested that HMGB-1, as a pro-inflammatory cytokine, may play a crucial role in the progression of knee OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry4V-4EFRosrVg90H21EOLACvtfcHk0lhqN_bCNYE35w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGhsLjN&md5=6314aa9a593dde70c1909f802da1182e</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.7754%2FClin.Lab.2015.141205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7754%252FClin.Lab.2015.141205%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DR.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DB.%26atitle%3DSynovial%2520fluid%2520hmgb-1%2520levels%2520are%2520associated%2520with%2520osteoarthritis%2520severity%26jtitle%3DClin.%2520Lab.%26date%3D2015%26volume%3D61%26issue%3D7%26spage%3D809%26epage%3D818%26doi%3D10.7754%2FClin.Lab.2015.141205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amin, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, A. B.</span></span> <span> </span><span class="NLM_article-title">Genomic analysis and differential expression of hmg and s100a family in human arthritis: Upregulated expression of chemokines, il-8 and nitric oxide by hmgb1</span>. <i>DNA Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">550</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1089/dna.2013.2198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1089%2Fdna.2013.2198" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=550-565&issue=8&author=A.+R.+Aminauthor=A.+B.+Islam&title=Genomic+analysis+and+differential+expression+of+hmg+and+s100a+family+in+human+arthritis%3A+Upregulated+expression+of+chemokines%2C+il-8+and+nitric+oxide+by+hmgb1&doi=10.1089%2Fdna.2013.2198"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1089%2Fdna.2013.2198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fdna.2013.2198%26sid%3Dliteratum%253Aachs%26aulast%3DAmin%26aufirst%3DA.%2BR.%26aulast%3DIslam%26aufirst%3DA.%2BB.%26atitle%3DGenomic%2520analysis%2520and%2520differential%2520expression%2520of%2520hmg%2520and%2520s100a%2520family%2520in%2520human%2520arthritis%253A%2520Upregulated%2520expression%2520of%2520chemokines%252C%2520il-8%2520and%2520nitric%2520oxide%2520by%2520hmgb1%26jtitle%3DDNA%2520Cell%2520Biol.%26date%3D2014%26volume%3D33%26issue%3D8%26spage%3D550%26epage%3D565%26doi%3D10.1089%2Fdna.2013.2198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pullerits, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schierbeck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uibo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liivamagi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarraste, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talvik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruunsild, C.</span></span> <span> </span><span class="NLM_article-title">High mobility group box protein 1-a prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis</span>. <i>Semin. Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1016/j.semarthrit.2016.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.semarthrit.2016.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27756498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslSnsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=444-450&issue=4&author=R.+Pulleritsauthor=H.+Schierbeckauthor=K.+Uiboauthor=H.+Liivamagiauthor=S.+Tarrasteauthor=T.+Talvikauthor=E.+Sundbergauthor=C.+Pruunsild&title=High+mobility+group+box+protein+1-a+prognostic+marker+for+structural+joint+damage+in+10-year+follow-up+of+patients+with+juvenile+idiopathic+arthritis&doi=10.1016%2Fj.semarthrit.2016.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box protein 1-A prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis</span></div><div class="casAuthors">Pullerits, Rille; Schierbeck, Hanna; Uibo, Karin; Liivamaegi, Hille; Tarraste, Sirje; Talvik, Tiina; Sundberg, Erik; Pruunsild, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Arthritis and Rheumatism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">444-450</span>CODEN:
                <span class="NLM_cas:coden">SAHRBF</span>;
        ISSN:<span class="NLM_cas:issn">0049-0172</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">High mobility group box protein 1 (HMGB1) is an important pro-inflammatory mediator in adult rheumatoid arthritis.  The diagnostic utility of HMGB1 in Juvenile Idiopathic Arthritis (JIA) is still unclear.  The aim was to examine whether serum HMGB1 levels are assocd. with inflammation, radiol. disease progression, and long-term prognosis in JIA.  We included 131 children with JIA from a population-based prevalence study; 38 of them were prospectively followed up for 10 years.  Clin. and lab. disease characteristics at study entry and after 10 years as well as radiol. progression over 10 years were recorded.  HMGB1 levels were analyzed by an ELISA.  The HMGB1 levels were similar in children with different JIA subgroups and in children with established (53%) or newly diagnosed (47%) disease.  HMGB1 levels did not differ between groups at entry into the study or at 10 years, by sex, or by the presence or absence of RF or ANA antibodies.  HMGB1 levels at the study entry correlated with HMGB1 levels at 10 years and with blood neutrophil count.  Most importantly, children with destructive arthritis at 10 years had a tendency toward higher HMGB1 levels at study entry (median 1.2 vs 0.6 ng/mL, ns) and displayed 4-fold higher circulating HMGB1 levels (median 3.4 vs 0.8 ng/mL, p = 0.0014) than children without radiol. destructions.  Our results suggest that HMGB1 is a marker of inflammatory activity in children with JIA.  Higher serum HMGB1 levels are related to more destructive JIA and could be used as a neg. prognostic marker at the disease start.  Trial registration: Clinicaltrials.gov NCT01905319.  Registered July 16, 2013.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpbmX5Izlws7Vg90H21EOLACvtfcHk0lhFnWTDxRS3iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslSnsLbM&md5=b3c0d1031312d9983c5cbe99c1ee0df5</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.semarthrit.2016.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semarthrit.2016.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DPullerits%26aufirst%3DR.%26aulast%3DSchierbeck%26aufirst%3DH.%26aulast%3DUibo%26aufirst%3DK.%26aulast%3DLiivamagi%26aufirst%3DH.%26aulast%3DTarraste%26aufirst%3DS.%26aulast%3DTalvik%26aufirst%3DT.%26aulast%3DSundberg%26aufirst%3DE.%26aulast%3DPruunsild%26aufirst%3DC.%26atitle%3DHigh%2520mobility%2520group%2520box%2520protein%25201-a%2520prognostic%2520marker%2520for%2520structural%2520joint%2520damage%2520in%252010-year%2520follow-up%2520of%2520patients%2520with%2520juvenile%2520idiopathic%2520arthritis%26jtitle%3DSemin.%2520Arthritis%2520Rheum.%26date%3D2017%26volume%3D46%26issue%3D4%26spage%3D444%26epage%3D450%26doi%3D10.1016%2Fj.semarthrit.2016.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yone, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashiguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijiri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, I.</span></span> <span> </span><span class="NLM_article-title">High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1002/art.10859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Fart.10859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=12687539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlKnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=971-981&issue=4&author=N.+Taniguchiauthor=K.+Kawaharaauthor=K.+Yoneauthor=T.+Hashiguchiauthor=M.+Yamakuchiauthor=M.+Gotoauthor=K.+Inoueauthor=S.+Yamadaauthor=K.+Ijiriauthor=S.+Matsunagaauthor=T.+Nakajimaauthor=S.+Komiyaauthor=I.+Maruyama&title=High+mobility+group+box+chromosomal+protein+1+plays+a+role+in+the+pathogenesis+of+rheumatoid+arthritis+as+a+novel+cytokine&doi=10.1002%2Fart.10859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine</span></div><div class="casAuthors">Taniguchi, Noboru; Kawahara, Ko-Ichi; Yone, Kazunori; Hashiguchi, Teruto; Yamakuchi, Munekazu; Goto, Masamichi; Inoue, Keiichi; Yamada, Shingo; Ijiri, Kosei; Matsunaga, Shunji; Nakajima, Toshihiro; Komiya, Setsuro; Maruyama, Ikuro</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">971-981</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">High mobility group box chromosomal protein 1 (HMGB-1), a nuclear DNA binding protein, was recently rediscovered as a new proinflammatory cytokine.  The purpose of this study was to demonstrate HMGB-1 expression in vivo and to identify the role of HMGB-1 in the pathogenesis of rheumatoid arthritis (RA).  HMGB-1 concns. in synovial fluid (SF) and serum from RA and osteoarthritis (OA) patients were measured by immunoblot anal.  The protein's specific receptor, receptor for advanced glycation end products (RAGE), was examd. in SF macrophages (SFMs).  We measured levels of proinflammatory cytokines released by SFMs treated with HMGB-1 via ELISA and used sol. RAGE (sRAGE) to block the release of tumor necrosis factor α (TNFα).  Immunohistochem. anal. and immunofluorescence assay were employed to examine localization of HMGB-1 in RA synovium and its translocation in SFMs after TNFα stimulation.  HMGB-1 concns. were significantly higher in SF of RA patients than in that of OA patients.  SFMs expressed RAGE and released TNFα, interleukin-1β (IL-1β), and IL-6 upon stimulation with HMGB-1.  HMGB-1 was found in CD68-pos. cells of RA synovium, and TNFα stimulation translocated HMGB-1 from the nucleus to the cytosol in SFMs.  Blockade by sRAGE inhibited the release of TNFα from SFMs.  HMGB-1 was more strongly expressed in SF of RA patients than in that of OA patients, inducing the release of proinflammatory cytokines from SFMs.  HMGB-1 plays a pivotal role in the pathogenesis of RA and may be an original target of therapy as a novel cytokine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS2txNCtkijrVg90H21EOLACvtfcHk0lhFnWTDxRS3iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlKnsrk%253D&md5=83823045c2a4cbe78cc66792f088544f</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1002%2Fart.10859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.10859%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DN.%26aulast%3DKawahara%26aufirst%3DK.%26aulast%3DYone%26aufirst%3DK.%26aulast%3DHashiguchi%26aufirst%3DT.%26aulast%3DYamakuchi%26aufirst%3DM.%26aulast%3DGoto%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DIjiri%26aufirst%3DK.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DKomiya%26aufirst%3DS.%26aulast%3DMaruyama%26aufirst%3DI.%26atitle%3DHigh%2520mobility%2520group%2520box%2520chromosomal%2520protein%25201%2520plays%2520a%2520role%2520in%2520the%2520pathogenesis%2520of%2520rheumatoid%2520arthritis%2520as%2520a%2520novel%2520cytokine%26jtitle%3DArthritis%2520Rheum.%26date%3D2003%26volume%3D48%26issue%3D4%26spage%3D971%26epage%3D981%26doi%3D10.1002%2Fart.10859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, F.</span></span> <span> </span><span class="NLM_article-title">High mobility group protein b1 (hmgb1) in asthma: Comparison of patients with chronic obstructive pulmonary disease and healthy controls</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">7–8</span>),  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.2119/molmed.2010.00173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2010.00173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21380479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVemurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=807-815&issue=7%E2%80%938&author=C.+Houauthor=H.+Zhaoauthor=L.+Liuauthor=W.+Liauthor=X.+Zhouauthor=Y.+Lvauthor=X.+Shenauthor=Z.+Liangauthor=S.+Caiauthor=F.+Zou&title=High+mobility+group+protein+b1+%28hmgb1%29+in+asthma%3A+Comparison+of+patients+with+chronic+obstructive+pulmonary+disease+and+healthy+controls&doi=10.2119%2Fmolmed.2010.00173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls</span></div><div class="casAuthors">Hou, Changchun; Zhao, Haijin; Liu, Laiyu; Li, Wenjun; Zhou, Xiaoting; Lv, Yanhua; Shen, Xiangbo; Liang, Zhenyu; Cai, Shaoxi; Zou, Fei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">807-815</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">High mobility group protein B1 (HMGB1) has been implicated as an important mediator in the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD).  However, the expression of HMGB1 in plasma and sputum of patients with asthma and COPD across disease severity needs to be defined.  The objective of the study was to examine the induced sputum and plasma concns. of HMGB1 in COPD and asthmatic patients to det. differences in HMGB1 levels between these diseases and their relationship with airway obstruction and inflammatory patterns.  A total of 147 participants were enrolled in this study.  The participants included 34 control subjects, 61 patients with persistent asthma (according to the Global Initiative for Asthma (GINA) guidelines) and 47 patients with stable COPD (stratified by Global Initiative for Chronic Obstructive Lung Disease [GOLD] status).  Spirometry was performed before sputum induction.  HMGB1 levels in induced sputum and plasma were detd. by ELISA.  Sputum and plasma concns. of HMGB1 in patients with asthma and COPD were significantly higher than concns. in control subjects and were significantly neg. correlated with forced expiratory vol. in 1 s (FEV1), FEV1 (% predicted) in all 147 participants.  The levels of HMGB1 in induced sputum of COPD patients were significantly higher than those of asthma patients and healthy controls (P < 0.001).  This difference was present even after adjusting for sex, age, smoking status, daily dose of inhaled corticosteroids and disease severity.  There were no significant differences in HMGB1 levels between patients with eosinophilic and noneosinophilic asthma.  HMGB1 levels in asthmatic and COPD patients were pos. correlated with neutrophil counts and percentage of neutrophils.  In multivariate anal., the two diseases (asthma and COPD) and disease severity were independent predictors of sputum HMGB1, but not smoking, age or use of inhaled corticosteroids.  In conclusion, these data support a potential role for HMGB1 as a biomarker and diagnostic tool for the differential diagnosis of asthma and COPD.  The importance of this observation on asthma and COPD mechanisms and outcomes should be further investigated in large prospective studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolxUaxVuByW7Vg90H21EOLACvtfcHk0lgehlJoo2WWFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVemurrN&md5=83ff0e5f5fcc1fe97fcec1037d9fbb9a</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2010.00173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2010.00173%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DS.%26aulast%3DZou%26aufirst%3DF.%26atitle%3DHigh%2520mobility%2520group%2520protein%2520b1%2520%2528hmgb1%2529%2520in%2520asthma%253A%2520Comparison%2520of%2520patients%2520with%2520chronic%2520obstructive%2520pulmonary%2520disease%2520and%2520healthy%2520controls%26jtitle%3DMol.%2520Med.%26date%3D2011%26volume%3D17%26issue%3D7%25E2%2580%25938%26spage%3D807%26epage%3D815%26doi%3D10.2119%2Fmolmed.2010.00173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 overexpression as a prognostic factor for survival in cancer: A meta-analysis and systematic review</span>. <i>Oncotarget.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">50417</span>– <span class="NLM_lpage">50427</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.18632%2Foncotarget.10413" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=50417-50427&issue=31&author=T.+Wuauthor=W.+Zhangauthor=G.+Yangauthor=H.+Liauthor=Q.+Chenauthor=R.+Songauthor=L.+Zhao&title=Hmgb1+overexpression+as+a+prognostic+factor+for+survival+in+cancer%3A+A+meta-analysis+and+systematic+review&doi=10.18632%2Foncotarget.10413"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10413%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DSong%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DL.%26atitle%3DHmgb1%2520overexpression%2520as%2520a%2520prognostic%2520factor%2520for%2520survival%2520in%2520cancer%253A%2520A%2520meta-analysis%2520and%2520systematic%2520review%26jtitle%3DOncotarget.%26date%3D2016%26volume%3D7%26issue%3D31%26spage%3D50417%26epage%3D50427%26doi%3D10.18632%2Foncotarget.10413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W. F.</span></span> <span> </span><span class="NLM_article-title">Increased serum hmgb1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>205</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">548</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2008.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.atherosclerosis.2008.12.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2009&pages=544-548&issue=2&author=X.+X.+Yanauthor=L.+Luauthor=W.+H.+Pengauthor=L.+J.+Wangauthor=Q.+Zhangauthor=R.+Y.+Zhangauthor=Q.+J.+Chenauthor=W.+F.+Shen&title=Increased+serum+hmgb1+level+is+associated+with+coronary+artery+disease+in+nondiabetic+and+type+2+diabetic+patients&doi=10.1016%2Fj.atherosclerosis.2008.12.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2008.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2008.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.%2BX.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DW.%2BH.%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DChen%26aufirst%3DQ.%2BJ.%26aulast%3DShen%26aufirst%3DW.%2BF.%26atitle%3DIncreased%2520serum%2520hmgb1%2520level%2520is%2520associated%2520with%2520coronary%2520artery%2520disease%2520in%2520nondiabetic%2520and%2520type%25202%2520diabetic%2520patients%26jtitle%3DAtherosclerosis%26date%3D2009%26volume%3D205%26issue%3D2%26spage%3D544%26epage%3D548%26doi%3D10.1016%2Fj.atherosclerosis.2008.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. A.</span></span> <span> </span><span class="NLM_article-title">Hmgb1modulates the treg/th17 ratio in atherosclerotic patients</span>. <i>J. Atheroscler. Thromb.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.5551/jat.31088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.5551%2Fjat.31088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26830200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVehsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=737-745&issue=6&author=J.+W.+Dingauthor=X.+X.+Zhengauthor=T.+Zhouauthor=X.+H.+Tongauthor=C.+Y.+Luoauthor=X.+A.+Wang&title=Hmgb1modulates+the+treg%2Fth17+ratio+in+atherosclerotic+patients&doi=10.5551%2Fjat.31088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1modulates the Treg/Th17 ratio in atherosclerotic patients</span></div><div class="casAuthors">Ding, Jia-wang; Zheng, Xia-xia; Zhou, Tian; Tong, Xiao-hong; Luo, Cai-yun; Wang, Xin-an</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Atherosclerosis and Thrombosis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-745</span>CODEN:
                <span class="NLM_cas:coden">JATHEH</span>;
        ISSN:<span class="NLM_cas:issn">1340-3478</span>.
    
            (<span class="NLM_cas:orgname">Japan Atherosclerosis Society</span>)
        </div><div class="casAbstract">Aim: Atherosclerosis (AS) characterized as a chronic inflammatory disease.  Multiple immune cells and inflammatory cytokines, such as high mobility group protein (HMGB1), regulatory T (Treg) cells, T helper (Th17) cells, and inflammation-related cytokines, play a key role in its pathophysiol.  A large no. of studies report that HMGB1 and Th17 cells may promote atherosclerosis progression, whereas Treg cells may play a protective role in atherosclerosis; thus, alterations in the Treg/Th17 ratio may exist in atherosclerosis diseases.  Up till now, the relationships between HMGB1 levels and the Treg/Th17 ratio remain incompletely understood.  The major purpose of this study was to investigate the relationship between HMGB1 levels and the Treg/Th17 ratio in patients with coronary artery atherosclerotic plaques.  Methods: We enrolled patients with coronary atherosclerosis and normal coronary artery as the research subjects.  Flow cytometry was used to analyze the Treg cells, the Th17 cells frequency, and the Treg/Th17 ratio.  Otherwise, real-time polymerase chain reaction was used for assays the mRNA expressions of HMGB1, retinoic acid-related orphan nuclear receptor C (RORC), and forkhead-winged helix transcription factor (Foxp3).  Moreover, enzyme-linked immunosorbent assays were used to detect the level of protein and cytokines, such as HMGB1, IL-10, TGF-β1, IL-17A, and IL-23.  Results: Using flow cytometry, we obsd. a significantly increased of Th17 cell frequency, whereas Treg cell frequency significantly decreased in atherosclerotic patients.  Consistently, the levels of RORC mRNA were significantly increased in coronary atherosclerosis (AS) group compared to normal coronary artery (NCA) group (P<0.01).  In contrast, the expression of Foxp3 mRNA was markedly lower in the AS group than in the NCA group (P<0.01).  Furthermore, we obsd. the serum concns. of HMGB1, IL-17A, and IL-23 were significantly higher in the AS group than in the NCA group (P<0.01, resp.), whereas the concns. of serum IL-10 and TGF-β1 were significantly lower in the AS group than in the NCA group (P<0.01, resp.).  In addn., we also found that HMGB1 levels showed neg. correlation with the Treg/Th17 ratio in the two groups (r = -0.6984, P<0.01).  Conclusions: The data in our study indicated that HMGB1 may promote atherosclerosis progression via modulating the imbalance in the Treg/Th17 ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW-gXUntaFmLVg90H21EOLACvtfcHk0lhm8TZAPvoAng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVehsLfJ&md5=f4e6ee21fd10035d9ec599ffbe5f351f</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.5551%2Fjat.31088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5551%252Fjat.31088%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DJ.%2BW.%26aulast%3DZheng%26aufirst%3DX.%2BX.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DTong%26aufirst%3DX.%2BH.%26aulast%3DLuo%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DX.%2BA.%26atitle%3DHmgb1modulates%2520the%2520treg%252Fth17%2520ratio%2520in%2520atherosclerotic%2520patients%26jtitle%3DJ.%2520Atheroscler.%2520Thromb.%26date%3D2016%26volume%3D23%26issue%3D6%26spage%3D737%26epage%3D745%26doi%3D10.5551%2Fjat.31088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nin, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalkwijk, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorsal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prins, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parving, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarnow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossing, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stehouwer, C. D.</span></span> <span> </span><span class="NLM_article-title">Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12 year follow-up study</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2489</span>– <span class="NLM_lpage">2493</span>, <span class="refDoi"> DOI: 10.1007/s00125-012-2622-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs00125-012-2622-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2489-2493&issue=9&author=J.+W.+Ninauthor=I.+Ferreiraauthor=C.+G.+Schalkwijkauthor=A.+Jorsalauthor=M.+H.+Prinsauthor=H.+H.+Parvingauthor=L.+Tarnowauthor=P.+Rossingauthor=C.+D.+Stehouwer&title=Higher+plasma+high-mobility+group+box+1+levels+are+associated+with+incident+cardiovascular+disease+and+all-cause+mortality+in+type+1+diabetes%3A+A+12+year+follow-up+study&doi=10.1007%2Fs00125-012-2622-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1007%2Fs00125-012-2622-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-012-2622-1%26sid%3Dliteratum%253Aachs%26aulast%3DNin%26aufirst%3DJ.%2BW.%26aulast%3DFerreira%26aufirst%3DI.%26aulast%3DSchalkwijk%26aufirst%3DC.%2BG.%26aulast%3DJorsal%26aufirst%3DA.%26aulast%3DPrins%26aufirst%3DM.%2BH.%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DTarnow%26aufirst%3DL.%26aulast%3DRossing%26aufirst%3DP.%26aulast%3DStehouwer%26aufirst%3DC.%2BD.%26atitle%3DHigher%2520plasma%2520high-mobility%2520group%2520box%25201%2520levels%2520are%2520associated%2520with%2520incident%2520cardiovascular%2520disease%2520and%2520all-cause%2520mortality%2520in%2520type%25201%2520diabetes%253A%2520A%252012%2520year%2520follow-up%2520study%26jtitle%3DDiabetologia%26date%3D2012%26volume%3D55%26issue%3D9%26spage%3D2489%26epage%3D2493%26doi%3D10.1007%2Fs00125-012-2622-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devaraj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasu, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jialal, I.</span></span> <span> </span><span class="NLM_article-title">Increased levels of ligands of toll-like receptors 2 and 4 in type 1 diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1668</span>, <span class="refDoi"> DOI: 10.1007/s00125-009-1394-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs00125-009-1394-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1665-1668&issue=8&author=S.+Devarajauthor=M.+R.+Dasuauthor=S.+H.+Parkauthor=I.+Jialal&title=Increased+levels+of+ligands+of+toll-like+receptors+2+and+4+in+type+1+diabetes&doi=10.1007%2Fs00125-009-1394-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1007%2Fs00125-009-1394-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-009-1394-8%26sid%3Dliteratum%253Aachs%26aulast%3DDevaraj%26aufirst%3DS.%26aulast%3DDasu%26aufirst%3DM.%2BR.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DJialal%26aufirst%3DI.%26atitle%3DIncreased%2520levels%2520of%2520ligands%2520of%2520toll-like%2520receptors%25202%2520and%25204%2520in%2520type%25201%2520diabetes%26jtitle%3DDiabetologia%26date%3D2009%26volume%3D52%26issue%3D8%26spage%3D1665%26epage%3D1668%26doi%3D10.1007%2Fs00125-009-1394-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span> <span> </span><span class="NLM_article-title">Plasma hmgb-1 levels in subjects with obesity and type 2 diabetes: A cross-sectional study in china</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">e0136564</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0136564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1371%2Fjournal.pone.0136564" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0136564&issue=8&author=H.+Wangauthor=H.+Quauthor=H.+Deng&title=Plasma+hmgb-1+levels+in+subjects+with+obesity+and+type+2+diabetes%3A+A+cross-sectional+study+in+china&doi=10.1371%2Fjournal.pone.0136564"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0136564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0136564%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DH.%26atitle%3DPlasma%2520hmgb-1%2520levels%2520in%2520subjects%2520with%2520obesity%2520and%2520type%25202%2520diabetes%253A%2520A%2520cross-sectional%2520study%2520in%2520china%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26issue%3D8%26spage%3De0136564%26doi%3D10.1371%2Fjournal.pone.0136564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 is activated in type 2 diabetes mellitus patients and in mesangial cells in response to high glucose</span>. <i>Int. J. Clin. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">6683</span>– <span class="NLM_lpage">6691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26261550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFChu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=6683-6691&issue=6&author=Y.+Chenauthor=F.+Qiaoauthor=Y.+Zhaoauthor=Y.+Wangauthor=G.+Liu&title=Hmgb1+is+activated+in+type+2+diabetes+mellitus+patients+and+in+mesangial+cells+in+response+to+high+glucose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1 is activated in type 2 diabetes mellitus patients and in mesangial cells in response to high glucose</span></div><div class="casAuthors">Chen, Yan; Qiao, Fengli; Zhao, Ying; Wang, Yanjun; Liu, Guifeng</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">6683-6691</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Diabetic nephropathy (DN) is one of the most devastating complications of diabetes, leading the cause of end-stage renal disease (ESRD).  And investigations into mechanisms underlying renal inflammation may provide new insight into novel therapeutic targets for patients with DN.  However, little is known about the promotion of inflammation in DN.  In the present study, we examd. the promotion by high glucose to High-mobility group box-1 (HMGB1) in patients with type 2 diabetes mellitus or in renal mesangial SV40 MES 13 cells.  Results demonstrated that high glucose promoted the pre-inflammatory cytokines, such as TNF-α, IL-1β and IL-6 in patients with T2DM or in SV40 MES 13 cells.  And the serum HMGB1 was also upregulated in T2DM patients, correlating with serum IL-6 and TNFα.  The in vitro results indicated that HMGB1 mediated the D-glucose-induced pro-inflammatory cytokines in mesangial cells.  And the NF-κB signaling pathway involved in the promotion of pro-inflammatory cytokines by D-glucose.  In summary, the present study indicated that HMGB1 was significantly promoted by the glucose in vivo or in vitro, in an assocn. with an upregulation of pro-inflammatory cytokines, via activating NF-κB signaling pathway.  And the strategy of HMGB1 inhibition reduced the upregulation of pro-inflammatory cytokines in response to high glucose, via inhibiting the NF-κB signaling pathway.  It implies the regulatory role of HMGB1 in the inflammatory responses in DN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosOhxSzFLKX7Vg90H21EOLACvtfcHk0lhm8TZAPvoAng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFChu7c%253D&md5=62e2f90e977eb013f7e476bfc732d2d8</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQiao%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DHmgb1%2520is%2520activated%2520in%2520type%25202%2520diabetes%2520mellitus%2520patients%2520and%2520in%2520mesangial%2520cells%2520in%2520response%2520to%2520high%2520glucose%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2015%26volume%3D8%26issue%3D6%26spage%3D6683%26epage%3D6691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Elevated serum hmgb1 in pulmonary arterial hypertension secondary to congenital heart disease</span>. <i>Vasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.vph.2016.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.vph.2016.08.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2016&pages=66-72&author=Y.+Y.+Huangauthor=W.+Suauthor=Z.+W.+Zhuauthor=L.+Tangauthor=X.+Q.+Huauthor=S.+H.+Zhouauthor=Z.+F.+Fangauthor=J.+Li&title=Elevated+serum+hmgb1+in+pulmonary+arterial+hypertension+secondary+to+congenital+heart+disease&doi=10.1016%2Fj.vph.2016.08.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.vph.2016.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vph.2016.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%2BY.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DZ.%2BW.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DX.%2BQ.%26aulast%3DZhou%26aufirst%3DS.%2BH.%26aulast%3DFang%26aufirst%3DZ.%2BF.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DElevated%2520serum%2520hmgb1%2520in%2520pulmonary%2520arterial%2520hypertension%2520secondary%2520to%2520congenital%2520heart%2520disease%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2016%26volume%3D85%26spage%3D66%26epage%3D72%26doi%3D10.1016%2Fj.vph.2016.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span> <span> </span><span class="NLM_article-title">Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 h1n1 influenza-infected children</span>. <i>Cytokine</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2011.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.cyto.2011.07.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2011&pages=180-187&issue=2&author=Y.+Itoauthor=Y.+Toriiauthor=R.+Ohtaauthor=M.+Imaiauthor=S.+Haraauthor=Y.+Kawanoauthor=T.+Matsubayashiauthor=A.+Inuiauthor=T.+Yoshikawaauthor=N.+Nishimuraauthor=T.+Ozakiauthor=T.+Morishimaauthor=H.+Kimura&title=Increased+levels+of+cytokines+and+high-mobility+group+box+1+are+associated+with+the+development+of+severe+pneumonia%2C+but+not+acute+encephalopathy%2C+in+2009+h1n1+influenza-infected+children&doi=10.1016%2Fj.cyto.2011.07.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2011.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2011.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DY.%26aulast%3DTorii%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DR.%26aulast%3DImai%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DY.%26aulast%3DMatsubayashi%26aufirst%3DT.%26aulast%3DInui%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DN.%26aulast%3DOzaki%26aufirst%3DT.%26aulast%3DMorishima%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DH.%26atitle%3DIncreased%2520levels%2520of%2520cytokines%2520and%2520high-mobility%2520group%2520box%25201%2520are%2520associated%2520with%2520the%2520development%2520of%2520severe%2520pneumonia%252C%2520but%2520not%2520acute%2520encephalopathy%252C%2520in%25202009%2520h1n1%2520influenza-infected%2520children%26jtitle%3DCytokine%26date%3D2011%26volume%3D56%26issue%3D2%26spage%3D180%26epage%3D187%26doi%3D10.1016%2Fj.cyto.2011.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angus, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellum, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delude, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissfeld, L.</span></span> <span> </span><span class="NLM_article-title">Circulating high-mobility group box 1 (hmgb1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis</span>. <i>Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1061</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1097/01.CCM.0000259534.68873.2A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2F01.CCM.0000259534.68873.2A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=17334246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BD2s3gslOgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1061-1067&issue=4&author=D.+C.+Angusauthor=L.+Yangauthor=L.+Kongauthor=J.+A.+Kellumauthor=R.+L.+Deludeauthor=K.+J.+Traceyauthor=L.+Weissfeld&title=Circulating+high-mobility+group+box+1+%28hmgb1%29+concentrations+are+elevated+in+both+uncomplicated+pneumonia+and+pneumonia+with+severe+sepsis&doi=10.1097%2F01.CCM.0000259534.68873.2A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis</span></div><div class="casAuthors">Angus Derek C; Yang Lihong; Kong Lan; Kellum John A; Delude Russell L; Tracey Kevin J; Weissfeld Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Critical care medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1061-7</span>
        ISSN:<span class="NLM_cas:issn">0090-3493</span>.
    </div><div class="casAbstract">OBJECTIVE:  High-mobility group box 1 (HMGB1) has been proposed as a late mediator of sepsis, but human data are sparse and conflicting.  We describe plasma HMGB1 concentrations in humans with community-acquired pneumonia (CAP), the most common cause of severe sepsis, and test the hypotheses that HMGB1 levels are higher in CAP than healthy controls, higher in CAP with severe sepsis than CAP without severe sepsis, and higher in severe sepsis nonsurvivors than survivors.  DESIGN:  Random, outcome-stratified sample from a prospective study of 1,895 subjects hospitalized with CAP.  SETTING:  Twenty-eight U.S. teaching and community hospitals.  PATIENTS:  There were 122 CAP subjects (43 never developed severe sepsis, 49 developed severe sepsis and survived hospitalization, and 30 developed severe sepsis and died) and 38 healthy controls.  INTERVENTIONS:  None.  MEASUREMENTS AND MAIN RESULTS:  Median day of onset of severe sepsis was day of admission.  HMGB1 was measured daily for the first week and analyzed using repeated-measures models with and without multivariable adjustment for baseline characteristics.  HMGB1 concentrations were higher in CAP subjects compared with controls (median concentration on day of admission vs. controls, 190 vs. 0 ng/mL, p = .0001; 93.7% of all CAP measurements were elevated).  HMGB1 remained elevated throughout the hospital course with no significant trend (p = .64) and did not differ between those with and without severe sepsis (p = .30).  HMGB1 concentrations were higher in severe sepsis nonsurvivors than survivors (p = .001).  HMGB1 concentrations remained elevated at discharge (median final HMGB1 measure, 176 ng/mL).  Findings persisted in multivariable models and were robust to sensitivity analyses using alternative definitions of severe sepsis.  CONCLUSIONS:  HMGB1 is elevated in almost all CAP subjects, and higher circulating HMGB1 is associated with mortality.  But immunodetectable HMGB1 levels were also persistently elevated in those patients who fared well.  Thus, additional work is needed to understand the biological activities of serum HMGB1 in sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgcpCsKHqCba__Jf7-eMvJfW6udTcc2eZpIz_HqnE57bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3gslOgsg%253D%253D&md5=5cc08abaa081f245ed8db0ee9bff71bf</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1097%2F01.CCM.0000259534.68873.2A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.CCM.0000259534.68873.2A%26sid%3Dliteratum%253Aachs%26aulast%3DAngus%26aufirst%3DD.%2BC.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DKellum%26aufirst%3DJ.%2BA.%26aulast%3DDelude%26aufirst%3DR.%2BL.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DWeissfeld%26aufirst%3DL.%26atitle%3DCirculating%2520high-mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520concentrations%2520are%2520elevated%2520in%2520both%2520uncomplicated%2520pneumonia%2520and%2520pneumonia%2520with%2520severe%2520sepsis%26jtitle%3DCrit.%2520Care%2520Med.%26date%3D2007%26volume%3D35%26issue%3D4%26spage%3D1061%26epage%3D1067%26doi%3D10.1097%2F01.CCM.0000259534.68873.2A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaya, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejima, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaka, A.</span></span> <span> </span><span class="NLM_article-title">Contributions of high mobility group box protein in experimental and clinical acute lung injury</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>170</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1310</span>– <span class="NLM_lpage">1316</span>, <span class="refDoi"> DOI: 10.1164/rccm.200402-188OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1164%2Frccm.200402-188OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=15374839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BD2cnhsFOquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2004&pages=1310-1316&issue=12&author=H.+Uenoauthor=T.+Matsudaauthor=S.+Hashimotoauthor=F.+Amayaauthor=Y.+Kitamuraauthor=M.+Tanakaauthor=A.+Kobayashiauthor=I.+Maruyamaauthor=S.+Yamadaauthor=N.+Hasegawaauthor=J.+Soejimaauthor=H.+Kohauthor=A.+Ishizaka&title=Contributions+of+high+mobility+group+box+protein+in+experimental+and+clinical+acute+lung+injury&doi=10.1164%2Frccm.200402-188OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Contributions of high mobility group box protein in experimental and clinical acute lung injury</span></div><div class="casAuthors">Ueno Hiroshi; Matsuda Tomoyuki; Hashimoto Satoru; Amaya Fumimasa; Kitamura Yoshihiro; Tanaka Masaki; Kobayashi Atsuko; Maruyama Ikuro; Yamada Shingo; Hasegawa Naoki; Soejima Junko; Koh Hidefumi; Ishizaka Akitoshi</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1310-6</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">This study was performed to examine the putative role of high mobility group box (HMGB) protein in the pathogenesis of acute lung injury (ALI).  Observations were made (1) in 21 patients who were septic with ALI and 15 patients with normal lung function and (2) in a mouse model 24 hours after intratracheal instillation of lipopolysaccharide (LPS).  The concentrations of HMGB1 were increased in plasma and lung epithelial lining fluid of patients with ALI and mice instilled with LPS.  LPS-induced ALI was mitigated by anti-HMGB1 antibody.  Although this protein was not detected in the plasma of control humans or mice, the concentrations of HMGB1 in lung epithelial lining fluid or in bronchoalveolar lavage fluid were unexpectedly high.  The nuclear expression of HMGB1 was apparent in epithelial cells surrounding terminal bronchioles in normal mice, whereas its nuclear and cytoplasmic expression was observed in alveolar macrophages in LPS-instilled mice.  Lung instillation of HMGB2 did not cause as much inflammation as HMGB1.  Extracellular HMGB1 may play a key role in the pathogenesis of clinical and experimental ALI.  However, its expression in normal airways is noteworthy and suggests that it also plays a physiologic role in the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0fiC8rEUIxIMcDoIzZtNkfW6udTcc2eaM0mWzaEhcf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnhsFOquw%253D%253D&md5=b166b9020cbf15ab906fce765b9fba2e</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1164%2Frccm.200402-188OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200402-188OC%26sid%3Dliteratum%253Aachs%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DS.%26aulast%3DAmaya%26aufirst%3DF.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DMaruyama%26aufirst%3DI.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DN.%26aulast%3DSoejima%26aufirst%3DJ.%26aulast%3DKoh%26aufirst%3DH.%26aulast%3DIshizaka%26aufirst%3DA.%26atitle%3DContributions%2520of%2520high%2520mobility%2520group%2520box%2520protein%2520in%2520experimental%2520and%2520clinical%2520acute%2520lung%2520injury%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2004%26volume%3D170%26issue%3D12%26spage%3D1310%26epage%3D1316%26doi%3D10.1164%2Frccm.200402-188OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ingels, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derese, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den
Berghe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhorebeek, I.</span></span> <span> </span><span class="NLM_article-title">Soluble rage and the rage ligands hmgb1 and s100a12 in critical illness: Impact of glycemic control with insulin and relation with clinical outcome</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1097/SHK.0000000000000278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2FSHK.0000000000000278" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=109-116&issue=2&author=C.+Ingelsauthor=I.+Dereseauthor=P.+J.+Woutersauthor=G.+Van+den%0ABergheauthor=I.+Vanhorebeek&title=Soluble+rage+and+the+rage+ligands+hmgb1+and+s100a12+in+critical+illness%3A+Impact+of+glycemic+control+with+insulin+and+relation+with+clinical+outcome&doi=10.1097%2FSHK.0000000000000278"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1097%2FSHK.0000000000000278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FSHK.0000000000000278%26sid%3Dliteratum%253Aachs%26aulast%3DIngels%26aufirst%3DC.%26aulast%3DDerese%26aufirst%3DI.%26aulast%3DWouters%26aufirst%3DP.%2BJ.%26aulast%3DVan%2Bden%2BBerghe%26aufirst%3DG.%26aulast%3DVanhorebeek%26aufirst%3DI.%26atitle%3DSoluble%2520rage%2520and%2520the%2520rage%2520ligands%2520hmgb1%2520and%2520s100a12%2520in%2520critical%2520illness%253A%2520Impact%2520of%2520glycemic%2520control%2520with%2520insulin%2520and%2520relation%2520with%2520clinical%2520outcome%26jtitle%3DShock%26date%3D2015%26volume%3D43%26issue%3D2%26spage%3D109%26epage%3D116%26doi%3D10.1097%2FSHK.0000000000000278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Caterina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W. F.</span></span> <span> </span><span class="NLM_article-title">Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure</span>. <i>Eur. J. Heart Failure</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1093/eurjhf/hfq231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1093%2Feurjhf%2Fhfq231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21266376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFegur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=440-449&issue=4&author=L.+J.+Wangauthor=L.+Luauthor=F.+R.+Zhangauthor=Q.+J.+Chenauthor=R.+De+Caterinaauthor=W.+F.+Shen&title=Increased+serum+high-mobility+group+box-1+and+cleaved+receptor+for+advanced+glycation+endproducts+levels+and+decreased+endogenous+secretory+receptor+for+advanced+glycation+endproducts+levels+in+diabetic+and+non-diabetic+patients+with+heart+failure&doi=10.1093%2Feurjhf%2Fhfq231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure</span></div><div class="casAuthors">Wang, Ling Jie; Lu, Lin; Zhang, Feng Ru; Chen, Qiu Jing; De Caterina, Raffaele; Shen, Wei Feng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Heart Failure</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">440-449</span>CODEN:
                <span class="NLM_cas:coden">EJHFFS</span>;
        ISSN:<span class="NLM_cas:issn">1388-9842</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims High-mobility group box-1 (HMGB1) is a ligand for the receptor for advanced glycation endproducts (RAGE).  An HMGB1-RAGE interaction has been implicated in cardiac dysfunction.  We assessed the assocn. of HMGB1 and RAGE isoforms with heart failure (HF) in diabetic and non-diabetic patients.  Methods and results We assayed serum levels of HMGB1, cleaved RAGE (cRAGE), endogenous secretory RAGE (esRAGE), high-sensitivity C-reactive protein (hsCRP), and N-terminal pro-brain natriuretic peptide (NT-proBNP) in parallel with assessment of left ventricular vols. and function in 125 diabetic and 222 non-diabetic Chinese patients with chronic HF.  Of the total, 79 diabetic patients without HF and 220 normal subjects served as diabetic and normal controls, resp.  Serum HMGB1, cRAGE, hsCRP, and NT-proBNP levels were higher and, in contrast, esRAGE levels lower in HF patients than in subjects without HF (for all; P < 0.01), with higher levels of cRAGE and hsCRP in diabetic HF vs. non-diabetic HF patients (P < 0.01).  For HF patients-with or without diabetes-HMGB1 levels correlated pos. with left ventricular end-diastolic and end-systolic vols. (r = 0.267 and r = 0.321, resp.) and NT-proBNP values (r = 0.497), and were inversely related to ejection fraction (r = -0.461; all P < 0.001).  Serum cRAGE levels correlated with NT-proBNP values (r = 0.451) and New York Heart Assocn. functional class (r = 0.402; both P < 0.001).  Multivariable regression anal. revealed that HMGB1, cRAGE, and esRAGE were consistently assocd. with HF in diabetic and non-diabetic patients.  Conclusion Heart failure patients have increased serum HMGB1 and cRAGE and decreased esRAGE levels, and these are related to the severity of HF in both diabetic and non-diabetic patients.  Such assocns. are worth further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXt4CUgpMgArVg90H21EOLACvtfcHk0ljfmJP6rDySkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFegur4%253D&md5=df1478cdd36c5ec00925bc09d4e9b30a</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1093%2Feurjhf%2Fhfq231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurjhf%252Fhfq231%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DF.%2BR.%26aulast%3DChen%26aufirst%3DQ.%2BJ.%26aulast%3DDe%2BCaterina%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DW.%2BF.%26atitle%3DIncreased%2520serum%2520high-mobility%2520group%2520box-1%2520and%2520cleaved%2520receptor%2520for%2520advanced%2520glycation%2520endproducts%2520levels%2520and%2520decreased%2520endogenous%2520secretory%2520receptor%2520for%2520advanced%2520glycation%2520endproducts%2520levels%2520in%2520diabetic%2520and%2520non-diabetic%2520patients%2520with%2520heart%2520failure%26jtitle%3DEur.%2520J.%2520Heart%2520Failure%26date%3D2011%26volume%3D13%26issue%3D4%26spage%3D440%26epage%3D449%26doi%3D10.1093%2Feurjhf%2Fhfq231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H. C.</span></span> <span> </span><span class="NLM_article-title">Increased serum hmgb1 level may predict the fatal outcomes in patients with chronic heart failure</span>. <i>Int. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1016/j.ijcard.2015.02.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.ijcard.2015.02.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25746492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhvFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2015&pages=318-320&author=T.+Liuauthor=D.+Y.+Zhangauthor=Y.+H.+Zhouauthor=Q.+F.+Hanauthor=L.+H.+Wangauthor=L.+Wuauthor=H.+C.+Yao&title=Increased+serum+hmgb1+level+may+predict+the+fatal+outcomes+in+patients+with+chronic+heart+failure&doi=10.1016%2Fj.ijcard.2015.02.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure</span></div><div class="casAuthors">Liu Tao; Zhang De-Yong; Zhou Yan-Hong; Han Qian-Feng; Wang Lan-Hua; Wu Lei; Yao Heng-Chen</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cardiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">318-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1KL40A2V-aGhHGZei4OW9fW6udTcc2eZs3UMIYZuaNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhvFOiug%253D%253D&md5=5678d306d9a36019f16856892817714e</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2015.02.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2015.02.088%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DD.%2BY.%26aulast%3DZhou%26aufirst%3DY.%2BH.%26aulast%3DHan%26aufirst%3DQ.%2BF.%26aulast%3DWang%26aufirst%3DL.%2BH.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DH.%2BC.%26atitle%3DIncreased%2520serum%2520hmgb1%2520level%2520may%2520predict%2520the%2520fatal%2520outcomes%2520in%2520patients%2520with%2520chronic%2520heart%2520failure%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2015%26volume%3D184%26spage%3D318%26epage%3D320%26doi%3D10.1016%2Fj.ijcard.2015.02.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallowitsch-Puerta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosas-Ballina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huston, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czura, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchfeld, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesser, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Church, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litroff, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sama, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia</span>. <i>Shock</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1097/01.shk.0000209540.99176.72</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2F01.shk.0000209540.99176.72" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=571-574&issue=6&author=R.+S.+Goldsteinauthor=M.+Gallowitsch-Puertaauthor=L.+Yangauthor=M.+Rosas-Ballinaauthor=J.+M.+Hustonauthor=C.+J.+Czuraauthor=D.+C.+Leeauthor=M.+F.+Wardauthor=A.+N.+Bruchfeldauthor=H.+Wangauthor=M.+L.+Lesserauthor=A.+L.+Churchauthor=A.+H.+Litroffauthor=A.+E.+Samaauthor=K.+J.+Tracey&title=Elevated+high-mobility+group+box+1+levels+in+patients+with+cerebral+and+myocardial+ischemia&doi=10.1097%2F01.shk.0000209540.99176.72"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1097%2F01.shk.0000209540.99176.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.shk.0000209540.99176.72%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DR.%2BS.%26aulast%3DGallowitsch-Puerta%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DRosas-Ballina%26aufirst%3DM.%26aulast%3DHuston%26aufirst%3DJ.%2BM.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DLee%26aufirst%3DD.%2BC.%26aulast%3DWard%26aufirst%3DM.%2BF.%26aulast%3DBruchfeld%26aufirst%3DA.%2BN.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLesser%26aufirst%3DM.%2BL.%26aulast%3DChurch%26aufirst%3DA.%2BL.%26aulast%3DLitroff%26aufirst%3DA.%2BH.%26aulast%3DSama%26aufirst%3DA.%2BE.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DElevated%2520high-mobility%2520group%2520box%25201%2520levels%2520in%2520patients%2520with%2520cerebral%2520and%2520myocardial%2520ischemia%26jtitle%3DShock%26date%3D2006%26volume%3D25%26issue%3D6%26spage%3D571%26epage%3D574%26doi%3D10.1097%2F01.shk.0000209540.99176.72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Momonaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushige, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichiyama, T.</span></span> <span> </span><span class="NLM_article-title">High mobility group box 1 in patients with 2009 pandemic h1n1 influenza-associated encephalopathy</span>. <i>Brain Dev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1016/j.braindev.2013.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.braindev.2013.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23907181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC3sflvFCnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2014&pages=484-488&issue=6&author=H.+Momonakaauthor=S.+Hasegawaauthor=T.+Matsushigeauthor=H.+Inoueauthor=M.+Kajimotoauthor=S.+Okadaauthor=K.+Nakatsukaauthor=T.+Morishimaauthor=T.+Ichiyama&title=High+mobility+group+box+1+in+patients+with+2009+pandemic+h1n1+influenza-associated+encephalopathy&doi=10.1016%2Fj.braindev.2013.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box 1 in patients with 2009 pandemic H1N1 influenza-associated encephalopathy</span></div><div class="casAuthors">Momonaka Hiroshi; Matsushige Takeshi; Inoue Hirofumi; Kajimoto Madoka; Okada Seigo; Ichiyama Takashi; Hasegawa Shunji; Nakatsuka Kenji; Morishima Tsuneo</div><div class="citationInfo"><span class="NLM_cas:title">Brain & development</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">484-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Patients with 2009 pandemic H1N1 influenza-associated encephalopathy (pIE) have been reported in Japan.  The most common clinical symptoms of this condition are seizures and progressive coma with high-grade fever.  We previously highlighted the cytokine profile of pIE; our results suggest that proinflammatory cytokines play an important role in the pathogenesis.  High mobility group box 1 (HMGB1) protein is a late mediator of inflammation or sepsis.  However, there are few reports regarding the serum and cerebrospinal fluid (CSF) levels of HMGB1 in pIE patients.  METHODS:  We measured serum and CSF levels of HMGB1 in the following: pIE patients with poor outcomes, pIE patients without neurological sequelae, influenza patients without pIE, and control subjects.  RESULTS:  Serum HMGB1 levels were significantly higher in pIE patients with poor outcomes compared to those without neurological sequelae.  In contrast, there was no difference in CSF HMGB1 levels among all groups.  Regarding pIE patients, we found a significant positive correlation between HMGB1 levels and IL-6 in the serum but not in the CSF.  CONCLUSIONS:  Our results suggest that HMGB1 protein may be involved in the pathogenesis of pIE and that a high serum, but not CSF, level of inflammatory cytokines plays an important role in the severity of pIE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRFLtycHlYaRUcLvDNbOD4DfW6udTcc2eZs3UMIYZuaNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sflvFCnug%253D%253D&md5=09a81e0a43cdce7b017f4ab01b07b422</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.braindev.2013.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.braindev.2013.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMomonaka%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DS.%26aulast%3DMatsushige%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DKajimoto%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DNakatsuka%26aufirst%3DK.%26aulast%3DMorishima%26aufirst%3DT.%26aulast%3DIchiyama%26aufirst%3DT.%26atitle%3DHigh%2520mobility%2520group%2520box%25201%2520in%2520patients%2520with%25202009%2520pandemic%2520h1n1%2520influenza-associated%2520encephalopathy%26jtitle%3DBrain%2520Dev.%26date%3D2014%26volume%3D36%26issue%3D6%26spage%3D484%26epage%3D488%26doi%3D10.1016%2Fj.braindev.2013.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchiara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierdomenico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negroni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aloi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felice, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stronati, L.</span></span> <span> </span><span class="NLM_article-title">Role of hmgb1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease</span>. <i>Inflamm Bowel Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1457</span>, <span class="refDoi"> DOI: 10.1097/MIB.0000000000000113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2FMIB.0000000000000113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24983978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2cfot1SrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1448-1457&issue=8&author=F.+Paloneauthor=R.+Vitaliauthor=S.+Cucchiaraauthor=M.+Pierdomenicoauthor=A.+Negroniauthor=M.+Aloiauthor=F.+Nutiauthor=C.+Feliceauthor=A.+Armuzziauthor=L.+Stronati&title=Role+of+hmgb1+as+a+suitable+biomarker+of+subclinical+intestinal+inflammation+and+mucosal+healing+in+patients+with+inflammatory+bowel+disease&doi=10.1097%2FMIB.0000000000000113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease</span></div><div class="casAuthors">Palone Francesca; Vitali Roberta; Cucchiara Salvatore; Pierdomenico Maria; Negroni Anna; Aloi Marina; Nuti Federica; Felice Carla; Armuzzi Alessandro; Stronati Laura</div><div class="citationInfo"><span class="NLM_cas:title">Inflammatory bowel diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1448-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Noninvasive biomarkers of high- and low-grade intestinal inflammation and of mucosal healing (MH) in patients with inflammatory bowel disease are currently lacking.  We have recently shown that fecal high mobility group box 1 (HMGB1) protein is a novel biomarker of gut inflammation.  We aimed at investigating in a mouse model if HMGB1 was able to foresee both a clinically evident and a subclinical gut inflammation and if its normalization indicated MH.  We also aimed at confirming the results in patients with Crohn's disease (CD) and ulcerative colitis.  METHODS:  C57BL6/J mice were treated with increasing doses of dextran sodium sulphate to induce colitis of different severity degrees; 28 with CD, 23 with ulcerative colitis, and 17 controls were also enrolled.  Fecal HMGB1 was analyzed by enzyme-linked immunosorbent assay and immunoblotting.  RESULTS:  Fecal HMGB1 increased by 5-, 11-, 18-, and 24-folds with dextran sodium sulphate doses of 0.25%, 0.50%, 1%, and 4%, respectively, showing that the protein detected a high-grade and a subclinical inflammation.  After a recovery time of 4-week posttreatment, HMGB1 returned to control levels, paralleling MH.  In patients, fecal HMGB1 significantly correlated with endoscopic indexes (Simple Endoscopic Score for Crohn's Disease [SES-CD], endoscopic Mayo subscore), but not with the disease activity indexes (Crohn's disease Activity Index, partial Mayo score).  CONCLUSIONS:  Fecal HMGB1 is a robust noninvasive biomarker of clinically overt and subclinical gut inflammation; it can also be a surrogate marker of MH.  We suggest the use of fecal HMGB1 to monitor the disease course and assess therapy outcomes in inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSa2XfG_ZAxDIxhnOQkIHOxfW6udTcc2eY02zhCJ7Fi9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfot1SrtQ%253D%253D&md5=0ce2e1ea71ff13c44c640b3b55ef2fb1</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1097%2FMIB.0000000000000113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMIB.0000000000000113%26sid%3Dliteratum%253Aachs%26aulast%3DPalone%26aufirst%3DF.%26aulast%3DVitali%26aufirst%3DR.%26aulast%3DCucchiara%26aufirst%3DS.%26aulast%3DPierdomenico%26aufirst%3DM.%26aulast%3DNegroni%26aufirst%3DA.%26aulast%3DAloi%26aufirst%3DM.%26aulast%3DNuti%26aufirst%3DF.%26aulast%3DFelice%26aufirst%3DC.%26aulast%3DArmuzzi%26aufirst%3DA.%26aulast%3DStronati%26aufirst%3DL.%26atitle%3DRole%2520of%2520hmgb1%2520as%2520a%2520suitable%2520biomarker%2520of%2520subclinical%2520intestinal%2520inflammation%2520and%2520mucosal%2520healing%2520in%2520patients%2520with%2520inflammatory%2520bowel%2520disease%26jtitle%3DInflamm%2520Bowel%2520Dis.%26date%3D2014%26volume%3D20%26issue%3D8%26spage%3D1448%26epage%3D1457%26doi%3D10.1097%2FMIB.0000000000000113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noronha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coukos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farraye, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganley-Leal, L. M.</span></span> <span> </span><span class="NLM_article-title">Systemic toll-like receptor ligands modify b-cell responses in human inflammatory bowel disease</span>. <i>Inflamm Bowel Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1002/ibd.21424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Fibd.21424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=20806343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FivFCjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=298-307&issue=1&author=M.+McDonnellauthor=Y.+Liangauthor=A.+Noronhaauthor=J.+Coukosauthor=D.+L.+Kasperauthor=F.+A.+Farrayeauthor=L.+M.+Ganley-Leal&title=Systemic+toll-like+receptor+ligands+modify+b-cell+responses+in+human+inflammatory+bowel+disease&doi=10.1002%2Fibd.21424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease</span></div><div class="casAuthors">McDonnell Marie; Liang Yanmei; Noronha Ansu; Coukos Jennifer; Kasper Dennis L; Farraye Francis A; Ganley-Leal Lisa M</div><div class="citationInfo"><span class="NLM_cas:title">Inflammatory bowel diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">298-307</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Bacteria have a central, although poorly understood, role in inflammatory bowel disease (IBD).  Host-bacteria interactions primarily take place in the gastrointestinal tract, but cells may also encounter translocated bacteria in the bloodstream.  IBD is associated with activated, circulating Toll-like receptor (TLR)2 and TLR4-expressing B cells suggesting that blood-borne microbial TLR ligands modulate B cell responses.  METHODS:  Serum levels of lipopolysaccharide (LPS)/endotoxin and high mobility group box 1 (HMGB1), an endogenous TLR ligand, were quantified in Crohn's disease (CD) and ulcerative colitis (UC).  Responses of purified B cells to LPS and HMGB1 were correlated with levels of systemic TLR ligands and clinical parameters of disease.  RESULTS:  While IBD patients have increased levels of blood LPS, the net effect of endotoxemia has unexpected characteristics illustrating that LPS has both pro- and antiinflammatory roles through TLR4+ B cells.  Experimental treatment of B cells demonstrates that the antiinflammatory effect of LPS is due to its hypo-acylation of lipid A suggesting an increased prevalence of systemic, hypo-acylated LPS in CD.  In contrast, high levels of LPS are associated with disease activity in UC.  HMGB1 activates B cells through TLR2 and CD36.  Serum levels of HMGB1 correlate with spontaneous IL-8 production by B cells suggesting that blood-borne TLR2 ligands increase B-cell activation in vivo.  CONCLUSIONS:  Systemic TLR ligands modulate B cells towards either proinflammatory or antiinflammatory activity depending on the predominant ligand(s).  Further, the circulating B cell may represent an important proxy for quantifying the LPS lipid A acylation burden in patients with IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYWESsH91pUMERNNga7KD-fW6udTcc2eY02zhCJ7Fi9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FivFCjuw%253D%253D&md5=560fef3319ddcb44f5c732c44841b0f8</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2Fibd.21424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fibd.21424%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DNoronha%26aufirst%3DA.%26aulast%3DCoukos%26aufirst%3DJ.%26aulast%3DKasper%26aufirst%3DD.%2BL.%26aulast%3DFarraye%26aufirst%3DF.%2BA.%26aulast%3DGanley-Leal%26aufirst%3DL.%2BM.%26atitle%3DSystemic%2520toll-like%2520receptor%2520ligands%2520modify%2520b-cell%2520responses%2520in%2520human%2520inflammatory%2520bowel%2520disease%26jtitle%3DInflamm%2520Bowel%2520Dis.%26date%3D2011%26volume%3D17%26issue%3D1%26spage%3D298%26epage%3D307%26doi%3D10.1002%2Fibd.21424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ilmakunnas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tukiainen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouhiainen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauvala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makisalo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hockerstedt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isoniemi, H.</span></span> <span> </span><span class="NLM_article-title">High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation</span>. <i>Liver Transpl.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1517</span>– <span class="NLM_lpage">1525</span>, <span class="refDoi"> DOI: 10.1002/lt.21573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Flt.21573" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1517-1525&issue=10&author=M.+Ilmakunnasauthor=E.+M.+Tukiainenauthor=A.+Rouhiainenauthor=H.+Rauvalaauthor=J.+Arolaauthor=A.+Nordinauthor=H.+Makisaloauthor=K.+Hockerstedtauthor=H.+Isoniemi&title=High+mobility+group+box+1+protein+as+a+marker+of+hepatocellular+injury+in+human+liver+transplantation&doi=10.1002%2Flt.21573"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1002%2Flt.21573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Flt.21573%26sid%3Dliteratum%253Aachs%26aulast%3DIlmakunnas%26aufirst%3DM.%26aulast%3DTukiainen%26aufirst%3DE.%2BM.%26aulast%3DRouhiainen%26aufirst%3DA.%26aulast%3DRauvala%26aufirst%3DH.%26aulast%3DArola%26aufirst%3DJ.%26aulast%3DNordin%26aufirst%3DA.%26aulast%3DMakisalo%26aufirst%3DH.%26aulast%3DHockerstedt%26aufirst%3DK.%26aulast%3DIsoniemi%26aufirst%3DH.%26atitle%3DHigh%2520mobility%2520group%2520box%25201%2520protein%2520as%2520a%2520marker%2520of%2520hepatocellular%2520injury%2520in%2520human%2520liver%2520transplantation%26jtitle%3DLiver%2520Transpl.%26date%3D2008%26volume%3D14%26issue%3D10%26spage%3D1517%26epage%3D1525%26doi%3D10.1002%2Flt.21573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacquaniti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colavita, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirico, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fede, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fede, C.</span></span> <span> </span><span class="NLM_article-title">High mobility group box 1 and tumor growth factor beta: Useful biomarkers in pediatric patients receiving peritoneal dialysis</span>. <i>Renal Failure</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1370</span>– <span class="NLM_lpage">1376</span>, <span class="refDoi"> DOI: 10.1080/0886022X.2016.1216711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1080%2F0886022X.2016.1216711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCisLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2016&pages=1370-1376&issue=9&author=R.+Chimenzauthor=A.+Lacquanitiauthor=L.+Colavitaauthor=V.+Chiricoauthor=C.+Fedeauthor=M.+Buemiauthor=C.+Fede&title=High+mobility+group+box+1+and+tumor+growth+factor+beta%3A+Useful+biomarkers+in+pediatric+patients+receiving+peritoneal+dialysis&doi=10.1080%2F0886022X.2016.1216711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box 1 and tumor growth factor β: useful biomarkers in pediatric patients receiving peritoneal dialysis</span></div><div class="casAuthors">Chimenz, Roberto; Lacquaniti, Antonio; Colavita, Laura; Chirico, Valeria; Fede, Claudia; Buemi, Michele; Fede, Carmelo</div><div class="citationInfo"><span class="NLM_cas:title">Renal Failure</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1370-1376</span>CODEN:
                <span class="NLM_cas:coden">REFAE8</span>;
        ISSN:<span class="NLM_cas:issn">0886-022X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Peritonitis, the most important limitation of peritoneal dialysis (PD), could be detected by biomarkers in dialyzate effluent, representing a noninvasive method to indirectly assess the peritoneum status.  The aim of our study was to test high mobility group box 1 (HMGB1) in PD patients, evaluating its role as precocious marker of peritoneum damage during peritonitis.  Transforming growth factor (TGF)-β was correlated with peritoneal transport characteristics.  Six patients, treated by ambulatory PD, were enrolled.  Samples were collected at the onset of peritonitis (T1) and every day until its resoln. (T-end).  Serum (s) and peritoneal (p) white blood cell (WBC) count was also evaluated.  Peritoneal Equilibration Test evaluated the filter activity of peritoneum.  In patients with acute peritonitis, the highest serum and peritoneal HMGB1 values (64 ± 3.6 and 70 ± 5.3 ng/mL, resp.) were assessed, with a progressive decrease of their levels at the resoln. time (T-end: sHMGB1:36 ± 2.5; pHMGB1:30.5 ± 7.0 ng/mL).  While no differences of sWBC and pWBC were obsd. between baseline and T-end values, pHMGB1 levels remained higher at T-end than those obsd. at T0 (pHMGB1:30.5 ± 7.0 vs. 6.9 ± 3.6; p < 0.0001).  TGF-β levels were higher in patients with low peritoneal permeability than in medium or high transporter patients (81 ± 15.5 vs. 24.3 ± 7.5 pg/mL; p = 0.01).  An inverse correlation was found between TGF-β levels and dialyzate/plasmatic creatinine values (r = -0.83; p = 0.03).  HMGB1 represents a useful biomarker for peritoneum evaluation in PD patients.  A prognostic role of this alarmin, as a marker of response to therapy, could be hypothesized.  TGF-β could predict the peritoneal transport status and dialysis technique adequacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO6KhqULEjC7Vg90H21EOLACvtfcHk0lj4Svbeo1bRRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCisLzF&md5=d142de5983253396ca7f4b838755c23b</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1080%2F0886022X.2016.1216711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F0886022X.2016.1216711%26sid%3Dliteratum%253Aachs%26aulast%3DChimenz%26aufirst%3DR.%26aulast%3DLacquaniti%26aufirst%3DA.%26aulast%3DColavita%26aufirst%3DL.%26aulast%3DChirico%26aufirst%3DV.%26aulast%3DFede%26aufirst%3DC.%26aulast%3DBuemi%26aufirst%3DM.%26aulast%3DFede%26aufirst%3DC.%26atitle%3DHigh%2520mobility%2520group%2520box%25201%2520and%2520tumor%2520growth%2520factor%2520beta%253A%2520Useful%2520biomarkers%2520in%2520pediatric%2520patients%2520receiving%2520peritoneal%2520dialysis%26jtitle%3DRenal%2520Failure%26date%3D2016%26volume%3D38%26issue%3D9%26spage%3D1370%26epage%3D1376%26doi%3D10.1080%2F0886022X.2016.1216711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakiyanov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalousova, M.</span></span> <span> </span><span class="NLM_article-title">Placental growth factor, pregnancy-associated plasma protein-a, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: A cross sectional study</span>. <i>BMC Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">245</span>, <span class="refDoi"> DOI: 10.1186/1471-2369-14-245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2F1471-2369-14-245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=24188108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVOhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=245&author=O.+Zakiyanovauthor=V.+Krihaauthor=J.+Vachekauthor=T.+Zimaauthor=V.+Tesarauthor=M.+Kalousova&title=Placental+growth+factor%2C+pregnancy-associated+plasma+protein-a%2C+soluble+receptor+for+advanced+glycation+end+products%2C+extracellular+newly+identified+receptor+for+receptor+for+advanced+glycation+end+products+binding+protein+and+high+mobility+group+box+1+levels+in+patients+with+acute+kidney+injury%3A+A+cross+sectional+study&doi=10.1186%2F1471-2369-14-245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study</span></div><div class="casAuthors">Zakiyanov, Oskar; Kriha, Vitezslav; Vachek, Jan; Zima, Tomas; Tesar, Vladimir; Kalousova, Marta</div><div class="citationInfo"><span class="NLM_cas:title">BMC Nephrology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245/1-245/11</span>CODEN:
                <span class="NLM_cas:coden">BNMEB7</span>;
        ISSN:<span class="NLM_cas:issn">1471-2369</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Placental growth factor (PlGF), pregnancy-assocd. plasma protein-A (PAPP-A), sol. receptor for advanced glycation end products (sRAGE), extracellular newly identified receptor for RAGE binding protein (EN-RAGE) and high mobility group box 1 (HMGB-1) are novel biomarkers in chronic kidney disease (CKD).  However, their clin. significance in acute kidney injury (AKI) is unknown.  The aim of this cross-sectional study was to det. whether selected biomarkers are changed in AKI patients.  Methods: Serum PlGF, PAPP-A, sRAGE, EN-RAGE and HMGB-1 levels were assessed in 40 patients with AKI, 42 CKD 5 patients, 31 haemodialysis patients (HD) and 39 age-matched healthy controls.  Results: PAPP-A was elevated in AKI (20.6 ± 16.9 mIU/L) compared with controls (9.1 ± 2.3 mIU/L, p < 0.001).  PlGF was not increased in AKI (11.7 ± 7.4 pg/mL) vs. controls (8.5 ± 2.4 pg/mL, n.s.), as well as sRAGE was not elevated in AKI (2400 ± 1400 pg/mL) compared with controls (1760 ± 730 pg/mL, n.s), but was lower compared with CKD 5 (3200 ± 1500 pg/mL, p < 0.05); EN-RAGE was elevated in AKI 480 ± 450 ng/mL in comparison with controls (60 ± 62 ng/mL), CKD 5 (190 ± 120 ng/mL), and HD (120 ± 100 ng/mL), all p < 0.001.  Similarly, HMGB-1 was increased in AKI (5.8 ± 7.5 ng/mL) vs. controls (1.7 ± 1.4 ng/mL), CKD 5 (3.2 ± 3.1 ng/mL) and HD (2.5 ±2.1 ng/mL), all p < 0.001.  In AKI group, in multivariate regression anal.: PAPP-A levels were assocd. with transferrin (p < 0.001), neg. with albumin (p < 0.01) and prealbumin (p < 0.05); PlGF levels were assocd. with C - reactive protein (p < 0.001).  EN-RAGE levels were assocd. with ferritin (p < 0.01) and orosomucoid (p = 0.02), and HMGB-1 levels with leukocyte count (p < 0.01) and neg. with proteinuria (p = 0.02).  Conclusions: In AKI patients, PAPP-A, EN-RAGE and HMGB1 are elevated, but sRAGE and PlGF are not increased.  Whereas PAPP-A correlates with markers of nutrition; PlGF, EN-RAGE and HMGB-1 are related to inflammatory parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzVr4FxfvZbVg90H21EOLACvtfcHk0lj4Svbeo1bRRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVOhtrY%253D&md5=3f44fcda1f93379cfc44a909e3b14ff6</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1186%2F1471-2369-14-245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2369-14-245%26sid%3Dliteratum%253Aachs%26aulast%3DZakiyanov%26aufirst%3DO.%26aulast%3DKriha%26aufirst%3DV.%26aulast%3DVachek%26aufirst%3DJ.%26aulast%3DZima%26aufirst%3DT.%26aulast%3DTesar%26aufirst%3DV.%26aulast%3DKalousova%26aufirst%3DM.%26atitle%3DPlacental%2520growth%2520factor%252C%2520pregnancy-associated%2520plasma%2520protein-a%252C%2520soluble%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%252C%2520extracellular%2520newly%2520identified%2520receptor%2520for%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520binding%2520protein%2520and%2520high%2520mobility%2520group%2520box%25201%2520levels%2520in%2520patients%2520with%2520acute%2520kidney%2520injury%253A%2520A%2520cross%2520sectional%2520study%26jtitle%3DBMC%2520Nephrol.%26date%3D2013%26volume%3D14%26spage%3D245%26doi%3D10.1186%2F1471-2369-14-245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhillon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromberg, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischereder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heeger, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroppel, B.</span></span> <span> </span><span class="NLM_article-title">Donor toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3390</span>– <span class="NLM_lpage">3395</span>, <span class="refDoi"> DOI: 10.1073/pnas.0810169106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1073%2Fpnas.0810169106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=3390-3395&issue=9&author=B.+Krugerauthor=S.+Krickauthor=N.+Dhillonauthor=S.+M.+Lernerauthor=S.+Amesauthor=J.+S.+Brombergauthor=M.+Linauthor=L.+Walshauthor=J.+Vellaauthor=M.+Fischerederauthor=B.+K.+Kramerauthor=R.+B.+Colvinauthor=P.+S.+Heegerauthor=B.+T.+Murphyauthor=B.+Schroppel&title=Donor+toll-like+receptor+4+contributes+to+ischemia+and+reperfusion+injury+following+human+kidney+transplantation&doi=10.1073%2Fpnas.0810169106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0810169106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0810169106%26sid%3Dliteratum%253Aachs%26aulast%3DKruger%26aufirst%3DB.%26aulast%3DKrick%26aufirst%3DS.%26aulast%3DDhillon%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DS.%2BM.%26aulast%3DAmes%26aufirst%3DS.%26aulast%3DBromberg%26aufirst%3DJ.%2BS.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DWalsh%26aufirst%3DL.%26aulast%3DVella%26aufirst%3DJ.%26aulast%3DFischereder%26aufirst%3DM.%26aulast%3DKramer%26aufirst%3DB.%2BK.%26aulast%3DColvin%26aufirst%3DR.%2BB.%26aulast%3DHeeger%26aufirst%3DP.%2BS.%26aulast%3DMurphy%26aufirst%3DB.%2BT.%26aulast%3DSchroppel%26aufirst%3DB.%26atitle%3DDonor%2520toll-like%2520receptor%25204%2520contributes%2520to%2520ischemia%2520and%2520reperfusion%2520injury%2520following%2520human%2520kidney%2520transplantation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D9%26spage%3D3390%26epage%3D3395%26doi%3D10.1073%2Fpnas.0810169106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruchfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qureshi, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindholm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barany, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvinkel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">High mobility group box protein-1 correlates with renal function in chronic kidney disease (ckd)</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.2119/2007-00107.Bruchfeld</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2F2007-00107.Bruchfeld" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=18317568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksVegu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=109-115&issue=3%E2%80%934&author=A.+Bruchfeldauthor=A.+R.+Qureshiauthor=B.+Lindholmauthor=P.+Baranyauthor=L.+Yangauthor=P.+Stenvinkelauthor=K.+J.+Tracey&title=High+mobility+group+box+protein-1+correlates+with+renal+function+in+chronic+kidney+disease+%28ckd%29&doi=10.2119%2F2007-00107.Bruchfeld"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)</span></div><div class="casAuthors">Bruchfeld, Annette; Qureshi, Abdul Rashid; Lindholm, Bengt; Barany, Peter; Yang, LiHong; Stenvinkel, Peter; Tracey, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">109-115</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Chronic kidney disease (CKD) is assocd. with inflammation and malnutrition and carries a markedly increased risk of cardiovascular disease (CVD).  High Mobility Group Box Protein-1 (HMGB-1) is a 30-kDa nuclear and cytosolic protein known as a transcription and growth factor, recently identified as a pro-inflammatory mediator of tissue injury.  Recent data implicates HMGB-1 in endotoxin lethality, rheumatoid arthritis, and atherosclerosis.  The aim of this post-hoc, cross-sectional study was to det. whether HMGB-1 serum levels are elevated in CKD patients.  The study groups were categorized as follows: 110 patients starting dialysis defined as CKD 5; 67 patients with moderately to severely reduced renal function or CKD 3-4; and 48 healthy controls.  High-sensitivity C-reactive-protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor (TNF), serum-albumin (S-albumin), Hb A1c (HbA1c), Hb, subjective global nutritional assessment (SGA), and glomerular filtration rate (GFR) were analyzed.  Kruskal-Wallis test was used to compare groups and Spearman's rank correlation test was used for continuous variables.  HMGB-1, measured by Western blot, was significantly (P < 0.001) elevated in CKD 5 (146.7 ± 58.6 ng/mL) and CKD 3-4 (85.6 ± 31.8) compared with controls (10.9 ± 10.5).  HMGB-1 levels were correlated pos. with TNF (Rho = 0.52; P < 0.001), hs-CRP (Rho = 0.38; P < 0.001), IL-6 (Rho = 0.30; P < 0.001), HbA1c (Rho = 0.14; P = 0.02) and SGA (Rho = 0.21; P = 0.002) and neg. correlated with GFR (Rho = -0.69; P = 0.0001), Hb (Rho = -0.60; P < 0.001), S-albumin (Rho = -0.31; P < 0.001).  The current study has revealed that HMGB-1 is elevated significantly in CKD patients and correlates with GFR as well as markers of inflammation and malnutrition.  Future studies may delineate whether HMGB-1 is also a marker of disease activity and severity as well as a predictor of outcome in CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxMoclencv4bVg90H21EOLACvtfcHk0ljvIPsZBasE6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksVegu7s%253D&md5=bd93c49c166a3e3ee5e83f517d5d38d5</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.2119%2F2007-00107.Bruchfeld&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252F2007-00107.Bruchfeld%26sid%3Dliteratum%253Aachs%26aulast%3DBruchfeld%26aufirst%3DA.%26aulast%3DQureshi%26aufirst%3DA.%2BR.%26aulast%3DLindholm%26aufirst%3DB.%26aulast%3DBarany%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DStenvinkel%26aufirst%3DP.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DHigh%2520mobility%2520group%2520box%2520protein-1%2520correlates%2520with%2520renal%2520function%2520in%2520chronic%2520kidney%2520disease%2520%2528ckd%2529%26jtitle%3DMol.%2520Med.%26date%3D2008%26volume%3D14%26issue%3D3%25E2%2580%25934%26spage%3D109%26epage%3D115%26doi%3D10.2119%2F2007-00107.Bruchfeld" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zamora, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vodovotz, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barclay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horslen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudnick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loomes, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squires, R. H.</span></span> <span> </span><span class="NLM_article-title">Data-driven modeling for precision medicine in pediatric acute liver failure</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">829</span>, <span class="refDoi"> DOI: 10.2119/molmed.2016.00183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.2119%2Fmolmed.2016.00183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosFagsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=821-829&author=R.+Zamoraauthor=Y.+Vodovotzauthor=Q.+Miauthor=D.+Barclayauthor=J.+Yinauthor=S.+Horslenauthor=D.+Rudnickauthor=K.+M.+Loomesauthor=R.+H.+Squires&title=Data-driven+modeling+for+precision+medicine+in+pediatric+acute+liver+failure&doi=10.2119%2Fmolmed.2016.00183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Data-driven modeling for precision medicine in pediatric acute liver failure</span></div><div class="casAuthors">Zamora, Ruben; Vodovotz, Yoram; Mi, Qi; Barclay, Derek; Yin, Jinling; Horslen, Simon; Rudnick, David; Loomes, Kathleen M.; Squires, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">821-829</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">The absence of early outcome biomarkers for pediatric acute liver failure (PALF) hinders medical and liver transplant decisions.  We sought to define dynamic interactions among circulating inflammatory mediators to gain insights into PALF outcome subgroups.  Serum samples from 101 participants in the PALF study, collected over the first 7 d following enrollment, were assayed for 27 inflammatory mediators.  Outcomes (spontaneous survivors (S, n = 61), nonsurvivors (NS, n = 12) and liver transplant patients [LTx, n = 28]) were assessed at 21 d post-enrollment.  Dynamic interrelations among mediators were defined using data-driven algorithms.  Dynamic Bayesian network inference identified a common network motif, with HMGB1 as a central node in all patient subgroups.  The networks in S and LTx were similar, and differed from NS.  Dynamic network anal. suggested similar dynamic connectivity in S and LTx, but a more highly interconnected network in NS that increased with time.  A dynamic robustness index calcd. to quantify how inflammatory network connectivity changes as a function of correlation stringency differentiated all three patient subgroups.  Our results suggest that increasing inflammatory network connectivity is assocd. with nonsurvival in PALF and could ultimately lead to better patient outcome stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooqi8lMx_ZpLVg90H21EOLACvtfcHk0ljvIPsZBasE6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosFagsb4%253D&md5=4d9eafadfd507acd97135b2070ad3221</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2016.00183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2016.00183%26sid%3Dliteratum%253Aachs%26aulast%3DZamora%26aufirst%3DR.%26aulast%3DVodovotz%26aufirst%3DY.%26aulast%3DMi%26aufirst%3DQ.%26aulast%3DBarclay%26aufirst%3DD.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DHorslen%26aufirst%3DS.%26aulast%3DRudnick%26aufirst%3DD.%26aulast%3DLoomes%26aufirst%3DK.%2BM.%26aulast%3DSquires%26aufirst%3DR.%2BH.%26atitle%3DData-driven%2520modeling%2520for%2520precision%2520medicine%2520in%2520pediatric%2520acute%2520liver%2520failure%26jtitle%3DMol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D821%26epage%3D829%26doi%3D10.2119%2Fmolmed.2016.00183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Turco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarra, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. M.</span></span> <span> </span><span class="NLM_article-title">Acute Liver Failure Study, G. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure</span>. <i>Liver Transpl.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">847</span>– <span class="NLM_lpage">854</span>, <span class="refDoi"> DOI: 10.1002/lt.24129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Flt.24129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=847-854&issue=6&author=G.+Bastaauthor=S.+Del+Turcoauthor=T.+Navarraauthor=W.+M.+Lee&title=Acute+Liver+Failure+Study%2C+G.+Circulating+levels+of+soluble+receptor+for+advanced+glycation+end+products+and+ligands+of+the+receptor+for+advanced+glycation+end+products+in+patients+with+acute+liver+failure&doi=10.1002%2Flt.24129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1002%2Flt.24129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Flt.24129%26sid%3Dliteratum%253Aachs%26aulast%3DBasta%26aufirst%3DG.%26aulast%3DDel%2BTurco%26aufirst%3DS.%26aulast%3DNavarra%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DW.%2BM.%26atitle%3DAcute%2520Liver%2520Failure%2520Study%252C%2520G.%2520Circulating%2520levels%2520of%2520soluble%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520and%2520ligands%2520of%2520the%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520in%2520patients%2520with%2520acute%2520liver%2520failure%26jtitle%3DLiver%2520Transpl.%26date%3D2015%26volume%3D21%26issue%3D6%26spage%3D847%26epage%3D854%26doi%3D10.1002%2Flt.24129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chawla, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M. P.</span></span> <span> </span><span class="NLM_article-title">High levels of circulating hmgb1 as a biomarker of acute liver failure in patients with viral hepatitis e</span>. <i>Liver Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1341</span>– <span class="NLM_lpage">1348</span>, <span class="refDoi"> DOI: 10.1111/liv.12197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fliv.12197" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1341-1348&issue=9&author=M.+Majumdarauthor=R.+Rathoauthor=Y.+Chawlaauthor=M.+P.+Singh&title=High+levels+of+circulating+hmgb1+as+a+biomarker+of+acute+liver+failure+in+patients+with+viral+hepatitis+e&doi=10.1111%2Fliv.12197"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1111%2Fliv.12197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fliv.12197%26sid%3Dliteratum%253Aachs%26aulast%3DMajumdar%26aufirst%3DM.%26aulast%3DRatho%26aufirst%3DR.%26aulast%3DChawla%26aufirst%3DY.%26aulast%3DSingh%26aufirst%3DM.%2BP.%26atitle%3DHigh%2520levels%2520of%2520circulating%2520hmgb1%2520as%2520a%2520biomarker%2520of%2520acute%2520liver%2520failure%2520in%2520patients%2520with%2520viral%2520hepatitis%2520e%26jtitle%3DLiver%2520Int.%26date%3D2013%26volume%3D33%26issue%3D9%26spage%3D1341%26epage%3D1348%26doi%3D10.1111%2Fliv.12197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covacu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunnemark, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danilov, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Bianco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khademi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallstrom, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brundin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. A.</span></span> <span> </span><span class="NLM_article-title">Pivotal advance: Hmgb1 expression in active lesions of human and experimental multiple sclerosis</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1248</span>– <span class="NLM_lpage">1255</span>, <span class="refDoi"> DOI: 10.1189/jlb.1207844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1189%2Fjlb.1207844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=18644848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWgu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2008&pages=1248-1255&issue=5&author=A.+Anderssonauthor=R.+Covacuauthor=D.+Sunnemarkauthor=A.+I.+Danilovauthor=A.+Dal+Biancoauthor=M.+Khademiauthor=E.+Wallstromauthor=A.+Lobellauthor=L.+Brundinauthor=H.+Lassmannauthor=R.+A.+Harris&title=Pivotal+advance%3A+Hmgb1+expression+in+active+lesions+of+human+and+experimental+multiple+sclerosis&doi=10.1189%2Fjlb.1207844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis</span></div><div class="casAuthors">Andersson, Aasa; Covacu, Ruxandra; Sunnemark, Dan; Danilov, Alexandre I.; Dal Bianco, Assunta; Khademi, Mohsen; Wallstroem, Erik; Lobell, Anna; Brundin, Lou; Lassmann, Hans; Harris, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1248-1255</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the CNS, most frequently starting with a series of bouts, each followed by complete remission and then a secondary, progressive phase during which the neurol. deficit increases steadily.  The underlying mol. mechanisms responsible for disease progression are still unclear.  Herein, we demonstrate that high mobility group box chromosomal protein 1 (HMGB1), a DNA-binding protein with proinflammatory properties, is evident in active lesions of MS and exptl. autoimmune encephalomyelitis (EAE) and that HMGB1 levels correlate with active inflammation.  Furthermore, the expression of the innate HMGB1 receptors-receptor for advanced glycation end products, TLR2, and TLR4-was also highly increased in MS and rodent EAE.  Addnl., in vitro activation of rodent CNS-derived microglia and bone marrow-derived macrophages demonstrated that microglia were equally as capable as macrophages of translocating HMGB1 following LPS/IFN-γ stimulation.  Significant expression of HMGB1 and its receptors on accumulating activated macrophages and resident microglia may thus provide a pos. feedback loop that amplifies the inflammatory response during MS and EAE pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoskdyS3KpNG7Vg90H21EOLACvtfcHk0ljRUAmVuGlchw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWgu7jI&md5=2db0ee24795ce9a882b0f3b871d80fcf</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1189%2Fjlb.1207844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.1207844%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DA.%26aulast%3DCovacu%26aufirst%3DR.%26aulast%3DSunnemark%26aufirst%3DD.%26aulast%3DDanilov%26aufirst%3DA.%2BI.%26aulast%3DDal%2BBianco%26aufirst%3DA.%26aulast%3DKhademi%26aufirst%3DM.%26aulast%3DWallstrom%26aufirst%3DE.%26aulast%3DLobell%26aufirst%3DA.%26aulast%3DBrundin%26aufirst%3DL.%26aulast%3DLassmann%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26atitle%3DPivotal%2520advance%253A%2520Hmgb1%2520expression%2520in%2520active%2520lesions%2520of%2520human%2520and%2520experimental%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2008%26volume%3D84%26issue%3D5%26spage%3D1248%26epage%3D1255%26doi%3D10.1189%2Fjlb.1207844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrigo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirico, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salpietro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munafo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gitto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacquaniti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salpietro, C.</span></span> <span> </span><span class="NLM_article-title">High-mobility group protein b1: A new biomarker of metabolic syndrome in obese children</span>. <i>Eur. J. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>168</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1530/EJE-13-0037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1530%2FEJE-13-0037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23384711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVanurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=631-638&issue=4&author=T.+Arrigoauthor=V.+Chiricoauthor=V.+Salpietroauthor=C.+Munafoauthor=V.+Ferrauauthor=E.+Gittoauthor=A.+Lacquanitiauthor=C.+Salpietro&title=High-mobility+group+protein+b1%3A+A+new+biomarker+of+metabolic+syndrome+in+obese+children&doi=10.1530%2FEJE-13-0037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children</span></div><div class="casAuthors">Arrigo, Teresa; Chirico, Valeria; Salpietro, Vincenzo; Munafo, Caterina; Ferrau, Valeria; Gitto, Eloisa; Lacquaniti, Antonio; Salpietro, Carmelo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">631-638</span>CODEN:
                <span class="NLM_cas:coden">EJOEEP</span>;
        ISSN:<span class="NLM_cas:issn">0804-4643</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">Introduction: Obesity is assocd. with a chronic low-grade inflammation.  High-mobility group box 1 protein (HMGB1) plays a key role in inflammation and immunostimulatory and chemotactic processes.  The aim of the study was to assess the role of HMGB1 in obese children and to evaluate its diagnostic profile in identifying childhood obesity-related complications, such as the metabolic syndrome (MS).  Patients and methods: Sixty obese children were enrolled and compared with 40 healthy children (control).  Homeostasis model assessment of insulin resistance (HOMA-IR), lipid profile, thyroid hormones, and pro- and anti-inflammatory peptides such as C-reactive protein (CRP), adiponectin, interleukin 6 (IL6), IL18, IL23, TNFα, resistin, and HMGB1 were evaluated.  Receiver operating characteristics (ROC) anal. was employed to calc. the area under the curve (AUC) for HMGB1, IL6, and adiponectin to find the best cutoff values capable of identifying MS in obese children.  Results: HMGB1 levels were statistically higher in obese patients than in the control group (19.4 ± 6.8 vs 3.7 ± 1.2 ng/mL; P<0.0001).  In obese patients, IL18, IL6, and resistin levels were significantly high, while adiponectin levels were low.  At multivariate anal., HMGB1 was found to be independently correlated with BMI, IL23, IL6, free triiodothyronine, HDL, and HOMA-IR.  At ROC anal., HMGB1 showed higher sensitivity and specificity (AUC, 0.992; sensitivity, 94.7%; specificity, 97.5%) than IL6 and adiponectin in identifying MS in obese children.  Conclusion: HMGB1 plays an important role in the inflammatory process assocd. with childhood obesity.  This peptide may be an important diagnostic marker for obesity-related complications, such as MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEy-ZgqfN7ULVg90H21EOLACvtfcHk0ljRUAmVuGlchw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVanurc%253D&md5=fda7f7aa22ec6d5a3e3e9f7cfc27d5d9</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1530%2FEJE-13-0037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FEJE-13-0037%26sid%3Dliteratum%253Aachs%26aulast%3DArrigo%26aufirst%3DT.%26aulast%3DChirico%26aufirst%3DV.%26aulast%3DSalpietro%26aufirst%3DV.%26aulast%3DMunafo%26aufirst%3DC.%26aulast%3DFerrau%26aufirst%3DV.%26aulast%3DGitto%26aufirst%3DE.%26aulast%3DLacquaniti%26aufirst%3DA.%26aulast%3DSalpietro%26aufirst%3DC.%26atitle%3DHigh-mobility%2520group%2520protein%2520b1%253A%2520A%2520new%2520biomarker%2520of%2520metabolic%2520syndrome%2520in%2520obese%2520children%26jtitle%3DEur.%2520J.%2520Endocrinol.%26date%3D2013%26volume%3D168%26issue%3D4%26spage%3D631%26epage%3D638%26doi%3D10.1530%2FEJE-13-0037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinzeki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajiki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujino, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, Y.</span></span> <span> </span><span class="NLM_article-title">Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis</span>. <i>Pancreas</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1097/01.mpa.0000236741.15477.8b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2F01.mpa.0000236741.15477.8b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=359-363&issue=4&author=T.+Yasudaauthor=T.+Uedaauthor=Y.+Takeyamaauthor=M.+Shinzekiauthor=H.+Sawaauthor=T.+Nakajimaauthor=T.+Ajikiauthor=Y.+Fujinoauthor=Y.+Suzukiauthor=Y.+Kuroda&title=Significant+increase+of+serum+high-mobility+group+box+chromosomal+protein+1+levels+in+patients+with+severe+acute+pancreatitis&doi=10.1097%2F01.mpa.0000236741.15477.8b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1097%2F01.mpa.0000236741.15477.8b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.mpa.0000236741.15477.8b%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DTakeyama%26aufirst%3DY.%26aulast%3DShinzeki%26aufirst%3DM.%26aulast%3DSawa%26aufirst%3DH.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DAjiki%26aufirst%3DT.%26aulast%3DFujino%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DKuroda%26aufirst%3DY.%26atitle%3DSignificant%2520increase%2520of%2520serum%2520high-mobility%2520group%2520box%2520chromosomal%2520protein%25201%2520levels%2520in%2520patients%2520with%2520severe%2520acute%2520pancreatitis%26jtitle%3DPancreas%26date%3D2006%26volume%3D33%26issue%3D4%26spage%3D359%26epage%3D363%26doi%3D10.1097%2F01.mpa.0000236741.15477.8b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. J.</span></span> <span> </span><span class="NLM_article-title">Increased of serum high-mobility group box chromosomal protein 1 correlated with intestinal mucosal barrier injury in patients with severe acute pancreatitis</span>. <i>World J. Emerg Surg.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1186/1749-7922-9-61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2F1749-7922-9-61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25926862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjptl2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=61&author=G.+F.+Xuauthor=M.+Guoauthor=Z.+Q.+Tianauthor=G.+Z.+Wuauthor=X.+P.+Zouauthor=W.+J.+Zhang&title=Increased+of+serum+high-mobility+group+box+chromosomal+protein+1+correlated+with+intestinal+mucosal+barrier+injury+in+patients+with+severe+acute+pancreatitis&doi=10.1186%2F1749-7922-9-61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Increased of serum high-mobility group box chromosomal protein 1 correlated with intestinal mucosal barrier injury in patients with severe acute pancreatitis</span></div><div class="casAuthors">Xu Gui-Fang; Zou Xiao-Ping; Guo Ming; Tian Zhi-Qiang; Wu Guo-Zhong; Zhang Wei-Jie</div><div class="citationInfo"><span class="NLM_cas:title">World journal of emergency surgery : WJES</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61</span>
        ISSN:<span class="NLM_cas:issn">1749-7922</span>.
    </div><div class="casAbstract">BACKGROUND:  Secondary infections are the leading cause of death in patients with severe acute pancreatitis (SAP).  The gut represents the main source of pancreatic contamination and related septic complications.  High-mobility group box chromosomal protein 1 (HMGB1) was recently identified to play an important role in the SAP intestinal mucosal barrier dysfunction.  OBJECTIVE:  To investigate the correlation of high-mobility group box 1 (HMGB1) with intestinal barrier injury and infections in patients with severe acute pancreatitis (SAP).  METHODS:  The serum levels of HMGB1, amylase, lipase, and biochemical indicators were measured in 80 patients with SAP at the time of admission.  Furthermore, relationship between their serum HMGB1 levels and intestinal barrier injury, infection and other clinical factors were analyzed.  RESULTS:  The mean value of serum HMGB1 levels was significantly higher in patients with SAP (6.02 ± 2.42 ng/mL) than that in healthy volunteers (1.87 ± 0.63 ng/mL).  Serum HMGB1 levels were significantly positively correlated with the Ranson score.  The HMGB1 levels were higher in patients with infection during the clinical course, the HMGB1 levels in non-survivors were higher than those in survivors, and positively correlated with DAO activity, L/M ratio, the concentration of endotoxin (R = 0.484, P <0.01).  CONCLUSIONS:  HMGBl level of patients with severe acute pancreatitis was significantly increased, and can be used as an important indicator to determine the intestinal barrier dysfunction and infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNxJHoYhBCXDUE-swuRqsHfW6udTcc2ea0uz-mexOpxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjptl2htg%253D%253D&md5=a570af3119c12e575ec3c5f63da8539a</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1186%2F1749-7922-9-61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1749-7922-9-61%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DG.%2BF.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DZ.%2BQ.%26aulast%3DWu%26aufirst%3DG.%2BZ.%26aulast%3DZou%26aufirst%3DX.%2BP.%26aulast%3DZhang%26aufirst%3DW.%2BJ.%26atitle%3DIncreased%2520of%2520serum%2520high-mobility%2520group%2520box%2520chromosomal%2520protein%25201%2520correlated%2520with%2520intestinal%2520mucosal%2520barrier%2520injury%2520in%2520patients%2520with%2520severe%2520acute%2520pancreatitis%26jtitle%3DWorld%2520J.%2520Emerg%2520Surg.%26date%3D2014%26volume%3D9%26spage%3D61%26doi%3D10.1186%2F1749-7922-9-61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span> <span> </span><span class="NLM_article-title">Hmgb1-rage signaling pathway in severe preeclampsia</span>. <i>Placenta</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1148</span>– <span class="NLM_lpage">1152</span>, <span class="refDoi"> DOI: 10.1016/j.placenta.2015.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.placenta.2015.08.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=1148-1152&issue=10&author=L.+Zhuauthor=Z.+Zhangauthor=L.+Zhangauthor=Y.+Shiauthor=J.+Qiauthor=A.+Changauthor=J.+Gaoauthor=Y.+Fengauthor=X.+Yang&title=Hmgb1-rage+signaling+pathway+in+severe+preeclampsia&doi=10.1016%2Fj.placenta.2015.08.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.placenta.2015.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.placenta.2015.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26atitle%3DHmgb1-rage%2520signaling%2520pathway%2520in%2520severe%2520preeclampsia%26jtitle%3DPlacenta%26date%3D2015%26volume%3D36%26issue%3D10%26spage%3D1148%26epage%3D1152%26doi%3D10.1016%2Fj.placenta.2015.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuno, N.</span></span> <span> </span><span class="NLM_article-title">Hmgb-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing pmx-dhp</span>. <i>J. Surg. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/j.jss.2009.11.708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.jss.2009.11.708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=20338589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlarsbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2011&pages=183-190&issue=1&author=T.+Uenoauthor=T.+Ikedaauthor=K.+Ikedaauthor=H.+Taniuchiauthor=S.+Sudaauthor=M.+Y.+Yeungauthor=N.+Matsuno&title=Hmgb-1+as+a+useful+prognostic+biomarker+in+sepsis-induced+organ+failure+in+patients+undergoing+pmx-dhp&doi=10.1016%2Fj.jss.2009.11.708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB-1 as a Useful Prognostic Biomarker in Sepsis-Induced Organ Failure in Patients Undergoing PMX-DHP</span></div><div class="casAuthors">Ueno, Takuya; Ikeda, Toshiaki; Ikeda, Kazumi; Taniuchi, Hitoshi; Suda, Shingo; Yeung, Melissa Y.; Matsuno, Naoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Surgical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">183-190</span>CODEN:
                <span class="NLM_cas:coden">JSGRA2</span>;
        ISSN:<span class="NLM_cas:issn">0022-4804</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: High mobility group box 1 (HMGB-1) has recently received attention as a late mediator of lipopolysaccharide-induced shock, and is thought to function as a mediator in such a disorder as multi-organ failure (MOF).  In Japan, we have access to an immobilized polymyxin B fiber column using a direct hemoperfusion (PMX-DHP) for patients with septic shock to improve hemodynamics and organ dysfunction.  In this study, we looked at HMGB-1 levels in each category based on the sequential organ failure assessment (SOFA) scores to further dissect its importance in specific aspects of organ failure in patients undergoing PMX-DHP.  Patients and Methods: Sixty patients with septic shock (40 survivors and 20 non-survivors).  We analyzed HMGB-1 and IL-6 levels before and after PMX-DHP and defined organ failure as two or more SOFA points.  Results: There was a significant pos. correlation between SOFA score and HMGB-1 level (P < 0.05).  The HMGB-1 level before PMX-DHP significantly increased as the no. of organ failures increased (P < 0.01: comparing 2 vs. 5 organ failures).  IL-6 levels decreased after PMX-DHP (P < 0.05 compared with before PMX-DHP), but HMGB-1 levels remained unchanged.  HMGB-1 levels of survivors with organ failure in liver decreased after PMX-DHP, but those of non-survivors significantly increased 24h after PMX-DHP compared with before PMX-DHP (P < 0.01).  In non-survivors with organ failure in liver, HMGB-1 levels were significantly higher than among survivors 24h after PMX-DHP (P < 0.01).  Conclusions: Our results indicate that HMGB-1 is a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0isKW5WOdm7Vg90H21EOLACvtfcHk0lgo99SgXav7YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlarsbrF&md5=dcbc4196cea2f6e0b08f613badc6c91f</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.jss.2009.11.708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jss.2009.11.708%26sid%3Dliteratum%253Aachs%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DTaniuchi%26aufirst%3DH.%26aulast%3DSuda%26aufirst%3DS.%26aulast%3DYeung%26aufirst%3DM.%2BY.%26aulast%3DMatsuno%26aufirst%3DN.%26atitle%3DHmgb-1%2520as%2520a%2520useful%2520prognostic%2520biomarker%2520in%2520sepsis-induced%2520organ%2520failure%2520in%2520patients%2520undergoing%2520pmx-dhp%26jtitle%3DJ.%2520Surg.%2520Res.%26date%3D2011%26volume%3D171%26issue%3D1%26spage%3D183%26epage%3D190%26doi%3D10.1016%2Fj.jss.2009.11.708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hatada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uemoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, I.</span></span> <span> </span><span class="NLM_article-title">Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation</span>. <i>Thromb. Haemostasis</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1160/TH05-05-0316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1160%2FTH05-05-0316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=16363239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Kgt7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=975-979&issue=5&author=T.+Hatadaauthor=H.+Wadaauthor=T.+Noboriauthor=K.+Okabayashiauthor=K.+Maruyamaauthor=Y.+Abeauthor=S.+Uemotoauthor=S.+Yamadaauthor=I.+Maruyama&title=Plasma+concentrations+and+importance+of+high+mobility+group+box+protein+in+the+prognosis+of+organ+failure+in+patients+with+disseminated+intravascular+coagulation&doi=10.1160%2FTH05-05-0316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation</span></div><div class="casAuthors">Hatada, Tsuyoshi; Wada, Hideo; Nobori, Tsutomu; Okabayashi, Kazuhiro; Maruyama, Kazuo; Abe, Yasunori; Uemoto, Shinji; Yamada, Shingo; Maruyama, Ikuro</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">975-979</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">High Mobility Group Box chromosomal protein 1 (HMGB1) is a nuclear DNA-binding protein acting as a proinflammatory cytokine when released in the extracellular space from necrotic cells, activated macrophages and dendritic cells.  HMGB1 acts on a specific receptor, RAGE (receptor for advanced glycation end-products), and induces prolonged inflammation, organ failure, septicemia and death.  The aim of the study was to det. the diagnostic value of plasma HMGB1 concn. and its role in the development of organ failure in patients with disseminated intravascular coagulation (DIC).  Plasma HMGB-1 levels were measured in patients with suspected DIC and their relationships with DIC, organ failure and clin. outcome were detd.  The study took place at the intensive care facility, Mie University School of Medicine and comprised 201 patients with suspected DIC.  Plasma HMGB1 was below the detection limit in normal subjects, but moderately elevated in patients with infectious diseases (4.54±8.18 ng/mL, mean±SD), malignancies (2.15±5.34 ng/mL), and traumas (6.47±13.13 ng/mL).  DIC was assocd. with significantly high plasma HMGB1 (14.05±12.56 ng/mL) in these patients.  The highest HMGB1 levels were in patients with organ failure (8.29±10.99 ng/mL) and non-survivors (16.58±11.01 ng/mL).  HMGB1 plasma levels correlated with the DIC score and sepsis-related organ failure assessment (SOFA) score.  In conclusion, our data suggest that HMGB-1 is a potentially suitable prognostic marker of OF or DIC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBj0AbJkMbZbVg90H21EOLACvtfcHk0lgNBV4AwXUkhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Kgt7zF&md5=be9434ba7a1be72d699c41cbfc631bcb</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1160%2FTH05-05-0316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH05-05-0316%26sid%3Dliteratum%253Aachs%26aulast%3DHatada%26aufirst%3DT.%26aulast%3DWada%26aufirst%3DH.%26aulast%3DNobori%26aufirst%3DT.%26aulast%3DOkabayashi%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DK.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DUemoto%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DMaruyama%26aufirst%3DI.%26atitle%3DPlasma%2520concentrations%2520and%2520importance%2520of%2520high%2520mobility%2520group%2520box%2520protein%2520in%2520the%2520prognosis%2520of%2520organ%2520failure%2520in%2520patients%2520with%2520disseminated%2520intravascular%2520coagulation%26jtitle%3DThromb.%2520Haemostasis%26date%3D2005%26volume%3D94%26issue%3D5%26spage%3D975%26epage%3D979%26doi%3D10.1160%2FTH05-05-0316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span> <span> </span><span class="NLM_article-title">Prognostic value of dynamic monitoring of cellular immunity and hmgb1 in severe sepsis: Delayed chronic inflammation may be the leading cause of death in late severe sepsis</span>. <i>Clin. Lab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2379</span>– <span class="NLM_lpage">2385</span>, <span class="refDoi"> DOI: 10.7754/Clin.Lab.2016.160530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.7754%2FClin.Lab.2016.160530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28164547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVWnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2016&pages=2379-2385&issue=12&author=H.+Yuauthor=Z.+Qiauthor=L.+Zhaoauthor=R.+Shaoauthor=Y.+Fangauthor=C.+Li&title=Prognostic+value+of+dynamic+monitoring+of+cellular+immunity+and+hmgb1+in+severe+sepsis%3A+Delayed+chronic+inflammation+may+be+the+leading+cause+of+death+in+late+severe+sepsis&doi=10.7754%2FClin.Lab.2016.160530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic value of dynamic monitoring of cellular immunity and HMGB1 in severe sepsis: delayed chronic inflammation may be the leading cause of death in late severe sepsis</span></div><div class="casAuthors">Yu, Han; Qi, Zhijiang; Zhao, Lianxiang; Shao, Rui; Fang, Yingying; Li, Chunsheng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Laboratory (Mainz, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2379-2385</span>CODEN:
                <span class="NLM_cas:coden">CLLAFP</span>;
        ISSN:<span class="NLM_cas:issn">1433-6510</span>.
    
            (<span class="NLM_cas:orgname">Clinical Laboratory Publications GmbH</span>)
        </div><div class="casAbstract">Background: Sepsis is a life-threatening response to infection with a high mortality rate.  In order to explore the prognostic value of dynamic monitoring of cellular immunity during late severe sepsis, we assessed levels of T-lymphocyte subsets, the human leukocyte antigen D-related (HLA-DR), and the high mobility group box-1 (HMGB1) protein.  Methods: Study participants included 247 consecutive severe sepsis patients who were admitted to Beijing Chao-Yang Hospital's Emergency Intensive Care Unit.  Patients were divided into survivors and non-survivors based on 90-day survival rates, and clin. data were collected.  T-lymphocyte subsets on days 1 and 7, HLA-DR on days 1 and 12, and HMGB1 on days 1, 3, 5, 7, and 12 were analyzed.  Results: Counts of CD3+, CD3+CD4+, and CD3+CD8+T cells on day 1 in non-survivors were lower than those in survivors.  By day 7 counts of all three types of T cells had increased in both survivors and non-survivors, but CD3+ and CD+CD8+ T cells remained lower in non-survivors than in survivors. there was no significant difference in HLA-DR levels between survivors and non-survivors on day 1, but HLA-DR levels increased in survivors and decreased in non-survivors by day 12.  In contrast, over days 1 - 12, HMGB1 levels increased in non-survivors and decreased in survivors.  Conclusions: Patients with severe sepsis present with cellular immune dysfunction and persistent chronic inflammation, both of which may lead to death in the late phase of severe sepsis.  Dynamic monitoring of indicators of cellular immunity and HMGB1 is useful for evaluating the immune status, chronic inflammation processes, and prognosis of patients with severe sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdCOklbVFjubVg90H21EOLACvtfcHk0lgNBV4AwXUkhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVWnu78%253D&md5=691cdaa1d80286a7d4b898f2d778fba2</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.7754%2FClin.Lab.2016.160530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7754%252FClin.Lab.2016.160530%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DQi%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DShao%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DPrognostic%2520value%2520of%2520dynamic%2520monitoring%2520of%2520cellular%2520immunity%2520and%2520hmgb1%2520in%2520severe%2520sepsis%253A%2520Delayed%2520chronic%2520inflammation%2520may%2520be%2520the%2520leading%2520cause%2520of%2520death%2520in%2520late%2520severe%2520sepsis%26jtitle%3DClin.%2520Lab.%26date%3D2016%26volume%3D62%26issue%3D12%26spage%3D2379%26epage%3D2385%26doi%3D10.7754%2FClin.Lab.2016.160530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bae, J. S.</span></span> <span> </span><span class="NLM_article-title">Role of high mobility group box 1 in inflammatory disease: Focus on sepsis</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1511</span>– <span class="NLM_lpage">1523</span>, <span class="refDoi"> DOI: 10.1007/s12272-012-0901-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs12272-012-0901-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23054707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKrur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=1511-1523&issue=9&author=J.+S.+Bae&title=Role+of+high+mobility+group+box+1+in+inflammatory+disease%3A+Focus+on+sepsis&doi=10.1007%2Fs12272-012-0901-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Role of high mobility group box 1 in inflammatory disease: Focus on sepsis</span></div><div class="casAuthors">Bae, Jong-Sup</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1511-1523</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  High mobility group box 1 (HMGB1) is a highly conserved, ubiquitous protein present in the nuclei and cytoplasm of nearly all cell types.  In response to infection or injury, HMGB1 is actively secreted by innate immune cells and/or released passively by injured or damaged cells.  Thus, serum and tissue levels of HMGB1 are elevated during infection, and esp. during sepsis.  Sepsis is a systemic inflammatory response to disease and the most severe complication of infections, and HMGB1 acts as a potent proinflammatory cytokine and is involved in delayed endotoxin lethality and sepsis.  Furthermore, the targeting of HMGB1 with antibodies or specific antagonists has been found to have protective effects in established preclin. inflammatory disease models, including models of lethal endotoxemia and sepsis.  In the present study, emerging evidence supporting the notion that extracellular HMGB1 acts as a proinflammatory danger signal is reviewed, and the potential therapeutic effects of a wide array of HMGB1 inhibitors agents in sepsis and ischemic injury are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm-dygrUAjh7Vg90H21EOLACvtfcHk0lgNBV4AwXUkhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKrur%252FM&md5=762ad1ccae4e251a3c28d5ad508cb6dd</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1007%2Fs12272-012-0901-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-012-0901-5%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DJ.%2BS.%26atitle%3DRole%2520of%2520high%2520mobility%2520group%2520box%25201%2520in%2520inflammatory%2520disease%253A%2520Focus%2520on%2520sepsis%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2012%26volume%3D35%26issue%3D9%26spage%3D1511%26epage%3D1523%26doi%3D10.1007%2Fs12272-012-0901-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, S.</span></span> <span> </span><span class="NLM_article-title">Hmgb1 promotes systemic lupus erythematosus by enhancing macrophage inflammatory response</span>. <i>J. Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2015</i></span>,  <span class="NLM_fpage">946748</span>, <span class="refDoi"> DOI: 10.1155/2015/946748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1155%2F2015%2F946748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=26078984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2MbktVOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2015&publication_year=2015&pages=946748&author=M.+Luauthor=S.+Yuauthor=W.+Xuauthor=B.+Gaoauthor=S.+Xiong&title=Hmgb1+promotes+systemic+lupus+erythematosus+by+enhancing+macrophage+inflammatory+response&doi=10.1155%2F2015%2F946748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response</span></div><div class="casAuthors">Lu Mudan; Yu Shanshan; Gao Bo; Xu Wei; Xiong Sidong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2015</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">946748</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Background/Purpose.  HMGB1, which may act as a proinflammatory mediator, has been proposed to contribute to the pathogenesis of multiple chronic inflammatory and autoimmune diseases including systemic lupus erythematosus (SLE); however, the precise mechanism of HMGB1 in the pathogenic process of SLE remains obscure.  Method.  The expression of HMGB1 was measured by ELISA and western blot.  The ELISA was also applied to detect proinflammatory cytokines levels.  Furthermore, nephritic pathology was evaluated by H&E staining of renal tissues.  Results.  In this study, we found that HMGB1 levels were significantly increased and correlated with SLE disease activity in both clinical patients and murine model.  Furthermore, gain- and loss-of-function analysis showed that HMGB1 exacerbated the severity of SLE.  Of note, the HMGB1 levels were found to be associated with the levels of proinflammatory cytokines such as TNF-α and IL-6 in SLE patients.  Further study demonstrated that increased HMGB1 expression deteriorated the severity of SLE via enhancing macrophage inflammatory response.  Moreover, we found that receptor of advanced glycation end products played a critical role in HMGB1-mediated macrophage inflammatory response.  Conclusion.  These findings suggested that HMGB1 might be a risk factor for SLE, and manipulation of HMGB1 signaling might provide a therapeutic strategy for SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpnJMlUSMmosRAV4D_Ins_fW6udTcc2ea_djQkTJPZVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbktVOgsA%253D%253D&md5=128cfe82f4e3b740b2b117512c8c1866</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1155%2F2015%2F946748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2015%252F946748%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DXiong%26aufirst%3DS.%26atitle%3DHmgb1%2520promotes%2520systemic%2520lupus%2520erythematosus%2520by%2520enhancing%2520macrophage%2520inflammatory%2520response%26jtitle%3DJ.%2520Immunol.%2520Res.%26date%3D2015%26volume%3D2015%26spage%3D946748%26doi%3D10.1155%2F2015%2F946748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus</span>. <i>J. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">766</span>– <span class="NLM_lpage">775</span>, <span class="refDoi"> DOI: 10.3899/jrheum.090663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3899%2Fjrheum.090663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=20110525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFCru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=766-775&issue=4&author=J.+Liauthor=H.+Xieauthor=T.+Wenauthor=H.+Liuauthor=W.+Zhuauthor=X.+Chen&title=Expression+of+high+mobility+group+box+chromosomal+protein+1+and+its+modulating+effects+on+downstream+cytokines+in+systemic+lupus+erythematosus&doi=10.3899%2Fjrheum.090663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus</span></div><div class="casAuthors">Li, Jie; Xie, Hongfu; Wen, Ting; Liu, Hongbo; Zhu, Wu; Chen, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">766-775</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">Objective. To compare the expression of high mobility group box chromosomal protein 1 (HMGB1) and the modulating effects on its downstream cytokines in patients with systemic lupus erythematosus (SLE) and healthy controls.  Methods. HMGB1 concns. in serum from SLE patients and controls were measured by immunoblot anal.  HMGB1 mRNA expression in peripheral blood mononuclear cells (PBMC) was detected by real-time reverse transcription-polymerase chain reaction.  Immunofluorescence assay was employed to examine the translocation of HMGB1 in monocytes after endotoxin stimulation.  Release of tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) by PBMC after rHMGB1 stimulation was also measured.  Results. Serum HMGB1 levels and HMGB1 mRNA expressions in PBMC were elevated in SLE patients compared with controls.  A pos. correlation was demonstrated between HMGB1 concns. and SLE Disease Activity Index.  There was an inverse correlation between HMGB1 levels and C4 and C3 concns. in SLE patients.  HMGB1 concns. were higher in patients with vasculitis and myositis.  Lipopolysaccharide stimulated a temporarily elevated release of HMGB1 in SLE patients compared with controls.  The pattern and localization of HMGB1 staining in monocytes were similar in both groups.  After stimulation with rHMGB1, TNF-α level decreased but IL-6 level increased in SLE patients compared with controls.  Conclusion. Our findings suggest that increased serum levels of HMGB1 in SLE may be assocd. with lupus disease activity.  The altered prodn. of TNF-α and IL-6 in response to rHMGB1 stimulation may participate in the disruption of cytokine homeostasis in SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMBThbWYnocrVg90H21EOLACvtfcHk0lgU3DzUkRlVgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFCru7o%253D&md5=cdea6c9bd43d332b635f4e05ae34084d</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.090663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.090663%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DWen%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DExpression%2520of%2520high%2520mobility%2520group%2520box%2520chromosomal%2520protein%25201%2520and%2520its%2520modulating%2520effects%2520on%2520downstream%2520cytokines%2520in%2520systemic%2520lupus%2520erythematosus%26jtitle%3DJ.%2520Rheumatol.%26date%3D2010%26volume%3D37%26issue%3D4%26spage%3D766%26epage%3D775%26doi%3D10.3899%2Fjrheum.090663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. R.</span></span> <span> </span><span class="NLM_article-title">Elevated plasma level of hmgb1 is associated with disease activity and combined alterations with ifn-alpha and tnf-alpha in systemic lupus erythematosus</span>. <i>Rheumatol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1007/s00296-010-1636-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1007%2Fs00296-010-1636-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21120500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=395-402&issue=2&author=C.+Y.+Maauthor=Y.+L.+Jiaoauthor=J.+Zhangauthor=Q.+R.+Yangauthor=Z.+F.+Zhangauthor=Y.+J.+Shenauthor=Z.+J.+Chenauthor=Y.+R.+Zhao&title=Elevated+plasma+level+of+hmgb1+is+associated+with+disease+activity+and+combined+alterations+with+ifn-alpha+and+tnf-alpha+in+systemic+lupus+erythematosus&doi=10.1007%2Fs00296-010-1636-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus</span></div><div class="casAuthors">Ma, Chun-yan; Jiao, Yu-lian; Zhang, Jie; Yang, Qing-rui; Zhang, Zhi-fen; Shen, Ya-juan; Chen, Zi-jiang; Zhao, Yue-ran</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">395-402</span>CODEN:
                <span class="NLM_cas:coden">RHINDE</span>;
        ISSN:<span class="NLM_cas:issn">0172-8172</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Recent studies indicate that high-mobility group box protein 1 (HMGB1) contributes to the pathogenesis of diverse autoimmune disorders.  It induces the prodn. of interferon-alpha (IFN-alpha) and tumor necrosis factor alpha (TNF-alpha) in vitro.  In the present study, plasma HMGB1, TNF-alpha, and IFN-alpha were detd. with ELISA in 37 patients with systemic lupus erythematosus (SLE) and 39 age- and sex-matched healthy controls (HC).  The possible assocns. of these cytokines with disease activities, autoantibodies, and certain lab. parameters were also explored.  The plasma levels of HMGB1, TNF-alpha, and IFN-alpha were increased in SLE patients compared with those of HC (P < 0.05).  Moreover, the levels of HMGB1 and TNF-alpha in the active SLE patients were elevated compared with those in inactive patients and HC.  Addnl., plasma HMGB1 was pos. correlated with peripheral neutrophils, and plasma TNF-alpha was pos. correlated with anti-Sm, ESR and CRP, while plasma IFN-alpha was inversely correlated with the age and platelet level in SLE patients.  Our data indicated that increased plasma HMGB1 was assocd. with disease activity in SLE, which was similar to TNF-alpha.  High level of plasma IFN-alpha may be related to nephritis and thrombocytopenia in SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3FeXc_9kb9LVg90H21EOLACvtfcHk0lizOf-mNPdIXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWhurk%253D&md5=29c00081677571473f51859e97767514</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs00296-010-1636-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00296-010-1636-6%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%2BY.%26aulast%3DJiao%26aufirst%3DY.%2BL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%2BR.%26aulast%3DZhang%26aufirst%3DZ.%2BF.%26aulast%3DShen%26aufirst%3DY.%2BJ.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%26aulast%3DZhao%26aufirst%3DY.%2BR.%26atitle%3DElevated%2520plasma%2520level%2520of%2520hmgb1%2520is%2520associated%2520with%2520disease%2520activity%2520and%2520combined%2520alterations%2520with%2520ifn-alpha%2520and%2520tnf-alpha%2520in%2520systemic%2520lupus%2520erythematosus%26jtitle%3DRheumatol.%2520Int.%26date%3D2012%26volume%3D32%26issue%3D2%26spage%3D395%26epage%3D402%26doi%3D10.1007%2Fs00296-010-1636-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zickert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmblad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundelin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunnarsson, I.</span></span> <span> </span><span class="NLM_article-title">Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">R36</span>, <span class="refDoi"> DOI: 10.1186/ar3747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2Far3747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22348591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVynsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=R36&issue=1&author=A.+Zickertauthor=K.+Palmbladauthor=B.+Sundelinauthor=S.+Chavanauthor=K.+J.+Traceyauthor=A.+Bruchfeldauthor=I.+Gunnarsson&title=Renal+expression+and+serum+levels+of+high+mobility+group+box+1+protein+in+lupus+nephritis&doi=10.1186%2Far3747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis</span></div><div class="casAuthors">Zickert, Agneta; Palmblad, Karin; Sundelin, Birgitta; Chavan, Sangeeta; Tracey, Kevin J.; Bruchfeld, Annette; Gunnarsson, Iva</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">R36</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">High mobility group box 1 protein (HMGB1) is a nuclear DNA binding protein acting as a pro-inflammatory mediator following extracellular release.  HMGB1 has been increasingly recognized as a pathogenic mediator in several inflammatory diseases.  Elevated serum levels of HMGB1 have been detected in autoimmune diseases including Systemic lupus erythematosus (SLE).  However, the local expression of HMGB1 in active lupus nephritis (LN) is not known.  Here we aimed to study both tissue expression and serum levels of HMGB1 in LN patients with active disease and after induction therapy.  Thirty-five patients with active LN were included.  Renal biopsies were performed at baseline and after std. induction therapy; corticosteroids combined with immunosuppressive drugs.  The biopsies were evaluated according to the World Health Organization (WHO) classification and renal disease activity was estd. using the British Isles lupus assessment group (BILAG) index.  Serum levels of HMGB1 were analyzed by western blot.  HMGB1 expression in renal tissue was assessed by immunohistochem. at baseline and follow-up biopsies in 25 patients.  Baseline biopsies showed WHO class III, IV or V and all patients had high renal disease activity (BILAG A/B).  Follow-up biopsies showed WHO I to II (n = 14), III (n = 6), IV (n = 3) or V (n = 12), and 15/35 patients were regarded as renal responders (BILAG C/D).  At baseline HMGB1 was significantly elevated in serum compared to healthy controls (P < 0.0001).  In all patients, serum levels decreased only slightly; however, in patients with baseline WHO class IV a significant decrease was obsd. (P = 0.03).  Immunostaining revealed a pronounced extranuclear HMGB1 expression predominantly outlining the glomerular endothelium and in the mesangium.  There was no clear difference in HMGB1 expression comparing baseline and follow-up biopsies or any apparent assocn. to histopathol. classification or clin. outcome.  Renal tissue expression and serum levels of HMGB1 were increased in LN.  The lack of decrease of HMGB1 in serum and tissue after immunosuppressive therapy in the current study may reflect persistent inflammatory activity.  This study clearly indicates a role for HMGB1 in LN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOQFcTyw1vsrVg90H21EOLACvtfcHk0lizOf-mNPdIXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVynsLw%253D&md5=1d4e68bd8e0e2e661e0974733f28285e</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1186%2Far3747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far3747%26sid%3Dliteratum%253Aachs%26aulast%3DZickert%26aufirst%3DA.%26aulast%3DPalmblad%26aufirst%3DK.%26aulast%3DSundelin%26aufirst%3DB.%26aulast%3DChavan%26aufirst%3DS.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DBruchfeld%26aufirst%3DA.%26aulast%3DGunnarsson%26aufirst%3DI.%26atitle%3DRenal%2520expression%2520and%2520serum%2520levels%2520of%2520high%2520mobility%2520group%2520box%25201%2520protein%2520in%2520lupus%2520nephritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2012%26volume%3D14%26issue%3D1%26spage%3DR36%26doi%3D10.1186%2Far3747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papatheodorou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bank, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sison, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, O.</span></span> <span> </span><span class="NLM_article-title">High-mobility group box 1 (hmgb1) is elevated systemically in persons with acute or chronic traumatic spinal cord injury</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">746</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1089/neu.2016.4596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1089%2Fneu.2016.4596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27673428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2svktVyrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=746-754&issue=3&author=A.+Papatheodorouauthor=A.+Steinauthor=M.+Bankauthor=C.+P.+Sisonauthor=K.+Gibbsauthor=P.+Daviesauthor=O.+Bloom&title=High-mobility+group+box+1+%28hmgb1%29+is+elevated+systemically+in+persons+with+acute+or+chronic+traumatic+spinal+cord+injury&doi=10.1089%2Fneu.2016.4596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury</span></div><div class="casAuthors">Papatheodorou Angelos; Bloom Ona; Stein Adam; Gibbs Katie; Bloom Ona; Bank Matthew; Sison Cristina P; Bloom Ona; Davies Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">746-754</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation in traumatic spinal cord injury (SCI) has been proposed to promote damage acutely and oppose functional recovery chronically.  However, we do not yet understand the signals that initiate or prolong inflammation in persons with SCI.  High-Mobility Group Box 1 (HMGB1) is a potent systemic inflammatory cytokine-or damage-associated molecular pattern molecule (DAMP)-studied in a variety of clinical settings.  It is elevated in pre-clinical models of traumatic spinal cord injury (SCI), where it promotes secondary injury, and strategies that block HMGB1 improve functional recovery.  To investigate the potential translational relevance of these observations, we measured HMGB1 in plasma from adults with acute (≤ 1 week post-SCI, n = 16) or chronic (≥ 1 year post-SCI, n = 47) SCI.  Plasma from uninjured persons (n = 51) served as controls for comparison.  In persons with acute SCI, average HMGB1 levels were significantly elevated within 0-3 days post-injury (6.00 ± 1.8 ng/mL, mean ± standard error of the mean [SEM]) or 4-7 (6.26 ± 1.3 ng/mL, mean ± SEM), compared with controls (1.26 ± 0.24 ng/mL, mean ± SEM; p ≤ 0.001 and p ≤ 0.01, respectively).  In persons with chronic SCI who were injured for 15 ± 1.5 years (mean ± SEM), HMGB1 also was significantly elevated, compared with uninjured persons (3.7 ± 0.69 vs. 1.26 ± 0.24 ng/mL, mean ± SEM; p ≤ 0.0001).  Together, these data suggest that HMGB1 may be a common, early, and persistent danger signal promoting inflammation in individuals with SCI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSPV-njIIuiOdfST00W0BcfW6udTcc2easHXIgQglWUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svktVyrsA%253D%253D&md5=195502f5801ac454cb068e72613c5e80</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1089%2Fneu.2016.4596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2016.4596%26sid%3Dliteratum%253Aachs%26aulast%3DPapatheodorou%26aufirst%3DA.%26aulast%3DStein%26aufirst%3DA.%26aulast%3DBank%26aufirst%3DM.%26aulast%3DSison%26aufirst%3DC.%2BP.%26aulast%3DGibbs%26aufirst%3DK.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DBloom%26aufirst%3DO.%26atitle%3DHigh-mobility%2520group%2520box%25201%2520%2528hmgb1%2529%2520is%2520elevated%2520systemically%2520in%2520persons%2520with%2520acute%2520or%2520chronic%2520traumatic%2520spinal%2520cord%2520injury%26jtitle%3DJ.%2520Neurotrauma%26date%3D2017%26volume%3D34%26issue%3D3%26spage%3D746%26epage%3D754%26doi%3D10.1089%2Fneu.2016.4596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z. Q.</span></span> <span> </span><span class="NLM_article-title">High plasma levels of high mobility group box 1 is associated with the risk of sepsis in severe blunt chest trauma patients: A prospective cohort study</span>. <i>J. Cardiothorac Surg.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">133</span>, <span class="refDoi"> DOI: 10.1186/s13019-014-0133-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1186%2Fs13019-014-0133-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25085006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2cbotFSgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=133&author=X.+W.+Wangauthor=A.+Karkiauthor=X.+J.+Zhaoauthor=X.+Y.+Xiangauthor=Z.+Q.+Lu&title=High+plasma+levels+of+high+mobility+group+box+1+is+associated+with+the+risk+of+sepsis+in+severe+blunt+chest+trauma+patients%3A+A+prospective+cohort+study&doi=10.1186%2Fs13019-014-0133-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">High plasma levels of high mobility group box 1 is associated with the risk of sepsis in severe blunt chest trauma patients: a prospective cohort study</span></div><div class="casAuthors">Wang Xiao-Wen; Karki Avash; Zhao Xing-Ji; Xiang Xiao-Yong; Lu Zhi-Qian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiothoracic surgery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  High mobility group box 1 (HMGB1) is a late mediator of systemic inflammation.  Extracellular HMGB1 play a central pathogenic role in critical illness.  The purpose of the study was to investigate the association between plasma HMGB1 concentrations and the risk of poor outcomes in patients with severe blunt chest trauma.  METHODS:  The plasma concentrations of HMGB1 in patients with severe blunt chest trauma (AIS ≥ 3) were measured by a quantitative enzyme-linked immunosorbent assay at four time points during seven days after admission, and the dynamic release patterns were monitored.  The biomarker levels were compared between patients with sepsis and non-sepsis, and between patients with multiple organ dysfunction syndrome (MODS) and non-MODS.  The related factors of prognosis were analyzed by using multivariate logistic regression analysis.  The short-form 36 was used to evaluate the quality of life of patients at 12 months after injury.  RESULTS:  Plasma HMGB1 levels were significantly higher both in sepsis and MODS group on post-trauma day 3, 5, and 7 compared with the non-sepsis and non-MODS groups, respectively.  Multivariate analysis showed that HMGB1 levels and ISS were independent risk factors for sepsis and MODS in patients with severe blunt chest trauma.  CONCLUSIONS:  Plasma HMGB1 levels were significantly elevated in patients with severe blunt chest trauma.  HMGB1 levels were associated with the risk of poor outcome in patients with severe blunt chest trauma.  Daily HMGB1 levels measurements is a potential useful tool in the early identification of post-trauma complications.  Further studies are needed to determine whether HMGB1 intervention could prevent the development of sepsis and MODS in patients with severe blunt chest trauma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVpWr6ZFcPPbqxQ2mb9Pu8fW6udTcc2eb9ijQww0hE1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbotFSgsw%253D%253D&md5=48c99235dbdf665ab69fa1eb802f80f2</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1186%2Fs13019-014-0133-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13019-014-0133-5%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BW.%26aulast%3DKarki%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DX.%2BJ.%26aulast%3DXiang%26aufirst%3DX.%2BY.%26aulast%3DLu%26aufirst%3DZ.%2BQ.%26atitle%3DHigh%2520plasma%2520levels%2520of%2520high%2520mobility%2520group%2520box%25201%2520is%2520associated%2520with%2520the%2520risk%2520of%2520sepsis%2520in%2520severe%2520blunt%2520chest%2520trauma%2520patients%253A%2520A%2520prospective%2520cohort%2520study%26jtitle%3DJ.%2520Cardiothorac%2520Surg.%26date%3D2014%26volume%3D9%26spage%3D133%26doi%3D10.1186%2Fs13019-014-0133-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X. Q.</span></span> <span> </span><span class="NLM_article-title">Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury</span>. <i>Clin. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>413</i></span> (<span class="NLM_issue">21–22</span>),  <span class="NLM_fpage">1737</span>– <span class="NLM_lpage">1741</span>, <span class="refDoi"> DOI: 10.1016/j.cca.2012.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.cca.2012.07.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2012&pages=1737-1741&issue=21%E2%80%9322&author=K.+Y.+Wangauthor=G.+F.+Yuauthor=Z.+Y.+Zhangauthor=Q.+Huangauthor=X.+Q.+Dong&title=Plasma+high-mobility+group+box+1+levels+and+prediction+of+outcome+in+patients+with+traumatic+brain+injury&doi=10.1016%2Fj.cca.2012.07.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2012.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2012.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%2BY.%26aulast%3DYu%26aufirst%3DG.%2BF.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DDong%26aufirst%3DX.%2BQ.%26atitle%3DPlasma%2520high-mobility%2520group%2520box%25201%2520levels%2520and%2520prediction%2520of%2520outcome%2520in%2520patients%2520with%2520traumatic%2520brain%2520injury%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2012%26volume%3D413%26issue%3D21%25E2%2580%259322%26spage%3D1737%26epage%3D1741%26doi%3D10.1016%2Fj.cca.2012.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Au, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adelson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochanek, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. S.</span></span> <span> </span><span class="NLM_article-title">Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome c predict outcome after pediatric traumatic brain injury</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2021</span>, <span class="refDoi"> DOI: 10.1089/neu.2011.2171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1089%2Fneu.2011.2171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22540160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC38ros1KnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=2013-2021&issue=11&author=A.+K.+Auauthor=R.+K.+Anejaauthor=M.+J.+Bellauthor=H.+Bayirauthor=K.+Feldmanauthor=P.+D.+Adelsonauthor=E.+L.+Finkauthor=P.+M.+Kochanekauthor=R.+S.+Clark&title=Cerebrospinal+fluid+levels+of+high-mobility+group+box+1+and+cytochrome+c+predict+outcome+after+pediatric+traumatic+brain+injury&doi=10.1089%2Fneu.2011.2171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury</span></div><div class="casAuthors">Au Alicia K; Aneja Rajesh K; Bell Michael J; Bayir Hulya; Feldman Keri; Adelson P David; Fink Ericka L; Kochanek Patrick M; Clark Robert S B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2013-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High-mobility group box 1 (HMGB1) is a ubiquitous nuclear protein that is passively released from damaged and necrotic cells, and actively released from immune cells.  In contrast, cytochrome c is released from mitochondria in apoptotic cells, and is considered a reliable biomarker of apoptosis.  Thus, HMGB1 and cytochrome c may in part reflect the degree of necrosis and apoptosis present after traumatic brain injury (TBI), where both are felt to contribute to cell death and neurological morbidity.  Ventricular cerebrospinal fluid (CSF) was obtained from children admitted to the intensive care unit (ICU) after TBI (n=37).  CSF levels of HMGB1 and cytochrome c were determined at four time intervals (0-24 h, 25-48 h, 49-72 h, and>72 h after injury) using enzyme-linked immunosorbent assay (ELISA).  Lumbar CSF from children without TBI served as controls (n=12).  CSF HMGB1 levels were: control=1.78±0.29, 0-24 h=5.73±1.45, 25-48 h=5.16±1.73, 49-72 h=4.13±0.75,>72 h=3.80±0.90 ng/mL (mean±SEM).  Peak HMGB1 levels were inversely and independently associated with favorable Glasgow Outcome Scale (GOS) scores at 6 mo (0.49 [0.24-0.97]; OR [5-95% CI]).  CSF cytochrome c levels were: control=0.37±0.10, 0-24 h=0.69±0.15, 25-48 h=0.82±0.48, 49-72 h=1.52±1.08,>72 h=1.38±1.02 ng/mL (mean±SEM).  Peak cytochrome c levels were independently associated with abusive head trauma (AHT; 24.29 [1.77-334.03]) and inversely and independently associated with favorable GOS scores (0.42 [0.18-0.99]).  In conclusion, increased CSF levels of HMGB1 and cytochrome c were associated with poor outcome after TBI in infants and children.  These data are also consistent with the designation of HMGB1 as a "danger signal." Distinctly increased CSF cytochrome c levels in infants and children with AHT and poor outcome suggests that apoptosis may play an important role in this unique patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVK9662BJ2E7rIbt-tGZmxfW6udTcc2eZm-RNrKToep7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38ros1KnsA%253D%253D&md5=ac3f4f7ddeeaef02f059952fb14ea97d</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1089%2Fneu.2011.2171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2011.2171%26sid%3Dliteratum%253Aachs%26aulast%3DAu%26aufirst%3DA.%2BK.%26aulast%3DAneja%26aufirst%3DR.%2BK.%26aulast%3DBell%26aufirst%3DM.%2BJ.%26aulast%3DBayir%26aufirst%3DH.%26aulast%3DFeldman%26aufirst%3DK.%26aulast%3DAdelson%26aufirst%3DP.%2BD.%26aulast%3DFink%26aufirst%3DE.%2BL.%26aulast%3DKochanek%26aufirst%3DP.%2BM.%26aulast%3DClark%26aufirst%3DR.%2BS.%26atitle%3DCerebrospinal%2520fluid%2520levels%2520of%2520high-mobility%2520group%2520box%25201%2520and%2520cytochrome%2520c%2520predict%2520outcome%2520after%2520pediatric%2520traumatic%2520brain%2520injury%26jtitle%3DJ.%2520Neurotrauma%26date%3D2012%26volume%3D29%26issue%3D11%26spage%3D2013%26epage%3D2021%26doi%3D10.1089%2Fneu.2011.2171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span> <span> </span><span class="NLM_article-title">Heparin inhibits the inflammatory response induced by lps and hmgb1 by blocking the binding of hmgb1 to the surface of macrophages</span>. <i>Cytokine</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2014.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.cyto.2014.12.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2015&pages=36-42&issue=1&author=L.+Liauthor=Y.+Lingauthor=M.+Huangauthor=T.+Yinauthor=S.+M.+Gouauthor=N.+Y.+Zhanauthor=J.+X.+Xiongauthor=H.+S.+Wuauthor=Z.+Y.+Yangauthor=C.+Y.+Wang&title=Heparin+inhibits+the+inflammatory+response+induced+by+lps+and+hmgb1+by+blocking+the+binding+of+hmgb1+to+the+surface+of+macrophages&doi=10.1016%2Fj.cyto.2014.12.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2014.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2014.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DT.%26aulast%3DGou%26aufirst%3DS.%2BM.%26aulast%3DZhan%26aufirst%3DN.%2BY.%26aulast%3DXiong%26aufirst%3DJ.%2BX.%26aulast%3DWu%26aufirst%3DH.%2BS.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DWang%26aufirst%3DC.%2BY.%26atitle%3DHeparin%2520inhibits%2520the%2520inflammatory%2520response%2520induced%2520by%2520lps%2520and%2520hmgb1%2520by%2520blocking%2520the%2520binding%2520of%2520hmgb1%2520to%2520the%2520surface%2520of%2520macrophages%26jtitle%3DCytokine%26date%3D2015%26volume%3D72%26issue%3D1%26spage%3D36%26epage%3D42%26doi%3D10.1016%2Fj.cyto.2014.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Opal, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laterre, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francois, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRosa, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angus, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mira, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittebole, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugernier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrotin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidswell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jauregui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peckelsen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordasco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalil, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nuffelen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossignol, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogate, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. L.</span></span> <span> </span><span class="NLM_article-title">Effect of eritoran, an antagonist of md2-tlr4, on mortality in patients with severe sepsis: The access randomized trial</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>309</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1154</span>– <span class="NLM_lpage">1162</span>, <span class="refDoi"> DOI: 10.1001/jama.2013.2194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1001%2Fjama.2013.2194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23512062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltlyqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2013&pages=1154-1162&issue=11&author=S.+M.+Opalauthor=P.+F.+Laterreauthor=B.+Francoisauthor=S.+P.+LaRosaauthor=D.+C.+Angusauthor=J.+P.+Miraauthor=X.+Witteboleauthor=T.+Dugernierauthor=D.+Perrotinauthor=M.+Tidswellauthor=L.+Jaureguiauthor=K.+Krellauthor=J.+Pachlauthor=T.+Takahashiauthor=C.+Peckelsenauthor=E.+Cordascoauthor=C.+S.+Changauthor=S.+Oeyenauthor=N.+Aikawaauthor=T.+Maruyamaauthor=R.+Scheinauthor=A.+C.+Kalilauthor=M.+Van+Nuffelenauthor=M.+Lynnauthor=D.+P.+Rossignolauthor=J.+Gogateauthor=M.+B.+Robertsauthor=J.+L.+Wheelerauthor=J.+L.+Vincent&title=Effect+of+eritoran%2C+an+antagonist+of+md2-tlr4%2C+on+mortality+in+patients+with+severe+sepsis%3A+The+access+randomized+trial&doi=10.1001%2Fjama.2013.2194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis. The ACCESS randomized trial</span></div><div class="casAuthors">Opal, Steven M.; Laterre, Pierre-Francois; Francois, Bruno; LaRosa, Steven P.; Angus, Derek C.; Mira, Jean-Paul; Wittebole, Xavier; Dugernier, Thierry; Perrotin, Dominique; Tidswell, Mark; Jauregui, Luis; Krell, Kenneth; Pachl, Jan; Takahashi, Takeshi; Peckelsen, Claus; Cordasco, Edward; Chang, Chia-Sheng; Oeyen, Sandra; Aikawa, Naoki; Maruyama, Tatsuya; Schein, Roland; Kalil, Andre C.; Van Nuffelen, Marc; Lynn, Melvyn; Rossignol, Daniel P.; Gogate, Jogadish; Roberts, Mary B.; Wheeler, Janice L.; Vincent, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1154-1162</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Importance: Eritoran is a synthetic lipid A antagonist that blocks Iipopolysaccharide (LPS) from binding at the cell surface MD2-TLR4 receptor.  LPS is a major component of the outer membrane of gram-neg. bacteria and is a potent activator of the acute inflammatory response.  Objective: To det. if eritoran, a TLR4 antagonist, would significantly reduce sepsis-induced mortality.  Design, Setting, and Participants: We performed a randomized, double-blind, placebo-controlled, multinational phase 3 trial in 197 intensive care units.  Patients were enrolled from June 2006 to Sept. 2010 and final follow-up was completed in Sept. 2011.  Interventions: Patients with severe sepsis (n = 1961) were randomized and treated within 12 h of onset of first organ dysfunction in a 2:1 ratio with a 6-day course of either eritoran tetrasodium (105 mg total) or placebo, with n = 1304 and n = 657 patients, resp.  Main Outcome Measures: The primary end point was 28-day all-cause mortality.  The secondary end points were all-cause mortality at 3, 6, and 12 mo after beginning treatment.  Results: Baseline characteristics of the 2 study groups were similar.  In the modified intent-to-treat anal. (randomized patients who received at least 1 dose) there was no significant difference in the primary end point of 28-day all-cause mortality with 28.1% (366/1304) in the eritoran group vs 26.9% (177/657) in the placebo group (P = .59; hazard ratio, 1.05; 95% CI, 0.88-1.26; difference in mortality rate, -1.1; 95% CI, -5.3 to 3.1) or in the key secondary end point of 1-yr all-cause mortality with 44.1% (290/657) in the eritoran group vs 43.3% (565/1304) in the placebo group, Kaplan-Meier anal. of time to death by 1 yr, P = .79 (hazard ratio, 0.98; 0.85-1.13).  No significant differences were obsd. in any of the prespecified subgroups.  Adverse events, including secondary infection rates, did not differ between study groups.  Conclusions and Relevance: Among patients with severe sepsis, the use of eritoran, compared with placebo, did not result in reduced 28-day mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrbHqr8OtY8bVg90H21EOLACvtfcHk0ljOVGqstUSsWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltlyqt7o%253D&md5=adf1d02bc28953d8e6b30e9d627fcfa9</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1001%2Fjama.2013.2194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2013.2194%26sid%3Dliteratum%253Aachs%26aulast%3DOpal%26aufirst%3DS.%2BM.%26aulast%3DLaterre%26aufirst%3DP.%2BF.%26aulast%3DFrancois%26aufirst%3DB.%26aulast%3DLaRosa%26aufirst%3DS.%2BP.%26aulast%3DAngus%26aufirst%3DD.%2BC.%26aulast%3DMira%26aufirst%3DJ.%2BP.%26aulast%3DWittebole%26aufirst%3DX.%26aulast%3DDugernier%26aufirst%3DT.%26aulast%3DPerrotin%26aufirst%3DD.%26aulast%3DTidswell%26aufirst%3DM.%26aulast%3DJauregui%26aufirst%3DL.%26aulast%3DKrell%26aufirst%3DK.%26aulast%3DPachl%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DPeckelsen%26aufirst%3DC.%26aulast%3DCordasco%26aufirst%3DE.%26aulast%3DChang%26aufirst%3DC.%2BS.%26aulast%3DOeyen%26aufirst%3DS.%26aulast%3DAikawa%26aufirst%3DN.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DSchein%26aufirst%3DR.%26aulast%3DKalil%26aufirst%3DA.%2BC.%26aulast%3DVan%2BNuffelen%26aufirst%3DM.%26aulast%3DLynn%26aufirst%3DM.%26aulast%3DRossignol%26aufirst%3DD.%2BP.%26aulast%3DGogate%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DM.%2BB.%26aulast%3DWheeler%26aufirst%3DJ.%2BL.%26aulast%3DVincent%26aufirst%3DJ.%2BL.%26atitle%3DEffect%2520of%2520eritoran%252C%2520an%2520antagonist%2520of%2520md2-tlr4%252C%2520on%2520mortality%2520in%2520patients%2520with%2520severe%2520sepsis%253A%2520The%2520access%2520randomized%2520trial%26jtitle%3DJAMA%26date%3D2013%26volume%3D309%26issue%3D11%26spage%3D1154%26epage%3D1162%26doi%3D10.1001%2Fjama.2013.2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perrin-Cocon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aublin-Gex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sestito, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirey, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotteau, V.</span></span> <span> </span><span class="NLM_article-title">Tlr4 antagonist fp7 inhibits lps-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">40791</span>, <span class="refDoi"> DOI: 10.1038/srep40791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fsrep40791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28106157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFalsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=40791&author=L.+Perrin-Coconauthor=A.+Aublin-Gexauthor=S.+E.+Sestitoauthor=K.+A.+Shireyauthor=M.+C.+Patelauthor=P.+Andreauthor=J.+C.+Blancoauthor=S.+N.+Vogelauthor=F.+Periauthor=V.+Lotteau&title=Tlr4+antagonist+fp7+inhibits+lps-induced+cytokine+production+and+glycolytic+reprogramming+in+dendritic+cells%2C+and+protects+mice+from+lethal+influenza+infection&doi=10.1038%2Fsrep40791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection</span></div><div class="casAuthors">Perrin-Cocon, Laure; Aublin-Gex, Anne; Sestito, Stefania E.; Shirey, Kari Ann; Patel, Mira C.; Andre, Patrice; Blanco, Jorge C.; Vogel, Stefanie N.; Peri, Francesco; Lotteau, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">40791</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dysregulated Toll-like receptor (TLR)-4 activation is involved in acute systemic sepsis, chronic inflammatory diseases, such as atherosclerosis and diabetes, and in viral infections, such as influenza infection.  Thus, therapeutic control of the TLR4 signalling pathway is of major interest.  Here we tested the activity of the small-mol. synthetic TLR4 antagonist, FP7, in vitro on human monocytes and monocyte-derived dendritic cells (DCs) and in vivo during influenza virus infection of mice.  Our results indicate that FP7 antagonized the secretion of proinflammatory cytokines (IL-6, IL-8, and MIP-1β) by monocytes and DCs (IC50 < 1 μM) and prevented DC maturation upon TLR4 activation by ultrapure lipopolysaccharide (LPS).  FP7 selectively blocked TLR4 stimulation, but not TLR1/2, TLR2/6, or TLR3 activation.  TLR4 stimulation of human DCs resulted in increased glycolytic activity that was also antagonized by FP7.  FP7 protected mice from influenza virus-induced lethality and reduced both proinflammatory cytokine gene expression in the lungs and acute lung injury (ALI).  Therefore, FP7 can antagonize TLR4 activation in vitro and protect mice from severe influenza infection, most likely by reducing TLR4-dependent cytokine storm mediated by damage-assocd. mol. patterns (DAMPs) like HMGB1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8FTFfz6-_h7Vg90H21EOLACvtfcHk0lhwoOBw8Sl4dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFalsbg%253D&md5=827f7dc6b699b416341bb3a627b817a7</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1038%2Fsrep40791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep40791%26sid%3Dliteratum%253Aachs%26aulast%3DPerrin-Cocon%26aufirst%3DL.%26aulast%3DAublin-Gex%26aufirst%3DA.%26aulast%3DSestito%26aufirst%3DS.%2BE.%26aulast%3DShirey%26aufirst%3DK.%2BA.%26aulast%3DPatel%26aufirst%3DM.%2BC.%26aulast%3DAndre%26aufirst%3DP.%26aulast%3DBlanco%26aufirst%3DJ.%2BC.%26aulast%3DVogel%26aufirst%3DS.%2BN.%26aulast%3DPeri%26aufirst%3DF.%26aulast%3DLotteau%26aufirst%3DV.%26atitle%3DTlr4%2520antagonist%2520fp7%2520inhibits%2520lps-induced%2520cytokine%2520production%2520and%2520glycolytic%2520reprogramming%2520in%2520dendritic%2520cells%252C%2520and%2520protects%2520mice%2520from%2520lethal%2520influenza%2520infection%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D40791%26doi%3D10.1038%2Fsrep40791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, L. A.</span></span> <span> </span><span class="NLM_article-title">Targeting toll-like receptors: Emerging therapeutics?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1038/nrd3203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1038%2Fnrd3203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=20380038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksF2itb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=293-307&issue=4&author=E.+J.+Hennessyauthor=A.+E.+Parkerauthor=L.+A.+O%E2%80%99Neill&title=Targeting+toll-like+receptors%3A+Emerging+therapeutics%3F&doi=10.1038%2Fnrd3203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Toll-like receptors: emerging therapeutics?</span></div><div class="casAuthors">Hennessy, Elizabeth J.; Parker, Andrew E.; O'Neill, Luke A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-307</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a growing interest in the targeting of Toll-like receptors (TLRs) for the prevention and treatment of cancer, rheumatoid arthritis, inflammatory bowel disease and systemic lupus erythematosus (SLE).  Several new compds. are now undergoing preclin. and clin. evaluation, with a particular focus on TLR7 and TLR9 activators as adjuvants in infection and cancer, and inhibitors of TLR2, TLR4, TLR7 and TLR9 for the treatment of sepsis and inflammatory diseases.  Here, we focus on TLRs that hold the most promise for drug discovery research, highlighting agents that are in the discovery phase and in clin. trials, and on the emerging new aspects of TLR-mediated signaling - such as control by ubiquitination and regulation by microRNAs - that might offer further possibilities of therapeutic manipulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHrGGa9XDou7Vg90H21EOLACvtfcHk0ljBigO0_yqnFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksF2itb4%253D&md5=ed2da43668217c9d470f5a53dd214708</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fnrd3203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3203%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DParker%26aufirst%3DA.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520toll-like%2520receptors%253A%2520Emerging%2520therapeutics%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26issue%3D4%26spage%3D293%26epage%3D307%26doi%3D10.1038%2Fnrd3203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anwar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Tlr4/md2 specific peptides stalled in vivo lps-induced immune exacerbation</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2017.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.biomaterials.2017.02.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28254693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Sjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=49-60&author=S.+Parkauthor=H.+J.+Shinauthor=M.+Shahauthor=H.+Y.+Choauthor=M.+A.+Anwarauthor=A.+Achekauthor=H.+K.+Kwonauthor=B.+Leeauthor=T.+H.+Yooauthor=S.+Choi&title=Tlr4%2Fmd2+specific+peptides+stalled+in+vivo+lps-induced+immune+exacerbation&doi=10.1016%2Fj.biomaterials.2017.02.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation</span></div><div class="casAuthors">Park, Seolhee; Shin, Hyeon-Jun; Shah, Masaud; Cho, Hey-Young; Anwar, Muhammad Ayaz; Achek, Asma; Kwon, Hyuk-Kwon; Lee, Byugsung; Yoo, Tae Hyeon; Choi, Sangdun</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Neg. regulation of Toll-like receptor-4 (TLR4) is anticipated to control the pathogen-induced exaggerated immune response.  However, effective TLR4 antagonists with scarce off-target effects are yet to be developed.  To fill this void, we sought to design small peptide-inhibitors of the TLR4/MD2-LPS interaction.  Here we report novel TLR4-antagonistic peptides (TAP), identified through phage display, endowed with the LPS-induced proinflammation inhibition, and confirmed in mice.  TAPs-attributed TLR4-antagonism were initially evaluated through NF-κB inhibition in HEK-blue hTLR4 and RAW264.7 cells, and further reinforced by the downregulation of MAPKs (mitogen-activated protein kinases), NF-κB, interleukin 6, and suppression of the oxidative-stress products and iNOS in macrophages and human peripheral blood mononuclear cells (hPBMCs).  Among these, TAP2 specifically halted the TLR4, but not other TLRs signaling, which was further confirmed by the biophys. kinetic assay.  Finally, TAP2 diminished LPS-elicited systemic cytokine response in vivo, suggesting that TAPs, specifically TAP2, have the potential to treat TLR4-mediated immune ailments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL_NlzP0ZTSbVg90H21EOLACvtfcHk0liJ8vVWusaQ4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Sjsr0%253D&md5=8a141d68f7dd155954e6007addc0a6f9</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2017.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2017.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%26aulast%3DShin%26aufirst%3DH.%2BJ.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DH.%2BY.%26aulast%3DAnwar%26aufirst%3DM.%2BA.%26aulast%3DAchek%26aufirst%3DA.%26aulast%3DKwon%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DYoo%26aufirst%3DT.%2BH.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DTlr4%252Fmd2%2520specific%2520peptides%2520stalled%2520in%2520vivo%2520lps-induced%2520immune%2520exacerbation%26jtitle%3DBiomaterials%26date%3D2017%26volume%3D126%26spage%3D49%26epage%3D60%26doi%3D10.1016%2Fj.biomaterials.2017.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youn, H. S.</span></span> <span> </span><span class="NLM_article-title">Suppression of toll-like receptor 4 dimerization by 1-[5-methoxy-2-(2-nitrovinyl)phenyl]pyrrolidine</span>. <i>Arch. Pharm. (Weinheim, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>349</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">785</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1002/ardp.201600159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Fardp.201600159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27515124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlagtbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2016&pages=785-790&issue=10&author=S.+I.+Ahnauthor=J.+S.+Kimauthor=G.+J.+Guauthor=H.+M.+Shinauthor=A.+Y.+Kimauthor=H.+J.+Shimauthor=Y.+J.+Kimauthor=K.+O.+Kohauthor=J.+Y.+Mangauthor=D.+Y.+Kimauthor=H.+S.+Youn&title=Suppression+of+toll-like+receptor+4+dimerization+by+1-%5B5-methoxy-2-%282-nitrovinyl%29phenyl%5Dpyrrolidine&doi=10.1002%2Fardp.201600159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of toll-like receptor 4 dimerization by 1-[5-methoxy-2-(2-nitrovinyl)phenyl]pyrrolidine</span></div><div class="casAuthors">Ahn, Sang-Il; Kim, Ji-Soo; Gu, Gyo-Jeong; Shin, Hyeon-Myeong; Kim, Ah-Yeon; Shim, Hyun-Jin; Kim, Yeon Joo; Koh, Kwang Oh; Mang, Joo Yang; Kim, Dae Young; Youn, Hyung-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">785-790</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Toll-like receptor 4 (TLR4) recognizes lipopolysaccharide (LPS) and triggers the activation of myeloid differentiation factor 88 (MyD88) and the Toll/interleukin-1 receptor domain-contg. adapter, inducing interferon-β (TRIF)-dependent major downstream signaling pathways.  To evaluate the therapeutic potential of 1-[5-methoxy-2-(2-nitrovinyl)phenyl]pyrrolidine (MNP), previously synthesized in our lab., its effect on signal transduction via the TLR signaling pathways was examd.  Here, we investigated whether MNP modulates the TLR4 signaling pathways and which anti-inflammatory target in TLR4 signaling is regulated by MNP.  MNP inhibited the activation of nuclear factor-κB (NF-κB) induced by LPS (TLR4 agonist), and it also inhibited the expression of cyclooxygenase-2 and inducible nitric oxide synthase.  MNP inhibited LPS-induced NF-κB activation by targeting TLR4 dimerization in addn. to IKKβ.  These results suggest that MNP can modulate the TLR4 signaling pathway at the receptor level to decrease inflammatory gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohrUKFSNZjpbVg90H21EOLACvtfcHk0liJ8vVWusaQ4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlagtbjF&md5=6a5444b461ed0cb3aac30aa415efabcc</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1002%2Fardp.201600159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201600159%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DS.%2BI.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DGu%26aufirst%3DG.%2BJ.%26aulast%3DShin%26aufirst%3DH.%2BM.%26aulast%3DKim%26aufirst%3DA.%2BY.%26aulast%3DShim%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DKoh%26aufirst%3DK.%2BO.%26aulast%3DMang%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DD.%2BY.%26aulast%3DYoun%26aufirst%3DH.%2BS.%26atitle%3DSuppression%2520of%2520toll-like%2520receptor%25204%2520dimerization%2520by%25201-%255B5-methoxy-2-%25282-nitrovinyl%2529phenyl%255Dpyrrolidine%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2016%26volume%3D349%26issue%3D10%26spage%3D785%26epage%3D790%26doi%3D10.1002%2Fardp.201600159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aletaha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roozbehkia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigdeli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asgary, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmoudi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirshafiey, A.</span></span> <span> </span><span class="NLM_article-title">M2000 (beta-d-mannuronic acid) as a novel antagonist for blocking the tlr2 and tlr4 downstream signalling pathway</span>. <i>Scand J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1111/sji.12519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fsji.12519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27943385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1SktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2017&pages=122-129&issue=2&author=S.+Aletahaauthor=L.+Haddadauthor=M.+Roozbehkiaauthor=R.+Bigdeliauthor=V.+Asgaryauthor=M.+Mahmoudiauthor=A.+Mirshafiey&title=M2000+%28beta-d-mannuronic+acid%29+as+a+novel+antagonist+for+blocking+the+tlr2+and+tlr4+downstream+signalling+pathway&doi=10.1111%2Fsji.12519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway</span></div><div class="casAuthors">Aletaha, S.; Haddad, L.; Roozbehkia, M.; Bigdeli, R.; Asgary, V.; Mahmoudi, M.; Mirshafiey, A.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">122-129</span>CODEN:
                <span class="NLM_cas:coden">SJIMAX</span>;
        ISSN:<span class="NLM_cas:issn">1365-3083</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">To date, selective blockade of Toll-like receptor (TLR) signalling has been developed as a new approach for treatment for many inflammatory diseases.  As β-D-mannuronic acid (M2000) has been known as an anti-inflammatory mol. in several exptl. models, we investigated the antagonistic effects of M2000 on TLR2 and TLR4 downstream signalling transduction pathway in human embryonic kidney (HEK) 293 cell lines overexpressing TLR2/CD14 and the TLR4/MD2/CD14 complex, resp.  M2000 effectively inhibited mRNA expression of MyD88 and p65, major subunit of nuclear factor-κB, in HEK293 cells stimulated by lipoteichoic acid (LTA, a TLR2 agonist) and lipopolysaccharide (LPS, a TLR4 agonist) with no evidence of cytotoxicity.  In addn., M2000 also suppressed LTA and LPS-induced prodn. of TNF-α and IL-6 inflammatory cytokines in these cells.  Furthermore, the results revealed that M2000 had no significant effect on Tollip mRNA expression as a neg. regulator of TLR signalling in aforesaid cells.  Overall, these data point to M2000 inhibitory effect on Toll-like receptor (TLR) 2, 4 signalling in HEK293 cells.  This information might provide new insights into the possible roles of this small drug in order to introduce it as a TLR signalling pathway inhibitor.  However, more studies are needed to confirm β-D-mannuronic acid antagonistic effects including the effects of M2000 on peritoneal isolated macrophages and also on blood cells in patients with inflammatory diseases such as ankylosing spondylitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnOdZm4x-q7Vg90H21EOLACvtfcHk0lgBSSsIbygDIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1SktLk%253D&md5=5955ebeb7da9f04072f8146d6d836559</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1111%2Fsji.12519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fsji.12519%26sid%3Dliteratum%253Aachs%26aulast%3DAletaha%26aufirst%3DS.%26aulast%3DHaddad%26aufirst%3DL.%26aulast%3DRoozbehkia%26aufirst%3DM.%26aulast%3DBigdeli%26aufirst%3DR.%26aulast%3DAsgary%26aufirst%3DV.%26aulast%3DMahmoudi%26aufirst%3DM.%26aulast%3DMirshafiey%26aufirst%3DA.%26atitle%3DM2000%2520%2528beta-d-mannuronic%2520acid%2529%2520as%2520a%2520novel%2520antagonist%2520for%2520blocking%2520the%2520tlr2%2520and%2520tlr4%2520downstream%2520signalling%2520pathway%26jtitle%3DScand%2520J.%2520Immunol.%26date%3D2017%26volume%3D85%26issue%3D2%26spage%3D122%26epage%3D129%26doi%3D10.1111%2Fsji.12519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Regidor, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarioh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Santamaria, S.</span></span> <span> </span><span class="NLM_article-title">Virtual screening approaches towards the discovery of toll-like receptor modulators</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1508</span>, <span class="refDoi"> DOI: 10.3390/ijms17091508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3390%2Fijms17091508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1508&issue=9&author=L.+Perez-Regidorauthor=M.+Zariohauthor=L.+Ortegaauthor=S.+Martin-Santamaria&title=Virtual+screening+approaches+towards+the+discovery+of+toll-like+receptor+modulators&doi=10.3390%2Fijms17091508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.3390%2Fijms17091508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17091508%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Regidor%26aufirst%3DL.%26aulast%3DZarioh%26aufirst%3DM.%26aulast%3DOrtega%26aufirst%3DL.%26aulast%3DMartin-Santamaria%26aufirst%3DS.%26atitle%3DVirtual%2520screening%2520approaches%2520towards%2520the%2520discovery%2520of%2520toll-like%2520receptor%2520modulators%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26issue%3D9%26spage%3D1508%26doi%3D10.3390%2Fijms17091508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Billod, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacetera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Caldentey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Santamaria, S.</span></span> <span> </span><span class="NLM_article-title">Computational approaches to toll-like receptor 4 modulation</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">994</span>, <span class="refDoi"> DOI: 10.3390/molecules21080994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3390%2Fmolecules21080994" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=994&issue=8&author=J.+M.+Billodauthor=A.+Laceteraauthor=J.+Guzman-Caldenteyauthor=S.+Martin-Santamaria&title=Computational+approaches+to+toll-like+receptor+4+modulation&doi=10.3390%2Fmolecules21080994"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21080994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21080994%26sid%3Dliteratum%253Aachs%26aulast%3DBillod%26aufirst%3DJ.%2BM.%26aulast%3DLacetera%26aufirst%3DA.%26aulast%3DGuzman-Caldentey%26aufirst%3DJ.%26aulast%3DMartin-Santamaria%26aufirst%3DS.%26atitle%3DComputational%2520approaches%2520to%2520toll-like%2520receptor%25204%2520modulation%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26issue%3D8%26spage%3D994%26doi%3D10.3390%2Fmolecules21080994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galasko, D.</span></span> <span> </span><span class="NLM_article-title">Pf-04494700, an oral inhibitor of receptor for advanced glycation end products (rage), in alzheimer disease</span>. <i>Alzheimer Dis. Assoc. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1097/WAD.0b013e318204b550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1097%2FWAD.0b013e318204b550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=21192237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2hurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=206-212&issue=3&author=M.+N.+Sabbaghauthor=A.+Agroauthor=J.+Bellauthor=P.+S.+Aisenauthor=E.+Schweizerauthor=D.+Galasko&title=Pf-04494700%2C+an+oral+inhibitor+of+receptor+for+advanced+glycation+end+products+%28rage%29%2C+in+alzheimer+disease&doi=10.1097%2FWAD.0b013e318204b550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease</span></div><div class="casAuthors">Sabbagh, Marwan N.; Agro, Albert; Bell, Joanne; Aisen, Paul S.; Schweizer, Edward; Galasko, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-212</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To evaluate the safety and tolerability of PF-04494700, an oral inhibitor of receptor for advanced glycation end products, in patients with mild-to-moderate dementia of the Alzheimer type.  Patients aged 50 years and older who met the National Institute of Neurol. and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Assocn. criteria for Alzheimer disease with an Mini-Mental State Examn. (MMSE) score between 12 and 26 (inclusive) were randomized to 10 wk of double-blind treatment with either a 10 mg "low dose" of PF-04494700 (after a 6-d loading dose of 30 mg/d), a 20 mg "high dose" of PF-04494700 (after a loading dose of 60 mg/d), or placebo.  Safety measures included adverse events, lab. tests, vital signs, and 12-lead ECG.  27 Patients received PF-04494700 30/co mg (female: 63%; mean age: 74.6 y; mean MMSE: 21.1), 28 patients received PF-04494700 60/20 mg (female: 57%; mean age: 76.6 y; mean MMSE: 21.6), and 12 patients received placebo (female: 67%; mean age: 74.1 y; mean MMSE: 19.2).  A higher proportion of patients completed 10 wk of double-blind treatment on both the "low-dose" regimen of PF-04494700 (88.9%) and the "high-dose" regimen (85.7%) than patients who were on placebo (66.7%).  Discontinuation owing to adverse events and incidence of severe adverse events, resp., were lower in the "low-dose" regimen (7.4%, 11.1%) and the "high-dose" regimen (3.6%, 10.7%) compared with placebo (25.0%, 16.7%).  There were no clin. meaningful differences in vital signs, lab. test results, or mean ECG parameters in patients treated with PF-04494700.  PF-04494700 had no consistent effect on plasma levels of β-amyloid, inflammatory biomarkers, or secondary cognitive outcomes.  Ten weeks of treatment with PF-04494700 was safe and well tolerated in patients with mild-to-moderate Alzheimer disease, indicating the feasibility of a larger long-term efficacy trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYOId4vbstBLVg90H21EOLACvtfcHk0liYDkFadRuSEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2hurfL&md5=99a792014511f247fe283378d8503ceb</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1097%2FWAD.0b013e318204b550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWAD.0b013e318204b550%26sid%3Dliteratum%253Aachs%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26aulast%3DAgro%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DJ.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DGalasko%26aufirst%3DD.%26atitle%3DPf-04494700%252C%2520an%2520oral%2520inhibitor%2520of%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520%2528rage%2529%252C%2520in%2520alzheimer%2520disease%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2011%26volume%3D25%26issue%3D3%26spage%3D206%26epage%3D212%26doi%3D10.1097%2FWAD.0b013e318204b550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seripa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solfrizzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbimbo, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozupone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagliardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lofano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creanza, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisceglia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellomo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logroscino, G.</span></span> <span> </span><span class="NLM_article-title">Emerging drugs to reduce abnormal beta-amyloid protein in Alzheimer’s disease patients</span>. <i>Expert Opin. Emerging Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">391</span>, <span class="refDoi"> DOI: 10.1080/14728214.2016.1241232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1080%2F14728214.2016.1241232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=27678025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GqsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=377-391&issue=4&author=F.+Panzaauthor=D.+Seripaauthor=V.+Solfrizziauthor=B.+P.+Imbimboauthor=M.+Lozuponeauthor=A.+Leoauthor=R.+Sardoneauthor=G.+Gagliardiauthor=L.+Lofanoauthor=B.+C.+Creanzaauthor=P.+Biscegliaauthor=A.+Danieleauthor=A.+Bellomoauthor=A.+Grecoauthor=G.+Logroscino&title=Emerging+drugs+to+reduce+abnormal+beta-amyloid+protein+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1080%2F14728214.2016.1241232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients</span></div><div class="casAuthors">Panza, Francesco; Seripa, Davide; Solfrizzi, Vincenzo; Imbimbo, Bruno P.; Lozupone, Madia; Leo, Antonio; Sardone, Rodolfo; Gagliardi, Gaetano; Lofano, Lucia; Creanza, Bianca C.; Bisceglia, Paola; Daniele, Antonio; Bellomo, Antonello; Greco, Antonio; Logroscino, Giancarlo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-391</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Currently available drugs against Alzheimer's disease (AD) target cholinergic and glutamatergic neurotransmissions without affecting the underlying disease process.  Putative disease-modifying drugs are in development and target β-amyloid (Aβ) peptide and tau protein, the principal neurophatol. hallmarks of the disease.  Phase III clin. studies of emerging anti-Aβ drugs for the treatment of AD were searched in US and EU clin. trial registries and in the medical literature until May 2016.  Drugs in Phase III clin. development for AD include one inhibitor of the β-secretase cleaving enzyme (BACE) (verubecestat), three anti-Aβ monoclonal antibodies (solanezumab, gantenerumab, and aducanumab), an inhibitor of receptor for advanced glycation end products (RAGE) (azeliragon) and the combination of cromolyn sodium and ibuprofen (ALZT-OP1).  These drugs are mainly being tested in subjects during early phases of AD or in subjects at preclin. stage of familial AD or even in asymptomatic subjects at high risk of developing AD.  The hope is to intervene in the disease process when it is not too late.  However, previous clin. failures with anti-Aβ drugs and the lack of fully understanding of the pathophysiol. role of Aβ in the development of AD, put the new drugs at substantial risk of failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosj9ZA53CLV7Vg90H21EOLACvtfcHk0lg7aHhw85HxPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GqsLzE&md5=21f712334120698ea46f008b4f9e62c0</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1080%2F14728214.2016.1241232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728214.2016.1241232%26sid%3Dliteratum%253Aachs%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DSeripa%26aufirst%3DD.%26aulast%3DSolfrizzi%26aufirst%3DV.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DLozupone%26aufirst%3DM.%26aulast%3DLeo%26aufirst%3DA.%26aulast%3DSardone%26aufirst%3DR.%26aulast%3DGagliardi%26aufirst%3DG.%26aulast%3DLofano%26aufirst%3DL.%26aulast%3DCreanza%26aufirst%3DB.%2BC.%26aulast%3DBisceglia%26aufirst%3DP.%26aulast%3DDaniele%26aufirst%3DA.%26aulast%3DBellomo%26aufirst%3DA.%26aulast%3DGreco%26aufirst%3DA.%26aulast%3DLogroscino%26aufirst%3DG.%26atitle%3DEmerging%2520drugs%2520to%2520reduce%2520abnormal%2520beta-amyloid%2520protein%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D377%26epage%3D391%26doi%3D10.1080%2F14728214.2016.1241232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deane, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagare, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deane, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiyagarajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarcone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">A multimodal rage-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of alzheimer disease</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1377</span>– <span class="NLM_lpage">1392</span>, <span class="refDoi"> DOI: 10.1172/JCI58642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1172%2FJCI58642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=1377-1392&issue=4&author=R.+Deaneauthor=I.+Singhauthor=A.+P.+Sagareauthor=R.+D.+Bellauthor=N.+T.+Rossauthor=B.+LaRueauthor=R.+Loveauthor=S.+Perryauthor=N.+Paquetteauthor=R.+J.+Deaneauthor=M.+Thiyagarajanauthor=T.+Zarconeauthor=G.+Fritzauthor=A.+E.+Friedmanauthor=B.+L.+Millerauthor=B.+V.+Zlokovic&title=A+multimodal+rage-specific+inhibitor+reduces+amyloid+beta-mediated+brain+disorder+in+a+mouse+model+of+alzheimer+disease&doi=10.1172%2FJCI58642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1172%2FJCI58642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI58642%26sid%3Dliteratum%253Aachs%26aulast%3DDeane%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DI.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DBell%26aufirst%3DR.%2BD.%26aulast%3DRoss%26aufirst%3DN.%2BT.%26aulast%3DLaRue%26aufirst%3DB.%26aulast%3DLove%26aufirst%3DR.%26aulast%3DPerry%26aufirst%3DS.%26aulast%3DPaquette%26aufirst%3DN.%26aulast%3DDeane%26aufirst%3DR.%2BJ.%26aulast%3DThiyagarajan%26aufirst%3DM.%26aulast%3DZarcone%26aufirst%3DT.%26aulast%3DFritz%26aufirst%3DG.%26aulast%3DFriedman%26aufirst%3DA.%2BE.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DA%2520multimodal%2520rage-specific%2520inhibitor%2520reduces%2520amyloid%2520beta-mediated%2520brain%2520disorder%2520in%2520a%2520mouse%2520model%2520of%2520alzheimer%2520disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26issue%3D4%26spage%3D1377%26epage%3D1392%26doi%3D10.1172%2FJCI58642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokkola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aveberger, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmblad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span> <span> </span><span class="NLM_article-title">Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2052</span>– <span class="NLM_lpage">2058</span>, <span class="refDoi"> DOI: 10.1002/art.11161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1002%2Fart.11161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=12847700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFartbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=2052-2058&issue=7&author=R.+Kokkolaauthor=J.+Liauthor=E.+Sundbergauthor=A.+C.+Avebergerauthor=K.+Palmbladauthor=H.+Yangauthor=K.+J.+Traceyauthor=U.+Anderssonauthor=H.+E.+Harris&title=Successful+treatment+of+collagen-induced+arthritis+in+mice+and+rats+by+targeting+extracellular+high+mobility+group+box+chromosomal+protein+1+activity&doi=10.1002%2Fart.11161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity</span></div><div class="casAuthors">Kokkola, R.; Li, J.; Sundberg, E.; Aveberger, A.-C.; Palmblad, K.; Yang, H.; Tracey, K. J.; Andersson, U.; Harris, H. Erlandsson</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2052-2058</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective.  Extracellular high mobility group box chromosomal protein 1 (HMGB-1) is a recently identified, endogenous, potent tumor necrosis factor- and interleukin-1 (IL-1)-inducing protein detectable in inflamed synovia in both human and exptl. disease.  In the present study, the authors examd. clin. effects in collagen-induced arthritis (CIA) using therapeutic administration of neutralizing HMGB-1 antibodies or truncated HMGB-1-derived A-box protein, a specific, competitive antagonist of HMGB-1.  Methods.  CIA was induced in DBA/1j mice or dark agouti rats, and animals were examd. daily for signs of arthritis.  Treatment with polyclonal anti-HMGB-1 antibodies or the A-box protein was initiated at the onset of disease and was administered i.p. twice daily for 7 days.  Animals were killed 8 days after initiation of therapy, and immunohistochem. anal. of synovial tissue specimens was performed.  Results.  Systemic administration of anti-HMGB-1 antibodies or A-box protein significantly reduced the mean arthritis score, the disease-induced wt., loss, and the histol. severity of arthritis.  Beneficial effects were obsd. in both mice and rats.  Immunohistochem. anal. revealed pronounced synovial IL-1β expression and articular cartilage destruction in vehicle-treated mice.  Both these features were significantly less manifested in animals treated with anti-HMGB-1 antibodies or A-box protein.  Conclusion.  Counteracting extracellular HMGB-1 with either neutralizing antibodies or a specific HMGB-1 antagonist may offer a new method for the successful treatment of arthritis.  Inflammation and tissue destruction were suppressed in CIA after HMGB-1 blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfIAT8v8joerVg90H21EOLACvtfcHk0lghQjikRHyvoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFartbc%253D&md5=4fd1bb6ee45519a8687c6e7b19ef748a</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1002%2Fart.11161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.11161%26sid%3Dliteratum%253Aachs%26aulast%3DKokkola%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSundberg%26aufirst%3DE.%26aulast%3DAveberger%26aufirst%3DA.%2BC.%26aulast%3DPalmblad%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26atitle%3DSuccessful%2520treatment%2520of%2520collagen-induced%2520arthritis%2520in%2520mice%2520and%2520rats%2520by%2520targeting%2520extracellular%2520high%2520mobility%2520group%2520box%2520chromosomal%2520protein%25201%2520activity%26jtitle%3DArthritis%2520Rheum.%26date%3D2003%26volume%3D48%26issue%3D7%26spage%3D2052%26epage%3D2058%26doi%3D10.1002%2Fart.11161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susarla, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulloa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiRaimo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czura, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracey, K. J.</span></span> <span> </span><span class="NLM_article-title">Reversing established sepsis with antagonists of endogenous high-mobility group box 1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1073/pnas.2434651100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1073%2Fpnas.2434651100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=296-301&issue=1&author=H.+Yangauthor=M.+Ochaniauthor=J.+Liauthor=X.+Qiangauthor=M.+Tanovicauthor=H.+E.+Harrisauthor=S.+M.+Susarlaauthor=L.+Ulloaauthor=H.+Wangauthor=R.+DiRaimoauthor=C.+J.+Czuraauthor=H.+Wangauthor=J.+Rothauthor=H.+S.+Warrenauthor=M.+P.+Finkauthor=M.+J.+Fentonauthor=U.+Anderssonauthor=K.+J.+Tracey&title=Reversing+established+sepsis+with+antagonists+of+endogenous+high-mobility+group+box+1&doi=10.1073%2Fpnas.2434651100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2434651100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2434651100%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DOchani%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DQiang%26aufirst%3DX.%26aulast%3DTanovic%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26aulast%3DSusarla%26aufirst%3DS.%2BM.%26aulast%3DUlloa%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDiRaimo%26aufirst%3DR.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DWarren%26aufirst%3DH.%2BS.%26aulast%3DFink%26aufirst%3DM.%2BP.%26aulast%3DFenton%26aufirst%3DM.%2BJ.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DReversing%2520established%2520sepsis%2520with%2520antagonists%2520of%2520endogenous%2520high-mobility%2520group%2520box%25201%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D1%26spage%3D296%26epage%3D301%26doi%3D10.1073%2Fpnas.2434651100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logsdon, C. D.</span></span> <span> </span><span class="NLM_article-title">S100p-derived rage antagonistic peptide reduces tumor growth and metastasis</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">4356</span>– <span class="NLM_lpage">4364</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-0221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1158%2F1078-0432.CCR-12-0221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=22718861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ajs7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=4356-4364&issue=16&author=T.+Arumugamauthor=V.+Ramachandranauthor=S.+B.+Gomezauthor=A.+M.+Schmidtauthor=C.+D.+Logsdon&title=S100p-derived+rage+antagonistic+peptide+reduces+tumor+growth+and+metastasis&doi=10.1158%2F1078-0432.CCR-12-0221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis</span></div><div class="casAuthors">Arumugam, Thiruvengadam; Ramachandran, Vijaya; Gomez, Sobeyda B.; Schmidt, Ann M.; Logsdon, Craig D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4356-4364</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The receptor for advanced glycation end products (RAGE) contributes to multiple pathologies, including diabetes, arthritis, neurodegenerative diseases, and cancer.  Despite the obvious need, no RAGE inhibitors are in common clin. use.  Therefore, we developed a novel small RAGE antagonist peptide (RAP) that blocks activation by multiple ligands.  Exptl. Design: RAGE and its ligands were visualized by immunohistochem. anal. of human pancreatic tissues, and siRNA was used to analyze their functions.  Interactions between RAGE and S100P, S100A4, and HMGB-1 were measured by ELISA.  Three S100P-derived small antagonistic peptides were designed, synthesized, and tested for inhibition of RAGE binding.  The effects of the peptide blockers on NFκB-luciferase reporter activity was used to assess effects on RAGE-mediated signaling.  The most effective peptide was tested on glioma and pancreatic ductal adenocarcinoma (PDAC) models.  Results: Immunohistochem. anal. confirmed the expression of RAGE and its ligands S100P, S100A4, and HMGB-1 in human PDAC. siRNA silencing of RAGE or its ligands reduced the growth and migration of PDAC cells in vitro.  The most effective RAP inhibited the interaction of S100P, S100A4, and HMGB-1 with RAGE at micromolar concns.  RAP also reduced the ability of the ligands to stimulate RAGE activation of NFκB in cancer cells in vitro and in vivo.  Importantly, systemic in vivo administration of RAP reduced the growth and metastasis of pancreatic tumors and also inhibited glioma tumor growth.  Conclusion: RAP shows promise as a tool for the investigation of RAGE function and as an in vivo treatment for RAGE-related disorders.  Clin Cancer Res; 18(16); 4356-64. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjzKO-K6XacrVg90H21EOLACvtfcHk0liVs6Dh9lgmmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ajs7fJ&md5=2b4c38aa9ed0163c4c280035649662ee</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-0221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-0221%26sid%3Dliteratum%253Aachs%26aulast%3DArumugam%26aufirst%3DT.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DGomez%26aufirst%3DS.%2BB.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26aulast%3DLogsdon%26aufirst%3DC.%2BD.%26atitle%3DS100p-derived%2520rage%2520antagonistic%2520peptide%2520reduces%2520tumor%2520growth%2520and%2520metastasis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26issue%3D16%26spage%3D4356%26epage%3D4364%26doi%3D10.1158%2F1078-0432.CCR-12-0221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnay-Verdier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borde, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marechal, V.</span></span> <span> </span><span class="NLM_article-title">Pca-elisa: A sensitive method to quantify free and masked forms of hmgb1</span>. <i>Cytokine</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2011.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.cyto.2011.03.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=4-7&issue=1&author=S.+Barnay-Verdierauthor=C.+Gaillardauthor=M.+Messmerauthor=C.+Bordeauthor=S.+Gibotauthor=V.+Marechal&title=Pca-elisa%3A+A+sensitive+method+to+quantify+free+and+masked+forms+of+hmgb1&doi=10.1016%2Fj.cyto.2011.03.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2011.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2011.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DBarnay-Verdier%26aufirst%3DS.%26aulast%3DGaillard%26aufirst%3DC.%26aulast%3DMessmer%26aufirst%3DM.%26aulast%3DBorde%26aufirst%3DC.%26aulast%3DGibot%26aufirst%3DS.%26aulast%3DMarechal%26aufirst%3DV.%26atitle%3DPca-elisa%253A%2520A%2520sensitive%2520method%2520to%2520quantify%2520free%2520and%2520masked%2520forms%2520of%2520hmgb1%26jtitle%3DCytokine%26date%3D2011%26volume%3D55%26issue%3D1%26spage%3D4%26epage%3D7%26doi%3D10.1016%2Fj.cyto.2011.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathish, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfp235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1093%2Ftoxsci%2Fkfp235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=19783637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVajurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2009&pages=521-531&issue=2&author=D.+J.+Antoineauthor=D.+P.+Williamsauthor=A.+Kiparauthor=R.+E.+Jenkinsauthor=S.+L.+Reganauthor=J.+G.+Sathishauthor=N.+R.+Kitteringhamauthor=B.+K.+Park&title=High-mobility+group+box-1+protein+and+keratin-18%2C+circulating+serum+proteins+informative+of+acetaminophen-induced+necrosis+and+apoptosis+in+vivo&doi=10.1093%2Ftoxsci%2Fkfp235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">High-Mobility Group Box-1 Protein and Keratin-18, Circulating Serum Proteins Informative of Acetaminophen-Induced Necrosis and Apoptosis In Vivo</span></div><div class="casAuthors">Antoine, Daniel J.; Williams, Dominic P.; Kipar, Anja; Jenkins, Rosalind E.; Regan, Sophie L.; Sathish, Jean G.; Kitteringham, Neil R.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">521-531</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Drug-induced hepatotoxicity represents a major clin. problem and an impediment to new medicine development.  Serum biomarkers hold the potential to provide information about pathways leading to cellular responses within inaccessible tissues, which can inform the medicinal chemist and the clinician with respect to safe drug design and use.  Hepatocyte apoptosis, necrosis, and innate immune activation have been defined as features of the toxicol. response assocd. with the hepatotoxin acetaminophen (APAP).  Within this investigation, we have unambiguously identified and characterized by liq. chromatog.-tandem mass spectrometry differing circulating mol. forms of high-mobility group box-1 protein (HMGB1) and keratin-18 (K18), which are linked to the mechanisms and pathol. changes induced by APAP in the mouse.  Hypoacetylated HMGB1 (necrosis indicator), caspase-cleaved K18 (apoptosis indicator), and full-length K18 (necrosis indicator) present in serum showed strong correlations with the histol. time course of cell death and was more sensitive than alanine aminotransferase activity.  We have further identified a hyperacetylated form of HMGB1 (inflammatory indicator) in serum, which indicated that hepatotoxicity was assocd. with an inflammatory response.  The inhibition of APAP-induced apoptosis and K18 cleavage by the caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp(OMe) fluoromethyl ketone are assocd. with increased hepatic damage, by a shift to necrotic cell death only.  These findings illustrate the initial verification of K18 and HMGB1 mol. forms as serum-based sensitive tools that provide insights into the cellular dynamics involved in APAP hepatotoxicity within an inaccessible tissue.  Based on these findings, potential exists for the qualification and measurement of these proteins to further assist in vitro, in vivo, and clin. bridging in toxicol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSh9ZHuQzS8rVg90H21EOLACvtfcHk0ljjuK0WxIZxJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVajurzF&md5=c11e67157cd922ba4e46270cf20a57b4</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfp235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfp235%26sid%3Dliteratum%253Aachs%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DKipar%26aufirst%3DA.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DRegan%26aufirst%3DS.%2BL.%26aulast%3DSathish%26aufirst%3DJ.%2BG.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DHigh-mobility%2520group%2520box-1%2520protein%2520and%2520keratin-18%252C%2520circulating%2520serum%2520proteins%2520informative%2520of%2520acetaminophen-induced%2520necrosis%2520and%2520apoptosis%2520in%2520vivo%26jtitle%3DToxicol.%2520Sci.%26date%3D2009%26volume%3D112%26issue%3D2%26spage%3D521%26epage%3D531%26doi%3D10.1093%2Ftoxsci%2Fkfp235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. H.</span></span> <span> </span><span class="NLM_article-title">In vivo relative quantitative proteomics reveals hmgb1 as a downstream mediator of oestrogen-stimulated keratinocyte migration</span>. <i>Exp Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1111/exd.12713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1111%2Fexd.12713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25828589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVKhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=478-480&issue=6&author=J.+U.+Shinauthor=J.+Y.+Nohauthor=J.+H.+Leeauthor=W.+J.+Leeauthor=J.+S.+Yooauthor=J.+Y.+Kimauthor=H.+Kimauthor=I.+Jungauthor=S.+Jinauthor=K.+H.+Lee&title=In+vivo+relative+quantitative+proteomics+reveals+hmgb1+as+a+downstream+mediator+of+oestrogen-stimulated+keratinocyte+migration&doi=10.1111%2Fexd.12713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo relative quantitative proteomics reveals HMGB1 as a downstream mediator of oestrogen-stimulated keratinocyte migration</span></div><div class="casAuthors">Shin, Jung U.; Noh, Ji Yeon; Lee, Ju Hee; Lee, Won Jai; Yoo, Jong Shin; Kim, Jin Young; Kim, Hyeran; Jung, Inhee; Jin, Shan; Lee, Kwang Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Dermatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">478-480</span>CODEN:
                <span class="NLM_cas:coden">EXDEEY</span>;
        ISSN:<span class="NLM_cas:issn">1600-0625</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">It is known that estrogen influences skin wound healing by modulating the inflammatory response, cytokine expression and extracellular matrix deposition; accelerating re-epithelialization; and stimulating angiogenesis.  To identify novel proteins assocd. with effects of estrogen on keratinocyte, stable isotope labeling by amino acids in cell culture (SILAC)-based mass spectrometry was performed.  Using SILAC, quantification of 1085 proteins was achieved.  Among these proteins, 60 proteins were upregulated and 32 proteins were downregulated.  Among significantly upregulated proteins, high-mobility group protein B1 (HMGB1) has been further evaluated for its role in the effect of estrogen on keratinocytes.  HMGB1 expression was strongly induced in estrogen-treated keratinocytes in dose- and time-dependent manner.  Further, HMGB1 was able to significantly accelerate the rate of HaCaT cell migration.  To det. whether HMGB1 is involved in E2-induced HaCaT cell migration, cells were transfected with HMGB1 siRNA.  Knockdown of HMGB1 blocked estrogen-induced keratinocyte migration.  Collectively, these expts. demonstrate that HMGB1 is a novel downstream mediator of estrogen-stimulated keratinocyte migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK_mVNtbfqgLVg90H21EOLACvtfcHk0ljjuK0WxIZxJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVKhsrs%253D&md5=b80f2086b7c2d0b2d968c2fad66bb952</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1111%2Fexd.12713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fexd.12713%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%2BU.%26aulast%3DNoh%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DW.%2BJ.%26aulast%3DYoo%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DI.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DIn%2520vivo%2520relative%2520quantitative%2520proteomics%2520reveals%2520hmgb1%2520as%2520a%2520downstream%2520mediator%2520of%2520oestrogen-stimulated%2520keratinocyte%2520migration%26jtitle%3DExp%2520Dermatol.%26date%3D2015%26volume%3D24%26issue%3D6%26spage%3D478%26epage%3D480%26doi%3D10.1111%2Fexd.12713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stridh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevenvall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoine, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. E.</span></span> <span> </span><span class="NLM_article-title">Characterization of the inflammatory properties of actively released hmgb1 in juvenile idiopathic arthritis</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1089/ars.2014.6039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1089%2Fars.2014.6039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=25532033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A280%3ADC%252BC2MzovVOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=605-619&issue=12&author=P.+Lundbackauthor=P.+Stridhauthor=L.+Klevenvallauthor=R.+E.+Jenkinsauthor=M.+Fischerauthor=E.+Sundbergauthor=U.+Anderssonauthor=D.+J.+Antoineauthor=H.+E.+Harris&title=Characterization+of+the+inflammatory+properties+of+actively+released+hmgb1+in+juvenile+idiopathic+arthritis&doi=10.1089%2Fars.2014.6039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis</span></div><div class="casAuthors">Lundback Peter; Fischer Marie; Harris Helena Erlandsson; Stridh Pernilla; Klevenvall Lena; Sundberg Erik; Andersson Ulf; Jenkins Rosalind E; Antoine Daniel J</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & redox signaling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">605-19</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  Pathogenic effects of the endogenous inflammatory mediator high mobility group box protein 1 (HMGB1) have been described in several inflammatory diseases.  Recent reports have underlined the importance of post-translational modifications (PTMs) in determination of HMGB1 function and release mechanisms.  We investigated the occurrence of PTMs of HMGB1 obtained from synovial fluid (SF) of juvenile idiopathic arthritis (JIA) patients.  RESULTS:  Analyses of 17 JIA patients confirmed high HMGB1 levels in SF.  Liquid chromatography tandem mass-spectrometry (LC-MS/MS) analyses of PTMs revealed that total HMGB1 levels were not associated with increased lactate dehydrogenase activity but strongly correlated with nuclear location sequence 2 (NLS2) hyperacetylation, indicating active release of HMGB1.  The correlation between total HMGB1 levels and NLS2 hypoacetylation suggests additional, acetylation-independent release mechanisms.  Monomethylation of lysine 43 (K43), a proposed neutrophil-specific PTM, was strongly associated with high HMGB1 levels, implying that neutrophils are a source of released HMGB1.  Analysis of cysteine redox isoforms, fully reduced HMGB1, disulfide HMGB1, and oxidized HMGB1, revealed that HMGB1 acts as both a chemotactic and a cytokine-inducing mediator.  These properties were associated with actively released HMGB1.  INNOVATION:  This is the first report that characterizes HMGB1-specific PTMs during a chronic inflammatory condition.  CONCLUSION:  HMGB1 in SF from JIA patients is actively released through both acetylation-dependent and -nondependent manners.  The presence of various functional HMGB1 redox isoforms confirms the complexity of their pathogenic role during chronic inflammation.  Defining HMGB1 release pathways and redox isoforms is critical for the understanding of the contribution of HMGB1 during inflammatory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLpa4wiLjfD3T4ugvCDgnZfW6udTcc2eZz1hWnZUJ7HLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzovVOgtw%253D%253D&md5=88504385bb3b6972452bd022069a63de</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1089%2Fars.2014.6039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2014.6039%26sid%3Dliteratum%253Aachs%26aulast%3DLundback%26aufirst%3DP.%26aulast%3DStridh%26aufirst%3DP.%26aulast%3DKlevenvall%26aufirst%3DL.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DSundberg%26aufirst%3DE.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DHarris%26aufirst%3DH.%2BE.%26atitle%3DCharacterization%2520of%2520the%2520inflammatory%2520properties%2520of%2520actively%2520released%2520hmgb1%2520in%2520juvenile%2520idiopathic%2520arthritis%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2016%26volume%3D24%26issue%3D12%26spage%3D605%26epage%3D619%26doi%3D10.1089%2Fars.2014.6039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span> <span> </span><span class="NLM_article-title">Itraq-based quantitative proteomic analysis for identification of oligodendroglioma biomarkers related with loss of heterozygosity on chromosomal arm 1p</span>. <i>J. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1016/j.jprot.2012.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.jprot.2012.09.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=23041135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1aqsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=480-491&author=L.+S.+Yangauthor=X.+E.+Xuauthor=X.+P.+Liuauthor=H.+Jinauthor=Z.+Q.+Chenauthor=X.+H.+Liuauthor=Y.+Wangauthor=F.+P.+Huangauthor=Q.+Shi&title=Itraq-based+quantitative+proteomic+analysis+for+identification+of+oligodendroglioma+biomarkers+related+with+loss+of+heterozygosity+on+chromosomal+arm+1p&doi=10.1016%2Fj.jprot.2012.09.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">iTRAQ-based quantitative proteomic analysis for identification of oligodendroglioma biomarkers related with loss of heterozygosity on chromosomal arm 1p</span></div><div class="casAuthors">Yang, Liu-song; Xu, Xiao-en; Liu, Xiu-ping; Jin, Hong; Chen, Zhong-qing; Liu, Xiao-hui; Wang, Yin; Huang, Feng-ping; Shi, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteomics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">480-491</span>CODEN:
                <span class="NLM_cas:coden">JPORFQ</span>;
        ISSN:<span class="NLM_cas:issn">1874-3919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The oligodendroglioma (OG) type of glial cell tumors accounts for 2-5% of primary brain neoplasms and 4-15% of gliomas diagnosed worldwide.  Allelic losses on 1p, or on 1p and 19q, correlate with chemotherapy response and good prognosis in OG patients; however, the underlying mechanisms are not yet clearly defined.  Therefore, we utilized a quant. proteomics strategy that combined 8-plex isobaric tags for relative and abs. quantitation (iTRAQ) labeling and two-dimensional liq. chromatog.-tandem mass spectrometry (2D-LC/MS/MS) to identify mol. signatures, reveal mechanisms, and develop predictive markers of OG patients with 1p loss of heterozygosity (LOH).  An initial screening of four OG patients with 1p LOH and four without were identified, and 449 differentially expressed proteins were quantified, 13 of which were significantly different between the two groups.  Anal. of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway suggested that 1p LOH may affect the actin network in OG.  The differential expression of four of the 13 candidates (UBA1, ubiquitin-like modifier activating enzyme 1; ATP6V1E1, ATPase, H + transporting, lysosomal 31 kDa, V1 subunit E1; MAP2, microtubule-assocd. protein 2; and HMGB1, high-mobility group protein B1) was validated in 39 addnl. OG samples using immunohistochem.  Decision tree modeling indicated that MAP2 expression is a powerful predictor of 1p LOH.  Our results not only demonstrate the utility of iTRAQ-based high-throughput quant. proteomic anal. in glioma research, but also provide novel markers that may help to reveal the mechanisms of 1p LOH-assocd. chemosensitivity, and to design diagnostic and prognostic assays and therapeutics for OG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroklGFOCXFhbVg90H21EOLACvtfcHk0lj8o52vn3NEUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1aqsrjF&md5=383306601ff7a677b9681426f256d554</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.jprot.2012.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jprot.2012.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%2BS.%26aulast%3DXu%26aufirst%3DX.%2BE.%26aulast%3DLiu%26aufirst%3DX.%2BP.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%2BQ.%26aulast%3DLiu%26aufirst%3DX.%2BH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DF.%2BP.%26aulast%3DShi%26aufirst%3DQ.%26atitle%3DItraq-based%2520quantitative%2520proteomic%2520analysis%2520for%2520identification%2520of%2520oligodendroglioma%2520biomarkers%2520related%2520with%2520loss%2520of%2520heterozygosity%2520on%2520chromosomal%2520arm%25201p%26jtitle%3DJ.%2520Proteomics%26date%3D2012%26volume%3D77%26spage%3D480%26epage%3D491%26doi%3D10.1016%2Fj.jprot.2012.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spacil, Z.</span></span> <span> </span><span class="NLM_article-title">A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition</span>. <i>Anal. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>964</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.aca.2017.01.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1016%2Fj.aca.2017.01.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=28351641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisVejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=964&publication_year=2017&pages=7-23&author=V.+Vidovaauthor=Z.+Spacil&title=A+review+on+mass+spectrometry-based+quantitative+proteomics%3A+Targeted+and+data+independent+acquisition&doi=10.1016%2Fj.aca.2017.01.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition</span></div><div class="casAuthors">Vidova, Veronika; Spacil, Zdenek</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">964</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-23</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the mass spectrometry-based targeted quant. proteomics based on the selected reaction monitoring (SRM) technol., and applications of SRM in basic biol. research and clin. biomarker studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq0mZ1OtmMdLVg90H21EOLACvtfcHk0lg1AJ_mtIGHMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisVejsrY%253D&md5=6bf1234e5a4756bc4e466b458c70cfce</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.aca.2017.01.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.aca.2017.01.059%26sid%3Dliteratum%253Aachs%26aulast%3DVidova%26aufirst%3DV.%26aulast%3DSpacil%26aufirst%3DZ.%26atitle%3DA%2520review%2520on%2520mass%2520spectrometry-based%2520quantitative%2520proteomics%253A%2520Targeted%2520and%2520data%2520independent%2520acquisition%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2017%26volume%3D964%26spage%3D7%26epage%3D23%26doi%3D10.1016%2Fj.aca.2017.01.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trenchevska, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedelkov, D.</span></span> <span> </span><span class="NLM_article-title">Mass spectrometric immunoassays in characterization of clinically significant proteoforms</span>. <i>Proteomes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">13</span>, <span class="refDoi"> DOI: 10.3390/proteomes4010013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.3390%2Fproteomes4010013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=13&issue=1&author=O.+Trenchevskaauthor=R.+W.+Nelsonauthor=D.+Nedelkov&title=Mass+spectrometric+immunoassays+in+characterization+of+clinically+significant+proteoforms&doi=10.3390%2Fproteomes4010013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.3390%2Fproteomes4010013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fproteomes4010013%26sid%3Dliteratum%253Aachs%26aulast%3DTrenchevska%26aufirst%3DO.%26aulast%3DNelson%26aufirst%3DR.%2BW.%26aulast%3DNedelkov%26aufirst%3DD.%26atitle%3DMass%2520spectrometric%2520immunoassays%2520in%2520characterization%2520of%2520clinically%2520significant%2520proteoforms%26jtitle%3DProteomes%26date%3D2016%26volume%3D4%26issue%3D1%26spage%3D13%26doi%3D10.3390%2Fproteomes4010013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, N. L.</span></span> <span> </span><span class="NLM_article-title">The clinical plasma proteome: A survey of clinical assays for proteins in plasma and serum</span>. <i>Clin. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1373/clinchem.2009.126706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1373%2Fclinchem.2009.126706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=19884488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslaksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2010&pages=177-185&issue=2&author=N.+L.+Anderson&title=The+clinical+plasma+proteome%3A+A+survey+of+clinical+assays+for+proteins+in+plasma+and+serum&doi=10.1373%2Fclinchem.2009.126706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum</span></div><div class="casAuthors">Anderson, N. Leigh</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-185</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">A review presents the available data regarding the clin. assays for proteins in plasma and serum.  The diagnostic protein portfolio is growing much too slowly to meet important medical needs, which include tests for Alzheimer's disease, chronic obstructive pulmonary disease, any imminent cardiovascular event, occlusive vs hemorrhagic stroke, and most forms of cancer.  In reality, early detection of almost any serious disease constitutes a significant unmet need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjyfjJrtUDfbVg90H21EOLACvtfcHk0lg1AJ_mtIGHMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslaksL4%253D&md5=83ec455863e9bf5bb58db9dd57961a1b</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2009.126706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2009.126706%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DN.%2BL.%26atitle%3DThe%2520clinical%2520plasma%2520proteome%253A%2520A%2520survey%2520of%2520clinical%2520assays%2520for%2520proteins%2520in%2520plasma%2520and%2520serum%26jtitle%3DClin.%2520Chem.%26date%3D2010%26volume%3D56%26issue%3D2%26spage%3D177%26epage%3D185%26doi%3D10.1373%2Fclinchem.2009.126706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowell, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keil, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platts-Mills, T. F.</span></span> <span> </span><span class="NLM_article-title">Non-publication of large randomized clinical trials: Cross sectional analysis</span>. <i>BMJ.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">f6104</span>, <span class="refDoi"> DOI: 10.1136/bmj.f6104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1136%2Fbmj.f6104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=f6104&author=C.+W.+Jonesauthor=L.+Handlerauthor=K.+E.+Crowellauthor=L.+G.+Keilauthor=M.+A.+Weaverauthor=T.+F.+Platts-Mills&title=Non-publication+of+large+randomized+clinical+trials%3A+Cross+sectional+analysis&doi=10.1136%2Fbmj.f6104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1136%2Fbmj.f6104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.f6104%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BW.%26aulast%3DHandler%26aufirst%3DL.%26aulast%3DCrowell%26aufirst%3DK.%2BE.%26aulast%3DKeil%26aufirst%3DL.%2BG.%26aulast%3DWeaver%26aufirst%3DM.%2BA.%26aulast%3DPlatts-Mills%26aufirst%3DT.%2BF.%26atitle%3DNon-publication%2520of%2520large%2520randomized%2520clinical%2520trials%253A%2520Cross%2520sectional%2520analysis%26jtitle%3DBMJ.%26date%3D2013%26volume%3D347%26spage%3Df6104%26doi%3D10.1136%2Fbmj.f6104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumholz, H. M.</span></span> <span> </span><span class="NLM_article-title">Publication of nih funded trials registered in clinicaltrials.Gov: Cross sectional analysis</span>. <i>BMJ.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">d7292</span>, <span class="refDoi"> DOI: 10.1136/bmj.d7292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;key=10.1136%2Fbmj.d7292" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2011&pages=d7292&author=J.+S.+Rossauthor=T.+Tseauthor=D.+A.+Zarinauthor=H.+Xuauthor=L.+Zhouauthor=H.+M.+Krumholz&title=Publication+of+nih+funded+trials+registered+in+clinicaltrials.Gov%3A+Cross+sectional+analysis&doi=10.1136%2Fbmj.d7292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1136%2Fbmj.d7292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.d7292%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DJ.%2BS.%26aulast%3DTse%26aufirst%3DT.%26aulast%3DZarin%26aufirst%3DD.%2BA.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DKrumholz%26aufirst%3DH.%2BM.%26atitle%3DPublication%2520of%2520nih%2520funded%2520trials%2520registered%2520in%2520clinicaltrials.Gov%253A%2520Cross%2520sectional%2520analysis%26jtitle%3DBMJ.%26date%3D2011%26volume%3D344%26spage%3Dd7292%26doi%3D10.1136%2Fbmj.d7292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YRQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YRQ','PDB','2YRQ'); return false;">PDB: 2YRQ</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01136&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01136%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01136" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992fa52bbd3d60","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
